Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Araria,1.1,Total number of pregnant women Registered for ANC,TOTAL,8189.0,8225.0,8140.0,7251.0,7559.0,6960.0,5961.0,5580.0,4564.0,5265.0,6780.0,7155.0,81629.0
Araria,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4438.0,4482.0,3922.0,4312.0,4066.0,4104.0,3190.0,3258.0,2748.0,3066.0,3781.0,4237.0,45604.0
Araria,1.2,Number of Pregnant women registered under JSY,TOTAL,8189.0,8225.0,8093.0,7249.0,7541.0,6941.0,5938.0,5477.0,4564.0,5265.0,6773.0,7155.0,81410.0
Araria,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3663.0,3709.0,3678.0,4411.0,4411.0,4015.0,3762.0,3678.0,3239.0,3329.0,3580.0,3632.0,45107.0
Araria,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6620.0,6320.0,6096.0,5464.0,5643.0,5059.0,4293.0,3852.0,3285.0,3782.0,4881.0,4989.0,60284.0
Araria,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6176.0,6742.0,6953.0,6884.0,6649.0,6703.0,5573.0,5141.0,4292.0,4556.0,5348.0,6252.0,71269.0
Araria,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4974.0,6459.0,5409.0,4306.0,4456.0,4458.0,3108.0,3681.0,3559.0,3799.0,4820.0,5319.0,54348.0
Araria,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,256.0,384.0,222.0,80.0,174.0,51.0,105.0,124.0,17.0,161.0,99.0,65.0,1738.0
Araria,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,8.0,9.0,2.0,0.0,6.0,6.0,0.0,2.0,6.0,4.0,2.0,8.0,53.0
Araria,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,876.0,1451.0,1836.0,1715.0,1907.0,1830.0,1778.0,1081.0,1380.0,1286.0,1505.0,1397.0,18042.0
Araria,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,61.0,33.0,2.0,28.0,6.0,128.0,53.0,75.0,158.0,202.0,147.0,315.0,1208.0
Araria,1.8,Number of pregnancy test kits used at SC level,TOTAL,248.0,279.0,254.0,642.0,351.0,332.0,439.0,651.0,386.0,469.0,675.0,670.0,5396.0
Araria,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,223.0,207.0,45.0,77.0,75.0,97.0,155.0,119.0,107.0,168.0,195.0,71.0,1539.0
Araria,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1436.0,1497.0,1371.0,1284.0,1403.0,1922.0,1781.0,2206.0,1567.0,1694.0,1841.0,1516.0,19518.0
Araria,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1659.0,1704.0,1416.0,1361.0,1478.0,2019.0,1936.0,2325.0,1674.0,1862.0,2036.0,1587.0,21057.0
Araria,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,337.0,352.0,133.0,190.0,164.0,210.0,246.0,247.0,229.0,216.0,303.0,135.0,2762.0
Araria,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Araria,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3139.0,3046.0,2525.0,3715.0,4968.0,5472.0,5960.0,3761.0,3321.0,2662.0,2881.0,2636.0,44086.0
Araria,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3022.0,2942.0,2367.0,3365.0,4695.0,5148.0,5622.0,3425.0,3058.0,2427.0,2711.0,2412.0,41194.0
Araria,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,833.0,1636.0,133.0,1536.0,234.0,616.0,935.0,742.0,721.0,1490.0,1806.0,2068.0,12750.0
Araria,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,197.0,638.0,343.0,1198.0,743.0,415.0,875.0,510.0,121.0,538.0,985.0,1695.0,8258.0
Araria,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Araria,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Araria,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Araria,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Araria,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Araria,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,23.0,30.0,19.0,47.0,40.0,51.0,33.0,18.0,0.0,0.0,0.0,16.0,277.0
Araria,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Araria,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,23.0,31.0,19.0,47.0,41.0,52.0,33.0,18.0,0.0,0.0,0.0,16.0,280.0
Araria,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Araria,4.1.1.a,Number of male live births,TOTAL,2559.0,2426.0,1994.0,2631.0,3340.0,3787.0,4009.0,3047.0,2554.0,2275.0,2447.0,2202.0,33271.0
Araria,4.1.1.b,Number of female live births,TOTAL,2307.0,2256.0,1899.0,2379.0,3074.0,3608.0,3805.0,2967.0,2416.0,2178.0,2453.0,1988.0,31330.0
Araria,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4866.0,4682.0,3893.0,5010.0,6414.0,7395.0,7814.0,6014.0,4970.0,4453.0,4900.0,4190.0,64601.0
Araria,4.1.2,Number of still births,TOTAL,70.0,92.0,76.0,97.0,93.0,129.0,135.0,80.0,56.0,60.0,52.0,64.0,1004.0
Araria,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,5.0,2.0,4.0,6.0,10.0,6.0,7.0,3.0,4.0,10.0,7.0,7.0,71.0
Araria,4.2.1,Number of Newborns weighed at birth,TOTAL,4665.0,4599.0,3777.0,4938.0,6343.0,7271.0,7642.0,5818.0,4816.0,4352.0,4758.0,4118.0,63097.0
Araria,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,627.0,726.0,488.0,630.0,814.0,1187.0,1462.0,818.0,731.0,581.0,573.0,510.0,9147.0
Araria,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3509.0,4585.0,3760.0,4915.0,6306.0,7263.0,7640.0,5851.0,4861.0,4386.0,4797.0,4186.0,62059.0
Araria,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,15.0,17.0,6.0,16.0,118.0,15.0,16.0,0.0,15.0,19.0,36.0,23.0,296.0
Araria,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,22.0,48.0,17.0,22.0,31.0,12.0,22.0,23.0,42.0,15.0,17.0,19.0,290.0
Araria,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,58.0,115.0,99.0,123.0,210.0,126.0,129.0,42.0,68.0,31.0,0.0,23.0,1024.0
Araria,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Araria,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,95.0,180.0,122.0,161.0,359.0,153.0,167.0,65.0,125.0,65.0,53.0,65.0,1610.0
Araria,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Araria,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1081.0,1207.0,1083.0,1627.0,2270.0,851.0,1548.0,969.0,1100.0,645.0,781.0,1717.0,14879.0
Araria,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,7.0,2.0,3.0,5.0,3.0,6.0,11.0,7.0,8.0,46.0,26.0,75.0,199.0
Araria,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1506.0,1282.0,1101.0,1507.0,1798.0,1878.0,184.0,659.0,682.0,283.0,301.0,1322.0,12503.0
Araria,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,60.0,62.0,55.0,55.0,53.0,52.0,48.0,42.0,36.0,31.0,26.0,50.0,570.0
Araria,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2308.0,2022.0,1711.0,2255.0,3513.0,3291.0,5581.0,3795.0,2035.0,2760.0,1422.0,2601.0,33294.0
Araria,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1521.0,1566.0,1118.0,1281.0,1369.0,1791.0,1713.0,2049.0,1313.0,1385.0,1795.0,1071.0,17972.0
Araria,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,5.0,4.0,0.0,5.0,6.0,4.0,0.0,11.0,35.0
Araria,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Araria,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,38.0,60.0,55.0,81.0,3.0,26.0,28.0,37.0,34.0,28.0,28.0,418.0
Araria,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,646.0,478.0,494.0,560.0,538.0,44.0,489.0,534.0,463.0,566.0,474.0,504.0,5790.0
Araria,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,646.0,516.0,554.0,615.0,619.0,47.0,515.0,562.0,500.0,600.0,502.0,532.0,6208.0
Araria,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,32.0,24.0,90.0,98.0,0.0,0.0,0.0,0.0,0.0,328.0,324.0,134.0,1030.0
Araria,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Araria,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Araria,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Araria,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Araria,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Araria,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Araria,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,191.0,0.0,0.0,0.0,191.0
Araria,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,3.0,0.0,23.0,6.0,0.0,0.0,0.0,111.0,,23.0,0.0,166.0
Araria,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Araria,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,3.0,0.0,23.0,6.0,0.0,0.0,0.0,302.0,0.0,23.0,0.0,357.0
Araria,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Araria,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,9.0,9.0,2.0,182.0,114.0,175.0,52.0,260.0,328.0,640.0,266.0,196.0,2233.0
Araria,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,4.0,0.0,0.0,33.0,0.0,10.0,23.0,99.0,327.0,330.0,160.0,123.0,1109.0
Araria,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,50.0,31.0,22.0,111.0,91.0,126.0,89.0,201.0,100.0,789.0,320.0,283.0,2213.0
Araria,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Araria,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,63.0,40.0,24.0,326.0,205.0,311.0,164.0,560.0,755.0,1759.0,746.0,602.0,5555.0
Araria,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Araria,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,39.0,0.0,0.0,0.0,0.0,39.0
Araria,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,6.0,6.0,0.0,0.0,0.0,,0.0,0.0,12.0
Araria,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,0.0,0.0,62.0,41.0,19.0,0.0,0.0,0.0,0.0,320.0,0.0,444.0
Araria,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Araria,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,0.0,0.0,62.0,47.0,25.0,0.0,39.0,0.0,0.0,320.0,0.0,495.0
Araria,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Araria,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,189.0,149.0,159.0,408.0,176.0,176.0,120.0,171.0,179.0,157.0,207.0,144.0,2235.0
Araria,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,44.0,35.0,46.0,126.0,69.0,31.0,29.0,37.0,32.0,18.0,13.0,10.0,490.0
Araria,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,20.0,25.0,11.0,639.0,14.0,8.0,16.0,,20.0,,13.0,1.0,767.0
Araria,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,14.0,3.0,13.0,68.0,14.0,16.0,11.0,5.0,67.0,9.0,6.0,9.0,235.0
Araria,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Araria,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,267.0,212.0,229.0,1241.0,273.0,231.0,176.0,213.0,298.0,184.0,239.0,164.0,3727.0
Araria,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,156.0,85.0,52.0,128.0,179.0,195.0,193.0,329.0,176.0,203.0,140.0,133.0,1969.0
Araria,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Araria,9.06,Number of IUCD removals,TOTAL,160.0,175.0,131.0,201.0,191.0,216.0,172.0,103.0,202.0,125.0,108.0,95.0,1879.0
Araria,9.07,Number of Oral Pills cycles distributed,TOTAL,2167.0,3022.0,2337.0,5244.0,2404.0,2256.0,2254.0,2278.0,2297.0,1946.0,2079.0,2210.0,30494.0
Araria,9.08,Number of Condom pieces distributed,TOTAL,11321.0,14064.0,11447.0,17555.0,15410.0,16501.0,12586.0,16754.0,11004.0,11336.0,12946.0,13500.0,164424.0
Araria,9.09,Number of Centchroman (weekly) pills given,TOTAL,65.0,110.0,212.0,33.0,46.0,27.0,272.0,40.0,0.0,39.0,97.0,25.0,966.0
Araria,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,295.0,103.0,190.0,797.0,289.0,479.0,330.0,422.0,556.0,414.0,512.0,580.0,4967.0
Araria,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,6.0,0.0,0.0,7.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,15.0
Araria,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,3.0
Araria,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,3.0
Araria,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Araria,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5868.0,8357.0,5198.0,6188.0,7529.0,8745.0,8704.0,7528.0,5986.0,6075.0,6345.0,5360.0,81883.0
Araria,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,6825.0,5943.0,5600.0,5805.0,5606.0,6210.0,6708.0,9125.0,7472.0,1842.0,20.0,0.0,61156.0
Araria,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,7580.0,7138.0,6053.0,6113.0,5980.0,5967.0,5342.0,6725.0,7102.0,7844.0,4225.0,1675.0,71744.0
Araria,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,7205.0,7233.0,6644.0,6296.0,5946.0,6052.0,5459.0,5744.0,5283.0,7686.0,7125.0,4731.0,75404.0
Araria,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,5.0,5781.0,7621.0,6225.0,19634.0
Araria,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3795.0,5694.0,9489.0
Araria,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,84.0,2733.0,2817.0
Araria,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4288.0,3820.0,3197.0,4363.0,5302.0,6011.0,6445.0,4081.0,3899.0,2948.0,3172.0,2889.0,50415.0
Araria,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,6614.0,5791.0,5584.0,5805.0,5189.0,6219.0,6476.0,7158.0,7349.0,6610.0,7419.0,6278.0,76492.0
Araria,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7315.0,6860.0,6085.0,6104.0,5483.0,5972.0,5173.0,5257.0,6684.0,6976.0,7223.0,7183.0,76315.0
Araria,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6958.0,6957.0,6500.0,6308.0,5468.0,6060.0,5278.0,4482.0,5031.0,6088.0,6681.0,7158.0,72969.0
Araria,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3133.0,2915.0,2349.0,3570.0,4750.0,5078.0,5530.0,3393.0,2769.0,2401.0,2582.0,2386.0,40856.0
Araria,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,6656.0,5857.0,5514.0,5750.0,5442.0,6143.0,6675.0,9143.0,7380.0,1365.0,45.0,13.0,59983.0
Araria,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7404.0,6997.0,5932.0,6054.0,5815.0,5902.0,5318.0,6714.0,7067.0,7704.0,4300.0,1889.0,71096.0
Araria,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,7049.0,7045.0,6552.0,6246.0,5801.0,5979.0,5438.0,5681.0,5269.0,6957.0,6921.0,5003.0,73941.0
Araria,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5252.0,5983.0,6055.0,6721.0,6886.0,7346.0,6279.0,6379.0,4826.0,5297.0,5709.0,5220.0,71953.0
Araria,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3231.0,2774.0,2891.0,3173.0,3453.0,4051.0,3587.0,3726.0,3361.0,3804.0,5173.0,5016.0,44240.0
Araria,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,647.0,10.0,1150.0,1839.0,5687.0,6467.0,4548.0,5097.0,3482.0,4110.0,5683.0,5123.0,43843.0
Araria,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2606.0,2946.0,3018.0,3311.0,3426.0,3573.0,2925.0,3046.0,2186.0,2410.0,2617.0,2468.0,34532.0
Araria,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2308.0,2787.0,2691.0,2973.0,3032.0,3333.0,2746.0,2683.0,2169.0,2280.0,2352.0,2193.0,31547.0
Araria,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4914.0,5733.0,5709.0,6284.0,6458.0,6906.0,5671.0,5729.0,4355.0,4690.0,4969.0,4661.0,66079.0
Araria,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4465.0,4308.0,4158.0,3991.0,3847.0,4085.0,3622.0,3675.0,3345.0,4095.0,5311.0,4984.0,49886.0
Araria,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4475.0,4194.0,4126.0,3981.0,3652.0,4074.0,3562.0,3156.0,3226.0,3821.0,5060.0,4930.0,48257.0
Araria,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,11.0,104.0,0.0,0.0,0.0,0.0,47.0,0.0,23.0,0.0,0.0,185.0
Araria,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1071.0,815.0,975.0,867.0,838.0,724.0,563.0,730.0,638.0,791.0,823.0,743.0,9578.0
Araria,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,944.0,715.0,909.0,791.0,756.0,702.0,526.0,637.0,565.0,753.0,773.0,738.0,8809.0
Araria,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2015.0,1530.0,1884.0,1658.0,1594.0,1426.0,1089.0,1367.0,1203.0,1544.0,1596.0,1481.0,18387.0
Araria,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,44.0,80.0,74.0,0.0,33.0,267.0,232.0,205.0,217.0,228.0,274.0,239.0,1893.0
Araria,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,813.0,962.0,942.0,1051.0,1017.0,903.0,863.0,911.0,787.0,879.0,885.0,790.0,10803.0
Araria,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1687.0,1886.0,1626.0,1982.0,1805.0,1594.0,1612.0,1860.0,1558.0,1700.0,1864.0,1674.0,20848.0
Araria,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,17.0
Araria,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,3.0,6.0,1.0,0.0,0.0,0.0,10.0
Araria,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,13.0,0.0,45.0,10.0,36.0,95.0,35.0,50.0,45.0,38.0,367.0
Araria,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2583.0,2591.0,2575.0,2693.0,2559.0,2643.0,2645.0,2647.0,2213.0,2551.0,2617.0,2667.0,30984.0
Araria,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2448.0,2486.0,2435.0,2514.0,2416.0,2481.0,2432.0,2513.0,2075.0,2339.0,2483.0,2422.0,29044.0
Araria,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2008.0,2001.0,2058.0,2143.0,2080.0,2126.0,2098.0,2167.0,1803.0,1987.0,2148.0,2015.0,24634.0
Araria,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1170.0,8.0,928.0,473.0,2313.0,3009.0,2422.0,2813.0,2421.0,3065.0,5195.0,4953.0,28770.0
Araria,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4094.0,4897.0,4866.0,5384.0,5932.0,6573.0,5811.0,5730.0,4247.0,4823.0,4973.0,4512.0,61842.0
Araria,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,512.0,455.0,823.0,669.0,670.0,828.0,898.0,968.0,1067.0,1058.0,1044.0,1147.0,10139.0
Araria,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,113.0,65.0,85.0,118.0,54.0,86.0,78.0,62.0,67.0,95.0,93.0,24.0,940.0
Araria,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Araria,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,37.0,51.0,16.0,1.0,26.0,6.0,9.0,91.0,48.0,10.0,10.0,25.0,330.0
Araria,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,263.0,240.0,382.0,435.0,779.0,757.0,777.0,1138.0,1282.0,1202.0,1169.0,1220.0,9644.0
Araria,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,1.0,7.0,49.0,30.0,12.0,14.0,11.0,21.0,47.0,9.0,7.0,210.0
Araria,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,18.0,14.0,10.0,0.0,2.0,0.0,0.0,44.0
Araria,13.1,Number of Patients operated for cataract,TOTAL,2.0,8.0,2.0,0.0,16.0,10.0,7.0,69.0,5.0,88.0,42.0,96.0,345.0
Araria,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,8.0,2.0,0.0,16.0,10.0,7.0,69.0,5.0,88.0,42.0,96.0,343.0
Araria,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,30.0,98.0,0.0,300.0,0.0,0.0,0.0,0.0,10.0,438.0
Araria,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,30.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,46.0
Araria,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Araria,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Araria,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1958.0,2006.0,1943.0,2080.0,1913.0,1919.0,1922.0,1940.0,1660.0,1827.0,1747.0,1882.0,-1.0
Araria,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Araria,14.05,Number of RKS meetings held during the month,TOTAL,6.0,9.0,5.0,5.0,8.0,4.0,6.0,7.0,4.0,4.0,5.0,6.0,69.0
Araria,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Araria,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,405.0,483.0,277.0,479.0,679.0,796.0,1195.0,788.0,887.0,785.0,964.0,1102.0,8840.0
Araria,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Araria,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,4.0,4.0,4.0,,,,,,-1.0
Araria,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,513.0,481.0,336.0,367.0,265.0,270.0,321.0,243.0,78.0,125.0,109.0,362.0,3470.0
Araria,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,908.0,931.0,813.0,675.0,728.0,508.0,572.0,266.0,367.0,249.0,388.0,641.0,7046.0
Araria,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,778.0,506.0,744.0,749.0,517.0,571.0,694.0,877.0,380.0,2006.0,1464.0,449.0,9735.0
Araria,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2978.0,2740.0,2470.0,3578.0,4658.0,5045.0,5388.0,2966.0,3296.0,1652.0,1873.0,2346.0,38990.0
Araria,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1291.0,987.0,1080.0,1116.0,782.0,841.0,1015.0,1120.0,458.0,2131.0,1573.0,811.0,13205.0
Araria,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3886.0,3671.0,3283.0,4253.0,5386.0,5553.0,5960.0,3232.0,3663.0,1901.0,2261.0,2987.0,46036.0
Araria,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,2.0,8.0,4.0,8.0,7.0,2.0,4.0,0.0,2.0,3.0,6.0,49.0
Araria,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,2.0,2.0,2.0,5.0,2.0,5.0,5.0,0.0,2.0,1.0,9.0,37.0
Araria,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,5.0,4.0,10.0,6.0,13.0,9.0,7.0,9.0,0.0,4.0,4.0,15.0,86.0
Araria,14.11,In-Patient Head Count at midnight,TOTAL,4664.0,4780.0,4211.0,5166.0,6153.0,6482.0,6455.0,4538.0,4527.0,3711.0,4191.0,3484.0,58362.0
Araria,14.12.1,OPD attendance (All),TOTAL,112061.0,114131.0,117585.0,145259.0,140804.0,145594.0,131843.0,102209.0,92494.0,92080.0,112388.0,118284.0,1424732.0
Araria,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,80.0,69.0,45.0,260.0,241.0,336.0,187.0,566.0,680.0,1429.0,812.0,541.0,5246.0
Araria,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,693.0,2.0,3.0,168.0,1.0,0.0,0.0,0.0,0.0,0.0,213.0,1.0,1081.0
Araria,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,946.0,2062.0,1534.0,2281.0,2456.0,2071.0,1991.0,1981.0,1306.0,1570.0,1244.0,1224.0,20666.0
Araria,14.14.a,Number of patients given AYUSH treatment,TOTAL,16177.0,16470.0,14392.0,21495.0,19032.0,23354.0,20581.0,14186.0,9484.0,15051.0,18180.0,17029.0,205431.0
Araria,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2730.0,2072.0,1674.0,1611.0,1829.0,1826.0,1360.0,1664.0,1308.0,1067.0,1090.0,1295.0,19526.0
Araria,14.14.c,Number of Adolescents counselled,TOTAL,621.0,0.0,0.0,0.0,21.0,37.0,6.0,0.0,0.0,0.0,0.0,0.0,685.0
Araria,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1535.0,1214.0,767.0,1010.0,1905.0,3372.0,3024.0,1968.0,2490.0,2452.0,2779.0,3311.0,25827.0
Araria,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,80.0,49.0,36.0,31.0,58.0,84.0,608.0,78.0,168.0,287.0,149.0,331.0,1959.0
Araria,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,564.0,685.0,561.0,704.0,969.0,700.0,544.0,781.0,951.0,750.0,382.0,358.0,7949.0
Araria,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,3.0,3.0,4.0,4.0,0.0,5.0,2.0,3.0,0.0,0.0,3.0,31.0
Araria,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,812.0,772.0,658.0,698.0,959.0,844.0,582.0,581.0,904.0,959.0,689.0,631.0,9089.0
Araria,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,0.0,1.0,1.0,3.0,2.0,4.0,2.0,1.0,0.0,0.0,1.0,19.0
Araria,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,893.0,988.0,795.0,1602.0,2212.0,2360.0,1349.0,974.0,1348.0,1356.0,1251.0,1541.0,16669.0
Araria,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Araria,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2269.0,2445.0,2014.0,3004.0,4140.0,3904.0,2475.0,2336.0,3203.0,3065.0,2322.0,2530.0,33707.0
Araria,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,3.0,4.0,5.0,7.0,3.0,10.0,4.0,4.0,0.0,0.0,4.0,52.0
Araria,15.2,Number of Widal tests conducted,Number tested,610.0,64.0,90.0,157.0,234.0,88.0,511.0,226.0,346.0,438.0,344.0,166.0,3274.0
Araria,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,1.0,0.0,10.0,4.0,1.0,14.0,1.0,69.0,3.0,103.0
Araria,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,66.0,17.0,6.0,63.0,66.0,100.0,60.0,378.0
Araria,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,150.0,155.0,142.0,2.0,2.0,45.0,46.0,26.0,274.0,23.0,122.0,26.0,1013.0
Araria,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,150.0,155.0,142.0,3.0,2.0,121.0,67.0,33.0,351.0,90.0,291.0,89.0,1494.0
Araria,15.4.1,Number of blood smears examined for Malaria,TOTAL,45.0,197.0,91.0,174.0,352.0,332.0,491.0,306.0,185.0,190.0,226.0,208.0,2797.0
Araria,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,2.0,0.0,12.0,10.0,4.0,3.0,2.0,1.0,1.0,0.0,35.0
Araria,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,6.0
Araria,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,550.0,1550.0,2550.0,,1450.0,2550.0,3250.0,,,,,,11900.0
Araria,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4750.0,4024.0,1000.0,,5750.0,3000.0,3000.0,,,,,,21524.0
Araria,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,,,,,,0.0
Araria,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3750.0,3024.0,2100.0,,4650.0,2300.0,3000.0,,,,,,18824.0
Araria,16.1.1,Stock position of DPT vaccines,5. Total Stock,1550.0,2550.0,1450.0,0.0,2550.0,3250.0,3250.0,0.0,0.0,0.0,0.0,0.0,14600.0
Araria,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Araria,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Araria,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Araria,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,700.0,700.0,1050.0,,225.0,350.0,500.0,,,,,,3525.0
Araria,16.1.2,Stock position of OPV vaccines,2. Stocks Received,3000.0,2200.0,1000.0,,2750.0,2500.0,1500.0,,,,,,12950.0
Araria,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,,,,,,0.0
Araria,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,1850.0,1825.0,,2625.0,2350.0,1825.0,,,,,,10475.0
Araria,16.1.2,Stock position of OPV vaccines,5. Total Stock,3700.0,1050.0,225.0,0.0,350.0,500.0,175.0,0.0,0.0,0.0,0.0,0.0,6000.0
Araria,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,350.0,1600.0,1750.0,,700.0,1550.0,1300.0,,,,,,7250.0
Araria,16.1.3,Stock position of TT vaccines,2. Stocks Received,,2400.0,500.0,,4500.0,2000.0,2000.0,,,,,,11400.0
Araria,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,0.0,0.0,,,0.0,0.0,,,,,,0.0
Araria,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2250.0,2250.0,1550.0,,3650.0,2250.0,1350.0,,,,,,13300.0
Araria,16.1.3,Stock position of TT vaccines,5. Total Stock,-1900.0,1750.0,700.0,0.0,1550.0,1300.0,1950.0,0.0,0.0,0.0,0.0,0.0,5350.0
Araria,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Araria,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Araria,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Araria,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Araria,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,750.0,850.0,,250.0,200.0,300.0,,,,,,2350.0
Araria,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,1800.0,1000.0,,2100.0,2000.0,1400.0,,,,,,8300.0
Araria,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,0.0,0.0,,,0.0,0.0,,,,,,0.0
Araria,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,1700.0,1600.0,,2150.0,1900.0,1550.0,,,,,,8900.0
Araria,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,850.0,250.0,0.0,200.0,300.0,150.0,0.0,0.0,0.0,0.0,0.0,1750.0
Araria,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,100.0,1200.0,1175.0,,50.0,1250.0,1200.0,,,,,,4975.0
Araria,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,2500.0,1000.0,,5700.0,2700.0,3000.0,,,,,,14900.0
Araria,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,,,,,,0.0
Araria,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2900.0,2525.0,2125.0,,4500.0,2750.0,3350.0,,,,,,18150.0
Araria,16.1.6,Stock position of Measles vaccines,5. Total Stock,-2800.0,1175.0,50.0,0.0,1250.0,1200.0,850.0,0.0,0.0,0.0,0.0,0.0,1725.0
Araria,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,923.0,0.0,0.0,,0.0,400.0,350.0,,,,,,1673.0
Araria,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,2260.0,,8000.0,0.0,2500.0,,,,,,12760.0
Araria,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,,,,,,0.0
Araria,16.1.7,Stock position of JE vaccines,4. Stock Distributed,923.0,0.0,2260.0,,7600.0,50.0,1950.0,,,,,,12783.0
Araria,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,400.0,350.0,900.0,0.0,0.0,0.0,0.0,0.0,1650.0
Araria,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,100.0,1330.0,2480.0,,1380.0,930.0,1720.0,,,,,,7940.0
Araria,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,4000.0,800.0,,3600.0,2800.0,2507.0,,,,,,13707.0
Araria,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,,,,,,0.0
Araria,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3220.0,2850.0,1900.0,,4050.0,2010.0,2290.0,,,,,,16320.0
Araria,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,-3120.0,2480.0,1380.0,0.0,930.0,1720.0,1937.0,0.0,0.0,0.0,0.0,0.0,5327.0
Araria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Araria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Araria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Araria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Araria,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Araria,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Araria,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Araria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Araria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Araria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Araria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Araria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Araria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Araria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Araria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Araria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Araria,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Araria,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Araria,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Araria,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Araria,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1700.0,4800.0,16300.0,,9400.0,11900.0,11400.0,,,,,,55500.0
Araria,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,20000.0,0.0,,10000.0,10000.0,8000.0,,,,,,48000.0
Araria,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,,,,,,0.0
Araria,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,11900.0,8500.0,6900.0,,7500.0,10500.0,12500.0,,,,,,57800.0
Araria,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,-10200.0,16300.0,9400.0,0.0,11900.0,11400.0,6900.0,0.0,0.0,0.0,0.0,0.0,45700.0
Araria,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,75287.0,6487.0,487.0,,32487.0,8000.0,19800.0,,,,,,142548.0
Araria,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,100000.0,,57600.0,102400.0,100000.0,,,,,,360000.0
Araria,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,,,,,,0.0
Araria,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,68800.0,6000.0,68000.0,,82087.0,90600.0,108000.0,,,,,,423487.0
Araria,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6487.0,487.0,32487.0,0.0,8000.0,19800.0,11800.0,0.0,0.0,0.0,0.0,0.0,79061.0
Araria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,41037.0,37537.0,,31037.0,26037.0,20537.0,,,,,,156185.0
Araria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,,,,,,0.0
Araria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,,,,,,0.0
Araria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3600.0,3500.0,6500.0,,4500.0,5500.0,8600.0,,,,,,32200.0
Araria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,-3600.0,37537.0,31037.0,0.0,26537.0,20537.0,11937.0,0.0,0.0,0.0,0.0,0.0,123985.0
Araria,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Araria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Araria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Araria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Araria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Araria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Araria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Araria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Araria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Araria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Araria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Araria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Araria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Araria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Araria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Araria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Araria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Araria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Araria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Araria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Araria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Araria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Araria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Araria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Araria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Araria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Araria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Araria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Araria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Araria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Araria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Araria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Araria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Araria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Araria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Araria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Araria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Araria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Araria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Araria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Araria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Araria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Araria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Araria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Araria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Araria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Araria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Araria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Araria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Araria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Araria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Araria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Araria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Araria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Araria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Araria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Araria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Araria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Araria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Araria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Araria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Araria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Araria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Arwal,1.1,Total number of pregnant women Registered for ANC,TOTAL,1624.0,1476.0,1660.0,1599.0,1475.0,1234.0,971.0,971.0,902.0,1074.0,1201.0,1454.0,15641.0
Arwal,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1153.0,1062.0,1127.0,1118.0,1015.0,839.0,747.0,641.0,628.0,676.0,895.0,900.0,10801.0
Arwal,1.2,Number of Pregnant women registered under JSY,TOTAL,1613.0,1469.0,1660.0,1560.0,1475.0,1234.0,971.0,971.0,902.0,1074.0,1201.0,1454.0,15584.0
Arwal,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,997.0,951.0,1017.0,1177.0,1086.0,1073.0,963.0,934.0,820.0,772.0,814.0,946.0,11550.0
Arwal,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1023.0,916.0,994.0,981.0,876.0,745.0,707.0,605.0,569.0,652.0,764.0,875.0,9707.0
Arwal,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1380.0,1432.0,1597.0,1554.0,1438.0,1242.0,1064.0,946.0,922.0,965.0,964.0,1359.0,14863.0
Arwal,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,575.0,741.0,999.0,1149.0,1117.0,978.0,915.0,893.0,851.0,839.0,814.0,950.0,10821.0
Arwal,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,11.0,,20.0,39.0
Arwal,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,8.0,19.0,33.0,8.0,10.0,0.0,10.0,0.0,2.0,14.0,12.0,2.0,118.0
Arwal,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Arwal,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,4.0,0.0,,23.0,27.0
Arwal,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,38.0,20.0,45.0,27.0,45.0,70.0,66.0,57.0,80.0,23.0,28.0,22.0,521.0
Arwal,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,66.0,66.0,61.0,93.0,138.0,175.0,149.0,230.0,162.0,187.0,157.0,124.0,1608.0
Arwal,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,104.0,86.0,106.0,120.0,183.0,245.0,215.0,287.0,242.0,210.0,185.0,146.0,2129.0
Arwal,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,50.0,54.0,58.0,35.0,43.0,56.0,82.0,90.0,94.0,100.0,80.0,75.0,817.0
Arwal,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,7.0,4.0,,,11.0,,,22.0
Arwal,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,503.0,612.0,503.0,744.0,926.0,961.0,1067.0,1001.0,916.0,806.0,655.0,558.0,9252.0
Arwal,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,503.0,558.0,411.0,724.0,926.0,961.0,1059.0,1001.0,808.0,785.0,655.0,558.0,8949.0
Arwal,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,217.0,95.0,301.0,410.0,286.0,308.0,247.0,565.0,2322.0,724.0,1404.0,6879.0
Arwal,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,190.0,134.0,87.0,182.0,261.0,416.0,92.0,1380.0,545.0,989.0,4276.0
Arwal,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Arwal,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Arwal,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Arwal,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Arwal,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Arwal,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,2.0,2.0,1.0,1.0,2.0,2.0,1.0,1.0,9.0,4.0,9.0,6.0,40.0
Arwal,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Arwal,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,2.0,2.0,1.0,1.0,2.0,2.0,1.0,1.0,9.0,4.0,9.0,6.0,40.0
Arwal,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Arwal,4.1.1.a,Number of male live births,TOTAL,296.0,367.0,322.0,433.0,586.0,614.0,627.0,667.0,593.0,513.0,423.0,348.0,5789.0
Arwal,4.1.1.b,Number of female live births,TOTAL,301.0,322.0,276.0,408.0,519.0,565.0,649.0,614.0,562.0,485.0,406.0,332.0,5439.0
Arwal,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,597.0,689.0,598.0,841.0,1105.0,1179.0,1276.0,1281.0,1155.0,998.0,829.0,680.0,11228.0
Arwal,4.1.2,Number of still births,TOTAL,10.0,9.0,11.0,22.0,18.0,29.0,24.0,15.0,17.0,25.0,13.0,15.0,208.0
Arwal,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,2.0,2.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,3.0,1.0,2.0,13.0
Arwal,4.2.1,Number of Newborns weighed at birth,TOTAL,535.0,650.0,536.0,781.0,952.0,1032.0,1148.0,1268.0,1124.0,989.0,804.0,660.0,10479.0
Arwal,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,40.0,50.0,15.0,24.0,67.0,44.0,59.0,88.0,39.0,43.0,15.0,18.0,502.0
Arwal,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,571.0,658.0,545.0,809.0,783.0,1104.0,1179.0,1271.0,1159.0,997.0,822.0,680.0,10578.0
Arwal,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,144.0,2.0,9.0,12.0,0.0,240.0,9.0,23.0,84.0,8.0,38.0,138.0,707.0
Arwal,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Arwal,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,144.0,169.0,157.0,164.0,241.0,274.0,297.0,259.0,241.0,220.0,205.0,169.0,2540.0
Arwal,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Arwal,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,288.0,171.0,166.0,176.0,241.0,514.0,306.0,282.0,325.0,228.0,243.0,307.0,3247.0
Arwal,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,0.0,0.0,0.0,,,,,,,,,0.0
Arwal,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,168.0,110.0,85.0,377.0,165.0,193.0,246.0,376.0,301.0,50.0,47.0,151.0,2269.0
Arwal,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,142.0,49.0,37.0,151.0,113.0,110.0,165.0,209.0,213.0,8.0,9.0,7.0,1213.0
Arwal,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,248.0,169.0,166.0,327.0,180.0,274.0,306.0,290.0,325.0,228.0,243.0,328.0,3084.0
Arwal,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,0.0,0.0,0.0,,0.0,,,,,,0.0,0.0
Arwal,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,318.0,372.0,421.0,389.0,518.0,540.0,540.0,633.0,471.0,400.0,434.0,484.0,5520.0
Arwal,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,363.0,254.0,303.0,556.0,631.0,686.0,666.0,684.0,576.0,641.0,513.0,425.0,6298.0
Arwal,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,,,,2.0
Arwal,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0,,1.0
Arwal,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,,,,1.0
Arwal,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,,1.0,,2.0
Arwal,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Arwal,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,8.0,0.0,29.0,14.0,6.0,5.0,5.0,5.0,17.0,4.0,8.0,8.0,109.0
Arwal,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,8.0,0.0,178.0,9.0,12.0,17.0,14.0,16.0,9.0,21.0,14.0,22.0,320.0
Arwal,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,16.0,0.0,207.0,23.0,18.0,22.0,19.0,21.0,26.0,25.0,22.0,30.0,429.0
Arwal,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,3.0,2.0,6.0,17.0
Arwal,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Arwal,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,,,,,,,,,1.0,1.0,,3.0
Arwal,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Arwal,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,4.0,3.0,6.0,20.0
Arwal,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,,0.0,,,,,,,,60.0,60.0
Arwal,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Arwal,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Arwal,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Arwal,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,0.0,,,,,,,,,0.0
Arwal,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,51.0,30.0,58.0,70.0,62.0,248.0,158.0,365.0,204.0,408.0,267.0,256.0,2177.0
Arwal,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Arwal,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,36.0,31.0,18.0,30.0,46.0,29.0,11.0,15.0,10.0,22.0,14.0,25.0,287.0
Arwal,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Arwal,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,87.0,61.0,76.0,100.0,108.0,277.0,169.0,380.0,214.0,430.0,281.0,281.0,2464.0
Arwal,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,0.0,,,,,,,,2321.0,2321.0
Arwal,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,0.0,3.0,13.0,94.0,4.0,69.0,188.0
Arwal,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Arwal,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,1.0,,,,1.0,,2.0
Arwal,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Arwal,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,1.0,3.0,13.0,94.0,5.0,69.0,190.0
Arwal,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,0.0,,,,,,,,65.0,65.0
Arwal,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,60.0,40.0,64.0,259.0,62.0,55.0,44.0,27.0,83.0,79.0,84.0,79.0,936.0
Arwal,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,59.0,53.0,165.0,226.0,342.0,119.0,42.0,189.0,419.0,53.0,45.0,66.0,1778.0
Arwal,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Arwal,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,108.0,124.0,64.0,33.0,20.0,15.0,20.0,30.0,47.0,40.0,27.0,44.0,572.0
Arwal,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Arwal,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,227.0,217.0,293.0,518.0,424.0,189.0,106.0,246.0,549.0,172.0,156.0,189.0,3286.0
Arwal,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,3.0,15.0,14.0,3.0,4.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,43.0
Arwal,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,,0.0,,,,,,,,3768.0,3768.0
Arwal,9.06,Number of IUCD removals,TOTAL,40.0,40.0,31.0,45.0,52.0,37.0,41.0,36.0,45.0,49.0,42.0,56.0,514.0
Arwal,9.07,Number of Oral Pills cycles distributed,TOTAL,354.0,218.0,403.0,422.0,470.0,255.0,126.0,562.0,488.0,243.0,255.0,5244.0,9040.0
Arwal,9.08,Number of Condom pieces distributed,TOTAL,5548.0,2703.0,2423.0,3971.0,4894.0,4114.0,3412.0,3129.0,4217.0,4721.0,3288.0,30037.0,72457.0
Arwal,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,15.0,1.0,152.0,0.0,0.0,1.0,0.0,0.0,0.0,20.0,4939.0,5128.0
Arwal,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,43.0,85.0,142.0,97.0,65.0,83.0,49.0,84.0,198.0,144.0,141.0,17660.0,18791.0
Arwal,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,2.0
Arwal,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Arwal,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,999.0,903.0,732.0,1037.0,1423.0,1530.0,1619.0,1751.0,1544.0,1415.0,1168.0,976.0,15097.0
Arwal,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1320.0,989.0,839.0,952.0,923.0,1195.0,1444.0,1912.0,1685.0,387.0,45.0,34.0,11725.0
Arwal,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1725.0,1147.0,977.0,1028.0,908.0,969.0,1068.0,1353.0,1639.0,1692.0,694.0,222.0,13422.0
Arwal,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1874.0,1470.0,1233.0,1227.0,1071.0,1074.0,952.0,1113.0,1299.0,1551.0,1400.0,906.0,15170.0
Arwal,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1275.0,1574.0,1349.0,4198.0
Arwal,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,753.0,1490.0,2244.0
Arwal,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,819.0,829.0
Arwal,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,784.0,799.0,650.0,940.0,1251.0,838.0,888.0,1248.0,1239.0,1001.0,899.0,688.0,11225.0
Arwal,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1349.0,977.0,863.0,895.0,817.0,705.0,793.0,1286.0,1800.0,1129.0,1010.0,1204.0,12828.0
Arwal,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1762.0,1137.0,1247.0,913.0,805.0,558.0,503.0,971.0,1385.0,1319.0,1193.0,1520.0,13313.0
Arwal,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2066.0,1461.0,1289.0,1093.0,919.0,613.0,541.0,790.0,1050.0,1175.0,1100.0,1668.0,13765.0
Arwal,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,562.0,618.0,489.0,695.0,884.0,924.0,976.0,969.0,832.0,719.0,569.0,487.0,8724.0
Arwal,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1482.0,1022.0,862.0,997.0,901.0,1214.0,1601.0,1699.0,1712.0,365.0,100.0,1.0,11956.0
Arwal,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1954.0,1285.0,1060.0,1048.0,939.0,1007.0,1076.0,1359.0,1647.0,1629.0,700.0,286.0,13990.0
Arwal,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2257.0,1710.0,1402.0,1331.0,1142.0,1134.0,968.0,1166.0,1345.0,1532.0,1391.0,1012.0,16390.0
Arwal,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1088.0,1139.0,1359.0,1592.0,1638.0,1756.0,1372.0,1209.0,929.0,656.0,579.0,1021.0,14338.0
Arwal,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1350.0,1032.0,1014.0,1071.0,791.0,841.0,669.0,705.0,767.0,687.0,540.0,1174.0,10641.0
Arwal,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,338.0,423.0,1197.0,685.0,908.0,786.0,905.0,854.0,888.0,549.0,648.0,874.0,9055.0
Arwal,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,517.0,568.0,670.0,818.0,807.0,910.0,721.0,634.0,481.0,376.0,198.0,446.0,7146.0
Arwal,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,501.0,508.0,581.0,735.0,774.0,791.0,632.0,520.0,423.0,275.0,187.0,427.0,6354.0
Arwal,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1018.0,1076.0,1251.0,1553.0,1581.0,1701.0,1353.0,1154.0,904.0,651.0,385.0,873.0,13500.0
Arwal,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1549.0,1125.0,1018.0,1083.0,854.0,913.0,721.0,898.0,977.0,1072.0,1181.0,1569.0,12960.0
Arwal,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1573.0,1128.0,1046.0,991.0,758.0,541.0,477.0,655.0,958.0,916.0,1019.0,1531.0,11593.0
Arwal,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,352.0,202.0,244.0,219.0,147.0,112.0,120.0,106.0,176.0,169.0,128.0,288.0,2263.0
Arwal,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,379.0,180.0,228.0,198.0,136.0,84.0,96.0,60.0,155.0,161.0,117.0,289.0,2083.0
Arwal,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,731.0,382.0,472.0,417.0,283.0,196.0,216.0,166.0,331.0,330.0,245.0,577.0,4346.0
Arwal,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,0.0,0.0,0.0,51.0,45.0,65.0,30.0,23.0,,29.0,59.0,302.0
Arwal,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,477.0,542.0,518.0,489.0,455.0,421.0,508.0,605.0,388.0,568.0,465.0,580.0,6016.0
Arwal,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,656.0,660.0,744.0,638.0,790.0,725.0,706.0,897.0,615.0,802.0,851.0,856.0,8940.0
Arwal,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,13.0,2.0,11.0,0.0,13.0,0.0,0.0,0.0,0.0,,,,39.0
Arwal,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,1.0
Arwal,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1048.0,974.0,830.0,974.0,868.0,880.0,905.0,903.0,934.0,953.0,826.0,905.0,11000.0
Arwal,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1044.0,975.0,828.0,969.0,856.0,874.0,905.0,903.0,931.0,947.0,822.0,904.0,10958.0
Arwal,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,969.0,923.0,813.0,953.0,805.0,842.0,869.0,878.0,902.0,907.0,802.0,872.0,10535.0
Arwal,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,272.0,418.0,998.0,509.0,516.0,536.0,569.0,697.0,883.0,721.0,838.0,1135.0,8092.0
Arwal,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,536.0,460.0,396.0,607.0,996.0,936.0,758.0,509.0,544.0,270.0,440.0,511.0,6963.0
Arwal,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,72.0,43.0,34.0,71.0,62.0,82.0,78.0,74.0,39.0,13.0,39.0,124.0,731.0
Arwal,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,20.0,0.0,0.0,10.0,0.0,15.0,12.0,39.0,0.0,,,9.0,105.0
Arwal,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,7.0,5.0,2.0,0.0,0.0,0.0,2.0,1.0,0.0,1.0,,,18.0
Arwal,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Arwal,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,,,,8.0
Arwal,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,119.0,250.0,148.0,254.0,,771.0
Arwal,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,254.0,,254.0
Arwal,13.3,Number of School children detected with Refractive errors,TOTAL,2.0,0.0,0.0,0.0,21.0,12.0,0.0,3.0,110.0,,536.0,124.0,808.0
Arwal,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,186.0,186.0
Arwal,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Arwal,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Arwal,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Arwal,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Arwal,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,425.0,441.0,425.0,429.0,428.0,430.0,429.0,450.0,448.0,426.0,423.0,451.0,-1.0
Arwal,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Arwal,14.05,Number of RKS meetings held during the month,TOTAL,5.0,1.0,2.0,4.0,2.0,2.0,1.0,2.0,2.0,7.0,2.0,5.0,35.0
Arwal,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Arwal,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,326.0,290.0,347.0,269.0,471.0,421.0,453.0,589.0,522.0,579.0,451.0,361.0,5079.0
Arwal,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Arwal,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,0.0,,,,,,,,,,,-1.0
Arwal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,129.0,104.0,108.0,211.0,132.0,103.0,78.0,135.0,111.0,53.0,81.0,85.0,1330.0
Arwal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,186.0,160.0,211.0,266.0,240.0,148.0,174.0,260.0,212.0,120.0,163.0,249.0,2389.0
Arwal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,98.0,53.0,75.0,120.0,92.0,69.0,92.0,99.0,72.0,73.0,89.0,96.0,1028.0
Arwal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,618.0,755.0,659.0,632.0,1141.0,1209.0,1280.0,1304.0,1255.0,1359.0,992.0,994.0,12198.0
Arwal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,227.0,157.0,183.0,331.0,224.0,172.0,170.0,234.0,183.0,126.0,170.0,181.0,2358.0
Arwal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,804.0,915.0,870.0,898.0,1381.0,1357.0,1454.0,1564.0,1467.0,1479.0,1155.0,1243.0,14587.0
Arwal,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,14.11,In-Patient Head Count at midnight,TOTAL,1145.0,1339.0,1206.0,1471.0,1775.0,1942.0,1972.0,2038.0,1699.0,1857.0,1639.0,1835.0,19918.0
Arwal,14.12.1,OPD attendance (All),TOTAL,47094.0,44183.0,50953.0,52041.0,46706.0,46218.0,40345.0,40165.0,41392.0,47510.0,40513.0,41250.0,538370.0
Arwal,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,98.0,158.0,50.0,74.0,82.0,138.0,85.0,135.0,164.0,385.0,1267.0,592.0,3228.0
Arwal,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,33.0,2.0,0.0,77.0,0.0,110.0,85.0,54.0,361.0
Arwal,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,180.0,222.0,218.0,276.0,278.0,240.0,286.0,238.0,305.0,384.0,321.0,427.0,3375.0
Arwal,14.14.a,Number of patients given AYUSH treatment,TOTAL,15090.0,17138.0,14660.0,17501.0,16874.0,16168.0,13630.0,14514.0,11223.0,14070.0,13249.0,10344.0,174461.0
Arwal,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1195.0,1159.0,1450.0,1238.0,1443.0,1853.0,1299.0,1374.0,978.0,1060.0,974.0,927.0,14950.0
Arwal,14.14.c,Number of Adolescents counselled,TOTAL,42.0,35.0,71.0,35.0,58.0,59.0,45.0,32.0,25.0,31.0,87.0,75.0,595.0
Arwal,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,531.0,618.0,595.0,549.0,793.0,708.0,692.0,472.0,551.0,621.0,705.0,746.0,7581.0
Arwal,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,6.0,9.0,4.0,5.0,6.0,3.0,8.0,3.0,2.0,3.0,4.0,4.0,57.0
Arwal,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,177.0,147.0,174.0,185.0,171.0,120.0,91.0,84.0,124.0,125.0,19.0,115.0,1532.0
Arwal,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,0.0,0.0,0.0,2.0,1.0,1.0,0.0,1.0,2.0,0.0,0.0,9.0
Arwal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,88.0,272.0,89.0,273.0,266.0,249.0,196.0,160.0,312.0,463.0,122.0,183.0,2673.0
Arwal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Arwal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,304.0,606.0,99.0,493.0,365.0,477.0,200.0,238.0,279.0,280.0,94.0,313.0,3748.0
Arwal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Arwal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,569.0,1025.0,362.0,951.0,802.0,846.0,487.0,482.0,715.0,868.0,235.0,611.0,7953.0
Arwal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,0.0,1.0,0.0,3.0,1.0,2.0,1.0,1.0,2.0,0.0,0.0,13.0
Arwal,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Arwal,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35.0,36.0,9.0,98.0,8.0,186.0
Arwal,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0,25.0,26.0,89.0,22.0,185.0
Arwal,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,51.0,90.0,35.0,258.0,290.0,724.0
Arwal,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,109.0,151.0,70.0,445.0,320.0,1095.0
Arwal,15.4.1,Number of blood smears examined for Malaria,TOTAL,13.0,21.0,25.0,21.0,19.0,16.0,11.0,16.0,22.0,8.0,9.0,12.0,193.0
Arwal,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Arwal,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Arwal,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1880.0,1400.0,1640.0,2390.0,1970.0,2320.0,1930.0,1070.0,1860.0,2610.0,2340.0,2290.0,23700.0
Arwal,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,1000.0,1000.0,500.0,1000.0,,,1000.0,1500.0,,,500.0,6500.0
Arwal,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,480.0,70.0,250.0,1100.0,410.0,450.0,860.0,,,270.0,50.0,475.0,4415.0
Arwal,16.1.1,Stock position of DPT vaccines,5. Total Stock,1400.0,2330.0,2390.0,1790.0,2560.0,1870.0,1070.0,2070.0,3360.0,2340.0,2290.0,2315.0,25785.0
Arwal,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,1350.0,,150.0,1500.0
Arwal,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Arwal,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,850.0,,50.0,900.0
Arwal,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,0.0,100.0,600.0
Arwal,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,450.0,25.0,75.0,50.0,75.0,,,20.0,250.0,,500.0,,1445.0
Arwal,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,700.0,600.0,600.0,200.0,143.0,300.0,350.0,300.0,100.0,,775.0,4068.0
Arwal,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,375.0,650.0,625.0,575.0,275.0,143.0,280.0,,550.0,100.0,500.0,425.0,4498.0
Arwal,16.1.2,Stock position of OPV vaccines,5. Total Stock,75.0,75.0,50.0,75.0,0.0,0.0,20.0,370.0,0.0,0.0,0.0,350.0,1015.0
Arwal,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1345.0,1095.0,840.0,1425.0,770.0,860.0,955.0,905.0,1190.0,1580.0,1380.0,1675.0,14020.0
Arwal,16.1.3,Stock position of TT vaccines,2. Stocks Received,,700.0,1000.0,300.0,700.0,700.0,800.0,800.0,1000.0,200.0,600.0,900.0,7700.0
Arwal,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.1.3,Stock position of TT vaccines,4. Stock Distributed,250.0,955.0,415.0,575.0,610.0,605.0,850.0,,,500.0,1675.0,750.0,7185.0
Arwal,16.1.3,Stock position of TT vaccines,5. Total Stock,1095.0,840.0,1425.0,1150.0,860.0,955.0,905.0,1705.0,2190.0,1280.0,305.0,1825.0,14535.0
Arwal,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Arwal,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Arwal,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Arwal,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Arwal,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,235.0,660.0,810.0,660.0,960.0,860.0,750.0,700.0,450.0,300.0,450.0,6835.0
Arwal,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,850.0,500.0,300.0,500.0,300.0,350.0,300.0,500.0,200.0,300.0,500.0,4600.0
Arwal,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,100.0,425.0,350.0,450.0,200.0,400.0,460.0,,,350.0,450.0,625.0,3810.0
Arwal,16.1.5,Stock position of BCG vaccines,5. Total Stock,-100.0,660.0,810.0,660.0,960.0,860.0,750.0,1050.0,1200.0,300.0,150.0,325.0,7625.0
Arwal,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,335.0,50.0,790.0,1090.0,600.0,790.0,140.0,60.0,30.0,,,,3885.0
Arwal,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,2000.0,1000.0,700.0,1000.0,300.0,470.0,300.0,500.0,350.0,350.0,1150.0,8120.0
Arwal,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,210.0,1260.0,700.0,1190.0,810.0,950.0,555.0,,530.0,350.0,350.0,1150.0,8055.0
Arwal,16.1.6,Stock position of Measles vaccines,5. Total Stock,125.0,790.0,1090.0,600.0,790.0,140.0,55.0,360.0,0.0,0.0,0.0,0.0,3950.0
Arwal,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,260.0,60.0,640.0,940.0,150.0,30.0,160.0,0.0,120.0,150.0,,60.0,2570.0
Arwal,16.1.7,Stock position of JE vaccines,2. Stocks Received,,1300.0,1000.0,800.0,400.0,800.0,400.0,800.0,800.0,100.0,700.0,1200.0,8300.0
Arwal,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.1.7,Stock position of JE vaccines,4. Stock Distributed,150.0,720.0,700.0,1590.0,520.0,730.0,500.0,,,250.0,640.0,1260.0,7060.0
Arwal,16.1.7,Stock position of JE vaccines,5. Total Stock,110.0,640.0,940.0,150.0,30.0,100.0,60.0,800.0,920.0,0.0,60.0,0.0,3810.0
Arwal,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,150.0,,510.0,610.0,310.0,460.0,560.0,1160.0,710.0,510.0,510.0,700.0,6190.0
Arwal,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,1440.0,700.0,500.0,700.0,600.0,600.0,600.0,300.0,300.0,500.0,500.0,6740.0
Arwal,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,150.0,930.0,600.0,800.0,550.0,500.0,600.0,,,300.0,960.0,475.0,5865.0
Arwal,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,510.0,610.0,310.0,460.0,560.0,560.0,1760.0,1010.0,510.0,50.0,725.0,7065.0
Arwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2300.0,2300.0,2000.0,2000.0,500.0,400.0,400.0,200.0,200.0,200.0,200.0,200.0,10900.0
Arwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Arwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,300.0,,1500.0,100.0,,200.0,,,,200.0,,2300.0
Arwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2300.0,2000.0,2000.0,500.0,400.0,400.0,200.0,200.0,200.0,200.0,0.0,200.0,8600.0
Arwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,12000.0,12000.0,12000.0,12000.0,11800.0,11800.0,11800.0,5800.0,5800.0,5800.0,5800.0,,106600.0
Arwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Arwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,200.0,,,6000.0,,,5800.0,5800.0,,17800.0
Arwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,12000.0,12000.0,12000.0,11800.0,11800.0,11800.0,5800.0,5800.0,5800.0,0.0,0.0,0.0,88800.0
Arwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,6000.0,6000.0,6000.0,6000.0,6000.0,5500.0,5500.0,4500.0,4500.0,4500.0,3500.0,3500.0,61500.0
Arwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Arwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,500.0,,1000.0,,,1000.0,3500.0,,6000.0
Arwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,6000.0,6000.0,6000.0,6000.0,5500.0,5500.0,4500.0,4500.0,4500.0,3500.0,0.0,3500.0,55500.0
Arwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1000.0,1000.0,1000.0,600.0,600.0,15400.0
Arwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Arwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,600.0,,,400.0,600.0,,1600.0
Arwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1000.0,1000.0,1000.0,600.0,0.0,600.0,13800.0
Arwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Arwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Arwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Arwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Arwal,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,50000.0,30000.0,14000.0,8000.0,4000.0,4000.0,4000.0,4000.0,,4000.0,,,122000.0
Arwal,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Arwal,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,2000.0,16000.0,6000.0,4000.0,,,,,,4000.0,,,32000.0
Arwal,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,48000.0,14000.0,8000.0,4000.0,4000.0,4000.0,4000.0,4000.0,0.0,0.0,0.0,0.0,90000.0
Arwal,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,1500.0,,1500.0,1100.0,300.0,,,,,,4400.0,8800.0
Arwal,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,5000.0,,5000.0
Arwal,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.3.02,Stock Position of Gloves,4. Stock Distributed,,1500.0,,400.0,800.0,300.0,,,,,600.0,2400.0,6000.0
Arwal,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,1100.0,300.0,0.0,0.0,0.0,0.0,0.0,4400.0,2000.0,7800.0
Arwal,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Arwal,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Arwal,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Arwal,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Arwal,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,4000.0,,,,40000.0,25000.0,1500.0,7000.0,,77500.0
Arwal,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,40000.0,,,,,,40000.0
Arwal,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,800.0,7000.0,,7800.0
Arwal,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,4000.0,0.0,0.0,40000.0,40000.0,25000.0,700.0,0.0,0.0,109700.0
Arwal,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Arwal,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Arwal,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Arwal,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Arwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Arwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Arwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Arwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Arwal,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,319900.0,121900.0,71900.0,33000.0,33000.0,,,,,,27680.0,607380.0
Arwal,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,616900.0,,,,,,,,,,67680.0,,684580.0
Arwal,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,29700.0,198000.0,33000.0,55900.0,,,,,,,40000.0,,356600.0
Arwal,16.3.07,Stock Position of IFA Tablets,5. Total Stock,587200.0,121900.0,88900.0,16000.0,33000.0,33000.0,0.0,0.0,0.0,0.0,27680.0,27680.0,935360.0
Arwal,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Arwal,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Arwal,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Arwal,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Arwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Arwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Arwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Arwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Arwal,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,150.0,150.0,150.0,150.0,100.0,100.0,100.0,65.0,965.0
Arwal,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,2450.0,,,,,,,,,2450.0
Arwal,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,20.0,,,,,20.0
Arwal,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,2300.0,,,,,,25.0,35.0,16.0,2376.0
Arwal,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,150.0,150.0,150.0,150.0,130.0,100.0,75.0,65.0,49.0,1019.0
Arwal,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,10000.0,31000.0,5000.0,,20000.0,6300.0,3400.0,4300.0,3400.0,3400.0,7630.0,2000.0,96430.0
Arwal,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,40000.0,,,40000.0,,,,,,,,,80000.0
Arwal,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,19800.0,26000.0,5000.0,20000.0,1360.0,2900.0,,,,,5630.0,,80690.0
Arwal,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,30200.0,5000.0,0.0,20000.0,18640.0,3400.0,3400.0,4300.0,3400.0,3400.0,2000.0,2000.0,95740.0
Arwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,12600.0,10600.0,13300.0,11700.0,17800.0,16800.0,12400.0,18600.0,16700.0,16800.0,12400.0,11300.0,171000.0
Arwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,5000.0,,1000.0,,,7000.0,,3000.0,,,3500.0,19500.0
Arwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000.0,2300.0,1600.0,3900.0,1000.0,4400.0,8000.0,,2900.0,4400.0,1100.0,13600.0,45200.0
Arwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,10600.0,13300.0,11700.0,8800.0,16800.0,12400.0,11400.0,18600.0,16800.0,12400.0,11300.0,1200.0,145300.0
Arwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,21800.0,140.0,21800.0,7400.0,27600.0,13200.0,1200.0,26200.0,4400.0,29400.0,20700.0,8500.0,182340.0
Arwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,50000.0,,80000.0,,,50000.0,,50000.0,,,5000.0,235000.0
Arwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,20400.0,29600.0,14400.0,29800.0,14400.0,12000.0,25000.0,,,15900.0,11200.0,9550.0,182250.0
Arwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,1400.0,20540.0,7400.0,57600.0,13200.0,1200.0,26200.0,26200.0,54400.0,13500.0,9500.0,3950.0,235090.0
Arwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5520.0,4300.0,5600.0,4300.0,5100.0,4100.0,1600.0,5100.0,3100.0,5100.0,3100.0,2500.0,49420.0
Arwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,5000.0,,5000.0,,,5000.0,,500.0,,,5000.0,20500.0
Arwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Arwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2020.0,2800.0,1300.0,4200.0,1000.0,2500.0,1500.0,,,2000.0,500.0,2500.0,20320.0
Arwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3500.0,6500.0,4300.0,5100.0,4100.0,1600.0,5100.0,5100.0,3600.0,3100.0,2600.0,5000.0,49600.0
Arwal,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Arwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Arwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Arwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Arwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Arwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Arwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Arwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Arwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Arwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Arwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Arwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Arwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Arwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Arwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Arwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Arwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Arwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Arwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Arwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Arwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Arwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Arwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Arwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Arwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Arwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Arwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Arwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Arwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Arwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Arwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Arwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,,,,,,,,,,1.0
Arwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Arwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Arwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Arwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Arwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Arwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Arwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Arwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Arwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Arwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Arwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Arwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Arwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Arwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Arwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Arwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Arwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Arwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Arwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Arwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Arwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Arwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Arwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Arwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,1.0,,,,,1.0,,,,,,2.0
Arwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,,,,,1.0,,,,,,2.0
Arwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,2.0,,,,,2.0,,,,,,4.0
Arwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Arwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Arwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Arwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Arwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Arwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Arwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Arwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Arwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,1.0,2.0,1.0,,,2.0,1.0,2.0,,9.0
Arwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,2.0,2.0,1.0,,,2.0,1.0,2.0,,10.0
Aurangabad,1.1,Total number of pregnant women Registered for ANC,TOTAL,5316.0,5588.0,6392.0,6234.0,5613.0,5144.0,3778.0,4609.0,4253.0,5200.0,5080.0,5675.0,62882.0
Aurangabad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2247.0,2212.0,2897.0,2404.0,2937.0,2640.0,2442.0,3504.0,3851.0,4319.0,4257.0,4979.0,38689.0
Aurangabad,1.2,Number of Pregnant women registered under JSY,TOTAL,5247.0,5537.0,6384.0,6225.0,5562.0,5135.0,3778.0,4569.0,4253.0,5200.0,5080.0,5675.0,62645.0
Aurangabad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2818.0,3234.0,3450.0,3656.0,4562.0,4976.0,3486.0,4087.0,4147.0,4385.0,4503.0,5296.0,48600.0
Aurangabad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3946.0,4166.0,4687.0,4294.0,3968.0,3753.0,2854.0,2957.0,2907.0,3549.0,3526.0,3709.0,44316.0
Aurangabad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4613.0,5164.0,5635.0,5762.0,6051.0,5591.0,4255.0,3900.0,3521.0,3878.0,3761.0,4883.0,57014.0
Aurangabad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2826.0,2992.0,3056.0,3001.0,2888.0,3359.0,2777.0,3863.0,4162.0,3947.0,4088.0,5127.0,42086.0
Aurangabad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,168.0,224.0,276.0,156.0,80.0,67.0,100.0,77.0,69.0,81.0,19.0,93.0,1410.0
Aurangabad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,29.0,8.0,12.0,12.0,7.0,20.0,15.0,5.0,12.0,12.0,2.0,3.0,137.0
Aurangabad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,836.0,1448.0,1485.0,1452.0,1416.0,1149.0,1039.0,916.0,961.0,852.0,963.0,1440.0,13957.0
Aurangabad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,42.0,45.0,44.0,23.0,24.0,20.0,46.0,12.0,48.0,28.0,7.0,24.0,363.0
Aurangabad,1.8,Number of pregnancy test kits used at SC level,TOTAL,198.0,298.0,412.0,252.0,28.0,17.0,80.0,60.0,73.0,76.0,130.0,152.0,1776.0
Aurangabad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,225.0,223.0,270.0,367.0,432.0,417.0,472.0,726.0,687.0,547.0,495.0,220.0,5081.0
Aurangabad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,578.0,602.0,648.0,682.0,898.0,1119.0,1011.0,1453.0,1177.0,1119.0,956.0,1160.0,11403.0
Aurangabad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,803.0,825.0,918.0,1049.0,1330.0,1536.0,1483.0,2179.0,1864.0,1666.0,1451.0,1380.0,16484.0
Aurangabad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,263.0,311.0,448.0,367.0,365.0,430.0,412.0,753.0,429.0,447.0,462.0,460.0,5147.0
Aurangabad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,2.0,9.0,0.0,0.0,0.0,0.0,4.0,1.0,45.0,15.0,21.0,97.0
Aurangabad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1773.0,2206.0,2010.0,2669.0,3412.0,3600.0,3754.0,3423.0,3351.0,3032.0,2532.0,2053.0,33815.0
Aurangabad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1895.0,1714.0,1593.0,2169.0,3065.0,3566.0,3710.0,3405.0,3314.0,3009.0,2287.0,1912.0,31639.0
Aurangabad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,284.0,2274.0,355.0,651.0,3758.0,2383.0,1741.0,5013.0,5655.0,3525.0,2582.0,2897.0,31118.0
Aurangabad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,139.0,887.0,427.0,891.0,1007.0,1079.0,604.0,1142.0,3754.0,1720.0,1793.0,3567.0,17010.0
Aurangabad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,26.0,51.0,8.0,26.0,25.0,,,,,,,,136.0
Aurangabad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Aurangabad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Aurangabad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Aurangabad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,8.0,6.0,11.0,13.0,25.0,17.0,19.0,11.0,22.0,8.0,8.0,11.0,159.0
Aurangabad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,4.0,4.0,3.0,4.0,3.0,3.0,3.0,6.0,5.0,5.0,4.0,5.0,49.0
Aurangabad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1.0,,0.0,0.0,2.0,6.0,4.0,7.0,3.0,1.0,3.0,3.0,30.0
Aurangabad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aurangabad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,13.0,10.0,14.0,17.0,30.0,26.0,26.0,24.0,30.0,14.0,15.0,19.0,238.0
Aurangabad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,10.0,20.0,3.0,7.0,5.0,,,,,,,,45.0
Aurangabad,4.1.1.a,Number of male live births,TOTAL,1493.0,1536.0,1576.0,2054.0,2434.0,2708.0,2721.0,2974.0,2887.0,2553.0,2199.0,1788.0,26923.0
Aurangabad,4.1.1.b,Number of female live births,TOTAL,1192.0,1361.0,1371.0,1690.0,2331.0,2452.0,2565.0,2779.0,2354.0,2157.0,1788.0,1643.0,23683.0
Aurangabad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2685.0,2897.0,2947.0,3744.0,4765.0,5160.0,5286.0,5753.0,5241.0,4710.0,3987.0,3431.0,50606.0
Aurangabad,4.1.2,Number of still births,TOTAL,38.0,34.0,35.0,45.0,59.0,85.0,79.0,61.0,61.0,47.0,44.0,38.0,626.0
Aurangabad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,4.0,4.0,4.0,12.0,8.0,15.0,1.0,8.0,7.0,6.0,5.0,5.0,79.0
Aurangabad,4.2.1,Number of Newborns weighed at birth,TOTAL,2497.0,2693.0,2636.0,3376.0,4543.0,5494.0,4933.0,5285.0,5039.0,4445.0,3818.0,3188.0,47947.0
Aurangabad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,140.0,126.0,132.0,135.0,174.0,205.0,245.0,209.0,138.0,158.0,104.0,135.0,1901.0
Aurangabad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2584.0,2680.0,2816.0,2928.0,4653.0,4841.0,5039.0,5413.0,5136.0,4469.0,3830.0,3187.0,47576.0
Aurangabad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6.0,3.0,9.0,18.0,21.0,12.0,8.0,7.0,16.0,0.0,7.0,0.0,107.0
Aurangabad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,6.0,1.0,4.0,7.0,6.0,6.0,6.0,6.0,7.0,5.0,3.0,5.0,62.0
Aurangabad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,12.0,12.0,20.0,15.0,7.0,12.0,9.0,13.0,13.0,12.0,8.0,15.0,148.0
Aurangabad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aurangabad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,24.0,16.0,33.0,40.0,34.0,30.0,23.0,26.0,36.0,17.0,18.0,20.0,317.0
Aurangabad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,7.0,5.0,,,,,,,,12.0
Aurangabad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,190.0,165.0,148.0,154.0,167.0,177.0,197.0,395.0,419.0,352.0,136.0,301.0,2801.0
Aurangabad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,60.0,39.0,58.0,49.0,48.0,54.0,70.0,62.0,51.0,191.0,62.0,54.0,798.0
Aurangabad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,125.0,70.0,85.0,87.0,107.0,117.0,135.0,394.0,452.0,444.0,194.0,683.0,2893.0
Aurangabad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10.0,10.0,4.0,10.0,5.0,6.0,11.0,10.0,7.0,7.0,10.0,6.0,96.0
Aurangabad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1084.0,987.0,1061.0,1435.0,1736.0,1723.0,1813.0,2259.0,2144.0,2238.0,1484.0,1700.0,19664.0
Aurangabad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,926.0,918.0,954.0,1001.0,1188.0,1405.0,1400.0,2061.0,1747.0,1239.0,1179.0,1042.0,15060.0
Aurangabad,6.3,PNC maternal complications attended,TOTAL,0.0,41.0,0.0,0.0,2.0,0.0,0.0,5.0,16.0,0.0,5.0,1.0,70.0
Aurangabad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,210.0,352.0,230.0,347.0,310.0,365.0,240.0,360.0,405.0,403.0,324.0,338.0,3884.0
Aurangabad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,320.0,452.0,324.0,355.0,324.0,245.0,393.0,308.0,422.0,424.0,292.0,358.0,4217.0
Aurangabad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,530.0,804.0,554.0,702.0,634.0,610.0,633.0,668.0,827.0,827.0,616.0,696.0,8101.0
Aurangabad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,17.0,0.0,0.0,14.0,2.0,2.0,6.0,21.0,16.0,13.0,16.0,14.0,121.0
Aurangabad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,3.0,1.0,0.0,4.0,1.0,1.0,1.0,7.0,6.0,1.0,2.0,1.0,28.0
Aurangabad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0,1.0,0.0,6.0
Aurangabad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aurangabad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,20.0,2.0,0.0,18.0,3.0,3.0,7.0,30.0,22.0,16.0,19.0,15.0,155.0
Aurangabad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,5.0,22.0,27.0,9.0,9.0,,,,,,,,72.0
Aurangabad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aurangabad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Aurangabad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aurangabad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Aurangabad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,80.0,60.0,102.0,310.0,253.0,470.0,191.0,971.0,722.0,931.0,970.0,599.0,5659.0
Aurangabad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,35.0,26.0,26.0,73.0,72.0,144.0,93.0,344.0,197.0,351.0,571.0,229.0,2161.0
Aurangabad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,11.0,18.0,16.0,24.0,100.0,57.0,71.0,112.0,60.0,470.0
Aurangabad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aurangabad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,116.0,86.0,128.0,394.0,343.0,630.0,308.0,1415.0,976.0,1353.0,1653.0,888.0,8290.0
Aurangabad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,60.0,117.0,135.0,94.0,38.0,,,,,,,3283.0,3727.0
Aurangabad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1.0,0.0,2.0,52.0,0.0,0.0,81.0,93.0,2.0,93.0,338.0,11.0,673.0
Aurangabad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,63.0,19.0,120.0,46.0,0.0,138.0,94.0,480.0
Aurangabad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,1.0,5.0
Aurangabad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aurangabad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,0.0,2.0,52.0,0.0,63.0,102.0,215.0,48.0,93.0,476.0,106.0,1158.0
Aurangabad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,4.0,5.0,2.0,0.0,,,,,,,,11.0
Aurangabad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,513.0,532.0,641.0,1274.0,764.0,664.0,859.0,1573.0,2027.0,1471.0,1173.0,1392.0,12883.0
Aurangabad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,165.0,183.0,195.0,834.0,301.0,421.0,446.0,705.0,794.0,467.0,519.0,501.0,5531.0
Aurangabad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,34.0,30.0,49.0,537.0,91.0,214.0,69.0,93.0,177.0,123.0,163.0,116.0,1696.0
Aurangabad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,24.0,29.0,214.0,32.0,16.0,20.0,15.0,120.0,12.0,119.0,10.0,61.0,672.0
Aurangabad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aurangabad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,736.0,774.0,1099.0,2677.0,1172.0,1319.0,1389.0,2491.0,3010.0,2180.0,1865.0,2070.0,20782.0
Aurangabad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,31.0,199.0,137.0,537.0,375.0,565.0,356.0,323.0,259.0,231.0,212.0,100.0,3325.0
Aurangabad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,43.0,45.0,92.0,123.0,75.0,,,,,,,150.0,528.0
Aurangabad,9.06,Number of IUCD removals,TOTAL,222.0,242.0,251.0,330.0,295.0,319.0,222.0,304.0,330.0,274.0,268.0,223.0,3280.0
Aurangabad,9.07,Number of Oral Pills cycles distributed,TOTAL,1101.0,1414.0,1549.0,2429.0,1787.0,2038.0,1243.0,2052.0,1853.0,1381.0,1026.0,2466.0,20339.0
Aurangabad,9.08,Number of Condom pieces distributed,TOTAL,14102.0,14282.0,13683.0,17722.0,11949.0,12177.0,8232.0,16978.0,7606.0,12862.0,10467.0,9362.0,149422.0
Aurangabad,9.09,Number of Centchroman (weekly) pills given,TOTAL,58.0,106.0,20.0,22.0,1.0,14.0,3.0,0.0,4.0,12.0,20.0,202.0,462.0
Aurangabad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,161.0,187.0,42.0,11.0,151.0,38.0,18.0,18.0,30.0,271.0,334.0,220.0,1481.0
Aurangabad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Aurangabad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,2.0,1.0,0.0,3.0,0.0,0.0,0.0,0.0,6.0
Aurangabad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Aurangabad,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Aurangabad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3373.0,3692.0,3575.0,4452.0,5555.0,6086.0,6416.0,6618.0,6076.0,5421.0,4617.0,3974.0,59855.0
Aurangabad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4206.0,3505.0,3754.0,3775.0,4295.0,4929.0,5517.0,6614.0,6203.0,1900.0,101.0,140.0,44939.0
Aurangabad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,5041.0,4454.0,3899.0,3631.0,4179.0,4427.0,4540.0,5236.0,6049.0,6306.0,2021.0,1041.0,50824.0
Aurangabad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,5789.0,4881.0,4651.0,4021.0,4427.0,4678.0,4282.0,4419.0,4901.0,5893.0,4925.0,2940.0,55807.0
Aurangabad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,21.0,0.0,0.0,0.0,4972.0,5084.0,5141.0,15218.0
Aurangabad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,49.0,0.0,0.0,61.0,1.0,3431.0,5362.0,8904.0
Aurangabad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,45.0,0.0,0.0,0.0,1.0,23.0,3173.0,3242.0
Aurangabad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2712.0,3002.0,2568.0,3620.0,4607.0,4717.0,4662.0,4884.0,4543.0,3876.0,3149.0,2958.0,45298.0
Aurangabad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4227.0,3505.0,3744.0,3788.0,4253.0,4892.0,5443.0,6648.0,6233.0,5185.0,4543.0,4107.0,56568.0
Aurangabad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5063.0,4306.0,3890.0,3624.0,4162.0,4446.0,4488.0,5261.0,6058.0,6260.0,4565.0,5163.0,57286.0
Aurangabad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5777.0,4883.0,4651.0,4036.0,4414.0,4771.0,4249.0,4434.0,4916.0,5758.0,4976.0,5267.0,58132.0
Aurangabad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2215.0,2604.0,2211.0,2982.0,3329.0,3692.0,3629.0,4176.0,3493.0,2973.0,2186.0,2101.0,35591.0
Aurangabad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4430.0,3716.0,3746.0,3787.0,4250.0,4935.0,5623.0,6640.0,6227.0,2608.0,154.0,88.0,46204.0
Aurangabad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,5038.0,4333.0,4090.0,3670.0,4221.0,4407.0,4525.0,5385.0,6050.0,6287.0,1879.0,1054.0,50939.0
Aurangabad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,5730.0,4911.0,4726.0,4093.0,4459.0,4643.0,4310.0,4434.0,4921.0,5897.0,4795.0,3013.0,55932.0
Aurangabad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4010.0,4550.0,5024.0,5675.0,6112.0,6423.0,5424.0,5286.0,4594.0,4461.0,4121.0,4291.0,59971.0
Aurangabad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4300.0,4284.0,4179.0,4283.0,3730.0,3613.0,3335.0,3342.0,3735.0,4043.0,4355.0,4700.0,47899.0
Aurangabad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3762.0,4263.0,4730.0,4964.0,5628.0,6163.0,5313.0,5240.0,4505.0,4383.0,4048.0,4062.0,57061.0
Aurangabad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1991.0,2426.0,2584.0,2910.0,3162.0,3315.0,2538.0,2692.0,2364.0,2320.0,2115.0,2196.0,30613.0
Aurangabad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1733.0,2009.0,2349.0,2620.0,2858.0,2951.0,2423.0,2436.0,2161.0,2055.0,1956.0,1951.0,27502.0
Aurangabad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3724.0,4435.0,4933.0,5530.0,6020.0,6266.0,4961.0,5128.0,4525.0,4375.0,4071.0,4147.0,58115.0
Aurangabad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4556.0,4158.0,4346.0,4367.0,3714.0,3635.0,3207.0,3375.0,3745.0,4091.0,4320.0,4755.0,48269.0
Aurangabad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4556.0,4158.0,4346.0,4367.0,3714.0,3635.0,3194.0,3433.0,3745.0,4053.0,4318.0,4753.0,48272.0
Aurangabad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,6.0,0.0,0.0,0.0,0.0,47.0,42.0,0.0,0.0,0.0,9.0,104.0
Aurangabad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,811.0,689.0,829.0,767.0,511.0,546.0,433.0,388.0,559.0,571.0,605.0,429.0,7138.0
Aurangabad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,688.0,597.0,725.0,721.0,472.0,450.0,349.0,327.0,514.0,460.0,574.0,365.0,6242.0
Aurangabad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1499.0,1286.0,1554.0,1488.0,983.0,996.0,782.0,715.0,1073.0,1031.0,1179.0,794.0,13380.0
Aurangabad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,230.0,361.0,172.0,188.0,347.0,330.0,447.0,394.0,458.0,364.0,326.0,430.0,4047.0
Aurangabad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1277.0,1417.0,1521.0,1682.0,1468.0,1666.0,1341.0,1605.0,1315.0,1309.0,1193.0,1235.0,17029.0
Aurangabad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1656.0,1867.0,1918.0,2477.0,2065.0,2083.0,1966.0,2149.0,1953.0,2111.0,1765.0,1538.0,23548.0
Aurangabad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,0.0,0.0,25.0
Aurangabad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,17.0,0.0,0.0,23.0,0.0,14.0,6.0,0.0,9.0,0.0,0.0,69.0
Aurangabad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2679.0,2815.0,2764.0,2812.0,2760.0,2792.0,2569.0,2822.0,2838.0,2816.0,2730.0,2793.0,33190.0
Aurangabad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2677.0,2815.0,2764.0,2812.0,2760.0,2792.0,2565.0,2815.0,2838.0,2816.0,2770.0,2852.0,33276.0
Aurangabad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2333.0,2501.0,2549.0,2585.0,2545.0,2471.0,2336.0,2514.0,2572.0,2399.0,2386.0,2442.0,29633.0
Aurangabad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,3625.0,3677.0,3899.0,3881.0,3475.0,3513.0,2982.0,3328.0,3746.0,3895.0,4286.0,4528.0,44835.0
Aurangabad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1905.0,2209.0,2205.0,3803.0,2814.0,3175.0,2632.0,2735.0,2753.0,2032.0,1971.0,2511.0,30745.0
Aurangabad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,709.0,782.0,481.0,5176.0,685.0,827.0,733.0,781.0,814.0,814.0,915.0,900.0,13617.0
Aurangabad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,43.0,42.0,85.0,9063.0,14.0,36.0,29.0,109.0,116.0,22.0,41.0,45.0,9645.0
Aurangabad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,1.0,0.0,0.0,0.0,6.0,8.0,3.0,0.0,0.0,0.0,1.0,19.0
Aurangabad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2.0,49.0,21.0,8.0,4.0,38.0,8.0,6.0,0.0,8.0,7.0,4.0,155.0
Aurangabad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,22.0,418.0,0.0,0.0,443.0
Aurangabad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,6.0,0.0,6.0,0.0,9.0,8.0,9.0,8.0,10.0,6.0,0.0,0.0,62.0
Aurangabad,13.1,Number of Patients operated for cataract,TOTAL,22.0,23.0,24.0,33.0,198.0,117.0,181.0,315.0,141.0,132.0,534.0,281.0,2001.0
Aurangabad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,22.0,23.0,24.0,33.0,198.0,117.0,181.0,315.0,141.0,132.0,534.0,281.0,2001.0
Aurangabad,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,8.0
Aurangabad,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,0.0,12.0
Aurangabad,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Aurangabad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Aurangabad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1940.0,2297.0,2291.0,2123.0,2247.0,2076.0,1723.0,2034.0,2340.0,2134.0,2121.0,2248.0,-1.0
Aurangabad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Aurangabad,14.05,Number of RKS meetings held during the month,TOTAL,12.0,18.0,14.0,15.0,12.0,12.0,16.0,19.0,17.0,12.0,19.0,20.0,186.0
Aurangabad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Aurangabad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,811.0,523.0,691.0,306.0,756.0,868.0,490.0,664.0,937.0,1152.0,832.0,860.0,8890.0
Aurangabad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Aurangabad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,2.0,3.0,2.0,,1.0,2.0,1.0,1.0,-1.0
Aurangabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,705.0,1005.0,1120.0,1050.0,1356.0,1217.0,1598.0,1013.0,1217.0,1415.0,956.0,990.0,13642.0
Aurangabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1388.0,1206.0,1455.0,1490.0,1266.0,1710.0,1326.0,1629.0,1709.0,2070.0,1031.0,1521.0,17801.0
Aurangabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1345.0,1855.0,1466.0,1843.0,2544.0,1891.0,2518.0,1389.0,1803.0,1201.0,1201.0,1245.0,20301.0
Aurangabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4127.0,4330.0,3920.0,4880.0,4914.0,5107.0,4861.0,5200.0,4369.0,4583.0,4928.0,4645.0,55864.0
Aurangabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2050.0,2860.0,2586.0,2893.0,3900.0,3108.0,4116.0,2402.0,3020.0,2616.0,2157.0,2235.0,33943.0
Aurangabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5515.0,5536.0,5375.0,6370.0,6180.0,6817.0,6187.0,6829.0,6078.0,6653.0,5959.0,6166.0,73665.0
Aurangabad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,8.0,7.0,6.0,8.0,7.0,5.0,9.0,7.0,6.0,8.0,9.0,87.0
Aurangabad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,8.0,5.0,3.0,5.0,5.0,4.0,6.0,5.0,7.0,6.0,5.0,66.0
Aurangabad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,14.0,16.0,12.0,9.0,13.0,12.0,9.0,15.0,12.0,13.0,14.0,14.0,153.0
Aurangabad,14.11,In-Patient Head Count at midnight,TOTAL,4432.0,4703.0,4815.0,6344.0,6639.0,6933.0,6139.0,6635.0,6608.0,6639.0,6362.0,6741.0,72990.0
Aurangabad,14.12.1,OPD attendance (All),TOTAL,178897.0,187166.0,199596.0,226483.0,229350.0,242095.0,212066.0,214170.0,208425.0,198564.0,191554.0,215059.0,2503425.0
Aurangabad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,483.0,447.0,354.0,880.0,3033.0,850.0,686.0,1383.0,1020.0,1503.0,2092.0,1083.0,13814.0
Aurangabad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,408.0,410.0,120.0,0.0,20.0,132.0,47.0,122.0,545.0,2.0,907.0,1200.0,3913.0
Aurangabad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3890.0,3753.0,4866.0,5315.0,4640.0,4903.0,4243.0,3891.0,3746.0,3043.0,3379.0,4163.0,49832.0
Aurangabad,14.14.a,Number of patients given AYUSH treatment,TOTAL,53698.0,45078.0,52610.0,62100.0,63372.0,64655.0,57137.0,60139.0,40221.0,51223.0,53717.0,52550.0,656500.0
Aurangabad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,10228.0,9460.0,11759.0,11494.0,9524.0,11364.0,10137.0,8853.0,10247.0,7956.0,7936.0,6559.0,115517.0
Aurangabad,14.14.c,Number of Adolescents counselled,TOTAL,198.0,215.0,226.0,259.0,245.0,259.0,236.0,12.0,146.0,12.0,15.0,362.0,2185.0
Aurangabad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3080.0,3225.0,4294.0,5713.0,5566.0,5798.0,3600.0,5159.0,4385.0,4787.0,6107.0,5039.0,56753.0
Aurangabad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,112.0,96.0,196.0,215.0,143.0,183.0,123.0,85.0,114.0,162.0,96.0,83.0,1608.0
Aurangabad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,179.0,257.0,176.0,389.0,313.0,267.0,308.0,268.0,207.0,30.0,161.0,205.0,2760.0
Aurangabad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,1.0,2.0,8.0,6.0,5.0,5.0,2.0,1.0,5.0,2.0,3.0,42.0
Aurangabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,243.0,216.0,265.0,288.0,291.0,275.0,252.0,334.0,345.0,517.0,310.0,333.0,3669.0
Aurangabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,1.0,6.0,3.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,20.0
Aurangabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,382.0,383.0,342.0,620.0,527.0,764.0,399.0,394.0,379.0,1.0,334.0,469.0,4994.0
Aurangabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Aurangabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,804.0,856.0,783.0,1297.0,1131.0,1306.0,959.0,996.0,931.0,548.0,805.0,1007.0,11423.0
Aurangabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,1.0,3.0,14.0,9.0,8.0,6.0,3.0,2.0,7.0,3.0,5.0,64.0
Aurangabad,15.2,Number of Widal tests conducted,Number tested,119.0,171.0,147.0,190.0,274.0,1030.0,309.0,271.0,58.0,10.0,142.0,34.0,2755.0
Aurangabad,15.3.a,Number of VDRL tests conducted on males,Number tested,343.0,4.0,57.0,157.0,122.0,14.0,8.0,120.0,8.0,62.0,40.0,7.0,942.0
Aurangabad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,125.0,60.0,77.0,62.0,169.0,21.0,18.0,105.0,2.0,35.0,43.0,7.0,724.0
Aurangabad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,412.0,92.0,115.0,220.0,146.0,36.0,22.0,216.0,0.0,0.0,125.0,14.0,1398.0
Aurangabad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,880.0,156.0,249.0,439.0,437.0,71.0,48.0,441.0,10.0,97.0,208.0,28.0,3064.0
Aurangabad,15.4.1,Number of blood smears examined for Malaria,TOTAL,2270.0,2890.0,2630.0,3280.0,3306.0,4018.0,2662.0,2629.0,1984.0,2431.0,2521.0,2306.0,32927.0
Aurangabad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10.0,9.0,10.0,20.0,24.0,85.0,20.0,18.0,9.0,4.0,14.0,11.0,234.0
Aurangabad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,1.0,9.0,0.0,0.0,0.0,0.0,122.0,3.0,135.0
Aurangabad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,0.0,6100.0,0.0,5650.0,5300.0,17050.0
Aurangabad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,0.0,0.0,1000.0,2000.0,0.0,3000.0
Aurangabad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,,,0.0,0.0
Aurangabad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,0.0,6000.0,850.0,2350.0,3050.0,12250.0
Aurangabad,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,150.0,5300.0,2250.0,7800.0
Aurangabad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,0.0,0.0,,12464.0,8314.0,20778.0
Aurangabad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,0.0,17700.0,1000.0,0.0,0.0,18700.0
Aurangabad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,0.0,0.0,,,0.0,0.0
Aurangabad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,0.0,1350.0,886.0,4150.0,5350.0,11736.0
Aurangabad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16350.0,114.0,8314.0,2964.0,27742.0
Aurangabad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,0.0,379.0,179.0,3696.0,2675.0,6929.0
Aurangabad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,0.0,93100.0,1150.0,3000.0,5000.0,102250.0
Aurangabad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,0.0,,,0.0,0.0
Aurangabad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,3360.0,1183.0,4021.0,6925.0,15489.0
Aurangabad,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,90119.0,146.0,2675.0,750.0,93690.0
Aurangabad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,11100.0,550.0,10050.0,7500.0,29200.0
Aurangabad,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,0.0,1000.0,0.0,0.0,1000.0
Aurangabad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,0.0,,,0.0,0.0
Aurangabad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,5850.0,1000.0,2550.0,3300.0,12700.0
Aurangabad,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5250.0,550.0,7500.0,4200.0,17500.0
Aurangabad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,0.0,0.0,,,0.0
Aurangabad,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,0.0,0.0,,,0.0
Aurangabad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,0.0,0.0,,,0.0
Aurangabad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,0.0,0.0,,,0.0
Aurangabad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,3000.0,400.0,4950.0,4950.0,13300.0
Aurangabad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,4000.0,2000.0,3200.0,3500.0,12700.0
Aurangabad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,0.0,0.0,,0.0,0.0
Aurangabad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,3700.0,1850.0,3200.0,5850.0,14600.0
Aurangabad,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3300.0,550.0,4950.0,2600.0,11400.0
Aurangabad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,250.0,70.0,7200.0,3750.0,11270.0
Aurangabad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,7000.0,2800.0,3000.0,6500.0,19300.0
Aurangabad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,0.0,,,0.0,0.0
Aurangabad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,5980.0,2620.0,6450.0,9700.0,24750.0
Aurangabad,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1270.0,250.0,3750.0,550.0,5820.0
Aurangabad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,920.0,940.0,5040.0,3240.0,10140.0
Aurangabad,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,4000.0,800.0,1000.0,3000.0,8800.0
Aurangabad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,0.0,,,0.0,0.0
Aurangabad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,3030.0,1250.0,2800.0,5890.0,12970.0
Aurangabad,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1890.0,490.0,3240.0,350.0,5970.0
Aurangabad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,3150.0,900.0,5450.0,5550.0,15050.0
Aurangabad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,2000.0,1202.0,4000.0,1000.0,8202.0
Aurangabad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,0.0,,,0.0,0.0
Aurangabad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,3550.0,1552.0,3900.0,5850.0,14852.0
Aurangabad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1600.0,550.0,5550.0,700.0,8400.0
Aurangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Aurangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Aurangabad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Aurangabad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Aurangabad,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Aurangabad,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Aurangabad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Aurangabad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,660.0,,,660.0
Aurangabad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Aurangabad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,0.0,,,0.0
Aurangabad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,660.0,0.0,0.0,660.0
Aurangabad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Aurangabad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Aurangabad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Aurangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Aurangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Aurangabad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Aurangabad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Aurangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Aurangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Aurangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Aurangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Aurangabad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Aurangabad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Aurangabad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Aurangabad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Aurangabad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Aurangabad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aurangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,18950.0,24150.0,27150.0,20750.0,91000.0
Aurangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,12000.0,10000.0,0.0,16500.0,38500.0
Aurangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,0.0,,,0.0,0.0
Aurangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,6800.0,7000.0,6400.0,15960.0,36160.0
Aurangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24150.0,27150.0,20750.0,21290.0,93340.0
Aurangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,78000.0,120400.0,173900.0,112900.0,485200.0
Aurangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,100000.0,100000.0,0.0,180000.0,380000.0
Aurangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,0.0,,,0.0,0.0
Aurangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,57600.0,46500.0,61000.0,122200.0,287300.0
Aurangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,120400.0,173900.0,112900.0,170700.0,577900.0
Aurangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,4500.0,6250.0,9250.0,4000.0,24000.0
Aurangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,7000.0,7000.0,0.0,12000.0,26000.0
Aurangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,0.0,,,0.0,0.0
Aurangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,5250.0,4000.0,5250.0,11800.0,26300.0
Aurangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6250.0,9250.0,4000.0,4200.0,23700.0
Aurangabad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Aurangabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Aurangabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Aurangabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Aurangabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Aurangabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Aurangabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Aurangabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Aurangabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Aurangabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Aurangabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Aurangabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Aurangabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Aurangabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Aurangabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aurangabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Aurangabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Aurangabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aurangabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Aurangabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Aurangabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aurangabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Aurangabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Aurangabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aurangabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Aurangabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Aurangabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Aurangabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Aurangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Aurangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Aurangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Aurangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Aurangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Banka,1.1,Total number of pregnant women Registered for ANC,TOTAL,5681.0,5219.0,5378.0,4637.0,4259.0,3950.0,3334.0,3478.0,3402.0,4387.0,4946.0,5283.0,53954.0
Banka,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2861.0,2551.0,2524.0,2178.0,1958.0,1801.0,1605.0,1699.0,1701.0,2245.0,2672.0,2715.0,26510.0
Banka,1.2,Number of Pregnant women registered under JSY,TOTAL,5675.0,5219.0,5378.0,4637.0,4259.0,3950.0,3334.0,3478.0,3402.0,4387.0,4946.0,5283.0,53948.0
Banka,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3750.0,3950.0,3941.0,4077.0,4046.0,3614.0,3413.0,3148.0,2739.0,2901.0,2824.0,3180.0,41583.0
Banka,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4186.0,3765.0,3849.0,3268.0,2958.0,2833.0,2382.0,2529.0,2403.0,3104.0,3527.0,3692.0,38496.0
Banka,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5358.0,5359.0,4986.0,4813.0,4481.0,4079.0,3993.0,3159.0,3240.0,3538.0,3961.0,5018.0,51985.0
Banka,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2267.0,2872.0,3284.0,3824.0,3809.0,3358.0,3113.0,2914.0,2574.0,2800.0,2599.0,2961.0,36375.0
Banka,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,42.0,19.0,9.0,12.0,49.0,10.0,16.0,27.0,9.0,12.0,23.0,7.0,235.0
Banka,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,2.0,4.0,2.0,5.0,5.0,1.0,2.0,3.0,2.0,2.0,2.0,31.0
Banka,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,4662.0,5396.0,5596.0,6102.0,6658.0,6319.0,5327.0,5167.0,4779.0,5430.0,6242.0,6352.0,68030.0
Banka,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,11.0,2.0,1.0,1.0,6.0,1.0,6.0,4.0,2.0,14.0,2.0,0.0,50.0
Banka,1.8,Number of pregnancy test kits used at SC level,TOTAL,273.0,906.0,968.0,932.0,864.0,785.0,565.0,474.0,594.0,579.0,582.0,636.0,8158.0
Banka,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,122.0,106.0,57.0,35.0,62.0,101.0,67.0,69.0,56.0,47.0,50.0,30.0,802.0
Banka,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,478.0,468.0,456.0,537.0,540.0,548.0,488.0,570.0,508.0,503.0,394.0,356.0,5846.0
Banka,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,600.0,574.0,513.0,572.0,602.0,649.0,555.0,639.0,564.0,550.0,444.0,386.0,6648.0
Banka,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,265.0,291.0,253.0,322.0,342.0,340.0,295.0,384.0,289.0,316.0,269.0,182.0,3548.0
Banka,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,3.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Banka,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2516.0,2746.0,2289.0,2971.0,3532.0,3833.0,4140.0,3464.0,3143.0,2612.0,2254.0,1966.0,35466.0
Banka,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2008.0,2111.0,1808.0,2387.0,2719.0,2869.0,3078.0,2588.0,2766.0,2295.0,2034.0,1796.0,28459.0
Banka,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,469.0,2702.0,205.0,693.0,1549.0,308.0,0.0,573.0,6487.0,7973.0,2374.0,2105.0,25438.0
Banka,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,253.0,676.0,4.0,766.0,618.0,68.0,0.0,2.0,2388.0,8220.0,3981.0,3235.0,20211.0
Banka,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33.0,7.0,24.0,64.0
Banka,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Banka,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Banka,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Banka,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Banka,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,4.0,1.0,0.0,12.0
Banka,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,2.0,3.0,4.0,0.0,10.0,8.0,2.0,8.0,12.0,0.0,5.0,5.0,59.0
Banka,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banka,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,6.0,3.0,4.0,0.0,10.0,8.0,3.0,10.0,12.0,4.0,6.0,5.0,71.0
Banka,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Banka,4.1.1.a,Number of male live births,TOTAL,1589.0,1696.0,1395.0,1749.0,2059.0,2286.0,2306.0,2071.0,1872.0,1613.0,1294.0,1214.0,21144.0
Banka,4.1.1.b,Number of female live births,TOTAL,1478.0,1557.0,1351.0,1733.0,1978.0,2115.0,2305.0,1970.0,1785.0,1487.0,1348.0,1090.0,20197.0
Banka,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3067.0,3253.0,2746.0,3482.0,4037.0,4401.0,4611.0,4041.0,3657.0,3100.0,2642.0,2304.0,41341.0
Banka,4.1.2,Number of still births,TOTAL,61.0,78.0,72.0,76.0,109.0,95.0,104.0,81.0,69.0,71.0,61.0,48.0,925.0
Banka,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,36.0,37.0,35.0,32.0,59.0,41.0,31.0,35.0,24.0,35.0,29.0,36.0,430.0
Banka,4.2.1,Number of Newborns weighed at birth,TOTAL,2925.0,3080.0,2587.0,3307.0,3884.0,4221.0,4442.0,3831.0,3471.0,2968.0,2559.0,2216.0,39491.0
Banka,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,171.0,161.0,185.0,242.0,290.0,315.0,264.0,268.0,210.0,192.0,137.0,124.0,2559.0
Banka,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2969.0,3188.0,2657.0,3407.0,3976.0,3848.0,4501.0,3950.0,3512.0,3026.0,2583.0,2238.0,39855.0
Banka,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,7.0,5.0,6.0,5.0,6.0,5.0,17.0,6.0,7.0,8.0,5.0,4.0,81.0
Banka,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,7.0,10.0,10.0,7.0,8.0,28.0,7.0,9.0,7.0,4.0,1.0,2.0,100.0
Banka,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,4.0,5.0,9.0,7.0,16.0,15.0,7.0,20.0,19.0,4.0,8.0,8.0,122.0
Banka,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banka,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,18.0,20.0,25.0,19.0,30.0,48.0,31.0,35.0,33.0,16.0,14.0,14.0,303.0
Banka,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Banka,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,13.0,18.0,23.0,15.0,26.0,46.0,24.0,30.0,31.0,13.0,13.0,13.0,265.0
Banka,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,4.0,10.0,10.0,6.0,6.0,6.0,5.0,7.0,5.0,0.0,0.0,2.0,61.0
Banka,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,13.0,17.0,21.0,18.0,28.0,45.0,21.0,24.0,152.0,11.0,10.0,9.0,369.0
Banka,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,1.0,2.0,0.0,1.0,4.0,0.0,0.0,1.0,2.0,2.0,0.0,0.0,13.0
Banka,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2701.0,2835.0,2581.0,3255.0,3848.0,4108.0,3926.0,3672.0,3226.0,2819.0,2413.0,2116.0,37500.0
Banka,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1621.0,1720.0,1428.0,1466.0,1980.0,1909.0,1790.0,2178.0,1680.0,1659.0,1396.0,1207.0,20034.0
Banka,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Banka,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,13.0,8.0,12.0,9.0,12.0,16.0,8.0,7.0,8.0,12.0,12.0,8.0,125.0
Banka,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,2.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,7.0
Banka,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,13.0,9.0,14.0,10.0,12.0,16.0,9.0,7.0,8.0,14.0,12.0,8.0,132.0
Banka,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,378.0,371.0,388.0,466.0,430.0,471.0,368.0,363.0,343.0,311.0,323.0,331.0,4543.0
Banka,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,216.0,227.0,237.0,273.0,274.0,307.0,220.0,209.0,232.0,196.0,212.0,214.0,2817.0
Banka,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,594.0,598.0,625.0,739.0,704.0,778.0,588.0,572.0,575.0,507.0,535.0,545.0,7360.0
Banka,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,1.0,4.0,1.0,1.0,0.0,0.0,8.0
Banka,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,4.0
Banka,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,5.0,8.0,4.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,20.0
Banka,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banka,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,5.0,9.0,4.0,2.0,0.0,0.0,1.0,5.0,1.0,2.0,3.0,0.0,32.0
Banka,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,5.0,4.0,9.0
Banka,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Banka,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banka,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Banka,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Banka,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,167.0,109.0,39.0,118.0,119.0,194.0,210.0,320.0,903.0,1158.0,1439.0,625.0,5401.0
Banka,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,73.0,26.0,17.0,40.0,38.0,80.0,106.0,121.0,388.0,739.0,681.0,412.0,2721.0
Banka,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,5.0,3.0,0.0,2.0,8.0,4.0,15.0,17.0,13.0,14.0,78.0,31.0,190.0
Banka,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banka,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,245.0,138.0,56.0,160.0,165.0,278.0,331.0,458.0,1304.0,1911.0,2198.0,1068.0,8312.0
Banka,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,21.0,19.0,,38.0,38.0,100.0,61.0,277.0
Banka,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,2.0,0.0,0.0,4.0,2.0,5.0,9.0,26.0,40.0,45.0,38.0,50.0,221.0
Banka,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,1.0,0.0,7.0,4.0,8.0,1.0,2.0,10.0,24.0,28.0,31.0,117.0
Banka,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,0.0,1.0,0.0,0.0,1.0,1.0,7.0,12.0,0.0,4.0,7.0,35.0
Banka,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banka,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,5.0,1.0,1.0,11.0,6.0,14.0,11.0,35.0,62.0,69.0,70.0,88.0,373.0
Banka,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,25.0,,,,,,,,,,,25.0
Banka,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,381.0,309.0,309.0,878.0,280.0,323.0,292.0,304.0,250.0,330.0,376.0,434.0,4466.0
Banka,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,69.0,34.0,21.0,267.0,35.0,25.0,25.0,41.0,27.0,37.0,71.0,85.0,737.0
Banka,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,3.0,0.0,0.0,8.0,38.0,46.0,40.0,38.0,27.0,35.0,42.0,277.0
Banka,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,20.0,30.0,7.0,12.0,,,5.0,1.0,6.0,6.0,6.0,8.0,101.0
Banka,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banka,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,470.0,376.0,337.0,1157.0,323.0,386.0,368.0,386.0,321.0,400.0,488.0,569.0,5581.0
Banka,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,71.0,98.0,69.0,117.0,42.0,47.0,77.0,79.0,54.0,148.0,104.0,77.0,983.0
Banka,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,4.0,,,,4.0
Banka,9.06,Number of IUCD removals,TOTAL,237.0,177.0,176.0,206.0,203.0,162.0,133.0,150.0,143.0,190.0,161.0,225.0,2163.0
Banka,9.07,Number of Oral Pills cycles distributed,TOTAL,571.0,924.0,802.0,761.0,706.0,619.0,410.0,402.0,432.0,740.0,912.0,1243.0,8522.0
Banka,9.08,Number of Condom pieces distributed,TOTAL,3515.0,4010.0,3609.0,4057.0,3860.0,2975.0,2449.0,2005.0,2000.0,3431.0,4139.0,4091.0,40141.0
Banka,9.09,Number of Centchroman (weekly) pills given,TOTAL,24.0,12.0,0.0,0.0,15.0,36.0,0.0,0.0,36.0,6.0,29.0,72.0,230.0
Banka,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,115.0,229.0,273.0,179.0,123.0,133.0,77.0,109.0,98.0,210.0,358.0,336.0,2240.0
Banka,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Banka,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,84.0,0.0,90.0
Banka,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,9.12,Number of Institutions having NSV trained doctors,TOTAL,,1.0,,,,,,,,,,,-1.0
Banka,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3769.0,3729.0,3197.0,3937.0,4701.0,5204.0,4000.0,5638.0,4733.0,3797.0,3428.0,3309.0,49442.0
Banka,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4356.0,3727.0,3862.0,3552.0,3533.0,4138.0,4273.0,5692.0,5186.0,720.0,27.0,4.0,39070.0
Banka,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,5435.0,4455.0,3894.0,3704.0,3708.0,3685.0,3805.0,4314.0,5139.0,5329.0,2169.0,916.0,46553.0
Banka,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,5774.0,5070.0,4360.0,4001.0,3698.0,3992.0,3377.0,3755.0,3906.0,4937.0,4502.0,3312.0,50684.0
Banka,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,29.0,39.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,4904.0,4528.0,4268.0,13771.0
Banka,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,37.0,28.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,2853.0,4525.0,7446.0
Banka,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,35.0,37.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,15.0,2257.0,2346.0
Banka,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2738.0,2940.0,2339.0,3080.0,3175.0,4092.0,2696.0,2931.0,3274.0,2387.0,2249.0,2023.0,33924.0
Banka,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4440.0,3812.0,3852.0,3422.0,2513.0,4544.0,2156.0,3946.0,5872.0,4227.0,4891.0,3896.0,47571.0
Banka,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5536.0,4511.0,3931.0,3542.0,2446.0,3809.0,1806.0,2656.0,4789.0,4424.0,4834.0,4730.0,47014.0
Banka,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5984.0,5235.0,4329.0,3804.0,2450.0,3971.0,1681.0,2380.0,3801.0,3732.0,4326.0,4817.0,46510.0
Banka,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2091.0,2305.0,1794.0,2547.0,3058.0,3537.0,3275.0,2983.0,2677.0,2274.0,1842.0,1722.0,30105.0
Banka,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4446.0,3795.0,3598.0,3676.0,3538.0,3924.0,4204.0,5820.0,4704.0,993.0,105.0,20.0,38823.0
Banka,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,5721.0,4591.0,3735.0,3827.0,4080.0,3508.0,3540.0,4319.0,4630.0,5338.0,2400.0,985.0,46674.0
Banka,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,6362.0,5448.0,4233.0,4317.0,3839.0,3864.0,3304.0,3788.0,3604.0,4962.0,4326.0,3391.0,51438.0
Banka,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3393.0,4081.0,4396.0,4841.0,4827.0,4523.0,3379.0,4184.0,3221.0,3257.0,2236.0,2776.0,45114.0
Banka,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4851.0,3871.0,3322.0,2995.0,2513.0,2399.0,1818.0,2341.0,2432.0,2850.0,2257.0,2906.0,34555.0
Banka,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,752.0,1366.0,1607.0,2805.0,2760.0,1403.0,1755.0,1964.0,2590.0,2803.0,2147.0,2620.0,24572.0
Banka,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1703.0,2052.0,2226.0,2441.0,2431.0,2231.0,1683.0,2039.0,1621.0,1644.0,1090.0,1410.0,22571.0
Banka,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1486.0,1883.0,1996.0,2209.0,2216.0,2071.0,1503.0,1944.0,1471.0,1432.0,1016.0,1244.0,20471.0
Banka,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3189.0,3935.0,4222.0,4650.0,4647.0,4302.0,3186.0,3983.0,3092.0,3076.0,2106.0,2654.0,43042.0
Banka,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4753.0,3888.0,3400.0,3027.0,2596.0,2542.0,2147.0,2543.0,2983.0,3462.0,3665.0,4198.0,39204.0
Banka,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4770.0,3876.0,3364.0,2912.0,2017.0,2638.0,1251.0,1949.0,3083.0,2816.0,3598.0,3740.0,36014.0
Banka,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,6.0,0.0,0.0,3.0,12.0
Banka,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,286.0,252.0,268.0,183.0,186.0,195.0,247.0,243.0,205.0,202.0,248.0,232.0,2747.0
Banka,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,234.0,242.0,230.0,190.0,152.0,149.0,140.0,168.0,255.0,183.0,242.0,190.0,2375.0
Banka,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,520.0,494.0,498.0,373.0,338.0,344.0,387.0,411.0,460.0,385.0,490.0,422.0,5122.0
Banka,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,63.0,49.0,26.0,90.0,54.0,112.0,79.0,79.0,106.0,107.0,160.0,86.0,1011.0
Banka,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,750.0,534.0,473.0,659.0,618.0,447.0,700.0,447.0,427.0,734.0,490.0,377.0,6656.0
Banka,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2159.0,1057.0,973.0,1531.0,1086.0,854.0,1844.0,907.0,1103.0,1809.0,1175.0,756.0,15254.0
Banka,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,6.0,12.0
Banka,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,8.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,10.0
Banka,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2254.0,2250.0,2143.0,2239.0,2172.0,2214.0,2190.0,2196.0,2213.0,2142.0,2181.0,2183.0,26377.0
Banka,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2251.0,2236.0,2133.0,2214.0,2162.0,2209.0,2156.0,2176.0,2204.0,2130.0,2106.0,2173.0,26150.0
Banka,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2137.0,2046.0,1977.0,2050.0,1975.0,2031.0,1981.0,1980.0,2030.0,1956.0,1976.0,1994.0,24133.0
Banka,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,110.0,94.0,113.0,231.0,433.0,290.0,150.0,167.0,621.0,1440.0,2594.0,3384.0,9627.0
Banka,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,625.0,701.0,535.0,1387.0,730.0,1002.0,617.0,688.0,578.0,526.0,274.0,254.0,7917.0
Banka,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,105.0,72.0,14.0,172.0,3.0,10.0,38.0,33.0,9.0,52.0,18.0,23.0,549.0
Banka,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,101.0,18.0,0.0,0.0,0.0,7.0,8.0,7.0,0.0,141.0
Banka,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,23.0,4.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,32.0
Banka,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,431.0,832.0,967.0,1379.0,2027.0,1662.0,1814.0,1260.0,1510.0,1306.0,1378.0,1715.0,16281.0
Banka,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Banka,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Banka,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,17.0,46.0,149.0,162.0,319.0,277.0,42.0,1012.0
Banka,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,17.0,46.0,149.0,162.0,319.0,277.0,42.0,1012.0
Banka,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Banka,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Banka,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1343.0,1481.0,1467.0,1367.0,1489.0,1481.0,1458.0,1478.0,1477.0,1480.0,1464.0,1489.0,-1.0
Banka,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Banka,14.05,Number of RKS meetings held during the month,TOTAL,4.0,4.0,6.0,7.0,4.0,5.0,5.0,5.0,4.0,7.0,11.0,5.0,67.0
Banka,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Banka,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,62.0,145.0,97.0,209.0,146.0,65.0,74.0,196.0,160.0,95.0,206.0,100.0,1555.0
Banka,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Banka,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,2.0,1.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Banka,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1326.0,1374.0,1095.0,1470.0,1633.0,1833.0,1975.0,1691.0,1548.0,1272.0,954.0,954.0,17125.0
Banka,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,618.0,671.0,678.0,750.0,850.0,1001.0,773.0,521.0,504.0,444.0,460.0,445.0,7715.0
Banka,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1301.0,1378.0,1351.0,1601.0,1802.0,1548.0,1932.0,1561.0,1476.0,1345.0,1162.0,898.0,17355.0
Banka,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4400.0,4802.0,4342.0,5085.0,5760.0,6490.0,6637.0,5911.0,5696.0,5677.0,6066.0,3735.0,64601.0
Banka,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2627.0,2752.0,2446.0,3071.0,3435.0,3381.0,3907.0,3252.0,3024.0,2617.0,2116.0,1852.0,34480.0
Banka,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5018.0,5473.0,5020.0,5835.0,6610.0,7491.0,7410.0,6432.0,6200.0,6121.0,6526.0,4180.0,72316.0
Banka,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,5.0,4.0,4.0,2.0,2.0,1.0,2.0,1.0,0.0,2.0,0.0,24.0
Banka,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,1.0,1.0,2.0,1.0,4.0,2.0,1.0,0.0,1.0,3.0,1.0,20.0
Banka,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,4.0,6.0,5.0,6.0,3.0,6.0,3.0,3.0,1.0,1.0,5.0,1.0,44.0
Banka,14.11,In-Patient Head Count at midnight,TOTAL,5526.0,5684.0,5268.0,6530.0,6969.0,7782.0,8073.0,5863.0,7475.0,6404.0,7129.0,4801.0,77504.0
Banka,14.12.1,OPD attendance (All),TOTAL,121669.0,127045.0,134963.0,169078.0,148636.0,167278.0,121031.0,121891.0,108212.0,100985.0,113964.0,109259.0,1544011.0
Banka,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,330.0,255.0,70.0,186.0,197.0,341.0,414.0,657.0,1675.0,2273.0,2796.0,1390.0,10584.0
Banka,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5.0,1.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,10.0
Banka,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2334.0,2514.0,2713.0,5985.0,3690.0,3189.0,2770.0,2875.0,2351.0,2727.0,2662.0,2151.0,35961.0
Banka,14.14.a,Number of patients given AYUSH treatment,TOTAL,24150.0,26771.0,28640.0,33032.0,33606.0,42106.0,23007.0,28195.0,14002.0,17785.0,24383.0,22391.0,318068.0
Banka,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,596.0,231.0,570.0,140.0,238.0,271.0,272.0,363.0,284.0,296.0,710.0,184.0,4155.0
Banka,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6891.0,7945.0,8168.0,9195.0,10005.0,10686.0,9405.0,9032.0,8787.0,9729.0,10478.0,12011.0,112332.0
Banka,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,44.0,38.0,19.0,20.0,45.0,37.0,16.0,33.0,14.0,21.0,53.0,54.0,394.0
Banka,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,271.0,265.0,317.0,417.0,333.0,88.0,185.0,307.0,237.0,242.0,205.0,65.0,2932.0
Banka,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,7.0,1.0,0.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,0.0,14.0
Banka,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,214.0,266.0,230.0,296.0,238.0,128.0,135.0,216.0,230.0,384.0,563.0,328.0,3228.0
Banka,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,4.0,0.0,0.0,0.0,0.0,2.0,0.0,4.0,0.0,0.0,0.0,10.0
Banka,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,462.0,344.0,383.0,631.0,498.0,223.0,181.0,429.0,378.0,281.0,364.0,119.0,4293.0
Banka,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,947.0,875.0,930.0,1344.0,1069.0,439.0,501.0,952.0,845.0,907.0,1132.0,512.0,10453.0
Banka,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,11.0,1.0,0.0,0.0,0.0,3.0,1.0,6.0,0.0,0.0,0.0,24.0
Banka,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,1.0,0.0,48.0,0.0,0.0,29.0,0.0,0.0,0.0,78.0
Banka,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,132.0,99.0,187.0,0.0,5.0,4.0,7.0,12.0,0.0,0.0,0.0,446.0
Banka,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,14.0,256.0,194.0,222.0,4.0,38.0,29.0,63.0,53.0,192.0,302.0,238.0,1605.0
Banka,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,144.0,216.0,94.0,141.0,167.0,180.0,126.0,103.0,137.0,61.0,0.0,0.0,1369.0
Banka,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,158.0,604.0,387.0,550.0,171.0,223.0,159.0,173.0,202.0,253.0,302.0,238.0,3420.0
Banka,15.4.1,Number of blood smears examined for Malaria,TOTAL,306.0,182.0,557.0,440.0,383.0,401.0,429.0,380.0,324.0,252.0,303.0,257.0,4214.0
Banka,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,0.0,5.0,5.0,3.0,2.0,0.0,6.0,0.0,0.0,0.0,0.0,24.0
Banka,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,1.0,1.0,0.0,1.0,4.0,0.0,2.0,0.0,0.0,1.0,1.0,12.0
Banka,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,250.0,,,200.0,200.0,1200.0,2050.0,,2150.0,950.0,750.0,7750.0
Banka,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,2000.0,,,2000.0,2500.0,1600.0,1500.0,,1600.0,1600.0,1600.0,16400.0
Banka,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Banka,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1750.0,1750.0,,,1800.0,1500.0,1550.0,1450.0,,2750.0,900.0,1350.0,14800.0
Banka,16.1.1,Stock position of DPT vaccines,5. Total Stock,250.0,500.0,0.0,0.0,400.0,1200.0,1250.0,2100.0,0.0,1000.0,1650.0,1000.0,9350.0
Banka,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,0.0,1600.0,1600.0
Banka,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,4150.0,0.0,4150.0
Banka,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Banka,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,1500.0,1200.0,2700.0
Banka,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2650.0,400.0,3050.0
Banka,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,75.0,50.0,,,25.0,375.0,0.0,50.0,,325.0,200.0,250.0,1350.0
Banka,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000.0,1500.0,,,1500.0,425.0,950.0,925.0,,950.0,1100.0,1350.0,9700.0
Banka,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Banka,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1025.0,1300.0,,,1125.0,800.0,900.0,600.0,,1250.0,700.0,1550.0,9250.0
Banka,16.1.2,Stock position of OPV vaccines,5. Total Stock,50.0,250.0,0.0,0.0,400.0,0.0,50.0,375.0,0.0,25.0,600.0,50.0,1800.0
Banka,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1700.0,2100.0,,,1800.0,800.0,2450.0,1450.0,,2950.0,1000.0,1000.0,15250.0
Banka,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,1000.0,,,500.0,2500.0,0.0,1500.0,,1600.0,1600.0,1200.0,11900.0
Banka,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Banka,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1600.0,1750.0,,,1000.0,850.0,650.0,1550.0,,2000.0,300.0,1200.0,10900.0
Banka,16.1.3,Stock position of TT vaccines,5. Total Stock,2100.0,1350.0,0.0,0.0,1300.0,2450.0,1800.0,1400.0,0.0,2550.0,2300.0,1000.0,16250.0
Banka,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,1200.0,,,,,,1200.0
Banka,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,1600.0,,,,,,1600.0
Banka,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Banka,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,1550.0,,,,,,1550.0
Banka,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1250.0,0.0,0.0,0.0,0.0,0.0,1250.0
Banka,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,50.0,,,650.0,1100.0,1100.0,1200.0,,950.0,800.0,450.0,6300.0
Banka,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,1000.0,,,1500.0,1000.0,1000.0,600.0,,950.0,500.0,950.0,8500.0
Banka,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Banka,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,950.0,700.0,,,,1000.0,900.0,850.0,,1100.0,350.0,750.0,6600.0
Banka,16.1.5,Stock position of BCG vaccines,5. Total Stock,50.0,350.0,0.0,0.0,2150.0,1100.0,1200.0,950.0,0.0,800.0,950.0,650.0,8200.0
Banka,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,200.0,100.0,,,,550.0,300.0,450.0,,0.0,0.0,175.0,1775.0
Banka,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1500.0,2500.0,,,,1500.0,1500.0,1400.0,,1500.0,1500.0,2000.0,13400.0
Banka,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Banka,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1600.0,2400.0,,,,1750.0,1350.0,1850.0,,1500.0,1350.0,2000.0,13800.0
Banka,16.1.6,Stock position of Measles vaccines,5. Total Stock,100.0,200.0,0.0,0.0,0.0,300.0,450.0,0.0,0.0,0.0,150.0,175.0,1375.0
Banka,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,,,,0.0,2450.0,150.0,,850.0,650.0,0.0,4100.0
Banka,16.1.7,Stock position of JE vaccines,2. Stocks Received,,2500.0,,,,2000.0,0.0,2500.0,,2000.0,1500.0,2400.0,12900.0
Banka,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Banka,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,2200.0,,,,1450.0,650.0,1850.0,,2150.0,950.0,1900.0,11150.0
Banka,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,300.0,0.0,0.0,0.0,550.0,1800.0,800.0,0.0,700.0,1200.0,500.0,5850.0
Banka,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,55.0,165.0,,,,550.0,550.0,900.0,,150.0,450.0,1000.0,3820.0
Banka,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1980.0,2000.0,,,,1600.0,2000.0,800.0,,2000.0,2000.0,800.0,13180.0
Banka,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Banka,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1870.0,1960.0,,,,1600.0,1800.0,1550.0,,1800.0,1400.0,650.0,12630.0
Banka,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,165.0,205.0,0.0,0.0,0.0,550.0,750.0,150.0,0.0,350.0,1050.0,1150.0,4370.0
Banka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Banka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Banka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Banka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Banka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Banka,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,,,,,,,,,,,0.0
Banka,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Banka,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Banka,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Banka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Banka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Banka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Banka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Banka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Banka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Banka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Banka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Banka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Banka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Banka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Banka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,71000.0,,,,14000.0,13800.0,13800.0,13800.0,,13800.0,13800.0,,154000.0
Banka,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,2000.0,,,,200.0,,,,,,,,2200.0
Banka,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,69000.0,0.0,0.0,0.0,13800.0,13800.0,13800.0,13800.0,0.0,13800.0,13800.0,0.0,151800.0
Banka,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Banka,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Banka,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Banka,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Banka,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Banka,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Banka,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,,,,0.0,,3250.0,1050.0,,193750.0,157750.0,,355800.0
Banka,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,,,0.0,6250.0,,193750.0,,,0.0,,200000.0
Banka,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,0.0,,,,,,0.0,,0.0
Banka,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,0.0,3000.0,2200.0,1050.0,,36000.0,29000.0,,71250.0
Banka,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,3250.0,1050.0,193750.0,0.0,157750.0,128750.0,0.0,484550.0
Banka,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Banka,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Banka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Banka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Banka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Banka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,,,,0.0,460000.0,277300.0,124800.0,,1000000.0,400000.0,,2262100.0
Banka,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,,,500000.0,52300.0,,1000000.0,,,,,1552300.0
Banka,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,,,,40000.0,235000.0,152500.0,124800.0,,600000.0,140000.0,,1292300.0
Banka,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,460000.0,277300.0,124800.0,1000000.0,0.0,400000.0,260000.0,0.0,2522100.0
Banka,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,50000.0,,,,1060.0,,,,,,,,51060.0
Banka,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,5000.0,,,,1060.0,,,,,,,,6060.0
Banka,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,45000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45000.0
Banka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Banka,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Banka,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Banka,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Banka,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banka,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,96400.0,,,,2100.0,,,,,,,,98500.0
Banka,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,,,,0.0,,,,,,,,0.0
Banka,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,11000.0,,,,2100.0,,,,,,,,13100.0
Banka,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,85400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,85400.0
Banka,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2900.0,0.0,,,,,2900.0,0.0,,,2700.0,900.0,9400.0
Banka,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,15000.0,,,,,0.0,16600.0,,,10000.0,12000.0,53600.0
Banka,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Banka,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2900.0,9900.0,,,,,2900.0,9600.0,,,4500.0,8600.0,38400.0
Banka,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,5100.0,0.0,0.0,0.0,0.0,0.0,7000.0,0.0,0.0,8200.0,4300.0,24600.0
Banka,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,73865.0,13865.0,,,,,46265.0,13665.0,,,40800.0,1900.0,190360.0
Banka,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,200000.0,,,,,0.0,130000.0,,,60000.0,80000.0,470000.0
Banka,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Banka,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,60000.0,62000.0,,,,,23600.0,84400.0,,,50400.0,60200.0,340600.0
Banka,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,13865.0,151865.0,0.0,0.0,0.0,0.0,22665.0,59265.0,0.0,0.0,50400.0,21700.0,319760.0
Banka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2900.0,0.0,,,,,,0.0,,,2900.0,3000.0,8800.0
Banka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,8000.0,,,,,,8000.0,,,6000.0,6000.0,28000.0
Banka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Banka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2900.0,4100.0,,,,,,6000.0,,,2100.0,5200.0,20300.0
Banka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,3900.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,6800.0,3800.0,16500.0
Banka,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Banka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Banka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Banka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Banka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Banka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Banka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Banka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Banka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Banka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Banka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Banka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Banka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Banka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Banka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Banka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Banka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Banka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Banka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Banka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Banka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Banka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Banka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Banka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Banka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Banka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Banka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Banka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Banka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Banka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Banka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Banka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Banka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Banka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Banka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Banka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Banka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Banka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Banka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Banka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Banka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Banka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Banka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Banka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Banka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Banka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Banka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Banka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Banka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Banka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Banka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Banka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Banka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Banka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Banka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Banka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Banka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Banka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Banka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Banka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Banka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Banka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Banka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Begusarai,1.1,Total number of pregnant women Registered for ANC,TOTAL,7315.0,6605.0,6537.0,7076.0,6557.0,6366.0,5891.0,6243.0,5767.0,6057.0,6619.0,7203.0,78236.0
Begusarai,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4791.0,4485.0,4499.0,5210.0,4468.0,4372.0,4124.0,4422.0,4440.0,4583.0,4557.0,5471.0,55422.0
Begusarai,1.2,Number of Pregnant women registered under JSY,TOTAL,7171.0,6399.0,6281.0,6791.0,6337.0,6060.0,5671.0,6038.0,5648.0,5992.0,6547.0,7134.0,76069.0
Begusarai,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4780.0,4182.0,4464.0,4635.0,4023.0,3966.0,3975.0,4205.0,4462.0,4262.0,4416.0,4895.0,52265.0
Begusarai,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4472.0,3780.0,4249.0,4420.0,3603.0,3294.0,3222.0,3166.0,3155.0,3369.0,3859.0,4159.0,44748.0
Begusarai,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,7077.0,5858.0,6642.0,6804.0,6176.0,5794.0,5730.0,5356.0,5147.0,5169.0,5391.0,6320.0,71464.0
Begusarai,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,5426.0,4457.0,5721.0,6286.0,6051.0,6109.0,5678.0,6086.0,6292.0,5962.0,6401.0,7129.0,71598.0
Begusarai,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,135.0,97.0,140.0,86.0,127.0,128.0,166.0,97.0,124.0,141.0,169.0,146.0,1556.0
Begusarai,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,263.0,382.0,295.0,243.0,137.0,131.0,139.0,131.0,110.0,128.0,596.0,183.0,2738.0
Begusarai,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,5.0
Begusarai,1.8,Number of pregnancy test kits used at SC level,TOTAL,592.0,392.0,656.0,556.0,691.0,1075.0,923.0,1272.0,1005.0,1213.0,1887.0,1722.0,11984.0
Begusarai,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,159.0,166.0,287.0,210.0,243.0,295.0,228.0,390.0,268.0,280.0,277.0,210.0,3013.0
Begusarai,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,262.0,223.0,354.0,296.0,294.0,384.0,260.0,428.0,398.0,284.0,337.0,340.0,3860.0
Begusarai,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,421.0,389.0,641.0,506.0,537.0,679.0,488.0,818.0,666.0,564.0,614.0,550.0,6873.0
Begusarai,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,281.0,281.0,405.0,378.0,339.0,417.0,324.0,635.0,524.0,381.0,508.0,414.0,4887.0
Begusarai,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,18.0,18.0,0.0,11.0,0.0,0.0,17.0,0.0,14.0,0.0,0.0,0.0,78.0
Begusarai,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3801.0,3852.0,3176.0,5094.0,5675.0,5109.0,5487.0,5152.0,4838.0,4828.0,4228.0,3341.0,54581.0
Begusarai,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3352.0,3626.0,3133.0,5013.0,5683.0,4643.0,5377.0,4987.0,4727.0,4670.0,4054.0,3305.0,52570.0
Begusarai,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2299.0,2632.0,2114.0,2975.0,3129.0,3008.0,3477.0,3060.0,6506.0,8248.0,4030.0,4927.0,46405.0
Begusarai,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1755.0,1892.0,1535.0,2625.0,2585.0,1302.0,2358.0,2458.0,5109.0,7658.0,3031.0,4505.0,36813.0
Begusarai,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,3.0,0.0,8.0
Begusarai,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,9.0,5.0,0.0,4.0,5.0,4.0,2.0,2.0,3.0,4.0,5.0,3.0,46.0
Begusarai,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Begusarai,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,10.0,5.0,1.0,5.0,5.0,5.0,2.0,2.0,3.0,5.0,8.0,3.0,54.0
Begusarai,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,4.1.1.a,Number of male live births,TOTAL,2700.0,2587.0,2436.0,3505.0,3645.0,3521.0,3374.0,3637.0,3353.0,3115.0,2784.0,2423.0,37080.0
Begusarai,4.1.1.b,Number of female live births,TOTAL,2460.0,2400.0,2178.0,3278.0,3372.0,3193.0,3160.0,3233.0,2966.0,2862.0,2668.0,2153.0,33923.0
Begusarai,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5160.0,4987.0,4614.0,6783.0,7017.0,6714.0,6534.0,6870.0,6319.0,5977.0,5452.0,4576.0,71003.0
Begusarai,4.1.2,Number of still births,TOTAL,64.0,56.0,59.0,92.0,102.0,78.0,86.0,88.0,89.0,71.0,60.0,47.0,892.0
Begusarai,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,2.0,7.0,11.0,10.0,18.0,1.0,19.0,197.0,231.0,10.0,17.0,7.0,530.0
Begusarai,4.2.1,Number of Newborns weighed at birth,TOTAL,4397.0,4456.0,3812.0,5909.0,6269.0,6031.0,6150.0,5517.0,5553.0,5611.0,5175.0,4148.0,63028.0
Begusarai,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,136.0,127.0,179.0,220.0,189.0,202.0,569.0,171.0,151.0,160.0,133.0,142.0,2379.0
Begusarai,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4365.0,4332.0,3868.0,5927.0,6299.0,6015.0,6148.0,6120.0,5563.0,5597.0,5140.0,4157.0,63531.0
Begusarai,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,6.0,2.0,3.0,23.0,5.0,3.0,0.0,0.0,0.0,5.0,1.0,51.0
Begusarai,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,9.0,5.0,0.0,4.0,5.0,4.0,2.0,2.0,3.0,4.0,5.0,3.0,46.0
Begusarai,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Begusarai,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,12.0,11.0,2.0,7.0,28.0,9.0,5.0,2.0,3.0,4.0,10.0,4.0,97.0
Begusarai,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,145.0,309.0,254.0,137.0,1254.0,1022.0,1091.0,914.0,528.0,1339.0,764.0,773.0,8530.0
Begusarai,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,45.0,25.0,0.0,39.0,4.0,0.0,7.0,0.0,11.0,54.0,15.0,69.0,269.0
Begusarai,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,81.0,37.0,25.0,551.0,1645.0,1374.0,1293.0,985.0,1260.0,663.0,709.0,618.0,9241.0
Begusarai,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,7.0,8.0,0.0,13.0,0.0,4.0,0.0,0.0,15.0,12.0,2.0,28.0,89.0
Begusarai,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2828.0,2636.0,2095.0,3529.0,3872.0,4332.0,3804.0,3474.0,3479.0,3352.0,3292.0,2507.0,39200.0
Begusarai,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1816.0,1864.0,2122.0,2535.0,2614.0,2666.0,2348.0,2688.0,3021.0,2502.0,2421.0,2002.0,28599.0
Begusarai,6.3,PNC maternal complications attended,TOTAL,13.0,0.0,0.0,0.0,0.0,4.0,2.0,0.0,0.0,0.0,0.0,1.0,20.0
Begusarai,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,7.0,8.0,8.0,13.0,0.0,13.0,8.0,19.0,9.0,14.0,0.0,99.0
Begusarai,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,7.0,8.0,8.0,13.0,0.0,13.0,8.0,19.0,9.0,14.0,0.0,99.0
Begusarai,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,33.0,55.0,14.0,61.0,28.0,27.0,49.0,46.0,8.0,18.0,12.0,14.0,365.0
Begusarai,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,49.0,87.0,21.0,40.0,33.0,35.0,53.0,50.0,32.0,29.0,50.0,11.0,490.0
Begusarai,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,82.0,142.0,35.0,101.0,61.0,62.0,102.0,96.0,40.0,47.0,62.0,25.0,855.0
Begusarai,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,8.0
Begusarai,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,9.0,4.0,6.0,2.0,7.0,5.0,7.0,2.0,9.0,51.0
Begusarai,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,3.0,3.0,1.0,16.0
Begusarai,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Begusarai,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,2.0,1.0,9.0,4.0,6.0,3.0,9.0,8.0,10.0,5.0,10.0,67.0
Begusarai,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Begusarai,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,168.0,34.0,77.0,1693.0,117.0,785.0,344.0,2565.0,2395.0,1505.0,2150.0,5065.0,16898.0
Begusarai,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,2.0,0.0,0.0,15.0,3.0,0.0,0.0,46.0,28.0,10.0,0.0,4.0,108.0
Begusarai,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,4.0,1.0,5.0,34.0,12.0,46.0,1.0,204.0,106.0,489.0,36.0,91.0,1029.0
Begusarai,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Begusarai,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,174.0,35.0,82.0,1742.0,132.0,831.0,345.0,2815.0,2529.0,2004.0,2186.0,5160.0,18035.0
Begusarai,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,115.0,0.0,0.0,0.0,0.0,504.0,0.0,0.0,2081.0,2700.0
Begusarai,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,2.0,0.0,10.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,29.0,50.0
Begusarai,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Begusarai,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,0.0,10.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,29.0,50.0
Begusarai,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,373.0,372.0,418.0,609.0,445.0,685.0,588.0,563.0,582.0,478.0,527.0,562.0,6202.0
Begusarai,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,195.0,299.0,455.0,911.0,456.0,426.0,510.0,491.0,387.0,636.0,588.0,566.0,5920.0
Begusarai,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,4.0,2.0,11.0,0.0,0.0,5.0,8.0,0.0,7.0,37.0
Begusarai,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,13.0,6.0,0.0,11.0,7.0,11.0,8.0,9.0,7.0,15.0,13.0,13.0,113.0
Begusarai,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Begusarai,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,581.0,677.0,873.0,1535.0,910.0,1133.0,1106.0,1063.0,981.0,1137.0,1128.0,1148.0,12272.0
Begusarai,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,159.0,267.0,230.0,887.0,358.0,652.0,429.0,347.0,289.0,318.0,274.0,252.0,4462.0
Begusarai,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.06,Number of IUCD removals,TOTAL,177.0,121.0,135.0,228.0,171.0,205.0,211.0,179.0,255.0,250.0,278.0,306.0,2516.0
Begusarai,9.07,Number of Oral Pills cycles distributed,TOTAL,784.0,832.0,1146.0,1356.0,1411.0,1678.0,1623.0,1656.0,1551.0,1518.0,1971.0,1643.0,17169.0
Begusarai,9.08,Number of Condom pieces distributed,TOTAL,3245.0,3598.0,3265.0,5539.0,4117.0,5581.0,4928.0,5325.0,6306.0,5317.0,6623.0,4294.0,58138.0
Begusarai,9.09,Number of Centchroman (weekly) pills given,TOTAL,110.0,55.0,60.0,112.0,129.0,103.0,57.0,67.0,83.0,78.0,42.0,93.0,989.0
Begusarai,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,133.0,61.0,52.0,143.0,134.0,146.0,177.0,293.0,242.0,299.0,485.0,212.0,2377.0
Begusarai,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Begusarai,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0,3.0,0.0,0.0,10.0
Begusarai,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,1.0,,,,,-1.0
Begusarai,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5331.0,5208.0,4805.0,6901.0,7083.0,6835.0,6366.0,7068.0,6368.0,6027.0,5537.0,4724.0,72253.0
Begusarai,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,6919.0,5497.0,6245.0,6307.0,5359.0,6070.0,6525.0,7440.0,6990.0,1700.0,504.0,39.0,59595.0
Begusarai,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,7301.0,5939.0,6420.0,6392.0,5405.0,5318.0,5638.0,6583.0,7083.0,6865.0,3342.0,1395.0,67681.0
Begusarai,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,7274.0,5895.0,6491.0,6452.0,5462.0,5394.0,5340.0,5862.0,6229.0,6765.0,5978.0,4315.0,71457.0
Begusarai,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0,5579.0,5694.0,6432.0,17729.0
Begusarai,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3298.0,5669.0,8967.0
Begusarai,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2824.0,2824.0
Begusarai,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,5336.0,5187.0,4796.0,6755.0,7003.0,6651.0,5481.0,5822.0,5498.0,5002.0,4993.0,4217.0,66741.0
Begusarai,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,6919.0,5490.0,6245.0,6307.0,5356.0,6010.0,5831.0,5683.0,6528.0,4430.0,6708.0,6537.0,72044.0
Begusarai,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7299.0,5934.0,6410.0,6392.0,5405.0,5253.0,5008.0,4810.0,6108.0,5829.0,6439.0,7139.0,72026.0
Begusarai,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,7274.0,5883.0,6491.0,6452.0,5470.0,5349.0,4768.0,4307.0,5401.0,5460.0,5976.0,7083.0,69914.0
Begusarai,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,4739.0,4647.0,4404.0,5781.0,6119.0,5873.0,5321.0,5295.0,5366.0,4460.0,4232.0,3123.0,59360.0
Begusarai,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,6883.0,5428.0,6130.0,6321.0,5332.0,6049.0,6508.0,7422.0,7021.0,1710.0,1116.0,296.0,60216.0
Begusarai,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7315.0,5840.0,6448.0,6368.0,5402.0,5327.0,5616.0,6559.0,7051.0,6792.0,3478.0,1331.0,67527.0
Begusarai,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,7308.0,5860.0,6451.0,6457.0,5446.0,5333.0,5302.0,5870.0,6228.0,6758.0,5850.0,4227.0,71090.0
Begusarai,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5633.0,5530.0,6473.0,7151.0,6069.0,6038.0,5357.0,6216.0,4960.0,5604.0,5458.0,5557.0,70046.0
Begusarai,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6181.0,4646.0,5414.0,5879.0,4564.0,4358.0,4037.0,4849.0,4422.0,5348.0,5684.0,6244.0,61626.0
Begusarai,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,16.0
Begusarai,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2868.0,2879.0,3224.0,3636.0,3125.0,3141.0,2819.0,3159.0,2633.0,2953.0,2831.0,2800.0,36068.0
Begusarai,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2625.0,2458.0,3029.0,3173.0,2768.0,2751.0,2533.0,2895.0,2285.0,2647.0,2570.0,2581.0,32315.0
Begusarai,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5493.0,5337.0,6253.0,6809.0,5893.0,5892.0,5352.0,6054.0,4918.0,5600.0,5401.0,5381.0,68383.0
Begusarai,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5959.0,4665.0,5355.0,5960.0,4538.0,4324.0,4153.0,4862.0,4693.0,5460.0,5667.0,5975.0,61611.0
Begusarai,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5959.0,4665.0,5355.0,5952.0,4538.0,4304.0,3815.0,3947.0,4501.0,4892.0,5880.0,6291.0,60099.0
Begusarai,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26.0,0.0,0.0,0.0,26.0
Begusarai,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2753.0,2325.0,2653.0,2759.0,2179.0,2324.0,2229.0,2372.0,2427.0,2575.0,2963.0,3218.0,30777.0
Begusarai,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2492.0,1907.0,2415.0,2533.0,1921.0,1990.0,2008.0,1983.0,1994.0,2253.0,2699.0,2906.0,27101.0
Begusarai,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,5245.0,4232.0,5068.0,5292.0,4100.0,4314.0,4237.0,4355.0,4421.0,4828.0,5662.0,6124.0,57878.0
Begusarai,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,390.0,258.0,249.0,290.0,337.0,275.0,342.0,437.0,396.0,424.0,392.0,600.0,4390.0
Begusarai,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,846.0,674.0,698.0,808.0,668.0,824.0,818.0,843.0,893.0,837.0,783.0,903.0,9595.0
Begusarai,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1102.0,1039.0,925.0,1125.0,970.0,1152.0,1141.0,1283.0,1166.0,1182.0,1140.0,1215.0,13440.0
Begusarai,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2976.0,2922.0,2868.0,3140.0,2824.0,2638.0,2900.0,2890.0,2957.0,2892.0,2699.0,2901.0,34607.0
Begusarai,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2970.0,2905.0,2850.0,3125.0,2811.0,2632.0,2893.0,2881.0,2956.0,2883.0,2684.0,2899.0,34489.0
Begusarai,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2633.0,2640.0,2566.0,2835.0,2519.0,2363.0,2642.0,2627.0,2709.0,2786.0,2602.0,2823.0,31745.0
Begusarai,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5130.0,5435.0,6360.0,8451.0,6069.0,6045.0,5347.0,5622.0,4914.0,5613.0,5316.0,5290.0,69592.0
Begusarai,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,494.0,644.0,673.0,30793.0,584.0,733.0,689.0,797.0,694.0,784.0,825.0,1401.0,39111.0
Begusarai,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,26.0,0.0,0.0,19102.0,0.0,9.0,13.0,14.0,11.0,0.0,4.0,0.0,19179.0
Begusarai,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,7.0,5.0,0.0,0.0,0.0,0.0,12.0
Begusarai,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,77.0,7.0,0.0,0.0,0.0,0.0,84.0
Begusarai,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,5.0
Begusarai,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Begusarai,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,24.0,0.0,15.0,17.0,0.0,14.0,0.0,9.0,4.0,0.0,0.0,0.0,83.0
Begusarai,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,223.0,130.0,158.0,124.0,219.0,239.0,301.0,347.0,461.0,1565.0,1336.0,1397.0,6500.0
Begusarai,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,9.0,0.0,10.0,1.0,4.0,0.0,5.0,2.0,0.0,0.0,0.0,0.0,31.0
Begusarai,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,51.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,7.0,0.0,0.0,62.0
Begusarai,13.1,Number of Patients operated for cataract,TOTAL,10.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,8.0,24.0,6.0,54.0
Begusarai,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,10.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,8.0,24.0,6.0,54.0
Begusarai,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Begusarai,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Begusarai,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2117.0,2224.0,2262.0,2258.0,2153.0,2065.0,2175.0,2301.0,2337.0,2298.0,2248.0,2300.0,-1.0
Begusarai,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Begusarai,14.05,Number of RKS meetings held during the month,TOTAL,11.0,11.0,10.0,15.0,8.0,12.0,9.0,9.0,9.0,10.0,17.0,16.0,137.0
Begusarai,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Begusarai,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,2034.0,1809.0,1828.0,2028.0,1726.0,1417.0,2119.0,2055.0,2395.0,2765.0,2040.0,2225.0,24441.0
Begusarai,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Begusarai,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,2.0,-1.0
Begusarai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,312.0,349.0,369.0,520.0,354.0,1423.0,505.0,544.0,372.0,550.0,329.0,353.0,5980.0
Begusarai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1194.0,1120.0,639.0,1348.0,1361.0,706.0,1084.0,1237.0,945.0,1050.0,1095.0,1014.0,12793.0
Begusarai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,251.0,310.0,357.0,376.0,475.0,570.0,407.0,397.0,419.0,539.0,350.0,380.0,4831.0
Begusarai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3665.0,4127.0,2947.0,6257.0,5026.0,5575.0,4968.0,6958.0,6677.0,5775.0,5387.0,4863.0,62225.0
Begusarai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,563.0,659.0,726.0,896.0,829.0,1993.0,912.0,941.0,791.0,1089.0,679.0,733.0,10811.0
Begusarai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4859.0,5247.0,3586.0,7605.0,6387.0,6281.0,6052.0,8195.0,7622.0,6825.0,6482.0,5877.0,75018.0
Begusarai,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,7.0,0.0,8.0,8.0,7.0,2.0,5.0,3.0,4.0,4.0,8.0,63.0
Begusarai,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,5.0,1.0,4.0,7.0,5.0,4.0,2.0,4.0,1.0,1.0,2.0,42.0
Begusarai,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13.0,12.0,1.0,12.0,15.0,12.0,6.0,7.0,7.0,5.0,5.0,10.0,105.0
Begusarai,14.11,In-Patient Head Count at midnight,TOTAL,5207.0,5320.0,3975.0,7352.0,6289.0,6556.0,6025.0,6954.0,7311.0,7045.0,6105.0,6212.0,74351.0
Begusarai,14.12.1,OPD attendance (All),TOTAL,125545.0,123747.0,118513.0,145653.0,140407.0,149763.0,142499.0,156509.0,148586.0,141466.0,142435.0,149272.0,1684395.0
Begusarai,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,17.0,22.0,31.0,18.0,18.0,58.0,142.0,23.0,16.0,25.0,398.0,11.0,779.0
Begusarai,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,31.0,0.0,0.0,0.0,0.0,33.0
Begusarai,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,106.0,59.0,40.0,126.0,97.0,137.0,85.0,60.0,86.0,108.0,114.0,112.0,1130.0
Begusarai,14.14.a,Number of patients given AYUSH treatment,TOTAL,17215.0,17611.0,20307.0,22243.0,18213.0,20641.0,17022.0,20863.0,17394.0,21013.0,21581.0,25154.0,239257.0
Begusarai,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2898.0,3357.0,2916.0,4037.0,3015.0,2952.0,3761.0,3763.0,3810.0,3963.0,4077.0,3083.0,41632.0
Begusarai,14.14.c,Number of Adolescents counselled,TOTAL,70.0,0.0,109.0,62.0,72.0,39.0,34.0,45.0,45.0,42.0,21.0,32.0,571.0
Begusarai,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1455.0,1269.0,805.0,1634.0,1157.0,1357.0,946.0,2074.0,1347.0,1049.0,1165.0,1146.0,15404.0
Begusarai,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,51.0,43.0,23.0,6.0,47.0,36.0,15.0,29.0,21.0,18.0,20.0,27.0,336.0
Begusarai,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,522.0,551.0,84.0,718.0,567.0,559.0,410.0,312.0,413.0,523.0,392.0,428.0,5479.0
Begusarai,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,28.0,44.0,4.0,33.0,36.0,33.0,23.0,26.0,24.0,15.0,24.0,11.0,301.0
Begusarai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,807.0,586.0,178.0,909.0,610.0,689.0,500.0,1445.0,1293.0,1472.0,622.0,671.0,9782.0
Begusarai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,26.0,28.0,5.0,24.0,26.0,23.0,14.0,25.0,16.0,15.0,21.0,5.0,228.0
Begusarai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,977.0,995.0,452.0,1234.0,1237.0,1123.0,759.0,770.0,1296.0,976.0,708.0,773.0,11300.0
Begusarai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,1.0,1.0,1.0,3.0,1.0,2.0,1.0,2.0,0.0,1.0,2.0,17.0
Begusarai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2306.0,2132.0,714.0,2861.0,2414.0,2371.0,1669.0,2527.0,3002.0,2971.0,1722.0,1872.0,26561.0
Begusarai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,56.0,73.0,10.0,58.0,65.0,57.0,39.0,52.0,42.0,30.0,46.0,18.0,546.0
Begusarai,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,83.0,29.0,0.0,158.0,73.0,0.0,0.0,343.0
Begusarai,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,15.4.1,Number of blood smears examined for Malaria,TOTAL,27.0,13.0,0.0,28.0,17.0,39.0,34.0,38.0,12.0,11.0,13.0,18.0,250.0
Begusarai,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3134.0,1292.0,751.0,3032.0,1657.0,4224.0,2175.0,2025.0,975.0,1265.0,1865.0,21065.0,43460.0
Begusarai,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,3000.0,5000.0,3000.0,5000.0,1000.0,3000.0,2000.0,3000.0,3000.0,2000.0,0.0,32000.0
Begusarai,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3842.0,3541.0,2719.0,4375.0,2433.0,3049.0,3150.0,3050.0,,2400.0,2100.0,1100.0,31759.0
Begusarai,16.1.1,Stock position of DPT vaccines,5. Total Stock,1292.0,751.0,3032.0,1657.0,4224.0,2175.0,2025.0,975.0,3975.0,1865.0,1765.0,19965.0,43701.0
Begusarai,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,5937.0,4272.0,3602.0,13811.0
Begusarai,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,2277.0,2277.0
Begusarai,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3801.0,1170.0,1325.0,6296.0
Begusarai,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2136.0,3102.0,0.0,5238.0
Begusarai,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1340.0,670.0,658.0,689.0,488.0,550.0,0.0,165.0,,0.0,500.0,800.0,5860.0
Begusarai,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1800.0,2500.0,2000.0,3000.0,1500.0,925.0,1500.0,0.0,,1500.0,1400.0,2440.0,18565.0
Begusarai,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2470.0,2512.0,1999.0,3201.0,1438.0,1475.0,1335.0,165.0,,1000.0,1625.0,2325.0,19545.0
Begusarai,16.1.2,Stock position of OPV vaccines,5. Total Stock,670.0,658.0,659.0,488.0,550.0,0.0,165.0,0.0,0.0,500.0,275.0,915.0,4880.0
Begusarai,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1834.0,1153.0,1880.0,2948.0,1574.0,674.0,1124.0,2324.0,,2724.0,2324.0,1974.0,20533.0
Begusarai,16.1.3,Stock position of TT vaccines,2. Stocks Received,1600.0,3000.0,3000.0,1500.0,1000.0,3000.0,3000.0,1000.0,,1000.0,1000.0,1000.0,20100.0
Begusarai,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2281.0,2273.0,1932.0,2874.0,1900.0,2550.0,1800.0,1274.0,,1400.0,1750.0,1500.0,21534.0
Begusarai,16.1.3,Stock position of TT vaccines,5. Total Stock,1153.0,1880.0,2948.0,1574.0,674.0,1124.0,2324.0,2050.0,0.0,2324.0,1574.0,1474.0,19099.0
Begusarai,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2436.0,2680.0,2557.0,1733.0,1633.0,1463.0,363.0,1008.0,,1033.0,1458.0,1658.0,18022.0
Begusarai,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1500.0,1000.0,0.0,1000.0,1000.0,0.0,1500.0,1000.0,,1500.0,1000.0,900.0,10400.0
Begusarai,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,1100.0,0.0,1100.0,0.0,0.0,,0.0,0.0,0.0,2200.0
Begusarai,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1256.0,1123.0,824.0,1633.0,1170.0,363.0,855.0,1170.0,,1075.0,1085.0,885.0,11439.0
Begusarai,16.1.5,Stock position of BCG vaccines,5. Total Stock,2680.0,2557.0,1733.0,0.0,1463.0,0.0,1008.0,838.0,0.0,1458.0,1373.0,1673.0,14783.0
Begusarai,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3762.0,1658.0,1865.0,1905.0,750.0,1900.0,100.0,50.0,0.0,150.0,1440.0,200.0,13780.0
Begusarai,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,3000.0,4000.0,1500.0,4000.0,900.0,2300.0,2300.0,2700.0,4300.0,2000.0,4000.0,32000.0
Begusarai,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3104.0,2793.0,3960.0,2655.0,2850.0,2700.0,2350.0,2350.0,2550.0,2910.0,3440.0,3000.0,34662.0
Begusarai,16.1.6,Stock position of Measles vaccines,5. Total Stock,1658.0,1865.0,1905.0,750.0,1900.0,100.0,50.0,0.0,150.0,1540.0,0.0,1200.0,11118.0
Begusarai,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,668.0,1572.0,3517.0,955.0,1155.0,3105.0,1305.0,1905.0,,1240.0,1700.0,1950.0,19072.0
Begusarai,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,4000.0,1600.0,4000.0,4000.0,1000.0,3000.0,2000.0,3000.0,3000.0,1500.0,0.0,30100.0
Begusarai,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,4162.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,700.0,4862.0
Begusarai,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2096.0,2055.0,955.0,3800.0,2050.0,2800.0,2400.0,2650.0,,2540.0,1750.0,1250.0,24346.0
Begusarai,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1572.0,3517.0,0.0,1155.0,3105.0,1305.0,1905.0,1255.0,3000.0,1700.0,1450.0,0.0,19964.0
Begusarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Begusarai,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7671.0,13921.0,20721.0,13621.0,15321.0,12121.0,1021.0,3121.0,,3600.0,4600.0,5300.0,101018.0
Begusarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,13000.0,15000.0,0.0,10000.0,7000.0,0.0,5000.0,8000.0,,10500.0,7000.0,10000.0,85500.0
Begusarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,6750.0,8200.0,7100.0,8300.0,10200.0,11100.0,2900.0,9500.0,8021.0,9500.0,8100.0,6200.0,95871.0
Begusarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,13921.0,20721.0,13621.0,15321.0,12121.0,1021.0,3121.0,1621.0,-8021.0,4600.0,3500.0,9100.0,90647.0
Begusarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,25478.0,34400.0,31800.0,70200.0,10800.0,22600.0,14400.0,44000.0,27000.0,2800.0,40200.0,63200.0,386878.0
Begusarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,70000.0,80000.0,100000.0,50000.0,90000.0,80000.0,80000.0,60000.0,80000.0,6000.0,80000.0,70000.0,846000.0
Begusarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,61078.0,82600.0,61600.0,109400.0,78200.0,88200.0,50400.0,77000.0,72800.0,4000.0,75000.0,88000.0,848278.0
Begusarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,34400.0,31800.0,70200.0,10800.0,22600.0,14400.0,44000.0,27000.0,34200.0,4800.0,45200.0,45200.0,384600.0
Begusarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1010.0,1185.0,2500.0,3200.0,1700.0,1400.0,0.0,1900.0,1200.0,34200.0,4800.0,3000.0,56095.0
Begusarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2500.0,4000.0,4000.0,5000.0,4000.0,3500.0,8000.0,4500.0,6000.0,80000.0,2000.0,5000.0,128500.0
Begusarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Begusarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2325.0,2685.0,3300.0,6500.0,4300.0,4900.0,6100.0,5200.0,4400.0,74000.0,5000.0,4300.0,123010.0
Begusarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1185.0,2500.0,3200.0,1700.0,1400.0,0.0,1900.0,1200.0,2800.0,40200.0,1800.0,3700.0,61585.0
Begusarai,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Begusarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Begusarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Begusarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Begusarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Begusarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Begusarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Begusarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Begusarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Begusarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Begusarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Begusarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Begusarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Begusarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Begusarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Begusarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Begusarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Begusarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Begusarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Begusarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Begusarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Begusarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Begusarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Begusarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Begusarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Begusarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Begusarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Begusarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Begusarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Begusarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Begusarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Begusarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Begusarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Begusarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Begusarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Begusarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Begusarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Begusarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Begusarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Begusarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Begusarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Begusarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Begusarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Begusarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Begusarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Begusarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Begusarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Begusarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Begusarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Begusarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Begusarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Begusarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Begusarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Begusarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Begusarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Begusarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Begusarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Bhagalpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,7223.0,6993.0,6995.0,6459.0,6184.0,6173.0,4418.0,4905.0,4579.0,5250.0,6228.0,6341.0,71748.0
Bhagalpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3204.0,2861.0,2732.0,2710.0,2639.0,2564.0,1949.0,2177.0,2159.0,2494.0,2828.0,2898.0,31215.0
Bhagalpur,1.2,Number of Pregnant women registered under JSY,TOTAL,7207.0,7005.0,6982.0,6455.0,6179.0,6169.0,4410.0,4892.0,4571.0,5245.0,6214.0,6279.0,71608.0
Bhagalpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3639.0,3733.0,3877.0,4049.0,4123.0,4177.0,3550.0,3464.0,3401.0,3183.0,3147.0,3533.0,43876.0
Bhagalpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4731.0,4490.0,4804.0,4017.0,3699.0,3625.0,2686.0,2922.0,2752.0,3441.0,4005.0,4024.0,45196.0
Bhagalpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6843.0,6748.0,6938.0,6135.0,6344.0,6055.0,4935.0,4410.0,4285.0,4641.0,5106.0,6037.0,68477.0
Bhagalpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3583.0,3585.0,3856.0,4009.0,4236.0,4369.0,3538.0,3610.0,3515.0,3355.0,3311.0,3732.0,44699.0
Bhagalpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,117.0,295.0,210.0,103.0,128.0,128.0,48.0,107.0,71.0,147.0,221.0,245.0,1820.0
Bhagalpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,12.0,10.0,50.0,37.0,8.0,4.0,32.0,19.0,17.0,26.0,45.0,35.0,295.0
Bhagalpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1440.0,2138.0,1583.0,1781.0,2109.0,2191.0,1298.0,1555.0,1731.0,1786.0,1879.0,2312.0,21803.0
Bhagalpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,16.0,23.0,14.0,43.0,14.0,43.0,17.0,23.0,33.0,14.0,23.0,48.0,311.0
Bhagalpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,77.0,141.0,181.0,88.0,145.0,71.0,51.0,68.0,64.0,103.0,65.0,18.0,1072.0
Bhagalpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,238.0,208.0,162.0,152.0,208.0,164.0,174.0,227.0,199.0,176.0,119.0,148.0,2175.0
Bhagalpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,733.0,690.0,755.0,683.0,883.0,1083.0,916.0,940.0,762.0,902.0,643.0,573.0,9563.0
Bhagalpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,971.0,898.0,917.0,835.0,1091.0,1247.0,1090.0,1167.0,961.0,1078.0,762.0,721.0,11738.0
Bhagalpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,527.0,405.0,633.0,464.0,823.0,709.0,578.0,624.0,800.0,523.0,297.0,334.0,6717.0
Bhagalpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,1.0,12.0,0.0,0.0,25.0
Bhagalpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3092.0,3047.0,2814.0,3854.0,4472.0,5085.0,5129.0,4501.0,4134.0,3655.0,3062.0,2739.0,45584.0
Bhagalpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2508.0,2875.0,1752.0,2919.0,3840.0,4521.0,3305.0,3141.0,3630.0,3151.0,2450.0,1980.0,36072.0
Bhagalpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2803.0,2371.0,2370.0,1865.0,1303.0,1730.0,2869.0,3795.0,10482.0,8389.0,3648.0,4548.0,46173.0
Bhagalpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1587.0,1937.0,1127.0,1383.0,910.0,1065.0,1764.0,1150.0,3629.0,8720.0,2282.0,6905.0,32459.0
Bhagalpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Bhagalpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Bhagalpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Bhagalpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Bhagalpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Bhagalpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,3.0
Bhagalpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,42.0,44.0,47.0,42.0,38.0,59.0,40.0,45.0,26.0,22.0,23.0,15.0,443.0
Bhagalpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhagalpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,42.0,45.0,48.0,42.0,38.0,59.0,40.0,45.0,26.0,23.0,23.0,15.0,446.0
Bhagalpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Bhagalpur,4.1.1.a,Number of male live births,TOTAL,2222.0,2222.0,2080.0,2586.0,3054.0,3423.0,3399.0,3197.0,2763.0,2544.0,2040.0,1926.0,31456.0
Bhagalpur,4.1.1.b,Number of female live births,TOTAL,2045.0,1996.0,1737.0,2367.0,2872.0,3251.0,3230.0,2863.0,2666.0,2399.0,1849.0,1743.0,29018.0
Bhagalpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4267.0,4218.0,3817.0,4953.0,5926.0,6674.0,6629.0,6060.0,5429.0,4943.0,3889.0,3669.0,60474.0
Bhagalpur,4.1.2,Number of still births,TOTAL,74.0,69.0,63.0,100.0,130.0,136.0,135.0,87.0,74.0,88.0,64.0,79.0,1099.0
Bhagalpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,45.0,43.0,22.0,46.0,39.0,35.0,19.0,20.0,18.0,41.0,13.0,48.0,389.0
Bhagalpur,4.2.1,Number of Newborns weighed at birth,TOTAL,3928.0,3818.0,3569.0,4596.0,5472.0,6137.0,5982.0,5509.0,5059.0,4667.0,3693.0,3506.0,55936.0
Bhagalpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,200.0,414.0,214.0,256.0,369.0,381.0,372.0,318.0,270.0,260.0,152.0,162.0,3368.0
Bhagalpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4083.0,3923.0,3685.0,4269.0,5590.0,6325.0,6199.0,5727.0,5195.0,4779.0,3814.0,3589.0,57178.0
Bhagalpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0,50.0,0.0,96.0
Bhagalpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,5.0,4.0,2.0,0.0,0.0,0.0,11.0,4.0,15.0,41.0
Bhagalpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhagalpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,1.0,5.0,4.0,2.0,0.0,0.0,0.0,56.0,54.0,15.0,137.0
Bhagalpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Bhagalpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,76.0,97.0,189.0,177.0,469.0,111.0,36.0,680.0,681.0,531.0,771.0,446.0,4264.0
Bhagalpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,16.0,15.0,0.0,9.0,8.0,16.0,15.0,2.0,17.0,6.0,322.0,10.0,436.0
Bhagalpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,110.0,118.0,21.0,19.0,62.0,16.0,1.0,514.0,384.0,232.0,578.0,249.0,2304.0
Bhagalpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,12.0,28.0,0.0,52.0,31.0,38.0,22.0,21.0,6.0,8.0,9.0,21.0,248.0
Bhagalpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2477.0,2277.0,2350.0,3337.0,4024.0,4143.0,3647.0,3117.0,3476.0,3039.0,2141.0,2322.0,36350.0
Bhagalpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1944.0,1792.0,1381.0,1719.0,2009.0,2250.0,2035.0,2101.0,2175.0,1989.0,1710.0,1758.0,22863.0
Bhagalpur,6.3,PNC maternal complications attended,TOTAL,212.0,26.0,1.0,36.0,21.0,47.0,6.0,28.0,17.0,27.0,39.0,11.0,471.0
Bhagalpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,11.0,56.0,21.0,95.0,7.0,12.0,4.0,6.0,0.0,3.0,0.0,8.0,223.0
Bhagalpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,71.0,33.0,65.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,169.0
Bhagalpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,11.0,127.0,54.0,160.0,7.0,12.0,4.0,6.0,0.0,3.0,0.0,8.0,392.0
Bhagalpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,152.0,150.0,20.0,102.0,152.0,65.0,39.0,492.0,87.0,77.0,21.0,82.0,1439.0
Bhagalpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,800.0,869.0,422.0,738.0,764.0,835.0,362.0,376.0,855.0,664.0,370.0,657.0,7712.0
Bhagalpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,952.0,1019.0,442.0,840.0,916.0,900.0,401.0,868.0,942.0,741.0,391.0,739.0,9151.0
Bhagalpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,379.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0,0.0,0.0,0.0,340.0,736.0
Bhagalpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,6.0,4.0,0.0,0.0,20.0
Bhagalpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Bhagalpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,1.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,12.0
Bhagalpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhagalpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,1.0,0.0,18.0,0.0,0.0,1.0,0.0,6.0,5.0,0.0,0.0,33.0
Bhagalpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,8.0,,,,9.0,17.0
Bhagalpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,71.0,0.0,0.0,0.0,81.0
Bhagalpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhagalpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,71.0,0.0,0.0,0.0,81.0
Bhagalpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bhagalpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,115.0,45.0,10.0,326.0,110.0,104.0,122.0,720.0,1026.0,953.0,1101.0,643.0,5275.0
Bhagalpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,64.0,27.0,16.0,184.0,16.0,60.0,66.0,478.0,603.0,389.0,624.0,350.0,2877.0
Bhagalpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,48.0,6.0,10.0,21.0,17.0,14.0,22.0,132.0,76.0,62.0,79.0,32.0,519.0
Bhagalpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhagalpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,227.0,78.0,36.0,531.0,143.0,178.0,210.0,1330.0,1705.0,1404.0,1804.0,1025.0,8671.0
Bhagalpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,19.0,,,318.0,,,,770.0,1107.0
Bhagalpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,31.0,21.0,17.0,17.0,90.0
Bhagalpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,6.0,5.0,3.0,8.0,0.0,10.0,2.0,22.0,68.0,50.0,55.0,40.0,269.0
Bhagalpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,16.0,8.0,17.0,25.0,9.0,10.0,0.0,5.0,33.0,8.0,38.0,27.0,196.0
Bhagalpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhagalpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,22.0,13.0,20.0,33.0,9.0,20.0,2.0,31.0,132.0,79.0,110.0,84.0,555.0
Bhagalpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,501.0,,,,,501.0
Bhagalpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,238.0,271.0,215.0,847.0,371.0,359.0,333.0,365.0,276.0,265.0,273.0,290.0,4103.0
Bhagalpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,86.0,99.0,62.0,587.0,101.0,85.0,46.0,111.0,112.0,200.0,79.0,80.0,1648.0
Bhagalpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,11.0,10.0,26.0,183.0,54.0,9.0,44.0,7.0,8.0,11.0,12.0,20.0,395.0
Bhagalpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,192.0,48.0,26.0,100.0,10.0,15.0,29.0,19.0,42.0,72.0,68.0,23.0,644.0
Bhagalpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhagalpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,527.0,428.0,329.0,1717.0,536.0,468.0,452.0,502.0,438.0,548.0,432.0,413.0,6790.0
Bhagalpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,287.0,168.0,214.0,277.0,187.0,207.0,152.0,143.0,162.0,173.0,188.0,254.0,2412.0
Bhagalpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bhagalpur,9.06,Number of IUCD removals,TOTAL,161.0,161.0,133.0,170.0,172.0,125.0,112.0,119.0,103.0,99.0,74.0,98.0,1527.0
Bhagalpur,9.07,Number of Oral Pills cycles distributed,TOTAL,1568.0,2155.0,1500.0,3451.0,1896.0,2166.0,1547.0,1561.0,1864.0,1820.0,2273.0,1964.0,23765.0
Bhagalpur,9.08,Number of Condom pieces distributed,TOTAL,6650.0,7444.0,8275.0,18689.0,11774.0,12325.0,10462.0,9356.0,12235.0,12225.0,10455.0,9893.0,129783.0
Bhagalpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,47.0,5.0,30.0,18.0,80.0,24.0,8.0,4.0,48.0,10.0,60.0,43.0,377.0
Bhagalpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,2.0,6.0,210.0,156.0,172.0,137.0,69.0,118.0,99.0,90.0,135.0,1194.0
Bhagalpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Bhagalpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,6.0,8.0,6.0,54.0,12.0,10.0,15.0,127.0,3.0,0.0,1.0,0.0,242.0
Bhagalpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bhagalpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Bhagalpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5159.0,5011.0,4880.0,5242.0,6412.0,8594.0,6103.0,8455.0,5537.0,6973.0,4148.0,5095.0,71609.0
Bhagalpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,6119.0,5567.0,5558.0,4387.0,4571.0,5766.0,6092.0,8384.0,7494.0,1512.0,181.0,83.0,55714.0
Bhagalpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,7464.0,6143.0,6154.0,4631.0,4972.0,5118.0,4891.0,5937.0,7499.0,7792.0,3443.0,1188.0,65232.0
Bhagalpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,8225.0,7128.0,6672.0,5341.0,5205.0,5704.0,4541.0,5057.0,5541.0,7464.0,6666.0,4460.0,72004.0
Bhagalpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6354.0,6485.0,5913.0,18755.0
Bhagalpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3435.0,6143.0,9593.0
Bhagalpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,96.0,2640.0,2737.0
Bhagalpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3454.0,3728.0,3247.0,3958.0,4648.0,5812.0,5092.0,5145.0,4282.0,4042.0,3094.0,2985.0,49487.0
Bhagalpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,6079.0,5646.0,5423.0,4321.0,4516.0,5855.0,5471.0,7431.0,7485.0,7302.0,6863.0,5905.0,72297.0
Bhagalpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7346.0,6084.0,6089.0,4498.0,4990.0,5196.0,4355.0,5136.0,6740.0,7814.0,6918.0,7046.0,72212.0
Bhagalpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,8019.0,7075.0,6465.0,5147.0,5254.0,5829.0,4113.0,4360.0,4961.0,6928.0,6695.0,6995.0,71841.0
Bhagalpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2635.0,2599.0,2514.0,3327.0,3697.0,4560.0,4243.0,3883.0,3568.0,3051.0,1988.0,2261.0,38326.0
Bhagalpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,6311.0,5615.0,5711.0,4488.0,4637.0,5898.0,6180.0,8501.0,7694.0,1656.0,786.0,172.0,57649.0
Bhagalpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7461.0,6190.0,6254.0,4698.0,5005.0,5133.0,4884.0,5914.0,7406.0,7716.0,3424.0,1372.0,65457.0
Bhagalpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,8276.0,7252.0,6940.0,5455.0,5350.0,5729.0,4593.0,5072.0,5529.0,7326.0,6537.0,4400.0,72459.0
Bhagalpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4517.0,5464.0,7307.0,6940.0,7018.0,5122.0,5347.0,6230.0,3367.0,5268.0,3345.0,4772.0,64697.0
Bhagalpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5812.0,4945.0,5140.0,4284.0,3807.0,2939.0,2782.0,3500.0,3007.0,4514.0,3588.0,5103.0,49421.0
Bhagalpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2121.0,2666.0,4040.0,4001.0,4848.0,3993.0,3657.0,4590.0,3472.0,3764.0,3162.0,2554.0,42868.0
Bhagalpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2509.0,2829.0,3855.0,3400.0,3612.0,2551.0,2676.0,3246.0,1823.0,2613.0,1655.0,2371.0,33140.0
Bhagalpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2267.0,2541.0,3472.0,3202.0,3299.0,2354.0,2316.0,2737.0,1564.0,2445.0,1695.0,2154.0,30046.0
Bhagalpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4776.0,5370.0,7327.0,6602.0,6911.0,4905.0,4992.0,5983.0,3387.0,5058.0,3350.0,4525.0,63186.0
Bhagalpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6236.0,5031.0,5121.0,4144.0,3668.0,3785.0,3136.0,3602.0,4446.0,5384.0,5824.0,5646.0,56023.0
Bhagalpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6199.0,4972.0,4975.0,4000.0,3615.0,3824.0,2822.0,3283.0,4228.0,5238.0,6037.0,5690.0,54883.0
Bhagalpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,13.0,0.0,0.0,0.0,30.0,0.0,0.0,0.0,0.0,43.0
Bhagalpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1330.0,765.0,1180.0,672.0,611.0,581.0,517.0,645.0,702.0,1011.0,996.0,1099.0,10109.0
Bhagalpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1279.0,655.0,1125.0,569.0,526.0,511.0,446.0,571.0,576.0,913.0,891.0,982.0,9044.0
Bhagalpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2609.0,1420.0,2305.0,1241.0,1137.0,1092.0,963.0,1216.0,1278.0,1924.0,1887.0,2081.0,19153.0
Bhagalpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,215.0,276.0,327.0,247.0,215.0,261.0,256.0,208.0,280.0,309.0,295.0,442.0,3331.0
Bhagalpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,796.0,931.0,916.0,710.0,630.0,720.0,727.0,808.0,634.0,666.0,789.0,850.0,9177.0
Bhagalpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,918.0,872.0,984.0,1113.0,981.0,1007.0,934.0,1242.0,1104.0,853.0,1120.0,1275.0,12403.0
Bhagalpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,1.0,0.0,1.0,3.0,0.0,0.0,5.0,2.0,0.0,0.0,13.0
Bhagalpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,10.0,8.0,0.0,2.0,1.0,3.0,1.0,5.0,8.0,4.0,0.0,0.0,42.0
Bhagalpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2640.0,2704.0,2577.0,2654.0,2655.0,2645.0,2742.0,2680.0,2652.0,2585.0,2614.0,2572.0,31720.0
Bhagalpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2576.0,2706.0,2525.0,2654.0,2623.0,2652.0,2742.0,2675.0,2644.0,2602.0,2588.0,2581.0,31568.0
Bhagalpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2435.0,2557.0,2318.0,2513.0,2481.0,2485.0,2596.0,2511.0,2496.0,2446.0,2420.0,2413.0,29671.0
Bhagalpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1764.0,1908.0,2276.0,2708.0,2761.0,2861.0,2518.0,2991.0,3443.0,4221.0,4563.0,3433.0,35447.0
Bhagalpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2221.0,2590.0,3351.0,3912.0,3272.0,2582.0,2380.0,2585.0,1794.0,2688.0,1703.0,2081.0,31159.0
Bhagalpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,789.0,562.0,564.0,3899.0,443.0,255.0,178.0,348.0,357.0,356.0,418.0,507.0,8676.0
Bhagalpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,39.0,102.0,67.0,119.0,58.0,90.0,54.0,42.0,52.0,49.0,37.0,52.0,761.0
Bhagalpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,3.0,0.0,0.0,8.0
Bhagalpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,18.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0
Bhagalpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,2.0,2.0,1.0,18.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,26.0
Bhagalpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,1.0,1.0,1.0,1.0,0.0,1.0,1.0,3.0,0.0,0.0,1.0,1.0,11.0
Bhagalpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,9.0,72.0,0.0,36.0,0.0,0.0,0.0,0.0,0.0,14.0,1.0,31.0,163.0
Bhagalpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2001.0,1601.0,954.0,1219.0,2894.0,3098.0,2201.0,1954.0,1653.0,1417.0,1856.0,2087.0,22935.0
Bhagalpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,10.0,16.0,4.0,8.0,2.0,10.0,2.0,3.0,13.0,22.0,5.0,8.0,103.0
Bhagalpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,20.0,20.0,11.0,27.0,32.0,34.0,33.0,19.0,7.0,20.0,15.0,25.0,263.0
Bhagalpur,13.1,Number of Patients operated for cataract,TOTAL,38.0,11.0,11.0,12.0,0.0,27.0,19.0,32.0,39.0,13.0,0.0,0.0,202.0
Bhagalpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,38.0,11.0,11.0,12.0,0.0,27.0,19.0,32.0,39.0,13.0,0.0,0.0,202.0
Bhagalpur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,3.0,0.0,3.0,0.0,0.0,1.0,2.0,0.0,0.0,6.0,5.0,20.0
Bhagalpur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Bhagalpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Bhagalpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2363.0,2297.0,2245.0,2354.0,2346.0,2411.0,2403.0,2408.0,2360.0,2330.0,2325.0,2344.0,-1.0
Bhagalpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Bhagalpur,14.05,Number of RKS meetings held during the month,TOTAL,8.0,11.0,14.0,5.0,10.0,10.0,9.0,10.0,7.0,10.0,8.0,16.0,118.0
Bhagalpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Bhagalpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,518.0,600.0,514.0,388.0,266.0,579.0,840.0,881.0,986.0,1085.0,1015.0,1252.0,8924.0
Bhagalpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Bhagalpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,5.0,5.0,5.0,5.0,2.0,2.0,3.0,4.0,4.0,4.0,2.0,-1.0
Bhagalpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1165.0,1241.0,1237.0,1600.0,1389.0,1694.0,1860.0,1429.0,1385.0,1313.0,1067.0,954.0,16334.0
Bhagalpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1242.0,1489.0,1691.0,1639.0,1590.0,1816.0,1443.0,1647.0,1569.0,1584.0,1237.0,1770.0,18717.0
Bhagalpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1080.0,1235.0,933.0,1362.0,1283.0,1883.0,1782.0,1375.0,1336.0,1089.0,923.0,824.0,15105.0
Bhagalpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3792.0,3959.0,4010.0,5173.0,5420.0,5535.0,5776.0,6331.0,5829.0,5448.0,4968.0,4553.0,60794.0
Bhagalpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2245.0,2476.0,2170.0,2962.0,2672.0,3577.0,3642.0,2804.0,2721.0,2402.0,1990.0,1778.0,31439.0
Bhagalpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5034.0,5448.0,5701.0,6812.0,7010.0,7351.0,7219.0,7978.0,7398.0,7032.0,6205.0,6323.0,79511.0
Bhagalpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,117.0,161.0,186.0,174.0,186.0,170.0,213.0,201.0,186.0,170.0,124.0,156.0,2044.0
Bhagalpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,83.0,95.0,107.0,103.0,99.0,110.0,132.0,98.0,116.0,107.0,84.0,100.0,1234.0
Bhagalpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,200.0,256.0,293.0,277.0,285.0,280.0,345.0,299.0,302.0,277.0,208.0,256.0,3278.0
Bhagalpur,14.11,In-Patient Head Count at midnight,TOTAL,7141.0,8075.0,8166.0,11225.0,11151.0,12804.0,13019.0,11477.0,10485.0,11171.0,9121.0,9265.0,123100.0
Bhagalpur,14.12.1,OPD attendance (All),TOTAL,164255.0,151736.0,163064.0,172024.0,172591.0,196994.0,147070.0,159061.0,128516.0,140610.0,151759.0,147523.0,1895203.0
Bhagalpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1792.0,1634.0,1701.0,2534.0,1788.0,1895.0,2775.0,3084.0,2960.0,2791.0,3261.0,2972.0,29187.0
Bhagalpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,40.0,1.0,1.0,72.0,2.0,221.0,0.0,186.0,0.0,1059.0,130.0,158.0,1870.0
Bhagalpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3468.0,3351.0,3510.0,3867.0,3244.0,3429.0,3270.0,3212.0,2992.0,3241.0,3707.0,3345.0,40636.0
Bhagalpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,36242.0,33829.0,34482.0,33902.0,31161.0,43630.0,31231.0,37763.0,22553.0,29445.0,32561.0,37467.0,404266.0
Bhagalpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5926.0,5861.0,5757.0,7554.0,6925.0,9006.0,6055.0,6942.0,5126.0,5932.0,6892.0,5929.0,77905.0
Bhagalpur,14.14.c,Number of Adolescents counselled,TOTAL,378.0,547.0,579.0,524.0,600.0,416.0,261.0,591.0,471.0,319.0,283.0,301.0,5270.0
Bhagalpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4792.0,4624.0,4053.0,5063.0,3963.0,5071.0,4086.0,4757.0,5128.0,5976.0,5958.0,6813.0,60284.0
Bhagalpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,88.0,84.0,119.0,79.0,71.0,75.0,63.0,142.0,175.0,198.0,166.0,237.0,1497.0
Bhagalpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,603.0,489.0,607.0,719.0,635.0,447.0,253.0,297.0,268.0,535.0,387.0,457.0,5697.0
Bhagalpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,17.0,1.0,21.0,24.0,31.0,9.0,14.0,9.0,12.0,19.0,7.0,41.0,205.0
Bhagalpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,317.0,522.0,636.0,612.0,577.0,462.0,241.0,692.0,599.0,678.0,754.0,725.0,6815.0
Bhagalpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,13.0,0.0,15.0,23.0,20.0,8.0,8.0,11.0,4.0,4.0,4.0,18.0,128.0
Bhagalpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1052.0,874.0,1116.0,1269.0,1207.0,1064.0,583.0,464.0,503.0,829.0,718.0,1139.0,10818.0
Bhagalpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,0.0,3.0,2.0,3.0,1.0,2.0,1.0,0.0,1.0,0.0,0.0,15.0
Bhagalpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1972.0,1885.0,2359.0,2600.0,2419.0,1973.0,1077.0,1453.0,1370.0,2042.0,1859.0,2321.0,23330.0
Bhagalpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,32.0,1.0,39.0,49.0,54.0,18.0,24.0,21.0,16.0,24.0,11.0,59.0,348.0
Bhagalpur,15.2,Number of Widal tests conducted,Number tested,20.0,37.0,33.0,33.0,18.0,57.0,3.0,20.0,6.0,9.0,27.0,19.0,282.0
Bhagalpur,15.3.a,Number of VDRL tests conducted on males,Number tested,7.0,0.0,0.0,1.0,3.0,0.0,13.0,0.0,19.0,3.0,42.0,7.0,95.0
Bhagalpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,5.0,0.0,0.0,1.0,1.0,0.0,11.0,0.0,28.0,70.0,384.0,116.0,616.0
Bhagalpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,70.0,9.0,4.0,11.0,97.0
Bhagalpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,13.0,0.0,0.0,2.0,4.0,0.0,26.0,0.0,117.0,82.0,430.0,134.0,808.0
Bhagalpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,222.0,169.0,322.0,211.0,288.0,297.0,277.0,321.0,223.0,238.0,219.0,299.0,3086.0
Bhagalpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,5.0,3.0,1.0,1.0,8.0,0.0,0.0,4.0,0.0,0.0,1.0,5.0,28.0
Bhagalpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,2.0,1.0,2.0,2.0,7.0,8.0,1.0,42.0,1.0,1.0,1.0,68.0
Bhagalpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,605.0,524.0,466.0,218.0,830.0,,,,,,,,2643.0
Bhagalpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3500.0,3500.0,2650.0,3500.0,3000.0,,,,,,,,16150.0
Bhagalpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3581.0,3558.0,2898.0,2888.0,3550.0,,,,,,,,16475.0
Bhagalpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,524.0,466.0,218.0,830.0,280.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2318.0
Bhagalpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,375.0,50.0,19.0,424.0,569.0,,,,,,,,1437.0
Bhagalpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1500.0,1669.0,2700.0,3000.0,3500.0,,,,,,,,12369.0
Bhagalpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1825.0,1700.0,2295.0,2855.0,3119.0,,,,,,,,11794.0
Bhagalpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,50.0,19.0,424.0,569.0,950.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2012.0
Bhagalpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,996.0,52.0,78.0,358.0,960.0,,,,,,,,2444.0
Bhagalpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000.0,1500.0,2000.0,2200.0,1500.0,,,,,,,,8200.0
Bhagalpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1944.0,1474.0,1720.0,1598.0,2360.0,,,,,,,,9096.0
Bhagalpur,16.1.3,Stock position of TT vaccines,5. Total Stock,52.0,78.0,358.0,960.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1548.0
Bhagalpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,832.0,552.0,805.0,155.0,400.0,,,,,,,,2744.0
Bhagalpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,1000.0,1000.0,2000.0,2000.0,,,,,,,,7000.0
Bhagalpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1280.0,747.0,1605.0,1755.0,2220.0,,,,,,,,7607.0
Bhagalpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,552.0,805.0,200.0,400.0,180.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2137.0
Bhagalpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,595.0,451.0,388.0,545.0,420.0,,,,,,,,2399.0
Bhagalpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,3000.0,3000.0,3500.0,3100.0,,,,,,,,15600.0
Bhagalpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3144.0,3063.0,2843.0,3625.0,3320.0,,,,,,,,15995.0
Bhagalpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,451.0,388.0,545.0,420.0,200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2004.0
Bhagalpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,479.0,110.0,448.0,218.0,268.0,,,,,,,,1523.0
Bhagalpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,2000.0,2400.0,2500.0,3500.0,3500.0,,,,,,,,13900.0
Bhagalpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2369.0,2062.0,2730.0,3450.0,3468.0,,,,,,,,14079.0
Bhagalpur,16.1.7,Stock position of JE vaccines,5. Total Stock,110.0,448.0,218.0,268.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1344.0
Bhagalpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,558.0,348.0,448.0,374.0,450.0,,,,,,,,2178.0
Bhagalpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2700.0,2500.0,2420.0,3000.0,3000.0,,,,,,,,13620.0
Bhagalpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2910.0,2400.0,2494.0,2924.0,2755.0,,,,,,,,13483.0
Bhagalpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,348.0,448.0,374.0,450.0,695.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2315.0
Bhagalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,0.0,,,,,,,,0.0
Bhagalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,1200.0,12000.0,,,,,,,,13200.0
Bhagalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,6000.0,7900.0,,,,,,,,13900.0
Bhagalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,-4800.0,4100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-700.0
Bhagalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,0.0,,,,,,,,0.0
Bhagalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,250000.0,250000.0,,,,,,,,500000.0
Bhagalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,125000.0,164000.0,,,,,,,,289000.0
Bhagalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,125000.0,86000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,211000.0
Bhagalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,0.0,,,,,,,,0.0
Bhagalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,39663.0,39663.0,,,,,,,,79326.0
Bhagalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,22663.0,29163.0,,,,,,,,51826.0
Bhagalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,17000.0,10500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27500.0
Bhagalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,0.0,,,,,,,,0.0
Bhagalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,1000.0,10000.0,,,,,,,,11000.0
Bhagalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,5800.0,6700.0,,,,,,,,12500.0
Bhagalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,-4800.0,3300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1500.0
Bhagalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Bhagalpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Bhagalpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Bhagalpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhagalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2900.0,8800.0,1400.0,9200.0,11900.0,,,,,,,,34200.0
Bhagalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,10000.0,0.0,15000.0,12000.0,15000.0,,,,,,,,52000.0
Bhagalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4100.0,7400.0,7200.0,9300.0,13400.0,,,,,,,,41400.0
Bhagalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8800.0,1400.0,9200.0,11900.0,13500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44800.0
Bhagalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,92200.0,36000.0,66514.0,4514.0,20914.0,,,,,,,,220142.0
Bhagalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,105714.0,0.0,100000.0,150000.0,,,,,,,,355714.0
Bhagalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,56200.0,75200.0,62000.0,83600.0,93800.0,,,,,,,,370800.0
Bhagalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,36000.0,66514.0,4514.0,20914.0,77114.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,205056.0
Bhagalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,19943.0,1604.0,10943.0,3643.0,0.0,,,,,,,,36133.0
Bhagalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,5000.0,5000.0,,,,,,,,10000.0
Bhagalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Bhagalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3900.0,5100.0,7300.0,8643.0,4050.0,,,,,,,,28993.0
Bhagalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,16043.0,-3496.0,3643.0,0.0,950.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17140.0
Bhagalpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Bhagalpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bhagalpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhagalpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Bhagalpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bhagalpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhagalpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Bhagalpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bhagalpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhagalpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Bhagalpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bhagalpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhagalpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Bhagalpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhagalpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhagalpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Bhagalpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhagalpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhagalpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Bhagalpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhagalpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhagalpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Bhagalpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhagalpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhagalpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bhagalpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhagalpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhagalpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Bhagalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Bhagalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Bhagalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Bhagalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Bhojpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,4779.0,4580.0,4186.0,5610.0,4407.0,4050.0,3237.0,3638.0,3041.0,3319.0,3566.0,4215.0,48628.0
Bhojpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2127.0,2114.0,2096.0,2419.0,2100.0,1912.0,1482.0,1687.0,1427.0,1530.0,1425.0,1569.0,21888.0
Bhojpur,1.2,Number of Pregnant women registered under JSY,TOTAL,4774.0,4580.0,4126.0,5610.0,4407.0,4050.0,3237.0,3638.0,3041.0,3319.0,3564.0,4215.0,48561.0
Bhojpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2412.0,2362.0,1986.0,2451.0,2287.0,2317.0,2032.0,2081.0,1858.0,2075.0,1869.0,2045.0,25775.0
Bhojpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3660.0,3523.0,3104.0,4379.0,3240.0,2949.0,2533.0,2688.0,2223.0,2441.0,2677.0,3186.0,36603.0
Bhojpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4515.0,4539.0,3507.0,5177.0,4946.0,4012.0,3709.0,3355.0,3156.0,2991.0,2935.0,3928.0,46770.0
Bhojpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2419.0,2313.0,1369.0,2139.0,2482.0,1729.0,1773.0,1908.0,1502.0,1651.0,1804.0,2043.0,23132.0
Bhojpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,110.0,72.0,53.0,11.0,18.0,36.0,53.0,92.0,48.0,24.0,53.0,42.0,612.0
Bhojpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,7.0,3.0,3.0,4.0,6.0,3.0,7.0,6.0,9.0,6.0,6.0,6.0,66.0
Bhojpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,174.0,453.0,107.0,265.0,240.0,788.0,528.0,764.0,193.0,138.0,156.0,131.0,3937.0
Bhojpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,17.0,18.0,12.0,14.0,16.0,96.0,67.0,290.0,2.0,3.0,2.0,3.0,540.0
Bhojpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,230.0,780.0,383.0,541.0,464.0,495.0,503.0,483.0,444.0,505.0,422.0,489.0,5739.0
Bhojpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,59.0,70.0,54.0,60.0,66.0,64.0,90.0,82.0,48.0,69.0,63.0,47.0,772.0
Bhojpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,176.0,191.0,187.0,232.0,261.0,292.0,288.0,356.0,359.0,308.0,265.0,246.0,3161.0
Bhojpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,235.0,261.0,241.0,292.0,327.0,356.0,378.0,438.0,407.0,377.0,328.0,293.0,3933.0
Bhojpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,206.0,176.0,176.0,207.0,270.0,263.0,302.0,334.0,319.0,310.0,283.0,259.0,3105.0
Bhojpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,0.0,0.0,0.0,0.0,1.0,2.0,7.0,3.0,0.0,0.0,0.0,15.0
Bhojpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2665.0,2625.0,2371.0,3032.0,3797.0,3843.0,4116.0,3732.0,3569.0,3218.0,2857.0,2496.0,38321.0
Bhojpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2315.0,2137.0,2090.0,1953.0,3290.0,3354.0,3457.0,3180.0,2784.0,2443.0,1794.0,1970.0,30767.0
Bhojpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,312.0,1543.0,235.0,392.0,879.0,1230.0,1146.0,1295.0,3117.0,2774.0,4028.0,4526.0,21477.0
Bhojpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,302.0,292.0,159.0,376.0,557.0,654.0,655.0,400.0,800.0,979.0,1113.0,1640.0,7927.0
Bhojpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,0.0,,,,,,,,,,,0.0
Bhojpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,,,,,,,,,,,0.0
Bhojpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,,,,,,,,,,,0.0
Bhojpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,,,,,,,,,,,0.0
Bhojpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,22.0,21.0,9.0,30.0,51.0,72.0,70.0,65.0,66.0,78.0,61.0,40.0,585.0
Bhojpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhojpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,22.0,21.0,9.0,30.0,51.0,72.0,70.0,65.0,66.0,78.0,61.0,40.0,585.0
Bhojpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,0.0,,,,,,,,,,,0.0
Bhojpur,4.1.1.a,Number of male live births,TOTAL,1523.0,1510.0,1356.0,1682.0,2170.0,2137.0,2306.0,2160.0,1982.0,1831.0,1617.0,1396.0,21670.0
Bhojpur,4.1.1.b,Number of female live births,TOTAL,1343.0,1333.0,1213.0,1585.0,1903.0,2004.0,2126.0,1950.0,1966.0,1711.0,1533.0,1366.0,20033.0
Bhojpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2866.0,2843.0,2569.0,3267.0,4073.0,4141.0,4432.0,4110.0,3948.0,3542.0,3150.0,2762.0,41703.0
Bhojpur,4.1.2,Number of still births,TOTAL,49.0,47.0,46.0,63.0,69.0,88.0,99.0,69.0,41.0,64.0,48.0,42.0,725.0
Bhojpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,4.0,3.0,2.0,1.0,0.0,2.0,3.0,3.0,5.0,7.0,7.0,3.0,40.0
Bhojpur,4.2.1,Number of Newborns weighed at birth,TOTAL,2738.0,2698.0,2195.0,3100.0,3540.0,3922.0,4176.0,3706.0,3596.0,3336.0,3037.0,2605.0,38649.0
Bhojpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,111.0,187.0,101.0,134.0,132.0,184.0,344.0,297.0,265.0,236.0,227.0,185.0,2403.0
Bhojpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2617.0,2724.0,2366.0,3091.0,3916.0,3969.0,4227.0,3890.0,3568.0,3354.0,3063.0,2600.0,39385.0
Bhojpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,4.0
Bhojpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,57.0,70.0,22.0,31.0,32.0,35.0,35.0,65.0,68.0,78.0,61.0,51.0,605.0
Bhojpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhojpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,57.0,70.0,22.0,31.0,32.0,35.0,39.0,65.0,68.0,78.0,61.0,51.0,609.0
Bhojpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,0.0,,,,,,,,,,,0.0
Bhojpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,46.0,98.0,84.0,100.0,32.0,35.0,51.0,280.0,68.0,78.0,61.0,97.0,1030.0
Bhojpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,32.0,74.0,61.0,69.0,0.0,0.0,0.0,1.0,0.0,78.0,61.0,56.0,432.0
Bhojpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,53.0,76.0,64.0,78.0,0.0,0.0,51.0,232.0,66.0,0.0,61.0,132.0,813.0
Bhojpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,11.0,14.0,10.0,8.0,22.0,13.0,10.0,11.0,8.0,18.0,18.0,27.0,170.0
Bhojpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,484.0,759.0,726.0,990.0,1363.0,1172.0,1455.0,1019.0,1360.0,1155.0,860.0,950.0,12293.0
Bhojpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1102.0,728.0,603.0,854.0,1095.0,1042.0,1067.0,1323.0,1099.0,1037.0,1038.0,1077.0,12065.0
Bhojpur,6.3,PNC maternal complications attended,TOTAL,1.0,134.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,135.0
Bhojpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,3.0
Bhojpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,3.0
Bhojpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,2.0,1.0,6.0
Bhojpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,48.0,54.0,100.0,62.0,98.0,62.0,30.0,40.0,32.0,31.0,35.0,49.0,641.0
Bhojpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,299.0,308.0,264.0,318.0,383.0,281.0,193.0,375.0,254.0,267.0,317.0,314.0,3573.0
Bhojpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,347.0,362.0,364.0,380.0,481.0,343.0,223.0,415.0,286.0,298.0,352.0,363.0,4214.0
Bhojpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,7.0,7.0,12.0,5.0,1.0,18.0,26.0,27.0,2.0,5.0,110.0
Bhojpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,1.0,1.0,2.0,1.0,8.0
Bhojpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,1.0,1.0,2.0,3.0,1.0,5.0,7.0,3.0,3.0,27.0
Bhojpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhojpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,7.0,10.0,13.0,7.0,4.0,20.0,32.0,35.0,7.0,9.0,145.0
Bhojpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,0.0,0.0,,1.0,3.0,,,1.0,2.0,1.0,5.0,13.0
Bhojpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhojpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,0.0,,,,,,,,,,,0.0
Bhojpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,31.0,0.0,0.0,199.0,135.0,212.0,213.0,619.0,666.0,509.0,509.0,341.0,3434.0
Bhojpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,15.0,0.0,0.0,66.0,46.0,87.0,73.0,191.0,168.0,98.0,269.0,261.0,1274.0
Bhojpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,24.0,22.0,10.0,16.0,12.0,32.0,35.0,109.0,111.0,86.0,86.0,76.0,619.0
Bhojpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhojpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,70.0,22.0,10.0,281.0,193.0,331.0,321.0,919.0,945.0,693.0,864.0,678.0,5327.0
Bhojpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,347.0,327.0,311.0,283.0,215.0,303.0,372.0,997.0,843.0,568.0,639.0,1497.0,6702.0
Bhojpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,20.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Bhojpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,6.0,6.0,1.0,0.0,9.0,10.0,12.0,18.0,20.0,15.0,19.0,15.0,131.0
Bhojpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhojpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,26.0,6.0,1.0,0.0,9.0,10.0,12.0,18.0,20.0,15.0,19.0,15.0,151.0
Bhojpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bhojpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,331.0,323.0,272.0,1257.0,285.0,353.0,199.0,260.0,220.0,249.0,263.0,264.0,4276.0
Bhojpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,55.0,39.0,40.0,168.0,30.0,61.0,37.0,31.0,37.0,40.0,33.0,63.0,634.0
Bhojpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,11.0,16.0,18.0,43.0,13.0,14.0,21.0,9.0,11.0,13.0,26.0,23.0,218.0
Bhojpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,92.0,34.0,16.0,37.0,27.0,25.0,33.0,10.0,7.0,113.0,14.0,29.0,437.0
Bhojpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhojpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,489.0,412.0,346.0,1505.0,355.0,453.0,290.0,310.0,275.0,415.0,336.0,379.0,5565.0
Bhojpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,9.0,13.0,17.0,21.0,10.0,4.0,4.0,5.0,2.0,2.0,71.0,14.0,172.0
Bhojpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,27.0,20.0,24.0,40.0,59.0,34.0,21.0,15.0,21.0,21.0,21.0,26.0,329.0
Bhojpur,9.06,Number of IUCD removals,TOTAL,200.0,198.0,204.0,351.0,276.0,209.0,169.0,168.0,148.0,145.0,172.0,178.0,2418.0
Bhojpur,9.07,Number of Oral Pills cycles distributed,TOTAL,1577.0,1659.0,3182.0,8162.0,2170.0,3326.0,2290.0,2031.0,2129.0,1978.0,2908.0,2677.0,34089.0
Bhojpur,9.08,Number of Condom pieces distributed,TOTAL,9836.0,8613.0,10247.0,32882.0,10540.0,13297.0,9399.0,9228.0,7684.0,8678.0,10047.0,10548.0,140999.0
Bhojpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,751.0,656.0,1029.0,2401.0,868.0,886.0,715.0,559.0,929.0,699.0,901.0,1159.0,11553.0
Bhojpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,7.0
Bhojpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,3.0
Bhojpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Bhojpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Bhojpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4207.0,4105.0,2935.0,4407.0,4835.0,5661.0,5618.0,5979.0,5017.0,5008.0,4505.0,4202.0,56479.0
Bhojpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,5184.0,4211.0,3294.0,4350.0,3761.0,4466.0,4758.0,6346.0,5852.0,1347.0,143.0,83.0,43795.0
Bhojpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,5865.0,4796.0,3320.0,4521.0,3998.0,3844.0,3992.0,4757.0,5528.0,5775.0,2367.0,1241.0,50004.0
Bhojpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,5683.0,5055.0,3571.0,4532.0,4186.0,4110.0,3865.0,4069.0,4257.0,5243.0,4067.0,3614.0,52252.0
Bhojpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,82.0,0.0,4.0,0.0,0.0,5.0,0.0,0.0,10.0,4901.0,4823.0,5146.0,14971.0
Bhojpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,54.0,0.0,10.0,0.0,0.0,9.0,0.0,0.0,0.0,9.0,2194.0,4673.0,6949.0
Bhojpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,68.0,0.0,5.0,0.0,0.0,9.0,0.0,0.0,0.0,10.0,21.0,1678.0,1791.0
Bhojpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2688.0,3007.0,2088.0,2867.0,3591.0,3860.0,3675.0,3453.0,2889.0,3176.0,2639.0,2663.0,36596.0
Bhojpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,5148.0,4084.0,3223.0,4363.0,3715.0,4432.0,4488.0,4740.0,4776.0,4605.0,4402.0,4796.0,52772.0
Bhojpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5815.0,4677.0,3241.0,4486.0,3932.0,3820.0,3679.0,3733.0,4537.0,5719.0,3821.0,5321.0,52781.0
Bhojpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5658.0,4936.0,3439.0,4525.0,4076.0,4105.0,3679.0,3257.0,3463.0,4919.0,3895.0,4949.0,50901.0
Bhojpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1678.0,1865.0,1179.0,1741.0,2327.0,2371.0,2700.0,2425.0,2321.0,2357.0,2136.0,1752.0,24852.0
Bhojpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,5200.0,4226.0,3322.0,4306.0,3766.0,4433.0,4721.0,6150.0,5714.0,1133.0,585.0,193.0,43749.0
Bhojpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,5821.0,4676.0,3361.0,4534.0,4025.0,3810.0,3853.0,4718.0,5433.0,5590.0,2360.0,1898.0,50079.0
Bhojpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,5622.0,5113.0,3684.0,4620.0,4175.0,4126.0,3851.0,4009.0,4253.0,5017.0,4028.0,3519.0,52017.0
Bhojpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4028.0,3958.0,3708.0,5347.0,4998.0,4676.0,3533.0,4749.0,4106.0,3397.0,3204.0,3096.0,48800.0
Bhojpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3498.0,2982.0,2256.0,3352.0,2770.0,2440.0,1928.0,2508.0,2486.0,2552.0,2888.0,3101.0,32761.0
Bhojpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2506.0,2778.0,2740.0,4614.0,4297.0,3510.0,2824.0,3231.0,3472.0,2515.0,2033.0,2601.0,37121.0
Bhojpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2169.0,2085.0,2046.0,2742.0,2723.0,2445.0,1796.0,2289.0,1994.0,1870.0,1591.0,1646.0,25396.0
Bhojpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1847.0,1815.0,1750.0,2483.0,2355.0,2190.0,1635.0,2019.0,1660.0,1506.0,1399.0,1400.0,22059.0
Bhojpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4016.0,3900.0,3796.0,5225.0,5078.0,4635.0,3431.0,4308.0,3654.0,3376.0,2990.0,3046.0,47455.0
Bhojpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4518.0,3469.0,2735.0,3809.0,3135.0,2787.0,2426.0,2998.0,2671.0,3026.0,3229.0,3893.0,38696.0
Bhojpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4509.0,3411.0,2687.0,3820.0,3096.0,2776.0,2314.0,2566.0,2401.0,3015.0,3030.0,3870.0,37495.0
Bhojpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1431.0,1049.0,866.0,1245.0,967.0,849.0,752.0,868.0,812.0,752.0,873.0,1001.0,11465.0
Bhojpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1201.0,853.0,779.0,1124.0,840.0,691.0,652.0,709.0,721.0,653.0,732.0,814.0,9769.0
Bhojpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2632.0,1902.0,1645.0,2369.0,1807.0,1540.0,1404.0,1577.0,1533.0,1405.0,1605.0,1815.0,21234.0
Bhojpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,505.0,458.0,375.0,516.0,391.0,527.0,499.0,455.0,587.0,569.0,505.0,642.0,6029.0
Bhojpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1560.0,1461.0,1270.0,1534.0,1476.0,1419.0,1520.0,1315.0,1324.0,1119.0,954.0,1100.0,16052.0
Bhojpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2127.0,1910.0,1636.0,2107.0,2085.0,1995.0,2322.0,2087.0,1870.0,1566.0,1505.0,1697.0,22907.0
Bhojpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,5.0,0.0,10.0,6.0,0.0,6.0,10.0,12.0,0.0,5.0,55.0
Bhojpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,14.0,14.0,0.0,0.0,8.0,0.0,0.0,1.0,3.0,11.0,0.0,0.0,51.0
Bhojpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3247.0,3295.0,3024.0,3405.0,3229.0,2959.0,3363.0,3382.0,3625.0,3687.0,3322.0,3518.0,40056.0
Bhojpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3254.0,3245.0,2755.0,3390.0,3195.0,2923.0,3271.0,3356.0,3597.0,3663.0,3097.0,3441.0,39187.0
Bhojpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2755.0,2765.0,2266.0,2960.0,2656.0,2499.0,2698.0,2561.0,2679.0,2689.0,2357.0,2743.0,31628.0
Bhojpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,604.0,943.0,1324.0,2235.0,2088.0,1925.0,1713.0,1744.0,2213.0,1812.0,1799.0,2675.0,21075.0
Bhojpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1155.0,979.0,750.0,2328.0,1824.0,1715.0,1232.0,1720.0,1168.0,877.0,667.0,679.0,15094.0
Bhojpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,969.0,506.0,391.0,1765.0,436.0,334.0,316.0,329.0,473.0,495.0,403.0,498.0,6915.0
Bhojpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,198.0,76.0,15.0,616.0,80.0,40.0,56.0,86.0,69.0,80.0,33.0,37.0,1386.0
Bhojpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Bhojpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5.0,20.0,0.0,4.0,9.0,12.0,0.0,2.0,0.0,0.0,0.0,0.0,52.0
Bhojpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,157.0,261.0,89.0,239.0,65.0,159.0,53.0,44.0,76.0,129.0,102.0,152.0,1526.0
Bhojpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,4.0,13.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,9.0,9.0,39.0
Bhojpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,13.1,Number of Patients operated for cataract,TOTAL,6.0,230.0,0.0,20.0,0.0,0.0,168.0,82.0,9.0,14.0,251.0,245.0,1025.0
Bhojpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,6.0,208.0,0.0,0.0,0.0,0.0,168.0,80.0,9.0,14.0,251.0,245.0,981.0
Bhojpur,13.3,Number of School children detected with Refractive errors,TOTAL,79.0,19.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,262.0,20.0,380.0
Bhojpur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Bhojpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Bhojpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1717.0,1705.0,1556.0,1732.0,1682.0,1691.0,1651.0,1721.0,1717.0,1722.0,1655.0,1720.0,-1.0
Bhojpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Bhojpur,14.05,Number of RKS meetings held during the month,TOTAL,16.0,15.0,16.0,17.0,14.0,15.0,14.0,13.0,14.0,11.0,17.0,11.0,173.0
Bhojpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Bhojpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,84.0,65.0,16.0,16.0,80.0,62.0,137.0,49.0,109.0,94.0,170.0,180.0,1062.0
Bhojpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Bhojpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Bhojpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1216.0,1269.0,1270.0,1255.0,1366.0,1400.0,1379.0,1368.0,1249.0,1170.0,1144.0,1193.0,15279.0
Bhojpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2399.0,2547.0,2483.0,2246.0,2582.0,2849.0,2962.0,2643.0,2496.0,2512.0,2054.0,2586.0,30359.0
Bhojpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1301.0,1306.0,1256.0,1349.0,1442.0,1278.0,1441.0,1268.0,1205.0,1225.0,941.0,1189.0,15201.0
Bhojpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3868.0,4196.0,4310.0,4541.0,5054.0,5558.0,6040.0,6428.0,5258.0,4763.0,4668.0,4631.0,59315.0
Bhojpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2517.0,2575.0,2526.0,2604.0,2808.0,2678.0,2820.0,2636.0,2454.0,2395.0,2085.0,2382.0,30480.0
Bhojpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6267.0,6743.0,6793.0,6787.0,7636.0,8407.0,9002.0,9071.0,7754.0,7275.0,6722.0,7217.0,89674.0
Bhojpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,31.0,17.0,20.0,24.0,29.0,30.0,26.0,26.0,21.0,26.0,18.0,20.0,288.0
Bhojpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,16.0,19.0,17.0,8.0,12.0,13.0,17.0,20.0,10.0,15.0,16.0,13.0,176.0
Bhojpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,47.0,36.0,37.0,32.0,41.0,43.0,43.0,46.0,31.0,41.0,34.0,33.0,464.0
Bhojpur,14.11,In-Patient Head Count at midnight,TOTAL,3204.0,3134.0,3336.0,3562.0,3967.0,4072.0,4808.0,4113.0,3943.0,3892.0,3342.0,2955.0,44328.0
Bhojpur,14.12.1,OPD attendance (All),TOTAL,145862.0,150721.0,146439.0,175350.0,159869.0,166186.0,147412.0,144579.0,125842.0,117456.0,127060.0,137447.0,1744223.0
Bhojpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,139.0,75.0,56.0,333.0,298.0,428.0,403.0,923.0,943.0,756.0,794.0,632.0,5780.0
Bhojpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,12.0,0.0,196.0,60.0,2189.0,0.0,0.0,0.0,0.0,0.0,0.0,2457.0
Bhojpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4781.0,5085.0,4593.0,4814.0,2615.0,2855.0,5005.0,5089.0,4614.0,4271.0,4698.0,4733.0,53153.0
Bhojpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,19711.0,19189.0,15286.0,20186.0,14639.0,15272.0,16094.0,14317.0,9778.0,11884.0,10726.0,11980.0,179062.0
Bhojpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5787.0,5154.0,5844.0,6719.0,5821.0,6057.0,4724.0,4437.0,5006.0,5343.0,4438.0,4360.0,63690.0
Bhojpur,14.14.c,Number of Adolescents counselled,TOTAL,790.0,934.0,742.0,1129.0,948.0,952.0,1042.0,1080.0,2016.0,1014.0,1215.0,818.0,12680.0
Bhojpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1901.0,1715.0,1562.0,2053.0,2014.0,1889.0,1207.0,1591.0,937.0,647.0,698.0,802.0,17016.0
Bhojpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,190.0,56.0,217.0,268.0,113.0,119.0,81.0,304.0,10.0,24.0,18.0,28.0,1428.0
Bhojpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,127.0,145.0,102.0,234.0,191.0,105.0,93.0,96.0,724.0,166.0,179.0,143.0,2305.0
Bhojpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,4.0,3.0,4.0,1.0,5.0,3.0,2.0,6.0,0.0,9.0,6.0,48.0
Bhojpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,194.0,270.0,270.0,322.0,235.0,282.0,294.0,502.0,932.0,373.0,399.0,407.0,4480.0
Bhojpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,1.0,5.0,6.0,4.0,2.0,3.0,3.0,5.0,0.0,4.0,4.0,39.0
Bhojpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,364.0,520.0,367.0,559.0,482.0,411.0,451.0,571.0,450.0,514.0,496.0,388.0,5573.0
Bhojpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,5.0
Bhojpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,685.0,935.0,739.0,1115.0,908.0,798.0,838.0,1169.0,2106.0,1053.0,1074.0,938.0,12358.0
Bhojpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,7.0,5.0,9.0,12.0,5.0,7.0,6.0,5.0,11.0,0.0,14.0,11.0,92.0
Bhojpur,15.2,Number of Widal tests conducted,Number tested,8.0,9.0,14.0,16.0,15.0,17.0,19.0,9.0,19.0,0.0,2.0,11.0,139.0
Bhojpur,15.3.a,Number of VDRL tests conducted on males,Number tested,1.0,19.0,2.0,0.0,0.0,3.0,0.0,1.0,0.0,20.0,12.0,27.0,85.0
Bhojpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,8.0,27.0,0.0,4.0,40.0
Bhojpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,5.0,9.0,6.0,3.0,7.0,9.0,0.0,8.0,17.0,4.0,0.0,68.0
Bhojpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1.0,24.0,12.0,6.0,3.0,10.0,9.0,1.0,16.0,64.0,16.0,31.0,193.0
Bhojpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,180.0,75.0,66.0,64.0,112.0,82.0,73.0,80.0,51.0,80.0,77.0,67.0,1007.0
Bhojpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bhojpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Bhojpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3400.0,1600.0,1750.0,4150.0,2650.0,5150.0,4100.0,5150.0,3850.0,2100.0,4650.0,4250.0,42800.0
Bhojpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,3500.0,3500.0,3000.0,4000.0,2000.0,3000.0,500.0,1000.0,5000.0,1000.0,0.0,28500.0
Bhojpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3800.0,3350.0,1100.0,4500.0,1500.0,3050.0,1950.0,1800.0,2750.0,2450.0,1400.0,1000.0,28650.0
Bhojpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,1600.0,1750.0,4150.0,2650.0,5150.0,4100.0,5150.0,3850.0,2100.0,4650.0,4250.0,3250.0,42650.0
Bhojpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,0.0,,,,,,0.0,5150.0,4075.0,2750.0,11975.0
Bhojpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,0.0,,,,,,5150.0,0.0,0.0,0.0,5150.0
Bhojpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,0.0,,,,,,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,0.0,,,,,,834.0,1075.0,1325.0,1350.0,4584.0
Bhojpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4316.0,4075.0,2750.0,1400.0,12541.0
Bhojpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2275.0,1550.0,1625.0,1725.0,1275.0,1400.0,25.0,325.0,0.0,25.0,0.0,625.0,10850.0
Bhojpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,2000.0,1000.0,2300.0,1500.0,800.0,1700.0,0.0,2000.0,800.0,1500.0,2500.0,18100.0
Bhojpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2725.0,1925.0,900.0,2750.0,1375.0,2175.0,1400.0,325.0,1975.0,825.0,875.0,1725.0,18975.0
Bhojpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,1550.0,1625.0,1725.0,1275.0,1400.0,25.0,325.0,0.0,25.0,0.0,625.0,1400.0,9975.0
Bhojpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,3200.0,2600.0,2550.0,3300.0,1200.0,4550.0,3300.0,4750.0,2950.0,2850.0,3250.0,2750.0,37250.0
Bhojpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,2000.0,1500.0,1500.0,5000.0,1500.0,3000.0,0.0,1000.0,2000.0,500.0,1000.0,21000.0
Bhojpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2600.0,2050.0,750.0,3600.0,1650.0,2750.0,1550.0,1350.0,1100.0,1600.0,1000.0,1150.0,21150.0
Bhojpur,16.1.3,Stock position of TT vaccines,5. Total Stock,2600.0,2550.0,3300.0,1200.0,4550.0,3300.0,4750.0,3400.0,2850.0,3250.0,2750.0,2600.0,37100.0
Bhojpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,0.0,,,,,0.0,0.0,,0.0,,0.0
Bhojpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,0.0,,,,,0.0,0.0,,0.0,,0.0
Bhojpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,0.0,,0.0,,,0.0,0.0,,0.0,,0.0
Bhojpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,0.0,,,,,0.0,0.0,,0.0,,0.0
Bhojpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,925.0,950.0,1180.0,2280.0,2280.0,1480.0,800.0,950.0,850.0,1050.0,750.0,1050.0,14545.0
Bhojpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,1500.0,1500.0,2000.0,200.0,900.0,1500.0,1300.0,2000.0,1300.0,1200.0,2000.0,17400.0
Bhojpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2175.0,1270.0,400.0,2000.0,1000.0,1580.0,1350.0,1400.0,1800.0,2450.0,150.0,1300.0,16875.0
Bhojpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,750.0,1180.0,2280.0,2280.0,1480.0,800.0,950.0,850.0,1050.0,-100.0,1800.0,1750.0,15070.0
Bhojpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2100.0,975.0,1175.0,2700.0,1500.0,300.0,0.0,250.0,300.0,50.0,4125.0,250.0,13725.0
Bhojpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,3000.0,3000.0,3000.0,400.0,1800.0,2400.0,2000.0,2000.0,2500.0,0.0,3500.0,25600.0
Bhojpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3125.0,2750.0,1175.0,4200.0,1600.0,2100.0,2150.0,1950.0,1950.0,2350.0,1350.0,2000.0,26700.0
Bhojpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,975.0,1225.0,3000.0,1500.0,300.0,0.0,250.0,300.0,350.0,200.0,2775.0,1750.0,12625.0
Bhojpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,23900.0,0.0,250.0,1350.0,600.0,150.0,50.0,0.0,350.0,300.0,0.0,0.0,26950.0
Bhojpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,1000.0,0.0,1000.0,200.0,2000.0,1000.0,2000.0,2500.0,500.0,1500.0,2200.0,13900.0
Bhojpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,23450.0,750.0,250.0,1750.0,650.0,2100.0,1050.0,1650.0,2550.0,800.0,1500.0,2050.0,38550.0
Bhojpur,16.1.7,Stock position of JE vaccines,5. Total Stock,450.0,250.0,0.0,600.0,150.0,50.0,0.0,350.0,300.0,0.0,0.0,150.0,2300.0
Bhojpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1400.0,1410.0,1650.0,3500.0,2180.0,3450.0,1650.0,3100.0,2300.0,1250.0,2250.0,2350.0,26490.0
Bhojpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,3000.0,3000.0,1980.0,3000.0,3000.0,3500.0,1000.0,1000.0,3000.0,1500.0,1600.0,28580.0
Bhojpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2990.0,2760.0,1150.0,3500.0,1730.0,4800.0,2050.0,1750.0,2100.0,2000.0,1400.0,850.0,27080.0
Bhojpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1410.0,1650.0,3500.0,1980.0,3450.0,1650.0,3100.0,2350.0,1200.0,2250.0,2350.0,3100.0,27990.0
Bhojpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,281.0,100.0,80.0,0.0,0.0,3400.0,3200.0,2900.0,2850.0,2850.0,2250.0,1950.0,19861.0
Bhojpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Bhojpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,100.0,20.0,80.0,0.0,1600.0,200.0,300.0,0.0,0.0,300.0,300.0,100.0,3000.0
Bhojpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,181.0,80.0,0.0,0.0,3400.0,3200.0,2900.0,2900.0,2850.0,2550.0,1950.0,1850.0,21861.0
Bhojpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,69260.0,66740.0,26470.0,24220.0,16660.0,78280.0,78280.0,72280.0,70280.0,70280.0,58280.0,37660.0,668690.0
Bhojpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,84000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,84000.0
Bhojpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,2520.0,40000.0,2520.0,5040.0,23040.0,0.0,6000.0,2000.0,0.0,12000.0,20620.0,3000.0,116740.0
Bhojpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,66740.0,26740.0,23950.0,19180.0,77620.0,78280.0,72280.0,70280.0,70280.0,58280.0,37660.0,34660.0,635950.0
Bhojpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,30500.0,29500.0,14700.0,12300.0,10700.0,39700.0,39700.0,37400.0,34700.0,34700.0,26700.0,18500.0,329100.0
Bhojpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,42000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42000.0
Bhojpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,29500.0,14800.0,2400.0,600.0,13000.0,0.0,5000.0,0.0,0.0,8000.0,8200.0,200.0,81700.0
Bhojpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1000.0,14700.0,12300.0,11700.0,39700.0,39700.0,34700.0,37400.0,34700.0,26700.0,18500.0,18300.0,289400.0
Bhojpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,18300.0,18300.0,10940.0,8540.0,7340.0,38340.0,38340.0,35340.0,35340.0,35340.0,27660.0,19980.0,293760.0
Bhojpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,42000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42000.0
Bhojpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,7360.0,2400.0,600.0,11000.0,0.0,3000.0,0.0,0.0,7680.0,7680.0,0.0,39720.0
Bhojpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,18300.0,10940.0,8540.0,7940.0,38340.0,38340.0,35340.0,35340.0,35340.0,27660.0,19980.0,19980.0,296040.0
Bhojpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,11652.0,,,,,,,,,,,,11652.0
Bhojpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,,,,,,,,,,,,0.0
Bhojpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Bhojpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,11652.0,,,,,,,,,,,,11652.0
Bhojpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,6000.0,1600.0,,0.0,24400.0,20000.0,11000.0,10000.0,6500.0,4300.0,600.0,84400.0
Bhojpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,6000.0,0.0,0.0,,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,36000.0
Bhojpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,4400.0,1600.0,,5600.0,4400.0,9000.0,1500.0,3500.0,2200.0,3700.0,600.0,36500.0
Bhojpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,6000.0,1600.0,0.0,0.0,24400.0,20000.0,11000.0,9500.0,6500.0,4300.0,600.0,0.0,83900.0
Bhojpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,,0.0,,0.0,29500.0,35500.0,29800.0,20790.0,19790.0,12290.0,41690.0,189360.0
Bhojpur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,,0.0,,0.0,1800.0,0.0,0.0,0.0,31400.0,31400.0,0.0,64600.0
Bhojpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,,0.0,,0.0,12000.0,2000.0,9100.0,1000.0,7500.0,1500.0,1500.0,34600.0
Bhojpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,19300.0,33500.0,20700.0,19790.0,43690.0,42190.0,40190.0,219360.0
Bhojpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,,0.0,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bhojpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,,0.0,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bhojpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,0.0,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bhojpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,,0.0,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bhojpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,6050.0,,0.0,,0.0,0.0,152000.0,137500.0,95500.0,95500.0,59500.0,45000.0,591050.0
Bhojpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,0.0,,0.0,200000.0,0.0,0.0,0.0,0.0,0.0,0.0,200000.0
Bhojpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,6050.0,,0.0,,0.0,48000.0,14500.0,42000.0,0.0,33000.0,14500.0,0.0,158050.0
Bhojpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,152000.0,137500.0,95500.0,95500.0,62500.0,45000.0,45000.0,633000.0
Bhojpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,,0.0,,0.0,0.0,1000.0,1000.0,1000.0,1000.0,0.0,0.0,4000.0
Bhojpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,0.0,,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Bhojpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,1000.0
Bhojpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,1000.0,1000.0,1000.0,1000.0,0.0,0.0,0.0,4000.0
Bhojpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bhojpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bhojpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bhojpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bhojpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,300000.0,150000.0,0.0,0.0,0.0,310000.0,99600.0,0.0,1730000.0,690000.0,3279600.0
Bhojpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,300000.0,30000.0,0.0,0.0,470000.0,3071.0,0.0,0.0,2000000.0,0.0,0.0,2803071.0
Bhojpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,180000.0,150000.0,0.0,245000.0,3071.0,220400.0,0.0,470000.0,1040000.0,160000.0,2468471.0
Bhojpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,300000.0,150000.0,0.0,0.0,225000.0,0.0,89600.0,99600.0,1530000.0,690000.0,530000.0,3614200.0
Bhojpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,225000.0,0.0,0.0,,0.0,0.0,225000.0
Bhojpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,7289.0,0.0,17640.0,0.0,,50000.0,0.0,0.0,,0.0,0.0,74929.0
Bhojpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,0.0,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bhojpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,936.0,0.0,4276.0,0.0,,345000.0,0.0,0.0,,0.0,0.0,350212.0
Bhojpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,6353.0,0.0,13364.0,0.0,0.0,-70000.0,0.0,0.0,0.0,0.0,0.0,-50283.0
Bhojpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,1600.0,580000.0,499500.0,529300.0,0.0,1200.0,1200.0,1000.0,200.0,0.0,1000.0,750.0,1615750.0
Bhojpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,1000.0
Bhojpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,1200.0,80500.0,70000.0,375000.0,0.0,0.0,1000.0,800.0,200.0,0.0,250.0,0.0,528950.0
Bhojpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,400.0,499500.0,429500.0,154300.0,0.0,1200.0,200.0,200.0,0.0,1000.0,750.0,750.0,1087800.0
Bhojpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,2300.0,2300.0,2300.0,2300.0,2300.0,11500.0
Bhojpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,7391.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,7391.0
Bhojpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,0.0,7391.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,7391.0
Bhojpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2300.0,2300.0,2300.0,2300.0,2300.0,11500.0
Bhojpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,0.0,,33184.0,21384.0,13584.0,210234.0,199434.0,195834.0,190434.0,213536.0,1077624.0
Bhojpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,0.0,,0.0,0.0,196650.0,0.0,0.0,0.0,28502.0,0.0,225152.0
Bhojpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,0.0,,11800.0,7800.0,0.0,10800.0,3600.0,1800.0,5400.0,36510.0,77710.0
Bhojpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,21384.0,13584.0,210234.0,199434.0,195834.0,194034.0,213536.0,177026.0,1225066.0
Bhojpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6100.0,0.0,97000.0,5900.0,12200.0,7657.0,7257.0,2257.0,9600.0,700.0,7500.0,2100.0,158271.0
Bhojpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,16000.0,0.0,14000.0,0.0,7000.0,0.0,10000.0,0.0,12000.0,0.0,12000.0,71000.0
Bhojpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,6100.0,6300.0,3800.0,7700.0,4543.0,7400.0,5000.0,2657.0,8900.0,5200.0,5400.0,4900.0,67900.0
Bhojpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,9700.0,93200.0,12200.0,7657.0,7257.0,2257.0,9600.0,700.0,7500.0,2100.0,9200.0,161371.0
Bhojpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,87600.0,39600.0,87600.0,59600.0,105740.0,57740.0,188140.0,137740.0,152740.0,87940.0,116340.0,67540.0,1188320.0
Bhojpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,2200.0,0.0,100000.0,0.0,200000.0,0.0,65000.0,0.0,100000.0,0.0,60000.0,527200.0
Bhojpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,4600.0,52000.0,28000.0,53860.0,57740.0,69600.0,50400.0,50000.0,64800.0,71600.0,48800.0,64800.0,616200.0
Bhojpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,83000.0,-10200.0,59600.0,105740.0,48000.0,188140.0,137740.0,152740.0,87940.0,116340.0,67540.0,62740.0,1099320.0
Bhojpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,14000.0,9100.0,6700.0,4000.0,5820.0,4428.0,4628.0,1028.0,5328.0,528.0,4428.0,1228.0,61216.0
Bhojpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,2200.0,0.0,2500.0,0.0,5000.0,0.0,5000.0,0.0,7000.0,0.0,7600.0,29300.0
Bhojpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhojpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4900.0,4600.0,2700.0,672.0,1390.0,4800.0,3600.0,700.0,4800.0,3100.0,3200.0,2600.0,37062.0
Bhojpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,9100.0,6700.0,4000.0,5828.0,4430.0,4628.0,1028.0,5328.0,528.0,4428.0,1228.0,6228.0,53454.0
Bhojpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Bhojpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bhojpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhojpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Bhojpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bhojpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhojpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Bhojpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bhojpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhojpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Bhojpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bhojpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhojpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Bhojpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhojpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhojpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Bhojpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhojpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhojpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Bhojpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhojpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhojpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Bhojpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhojpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhojpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bhojpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhojpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhojpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Bhojpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Bhojpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Bhojpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Bhojpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Bhojpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Buxar,1.1,Total number of pregnant women Registered for ANC,TOTAL,3998.0,4111.0,4263.0,4376.0,4098.0,3319.0,3200.0,3248.0,3177.0,3205.0,3227.0,3966.0,44188.0
Buxar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1904.0,2067.0,1965.0,2032.0,2220.0,1950.0,2096.0,2050.0,1806.0,2033.0,2183.0,2514.0,24820.0
Buxar,1.2,Number of Pregnant women registered under JSY,TOTAL,3998.0,4111.0,4263.0,4376.0,4098.0,3319.0,3200.0,3248.0,3177.0,3205.0,3227.0,3966.0,44188.0
Buxar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2597.0,2808.0,2629.0,2970.0,3264.0,3237.0,3286.0,3093.0,2866.0,2774.0,2526.0,2694.0,34744.0
Buxar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2748.0,2899.0,3059.0,3028.0,2820.0,2286.0,2308.0,2252.0,2241.0,2110.0,2159.0,2468.0,30378.0
Buxar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3564.0,3678.0,3412.0,3599.0,4030.0,3301.0,3046.0,2796.0,3015.0,2672.0,2502.0,3714.0,39329.0
Buxar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2189.0,2609.0,2336.0,1829.0,1628.0,1475.0,1146.0,1038.0,1313.0,1244.0,1328.0,1492.0,19627.0
Buxar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,18.0,37.0,18.0,60.0,28.0,22.0,28.0,259.0,14.0,15.0,0.0,4.0,503.0
Buxar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,2.0,0.0,0.0,1.0,0.0,2.0,0.0,2.0,0.0,0.0,0.0,7.0
Buxar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,315.0,336.0,89.0,87.0,163.0,57.0,267.0,218.0,285.0,84.0,71.0,47.0,2019.0
Buxar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,6.0,4.0,0.0,1.0,2.0,31.0,2.0,8.0,2.0,5.0,8.0,73.0
Buxar,1.8,Number of pregnancy test kits used at SC level,TOTAL,162.0,200.0,175.0,220.0,248.0,179.0,114.0,244.0,303.0,262.0,257.0,291.0,2655.0
Buxar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,26.0,48.0,50.0,58.0,62.0,106.0,116.0,147.0,141.0,93.0,104.0,93.0,1044.0
Buxar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,199.0,224.0,196.0,239.0,260.0,299.0,314.0,311.0,258.0,323.0,230.0,196.0,3049.0
Buxar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,225.0,272.0,246.0,297.0,322.0,405.0,430.0,458.0,399.0,416.0,334.0,289.0,4093.0
Buxar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,136.0,219.0,183.0,212.0,232.0,269.0,263.0,284.0,210.0,284.0,165.0,164.0,2621.0
Buxar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Buxar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1491.0,1507.0,1308.0,1625.0,2160.0,2489.0,2488.0,2254.0,2140.0,1889.0,1613.0,1475.0,22439.0
Buxar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1484.0,1493.0,1304.0,1413.0,2137.0,2463.0,1887.0,1994.0,2132.0,1881.0,1452.0,1306.0,20946.0
Buxar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,761.0,974.0,578.0,685.0,1664.0,1388.0,1087.0,3236.0,3530.0,1936.0,4210.0,2207.0,22256.0
Buxar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,424.0,771.0,816.0,1076.0,1296.0,1502.0,1236.0,1704.0,3061.0,1482.0,2494.0,1390.0,17252.0
Buxar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,,,,0.0,0.0,0.0,,0.0,,,0.0
Buxar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,,,0.0,0.0,0.0,,0.0,,,0.0
Buxar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,,,0.0,0.0,0.0,,0.0,,,0.0
Buxar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,,,,0.0,0.0,0.0,,0.0,,,0.0
Buxar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Buxar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,4.0,11.0,6.0,10.0,18.0,13.0,7.0,9.0,9.0,8.0,10.0,1.0,106.0
Buxar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Buxar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,4.0,11.0,6.0,10.0,18.0,13.0,7.0,9.0,9.0,8.0,10.0,1.0,106.0
Buxar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,,,,0.0,0.0,0.0,,0.0,,,0.0
Buxar,4.1.1.a,Number of male live births,TOTAL,946.0,913.0,785.0,1042.0,1285.0,1479.0,1501.0,1386.0,1252.0,1173.0,982.0,882.0,13626.0
Buxar,4.1.1.b,Number of female live births,TOTAL,769.0,822.0,782.0,881.0,1178.0,1383.0,1389.0,1304.0,1209.0,1117.0,940.0,849.0,12623.0
Buxar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1715.0,1735.0,1567.0,1923.0,2463.0,2862.0,2890.0,2690.0,2461.0,2290.0,1922.0,1731.0,26249.0
Buxar,4.1.2,Number of still births,TOTAL,27.0,29.0,28.0,24.0,36.0,35.0,34.0,34.0,28.0,23.0,26.0,28.0,352.0
Buxar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,7.0,3.0,9.0,4.0,1.0,3.0,3.0,3.0,2.0,2.0,2.0,9.0,48.0
Buxar,4.2.1,Number of Newborns weighed at birth,TOTAL,1701.0,1724.0,1443.0,1859.0,2418.0,2715.0,2823.0,2634.0,2390.0,2223.0,1884.0,1646.0,25460.0
Buxar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,49.0,54.0,59.0,93.0,160.0,194.0,173.0,131.0,82.0,75.0,57.0,64.0,1191.0
Buxar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1696.0,1726.0,1457.0,1894.0,2400.0,2723.0,2838.0,2648.0,2422.0,2252.0,1907.0,1662.0,25625.0
Buxar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Buxar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Buxar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,11.0,6.0,10.0,18.0,13.0,7.0,9.0,9.0,8.0,4.0,1.0,96.0
Buxar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Buxar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,11.0,6.0,10.0,18.0,13.0,7.0,9.0,9.0,10.0,4.0,1.0,98.0
Buxar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,,,,0.0,0.0,0.0,,0.0,0.0,,0.0
Buxar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,4.0,11.0,6.0,10.0,18.0,13.0,7.0,9.0,9.0,8.0,10.0,1.0,106.0
Buxar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,14.0
Buxar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,4.0,11.0,6.0,10.0,18.0,10.0,7.0,9.0,9.0,10.0,10.0,1.0,105.0
Buxar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,2.0,4.0,1.0,0.0,3.0,2.0,1.0,2.0,2.0,3.0,1.0,23.0
Buxar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1333.0,1538.0,1386.0,1545.0,1912.0,1740.0,1706.0,2259.0,1850.0,1815.0,1250.0,1422.0,19756.0
Buxar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1015.0,1050.0,1000.0,1204.0,1050.0,1178.0,1268.0,1811.0,1567.0,1503.0,1346.0,978.0,14970.0
Buxar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Buxar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,6.0,3.0,0.0,3.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,7.0,23.0
Buxar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,4.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Buxar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,6.0,3.0,4.0,3.0,0.0,2.0,1.0,1.0,2.0,0.0,0.0,7.0,29.0
Buxar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,42.0,25.0,30.0,27.0,17.0,19.0,15.0,32.0,32.0,33.0,29.0,35.0,336.0
Buxar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,106.0,91.0,91.0,128.0,106.0,129.0,124.0,135.0,115.0,84.0,95.0,94.0,1298.0
Buxar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,148.0,116.0,121.0,155.0,123.0,148.0,139.0,167.0,147.0,117.0,124.0,129.0,1634.0
Buxar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,2.0,4.0,0.0,0.0,1.0,2.0,3.0,2.0,0.0,14.0
Buxar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Buxar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,2.0,5.0
Buxar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Buxar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,2.0,4.0,0.0,1.0,2.0,3.0,3.0,2.0,2.0,19.0
Buxar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,,,,0.0,0.0,0.0,,0.0,,,0.0
Buxar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Buxar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Buxar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,,,0.0,0.0,0.0,,0.0,,,0.0
Buxar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,88.0,39.0,91.0,375.0,164.0,237.0,277.0,582.0,697.0,660.0,831.0,591.0,4632.0
Buxar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Buxar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,56.0,29.0,15.0,119.0,41.0,73.0,89.0,214.0,297.0,234.0,211.0,92.0,1470.0
Buxar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Buxar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,144.0,68.0,106.0,494.0,205.0,310.0,366.0,796.0,994.0,894.0,1042.0,683.0,6102.0
Buxar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,16.0,,,0.0,0.0,0.0,,60.0,,,76.0
Buxar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,7.0,6.0,5.0,3.0,23.0
Buxar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Buxar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,6.0,15.0,20.0,40.0,8.0,14.0,24.0,16.0,14.0,4.0,161.0
Buxar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Buxar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,6.0,15.0,20.0,40.0,8.0,16.0,31.0,22.0,19.0,7.0,184.0
Buxar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,,,0.0,0.0,0.0,,0.0,,,0.0
Buxar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,215.0,231.0,154.0,510.0,308.0,246.0,257.0,309.0,331.0,320.0,304.0,355.0,3540.0
Buxar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,76.0,69.0,87.0,251.0,109.0,81.0,112.0,89.0,104.0,110.0,146.0,125.0,1359.0
Buxar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Buxar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,11.0,22.0,17.0,9.0,43.0,6.0,18.0,18.0,26.0,11.0,18.0,42.0,241.0
Buxar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Buxar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,302.0,322.0,258.0,770.0,460.0,333.0,387.0,416.0,461.0,441.0,468.0,522.0,5140.0
Buxar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,7.0,9.0,64.0,59.0,57.0,70.0,40.0,30.0,25.0,16.0,29.0,112.0,518.0
Buxar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,39.0,,17.0,0.0,0.0,0.0,,21.0,,,77.0
Buxar,9.06,Number of IUCD removals,TOTAL,150.0,123.0,109.0,120.0,116.0,100.0,131.0,121.0,165.0,193.0,129.0,198.0,1655.0
Buxar,9.07,Number of Oral Pills cycles distributed,TOTAL,1248.0,1170.0,1339.0,1314.0,1049.0,366.0,1079.0,962.0,1223.0,1292.0,1168.0,1272.0,13482.0
Buxar,9.08,Number of Condom pieces distributed,TOTAL,6877.0,6165.0,4423.0,4163.0,5176.0,1791.0,2743.0,6541.0,5420.0,5309.0,4235.0,4611.0,57454.0
Buxar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Buxar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,419.0,162.0,170.0,227.0,365.0,82.0,110.0,275.0,360.0,350.0,280.0,338.0,3138.0
Buxar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,1.0,1.0,,,,,,-1.0
Buxar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3162.0,3083.0,2552.0,2735.0,3568.0,3960.0,4059.0,4031.0,3911.0,3296.0,2900.0,2856.0,40113.0
Buxar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3281.0,2912.0,2568.0,2797.0,2851.0,3202.0,3706.0,4242.0,4159.0,775.0,78.0,82.0,30653.0
Buxar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3885.0,3335.0,2742.0,2746.0,2977.0,2894.0,2962.0,3246.0,4057.0,4036.0,1515.0,846.0,35241.0
Buxar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4125.0,3620.0,3028.0,2987.0,3066.0,3001.0,2854.0,2719.0,3237.0,3866.0,3092.0,2705.0,38300.0
Buxar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3144.0,3158.0,3631.0,9933.0
Buxar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1604.0,3184.0,4789.0
Buxar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,10.0,1137.0,1149.0
Buxar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1940.0,2033.0,1426.0,1898.0,2592.0,1719.0,1626.0,2084.0,2248.0,2001.0,1707.0,1635.0,22909.0
Buxar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3226.0,2745.0,2501.0,2707.0,2741.0,1193.0,1142.0,3456.0,4335.0,3852.0,3072.0,3748.0,34718.0
Buxar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3865.0,3126.0,2604.0,2650.0,2845.0,1166.0,771.0,2160.0,3476.0,4129.0,2973.0,3895.0,33660.0
Buxar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4068.0,3477.0,2915.0,2842.0,2886.0,1091.0,816.0,1875.0,2704.0,3398.0,3030.0,3954.0,33056.0
Buxar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1435.0,1437.0,1105.0,1422.0,2123.0,2293.0,2417.0,2115.0,2086.0,1654.0,1466.0,1360.0,20913.0
Buxar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3245.0,2859.0,2621.0,2821.0,2828.0,3087.0,3684.0,4233.0,4165.0,744.0,94.0,113.0,30494.0
Buxar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3853.0,3208.0,2695.0,2809.0,2962.0,2901.0,2952.0,3239.0,4054.0,3937.0,1533.0,890.0,35033.0
Buxar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4009.0,3512.0,3102.0,3011.0,3145.0,3060.0,2863.0,2746.0,3253.0,3757.0,3030.0,2685.0,38173.0
Buxar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2762.0,3016.0,3167.0,3696.0,3852.0,3718.0,3232.0,3174.0,2692.0,2819.0,2350.0,2606.0,37084.0
Buxar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3032.0,2555.0,2244.0,2581.0,2137.0,2101.0,1884.0,2085.0,1939.0,2327.0,2423.0,2709.0,28017.0
Buxar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1872.0,2191.0,1262.0,1193.0,3405.0,1159.0,2283.0,269.0,2260.0,2730.0,1426.0,1285.0,21335.0
Buxar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1446.0,1599.0,1693.0,1957.0,2010.0,1866.0,1658.0,1581.0,1381.0,1393.0,1268.0,1407.0,19259.0
Buxar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1247.0,1384.0,1468.0,1690.0,1723.0,1739.0,1401.0,1466.0,1233.0,1280.0,1045.0,1196.0,16872.0
Buxar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2693.0,2983.0,3161.0,3647.0,3733.0,3605.0,3059.0,3047.0,2614.0,2673.0,2313.0,2603.0,36131.0
Buxar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3363.0,2822.0,2618.0,2731.0,2315.0,2234.0,2153.0,2268.0,2240.0,2419.0,2494.0,2877.0,30534.0
Buxar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3302.0,2721.0,2586.0,2595.0,2175.0,906.0,559.0,1655.0,2094.0,2325.0,2355.0,2779.0,26052.0
Buxar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,5.0
Buxar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1063.0,861.0,663.0,670.0,615.0,649.0,492.0,650.0,533.0,577.0,638.0,633.0,8044.0
Buxar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,914.0,752.0,586.0,583.0,447.0,563.0,415.0,567.0,431.0,529.0,552.0,563.0,6902.0
Buxar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1977.0,1613.0,1249.0,1253.0,1062.0,1212.0,907.0,1217.0,964.0,1106.0,1190.0,1196.0,14946.0
Buxar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,0.0,0.0,46.0,169.0,176.0,183.0,160.0,69.0,330.0,204.0,232.0,1569.0
Buxar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,731.0,718.0,804.0,814.0,772.0,778.0,859.0,684.0,770.0,662.0,605.0,662.0,8859.0
Buxar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1239.0,1441.0,1190.0,1597.0,1351.0,1335.0,1524.0,1317.0,1363.0,1452.0,1061.0,1107.0,15977.0
Buxar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,3.0,16.0,21.0,2.0,9.0,0.0,8.0,21.0,0.0,0.0,9.0,89.0
Buxar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,2.0,0.0,8.0,6.0,3.0,6.0,12.0,3.0,5.0,4.0,49.0
Buxar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2015.0,2036.0,1875.0,2021.0,1926.0,1832.0,2007.0,1940.0,1961.0,2015.0,1800.0,1936.0,23364.0
Buxar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1981.0,2024.0,1776.0,2013.0,1920.0,1828.0,1992.0,1931.0,1951.0,1990.0,1638.0,1921.0,22965.0
Buxar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1740.0,1764.0,1552.0,1719.0,1629.0,1615.0,1748.0,1617.0,1706.0,1711.0,1394.0,1611.0,19806.0
Buxar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,942.0,1230.0,635.0,792.0,1716.0,637.0,1264.0,197.0,1479.0,2351.0,1283.0,1211.0,13737.0
Buxar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,841.0,873.0,815.0,3732.0,1494.0,1209.0,1181.0,961.0,747.0,629.0,516.0,554.0,13552.0
Buxar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,81.0,102.0,138.0,13378.0,132.0,124.0,183.0,96.0,101.0,112.0,165.0,164.0,14776.0
Buxar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,26.0,13.0,67.0,1005.0,48.0,18.0,50.0,41.0,31.0,16.0,23.0,3.0,1341.0
Buxar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Buxar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,0.0,8.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,14.0
Buxar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,120.0,107.0,188.0,3161.0,5054.0,997.0,375.0,647.0,559.0,737.0,392.0,391.0,12728.0
Buxar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,3.0,1.0,0.0,0.0,4.0,0.0,0.0,5.0,0.0,13.0
Buxar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,105.0,0.0,0.0,105.0
Buxar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,105.0,0.0,0.0,105.0
Buxar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,18.0,0.0,27.0,16.0,16.0,8.0,0.0,0.0,6.0,6.0,8.0,105.0
Buxar,13.4,Number of children provided free glasses,TOTAL,0.0,16.0,0.0,7.0,16.0,8.0,0.0,0.0,0.0,6.0,6.0,8.0,67.0
Buxar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,,,1.0,1.0,1.0,,,1.0,1.0,,-1.0
Buxar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Buxar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1093.0,1088.0,1041.0,1084.0,1081.0,1084.0,1076.0,1082.0,1091.0,1088.0,1014.0,1124.0,-1.0
Buxar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,,,1.0,1.0,1.0,,,1.0,1.0,,-1.0
Buxar,14.05,Number of RKS meetings held during the month,TOTAL,16.0,15.0,14.0,11.0,15.0,13.0,16.0,11.0,12.0,13.0,11.0,16.0,163.0
Buxar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,1.0,,,,1.0,1.0,,,1.0,1.0,,-1.0
Buxar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,0.0,0.0,2.0,0.0,10.0,21.0,13.0,19.0,86.0,299.0,326.0,776.0
Buxar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,,,1.0,1.0,1.0,,,1.0,1.0,,-1.0
Buxar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,,-1.0
Buxar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,501.0,518.0,415.0,663.0,631.0,617.0,519.0,252.0,260.0,284.0,421.0,196.0,5277.0
Buxar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,279.0,677.0,541.0,435.0,767.0,577.0,761.0,308.0,268.0,606.0,377.0,696.0,6292.0
Buxar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,746.0,527.0,413.0,702.0,516.0,462.0,573.0,251.0,303.0,296.0,750.0,339.0,5878.0
Buxar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2032.0,2524.0,2500.0,2500.0,3005.0,3520.0,3680.0,3299.0,3455.0,3180.0,3032.0,2300.0,35027.0
Buxar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1247.0,1045.0,828.0,1365.0,1147.0,1079.0,1092.0,503.0,563.0,580.0,1171.0,535.0,11155.0
Buxar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2311.0,3201.0,3041.0,2935.0,3772.0,4097.0,4441.0,3607.0,3723.0,3786.0,3409.0,2996.0,41319.0
Buxar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,9.0,10.0,7.0,8.0,6.0,2.0,4.0,6.0,3.0,5.0,5.0,70.0
Buxar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,5.0,4.0,6.0,3.0,4.0,8.0,4.0,8.0,2.0,2.0,2.0,54.0
Buxar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,11.0,14.0,14.0,13.0,11.0,10.0,10.0,8.0,14.0,5.0,7.0,7.0,124.0
Buxar,14.11,In-Patient Head Count at midnight,TOTAL,5773.0,4957.0,4699.0,5117.0,5639.0,6296.0,6462.0,6011.0,5695.0,5340.0,5571.0,5044.0,66604.0
Buxar,14.12.1,OPD attendance (All),TOTAL,101622.0,100426.0,103889.0,128476.0,125944.0,125971.0,105775.0,104999.0,79563.0,83694.0,82864.0,81006.0,1224229.0
Buxar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,254.0,151.0,222.0,873.0,583.0,396.0,427.0,903.0,1254.0,974.0,1112.0,545.0,7694.0
Buxar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Buxar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3576.0,3009.0,3009.0,3445.0,2681.0,3589.0,2555.0,3125.0,2749.0,1816.0,2239.0,1701.0,33494.0
Buxar,14.14.a,Number of patients given AYUSH treatment,TOTAL,20490.0,19426.0,20093.0,24543.0,29670.0,37170.0,30987.0,26675.0,17366.0,23273.0,19586.0,23290.0,292569.0
Buxar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,289.0,475.0,504.0,1740.0,738.0,768.0,716.0,943.0,589.0,914.0,755.0,998.0,9429.0
Buxar,14.14.c,Number of Adolescents counselled,TOTAL,37.0,34.0,26.0,0.0,0.0,0.0,0.0,0.0,24.0,24.0,24.0,25.0,194.0
Buxar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,296.0,225.0,301.0,567.0,621.0,435.0,820.0,526.0,684.0,687.0,748.0,744.0,6654.0
Buxar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,4.0,11.0,14.0,19.0,10.0,11.0,37.0,8.0,10.0,254.0,251.0,12.0,641.0
Buxar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,234.0,230.0,171.0,243.0,227.0,67.0,131.0,249.0,143.0,310.0,107.0,139.0,2251.0
Buxar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,4.0,4.0,3.0,5.0,2.0,3.0,7.0,2.0,4.0,0.0,1.0,38.0
Buxar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,167.0,160.0,117.0,218.0,155.0,118.0,187.0,273.0,295.0,294.0,376.0,126.0,2486.0
Buxar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,5.0,2.0,1.0,3.0,3.0,5.0,2.0,3.0,0.0,0.0,4.0,28.0
Buxar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,354.0,339.0,232.0,362.0,413.0,144.0,184.0,259.0,277.0,270.0,204.0,253.0,3291.0
Buxar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Buxar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,755.0,729.0,520.0,823.0,795.0,329.0,502.0,781.0,715.0,874.0,687.0,518.0,8028.0
Buxar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,10.0,6.0,4.0,8.0,5.0,8.0,9.0,5.0,4.0,0.0,6.0,68.0
Buxar,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,25.0,12.0,0.0,0.0,0.0,0.0,0.0,37.0
Buxar,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,15.4.1,Number of blood smears examined for Malaria,TOTAL,0.0,0.0,0.0,0.0,0.0,30.0,0.0,0.0,1.0,3.0,1.0,1.0,36.0
Buxar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Buxar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2150.0,500.0,700.0,1200.0,1500.0,2400.0,2900.0,3450.0,2050.0,2250.0,1700.0,3800.0,24600.0
Buxar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,2000.0,2500.0,2000.0,3000.0,2000.0,2000.0,0.0,2000.0,500.0,3500.0,500.0,20000.0
Buxar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1650.0,1800.0,2000.0,1700.0,2100.0,1300.0,1450.0,1400.0,1800.0,1050.0,1800.0,2150.0,20200.0
Buxar,16.1.1,Stock position of DPT vaccines,5. Total Stock,500.0,700.0,1200.0,1500.0,2400.0,3100.0,3450.0,2050.0,2250.0,1700.0,3400.0,2150.0,24400.0
Buxar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,0.0,,0.0,0.0,2885.0,2143.0,5028.0
Buxar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,0.0,,0.0,3300.0,0.0,0.0,3300.0
Buxar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0
Buxar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,0.0,,0.0,415.0,764.0,1305.0,2484.0
Buxar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2885.0,2121.0,838.0,5844.0
Buxar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1150.0,175.0,300.0,450.0,625.0,250.0,275.0,950.0,275.0,300.0,500.0,950.0,6200.0
Buxar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,1425.0,1600.0,1500.0,600.0,350.0,1250.0,0.0,1250.0,800.0,1500.0,2000.0,12275.0
Buxar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,975.0,1300.0,1450.0,1325.0,975.0,275.0,575.0,675.0,1225.0,600.0,1100.0,1350.0,11825.0
Buxar,16.1.2,Stock position of OPV vaccines,5. Total Stock,175.0,300.0,450.0,625.0,250.0,325.0,950.0,275.0,300.0,500.0,900.0,1600.0,6650.0
Buxar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2350.0,650.0,1300.0,1150.0,850.0,300.0,1700.0,2050.0,800.0,2300.0,2000.0,3000.0,18450.0
Buxar,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,2000.0,1500.0,1000.0,600.0,200.0,2000.0,0.0,3000.0,500.0,2500.0,500.0,13800.0
Buxar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1700.0,1350.0,1650.0,1300.0,1150.0,350.0,1650.0,1250.0,1500.0,800.0,1500.0,1350.0,15550.0
Buxar,16.1.3,Stock position of TT vaccines,5. Total Stock,650.0,1300.0,1150.0,850.0,300.0,150.0,2050.0,800.0,2300.0,2000.0,3000.0,2150.0,16700.0
Buxar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,0.0,,,0.0
Buxar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,0.0,,,0.0
Buxar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Buxar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,0.0,,,0.0
Buxar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1150.0,250.0,200.0,500.0,700.0,1050.0,1100.0,1350.0,450.0,775.0,1225.0,1075.0,9825.0
Buxar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,1000.0,1000.0,1000.0,1000.0,1000.0,1300.0,0.0,1250.0,1000.0,800.0,1500.0,10850.0
Buxar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,900.0,1050.0,700.0,800.0,650.0,750.0,1000.0,900.0,925.0,550.0,1050.0,750.0,10025.0
Buxar,16.1.5,Stock position of BCG vaccines,5. Total Stock,250.0,200.0,500.0,700.0,1050.0,1300.0,1400.0,450.0,775.0,1225.0,975.0,1825.0,10650.0
Buxar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1500.0,300.0,575.0,1300.0,1650.0,1600.0,950.0,1500.0,250.0,350.0,1350.0,1100.0,12425.0
Buxar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,2000.0,3000.0,2000.0,2000.0,1000.0,2000.0,0.0,2000.0,2000.0,1500.0,2500.0,20000.0
Buxar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1200.0,1725.0,2275.0,1650.0,2050.0,1450.0,1400.0,1250.0,1900.0,1000.0,1850.0,1650.0,19400.0
Buxar,16.1.6,Stock position of Measles vaccines,5. Total Stock,300.0,575.0,1300.0,1650.0,1600.0,1150.0,1550.0,250.0,350.0,1350.0,1000.0,1950.0,13025.0
Buxar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,8300.0,2950.0,50.0,0.0,600.0,100.0,900.0,0.0,0.0,500.0,50.0,200.0,13650.0
Buxar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,2000.0,800.0,1200.0,0.0,0.0,2000.0,500.0,1000.0,2000.0,9500.0
Buxar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,5350.0,2900.0,50.0,1400.0,1300.0,100.0,900.0,0.0,2000.0,950.0,850.0,900.0,16700.0
Buxar,16.1.7,Stock position of JE vaccines,5. Total Stock,2950.0,50.0,0.0,600.0,100.0,1200.0,0.0,0.0,0.0,50.0,200.0,1300.0,6450.0
Buxar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1410.0,180.0,575.0,1250.0,1450.0,1680.0,2030.0,2350.0,700.0,500.0,1650.0,1600.0,15375.0
Buxar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,2000.0,3000.0,2000.0,1680.0,2000.0,1950.0,0.0,1000.0,2000.0,1600.0,1000.0,18230.0
Buxar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1230.0,1880.0,2275.0,1800.0,1450.0,1410.0,1630.0,1650.0,1200.0,850.0,1950.0,1050.0,18375.0
Buxar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,180.0,300.0,1300.0,1450.0,1680.0,2270.0,2350.0,700.0,500.0,1650.0,1300.0,1550.0,15230.0
Buxar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Buxar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Buxar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,0.0,100000.0
Buxar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,0.0,100000.0
Buxar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,15000.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0
Buxar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,15000.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0
Buxar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,7500.0,0.0,0.0,0.0,0.0,0.0,0.0,7500.0
Buxar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,7500.0,0.0,0.0,0.0,0.0,0.0,0.0,7500.0
Buxar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Buxar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Buxar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Buxar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Buxar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2800.0,8600.0,3800.0,8800.0,4500.0,5700.0,1400.0,6700.0,2800.0,7700.0,4600.0,3800.0,61200.0
Buxar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,8500.0,0.0,8000.0,0.0,4000.0,0.0,8000.0,0.0,10000.0,0.0,3300.0,6000.0,47800.0
Buxar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2700.0,4800.0,3000.0,4300.0,2800.0,3900.0,2700.0,3900.0,5100.0,3100.0,4100.0,3500.0,43900.0
Buxar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8600.0,3800.0,8800.0,4500.0,5700.0,1800.0,6700.0,2800.0,7700.0,4600.0,3800.0,6300.0,65100.0
Buxar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,22000.0,76000.0,26000.0,78000.0,23000.0,77000.0,16800.0,65600.0,26800.0,49000.0,18800.0,53000.0,532000.0
Buxar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,80000.0,0.0,80000.0,0.0,80000.0,0.0,80000.0,0.0,70000.0,0.0,75000.0,36000.0,501000.0
Buxar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,26000.0,50000.0,28000.0,55000.0,26000.0,53200.0,31200.0,35800.0,47800.0,30600.0,40800.0,38000.0,462400.0
Buxar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,76000.0,26000.0,78000.0,23000.0,77000.0,23800.0,65600.0,29800.0,49000.0,18400.0,53000.0,51000.0,570600.0
Buxar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,9500.0,7800.0,4600.0,6300.0,2400.0,5100.0,1300.0,5000.0,2700.0,4200.0,2000.0,0.0,50900.0
Buxar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,4500.0,0.0,5000.0,0.0,6000.0,0.0,6000.0,0.0,0.0,5000.0,26500.0
Buxar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Buxar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1700.0,3200.0,2800.0,3900.0,2300.0,3100.0,2300.0,2300.0,4500.0,2200.0,2000.0,1000.0,31300.0
Buxar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,7800.0,4600.0,6300.0,2400.0,5100.0,2000.0,5000.0,2700.0,4200.0,2000.0,0.0,4000.0,46100.0
Buxar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Buxar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Buxar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Buxar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Buxar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Buxar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Buxar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Buxar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Buxar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Buxar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Buxar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Buxar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Buxar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Buxar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Buxar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Buxar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Buxar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Buxar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Buxar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Buxar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Buxar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Buxar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Buxar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Buxar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Buxar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Buxar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Buxar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Buxar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Buxar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Buxar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Buxar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Buxar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Buxar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Buxar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Buxar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Buxar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,,,,,,,,,,,1.0
Buxar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Buxar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Buxar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Buxar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Buxar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Buxar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Buxar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Buxar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Buxar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Buxar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Buxar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Buxar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Buxar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Buxar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Buxar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Buxar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Buxar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Buxar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Buxar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Buxar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Buxar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Buxar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Buxar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Buxar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Buxar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Buxar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Buxar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Buxar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Darbhanga,1.1,Total number of pregnant women Registered for ANC,TOTAL,8470.0,8611.0,7987.0,8276.0,9925.0,8402.0,7308.0,7366.0,6870.0,7783.0,7157.0,9457.0,97612.0
Darbhanga,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3354.0,3238.0,3111.0,2791.0,3254.0,3004.0,2881.0,3202.0,3296.0,3880.0,3596.0,4074.0,39681.0
Darbhanga,1.2,Number of Pregnant women registered under JSY,TOTAL,8453.0,8611.0,7976.0,8276.0,9924.0,8402.0,7286.0,7356.0,6866.0,7774.0,7154.0,9457.0,97535.0
Darbhanga,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4783.0,4716.0,4611.0,4883.0,5367.0,5520.0,5497.0,5188.0,4963.0,4947.0,4504.0,5022.0,60001.0
Darbhanga,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6745.0,6874.0,6389.0,6375.0,7857.0,6398.0,5426.0,5444.0,5060.0,5698.0,5532.0,6761.0,74559.0
Darbhanga,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,7782.0,8724.0,7138.0,7003.0,9209.0,8467.0,7755.0,7217.0,6860.0,6846.0,5942.0,8306.0,91249.0
Darbhanga,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4830.0,5048.0,5370.0,5931.0,6775.0,5512.0,5073.0,5442.0,4055.0,5023.0,4035.0,4804.0,61898.0
Darbhanga,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,60.0,42.0,54.0,204.0,79.0,45.0,60.0,41.0,64.0,59.0,58.0,36.0,802.0
Darbhanga,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,4.0,4.0,3.0,0.0,2.0,0.0,0.0,0.0,8.0,0.0,5.0,28.0
Darbhanga,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,295.0,340.0,223.0,355.0,177.0,241.0,332.0,310.0,247.0,279.0,335.0,522.0,3656.0
Darbhanga,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,3.0,8.0,5.0,9.0,4.0,4.0,3.0,1.0,2.0,8.0,7.0,15.0,69.0
Darbhanga,1.8,Number of pregnancy test kits used at SC level,TOTAL,54.0,150.0,183.0,90.0,133.0,120.0,108.0,116.0,97.0,133.0,133.0,149.0,1466.0
Darbhanga,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,535.0,531.0,473.0,476.0,704.0,698.0,571.0,779.0,618.0,656.0,601.0,647.0,7289.0
Darbhanga,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1372.0,1402.0,1281.0,1349.0,1600.0,1748.0,1746.0,2153.0,2072.0,1966.0,1721.0,1571.0,19981.0
Darbhanga,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1907.0,1933.0,1754.0,1825.0,2304.0,2446.0,2317.0,2932.0,2690.0,2622.0,2322.0,2218.0,27270.0
Darbhanga,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1298.0,1348.0,1123.0,1183.0,1551.0,1608.0,1608.0,1940.0,1829.0,1722.0,1714.0,1547.0,18471.0
Darbhanga,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,54.0,57.0
Darbhanga,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2671.0,2623.0,2267.0,3372.0,4069.0,4236.0,4136.0,4121.0,4068.0,3686.0,3150.0,2451.0,40850.0
Darbhanga,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2657.0,2603.0,2070.0,3323.0,4035.0,4196.0,3662.0,4077.0,4202.0,4094.0,3233.0,2760.0,40912.0
Darbhanga,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,431.0,2359.0,153.0,365.0,2129.0,254.0,1193.0,4161.0,4453.0,4088.0,3144.0,2727.0,25457.0
Darbhanga,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,243.0,553.0,275.0,1257.0,368.0,44.0,258.0,762.0,1040.0,3157.0,1980.0,3753.0,13690.0
Darbhanga,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,2.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Darbhanga,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Darbhanga,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darbhanga,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,2.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Darbhanga,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,35.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35.0
Darbhanga,4.1.1.a,Number of male live births,TOTAL,2365.0,2558.0,2150.0,2674.0,3298.0,3367.0,3472.0,3691.0,3630.0,3548.0,3085.0,2609.0,36447.0
Darbhanga,4.1.1.b,Number of female live births,TOTAL,2176.0,2271.0,1991.0,2412.0,3108.0,3217.0,3005.0,3396.0,3467.0,3324.0,2891.0,2483.0,33741.0
Darbhanga,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4541.0,4829.0,4141.0,5086.0,6406.0,6584.0,6477.0,7087.0,7097.0,6872.0,5976.0,5092.0,70188.0
Darbhanga,4.1.2,Number of still births,TOTAL,45.0,50.0,57.0,87.0,77.0,133.0,86.0,67.0,70.0,58.0,45.0,48.0,823.0
Darbhanga,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,32.0,48.0,57.0,44.0,45.0,33.0,25.0,28.0,31.0,27.0,29.0,32.0,431.0
Darbhanga,4.2.1,Number of Newborns weighed at birth,TOTAL,4145.0,4471.0,3763.0,4758.0,5729.0,6074.0,5818.0,6393.0,6153.0,6344.0,5514.0,4723.0,63885.0
Darbhanga,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,225.0,191.0,202.0,264.0,290.0,339.0,232.0,410.0,716.0,296.0,258.0,179.0,3602.0
Darbhanga,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4444.0,4681.0,4041.0,5008.0,6162.0,6518.0,6204.0,6887.0,6595.0,6676.0,5846.0,5060.0,68122.0
Darbhanga,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,8.0,13.0,0.0,7.0,5.0,0.0,0.0,3.0,4.0,40.0
Darbhanga,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darbhanga,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,8.0,13.0,0.0,7.0,5.0,0.0,0.0,3.0,4.0,40.0
Darbhanga,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,5.0,5.0,0.0,2.0,1.0,58.0,2.0,1.0,0.0,74.0
Darbhanga,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,55.0,0.0,0.0,0.0,55.0
Darbhanga,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,3.0,8.0,0.0,5.0,4.0,59.0,3.0,2.0,0.0,84.0
Darbhanga,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1707.0,2066.0,1855.0,2211.0,2699.0,2679.0,2477.0,2758.0,2251.0,2585.0,2419.0,2016.0,27723.0
Darbhanga,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1442.0,1520.0,1665.0,2017.0,2115.0,2170.0,1956.0,2922.0,2167.0,2400.0,1771.0,1824.0,23969.0
Darbhanga,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0,0.0,0.0,0.0,2.0,33.0
Darbhanga,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,4.0,9.0,4.0,8.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,1.0,29.0
Darbhanga,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Darbhanga,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,4.0,9.0,4.0,8.0,1.0,0.0,1.0,2.0,0.0,0.0,0.0,1.0,30.0
Darbhanga,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,0.0,36.0,0.0,18.0,12.0,2.0,5.0,8.0,38.0,100.0,17.0,236.0
Darbhanga,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0.0,0.0,44.0,0.0,26.0,17.0,8.0,4.0,12.0,58.0,109.0,15.0,293.0
Darbhanga,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,0.0,0.0,80.0,0.0,44.0,29.0,10.0,9.0,20.0,96.0,209.0,32.0,529.0
Darbhanga,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,2.0,1.0,2.0,3.0,1.0,0.0,2.0,6.0,1.0,19.0
Darbhanga,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,2.0,1.0,0.0,6.0
Darbhanga,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Darbhanga,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darbhanga,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,0.0,4.0,1.0,2.0,3.0,1.0,3.0,4.0,7.0,1.0,27.0
Darbhanga,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darbhanga,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,107.0,96.0,80.0,943.0,360.0,485.0,340.0,1387.0,3246.0,2192.0,1552.0,771.0,11559.0
Darbhanga,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,28.0,24.0,16.0,62.0,12.0,37.0,65.0,172.0,191.0,117.0,123.0,31.0,878.0
Darbhanga,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,8.0,11.0,4.0,4.0,10.0,31.0,25.0,46.0,78.0,114.0,77.0,34.0,442.0
Darbhanga,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darbhanga,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,143.0,131.0,100.0,1009.0,382.0,553.0,430.0,1605.0,3515.0,2423.0,1752.0,836.0,12879.0
Darbhanga,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,45.0,41.0,55.0,55.0,42.0,65.0,105.0,105.0,90.0,175.0,136.0,8600.0,9514.0
Darbhanga,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,5.0,7.0
Darbhanga,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darbhanga,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,5.0,7.0
Darbhanga,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,124.0,167.0,135.0,395.0,307.0,456.0,405.0,436.0,395.0,356.0,410.0,513.0,4099.0
Darbhanga,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,382.0,248.0,137.0,873.0,758.0,390.0,385.0,400.0,437.0,334.0,306.0,382.0,5032.0
Darbhanga,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,74.0,87.0,45.0,109.0,54.0,42.0,45.0,82.0,51.0,56.0,63.0,40.0,748.0
Darbhanga,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,23.0,2.0,7.0,6.0,8.0,8.0,8.0,11.0,13.0,86.0
Darbhanga,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Darbhanga,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,580.0,502.0,317.0,1400.0,1121.0,895.0,841.0,926.0,891.0,754.0,790.0,948.0,9965.0
Darbhanga,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,73.0,95.0,18.0,89.0,87.0,110.0,29.0,81.0,69.0,73.0,98.0,107.0,929.0
Darbhanga,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Darbhanga,9.06,Number of IUCD removals,TOTAL,121.0,110.0,209.0,227.0,255.0,276.0,188.0,298.0,256.0,261.0,272.0,281.0,2754.0
Darbhanga,9.07,Number of Oral Pills cycles distributed,TOTAL,230.0,112.0,1004.0,1560.0,2620.0,4043.0,2606.0,3186.0,2981.0,3311.0,3370.0,3332.0,28355.0
Darbhanga,9.08,Number of Condom pieces distributed,TOTAL,6655.0,5133.0,10871.0,26198.0,20655.0,19801.0,16405.0,19214.0,19908.0,19586.0,23575.0,23196.0,211197.0
Darbhanga,9.09,Number of Centchroman (weekly) pills given,TOTAL,2.0,70.0,213.0,412.0,40.0,32.0,233.0,339.0,91.0,15.0,72.0,108.0,1627.0
Darbhanga,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,75.0,13.0,21.0,20.0,57.0,46.0,21.0,48.0,31.0,54.0,38.0,23.0,447.0
Darbhanga,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Darbhanga,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Darbhanga,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,7285.0,6857.0,6039.0,6555.0,9924.0,10212.0,10278.0,11637.0,9361.0,11666.0,8759.0,9323.0,107896.0
Darbhanga,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,9010.0,7505.0,6308.0,6314.0,7597.0,8641.0,9107.0,10833.0,9425.0,2841.0,732.0,1570.0,79883.0
Darbhanga,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,9768.0,8503.0,6804.0,6821.0,7611.0,7673.0,7813.0,9070.0,9215.0,9791.0,4220.0,3828.0,91117.0
Darbhanga,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,9649.0,9012.0,7362.0,7330.0,8085.0,8025.0,7495.0,7682.0,8030.0,9240.0,7359.0,7990.0,97259.0
Darbhanga,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,35.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8225.0,8296.0,9379.0,25935.0
Darbhanga,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,49.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4462.0,8212.0,12724.0
Darbhanga,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,65.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4181.0,4246.0
Darbhanga,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3590.0,3888.0,3309.0,4230.0,5299.0,4725.0,5055.0,3763.0,2996.0,6023.0,4638.0,4684.0,52200.0
Darbhanga,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,9002.0,7407.0,6172.0,6137.0,7430.0,7018.0,6685.0,6631.0,5174.0,9691.0,8668.0,10690.0,90705.0
Darbhanga,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,9747.0,8182.0,6631.0,6630.0,7464.0,6397.0,5368.0,5250.0,4674.0,9033.0,7922.0,11396.0,88694.0
Darbhanga,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,9662.0,8367.0,7091.0,7063.0,7849.0,6653.0,5125.0,4690.0,4143.0,8220.0,7260.0,10867.0,86990.0
Darbhanga,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2183.0,2058.0,1908.0,2773.0,3353.0,3745.0,4440.0,3341.0,3269.0,3537.0,2683.0,2143.0,35433.0
Darbhanga,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,9244.0,7058.0,6265.0,6251.0,7552.0,8574.0,9123.0,11120.0,9292.0,3094.0,1133.0,1761.0,80467.0
Darbhanga,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,9741.0,7891.0,6710.0,6779.0,7434.0,7731.0,7669.0,8873.0,9079.0,9659.0,4569.0,3834.0,89969.0
Darbhanga,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,9604.0,8342.0,7373.0,7280.0,7886.0,8090.0,7557.0,7753.0,7964.0,9094.0,7371.0,7740.0,96054.0
Darbhanga,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7142.0,7371.0,7210.0,7864.0,9216.0,8531.0,8058.0,9865.0,6322.0,7694.0,7069.0,8889.0,95231.0
Darbhanga,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4814.0,4689.0,3664.0,3566.0,5011.0,3848.0,3450.0,4552.0,3561.0,4843.0,5388.0,6743.0,54129.0
Darbhanga,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,955.0,833.0,294.0,130.0,38.0,41.0,1543.0,4646.0,5098.0,6621.0,20199.0
Darbhanga,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3442.0,4012.0,3600.0,3911.0,4782.0,4301.0,4025.0,4798.0,3167.0,3963.0,3764.0,4523.0,48288.0
Darbhanga,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3060.0,3385.0,3355.0,3464.0,4275.0,3792.0,3601.0,4563.0,2976.0,3544.0,3218.0,4080.0,43313.0
Darbhanga,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6502.0,7397.0,6955.0,7375.0,9057.0,8093.0,7626.0,9361.0,6143.0,7507.0,6982.0,8603.0,91601.0
Darbhanga,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6902.0,5863.0,4642.0,4376.0,5816.0,5217.0,4996.0,5170.0,4961.0,5841.0,6194.0,7377.0,67355.0
Darbhanga,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6929.0,5855.0,4631.0,4362.0,5724.0,4381.0,3550.0,2957.0,2708.0,5497.0,6116.0,7237.0,59947.0
Darbhanga,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1093.0,1112.0,781.0,702.0,938.0,783.0,661.0,841.0,792.0,926.0,1249.0,1119.0,10997.0
Darbhanga,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1000.0,966.0,695.0,649.0,792.0,691.0,571.0,697.0,848.0,810.0,1189.0,1164.0,10072.0
Darbhanga,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2093.0,2078.0,1476.0,1351.0,1730.0,1474.0,1232.0,1538.0,1640.0,1736.0,2438.0,2283.0,21069.0
Darbhanga,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,979.0,974.0,785.0,660.0,1092.0,935.0,1013.0,1025.0,1184.0,1087.0,890.0,1177.0,11801.0
Darbhanga,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1318.0,1413.0,1265.0,1097.0,1495.0,1377.0,1318.0,1325.0,1400.0,1444.0,1505.0,1472.0,16429.0
Darbhanga,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2181.0,2102.0,2026.0,1942.0,2465.0,2270.0,2160.0,2573.0,2706.0,2696.0,2489.0,2626.0,28236.0
Darbhanga,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Darbhanga,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3698.0,3505.0,3281.0,3670.0,3746.0,3668.0,3636.0,3609.0,3533.0,3618.0,3603.0,3687.0,43254.0
Darbhanga,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3665.0,3545.0,3005.0,3312.0,3703.0,3437.0,3329.0,3518.0,3460.0,3549.0,3287.0,3593.0,41403.0
Darbhanga,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3030.0,2908.0,2487.0,2648.0,2823.0,2659.0,2646.0,2720.0,2670.0,2698.0,2513.0,2777.0,32579.0
Darbhanga,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,17730.0,994.0,83.0,81.0,0.0,10.0,743.0,2248.0,3729.0,5426.0,31044.0
Darbhanga,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5318.0,5241.0,4763.0,6858.0,7292.0,6373.0,5967.0,7303.0,5373.0,5710.0,5542.0,6119.0,71859.0
Darbhanga,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1058.0,959.0,843.0,3322.0,1156.0,907.0,808.0,918.0,2448.0,882.0,1078.0,1487.0,15866.0
Darbhanga,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,116.0,185.0,213.0,1968.0,559.0,215.0,223.0,223.0,1134.0,213.0,142.0,190.0,5381.0
Darbhanga,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,36.0,15.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,56.0
Darbhanga,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Darbhanga,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,6.0,0.0,0.0,12.0,10.0,0.0,0.0,12.0,0.0,0.0,0.0,5.0,45.0
Darbhanga,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,3.0,0.0,0.0,9.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,17.0
Darbhanga,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,43.0,55.0,16.0,32.0,0.0,23.0,2.0,14.0,0.0,7.0,23.0,39.0,254.0
Darbhanga,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,552.0,459.0,530.0,490.0,555.0,560.0,517.0,318.0,380.0,433.0,385.0,615.0,5794.0
Darbhanga,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,34.0,3.0,14.0,9.0,30.0,0.0,0.0,41.0,14.0,22.0,0.0,167.0
Darbhanga,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,100.0,120.0,112.0,119.0,112.0,30.0,102.0,96.0,55.0,4.0,3.0,29.0,882.0
Darbhanga,13.1,Number of Patients operated for cataract,TOTAL,55.0,52.0,32.0,46.0,32.0,45.0,12.0,42.0,107.0,93.0,120.0,69.0,705.0
Darbhanga,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,13.3,Number of School children detected with Refractive errors,TOTAL,6.0,9.0,7.0,1.0,6.0,7.0,6.0,6.0,5.0,7.0,5.0,5.0,70.0
Darbhanga,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Darbhanga,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Darbhanga,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2314.0,2306.0,2151.0,1969.0,2377.0,2375.0,2382.0,1870.0,1724.0,2009.0,2012.0,1937.0,-1.0
Darbhanga,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Darbhanga,14.05,Number of RKS meetings held during the month,TOTAL,9.0,15.0,14.0,12.0,10.0,8.0,10.0,5.0,9.0,10.0,6.0,7.0,115.0
Darbhanga,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Darbhanga,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,130.0,113.0,132.0,219.0,38.0,183.0,49.0,189.0,100.0,527.0,335.0,115.0,2130.0
Darbhanga,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Darbhanga,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Darbhanga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1166.0,1406.0,1610.0,1922.0,1591.0,1637.0,1622.0,1345.0,1582.0,1438.0,1783.0,1711.0,18813.0
Darbhanga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1997.0,1877.0,2171.0,2080.0,2170.0,2072.0,2331.0,1887.0,1874.0,2884.0,2689.0,2536.0,26568.0
Darbhanga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1590.0,1804.0,2141.0,1747.0,1998.0,2127.0,1907.0,2131.0,2205.0,1663.0,2006.0,2235.0,23554.0
Darbhanga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4952.0,4755.0,4558.0,5871.0,6313.0,6754.0,6378.0,6273.0,8215.0,7634.0,6343.0,6610.0,74656.0
Darbhanga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2756.0,3210.0,3751.0,3669.0,3589.0,3764.0,3529.0,3476.0,3787.0,3101.0,3789.0,3946.0,42367.0
Darbhanga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6949.0,6632.0,6729.0,7951.0,8483.0,8826.0,8709.0,8160.0,10089.0,10518.0,9032.0,9146.0,101224.0
Darbhanga,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,3.0,5.0,1.0,0.0,1.0,0.0,0.0,3.0,0.0,1.0,0.0,16.0
Darbhanga,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,6.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,11.0
Darbhanga,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,3.0,9.0,5.0,2.0,0.0,1.0,0.0,1.0,4.0,0.0,2.0,0.0,27.0
Darbhanga,14.11,In-Patient Head Count at midnight,TOTAL,6852.0,6802.0,7255.0,7970.0,8070.0,7993.0,8014.0,7799.0,8822.0,8527.0,8375.0,7471.0,93950.0
Darbhanga,14.12.1,OPD attendance (All),TOTAL,163731.0,183112.0,184219.0,193079.0,212393.0,211061.0,188940.0,192208.0,218032.0,200415.0,203293.0,215755.0,2366238.0
Darbhanga,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,154.0,314.0,121.0,968.0,409.0,529.0,557.0,1689.0,4766.0,2979.0,1813.0,1426.0,15725.0
Darbhanga,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,211.0,54.0,404.0,83.0,753.0
Darbhanga,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4694.0,4461.0,5351.0,5886.0,5631.0,5672.0,5553.0,5402.0,7025.0,5224.0,4772.0,5090.0,64761.0
Darbhanga,14.14.a,Number of patients given AYUSH treatment,TOTAL,31813.0,33798.0,37747.0,39063.0,43698.0,40313.0,35233.0,37169.0,25917.0,30820.0,31297.0,32236.0,419104.0
Darbhanga,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,12124.0,11788.0,13504.0,13865.0,12627.0,13670.0,10121.0,10816.0,10326.0,9660.0,10203.0,9277.0,137981.0
Darbhanga,14.14.c,Number of Adolescents counselled,TOTAL,44.0,77.0,54.0,104.0,338.0,294.0,482.0,343.0,255.0,365.0,202.0,236.0,2794.0
Darbhanga,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,863.0,759.0,1269.0,1122.0,1189.0,924.0,895.0,930.0,704.0,1250.0,1107.0,1065.0,12077.0
Darbhanga,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,29.0,13.0,18.0,20.0,14.0,15.0,13.0,15.0,13.0,14.0,22.0,18.0,204.0
Darbhanga,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,445.0,206.0,357.0,628.0,589.0,785.0,634.0,293.0,338.0,492.0,329.0,165.0,5261.0
Darbhanga,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,2.0,10.0,5.0,6.0,3.0,4.0,7.0,4.0,4.0,0.0,0.0,46.0
Darbhanga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,456.0,299.0,326.0,716.0,492.0,446.0,605.0,629.0,1518.0,1172.0,691.0,354.0,7704.0
Darbhanga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,2.0,4.0,2.0,5.0,4.0,4.0,7.0,1.0,5.0,0.0,5.0,42.0
Darbhanga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,516.0,441.0,322.0,853.0,934.0,1232.0,1096.0,601.0,785.0,1053.0,546.0,423.0,8802.0
Darbhanga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Darbhanga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1417.0,946.0,1005.0,2197.0,2015.0,2463.0,2335.0,1523.0,2641.0,2717.0,1566.0,942.0,21767.0
Darbhanga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,4.0,14.0,7.0,11.0,9.0,8.0,14.0,5.0,9.0,0.0,5.0,91.0
Darbhanga,15.2,Number of Widal tests conducted,Number tested,0.0,24.0,0.0,658.0,53.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,735.0
Darbhanga,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,15.4.1,Number of blood smears examined for Malaria,TOTAL,32.0,19.0,58.0,56.0,111.0,22.0,64.0,58.0,19.0,27.0,96.0,62.0,624.0
Darbhanga,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,5.0,9.0
Darbhanga,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,3.0,5.0
Darbhanga,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,39.0,3861.0,8959.0,8287.0,21535.0,13936.0,10646.0,14926.0,9136.0,1886.0,110.0,2500.0,95821.0
Darbhanga,16.1.1,Stock position of DPT vaccines,2. Stocks Received,12000.0,15000.0,100000.0,30000.0,0.0,8000.0,15000.0,5000.0,5000.0,0.0,5000.0,17500.0,212500.0
Darbhanga,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,12057.0,9902.0,100672.0,16752.0,7599.0,11290.0,10721.0,10789.0,12250.0,1886.0,3273.0,10000.0,207191.0
Darbhanga,16.1.1,Stock position of DPT vaccines,5. Total Stock,-18.0,8959.0,8287.0,21535.0,13936.0,10646.0,14925.0,9137.0,1886.0,0.0,1837.0,10000.0,101130.0
Darbhanga,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30200.0,4850.0,6200.0,41250.0
Darbhanga,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19000.0,1499.0,3000.0,23499.0
Darbhanga,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11200.0,3351.0,3200.0,17751.0
Darbhanga,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1920.0,938.0,4003.0,1216.0,6000.0,675.0,0.0,143.0,0.0,2000.0,431.0,800.0,18126.0
Darbhanga,16.1.2,Stock position of OPV vaccines,2. Stocks Received,6000.0,11892.0,6000.0,13000.0,3000.0,4250.0,6100.0,0.0,7550.0,1500.0,2000.0,17500.0,78792.0
Darbhanga,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,6982.0,8827.0,8787.0,8216.0,2295.0,4925.0,5957.0,143.0,5550.0,3500.0,2263.0,9800.0,67245.0
Darbhanga,16.1.2,Stock position of OPV vaccines,5. Total Stock,938.0,4003.0,1216.0,6000.0,6705.0,0.0,143.0,0.0,2000.0,0.0,168.0,8500.0,29673.0
Darbhanga,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2596.0,4148.0,7863.0,7293.0,11753.0,6018.0,3347.0,8106.0,10311.0,5911.0,1222.0,3911.0,72479.0
Darbhanga,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,10000.0,7000.0,14000.0,0.0,8000.0,14700.0,8000.0,3000.0,10000.0,4000.0,6000.0,94700.0
Darbhanga,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8448.0,6285.0,7570.0,9540.0,5735.0,10671.0,9942.0,5794.0,7400.0,7000.0,1898.0,5000.0,85283.0
Darbhanga,16.1.3,Stock position of TT vaccines,5. Total Stock,4148.0,7863.0,7293.0,11753.0,6018.0,3347.0,8105.0,10312.0,5911.0,8911.0,3324.0,4911.0,81896.0
Darbhanga,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,618.0,622.0,2996.0,2275.0,7420.0,3891.0,3541.0,3401.0,3227.0,2017.0,1410.0,2717.0,34135.0
Darbhanga,16.1.5,Stock position of BCG vaccines,2. Stocks Received,6000.0,7000.0,5000.0,13000.0,0.0,6000.0,6100.0,6000.0,6000.0,6000.0,3000.0,12150.0,76250.0
Darbhanga,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5996.0,4626.0,5721.0,7855.0,3529.0,6350.0,6240.0,6174.0,7210.0,7000.0,2440.0,6000.0,69141.0
Darbhanga,16.1.5,Stock position of BCG vaccines,5. Total Stock,622.0,2996.0,2275.0,7420.0,3891.0,3541.0,3401.0,3227.0,2017.0,1017.0,1970.0,8867.0,41244.0
Darbhanga,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,33314.0,25461.0,13174.0,3057.0,10503.0,838.0,1286.0,1364.0,1326.0,5526.0,1742.0,2826.0,100417.0
Darbhanga,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,0.0,18000.0,1000.0,12600.0,9900.0,9600.0,8600.0,9000.0,4000.0,19300.0,92000.0
Darbhanga,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7853.0,12287.0,10117.0,10554.0,10665.0,1215.0,9822.0,9638.0,4400.0,14500.0,4183.0,10500.0,105734.0
Darbhanga,16.1.6,Stock position of Measles vaccines,5. Total Stock,25461.0,13174.0,3057.0,10503.0,838.0,12223.0,1364.0,1326.0,5526.0,26.0,1559.0,11626.0,86683.0
Darbhanga,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,750.0,2000.0,6750.0
Darbhanga,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,211920.0,0.0,1000.0,2000.0,0.0,0.0,9000.0,0.0,2200.0,16000.0,242120.0
Darbhanga,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,77000.0,0.0,1000.0,2000.0,0.0,0.0,5000.0,4000.0,2898.0,7000.0,98898.0
Darbhanga,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,134920.0,0.0,0.0,0.0,0.0,0.0,4000.0,0.0,52.0,11000.0,149972.0
Darbhanga,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,257.0,14.0,3123.0,1621.0,10694.0,2187.0,3247.0,8787.0,3957.0,2257.0,1700.0,1807.0,39651.0
Darbhanga,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,9000.0,10000.0,7000.0,21000.0,3000.0,12000.0,14000.0,5000.0,8000.0,7500.0,2000.0,10000.0,108500.0
Darbhanga,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,9243.0,6891.0,8502.0,11927.0,11507.0,10940.0,8460.0,9830.0,9700.0,9450.0,2730.0,8800.0,107980.0
Darbhanga,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,14.0,3123.0,1621.0,10694.0,2187.0,3247.0,8787.0,3957.0,2257.0,307.0,970.0,3007.0,40171.0
Darbhanga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1100.0,750.0,,,30750.0,16300.0,16300.0,,,,,,65200.0
Darbhanga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,30000.0,,,0.0,0.0,0.0,,,,,,30000.0
Darbhanga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,,,,,,0.0
Darbhanga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,350.0,0.0,,,14450.0,0.0,3600.0,,,,,,18400.0
Darbhanga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,750.0,30750.0,0.0,0.0,16300.0,16300.0,12700.0,0.0,0.0,0.0,0.0,0.0,76800.0
Darbhanga,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,18600.0,1100.0,,,501100.0,212600.0,212600.0,,,,,,946000.0
Darbhanga,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,500000.0,,,0.0,0.0,0.0,,,,,,500000.0
Darbhanga,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,,,,,,0.0
Darbhanga,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,17500.0,0.0,,,288500.0,0.0,72000.0,,,,,,378000.0
Darbhanga,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,1100.0,501100.0,0.0,0.0,212600.0,212600.0,140600.0,0.0,0.0,0.0,0.0,0.0,1068000.0
Darbhanga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,50000.0,19900.0,19900.0,,,,,,89800.0
Darbhanga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,50000.0,,,0.0,0.0,0.0,,,,,,50000.0
Darbhanga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,,,,,,0.0
Darbhanga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,30100.0,0.0,6000.0,,,,,,36100.0
Darbhanga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,50000.0,0.0,0.0,19900.0,19900.0,13900.0,0.0,0.0,0.0,0.0,0.0,103700.0
Darbhanga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,,,,,,0.0
Darbhanga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,,,,,,0.0
Darbhanga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,,,,,,0.0
Darbhanga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,,,,,,0.0
Darbhanga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,54.0,54.0,,,54.0,54.0,54.0,,,,,,270.0
Darbhanga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,,,,,,0.0
Darbhanga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,,,,,,0.0
Darbhanga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,,,,,,0.0
Darbhanga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,54.0,54.0,0.0,0.0,54.0,54.0,54.0,0.0,0.0,0.0,0.0,0.0,270.0
Darbhanga,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,10000.0,2100.0,1900.0,,300.0,0.0,0.0,50.0,0.0,0.0,,,14350.0
Darbhanga,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,1600.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,1600.0
Darbhanga,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,7800.0,600.0,900.0,,100.0,0.0,0.0,0.0,0.0,0.0,,,9400.0
Darbhanga,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,2200.0,1500.0,2600.0,0.0,200.0,0.0,0.0,50.0,0.0,0.0,0.0,0.0,6550.0
Darbhanga,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,16450.0,15950.0,9150.0,,33600.0,6450.0,4350.0,2150.0,475.0,25.0,,,88600.0
Darbhanga,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,10000.0,,,10000.0
Darbhanga,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.02,Stock Position of Gloves,4. Stock Distributed,200.0,1000.0,0.0,,5100.0,2100.0,2200.0,1675.0,450.0,0.0,,,12725.0
Darbhanga,16.3.02,Stock Position of Gloves,5. Total Stock,16250.0,14950.0,9150.0,0.0,28500.0,4350.0,2150.0,475.0,25.0,10025.0,0.0,0.0,85875.0
Darbhanga,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,170.0,0.0,0.0,,,0.0,0.0,0.0,2680.0,16100.0,,,18950.0
Darbhanga,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,,,,0.0
Darbhanga,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,170.0,0.0,0.0,,,0.0,0.0,0.0,10200.0,100.0,,,10470.0
Darbhanga,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-7520.0,16000.0,0.0,0.0,8480.0
Darbhanga,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,100.0,,,100.0
Darbhanga,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,,,0.0
Darbhanga,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,100.0
Darbhanga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,,,0.0
Darbhanga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,,,0.0
Darbhanga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,,,0.0
Darbhanga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,5051000.0,794000.0,459000.0,,99000.0,30700.0,234800.0,194800.0,,177580.0,,,7040880.0
Darbhanga,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,,200000.0,0.0,0.0,300000.0,,0.0,,,500000.0
Darbhanga,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,,,0.0
Darbhanga,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,4252000.0,5000.0,270000.0,,60000.0,42200.0,30000.0,118000.0,,5000.0,,,4782200.0
Darbhanga,16.3.07,Stock Position of IFA Tablets,5. Total Stock,799000.0,789000.0,189000.0,0.0,239000.0,-11500.0,204800.0,376800.0,0.0,172580.0,0.0,0.0,2758680.0
Darbhanga,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,,,0.0
Darbhanga,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,,,0.0
Darbhanga,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,,,0.0
Darbhanga,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,5174.0,3740.0,3740.0,,620.0,2000.0,1380.0,660.0,,20.0,,,17334.0
Darbhanga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,,2000.0,0.0,0.0,0.0,,0.0,,,2000.0
Darbhanga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,400.0,0.0,400.0,,500.0,600.0,520.0,520.0,,0.0,,,2940.0
Darbhanga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,4774.0,3740.0,3340.0,0.0,2120.0,1400.0,860.0,140.0,0.0,20.0,0.0,0.0,16394.0
Darbhanga,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,182.0,182.0,132.0,,180.0,112.0,119.0,119.0,100.0,69.0,,,1195.0
Darbhanga,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,10666.0,,0.0,0.0,0.0,0.0,9698.0,0.0,,,20364.0
Darbhanga,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,119.0,119.0,9615.0,0.0,,,9853.0
Darbhanga,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,182.0,182.0,10798.0,0.0,180.0,112.0,0.0,0.0,183.0,69.0,0.0,0.0,11706.0
Darbhanga,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,29042.0,3937.0,43267.0,,15717.0,103717.0,93227.0,127527.0,120657.0,7100.0,,,544191.0
Darbhanga,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,79500.0,42000.0,,90000.0,0.0,0.0,94165.0,46165.0,0.0,,,351830.0
Darbhanga,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Darbhanga,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,24905.0,1460.0,0.0,,4200.0,10200.0,10000.0,6670.0,10820.0,3000.0,,,71255.0
Darbhanga,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,4137.0,81977.0,85267.0,0.0,101517.0,93517.0,83227.0,215022.0,156002.0,4100.0,0.0,0.0,824766.0
Darbhanga,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,100.0,200.0,2400.0,5200.0,13000.0,0.0,0.0,1400.0,4860.0,300.0,1400.0,1300.0,30160.0
Darbhanga,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,11000.0,14000.0,12000.0,13000.0,0.0,8000.0,12000.0,13000.0,10000.0,10000.0,12000.0,12000.0,127000.0
Darbhanga,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,10900.0,11800.0,9120.0,5200.0,13000.0,8000.0,10600.0,9540.0,14560.0,8900.0,12100.0,11900.0,125620.0
Darbhanga,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,200.0,2400.0,5280.0,13000.0,0.0,0.0,1400.0,4860.0,300.0,1400.0,1300.0,1400.0,31540.0
Darbhanga,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,77172.0,172.0,18000.0,53400.0,106200.0,18600.0,31250.0,57600.0,50040.0,12040.0,21740.0,59740.0,505954.0
Darbhanga,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,100000.0,518000.0,100000.0,0.0,100000.0,100000.0,70000.0,50000.0,90000.0,125000.0,50000.0,1303000.0
Darbhanga,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,77000.0,82172.0,458600.0,47200.0,87600.0,87350.0,73650.0,77560.0,88000.0,80300.0,87000.0,84000.0,1330432.0
Darbhanga,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,172.0,18000.0,77400.0,106200.0,18600.0,31250.0,57600.0,50040.0,12040.0,21740.0,59740.0,25740.0,478522.0
Darbhanga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,408.0,693.0,1200.0,3400.0,4690.0,149.0,2089.0,4200.0,3135.0,1035.0,1300.0,550.0,22849.0
Darbhanga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4500.0,6000.0,56000.0,4500.0,0.0,5000.0,6000.0,3000.0,3500.0,4000.0,5000.0,6000.0,103500.0
Darbhanga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Darbhanga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4215.0,5493.0,53520.0,3210.0,4541.0,3060.0,3889.0,4065.0,5600.0,3735.0,5750.0,5250.0,102328.0
Darbhanga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,693.0,1200.0,3680.0,4690.0,149.0,2089.0,4200.0,3135.0,1035.0,1300.0,550.0,1300.0,24021.0
Darbhanga,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Darbhanga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Darbhanga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Darbhanga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Darbhanga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Darbhanga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Darbhanga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Darbhanga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Darbhanga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Darbhanga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Darbhanga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Darbhanga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Darbhanga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Darbhanga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Darbhanga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Darbhanga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Darbhanga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Darbhanga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Darbhanga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Darbhanga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Darbhanga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Darbhanga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Darbhanga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Darbhanga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Darbhanga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Darbhanga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Darbhanga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Darbhanga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Darbhanga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Darbhanga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Darbhanga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Darbhanga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Darbhanga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
East Champaran,1.1,Total number of pregnant women Registered for ANC,TOTAL,9813.0,9273.0,8821.0,11169.0,10183.0,9856.0,7741.0,8681.0,9787.0,10453.0,10292.0,10387.0,116456.0
East Champaran,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3929.0,3443.0,3493.0,4285.0,3619.0,3741.0,3013.0,3963.0,6820.0,6437.0,5824.0,5839.0,54406.0
East Champaran,1.2,Number of Pregnant women registered under JSY,TOTAL,9797.0,9273.0,8931.0,11179.0,10183.0,9856.0,7754.0,8412.0,9787.0,10453.0,10292.0,10387.0,116304.0
East Champaran,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5218.0,5478.0,5399.0,6153.0,5988.0,6051.0,5577.0,5262.0,8225.0,7747.0,6832.0,6958.0,74888.0
East Champaran,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,8383.0,7902.0,7405.0,9506.0,8646.0,8340.0,6448.0,7061.0,7866.0,7981.0,8401.0,8337.0,96276.0
East Champaran,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,8260.0,9273.0,8176.0,9802.0,10332.0,10705.0,8810.0,8080.0,9063.0,9632.0,8480.0,10879.0,111492.0
East Champaran,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2439.0,3098.0,3542.0,4392.0,5355.0,4599.0,4467.0,3964.0,7464.0,8036.0,7216.0,7334.0,61906.0
East Champaran,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,96.0,22.0,8.0,19.0,16.0,14.0,8.0,55.0,89.0,108.0,74.0,24.0,533.0
East Champaran,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,2.0,0.0,0.0,6.0,2.0,1.0,3.0,10.0,6.0,0.0,30.0
East Champaran,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,71.0,17.0,17.0,40.0,17.0,29.0,18.0,80.0,24.0,136.0,35.0,95.0,579.0
East Champaran,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,5.0,5.0,9.0,8.0,8.0,11.0,7.0,9.0,11.0,5.0,9.0,10.0,97.0
East Champaran,1.8,Number of pregnancy test kits used at SC level,TOTAL,113.0,80.0,78.0,128.0,82.0,80.0,115.0,155.0,161.0,790.0,892.0,898.0,3572.0
East Champaran,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,321.0,306.0,374.0,387.0,567.0,422.0,495.0,589.0,596.0,626.0,529.0,427.0,5639.0
East Champaran,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1546.0,1337.0,1316.0,1485.0,1564.0,1868.0,1806.0,2036.0,2348.0,2385.0,2088.0,1902.0,21681.0
East Champaran,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1867.0,1643.0,1690.0,1872.0,2131.0,2290.0,2301.0,2625.0,2944.0,3011.0,2617.0,2329.0,27320.0
East Champaran,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,643.0,706.0,616.0,778.0,873.0,865.0,852.0,1067.0,954.0,1162.0,806.0,849.0,10171.0
East Champaran,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,3.0,0.0,0.0,20.0,12.0,9.0,29.0,23.0,7.0,23.0,6.0,68.0,200.0
East Champaran,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,4350.0,3843.0,3673.0,4805.0,6262.0,6282.0,6225.0,5541.0,5525.0,5017.0,4448.0,4118.0,60089.0
East Champaran,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3685.0,3322.0,3241.0,4219.0,5417.0,5341.0,5108.0,4268.0,4716.0,4639.0,4248.0,3688.0,51892.0
East Champaran,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2335.0,2422.0,2391.0,4715.0,4547.0,4443.0,3806.0,3576.0,5483.0,4722.0,5158.0,4912.0,48510.0
East Champaran,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2059.0,2112.0,1702.0,3410.0,3593.0,3894.0,3145.0,3217.0,4685.0,3310.0,3928.0,4114.0,39169.0
East Champaran,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
East Champaran,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
East Champaran,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
East Champaran,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
East Champaran,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,10.0
East Champaran,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0
East Champaran,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,11.0,3.0,6.0,14.0,11.0,13.0,8.0,21.0,10.0,19.0,8.0,4.0,128.0
East Champaran,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Champaran,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,11.0,3.0,6.0,17.0,11.0,13.0,9.0,21.0,20.0,19.0,8.0,4.0,142.0
East Champaran,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
East Champaran,4.1.1.a,Number of male live births,TOTAL,3038.0,2859.0,2770.0,3493.0,4187.0,4317.0,4287.0,3957.0,4263.0,4044.0,3740.0,3236.0,44191.0
East Champaran,4.1.1.b,Number of female live births,TOTAL,2886.0,2755.0,2798.0,3502.0,4141.0,4218.0,4399.0,3754.0,4148.0,3989.0,3543.0,3194.0,43327.0
East Champaran,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5924.0,5614.0,5568.0,6995.0,8328.0,8535.0,8686.0,7711.0,8411.0,8033.0,7283.0,6430.0,87518.0
East Champaran,4.1.2,Number of still births,TOTAL,74.0,60.0,48.0,110.0,100.0,84.0,130.0,118.0,85.0,65.0,69.0,37.0,980.0
East Champaran,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,19.0,5.0,13.0,11.0,21.0,19.0,4.0,9.0,17.0,14.0,8.0,8.0,148.0
East Champaran,4.2.1,Number of Newborns weighed at birth,TOTAL,5219.0,5333.0,5071.0,6149.0,7453.0,7801.0,8140.0,6735.0,7701.0,7078.0,6553.0,5792.0,79025.0
East Champaran,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,207.0,182.0,182.0,235.0,308.0,281.0,340.0,255.0,258.0,207.0,237.0,144.0,2836.0
East Champaran,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,5882.0,5591.0,5509.0,6688.0,8222.0,8399.0,8552.0,7299.0,8385.0,7755.0,7040.0,6346.0,85668.0
East Champaran,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,24.0,24.0,15.0,30.0,25.0,21.0,23.0,18.0,23.0,24.0,53.0,285.0
East Champaran,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,6.0,4.0,0.0,0.0,0.0,12.0,1.0,0.0,0.0,0.0,0.0,0.0,23.0
East Champaran,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Champaran,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,11.0,28.0,24.0,15.0,30.0,37.0,22.0,23.0,18.0,23.0,24.0,53.0,308.0
East Champaran,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
East Champaran,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,11.0,28.0,13.0,10.0,10.0,32.0,17.0,20.0,13.0,19.0,20.0,51.0,244.0
East Champaran,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,15.0,3.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,21.0
East Champaran,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,11.0,13.0,11.0,2.0,23.0,25.0,18.0,15.0,11.0,14.0,13.0,47.0,203.0
East Champaran,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2057.0,1652.0,1810.0,2393.0,2608.0,2733.0,2059.0,2267.0,3550.0,3713.0,2843.0,2992.0,30677.0
East Champaran,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1725.0,1554.0,1462.0,1747.0,1808.0,2066.0,2111.0,1733.0,2461.0,3088.0,1919.0,2739.0,24413.0
East Champaran,6.3,PNC maternal complications attended,TOTAL,4.0,9.0,0.0,0.0,20.0,0.0,5.0,2.0,2.0,2.0,0.0,70.0,114.0
East Champaran,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,2.0,8.0,7.0,9.0,11.0,1.0,5.0,13.0,4.0,4.0,5.0,74.0
East Champaran,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5.0,2.0,8.0,7.0,9.0,11.0,1.0,5.0,13.0,4.0,4.0,5.0,74.0
East Champaran,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,523.0,480.0,504.0,498.0,230.0,191.0,176.0,213.0,160.0,176.0,197.0,184.0,3532.0
East Champaran,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,989.0,947.0,959.0,926.0,239.0,282.0,173.0,257.0,203.0,207.0,203.0,154.0,5539.0
East Champaran,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1512.0,1427.0,1463.0,1424.0,469.0,473.0,349.0,470.0,363.0,383.0,400.0,338.0,9071.0
East Champaran,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,6.0,1.0,17.0,12.0,30.0,1.0,10.0,5.0,2.0,25.0,316.0,425.0
East Champaran,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,23.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0
East Champaran,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,21.0,4.0,9.0,13.0,17.0,17.0,10.0,16.0,40.0,10.0,1.0,0.0,158.0
East Champaran,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Champaran,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,21.0,10.0,33.0,30.0,29.0,48.0,11.0,26.0,45.0,12.0,26.0,316.0,607.0
East Champaran,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
East Champaran,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
East Champaran,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Champaran,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
East Champaran,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
East Champaran,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,335.0,103.0,55.0,1086.0,510.0,522.0,204.0,1482.0,2344.0,1961.0,2500.0,1967.0,13069.0
East Champaran,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,53.0,29.0,46.0,242.0,114.0,176.0,53.0,334.0,588.0,518.0,601.0,380.0,3134.0
East Champaran,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,355.0,15.0,21.0,49.0,38.0,46.0,22.0,509.0,346.0,154.0,204.0,183.0,1942.0
East Champaran,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Champaran,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,743.0,147.0,122.0,1377.0,662.0,744.0,279.0,2325.0,3278.0,2633.0,3305.0,2530.0,18145.0
East Champaran,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,493.0,1213.0,897.0,702.0,942.0,461.0,389.0,1169.0,975.0,3169.0,1240.0,5559.0,17209.0
East Champaran,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,105.0,18.0,14.0,46.0,105.0,24.0,20.0,0.0,88.0,76.0,105.0,57.0,658.0
East Champaran,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,34.0,20.0,0.0,0.0,63.0,40.0,0.0,0.0,0.0,0.0,118.0,1.0,276.0
East Champaran,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,7.0,4.0,6.0,2.0,2.0,23.0
East Champaran,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Champaran,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,139.0,38.0,14.0,46.0,168.0,64.0,22.0,7.0,92.0,82.0,225.0,60.0,957.0
East Champaran,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
East Champaran,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,397.0,269.0,251.0,432.0,305.0,342.0,167.0,170.0,1115.0,541.0,511.0,708.0,5208.0
East Champaran,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,234.0,171.0,143.0,381.0,206.0,160.0,261.0,341.0,478.0,228.0,283.0,278.0,3164.0
East Champaran,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,32.0,18.0,57.0,27.0,22.0,17.0,12.0,3.0,136.0,80.0,61.0,103.0,568.0
East Champaran,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,6.0,4.0,113.0,6.0,9.0,9.0,6.0,8.0,6.0,5.0,5.0,177.0
East Champaran,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
East Champaran,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,663.0,464.0,455.0,953.0,539.0,528.0,449.0,520.0,1737.0,855.0,860.0,1094.0,9117.0
East Champaran,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,116.0,43.0,78.0,94.0,67.0,44.0,38.0,122.0,196.0,322.0,377.0,353.0,1850.0
East Champaran,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,222.0,,,,,545.0,233.0,,,,1000.0
East Champaran,9.06,Number of IUCD removals,TOTAL,175.0,164.0,200.0,436.0,287.0,200.0,229.0,158.0,436.0,416.0,318.0,361.0,3380.0
East Champaran,9.07,Number of Oral Pills cycles distributed,TOTAL,1364.0,855.0,1499.0,1422.0,893.0,1299.0,1297.0,2389.0,4221.0,3058.0,2367.0,2692.0,23356.0
East Champaran,9.08,Number of Condom pieces distributed,TOTAL,15848.0,13057.0,11658.0,8234.0,11632.0,8355.0,10394.0,24661.0,13674.0,16824.0,13328.0,12279.0,159944.0
East Champaran,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
East Champaran,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,67.0,56.0,46.0,23.0,31.0,74.0,81.0,32.0,115.0,213.0,116.0,107.0,961.0
East Champaran,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
East Champaran,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
East Champaran,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,11283.0,9391.0,9044.0,10599.0,12584.0,13821.0,11712.0,13371.0,15303.0,13943.0,13342.0,10451.0,144844.0
East Champaran,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,11417.0,9927.0,8662.0,10320.0,9516.0,11506.0,11143.0,13040.0,14492.0,3999.0,575.0,85.0,104682.0
East Champaran,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,11539.0,11009.0,9221.0,10629.0,10198.0,10687.0,10134.0,11111.0,13668.0,14971.0,8500.0,3976.0,125643.0
East Champaran,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,10560.0,10585.0,9024.0,10829.0,10106.0,10760.0,9735.0,10293.0,12685.0,14123.0,12136.0,9134.0,129970.0
East Champaran,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,531.0,0.0,10492.0,12609.0,11764.0,35396.0
East Champaran,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,199.0,0.0,5.0,5159.0,9911.0,15276.0
East Champaran,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,0.0,3.0,3.0,3847.0,3873.0
East Champaran,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,5093.0,5020.0,4397.0,5351.0,6772.0,8085.0,7574.0,6621.0,8410.0,7156.0,6638.0,5131.0,76248.0
East Champaran,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,11595.0,10004.0,8904.0,10454.0,9455.0,11491.0,11158.0,13178.0,14335.0,13309.0,12968.0,11290.0,138141.0
East Champaran,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,11568.0,10971.0,9640.0,10620.0,10099.0,10503.0,10155.0,11230.0,13514.0,14899.0,12844.0,13287.0,139330.0
East Champaran,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,10557.0,10503.0,9096.0,10816.0,9982.0,10790.0,9700.0,10280.0,12603.0,14003.0,11955.0,12407.0,132692.0
East Champaran,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2927.0,3148.0,3419.0,3680.0,4477.0,5701.0,5899.0,4686.0,5672.0,4602.0,4367.0,3769.0,52347.0
East Champaran,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,11524.0,9687.0,8794.0,10329.0,9490.0,11492.0,11033.0,12931.0,14430.0,4562.0,550.0,85.0,104907.0
East Champaran,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,11358.0,10883.0,9212.0,10582.0,10201.0,10667.0,10026.0,11121.0,13631.0,14866.0,8426.0,4070.0,125043.0
East Champaran,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,10329.0,10479.0,8983.0,10844.0,10080.0,10733.0,9689.0,10323.0,12645.0,14078.0,12046.0,9064.0,129293.0
East Champaran,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7780.0,7853.0,8140.0,10522.0,9920.0,9732.0,8970.0,9653.0,12000.0,11308.0,10482.0,8775.0,115135.0
East Champaran,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6239.0,6354.0,5820.0,6906.0,5631.0,6314.0,5419.0,5709.0,8235.0,8507.0,9405.0,8455.0,82994.0
East Champaran,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3169.0,4087.0,6664.0,6026.0,5529.0,5757.0,5664.0,6396.0,9723.0,10376.0,10646.0,8103.0,82140.0
East Champaran,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4080.0,4022.0,4265.0,5525.0,5094.0,4941.0,4648.0,4843.0,5946.0,5474.0,5246.0,4456.0,58540.0
East Champaran,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3436.0,3629.0,3682.0,4720.0,4484.0,4446.0,4285.0,4353.0,5579.0,4765.0,4701.0,3966.0,52046.0
East Champaran,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,7516.0,7651.0,7947.0,10245.0,9578.0,9387.0,8933.0,9196.0,11525.0,10239.0,9947.0,8422.0,110586.0
East Champaran,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,7439.0,7300.0,6956.0,7638.0,6822.0,7159.0,5752.0,6243.0,8460.0,9226.0,10011.0,8509.0,91515.0
East Champaran,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7428.0,7357.0,6945.0,7638.0,6757.0,7113.0,5752.0,6223.0,8450.0,9243.0,9966.0,8505.0,91377.0
East Champaran,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1836.0,1513.0,1693.0,1795.0,1744.0,1689.0,1552.0,1666.0,2213.0,2205.0,2649.0,2008.0,22563.0
East Champaran,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1612.0,1219.0,1461.0,1479.0,1498.0,1527.0,1405.0,1566.0,2011.0,1864.0,2288.0,1821.0,19751.0
East Champaran,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3448.0,2732.0,3154.0,3274.0,3242.0,3216.0,2957.0,3232.0,4224.0,4069.0,4937.0,3829.0,42314.0
East Champaran,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,221.0,136.0,284.0,303.0,309.0,589.0,909.0,753.0,1054.0,1038.0,1166.0,1386.0,8148.0
East Champaran,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1527.0,1478.0,1439.0,1695.0,1609.0,1913.0,1769.0,1818.0,1990.0,2033.0,2223.0,2181.0,21675.0
East Champaran,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2822.0,2838.0,2840.0,3114.0,2856.0,3448.0,3121.0,3075.0,3427.0,3738.0,4207.0,3717.0,39203.0
East Champaran,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,10.0
East Champaran,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
East Champaran,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,7.0,0.0,14.0
East Champaran,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,4479.0,4798.0,4698.0,4719.0,4587.0,4656.0,4385.0,4636.0,4742.0,4950.0,4954.0,4977.0,56581.0
East Champaran,10.4.2,Number of Immunisation sessions held during the month,TOTAL,4310.0,4584.0,4045.0,4580.0,4497.0,4592.0,4260.0,4479.0,4685.0,4821.0,4588.0,4673.0,54114.0
East Champaran,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2735.0,3066.0,2679.0,2961.0,2871.0,2914.0,2894.0,2874.0,3098.0,3055.0,3181.0,3108.0,35436.0
East Champaran,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2569.0,3191.0,2810.0,6431.0,4047.0,4834.0,4332.0,4739.0,7156.0,8139.0,8705.0,8216.0,65169.0
East Champaran,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,6957.0,6815.0,7042.0,9557.0,8887.0,8827.0,8446.0,8510.0,10634.0,9954.0,10004.0,8211.0,103844.0
East Champaran,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2777.0,2502.0,2166.0,3188.0,2680.0,3002.0,2684.0,2223.0,4052.0,3577.0,4411.0,3788.0,37050.0
East Champaran,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,4.0,20.0,59.0,0.0,0.0,0.0,0.0,0.0,0.0,75.0,26.0,184.0
East Champaran,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,7.0,25.0,29.0,15.0,5.0,28.0,3.0,11.0,10.0,31.0,4.0,0.0,168.0
East Champaran,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,511.0,486.0,1275.0,1321.0,1821.0,1229.0,903.0,807.0,1273.0,961.0,1252.0,1016.0,12855.0
East Champaran,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,8.0,0.0,1.0,2.0,0.0,8.0,0.0,0.0,6.0,0.0,0.0,25.0
East Champaran,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,6.0,2.0,24.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32.0
East Champaran,13.1,Number of Patients operated for cataract,TOTAL,325.0,0.0,0.0,0.0,0.0,0.0,0.0,492.0,354.0,300.0,1524.0,490.0,3485.0
East Champaran,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,325.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,354.0,300.0,1524.0,490.0,2993.0
East Champaran,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,6.0
East Champaran,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,6.0
East Champaran,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
East Champaran,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
East Champaran,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2401.0,3030.0,1561.0,2838.0,3058.0,2510.0,2233.0,2483.0,2912.0,3324.0,3211.0,3242.0,-1.0
East Champaran,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
East Champaran,14.05,Number of RKS meetings held during the month,TOTAL,16.0,14.0,17.0,19.0,22.0,20.0,16.0,13.0,15.0,14.0,16.0,13.0,195.0
East Champaran,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
East Champaran,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,619.0,827.0,432.0,413.0,764.0,915.0,1029.0,1182.0,1350.0,1540.0,1583.0,1897.0,12551.0
East Champaran,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
East Champaran,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
East Champaran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,910.0,1334.0,774.0,1270.0,1461.0,1567.0,1519.0,1709.0,1433.0,1276.0,1375.0,1147.0,15775.0
East Champaran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2481.0,2811.0,2862.0,2488.0,3092.0,2796.0,2319.0,2121.0,2398.0,2591.0,2736.0,2668.0,31363.0
East Champaran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1188.0,1416.0,1170.0,1315.0,1532.0,1720.0,1617.0,1606.0,1498.0,1533.0,1453.0,1174.0,17222.0
East Champaran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4784.0,4496.0,3813.0,6313.0,6880.0,7025.0,6657.0,6833.0,7391.0,6671.0,6674.0,5953.0,73490.0
East Champaran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2098.0,2750.0,1944.0,2585.0,2993.0,3287.0,3136.0,3315.0,2931.0,2809.0,2828.0,2321.0,32997.0
East Champaran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7265.0,7307.0,6675.0,8801.0,9972.0,9821.0,8976.0,8954.0,9789.0,9262.0,9410.0,8621.0,104853.0
East Champaran,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,6.0,7.0,8.0,1.0,9.0,5.0,4.0,10.0,2.0,4.0,3.0,67.0
East Champaran,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,2.0,3.0,5.0,6.0,3.0,1.0,2.0,3.0,3.0,1.0,3.0,37.0
East Champaran,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13.0,8.0,10.0,13.0,7.0,12.0,6.0,6.0,13.0,5.0,5.0,6.0,104.0
East Champaran,14.11,In-Patient Head Count at midnight,TOTAL,7460.0,7731.0,7110.0,16683.0,10670.0,9420.0,9694.0,8973.0,10553.0,9681.0,9601.0,8954.0,116530.0
East Champaran,14.12.1,OPD attendance (All),TOTAL,248442.0,247551.0,247284.0,255525.0,256957.0,284224.0,245489.0,238285.0,290019.0,267267.0,277388.0,293115.0,3151546.0
East Champaran,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,618.0,166.0,160.0,1395.0,682.0,1485.0,297.0,3047.0,3646.0,2213.0,4127.0,2031.0,19867.0
East Champaran,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,186.0,187.0,0.0,120.0,277.0,0.0,0.0,0.0,45.0,815.0
East Champaran,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3704.0,3495.0,3216.0,2866.0,3577.0,3552.0,3322.0,2528.0,3731.0,2848.0,3844.0,3085.0,39768.0
East Champaran,14.14.a,Number of patients given AYUSH treatment,TOTAL,41031.0,39010.0,34463.0,40420.0,33178.0,41758.0,38726.0,38008.0,31044.0,39166.0,30068.0,40724.0,447596.0
East Champaran,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,10699.0,11946.0,11643.0,13437.0,11860.0,13219.0,12298.0,9379.0,11013.0,12764.0,10889.0,12867.0,142014.0
East Champaran,14.14.c,Number of Adolescents counselled,TOTAL,1078.0,789.0,2900.0,867.0,836.0,959.0,818.0,871.0,715.0,1578.0,1296.0,963.0,13670.0
East Champaran,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,370.0,631.0,1091.0,585.0,808.0,539.0,560.0,1289.0,962.0,1822.0,1487.0,1632.0,11776.0
East Champaran,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,20.0,15.0,21.0,52.0,37.0,11.0,14.0,26.0,17.0,177.0,40.0,17.0,447.0
East Champaran,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1006.0,1335.0,611.0,845.0,1514.0,809.0,675.0,912.0,1112.0,651.0,601.0,738.0,10809.0
East Champaran,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,36.0,198.0,34.0,32.0,37.0,37.0,18.0,22.0,27.0,27.0,40.0,23.0,531.0
East Champaran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1151.0,1564.0,544.0,834.0,1404.0,927.0,766.0,1322.0,1962.0,1179.0,1953.0,1306.0,14912.0
East Champaran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,29.0,185.0,32.0,20.0,22.0,30.0,8.0,21.0,20.0,28.0,22.0,11.0,428.0
East Champaran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1499.0,1678.0,1034.0,1725.0,1824.0,1331.0,1092.0,1319.0,1807.0,1177.0,1412.0,1505.0,17403.0
East Champaran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,1.0,3.0,2.0,7.0,4.0,2.0,2.0,2.0,2.0,5.0,5.0,36.0
East Champaran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3656.0,4577.0,2189.0,3404.0,4742.0,3067.0,2533.0,3553.0,4881.0,3007.0,3966.0,3549.0,43124.0
East Champaran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,66.0,384.0,69.0,54.0,66.0,71.0,28.0,45.0,49.0,57.0,67.0,39.0,995.0
East Champaran,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,120.0,0.0,120.0
East Champaran,15.3.a,Number of VDRL tests conducted on males,Number tested,195.0,160.0,205.0,149.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0,727.0
East Champaran,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,305.0,200.0,190.0,187.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,882.0
East Champaran,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,309.0,250.0,179.0,239.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0,1000.0
East Champaran,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,809.0,610.0,574.0,575.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,41.0,2609.0
East Champaran,15.4.1,Number of blood smears examined for Malaria,TOTAL,37.0,82.0,45.0,27.0,37.0,19.0,66.0,32.0,26.0,21.0,24.0,23.0,439.0
East Champaran,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,19.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0
East Champaran,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,800.0,,6450.0,,21900.0,11000.0,11900.0,13100.0,20350.0,13150.0,2500.0,1800.0,102950.0
East Champaran,16.1.1,Stock position of DPT vaccines,2. Stocks Received,8000.0,,0.0,,0.0,0.0,10000.0,15000.0,0.0,8350.0,2000.0,3000.0,46350.0
East Champaran,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,8300.0,,4750.0,,8050.0,7750.0,8800.0,7750.0,7200.0,11650.0,2700.0,2550.0,69500.0
East Champaran,16.1.1,Stock position of DPT vaccines,5. Total Stock,500.0,0.0,1700.0,0.0,13850.0,3250.0,13100.0,20350.0,13150.0,9850.0,1800.0,2250.0,79800.0
East Champaran,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,,0.0,,0.0,0.0,,4080.0,,24000.0,3700.0,2250.0,34030.0
East Champaran,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,0.0,,0.0,0.0,,6000.0,,0.0,0.0,5000.0,11000.0
East Champaran,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,0.0,,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0
East Champaran,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,0.0,,0.0,0.0,,3505.0,,15000.0,1450.0,2550.0,22505.0
East Champaran,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6575.0,0.0,9000.0,2250.0,4700.0,22525.0
East Champaran,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,813.0,,4180.0,,3155.0,3480.0,3480.0,1000.0,1850.0,1075.0,1250.0,390.0,20673.0
East Champaran,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5892.0,,0.0,,6000.0,2200.0,5000.0,5800.0,2800.0,5350.0,1500.0,6000.0,40542.0
East Champaran,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,5150.0,,3125.0,,4475.0,4055.0,7480.0,4950.0,3575.0,4675.0,2360.0,3165.0,43010.0
East Champaran,16.1.2,Stock position of OPV vaccines,5. Total Stock,1555.0,0.0,1055.0,0.0,4680.0,1625.0,1000.0,1850.0,1075.0,1750.0,390.0,3225.0,18205.0
East Champaran,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1275.0,,4475.0,,4725.0,5575.0,5575.0,9475.0,7575.0,6275.0,2050.0,2700.0,49700.0
East Champaran,16.1.3,Stock position of TT vaccines,2. Stocks Received,6000.0,,0.0,,10000.0,6000.0,10000.0,5000.0,9000.0,6000.0,2000.0,3000.0,57000.0
East Champaran,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
East Champaran,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5950.0,,3150.0,,7950.0,5850.0,6100.0,6900.0,10300.0,9825.0,1350.0,2500.0,59875.0
East Champaran,16.1.3,Stock position of TT vaccines,5. Total Stock,1325.0,0.0,1325.0,0.0,6775.0,5725.0,9475.0,7575.0,6275.0,2450.0,2700.0,3200.0,46825.0
East Champaran,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1195.0,,3320.0,,3620.0,1345.0,1345.0,395.0,1095.0,125.0,900.0,350.0,13690.0
East Champaran,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,,0.0,,1600.0,4100.0,4600.0,6700.0,4700.0,3850.0,2000.0,4500.0,37050.0
East Champaran,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5400.0,,1950.0,,5025.0,4850.0,5550.0,6000.0,5670.0,1350.0,2550.0,2800.0,41145.0
East Champaran,16.1.5,Stock position of BCG vaccines,5. Total Stock,795.0,0.0,1370.0,0.0,195.0,595.0,395.0,1095.0,125.0,2625.0,350.0,2050.0,9595.0
East Champaran,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,805.0,,4480.0,,3550.0,3550.0,3550.0,3175.0,2550.0,1650.0,2850.0,200.0,26360.0
East Champaran,16.1.6,Stock position of Measles vaccines,2. Stocks Received,8000.0,,0.0,,4600.0,4600.0,9600.0,8000.0,7400.0,14550.0,1000.0,8500.0,66250.0
East Champaran,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6675.0,,4050.0,,5680.0,5680.0,9975.0,8625.0,8300.0,12700.0,3650.0,4000.0,69335.0
East Champaran,16.1.6,Stock position of Measles vaccines,5. Total Stock,2130.0,0.0,430.0,0.0,2470.0,2470.0,3175.0,2550.0,1650.0,3500.0,200.0,4700.0,23275.0
East Champaran,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,57075.0,,2225.0,,1810.0,6450.0,6450.0,25.0,2125.0,425.0,3825.0,875.0,81285.0
East Champaran,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,14400.0,,7990.0,7600.0,4000.0,9000.0,6000.0,12600.0,1500.0,7000.0,70090.0
East Champaran,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,6900.0,0.0,0.0,0.0,0.0,6900.0
East Champaran,16.1.7,Stock position of JE vaccines,4. Stock Distributed,4900.0,,11900.0,,4850.0,11325.0,10425.0,2125.0,7700.0,8225.0,4450.0,4135.0,70035.0
East Champaran,16.1.7,Stock position of JE vaccines,5. Total Stock,52175.0,0.0,4725.0,0.0,4950.0,2725.0,25.0,0.0,425.0,4800.0,875.0,3740.0,74440.0
East Champaran,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,805.0,,4885.0,,3055.0,2355.0,2355.0,4080.0,3506.0,1005.0,2755.0,2005.0,26806.0
East Champaran,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,8280.0,,0.0,,6000.0,8000.0,9000.0,6000.0,6000.0,7000.0,1550.0,2000.0,53830.0
East Champaran,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,8300.0,,3880.0,,5700.0,7525.0,7275.0,6575.0,8500.0,4850.0,2250.0,1800.0,56655.0
East Champaran,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,785.0,0.0,1005.0,0.0,3355.0,2830.0,4080.0,3505.0,1006.0,3155.0,2055.0,2205.0,23981.0
East Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,7100.0,7100.0,,,7100.0,7100.0,7100.0,7100.0,7100.0,,7100.0,56800.0
East Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,,7000.0,700.0,7000.0,7000.0,7000.0,,7000.0,35700.0
East Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,6200.0,7100.0,,,4300.0,4100.0,4900.0,4900.0,6000.0,,4900.0,42400.0
East Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,900.0,0.0,0.0,0.0,9800.0,3700.0,9200.0,9200.0,8100.0,0.0,9200.0,50100.0
East Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,68798.0,68798.0,,,68998.0,68798.0,68798.0,68798.0,68798.0,,68798.0,550584.0
East Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,,100000.0,100000.0,100000.0,100000.0,100000.0,,100000.0,600000.0
East Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,68798.0,68798.0,,,145798.0,154898.0,158398.0,160078.0,91280.0,,160078.0,1008126.0
East Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,23200.0,13900.0,10400.0,8720.0,77518.0,0.0,8720.0,142458.0
East Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,3734.0,3734.0,,,3734.0,3734.0,3734.0,3734.0,3734.0,,3747.0,29885.0
East Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,,20000.0,20000.0,20000.0,20000.0,20000.0,,20000.0,120000.0
East Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,3734.0,3734.0,,,15600.0,17000.0,17700.0,21434.0,18050.0,,21434.0,118686.0
East Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,8134.0,6734.0,6034.0,2300.0,5684.0,0.0,2313.0,31199.0
East Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,,10000.0,10000.0,10000.0,10000.0,10000.0,,10000.0,60000.0
East Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,,,7920.0,8640.0,9000.0,9000.0,9000.0,,9000.0,52560.0
East Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,2080.0,1360.0,1000.0,1000.0,1000.0,0.0,1000.0,7440.0
East Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,65.0,65.0,,,65.0,65.0,65.0,65.0,65.0,,65.0,520.0
East Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,65.0,65.0,,,65.0,65.0,65.0,65.0,65.0,,65.0,520.0
East Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,4000.0,4000.0,,,4000.0,4000.0,4000.0,4000.0,4000.0,,4000.0,32000.0
East Champaran,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,9804.0,9804.0,,,9804.0,9804.0,9804.0,9804.0,9804.0,,9804.0,78432.0
East Champaran,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,6200.0,13804.0,,,13804.0,13804.0,13804.0,13804.0,13804.0,,13804.0,102828.0
East Champaran,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,7604.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7604.0
East Champaran,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.3.02,Stock Position of Gloves,2. Stocks Received,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.3.02,Stock Position of Gloves,4. Stock Distributed,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,16000.0,26000.0,,,53600.0,101600.0,104600.0,101600.0,235550.0,,101600.0,740550.0
East Champaran,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,16000.0,16000.0,,,53600.0,59800.0,88600.0,96600.0,121600.0,,96600.0,548800.0
East Champaran,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,10000.0,0.0,0.0,0.0,41800.0,16000.0,5000.0,113950.0,0.0,5000.0,191750.0
East Champaran,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,4150000.0,415000.0,,,41500.0,415000.0,415000.0,415000.0,415000.0,,415000.0,6681500.0
East Champaran,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,300000.0,481100.0,,,549800.0,949800.0,949800.0,949800.0,949800.0,,949800.0,6079900.0
East Champaran,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,465000.0,706100.0,,,757900.0,840000.0,0.0,639800.0,,,639800.0,4048600.0
East Champaran,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,3985000.0,190000.0,0.0,0.0,-166600.0,524800.0,1364800.0,725000.0,1364800.0,0.0,725000.0,8712800.0
East Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,6000.0,6000.0,,,6000.0,6000.0,6000.0,6000.0,6000.0,,6000.0,48000.0
East Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,100000.0,10000.0,,,14000.0,10000.0,10000.0,10000.0,10000.0,,10000.0,174000.0
East Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,7000.0,12700.0,,,15600.0,15200.0,15500.0,16000.0,16000.0,,16000.0,114000.0
East Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,99000.0,3300.0,0.0,0.0,4400.0,800.0,500.0,0.0,0.0,0.0,0.0,108000.0
East Champaran,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,190.0,900.0,,,9000.0,9000.0,90.0,600.0,900.0,,900.0,21580.0
East Champaran,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,27790.0,13800.0,,,13800.0,13800.0,13800.0,27250.0,27250.0,,27250.0,164740.0
East Champaran,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
East Champaran,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,27080.0,14700.0,,,14230.0,14230.0,14530.0,27030.0,27950.0,,27030.0,166780.0
East Champaran,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,900.0,0.0,0.0,0.0,8570.0,8570.0,-640.0,820.0,200.0,0.0,1120.0,19540.0
East Champaran,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,190.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,190.0
East Champaran,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,269000.0,269000.0,,,457400.0,457400.0,726800.0,244548.0,7445098.0,,724548.0,10593794.0
East Champaran,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0,0.0
East Champaran,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,71860.0,238000.0,,,427400.0,428600.0,428600.0,10110.0,58182.0,,101100.0,1763852.0
East Champaran,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,197330.0,31000.0,0.0,0.0,30000.0,28800.0,298200.0,234438.0,7386916.0,0.0,623448.0,8830132.0
East Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,9010.0,,16610.0,,35710.0,19410.0,19410.0,2110.0,17560.0,11160.0,60.0,9000.0,140040.0
East Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,14000.0,,10000.0,,0.0,0.0,10000.0,30000.0,12000.0,10000.0,10000.0,20000.0,116000.0
East Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,10200.0,,8900.0,,13300.0,15500.0,27300.0,14550.0,18400.0,14760.0,1650.0,13000.0,137560.0
East Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,12810.0,0.0,17710.0,0.0,22410.0,3910.0,2110.0,17560.0,11160.0,6400.0,8410.0,16000.0,118480.0
East Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,151355.0,,103041.0,,440841.0,266840.0,266840.0,82440.0,120440.0,28240.0,1840.0,89240.0,1551117.0
East Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,,219000.0,,0.0,0.0,70000.0,140000.0,70000.0,12000.0,100000.0,120000.0,731000.0
East Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,102600.0,,138200.0,,132000.0,135200.0,254400.0,102000.0,162200.0,32400.0,12600.0,125800.0,1197400.0
East Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,48755.0,0.0,183841.0,0.0,308841.0,131640.0,82440.0,120440.0,28240.0,7840.0,89240.0,83440.0,1084717.0
East Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1925.0,,13212.0,,15212.0,4712.0,4712.0,3200.0,7100.0,3500.0,4800.0,9700.0,68073.0
East Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,5000.0,,20600.0,,0.0,8000.0,10000.0,14000.0,8500.0,15000.0,10000.0,10000.0,101100.0
East Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
East Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2750.0,,15800.0,,8000.0,9812.0,11512.0,10100.0,12640.0,16240.0,5100.0,11300.0,103254.0
East Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4175.0,0.0,18012.0,0.0,7212.0,2900.0,3200.0,7100.0,2960.0,2260.0,9700.0,8400.0,65919.0
East Champaran,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
East Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
East Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
East Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
East Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
East Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
East Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
East Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
East Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
East Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
East Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
East Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
East Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
East Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
East Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
East Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
East Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
East Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
East Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
East Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
East Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
East Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
East Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
East Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
East Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
East Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
East Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
East Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
East Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
East Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
East Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
East Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
East Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
East Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
East Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
East Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
East Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
East Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
East Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
East Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
East Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
East Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
East Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
East Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
East Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Gaya,1.1,Total number of pregnant women Registered for ANC,TOTAL,10057.0,11414.0,11673.0,13025.0,11172.0,9706.0,8455.0,8625.0,8259.0,8086.0,9342.0,9537.0,119351.0
Gaya,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4579.0,4504.0,4360.0,4962.0,4003.0,6005.0,5431.0,5008.0,4970.0,5285.0,6178.0,5895.0,61180.0
Gaya,1.2,Number of Pregnant women registered under JSY,TOTAL,9617.0,11087.0,10802.0,12328.0,10362.0,9236.0,7671.0,7710.0,7399.0,7735.0,9010.0,9188.0,112145.0
Gaya,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5880.0,6474.0,6592.0,7602.0,8385.0,7886.0,7558.0,7419.0,7031.0,6619.0,6897.0,7565.0,85908.0
Gaya,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,7237.0,8062.0,7690.0,9017.0,6866.0,6561.0,5536.0,5532.0,5426.0,5662.0,6340.0,6367.0,80296.0
Gaya,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,9194.0,9639.0,9501.0,12030.0,11433.0,9230.0,8843.0,7140.0,6973.0,6508.0,6880.0,8003.0,105374.0
Gaya,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6389.0,6191.0,6222.0,7229.0,7802.0,7837.0,7750.0,7428.0,7320.0,7074.0,6641.0,8210.0,86093.0
Gaya,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,141.0,167.0,161.0,153.0,198.0,160.0,293.0,88.0,297.0,150.0,172.0,148.0,2128.0
Gaya,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,3.0,39.0,0.0,4.0,8.0,4.0,11.0,6.0,11.0,19.0,16.0,123.0
Gaya,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1229.0,1196.0,925.0,1255.0,1250.0,1212.0,689.0,958.0,1035.0,884.0,1174.0,1132.0,12939.0
Gaya,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,5.0,6.0,7.0,6.0,9.0,7.0,8.0,0.0,8.0,1.0,6.0,6.0,69.0
Gaya,1.8,Number of pregnancy test kits used at SC level,TOTAL,265.0,318.0,413.0,347.0,367.0,327.0,264.0,2479.0,320.0,373.0,249.0,302.0,6024.0
Gaya,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,104.0,110.0,119.0,174.0,143.0,205.0,185.0,211.0,202.0,202.0,197.0,193.0,2045.0
Gaya,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1630.0,1719.0,1519.0,1769.0,2184.0,2301.0,2235.0,2643.0,2438.0,2258.0,2079.0,1851.0,24626.0
Gaya,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1734.0,1829.0,1638.0,1943.0,2327.0,2506.0,2420.0,2854.0,2640.0,2460.0,2276.0,2044.0,26671.0
Gaya,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,730.0,765.0,735.0,836.0,1020.0,1186.0,1107.0,1488.0,1280.0,1175.0,1030.0,930.0,12282.0
Gaya,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,26.0,21.0,0.0,8.0,6.0,0.0,25.0,3.0,13.0,19.0,6.0,74.0,201.0
Gaya,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2935.0,3443.0,3328.0,4106.0,4897.0,5322.0,4986.0,4139.0,4536.0,3966.0,3553.0,3159.0,48370.0
Gaya,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2359.0,2867.0,2741.0,3382.0,3897.0,4357.0,4342.0,3854.0,3705.0,3465.0,2881.0,2606.0,40456.0
Gaya,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1627.0,3239.0,2466.0,1776.0,2175.0,7179.0,7009.0,3178.0,6250.0,4934.0,3725.0,3247.0,46805.0
Gaya,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1092.0,1753.0,2260.0,1837.0,1912.0,3336.0,3970.0,2516.0,3092.0,4403.0,4135.0,3555.0,33861.0
Gaya,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Gaya,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Gaya,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Gaya,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Gaya,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,4.0,7.0,4.0,3.0,0.0,3.0,1.0,0.0,1.0,1.0,4.0,3.0,31.0
Gaya,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Gaya,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,185.0,156.0,139.0,155.0,153.0,155.0,121.0,58.0,110.0,134.0,109.0,92.0,1567.0
Gaya,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gaya,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,189.0,163.0,143.0,158.0,153.0,158.0,122.0,58.0,111.0,135.0,113.0,95.0,1598.0
Gaya,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Gaya,4.1.1.a,Number of male live births,TOTAL,2655.0,2853.0,2742.0,3320.0,4035.0,4193.0,4033.0,3699.0,3758.0,3499.0,3120.0,2744.0,40651.0
Gaya,4.1.1.b,Number of female live births,TOTAL,2345.0,2670.0,2394.0,2975.0,3854.0,3806.0,3713.0,3563.0,3518.0,3279.0,2798.0,2462.0,37377.0
Gaya,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5000.0,5523.0,5136.0,6295.0,7889.0,7999.0,7746.0,7262.0,7276.0,6778.0,5918.0,5206.0,78028.0
Gaya,4.1.2,Number of still births,TOTAL,88.0,106.0,116.0,127.0,170.0,145.0,130.0,151.0,142.0,117.0,90.0,81.0,1463.0
Gaya,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,13.0,12.0,17.0,18.0,21.0,14.0,9.0,7.0,25.0,14.0,13.0,13.0,176.0
Gaya,4.2.1,Number of Newborns weighed at birth,TOTAL,4062.0,4802.0,4468.0,5571.0,7056.0,7361.0,6957.0,6391.0,6520.0,5978.0,5444.0,4791.0,69401.0
Gaya,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,354.0,353.0,455.0,535.0,726.0,696.0,562.0,437.0,505.0,492.0,444.0,341.0,5900.0
Gaya,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4525.0,5050.0,4656.0,5952.0,7258.0,7692.0,7320.0,6834.0,6940.0,5913.0,5616.0,4759.0,72515.0
Gaya,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,2.0,16.0,34.0,9.0,55.0,57.0,29.0,30.0,43.0,22.0,92.0,15.0,404.0
Gaya,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Gaya,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,187.0,178.0,144.0,163.0,162.0,160.0,133.0,60.0,123.0,152.0,122.0,103.0,1687.0
Gaya,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gaya,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,189.0,194.0,178.0,172.0,217.0,217.0,162.0,90.0,166.0,174.0,214.0,118.0,2091.0
Gaya,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Gaya,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,811.0,939.0,921.0,1491.0,2226.0,2169.0,1784.0,1435.0,1843.0,1876.0,1571.0,1219.0,18285.0
Gaya,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,397.0,369.0,389.0,543.0,637.0,570.0,527.0,147.0,509.0,583.0,426.0,398.0,5495.0
Gaya,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,679.0,739.0,780.0,1347.0,1716.0,1709.0,1557.0,1033.0,1414.0,1443.0,1203.0,1277.0,14897.0
Gaya,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,1.0,1.0,1.0,2.0,1.0,0.0,5.0,0.0,1.0,0.0,1.0,1.0,14.0
Gaya,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2310.0,2888.0,2916.0,3581.0,4069.0,4906.0,4330.0,3391.0,4285.0,4153.0,3150.0,2762.0,42741.0
Gaya,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2269.0,2702.0,2880.0,2737.0,3272.0,3792.0,4022.0,3857.0,3966.0,3813.0,3248.0,2758.0,39316.0
Gaya,6.3,PNC maternal complications attended,TOTAL,3.0,2.0,1.0,103.0,6.0,10.0,3.0,38.0,57.0,38.0,0.0,8.0,269.0
Gaya,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,2.0,2.0,3.0,3.0,2.0,2.0,1.0,2.0,2.0,1.0,0.0,21.0
Gaya,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Gaya,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1.0,2.0,2.0,5.0,3.0,2.0,2.0,1.0,2.0,2.0,1.0,0.0,23.0
Gaya,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,282.0,484.0,440.0,309.0,376.0,187.0,221.0,450.0,475.0,521.0,255.0,393.0,4393.0
Gaya,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,386.0,632.0,882.0,831.0,827.0,419.0,337.0,803.0,562.0,709.0,577.0,739.0,7704.0
Gaya,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,668.0,1116.0,1322.0,1140.0,1203.0,606.0,558.0,1253.0,1037.0,1230.0,832.0,1132.0,12097.0
Gaya,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Gaya,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,3.0,3.0,0.0,2.0,8.0,11.0,5.0,7.0,10.0,49.0
Gaya,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Gaya,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,0.0,2.0,2.0,2.0,0.0,6.0,7.0,11.0,3.0,1.0,36.0
Gaya,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gaya,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,1.0,0.0,5.0,5.0,2.0,2.0,14.0,18.0,16.0,10.0,11.0,85.0
Gaya,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,2.0,2.0,,4.0
Gaya,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Gaya,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Gaya,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gaya,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Gaya,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gaya,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,58.0,82.0,112.0,988.0,427.0,1114.0,472.0,1536.0,2727.0,2431.0,2625.0,884.0,13456.0
Gaya,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Gaya,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,59.0,58.0,44.0,87.0,101.0,172.0,87.0,167.0,398.0,315.0,292.0,174.0,1954.0
Gaya,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gaya,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,117.0,140.0,156.0,1075.0,528.0,1286.0,559.0,1703.0,3125.0,2746.0,2917.0,1058.0,15410.0
Gaya,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,126.0,103.0,,229.0
Gaya,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,4.0,21.0,0.0,0.0,0.0,5.0,0.0,29.0,148.0,30.0,27.0,22.0,286.0
Gaya,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Gaya,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,55.0,38.0,51.0,72.0,56.0,69.0,49.0,41.0,74.0,107.0,54.0,17.0,683.0
Gaya,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gaya,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,59.0,59.0,51.0,72.0,56.0,74.0,49.0,70.0,222.0,137.0,81.0,39.0,969.0
Gaya,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gaya,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,249.0,306.0,270.0,684.0,446.0,917.0,731.0,786.0,973.0,844.0,893.0,901.0,8000.0
Gaya,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,190.0,131.0,180.0,899.0,199.0,621.0,572.0,796.0,430.0,264.0,478.0,356.0,5116.0
Gaya,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Gaya,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,142.0,72.0,123.0,271.0,187.0,136.0,180.0,74.0,134.0,115.0,72.0,36.0,1542.0
Gaya,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gaya,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,581.0,509.0,573.0,1854.0,832.0,1674.0,1483.0,1656.0,1537.0,1223.0,1443.0,1293.0,14658.0
Gaya,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,135.0,72.0,97.0,94.0,185.0,296.0,193.0,146.0,214.0,212.0,325.0,246.0,2215.0
Gaya,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gaya,9.06,Number of IUCD removals,TOTAL,202.0,205.0,198.0,302.0,270.0,424.0,534.0,518.0,549.0,555.0,547.0,507.0,4811.0
Gaya,9.07,Number of Oral Pills cycles distributed,TOTAL,1299.0,1033.0,1020.0,1834.0,1237.0,3785.0,4304.0,5018.0,4053.0,3428.0,4367.0,5797.0,37175.0
Gaya,9.08,Number of Condom pieces distributed,TOTAL,7519.0,7338.0,8082.0,9234.0,9794.0,15428.0,20591.0,16931.0,16176.0,13827.0,19853.0,18655.0,163428.0
Gaya,9.09,Number of Centchroman (weekly) pills given,TOTAL,486.0,30.0,11.0,112.0,143.0,155.0,313.0,123.0,83.0,311.0,155.0,496.0,2418.0
Gaya,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,10.0,0.0,33.0,404.0,246.0,665.0,502.0,598.0,568.0,721.0,713.0,1074.0,5534.0
Gaya,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1800.0,0.0,0.0,1801.0
Gaya,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,3.0,6.0,1.0,0.0,0.0,2.0,0.0,13.0
Gaya,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,3.0
Gaya,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gaya,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Gaya,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,6784.0,8022.0,7027.0,8935.0,9346.0,10015.0,9508.0,10059.0,9851.0,8607.0,7888.0,6979.0,103021.0
Gaya,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,8709.0,7877.0,6815.0,8306.0,7320.0,8375.0,9287.0,11050.0,10628.0,2726.0,848.0,230.0,82171.0
Gaya,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,10042.0,8855.0,6831.0,8476.0,7614.0,7796.0,7736.0,9021.0,10897.0,9864.0,4755.0,2019.0,93906.0
Gaya,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,10056.0,9786.0,7575.0,8971.0,7687.0,7868.0,7418.0,7858.0,9187.0,9914.0,8879.0,5883.0,101082.0
Gaya,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7390.0,9375.0,8834.0,25601.0
Gaya,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,9.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,18.0,270.0,4805.0,8598.0,13709.0
Gaya,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,4.0,0.0,0.0,235.0,46.0,3966.0,4259.0
Gaya,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3608.0,4149.0,3821.0,5133.0,5879.0,7525.0,6323.0,6360.0,6180.0,4664.0,4458.0,3995.0,62095.0
Gaya,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,8816.0,7992.0,6763.0,8333.0,7358.0,7864.0,7794.0,10089.0,10526.0,9221.0,8841.0,8887.0,102484.0
Gaya,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,9633.0,8991.0,6913.0,8481.0,7576.0,7345.0,6414.0,7772.0,10216.0,9590.0,8213.0,10057.0,101201.0
Gaya,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,10236.0,9943.0,7611.0,8914.0,7802.0,7436.0,6245.0,6767.0,8595.0,9288.0,8345.0,9278.0,100460.0
Gaya,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2310.0,2626.0,2821.0,3929.0,3396.0,6064.0,5224.0,4364.0,4537.0,3219.0,3279.0,2815.0,44584.0
Gaya,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,7723.0,8144.0,7022.0,8570.0,7322.0,8186.0,9326.0,11046.0,17124.0,2422.0,933.0,568.0,88386.0
Gaya,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,9022.0,9144.0,7218.0,8656.0,7683.0,7859.0,7759.0,9026.0,15455.0,9629.0,4774.0,2351.0,98576.0
Gaya,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,9262.0,9985.0,7895.0,9553.0,8100.0,8077.0,7639.0,7785.0,9261.0,9410.0,8591.0,6282.0,101840.0
Gaya,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5762.0,7656.0,7402.0,10118.0,8897.0,7657.0,7180.0,9025.0,7785.0,6791.0,5917.0,4270.0,88460.0
Gaya,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6295.0,6548.0,5617.0,6865.0,5549.0,4624.0,4039.0,5275.0,5752.0,6085.0,6006.0,4101.0,66756.0
Gaya,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,4648.0,6541.0,9079.0,9640.0,8009.0,7405.0,6801.0,6973.0,7612.0,6172.0,5550.0,4769.0,83199.0
Gaya,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2802.0,3708.0,3703.0,4622.0,4541.0,3739.0,3531.0,4212.0,3664.0,3243.0,3206.0,2312.0,43283.0
Gaya,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2608.0,3330.0,3227.0,4254.0,4029.0,3441.0,3137.0,3843.0,3398.0,2955.0,2959.0,2119.0,39300.0
Gaya,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5410.0,7038.0,6930.0,8876.0,8570.0,7180.0,6668.0,8055.0,7062.0,6198.0,6165.0,4431.0,82583.0
Gaya,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,7682.0,7379.0,6038.0,7293.0,5599.0,5335.0,5001.0,5121.0,6319.0,6612.0,7011.0,7144.0,76534.0
Gaya,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7746.0,7450.0,5971.0,7267.0,5600.0,5056.0,4383.0,4798.0,6053.0,6299.0,6775.0,7128.0,74526.0
Gaya,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,193.0,249.0,230.0,253.0,177.0,99.0,130.0,31.0,42.0,80.0,87.0,32.0,1603.0
Gaya,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1699.0,1916.0,1447.0,1843.0,1514.0,1454.0,1272.0,1419.0,1712.0,1724.0,1949.0,1493.0,19442.0
Gaya,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1574.0,1694.0,1266.0,1673.0,1373.0,1259.0,1100.0,1277.0,1568.0,1596.0,1701.0,1370.0,17451.0
Gaya,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3273.0,3610.0,2713.0,3516.0,2887.0,2713.0,2372.0,2696.0,3280.0,3320.0,3650.0,2863.0,36893.0
Gaya,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,361.0,293.0,275.0,319.0,395.0,383.0,435.0,274.0,458.0,432.0,519.0,367.0,4511.0
Gaya,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2174.0,2250.0,2097.0,2504.0,2247.0,2249.0,2430.0,2342.0,2368.0,2186.0,2471.0,2248.0,27566.0
Gaya,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2670.0,2838.0,2503.0,3438.0,2910.0,2809.0,3064.0,3157.0,3239.0,3025.0,2825.0,2929.0,35407.0
Gaya,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,3.0,9.0,45.0,7.0,15.0,13.0,7.0,0.0,9.0,17.0,52.0,177.0
Gaya,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,9.0,7.0,7.0,18.0,8.0,2.0,19.0,9.0,0.0,0.0,1.0,0.0,80.0
Gaya,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,5311.0,5489.0,5149.0,5652.0,5072.0,4774.0,5110.0,4800.0,5242.0,4784.0,4764.0,4767.0,60914.0
Gaya,10.4.2,Number of Immunisation sessions held during the month,TOTAL,5499.0,5563.0,4864.0,5558.0,5042.0,4714.0,5032.0,4724.0,5173.0,4734.0,4601.0,4692.0,60196.0
Gaya,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,4780.0,4998.0,4200.0,4715.0,4596.0,4344.0,4587.0,4343.0,4475.0,4338.0,4288.0,4328.0,53992.0
Gaya,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,5429.0,6050.0,18405.0,9138.0,5823.0,4901.0,4457.0,4422.0,6700.0,5819.0,6221.0,6215.0,83580.0
Gaya,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2686.0,3205.0,3250.0,20569.0,4350.0,3628.0,3252.0,3699.0,28675.0,2580.0,2518.0,2113.0,80525.0
Gaya,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,802.0,613.0,485.0,15146.0,532.0,785.0,1175.0,1136.0,23615.0,693.0,891.0,983.0,46856.0
Gaya,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,127.0,72.0,89.0,19769.0,104.0,189.0,221.0,261.0,5484.0,197.0,215.0,243.0,26971.0
Gaya,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,4.0
Gaya,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,6.0,23.0,0.0,0.0,13.0,25.0,1.0,31.0,3.0,0.0,33.0,49.0,184.0
Gaya,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1382.0,1696.0,2187.0,2436.0,2710.0,2375.0,2042.0,1369.0,1322.0,1032.0,1435.0,1691.0,21677.0
Gaya,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,3.0,65.0,0.0,1.0,11.0,79.0,4.0,0.0,0.0,26.0,36.0,225.0
Gaya,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,250.0,28.0,248.0,16.0,18.0,16.0,18.0,130.0,76.0,33.0,132.0,19.0,984.0
Gaya,13.1,Number of Patients operated for cataract,TOTAL,4.0,10.0,3.0,0.0,1.0,1.0,5049.0,18338.0,5.0,14.0,25.0,17149.0,40599.0
Gaya,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,4.0,10.0,2.0,0.0,0.0,0.0,2.0,20.0,5.0,14.0,25.0,24.0,106.0
Gaya,13.3,Number of School children detected with Refractive errors,TOTAL,2.0,3.0,0.0,1.0,4.0,2.0,4.0,1.0,3.0,2.0,1.0,0.0,23.0
Gaya,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Gaya,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Gaya,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2964.0,2982.0,2827.0,2772.0,2981.0,2928.0,2938.0,2919.0,2747.0,2848.0,2949.0,2930.0,-1.0
Gaya,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Gaya,14.05,Number of RKS meetings held during the month,TOTAL,33.0,37.0,39.0,40.0,37.0,43.0,32.0,31.0,35.0,35.0,38.0,41.0,441.0
Gaya,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Gaya,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1710.0,2032.0,1890.0,2424.0,2434.0,2475.0,2403.0,2261.0,2801.0,2487.0,2372.0,2025.0,27314.0
Gaya,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Gaya,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Gaya,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2024.0,2168.0,2335.0,2714.0,2710.0,2733.0,2527.0,2342.0,2114.0,2297.0,2078.0,1816.0,27858.0
Gaya,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2427.0,3015.0,2923.0,3127.0,3087.0,2790.0,3579.0,2828.0,2164.0,2266.0,2021.0,2437.0,32664.0
Gaya,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2105.0,2114.0,2115.0,2566.0,2795.0,2468.0,2738.0,2399.0,2343.0,2418.0,2155.0,1970.0,28186.0
Gaya,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4565.0,5479.0,4893.0,6680.0,7302.0,6725.0,7126.0,6218.0,8211.0,7384.0,7029.0,5253.0,76865.0
Gaya,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,4129.0,4282.0,4450.0,5280.0,5505.0,5201.0,5265.0,4741.0,4457.0,4715.0,4233.0,3786.0,56044.0
Gaya,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6992.0,8494.0,7816.0,9807.0,10389.0,9515.0,10705.0,9046.0,10375.0,9650.0,9050.0,7690.0,109529.0
Gaya,14.10.2.a,Number of death cases of Inpatient males,TOTAL,61.0,88.0,96.0,72.0,77.0,9.0,85.0,76.0,77.0,51.0,62.0,57.0,811.0
Gaya,14.10.2.b,Number of death cases of Inpatient females,TOTAL,58.0,68.0,71.0,66.0,51.0,5.0,106.0,53.0,51.0,39.0,41.0,36.0,645.0
Gaya,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,119.0,156.0,167.0,138.0,128.0,14.0,191.0,129.0,128.0,90.0,103.0,93.0,1456.0
Gaya,14.11,In-Patient Head Count at midnight,TOTAL,6897.0,8995.0,7314.0,9686.0,9968.0,11096.0,10172.0,9069.0,11189.0,10590.0,9628.0,7479.0,112083.0
Gaya,14.12.1,OPD attendance (All),TOTAL,215528.0,238356.0,260494.0,304460.0,296985.0,326151.0,287821.0,284851.0,264330.0,263710.0,289139.0,282845.0,3314670.0
Gaya,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1058.0,1297.0,1422.0,1994.0,1437.0,1508.0,1356.0,2789.0,3804.0,4521.0,3479.0,1326.0,25991.0
Gaya,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,365.0,30.0,84.0,182.0,100.0,143.0,90.0,61.0,273.0,168.0,234.0,863.0,2593.0
Gaya,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4293.0,3362.0,3919.0,4998.0,4401.0,4383.0,5493.0,4539.0,4900.0,4693.0,4277.0,3791.0,53049.0
Gaya,14.14.a,Number of patients given AYUSH treatment,TOTAL,42241.0,42067.0,41128.0,57561.0,46239.0,49845.0,39575.0,45016.0,21872.0,37580.0,45499.0,44278.0,512901.0
Gaya,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,7121.0,7768.0,10207.0,10671.0,9747.0,11559.0,6769.0,9214.0,7896.0,5543.0,7455.0,5093.0,99043.0
Gaya,14.14.c,Number of Adolescents counselled,TOTAL,394.0,185.0,448.0,1425.0,805.0,874.0,724.0,998.0,940.0,883.0,6297.0,4153.0,18126.0
Gaya,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2423.0,3185.0,2694.0,2795.0,3550.0,1905.0,3174.0,2442.0,2614.0,2207.0,3396.0,3390.0,33775.0
Gaya,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,54.0,81.0,41.0,63.0,59.0,10.0,51.0,48.0,39.0,61.0,125.0,129.0,761.0
Gaya,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,500.0,582.0,534.0,561.0,401.0,212.0,196.0,468.0,608.0,412.0,340.0,610.0,5424.0
Gaya,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,20.0,29.0,30.0,38.0,22.0,4.0,17.0,19.0,16.0,16.0,27.0,24.0,262.0
Gaya,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,597.0,686.0,632.0,665.0,568.0,359.0,173.0,532.0,587.0,427.0,451.0,300.0,5977.0
Gaya,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,9.0,19.0,21.0,18.0,15.0,3.0,13.0,8.0,13.0,8.0,15.0,10.0,152.0
Gaya,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,959.0,1093.0,1159.0,1062.0,889.0,35.0,83.0,196.0,778.0,1114.0,463.0,882.0,8713.0
Gaya,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4.0,61.0,2.0,0.0,1.0,0.0,0.0,1.0,0.0,2.0,2.0,10.0,83.0
Gaya,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2056.0,2361.0,2325.0,2288.0,1858.0,606.0,452.0,1196.0,1973.0,1953.0,1254.0,1792.0,20114.0
Gaya,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,33.0,109.0,53.0,56.0,38.0,7.0,30.0,28.0,29.0,26.0,44.0,44.0,497.0
Gaya,15.2,Number of Widal tests conducted,Number tested,58.0,69.0,75.0,132.0,189.0,49.0,156.0,139.0,12.0,32.0,27.0,163.0,1101.0
Gaya,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,79.0,52.0,40.0,32.0,0.0,34.0,30.0,0.0,49.0,0.0,26.0,342.0
Gaya,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,7.0,16.0,29.0,30.0,0.0,18.0,27.0,0.0,12.0,0.0,23.0,162.0
Gaya,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,172.0,365.0,348.0,399.0,390.0,206.0,205.0,305.0,236.0,302.0,197.0,391.0,3516.0
Gaya,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,172.0,451.0,416.0,468.0,452.0,206.0,257.0,362.0,236.0,363.0,197.0,440.0,4020.0
Gaya,15.4.1,Number of blood smears examined for Malaria,TOTAL,1215.0,1222.0,1929.0,1919.0,1717.0,2312.0,1654.0,1360.0,1331.0,883.0,1085.0,1807.0,18434.0
Gaya,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,17.0,12.0,9.0,15.0,16.0,9.0,7.0,19.0,13.0,4.0,7.0,8.0,136.0
Gaya,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,9.0,5.0,3.0,8.0,8.0,3.0,4.0,12.0,11.0,2.0,2.0,7.0,74.0
Gaya,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,875.0,3400.0,337.0,2847.0,,7651.0,7651.0,,,2565.0,3150.0,28476.0
Gaya,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4000.0,6000.0,0.0,7000.0,5000.0,,2000.0,2000.0,,,3000.0,5000.0,34000.0
Gaya,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,0.0,,,0.0,0.0,0.0
Gaya,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,3274.0,3063.0,5386.0,5369.0,,3016.0,3896.0,,,2415.0,6806.0,33225.0
Gaya,16.1.1,Stock position of DPT vaccines,5. Total Stock,4000.0,3601.0,337.0,1951.0,2478.0,0.0,6635.0,5755.0,0.0,0.0,3150.0,1344.0,29251.0
Gaya,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,326.0,3150.0,3476.0
Gaya,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,0.0,5000.0,5000.0
Gaya,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Gaya,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,242.0,6806.0,7048.0
Gaya,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,84.0,1344.0,1428.0
Gaya,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2395.0,1709.0,3887.0,449.0,526.0,,1175.0,1175.0,,,250.0,775.0,12341.0
Gaya,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,3000.0,0.0,3500.0,3500.0,,0.0,2000.0,,,3000.0,8000.0,23000.0
Gaya,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,,,0.0,,,0.0,0.0,0.0
Gaya,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4563.0,507.0,3438.0,3423.0,3957.0,,525.0,1175.0,,,2625.0,5176.0,25389.0
Gaya,16.1.2,Stock position of OPV vaccines,5. Total Stock,-2168.0,4202.0,449.0,526.0,69.0,0.0,650.0,2000.0,0.0,0.0,625.0,3599.0,9952.0
Gaya,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,401.0,1037.0,4288.0,1321.0,69.0,,2152.0,2152.0,2889.0,,2459.0,3397.0,20165.0
Gaya,16.1.3,Stock position of TT vaccines,2. Stocks Received,4000.0,4000.0,0.0,3000.0,4000.0,,4000.0,4000.0,4000.0,,3000.0,7000.0,37000.0
Gaya,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0
Gaya,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,3723.0,2967.0,3713.0,3948.0,,5752.0,3263.0,2990.0,,2062.0,8896.0,37314.0
Gaya,16.1.3,Stock position of TT vaccines,5. Total Stock,4401.0,1314.0,1321.0,608.0,121.0,0.0,400.0,2889.0,3899.0,0.0,3397.0,1501.0,19851.0
Gaya,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Gaya,16.1.4,Stock position of DT vaccines,2. Stocks Received,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Gaya,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0
Gaya,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Gaya,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,1231.0,3920.0,1710.0,1951.0,,742.0,742.0,517.0,,0.0,50.0,10863.0
Gaya,16.1.5,Stock position of BCG vaccines,2. Stocks Received,3000.0,3000.0,0.0,3000.0,2000.0,,2100.0,2100.0,2000.0,,2000.0,6000.0,25200.0
Gaya,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0
Gaya,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,2833.0,2210.0,2759.0,2653.0,,2530.0,2325.0,2360.0,,1950.0,3151.0,22771.0
Gaya,16.1.5,Stock position of BCG vaccines,5. Total Stock,3000.0,1398.0,1710.0,1951.0,1298.0,0.0,312.0,517.0,157.0,0.0,50.0,2899.0,13292.0
Gaya,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,351.0,3541.0,87.0,86.0,,1250.0,1250.0,572.0,,120.0,0.0,7257.0
Gaya,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,4000.0,0.0,5000.0,5000.0,,3485.0,3485.0,8000.0,,3000.0,7000.0,43970.0
Gaya,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0
Gaya,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,4288.0,3454.0,5001.0,4861.0,,4440.0,4163.0,8567.0,,470.0,2890.0,38134.0
Gaya,16.1.6,Stock position of Measles vaccines,5. Total Stock,5000.0,63.0,87.0,86.0,225.0,0.0,295.0,572.0,5.0,0.0,2650.0,4110.0,13093.0
Gaya,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,330.0,2254.0,0.0,475.0,,7.0,11.0,1155.0,,900.0,330.0,5462.0
Gaya,16.1.7,Stock position of JE vaccines,2. Stocks Received,3000.0,4000.0,13500.0,8000.0,2500.0,,4000.0,5000.0,4000.0,,3000.0,8200.0,55200.0
Gaya,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0
Gaya,16.1.7,Stock position of JE vaccines,4. Stock Distributed,3022.0,3862.0,15754.0,7525.0,2952.0,,320.0,3856.0,4585.0,,3570.0,5201.0,50647.0
Gaya,16.1.7,Stock position of JE vaccines,5. Total Stock,-22.0,468.0,0.0,475.0,23.0,0.0,3687.0,1155.0,570.0,0.0,330.0,3329.0,10015.0
Gaya,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,752.0,4234.0,269.0,843.0,,,1931.0,1068.0,,1131.0,654.0,10882.0
Gaya,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,4050.0,0.0,5000.0,5000.0,,,3000.0,4000.0,,1500.0,4600.0,27150.0
Gaya,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0
Gaya,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3329.0,3938.0,3965.0,4426.0,4662.0,,,3863.0,2670.0,,1977.0,4105.0,32935.0
Gaya,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,-3329.0,864.0,269.0,843.0,1181.0,0.0,0.0,1068.0,2398.0,0.0,654.0,1149.0,5097.0
Gaya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,480.0,480.0,430.0,11330.0,11330.0,,11330.0,5830.0,1150.0,,350.0,350.0,43060.0
Gaya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,15500.0,0.0,0.0,,0.0,1350.0,0.0,,0.0,0.0,16850.0
Gaya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Gaya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,100.0,50.0,10880.0,550.0,5500.0,,5500.0,6030.0,50.0,,300.0,300.0,29260.0
Gaya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,380.0,430.0,5050.0,10780.0,5830.0,0.0,5830.0,1150.0,1100.0,0.0,50.0,50.0,30650.0
Gaya,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,253124.0,253124.0,24000.0,139124.0,139124.0,,139124.0,79124.0,1043230.0,,177360.0,177360.0,2424694.0
Gaya,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,30000.0,0.0,0.0,,0.0,1265000.0,0.0,,0.0,0.0,1295000.0
Gaya,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Gaya,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,36000.0,24000.0,42000.0,60000.0,60000.0,,60000.0,300894.0,445436.0,,165360.0,165360.0,1359050.0
Gaya,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,217124.0,229124.0,12000.0,79124.0,79124.0,0.0,79124.0,1043230.0,597794.0,0.0,12000.0,12000.0,2360644.0
Gaya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2200.0,2200.0,1600.0,23600.0,23600.0,,23600.0,11600.0,51600.0,,7200.0,7200.0,154400.0
Gaya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,25000.0,0.0,0.0,,0.0,60000.0,0.0,,0.0,0.0,85000.0
Gaya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Gaya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,300.0,600.0,4600.0,12000.0,12000.0,,12000.0,20000.0,13200.0,,6600.0,6600.0,87900.0
Gaya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1900.0,1600.0,22000.0,11600.0,11600.0,0.0,11600.0,51600.0,38400.0,0.0,600.0,600.0,151500.0
Gaya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,,,0.0,,0.0,0.0,43000.0,,7200.0,7200.0,57400.0
Gaya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,,,0.0,,0.0,50000.0,0.0,,0.0,0.0,50000.0
Gaya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Gaya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,,,0.0,,0.0,7000.0,21710.0,,7200.0,7200.0,43110.0
Gaya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,43000.0,21290.0,0.0,0.0,0.0,64290.0
Gaya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,0.0,,,0.0,,0.0,,,,0.0,,0.0
Gaya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,,,0.0,,0.0,,,,0.0,,0.0
Gaya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,,,0.0,,0.0,,,,0.0,,0.0
Gaya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,0.0,,,0.0,,0.0,,,,0.0,,0.0
Gaya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.02,Stock Position of Gloves,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.02,Stock Position of Gloves,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Gaya,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,0.0,,,,,,,,,,,0.0
Gaya,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gaya,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Gaya,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gaya,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6426.0,5026.0,27646.0,10894.0,20478.0,,17368.0,17368.0,11968.0,,11140.0,4510.0,132824.0
Gaya,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000.0,200000.0,0.0,18000.0,10000.0,,0.0,8000.0,10000.0,,4500.0,1000.0,263500.0
Gaya,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Gaya,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,13400.0,177380.0,10952.0,8416.0,17750.0,,15068.0,13400.0,12168.0,,11130.0,12260.0,291924.0
Gaya,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5026.0,27646.0,16694.0,20478.0,12728.0,0.0,2300.0,11968.0,9800.0,0.0,4510.0,-6750.0,104400.0
Gaya,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,43720.0,24790.0,133840.0,0.0,72760.0,,115160.0,115160.0,105260.0,,56260.0,76200.0,743150.0
Gaya,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000.0,250000.0,0.0,200000.0,200000.0,,0.0,100000.0,70000.0,,90000.0,50000.0,1060000.0
Gaya,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Gaya,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,118930.0,140950.0,133840.0,127240.0,187200.0,,12000.0,109900.0,100400.0,,70060.0,115820.0,1116340.0
Gaya,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,24790.0,133840.0,0.0,72760.0,85560.0,0.0,103160.0,105260.0,74860.0,0.0,76200.0,10380.0,686810.0
Gaya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1640.0,5000.0,5340.0,165.0,1979.0,,4019.0,4019.0,5684.0,,5934.0,3215.0,36995.0
Gaya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,3200.0,6000.0,0.0,8000.0,4000.0,,0.0,6000.0,5000.0,,2000.0,5000.0,39200.0
Gaya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Gaya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3730.0,5660.0,5175.0,6186.0,5590.0,,555.0,4335.0,5530.0,,4719.0,6445.0,47925.0
Gaya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1110.0,5340.0,165.0,1979.0,389.0,0.0,3464.0,5684.0,5154.0,0.0,3215.0,1770.0,28270.0
Gaya,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Gaya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gaya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gaya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Gaya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gaya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gaya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Gaya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gaya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gaya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Gaya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gaya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gaya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Gaya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gaya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gaya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Gaya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gaya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gaya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Gaya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gaya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gaya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Gaya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gaya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gaya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Gaya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Gaya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Gaya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Gaya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Gaya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Gaya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Gaya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Gaya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Gaya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Gaya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Gaya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Gaya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Gaya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Gaya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Gaya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Gaya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Gaya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Gaya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Gaya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Gaya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Gaya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Gaya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Gaya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Gaya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Gaya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Gaya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Gaya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Gaya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Gaya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Gaya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Gaya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Gaya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Gaya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Gaya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Gaya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Gaya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Gaya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Gaya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Gopalganj,1.1,Total number of pregnant women Registered for ANC,TOTAL,6315.0,6173.0,5570.0,6125.0,6075.0,6517.0,5138.0,4778.0,4984.0,5321.0,5698.0,5879.0,68573.0
Gopalganj,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3101.0,2950.0,2528.0,2926.0,3087.0,3378.0,3168.0,2765.0,3050.0,3348.0,3479.0,3183.0,36963.0
Gopalganj,1.2,Number of Pregnant women registered under JSY,TOTAL,6315.0,6153.0,5533.0,6125.0,6062.0,6255.0,5138.0,4778.0,4984.0,5321.0,5698.0,5879.0,68241.0
Gopalganj,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3340.0,3132.0,2738.0,3448.0,3584.0,4029.0,3647.0,3242.0,3024.0,3237.0,3609.0,3613.0,40643.0
Gopalganj,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4735.0,4495.0,3920.0,4488.0,4458.0,5035.0,4206.0,3500.0,3744.0,4122.0,4441.0,4271.0,51415.0
Gopalganj,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4145.0,4433.0,3756.0,4442.0,4293.0,4840.0,4582.0,3332.0,3691.0,3946.0,3978.0,4405.0,49843.0
Gopalganj,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2455.0,2566.0,2269.0,2278.0,2246.0,3076.0,2633.0,2277.0,2831.0,2942.0,2561.0,2302.0,30436.0
Gopalganj,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,44.0,93.0,12.0,35.0,40.0,21.0,31.0,23.0,35.0,11.0,44.0,38.0,427.0
Gopalganj,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,4.0,4.0,3.0,3.0,5.0,4.0,4.0,5.0,4.0,5.0,4.0,47.0
Gopalganj,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,366.0,373.0,430.0,669.0,63.0,926.0,547.0,230.0,23.0,58.0,26.0,304.0,4015.0
Gopalganj,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,17.0,7.0,9.0,16.0,0.0,26.0,11.0,0.0,1.0,0.0,0.0,16.0,103.0
Gopalganj,1.8,Number of pregnancy test kits used at SC level,TOTAL,155.0,185.0,117.0,164.0,186.0,155.0,170.0,50.0,103.0,35.0,159.0,68.0,1547.0
Gopalganj,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,176.0,187.0,160.0,161.0,174.0,239.0,246.0,164.0,140.0,147.0,176.0,154.0,2124.0
Gopalganj,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,356.0,391.0,326.0,388.0,473.0,563.0,461.0,475.0,459.0,517.0,492.0,488.0,5389.0
Gopalganj,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,532.0,578.0,486.0,549.0,647.0,802.0,707.0,639.0,599.0,664.0,668.0,642.0,7513.0
Gopalganj,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,413.0,453.0,355.0,409.0,488.0,734.0,685.0,523.0,436.0,510.0,540.0,514.0,6060.0
Gopalganj,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,4.0
Gopalganj,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3061.0,2562.0,2455.0,3331.0,3912.0,3846.0,3823.0,3229.0,3309.0,3332.0,3098.0,2624.0,38582.0
Gopalganj,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2994.0,2294.0,2427.0,3202.0,3858.0,3742.0,3770.0,3186.0,3259.0,3210.0,3064.0,2585.0,37591.0
Gopalganj,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1601.0,1306.0,111.0,414.0,729.0,628.0,3817.0,6312.0,6945.0,6862.0,4549.0,2155.0,35429.0
Gopalganj,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,641.0,76.0,42.0,495.0,669.0,496.0,1320.0,2457.0,3214.0,3287.0,3000.0,1955.0,17652.0
Gopalganj,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Gopalganj,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Gopalganj,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Gopalganj,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Gopalganj,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,50.0,32.0,18.0,21.0,43.0,38.0,34.0,32.0,27.0,22.0,25.0,24.0,366.0
Gopalganj,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gopalganj,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,50.0,32.0,18.0,21.0,43.0,38.0,34.0,32.0,27.0,22.0,25.0,24.0,366.0
Gopalganj,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Gopalganj,4.1.1.a,Number of male live births,TOTAL,1887.0,1658.0,1521.0,1998.0,2340.0,2361.0,2269.0,1921.0,1973.0,2006.0,1943.0,1633.0,23510.0
Gopalganj,4.1.1.b,Number of female live births,TOTAL,1685.0,1547.0,1425.0,1821.0,2173.0,2223.0,2208.0,1899.0,1880.0,1952.0,1789.0,1606.0,22208.0
Gopalganj,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3572.0,3205.0,2946.0,3819.0,4513.0,4584.0,4477.0,3820.0,3853.0,3958.0,3732.0,3239.0,45718.0
Gopalganj,4.1.2,Number of still births,TOTAL,47.0,60.0,48.0,69.0,82.0,82.0,45.0,73.0,72.0,52.0,56.0,43.0,729.0
Gopalganj,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,4.0,7.0,6.0,5.0,5.0,6.0,7.0,9.0,7.0,9.0,5.0,10.0,80.0
Gopalganj,4.2.1,Number of Newborns weighed at birth,TOTAL,3505.0,3134.0,2827.0,3729.0,4391.0,4455.0,4367.0,3580.0,3728.0,3789.0,3558.0,2997.0,44060.0
Gopalganj,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,152.0,127.0,152.0,129.0,191.0,236.0,195.0,154.0,120.0,128.0,95.0,116.0,1795.0
Gopalganj,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3575.0,3169.0,2871.0,3787.0,4484.0,4521.0,4438.0,3785.0,3828.0,3898.0,3709.0,3091.0,45156.0
Gopalganj,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,19.0
Gopalganj,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,63.0,47.0,41.0,60.0,79.0,65.0,83.0,67.0,66.0,48.0,45.0,48.0,712.0
Gopalganj,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gopalganj,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,63.0,47.0,41.0,75.0,79.0,65.0,83.0,67.0,66.0,48.0,45.0,52.0,731.0
Gopalganj,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Gopalganj,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,56.0,47.0,41.0,52.0,79.0,144.0,48.0,40.0,66.0,53.0,45.0,48.0,719.0
Gopalganj,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,4.0,4.0,6.0,3.0,7.0,4.0,4.0,5.0,4.0,5.0,4.0,52.0
Gopalganj,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,28.0,36.0,41.0,43.0,49.0,458.0,29.0,40.0,33.0,29.0,45.0,294.0,1125.0
Gopalganj,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,40.0,13.0,25.0,17.0,8.0,18.0,0.0,9.0,16.0,13.0,0.0,20.0,179.0
Gopalganj,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1906.0,2156.0,1568.0,2151.0,2602.0,2404.0,2349.0,2305.0,2237.0,2251.0,1902.0,1925.0,25756.0
Gopalganj,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1383.0,892.0,891.0,1255.0,1332.0,1242.0,1350.0,1282.0,1146.0,1066.0,1309.0,1410.0,14558.0
Gopalganj,6.3,PNC maternal complications attended,TOTAL,1.0,4.0,6.0,5.0,3.0,0.0,10.0,7.0,5.0,2.0,4.0,4.0,51.0
Gopalganj,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,4.0
Gopalganj,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,4.0
Gopalganj,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,118.0,60.0,60.0,95.0,178.0,136.0,0.0,141.0,153.0,0.0,206.0,117.0,1264.0
Gopalganj,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,552.0,205.0,221.0,358.0,415.0,338.0,0.0,223.0,350.0,1.0,597.0,437.0,3697.0
Gopalganj,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,670.0,265.0,281.0,453.0,593.0,474.0,0.0,364.0,503.0,1.0,803.0,554.0,4961.0
Gopalganj,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,2.0,0.0,1.0,6.0,0.0,1.0,1.0,0.0,0.0,3.0,0.0,14.0
Gopalganj,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Gopalganj,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gopalganj,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,2.0,0.0,1.0,6.0,0.0,1.0,1.0,1.0,0.0,3.0,0.0,15.0
Gopalganj,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gopalganj,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gopalganj,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gopalganj,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,276.0,121.0,66.0,214.0,157.0,278.0,101.0,612.0,563.0,488.0,897.0,695.0,4468.0
Gopalganj,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,15.0,5.0,5.0,67.0,39.0,27.0,31.0,140.0,148.0,142.0,267.0,153.0,1039.0
Gopalganj,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,48.0,31.0,18.0,60.0,43.0,62.0,60.0,151.0,124.0,99.0,263.0,151.0,1110.0
Gopalganj,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gopalganj,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,339.0,157.0,89.0,341.0,239.0,367.0,192.0,903.0,835.0,729.0,1427.0,999.0,6617.0
Gopalganj,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,175.0,,,,,,,,,,,,175.0
Gopalganj,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,1.0,0.0,1.0,3.0,3.0,10.0,5.0,2.0,6.0,1.0,0.0,32.0
Gopalganj,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,1.0,4.0,0.0,25.0
Gopalganj,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,12.0,9.0,6.0,4.0,31.0,15.0,9.0,5.0,4.0,6.0,6.0,8.0,115.0
Gopalganj,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gopalganj,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,12.0,10.0,6.0,5.0,34.0,38.0,19.0,10.0,6.0,13.0,11.0,8.0,172.0
Gopalganj,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gopalganj,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,337.0,326.0,290.0,585.0,229.0,336.0,283.0,304.0,348.0,327.0,371.0,406.0,4142.0
Gopalganj,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,50.0,57.0,37.0,102.0,49.0,47.0,47.0,53.0,39.0,70.0,34.0,46.0,631.0
Gopalganj,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,6.0,14.0,2.0,43.0,12.0,17.0,6.0,9.0,6.0,8.0,9.0,12.0,144.0
Gopalganj,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,10.0,11.0,10.0,7.0,9.0,4.0,13.0,30.0,18.0,14.0,7.0,23.0,156.0
Gopalganj,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gopalganj,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,403.0,408.0,339.0,737.0,299.0,404.0,349.0,396.0,411.0,419.0,421.0,487.0,5073.0
Gopalganj,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,92.0,51.0,51.0,45.0,47.0,64.0,58.0,70.0,169.0,140.0,174.0,240.0,1201.0
Gopalganj,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gopalganj,9.06,Number of IUCD removals,TOTAL,127.0,138.0,90.0,113.0,63.0,95.0,71.0,139.0,116.0,149.0,284.0,138.0,1523.0
Gopalganj,9.07,Number of Oral Pills cycles distributed,TOTAL,1333.0,1333.0,1248.0,1905.0,1277.0,2708.0,1624.0,1586.0,2513.0,1497.0,2192.0,1280.0,20496.0
Gopalganj,9.08,Number of Condom pieces distributed,TOTAL,12899.0,10052.0,8153.0,14568.0,10382.0,13342.0,10628.0,8121.0,9611.0,8883.0,11682.0,7749.0,126070.0
Gopalganj,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,126.0,180.0,3.0,0.0,5.0,12.0,23.0,56.0,405.0
Gopalganj,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,28.0,10.0,63.0,16.0,94.0,129.0,88.0,112.0,140.0,160.0,178.0,113.0,1131.0
Gopalganj,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,0.0,0.0,95.0,1.0,108.0
Gopalganj,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Gopalganj,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4651.0,4292.0,3407.0,4659.0,5172.0,6363.0,5742.0,4068.0,6515.0,5354.0,5192.0,4905.0,60320.0
Gopalganj,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,5208.0,4805.0,3819.0,4347.0,4110.0,5479.0,5625.0,5953.0,5829.0,1016.0,146.0,73.0,46410.0
Gopalganj,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,5514.0,4992.0,3862.0,4565.0,4292.0,4787.0,5043.0,5100.0,5843.0,5924.0,2284.0,1163.0,53369.0
Gopalganj,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,5355.0,5096.0,4036.0,4538.0,4568.0,5147.0,4626.0,4518.0,5126.0,5719.0,5165.0,3216.0,57110.0
Gopalganj,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,60.0,57.0,0.0,0.0,0.0,0.0,1.0,0.0,5082.0,5295.0,5015.0,15510.0
Gopalganj,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,69.0,46.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,3373.0,4341.0,7830.0
Gopalganj,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,56.0,56.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,15.0,2324.0,2453.0
Gopalganj,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3194.0,3310.0,2749.0,3565.0,4061.0,3525.0,3462.0,2500.0,4128.0,3438.0,3259.0,2793.0,39984.0
Gopalganj,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,5091.0,4632.0,3614.0,3996.0,3970.0,3458.0,4735.0,5177.0,5758.0,5288.0,4729.0,4753.0,55201.0
Gopalganj,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5335.0,4826.0,3494.0,4356.0,4131.0,3047.0,4145.0,4400.0,5766.0,5652.0,4818.0,4944.0,54914.0
Gopalganj,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5202.0,4917.0,3665.0,4290.0,4394.0,3164.0,3723.0,3810.0,5033.0,5535.0,5112.0,4895.0,53740.0
Gopalganj,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2607.0,2354.0,2059.0,2985.0,3264.0,3593.0,3183.0,2433.0,2964.0,2619.0,2412.0,2317.0,32790.0
Gopalganj,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,5433.0,4690.0,3716.0,4255.0,4225.0,5467.0,5601.0,5570.0,4878.0,745.0,337.0,155.0,45072.0
Gopalganj,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,5591.0,4886.0,3646.0,4607.0,4448.0,4797.0,5087.0,4790.0,4960.0,3841.0,2561.0,1692.0,50906.0
Gopalganj,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,5046.0,4817.0,4033.0,4538.0,4697.0,5201.0,4722.0,4223.0,4294.0,3789.0,4113.0,3660.0,53133.0
Gopalganj,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3943.0,3849.0,4088.0,4909.0,4875.0,5866.0,4989.0,4398.0,3977.0,4810.0,3271.0,3462.0,52437.0
Gopalganj,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3711.0,3274.0,2742.0,3250.0,3161.0,3841.0,3403.0,2833.0,2961.0,3920.0,2971.0,3139.0,39206.0
Gopalganj,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3223.0,3120.0,1993.0,1141.0,1243.0,3991.0,3958.0,991.0,2910.0,2346.0,986.0,2429.0,28331.0
Gopalganj,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2072.0,2019.0,2208.0,2531.0,2600.0,3061.0,2722.0,2343.0,2104.0,2434.0,1616.0,1733.0,27443.0
Gopalganj,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1835.0,1777.0,1823.0,2189.0,2176.0,2752.0,2268.0,1935.0,1668.0,2139.0,1353.0,1463.0,23378.0
Gopalganj,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3907.0,3796.0,4031.0,4720.0,4776.0,5813.0,4990.0,4278.0,3772.0,4573.0,2969.0,3196.0,50821.0
Gopalganj,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4656.0,4326.0,3336.0,4014.0,3465.0,4137.0,3272.0,3266.0,3729.0,4302.0,4351.0,4430.0,47284.0
Gopalganj,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4601.0,3976.0,3217.0,3972.0,3435.0,2841.0,2869.0,2949.0,3733.0,4233.0,4160.0,4431.0,44417.0
Gopalganj,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,324.0,312.0,209.0,223.0,270.0,485.0,389.0,391.0,455.0,647.0,401.0,603.0,4709.0
Gopalganj,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,288.0,251.0,192.0,218.0,252.0,403.0,340.0,341.0,382.0,574.0,345.0,492.0,4078.0
Gopalganj,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,612.0,563.0,401.0,441.0,522.0,888.0,729.0,732.0,837.0,1221.0,746.0,1095.0,8787.0
Gopalganj,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,470.0,424.0,347.0,436.0,405.0,673.0,633.0,564.0,1002.0,899.0,1075.0,1115.0,8043.0
Gopalganj,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,534.0,427.0,446.0,501.0,505.0,712.0,690.0,684.0,921.0,871.0,917.0,895.0,8103.0
Gopalganj,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,846.0,730.0,642.0,890.0,800.0,1308.0,929.0,980.0,1325.0,1458.0,1285.0,1404.0,12597.0
Gopalganj,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,13.0,0.0,0.0,0.0,5.0,38.0,0.0,0.0,8.0,0.0,74.0,20.0,158.0
Gopalganj,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5.0,10.0,0.0,0.0,8.0,10.0,0.0,0.0,0.0,0.0,2.0,5.0,40.0
Gopalganj,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2252.0,2239.0,2224.0,2245.0,2226.0,2253.0,2272.0,2265.0,2250.0,2279.0,2257.0,2245.0,27007.0
Gopalganj,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2235.0,2186.0,2105.0,2163.0,2150.0,2176.0,2173.0,2105.0,2159.0,2184.0,2175.0,2200.0,26011.0
Gopalganj,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2086.0,2069.0,1924.0,2026.0,1991.0,2013.0,2018.0,1955.0,1962.0,2017.0,2058.0,2027.0,24146.0
Gopalganj,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,3525.0,3184.0,1526.0,965.0,1045.0,2942.0,2740.0,787.0,2315.0,1747.0,960.0,2399.0,24135.0
Gopalganj,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2509.0,2445.0,2663.0,4940.0,3412.0,3660.0,3675.0,3269.0,2495.0,3087.0,1706.0,2110.0,35971.0
Gopalganj,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,254.0,217.0,200.0,20415.0,170.0,147.0,214.0,136.0,228.0,387.0,393.0,277.0,23038.0
Gopalganj,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,58.0,24.0,8.0,14.0,0.0,15.0,47.0,25.0,87.0,67.0,47.0,51.0,443.0
Gopalganj,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,85.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,85.0
Gopalganj,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,235.0,480.0,607.0,487.0,343.0,909.0,788.0,714.0,709.0,807.0,884.0,909.0,7872.0
Gopalganj,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,9.0,22.0,0.0,0.0,0.0,0.0,0.0,31.0
Gopalganj,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,17.0,9.0,13.0,8.0,13.0,9.0,9.0,43.0,49.0,13.0,13.0,14.0,210.0
Gopalganj,13.1,Number of Patients operated for cataract,TOTAL,257.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,122.0,0.0,0.0,379.0
Gopalganj,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,122.0,0.0,0.0,122.0
Gopalganj,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Gopalganj,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Gopalganj,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2026.0,2005.0,1939.0,1984.0,2011.0,2005.0,1992.0,1852.0,1959.0,2015.0,1909.0,1935.0,-1.0
Gopalganj,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Gopalganj,14.05,Number of RKS meetings held during the month,TOTAL,4.0,2.0,1.0,2.0,4.0,6.0,5.0,2.0,3.0,3.0,2.0,5.0,39.0
Gopalganj,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Gopalganj,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,883.0,1187.0,804.0,823.0,902.0,927.0,773.0,528.0,618.0,1063.0,1514.0,1019.0,11041.0
Gopalganj,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Gopalganj,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Gopalganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1806.0,1618.0,1551.0,2024.0,1664.0,2083.0,2020.0,1758.0,1772.0,1813.0,1854.0,1518.0,21481.0
Gopalganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,966.0,1360.0,1140.0,1270.0,403.0,1087.0,977.0,832.0,739.0,738.0,714.0,1370.0,11596.0
Gopalganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1673.0,1428.0,1469.0,1818.0,1410.0,2031.0,2048.0,1830.0,1646.0,1779.0,1590.0,1512.0,20234.0
Gopalganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3546.0,3075.0,2926.0,3786.0,3282.0,4516.0,4429.0,4585.0,4335.0,4273.0,4698.0,3486.0,46937.0
Gopalganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,3479.0,3046.0,3020.0,3842.0,3074.0,4114.0,4068.0,3588.0,3418.0,3592.0,3444.0,3030.0,41715.0
Gopalganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4512.0,4435.0,4066.0,5056.0,3685.0,5603.0,5406.0,5417.0,5074.0,5011.0,5412.0,4856.0,58533.0
Gopalganj,14.10.2.a,Number of death cases of Inpatient males,TOTAL,26.0,20.0,15.0,24.0,0.0,17.0,24.0,16.0,17.0,0.0,12.0,13.0,184.0
Gopalganj,14.10.2.b,Number of death cases of Inpatient females,TOTAL,18.0,11.0,12.0,25.0,0.0,27.0,9.0,16.0,12.0,0.0,11.0,11.0,152.0
Gopalganj,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,44.0,31.0,27.0,49.0,0.0,44.0,33.0,32.0,29.0,0.0,23.0,24.0,336.0
Gopalganj,14.11,In-Patient Head Count at midnight,TOTAL,7255.0,6891.0,6821.0,8747.0,6430.0,9423.0,9205.0,8476.0,8169.0,8308.0,8306.0,7449.0,95480.0
Gopalganj,14.12.1,OPD attendance (All),TOTAL,109778.0,104409.0,101915.0,115586.0,107796.0,121963.0,96942.0,101735.0,87680.0,85330.0,94936.0,98411.0,1226481.0
Gopalganj,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,417.0,752.0,174.0,337.0,283.0,424.0,239.0,838.0,791.0,723.0,1447.0,854.0,7279.0
Gopalganj,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,46.0,4.0,34.0,1.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,88.0
Gopalganj,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1415.0,1127.0,1064.0,1124.0,1313.0,1437.0,1075.0,1339.0,1259.0,1230.0,1398.0,1306.0,15087.0
Gopalganj,14.14.a,Number of patients given AYUSH treatment,TOTAL,17862.0,18225.0,20206.0,21152.0,20831.0,20950.0,17616.0,19771.0,15922.0,15973.0,17534.0,18785.0,224827.0
Gopalganj,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4915.0,4242.0,4229.0,2541.0,3762.0,4870.0,3296.0,3814.0,3203.0,3331.0,4525.0,3517.0,46245.0
Gopalganj,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,850.0,156.0,1052.0,1435.0,360.0,1439.0,875.0,534.0,328.0,317.0,877.0,988.0,9211.0
Gopalganj,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,19.0,2.0,26.0,52.0,23.0,50.0,30.0,21.0,10.0,14.0,14.0,40.0,301.0
Gopalganj,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,432.0,364.0,387.0,377.0,466.0,415.0,197.0,447.0,384.0,473.0,312.0,354.0,4608.0
Gopalganj,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,14.0,15.0,28.0,17.0,24.0,19.0,2.0,12.0,16.0,15.0,17.0,16.0,195.0
Gopalganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,659.0,500.0,510.0,623.0,525.0,575.0,164.0,962.0,753.0,820.0,839.0,723.0,7653.0
Gopalganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,13.0,14.0,13.0,6.0,22.0,14.0,2.0,12.0,8.0,10.0,6.0,7.0,127.0
Gopalganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1099.0,1104.0,1037.0,1281.0,1063.0,1257.0,169.0,1200.0,1258.0,1168.0,848.0,1092.0,12576.0
Gopalganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,2.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,3.0,0.0,12.0
Gopalganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2190.0,1968.0,1934.0,2281.0,2054.0,2247.0,530.0,2609.0,2395.0,2461.0,1999.0,2169.0,24837.0
Gopalganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,30.0,31.0,42.0,23.0,47.0,33.0,4.0,25.0,25.0,25.0,26.0,23.0,334.0
Gopalganj,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,20.0,0.0,20.0,0.0,10.0,0.0,0.0,72.0,0.0,0.0,122.0
Gopalganj,15.3.a,Number of VDRL tests conducted on males,Number tested,55.0,26.0,25.0,42.0,102.0,84.0,64.0,4.0,0.0,4.0,18.0,56.0,480.0
Gopalganj,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,33.0,23.0,300.0,2.0,585.0,122.0,506.0,14.0,0.0,0.0,59.0,0.0,1644.0
Gopalganj,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,253.0,17.0,1.0,442.0,0.0,680.0,0.0,0.0,0.0,0.0,9.0,258.0,1660.0
Gopalganj,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,341.0,66.0,326.0,486.0,687.0,886.0,570.0,18.0,0.0,4.0,86.0,314.0,3784.0
Gopalganj,15.4.1,Number of blood smears examined for Malaria,TOTAL,19.0,12.0,15.0,18.0,0.0,67.0,59.0,47.0,10.0,1.0,33.0,43.0,324.0
Gopalganj,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0
Gopalganj,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gopalganj,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,370.0,570.0,745.0,2395.0,3435.0,2200.0,3740.0,1710.0,,,,,15165.0
Gopalganj,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4000.0,2500.0,4000.0,3000.0,1000.0,4000.0,0.0,2000.0,,,,,20500.0
Gopalganj,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3800.0,2325.0,2350.0,1960.0,2235.0,2460.0,2030.0,2360.0,,,,,19520.0
Gopalganj,16.1.1,Stock position of DPT vaccines,5. Total Stock,570.0,745.0,2395.0,3435.0,2200.0,3740.0,1710.0,1350.0,0.0,0.0,0.0,0.0,16145.0
Gopalganj,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,675.0,225.0,160.0,315.0,0.0,19.0,800.0,275.0,,,,,2469.0
Gopalganj,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1750.0,1200.0,3500.0,1600.0,1500.0,1100.0,1200.0,1200.0,,,,,13050.0
Gopalganj,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2200.0,1400.0,2120.0,1915.0,1481.0,319.0,1725.0,975.0,,,,,12135.0
Gopalganj,16.1.2,Stock position of OPV vaccines,5. Total Stock,225.0,25.0,1540.0,0.0,19.0,800.0,275.0,500.0,0.0,0.0,0.0,0.0,3384.0
Gopalganj,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,205.0,455.0,160.0,1540.0,1590.0,0.0,1530.0,70.0,,,,,5550.0
Gopalganj,16.1.3,Stock position of TT vaccines,2. Stocks Received,3000.0,2000.0,3500.0,2000.0,0.0,3500.0,0.0,1500.0,,,,,15500.0
Gopalganj,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2750.0,2295.0,2120.0,1950.0,1590.0,1970.0,1460.0,975.0,,,,,15110.0
Gopalganj,16.1.3,Stock position of TT vaccines,5. Total Stock,455.0,160.0,1540.0,1590.0,0.0,1530.0,70.0,595.0,0.0,0.0,0.0,0.0,5940.0
Gopalganj,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,150.0,625.0,215.0,950.0,1600.0,770.0,1495.0,195.0,,,,,6000.0
Gopalganj,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2500.0,1000.0,1700.0,2000.0,400.0,2400.0,0.0,1000.0,,,,,11000.0
Gopalganj,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2025.0,1410.0,965.0,1350.0,1230.0,1675.0,1300.0,710.0,,,,,10665.0
Gopalganj,16.1.5,Stock position of BCG vaccines,5. Total Stock,625.0,215.0,950.0,1600.0,770.0,1495.0,195.0,485.0,0.0,0.0,0.0,0.0,6335.0
Gopalganj,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,45.0,100.0,95.0,1080.0,1880.0,1140.0,1700.0,1300.0,,,,,7340.0
Gopalganj,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,2000.0,3200.0,3000.0,1500.0,2700.0,2000.0,1000.0,,,,,18400.0
Gopalganj,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2945.0,2005.0,2215.0,2200.0,2240.0,2140.0,2400.0,2060.0,,,,,18205.0
Gopalganj,16.1.6,Stock position of Measles vaccines,5. Total Stock,100.0,95.0,1080.0,1880.0,1140.0,1700.0,1300.0,240.0,0.0,0.0,0.0,0.0,7535.0
Gopalganj,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,720.0,1800.0,400.0,0.0,0.0,110.0,2000.0,0.0,,,,,5030.0
Gopalganj,16.1.7,Stock position of JE vaccines,2. Stocks Received,4500.0,2000.0,0.0,600.0,1000.0,4000.0,0.0,1000.0,,,,,13100.0
Gopalganj,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.7,Stock position of JE vaccines,4. Stock Distributed,3420.0,3400.0,400.0,600.0,890.0,2110.0,2000.0,710.0,,,,,13530.0
Gopalganj,16.1.7,Stock position of JE vaccines,5. Total Stock,1800.0,400.0,0.0,0.0,110.0,2000.0,0.0,290.0,0.0,0.0,0.0,0.0,4600.0
Gopalganj,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,80.0,290.0,810.0,1135.0,1110.0,2510.0,610.0,,,,,6545.0
Gopalganj,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,2000.0,2000.0,2600.0,1980.0,4000.0,0.0,1500.0,,,,,17080.0
Gopalganj,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2920.0,1790.0,1480.0,2275.0,2005.0,2600.0,1900.0,1510.0,,,,,16480.0
Gopalganj,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,80.0,290.0,810.0,1135.0,1110.0,2510.0,610.0,600.0,0.0,0.0,0.0,0.0,7145.0
Gopalganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Gopalganj,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Gopalganj,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Gopalganj,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Gopalganj,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gopalganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,400.0,3200.0,0.0,11600.0,5100.0,13400.0,2700.0,9400.0,,,,,45800.0
Gopalganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000.0,0.0,15000.0,0.0,14000.0,0.0,10000.0,0.0,,,,,51000.0
Gopalganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,9200.0,3200.0,3400.0,6500.0,5700.0,10700.0,3300.0,7400.0,,,,,49400.0
Gopalganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3200.0,0.0,11600.0,5100.0,13400.0,2700.0,9400.0,2000.0,0.0,0.0,0.0,0.0,47400.0
Gopalganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,44000.0,112000.0,58000.0,83000.0,43800.0,145200.0,59800.0,100000.0,,,,,645800.0
Gopalganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,150000.0,0.0,60000.0,0.0,150000.0,0.0,100000.0,0.0,,,,,460000.0
Gopalganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,82000.0,54000.0,35000.0,39200.0,48600.0,85400.0,59800.0,85300.0,,,,,489300.0
Gopalganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,112000.0,58000.0,83000.0,43800.0,145200.0,59800.0,100000.0,14700.0,0.0,0.0,0.0,0.0,616500.0
Gopalganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,600.0,1700.0,0.0,4100.0,1000.0,3600.0,0.0,5000.0,,,,,16000.0
Gopalganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,5000.0,0.0,6000.0,0.0,4000.0,0.0,5000.0,0.0,,,,,20000.0
Gopalganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Gopalganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3900.0,1700.0,1900.0,3100.0,1400.0,3600.0,0.0,4800.0,,,,,20400.0
Gopalganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1700.0,0.0,4100.0,1000.0,3600.0,0.0,5000.0,200.0,0.0,0.0,0.0,0.0,15600.0
Gopalganj,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Gopalganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gopalganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gopalganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Gopalganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gopalganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gopalganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Gopalganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gopalganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gopalganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Gopalganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gopalganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gopalganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Gopalganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gopalganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gopalganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Gopalganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gopalganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gopalganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Gopalganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gopalganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gopalganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Gopalganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gopalganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gopalganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Gopalganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Gopalganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Gopalganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Gopalganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Gopalganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Gopalganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Gopalganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Gopalganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Jamui,1.1,Total number of pregnant women Registered for ANC,TOTAL,3595.0,3231.0,4356.0,4601.0,3764.0,3009.0,2654.0,2551.0,2787.0,2880.0,3931.0,3601.0,40960.0
Jamui,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1956.0,1632.0,2258.0,2315.0,1936.0,1576.0,1447.0,1331.0,1528.0,1727.0,2237.0,1975.0,21918.0
Jamui,1.2,Number of Pregnant women registered under JSY,TOTAL,3595.0,3236.0,4356.0,4601.0,3764.0,3009.0,2654.0,2551.0,2787.0,2880.0,3931.0,3601.0,40965.0
Jamui,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1816.0,1678.0,2038.0,2253.0,2442.0,2629.0,2753.0,2365.0,2148.0,2285.0,2330.0,2257.0,26994.0
Jamui,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2814.0,2330.0,3127.0,3501.0,3231.0,2534.0,2264.0,2101.0,2169.0,2430.0,3154.0,2960.0,32615.0
Jamui,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3286.0,2905.0,2934.0,3737.0,3742.0,3262.0,2885.0,2293.0,2463.0,2467.0,2787.0,3427.0,36188.0
Jamui,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1257.0,1113.0,1640.0,2066.0,2432.0,2391.0,2391.0,2082.0,1986.0,2192.0,2489.0,2261.0,24300.0
Jamui,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,55.0,45.0,89.0,102.0,56.0,70.0,41.0,37.0,8.0,10.0,32.0,23.0,568.0
Jamui,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,4.0,2.0,3.0,2.0,3.0,1.0,0.0,4.0,1.0,1.0,0.0,24.0
Jamui,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,252.0,328.0,295.0,338.0,68.0,106.0,100.0,103.0,142.0,502.0,965.0,499.0,3698.0
Jamui,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,32.0,28.0,32.0,35.0,5.0,8.0,5.0,7.0,20.0,6.0,11.0,7.0,196.0
Jamui,1.8,Number of pregnancy test kits used at SC level,TOTAL,140.0,56.0,112.0,180.0,169.0,156.0,118.0,71.0,94.0,236.0,281.0,445.0,2058.0
Jamui,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,158.0,143.0,201.0,226.0,332.0,236.0,268.0,337.0,299.0,384.0,335.0,303.0,3222.0
Jamui,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,593.0,390.0,607.0,723.0,775.0,781.0,812.0,891.0,842.0,829.0,767.0,559.0,8569.0
Jamui,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,751.0,533.0,808.0,949.0,1107.0,1017.0,1080.0,1228.0,1141.0,1213.0,1102.0,862.0,11791.0
Jamui,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,534.0,343.0,630.0,544.0,787.0,626.0,628.0,774.0,731.0,773.0,655.0,575.0,7600.0
Jamui,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,19.0,0.0,0.0,0.0,0.0,0.0,14.0,0.0,0.0,0.0,33.0
Jamui,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1900.0,2024.0,1976.0,2578.0,3026.0,2793.0,2812.0,2274.0,2471.0,2155.0,1847.0,1464.0,27320.0
Jamui,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1161.0,1838.0,1423.0,2487.0,2783.0,1922.0,2695.0,2223.0,2042.0,1856.0,1591.0,1312.0,23333.0
Jamui,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,798.0,889.0,197.0,162.0,810.0,1104.0,575.0,844.0,1447.0,1391.0,1229.0,2482.0,11928.0
Jamui,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,773.0,656.0,248.0,273.0,648.0,1063.0,536.0,649.0,813.0,1240.0,1094.0,2195.0,10188.0
Jamui,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jamui,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Jamui,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,46.0,42.0,35.0,46.0,42.0,35.0,32.0,35.0,40.0,40.0,38.0,38.0,469.0
Jamui,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamui,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,46.0,42.0,35.0,58.0,42.0,35.0,32.0,35.0,40.0,40.0,38.0,38.0,481.0
Jamui,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,4.1.1.a,Number of male live births,TOTAL,1323.0,1315.0,1491.0,1833.0,2114.0,1936.0,1998.0,1798.0,1826.0,1737.0,1546.0,1207.0,20124.0
Jamui,4.1.1.b,Number of female live births,TOTAL,1283.0,1221.0,1269.0,1658.0,1966.0,1823.0,1842.0,1674.0,1738.0,1610.0,1395.0,1094.0,18573.0
Jamui,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2606.0,2536.0,2760.0,3491.0,4080.0,3759.0,3840.0,3472.0,3564.0,3347.0,2941.0,2301.0,38697.0
Jamui,4.1.2,Number of still births,TOTAL,53.0,50.0,55.0,62.0,54.0,60.0,58.0,35.0,41.0,25.0,23.0,27.0,543.0
Jamui,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Jamui,4.2.1,Number of Newborns weighed at birth,TOTAL,2489.0,2428.0,2633.0,3321.0,3871.0,3537.0,3657.0,3252.0,3320.0,3088.0,2689.0,2103.0,36388.0
Jamui,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,128.0,113.0,347.0,155.0,229.0,191.0,169.0,186.0,163.0,137.0,110.0,67.0,1995.0
Jamui,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2553.0,2471.0,2683.0,3352.0,3991.0,3613.0,3764.0,3387.0,3425.0,3243.0,2855.0,2240.0,37577.0
Jamui,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,3.0,7.0,13.0,0.0,0.0,2.0,0.0,0.0,0.0,25.0
Jamui,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,21.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Jamui,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,46.0,42.0,35.0,46.0,42.0,35.0,32.0,35.0,40.0,41.0,39.0,38.0,471.0
Jamui,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamui,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,46.0,42.0,35.0,49.0,70.0,48.0,32.0,35.0,42.0,41.0,39.0,38.0,517.0
Jamui,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,46.0,42.0,35.0,46.0,42.0,35.0,32.0,35.0,42.0,222.0,51.0,158.0,786.0
Jamui,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,46.0,42.0,35.0,46.0,42.0,35.0,32.0,35.0,0.0,31.0,1.0,0.0,345.0
Jamui,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,46.0,42.0,35.0,46.0,42.0,35.0,32.0,35.0,40.0,397.0,39.0,158.0,947.0
Jamui,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,46.0,65.0,17.0,59.0,32.0,25.0,14.0,15.0,26.0,81.0,61.0,56.0,497.0
Jamui,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1906.0,1684.0,1875.0,2475.0,2911.0,2778.0,2598.0,2402.0,2573.0,2086.0,1965.0,1494.0,26747.0
Jamui,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1086.0,749.0,1168.0,1288.0,1722.0,1611.0,1556.0,1705.0,1493.0,1422.0,1226.0,1006.0,16032.0
Jamui,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,84.0,68.0,59.0,61.0,65.0,70.0,65.0,85.0,91.0,110.0,101.0,91.0,950.0
Jamui,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,331.0,309.0,201.0,212.0,221.0,225.0,175.0,150.0,214.0,220.0,232.0,246.0,2736.0
Jamui,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,415.0,377.0,260.0,273.0,286.0,295.0,240.0,235.0,305.0,330.0,333.0,337.0,3686.0
Jamui,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Jamui,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Jamui,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0
Jamui,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamui,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,4.0
Jamui,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1.0,0.0,0.0,0.0,0.0,4.0,3.0,0.0,1.0,0.0,6.0,16.0,31.0
Jamui,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0
Jamui,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamui,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,23.0,0.0,1.0,25.0,25.0,96.0,84.0,384.0,623.0,660.0,682.0,316.0,2919.0
Jamui,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,6.0,0.0,0.0,9.0,7.0,21.0,0.0,237.0,318.0,472.0,435.0,127.0,1632.0
Jamui,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,12.0,10.0,9.0,11.0,18.0,12.0,19.0,51.0,87.0,67.0,171.0,66.0,533.0
Jamui,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamui,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,41.0,10.0,10.0,45.0,50.0,129.0,103.0,672.0,1028.0,1199.0,1288.0,509.0,5084.0
Jamui,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,85.0,57.0,48.0,35.0,83.0,123.0,104.0,169.0,140.0,312.0,374.0,299.0,1829.0
Jamui,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,12.0,7.0,9.0,17.0,8.0,14.0,21.0,13.0,101.0
Jamui,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamui,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,12.0,7.0,9.0,17.0,8.0,14.0,21.0,13.0,101.0
Jamui,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,35.0,64.0,40.0,84.0,35.0,63.0,83.0,108.0,108.0,133.0,188.0,170.0,1111.0
Jamui,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,2.0,19.0,17.0,27.0,14.0,21.0,23.0,32.0,36.0,46.0,47.0,43.0,327.0
Jamui,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,3.0,,6.0,4.0,5.0,0.0,1.0,1.0,3.0,5.0,,3.0,31.0
Jamui,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,10.0,37.0,62.0,29.0,32.0,20.0,15.0,9.0,22.0,22.0,10.0,26.0,294.0
Jamui,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamui,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,50.0,120.0,125.0,144.0,86.0,104.0,122.0,150.0,169.0,206.0,245.0,242.0,1763.0
Jamui,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,8.0,31.0,3.0,0.0,27.0,9.0,27.0,5.0,19.0,27.0,1.0,29.0,186.0
Jamui,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,5.0,3.0,4.0,4.0,4.0,5.0,8.0,3.0,4.0,2.0,6.0,22.0,70.0
Jamui,9.06,Number of IUCD removals,TOTAL,54.0,40.0,58.0,62.0,51.0,42.0,65.0,72.0,103.0,74.0,80.0,123.0,824.0
Jamui,9.07,Number of Oral Pills cycles distributed,TOTAL,237.0,628.0,451.0,489.0,320.0,409.0,683.0,594.0,689.0,801.0,1013.0,1062.0,7376.0
Jamui,9.08,Number of Condom pieces distributed,TOTAL,3122.0,3636.0,4448.0,9454.0,2565.0,5801.0,6819.0,5978.0,6161.0,5930.0,6452.0,6597.0,66963.0
Jamui,9.09,Number of Centchroman (weekly) pills given,TOTAL,74.0,138.0,206.0,185.0,15.0,106.0,144.0,295.0,268.0,163.0,169.0,355.0,2118.0
Jamui,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2.0,7.0,10.0,45.0,36.0,185.0,210.0,239.0,381.0,515.0,519.0,624.0,2773.0
Jamui,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,6.0,0.0,0.0,9.0
Jamui,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Jamui,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2532.0,2066.0,2282.0,3300.0,4295.0,3823.0,4051.0,3975.0,3803.0,3412.0,3449.0,2466.0,39454.0
Jamui,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3177.0,2260.0,2878.0,3535.0,3848.0,3657.0,3930.0,4216.0,4350.0,1146.0,234.0,196.0,33427.0
Jamui,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3690.0,2281.0,2717.0,3223.0,3612.0,3265.0,3541.0,3422.0,4195.0,4087.0,1834.0,1114.0,36981.0
Jamui,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3687.0,2409.0,2794.0,3105.0,3506.0,3105.0,3392.0,3033.0,3550.0,3769.0,3655.0,2637.0,38642.0
Jamui,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,2628.0,4074.0,3328.0,10037.0
Jamui,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2028.0,3120.0,5148.0
Jamui,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,1256.0,1306.0
Jamui,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1949.0,1623.0,2046.0,2660.0,3447.0,2893.0,2824.0,2169.0,2495.0,2092.0,1780.0,1354.0,27332.0
Jamui,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3131.0,1930.0,2976.0,3522.0,3391.0,3822.0,3476.0,2920.0,4477.0,2995.0,3869.0,3017.0,39526.0
Jamui,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3512.0,1990.0,2759.0,3190.0,3062.0,3365.0,3181.0,2340.0,3908.0,3648.0,3690.0,3604.0,38249.0
Jamui,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3490.0,2142.0,2803.0,3086.0,2975.0,3143.0,3060.0,2156.0,3323.0,3141.0,3691.0,3540.0,36550.0
Jamui,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1577.0,1487.0,1596.0,2384.0,2991.0,2397.0,2415.0,1902.0,2353.0,1972.0,1656.0,1257.0,23987.0
Jamui,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3031.0,2229.0,2784.0,3508.0,3795.0,3625.0,3911.0,4145.0,4351.0,1590.0,863.0,345.0,34177.0
Jamui,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3502.0,2310.0,2659.0,3209.0,3608.0,3374.0,3872.0,3364.0,4212.0,4047.0,2454.0,1254.0,37865.0
Jamui,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3536.0,2852.0,2756.0,3237.0,3563.0,3148.0,3404.0,3064.0,3554.0,3819.0,3671.0,2573.0,39177.0
Jamui,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2431.0,2270.0,3148.0,3981.0,4251.0,3155.0,2281.0,3101.0,2878.0,2600.0,3073.0,2126.0,35295.0
Jamui,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2189.0,1199.0,1505.0,1910.0,1980.0,1713.0,1143.0,1612.0,1909.0,2068.0,2712.0,1878.0,21818.0
Jamui,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,3145.0,17.0,3.0,0.0,0.0,0.0,0.0,897.0,2022.0,2307.0,916.0,9307.0
Jamui,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1185.0,1040.0,1469.0,1763.0,1941.0,1480.0,1105.0,1440.0,1375.0,1219.0,1455.0,968.0,16440.0
Jamui,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1048.0,926.0,1371.0,1666.0,1759.0,1324.0,998.0,1372.0,1159.0,1090.0,1338.0,800.0,14851.0
Jamui,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2233.0,1966.0,2840.0,3429.0,3700.0,2804.0,2103.0,2812.0,2534.0,2309.0,2793.0,1768.0,31291.0
Jamui,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2421.0,1481.0,1690.0,2124.0,2109.0,1971.0,1703.0,1826.0,2225.0,2526.0,2836.0,2385.0,25297.0
Jamui,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2358.0,1267.0,1659.0,2092.0,1937.0,1979.0,1601.0,1477.0,2158.0,2451.0,2858.0,2393.0,24230.0
Jamui,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,672.0,462.0,500.0,577.0,509.0,514.0,343.0,443.0,531.0,610.0,688.0,550.0,6399.0
Jamui,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,679.0,413.0,476.0,510.0,468.0,419.0,304.0,374.0,424.0,568.0,662.0,488.0,5785.0
Jamui,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1351.0,875.0,976.0,1087.0,977.0,933.0,647.0,817.0,955.0,1178.0,1350.0,1038.0,12184.0
Jamui,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,101.0,34.0,75.0,93.0,107.0,51.0,55.0,69.0,89.0,117.0,159.0,146.0,1096.0
Jamui,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1277.0,943.0,1023.0,1259.0,1311.0,1247.0,1316.0,1202.0,1368.0,1274.0,1209.0,1242.0,14671.0
Jamui,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1207.0,1015.0,1001.0,1404.0,1410.0,1298.0,1470.0,1329.0,1391.0,1377.0,1437.0,1194.0,15533.0
Jamui,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Jamui,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Jamui,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1942.0,1733.0,1783.0,1951.0,1957.0,1842.0,1909.0,1871.0,1848.0,1931.0,2073.0,1971.0,22811.0
Jamui,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1927.0,1619.0,1722.0,1917.0,1924.0,1802.0,1881.0,1786.0,1809.0,1887.0,2020.0,1944.0,22238.0
Jamui,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1585.0,1221.0,1419.0,1545.0,1624.0,1492.0,1585.0,1434.0,1521.0,1522.0,1721.0,1661.0,18330.0
Jamui,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,653.0,1454.0,2014.0,925.0,5062.0
Jamui,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,233.0,197.0,599.0,4491.0,1170.0,481.0,323.0,505.0,7212.0,594.0,574.0,291.0,16670.0
Jamui,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,139.0,82.0,54.0,22993.0,273.0,256.0,187.0,276.0,24527.0,299.0,387.0,255.0,49728.0
Jamui,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,42.0,25.0,20.0,11103.0,88.0,37.0,33.0,32.0,10837.0,22.0,56.0,52.0,22347.0
Jamui,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,12.0,0.0,5.0,0.0,8.0,0.0,1.0,0.0,0.0,1.0,5.0,32.0
Jamui,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1.0,2.0,91.0,175.0,160.0,42.0,21.0,35.0,49.0,228.0,206.0,173.0,1183.0
Jamui,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,10.0,11.0,2.0,15.0,2.0,5.0,15.0,12.0,15.0,22.0,19.0,29.0,157.0
Jamui,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,256.0,220.0,142.0,618.0
Jamui,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,256.0,220.0,142.0,618.0
Jamui,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Jamui,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Jamui,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1368.0,1231.0,1353.0,1304.0,1394.0,1417.0,1282.0,1324.0,1445.0,1405.0,1222.0,1440.0,-1.0
Jamui,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Jamui,14.05,Number of RKS meetings held during the month,TOTAL,5.0,8.0,12.0,7.0,8.0,10.0,8.0,10.0,7.0,10.0,8.0,10.0,103.0
Jamui,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Jamui,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,701.0,646.0,369.0,874.0,884.0,954.0,1027.0,1152.0,1413.0,933.0,821.0,552.0,10326.0
Jamui,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Jamui,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,,3.0,3.0,3.0,3.0,,,,,,,-1.0
Jamui,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,960.0,1251.0,965.0,1063.0,1294.0,1125.0,1348.0,972.0,959.0,900.0,725.0,589.0,12151.0
Jamui,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,941.0,1182.0,781.0,942.0,929.0,1053.0,1285.0,953.0,241.0,412.0,181.0,210.0,9110.0
Jamui,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,800.0,1162.0,759.0,1194.0,1262.0,1032.0,1086.0,827.0,934.0,783.0,765.0,534.0,11138.0
Jamui,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1765.0,1646.0,2033.0,2167.0,2632.0,2271.0,2415.0,2404.0,3240.0,4083.0,2776.0,2402.0,29834.0
Jamui,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1760.0,2413.0,1724.0,2257.0,2556.0,2157.0,2434.0,1799.0,1893.0,1683.0,1490.0,1123.0,23289.0
Jamui,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2706.0,2828.0,2814.0,3109.0,3561.0,3324.0,3700.0,3357.0,3481.0,4495.0,2957.0,2612.0,38944.0
Jamui,14.10.2.a,Number of death cases of Inpatient males,TOTAL,12.0,3.0,6.0,13.0,11.0,10.0,17.0,0.0,7.0,10.0,8.0,8.0,105.0
Jamui,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,4.0,3.0,10.0,10.0,8.0,6.0,0.0,6.0,6.0,8.0,5.0,70.0
Jamui,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,16.0,7.0,9.0,23.0,21.0,18.0,23.0,0.0,13.0,16.0,16.0,13.0,175.0
Jamui,14.11,In-Patient Head Count at midnight,TOTAL,3087.0,3802.0,2453.0,2514.0,4193.0,3914.0,3590.0,3463.0,3270.0,3977.0,2817.0,3083.0,40163.0
Jamui,14.12.1,OPD attendance (All),TOTAL,85442.0,77256.0,79900.0,90991.0,94025.0,83299.0,79217.0,78136.0,66766.0,67675.0,67686.0,65173.0,935566.0
Jamui,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,113.0,60.0,44.0,97.0,92.0,148.0,131.0,521.0,984.0,1222.0,1344.0,1436.0,6192.0
Jamui,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,15.0,7.0,6.0,0.0,1.0,75.0,0.0,6.0,8.0,2.0,17.0,9.0,146.0
Jamui,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,987.0,826.0,970.0,1203.0,1075.0,1190.0,1246.0,1136.0,975.0,1208.0,1336.0,1077.0,13229.0
Jamui,14.14.a,Number of patients given AYUSH treatment,TOTAL,9426.0,8656.0,8868.0,9097.0,10207.0,10966.0,9327.0,7967.0,4428.0,7147.0,7795.0,7847.0,101731.0
Jamui,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1934.0,2158.0,2243.0,2006.0,1761.0,1566.0,1248.0,1183.0,838.0,904.0,1033.0,943.0,17817.0
Jamui,14.14.c,Number of Adolescents counselled,TOTAL,327.0,547.0,218.0,220.0,208.0,213.0,209.0,206.0,216.0,210.0,160.0,85.0,2819.0
Jamui,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1492.0,1123.0,1408.0,1494.0,1568.0,1447.0,1613.0,1557.0,1118.0,1607.0,2691.0,1995.0,19113.0
Jamui,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,159.0,88.0,112.0,156.0,92.0,45.0,55.0,49.0,35.0,32.0,30.0,9.0,862.0
Jamui,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,266.0,380.0,304.0,370.0,603.0,500.0,461.0,453.0,475.0,438.0,107.0,18.0,4375.0
Jamui,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,4.0,2.0,2.0,1.0,2.0,0.0,3.0,4.0,6.0,4.0,6.0,36.0
Jamui,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,252.0,276.0,336.0,982.0,122.0,143.0,99.0,163.0,137.0,139.0,98.0,81.0,2828.0
Jamui,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,5.0,6.0,7.0,2.0,27.0
Jamui,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,668.0,717.0,962.0,652.0,684.0,710.0,482.0,616.0,545.0,422.0,328.0,20.0,6806.0
Jamui,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,6.0
Jamui,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1186.0,1373.0,1602.0,2004.0,1409.0,1353.0,1042.0,1232.0,1157.0,999.0,533.0,119.0,14009.0
Jamui,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,6.0,3.0,3.0,4.0,4.0,1.0,3.0,9.0,12.0,11.0,9.0,69.0
Jamui,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,15.0,21.0,43.0
Jamui,15.3.a,Number of VDRL tests conducted on males,Number tested,84.0,68.0,51.0,61.0,61.0,70.0,65.0,85.0,91.0,110.0,101.0,91.0,938.0
Jamui,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,331.0,309.0,198.0,212.0,218.0,225.0,175.0,150.0,214.0,220.0,232.0,246.0,2730.0
Jamui,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,585.0,603.0,626.0,652.0,104.0,103.0,73.0,83.0,105.0,83.0,138.0,113.0,3268.0
Jamui,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1000.0,980.0,875.0,925.0,383.0,398.0,313.0,318.0,410.0,413.0,471.0,450.0,6936.0
Jamui,15.4.1,Number of blood smears examined for Malaria,TOTAL,524.0,380.0,404.0,485.0,642.0,223.0,249.0,224.0,303.0,278.0,280.0,357.0,4349.0
Jamui,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,21.0,6.0,12.0,20.0,29.0,5.0,10.0,9.0,10.0,5.0,13.0,19.0,159.0
Jamui,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,6.0,2.0,5.0,6.0,10.0,4.0,3.0,1.0,4.0,2.0,3.0,5.0,51.0
Jamui,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1215.0,1040.0,240.0,2115.0,1390.0,1225.0,1415.0,1665.0,1465.0,950.0,1200.0,1550.0,15470.0
Jamui,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2500.0,0.0,2500.0,2000.0,2000.0,800.0,2000.0,1200.0,1000.0,2250.0,800.0,1200.0,18250.0
Jamui,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2675.0,800.0,625.0,2725.0,2165.0,625.0,1750.0,1400.0,1515.0,2000.0,550.0,1400.0,18230.0
Jamui,16.1.1,Stock position of DPT vaccines,5. Total Stock,1040.0,240.0,2115.0,1390.0,1225.0,1400.0,1665.0,1465.0,950.0,1200.0,1450.0,1350.0,15490.0
Jamui,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,0.0,1300.0,1400.0,2700.0
Jamui,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,3650.0,600.0,0.0,4250.0
Jamui,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Jamui,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,2350.0,500.0,950.0,3800.0
Jamui,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1300.0,1400.0,450.0,3150.0
Jamui,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,0.0,200.0,750.0,50.0,500.0,150.0,75.0,25.0,0.0,125.0,250.0,2125.0
Jamui,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000.0,1250.0,1200.0,1300.0,2000.0,350.0,800.0,800.0,800.0,1400.0,1000.0,1600.0,13500.0
Jamui,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1000.0,1050.0,650.0,2000.0,1550.0,575.0,875.0,825.0,825.0,1275.0,875.0,1450.0,12950.0
Jamui,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,200.0,750.0,50.0,500.0,275.0,75.0,50.0,0.0,125.0,250.0,400.0,2675.0
Jamui,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1600.0,2325.0,1375.0,1725.0,625.0,1375.0,1275.0,3300.0,2275.0,2625.0,1775.0,2400.0,22675.0
Jamui,16.1.3,Stock position of TT vaccines,2. Stocks Received,2700.0,0.0,1000.0,2000.0,3000.0,500.0,3500.0,0.0,1000.0,800.0,1000.0,0.0,15500.0
Jamui,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1975.0,950.0,650.0,3100.0,2250.0,600.0,1475.0,1025.0,650.0,1650.0,375.0,900.0,15600.0
Jamui,16.1.3,Stock position of TT vaccines,5. Total Stock,2325.0,1375.0,1725.0,625.0,1375.0,1275.0,3300.0,2275.0,2625.0,1775.0,2400.0,1500.0,22575.0
Jamui,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
Jamui,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,0.0,,,,0.0
Jamui,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,0.0,,,,0.0
Jamui,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,0.0,,,,0.0
Jamui,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,350.0,150.0,800.0,1150.0,75.0,350.0,650.0,850.0,300.0,250.0,250.0,500.0,5675.0
Jamui,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,1000.0,1000.0,1000.0,1500.0,1000.0,1550.0,600.0,850.0,1400.0,800.0,1000.0,12700.0
Jamui,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1200.0,350.0,650.0,2075.0,1225.0,650.0,1350.0,1150.0,900.0,1400.0,550.0,1050.0,12550.0
Jamui,16.1.5,Stock position of BCG vaccines,5. Total Stock,150.0,800.0,1150.0,75.0,350.0,700.0,850.0,300.0,250.0,250.0,500.0,450.0,5825.0
Jamui,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1300.0,1225.0,475.0,1575.0,1350.0,1075.0,125.0,1050.0,0.0,100.0,300.0,350.0,8925.0
Jamui,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2500.0,500.0,2000.0,2000.0,1900.0,200.0,2100.0,1200.0,1300.0,1350.0,1000.0,2000.0,18050.0
Jamui,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2575.0,1250.0,900.0,2225.0,2175.0,1150.0,1175.0,1200.0,1200.0,1150.0,950.0,1850.0,17800.0
Jamui,16.1.6,Stock position of Measles vaccines,5. Total Stock,1225.0,475.0,1575.0,1350.0,1075.0,125.0,1050.0,1050.0,100.0,300.0,350.0,500.0,9175.0
Jamui,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,5200.0,1095.0,,,0.0,0.0,430.0,400.0,150.0,0.0,7275.0
Jamui,16.1.7,Stock position of JE vaccines,2. Stocks Received,,122600.0,0.0,0.0,,,0.0,750.0,2000.0,1200.0,500.0,2500.0,129550.0
Jamui,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,117400.0,4105.0,0.0,,,0.0,320.0,2030.0,1450.0,650.0,1480.0,127435.0
Jamui,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,5200.0,1095.0,1095.0,0.0,0.0,0.0,430.0,400.0,150.0,0.0,1020.0,9390.0
Jamui,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,100.0,410.0,800.0,1350.0,1050.0,1550.0,1400.0,3250.0,1950.0,1500.0,650.0,2050.0,16060.0
Jamui,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1980.0,1800.0,1600.0,2000.0,3000.0,500.0,4000.0,0.0,1000.0,900.0,2000.0,0.0,18780.0
Jamui,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1670.0,1410.0,1050.0,2300.0,1050.0,550.0,2150.0,1300.0,1450.0,1750.0,600.0,700.0,15980.0
Jamui,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,410.0,800.0,1350.0,1050.0,3000.0,1500.0,3250.0,1950.0,1500.0,650.0,2050.0,1350.0,18860.0
Jamui,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,3900.0,,,,,,,,3900.0
Jamui,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,0.0,,,,,,,,0.0
Jamui,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Jamui,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,2100.0,,,,,,,,2100.0
Jamui,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,1800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0
Jamui,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,98000.0,,,,,,1000.0,,99000.0
Jamui,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,0.0,,,,,,0.0,,0.0
Jamui,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,0.0,,0.0
Jamui,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,24000.0,,,,,,0.0,,24000.0
Jamui,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,74000.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,75000.0
Jamui,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,45000.0,,,,,,,,45000.0
Jamui,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,0.0,,,,,,,,0.0
Jamui,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Jamui,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,13000.0,,,,,,,,13000.0
Jamui,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,32000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32000.0
Jamui,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,27000.0,,,,,,4000.0,,31000.0
Jamui,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,0.0,,,,,,0.0,,0.0
Jamui,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,0.0,,0.0
Jamui,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,13000.0,,,,,,0.0,,13000.0
Jamui,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,14000.0,0.0,0.0,0.0,0.0,0.0,4000.0,0.0,18000.0
Jamui,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Jamui,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jamui,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jamui,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Jamui,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,52000.0,,,,,,,,,,,52000.0
Jamui,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Jamui,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Jamui,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,18000.0,,,,,,,,,,,18000.0
Jamui,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,34000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34000.0
Jamui,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,0.0,,,43800.0,,,,,400.0,400.0,,44600.0
Jamui,16.3.02,Stock Position of Gloves,2. Stocks Received,,54800.0,,,0.0,,,,,0.0,0.0,,54800.0
Jamui,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,,,0.0,,,,,0.0,0.0,,0.0
Jamui,16.3.02,Stock Position of Gloves,4. Stock Distributed,,17600.0,,,2800.0,,,,,0.0,0.0,,20400.0
Jamui,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,37200.0,0.0,0.0,41000.0,0.0,0.0,0.0,0.0,400.0,400.0,0.0,79000.0
Jamui,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Jamui,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Jamui,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Jamui,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Jamui,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Jamui,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Jamui,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Jamui,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Jamui,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Jamui,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Jamui,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Jamui,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Jamui,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Jamui,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Jamui,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Jamui,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Jamui,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,70000.0,2000.0,,72000.0
Jamui,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,0.0,0.0,,0.0
Jamui,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Jamui,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,58000.0,0.0,,58000.0
Jamui,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,2000.0,0.0,14000.0
Jamui,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,728.0,,,728.0
Jamui,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,0.0,,,0.0
Jamui,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Jamui,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,728.0,,,728.0
Jamui,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Jamui,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Jamui,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Jamui,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Jamui,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,36.0,,,1043.0,,,,,,,,1079.0
Jamui,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,,,0.0,,,,,,,,0.0
Jamui,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,,,0.0,,,,,,,,0.0
Jamui,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,10.0,,,0.0,,,,,,,,10.0
Jamui,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,26.0,0.0,0.0,1043.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1069.0
Jamui,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,0.0,,,5000.0,,,,,205100.0,218400.0,,428500.0
Jamui,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,100000.0,,,0.0,,,,,0.0,18400.0,,118400.0
Jamui,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,,,0.0,,,,,0.0,0.0,,0.0
Jamui,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,38000.0,,,1000.0,,,,,200000.0,0.0,,239000.0
Jamui,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,62000.0,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,5100.0,236800.0,0.0,307900.0
Jamui,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,11600.0,7400.0,13700.0,10400.0,5100.0,8300.0,5000.0,9300.0,5300.0,0.0,4600.0,2200.0,82900.0
Jamui,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,8000.0,0.0,0.0,16000.0,0.0,10000.0,0.0,0.0,12000.0,0.0,9000.0,55000.0
Jamui,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4200.0,1700.0,3300.0,5300.0,12800.0,2700.0,5700.0,4000.0,5300.0,7400.0,2400.0,5800.0,60600.0
Jamui,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,7400.0,13700.0,10400.0,5100.0,8300.0,5600.0,9300.0,5300.0,0.0,4600.0,2200.0,5400.0,77300.0
Jamui,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,66000.0,562000.0,166050.0,131050.0,77050.0,35200.0,16000.0,81600.0,58000.0,30200.0,13200.0,3600.0,1239950.0
Jamui,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,542000.0,226000.0,0.0,0.0,72000.0,0.0,86400.0,0.0,0.0,60000.0,0.0,90000.0,1076400.0
Jamui,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,46000.0,621950.0,35000.0,54000.0,113850.0,19200.0,20800.0,23600.0,27800.0,77000.0,9600.0,34200.0,1083000.0
Jamui,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,562000.0,166050.0,131050.0,77050.0,35200.0,16000.0,81600.0,58000.0,30200.0,13200.0,3600.0,59400.0,1233350.0
Jamui,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4000.0,139300.0,9365.0,7665.0,4665.0,6000.0,5300.0,11100.0,9100.0,6500.0,5300.0,3500.0,211795.0
Jamui,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,138000.0,4500.0,0.0,0.0,8000.0,0.0,7000.0,0.0,0.0,4000.0,0.0,6000.0,167500.0
Jamui,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamui,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2700.0,134435.0,1700.0,3000.0,6665.0,700.0,1200.0,2000.0,2600.0,5200.0,1800.0,3900.0,165900.0
Jamui,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,139300.0,9365.0,7665.0,4665.0,6000.0,5300.0,11100.0,9100.0,6500.0,5300.0,3500.0,5600.0,213395.0
Jamui,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Jamui,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jamui,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jamui,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Jamui,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jamui,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jamui,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Jamui,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jamui,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jamui,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Jamui,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jamui,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jamui,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Jamui,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jamui,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamui,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Jamui,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jamui,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamui,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Jamui,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jamui,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamui,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Jamui,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jamui,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamui,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Jamui,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Jamui,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamui,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Jamui,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Jamui,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Jamui,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Jamui,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Jamui,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Jamui,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Jamui,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Jamui,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Jamui,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Jamui,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Jamui,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Jamui,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Jamui,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Jamui,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Jamui,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Jamui,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Jamui,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Jamui,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Jamui,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Jamui,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Jamui,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Jamui,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Jamui,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Jamui,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Jamui,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Jamui,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Jamui,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Jamui,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Jamui,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Jamui,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Jamui,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Jamui,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Jamui,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Jamui,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Jamui,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Jehanabad,1.1,Total number of pregnant women Registered for ANC,TOTAL,2664.0,2697.0,2775.0,2541.0,2130.0,1943.0,1520.0,1451.0,1679.0,1790.0,2108.0,2179.0,25477.0
Jehanabad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1767.0,1821.0,1879.0,1766.0,1449.0,1272.0,1061.0,988.0,1233.0,1180.0,1333.0,1278.0,17027.0
Jehanabad,1.2,Number of Pregnant women registered under JSY,TOTAL,2664.0,2697.0,2775.0,2541.0,2122.0,1931.0,1520.0,1451.0,1689.0,1790.0,2108.0,2171.0,25459.0
Jehanabad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1975.0,2195.0,2229.0,2256.0,2334.0,2389.0,2224.0,2015.0,1800.0,1365.0,1435.0,1522.0,23739.0
Jehanabad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1991.0,2138.0,1999.0,1924.0,1684.0,1485.0,1153.0,1137.0,1232.0,1397.0,1571.0,1600.0,19311.0
Jehanabad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2509.0,2601.0,2843.0,3249.0,2588.0,2254.0,1996.0,1484.0,1634.0,1531.0,1879.0,2113.0,26681.0
Jehanabad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1482.0,1857.0,1713.0,1831.0,2086.0,2264.0,1649.0,1228.0,1947.0,1416.0,1453.0,1440.0,20366.0
Jehanabad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,35.0,64.0,98.0,107.0,8.0,42.0,35.0,48.0,35.0,62.0,37.0,25.0,596.0
Jehanabad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,0.0,5.0,14.0,3.0,4.0,3.0,9.0,8.0,4.0,3.0,54.0
Jehanabad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,143.0,537.0,392.0,208.0,211.0,808.0,331.0,323.0,529.0,489.0,624.0,450.0,5045.0
Jehanabad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,29.0,4.0,4.0,9.0,12.0,2.0,0.0,60.0
Jehanabad,1.8,Number of pregnancy test kits used at SC level,TOTAL,89.0,92.0,81.0,110.0,1.0,52.0,1.0,55.0,139.0,157.0,59.0,291.0,1127.0
Jehanabad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,74.0,85.0,121.0,141.0,172.0,194.0,152.0,189.0,147.0,136.0,130.0,21.0,1562.0
Jehanabad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,80.0,18.0,18.0,26.0,21.0,47.0,78.0,70.0,50.0,76.0,65.0,73.0,622.0
Jehanabad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,154.0,103.0,139.0,167.0,193.0,241.0,230.0,259.0,197.0,212.0,195.0,94.0,2184.0
Jehanabad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,134.0,77.0,120.0,111.0,140.0,117.0,112.0,128.0,86.0,111.0,114.0,69.0,1319.0
Jehanabad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,4.0,1.0,3.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,2.0,14.0
Jehanabad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1093.0,1134.0,1056.0,1432.0,1831.0,1920.0,1948.0,1742.0,1726.0,1452.0,1138.0,899.0,17371.0
Jehanabad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,448.0,773.0,756.0,850.0,1362.0,1361.0,1179.0,1032.0,1221.0,954.0,776.0,551.0,11263.0
Jehanabad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,606.0,598.0,496.0,582.0,683.0,1015.0,379.0,3095.0,3012.0,3303.0,1961.0,1308.0,17038.0
Jehanabad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,114.0,335.0,486.0,982.0,609.0,302.0,333.0,2108.0,3319.0,2617.0,1331.0,2348.0,14884.0
Jehanabad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,0.0,,,,,,0.0
Jehanabad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Jehanabad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,0.0,,,,,,0.0
Jehanabad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Jehanabad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,22.0,19.0,13.0,6.0,11.0,30.0,18.0,22.0,13.0,14.0,17.0,2.0,187.0
Jehanabad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jehanabad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,22.0,19.0,14.0,6.0,11.0,30.0,18.0,22.0,13.0,14.0,17.0,2.0,188.0
Jehanabad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,0.0,,,,,,0.0
Jehanabad,4.1.1.a,Number of male live births,TOTAL,622.0,627.0,633.0,814.0,1040.0,1114.0,1088.0,1022.0,1035.0,857.0,706.0,499.0,10057.0
Jehanabad,4.1.1.b,Number of female live births,TOTAL,611.0,584.0,557.0,751.0,953.0,1002.0,1045.0,937.0,875.0,772.0,602.0,487.0,9176.0
Jehanabad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1233.0,1211.0,1190.0,1565.0,1993.0,2116.0,2133.0,1959.0,1910.0,1629.0,1308.0,986.0,19233.0
Jehanabad,4.1.2,Number of still births,TOTAL,18.0,21.0,23.0,51.0,36.0,35.0,35.0,40.0,27.0,37.0,16.0,5.0,344.0
Jehanabad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,12.0,8.0,8.0,0.0,4.0,0.0,1.0,0.0,0.0,4.0,0.0,9.0,46.0
Jehanabad,4.2.1,Number of Newborns weighed at birth,TOTAL,1130.0,1211.0,1171.0,1541.0,1986.0,2096.0,2127.0,1954.0,1921.0,1616.0,1300.0,949.0,19002.0
Jehanabad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,256.0,301.0,251.0,411.0,431.0,482.0,418.0,400.0,411.0,606.0,176.0,136.0,4279.0
Jehanabad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1106.0,1189.0,1131.0,1510.0,1955.0,1996.0,2044.0,1862.0,1868.0,1562.0,1281.0,888.0,18392.0
Jehanabad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,18.0,22.0,4.0,0.0,1.0,16.0,0.0,2.0,0.0,2.0,3.0,6.0,74.0
Jehanabad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,30.0,6.0,13.0,81.0,14.0,54.0,12.0,46.0,22.0,35.0,13.0,6.0,332.0
Jehanabad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jehanabad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,48.0,28.0,17.0,81.0,15.0,70.0,12.0,48.0,22.0,37.0,16.0,12.0,406.0
Jehanabad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,0.0,,,,,,0.0
Jehanabad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,104.0,186.0,419.0,353.0,825.0,393.0,255.0,67.0,22.0,122.0,17.0,35.0,2798.0
Jehanabad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,18.0,2.0,16.0,32.0,92.0,4.0,35.0,35.0,7.0,16.0,4.0,262.0
Jehanabad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,182.0,296.0,199.0,355.0,739.0,351.0,339.0,32.0,89.0,436.0,32.0,25.0,3075.0
Jehanabad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,5.0,7.0,24.0,0.0,14.0,6.0,5.0,4.0,2.0,5.0,4.0,0.0,76.0
Jehanabad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,865.0,594.0,882.0,1232.0,1541.0,1675.0,1454.0,1456.0,1369.0,1036.0,934.0,722.0,13760.0
Jehanabad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,659.0,700.0,586.0,607.0,681.0,558.0,994.0,705.0,817.0,946.0,632.0,752.0,8637.0
Jehanabad,6.3,PNC maternal complications attended,TOTAL,0.0,8.0,16.0,141.0,207.0,27.0,240.0,0.0,20.0,24.0,2.0,20.0,705.0
Jehanabad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Jehanabad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Jehanabad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,127.0,25.0,160.0,0.0,9.0,111.0,87.0,131.0,115.0,109.0,65.0,135.0,1074.0
Jehanabad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,101.0,34.0,121.0,0.0,17.0,88.0,87.0,147.0,156.0,119.0,263.0,111.0,1244.0
Jehanabad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,228.0,59.0,281.0,0.0,26.0,199.0,174.0,278.0,271.0,228.0,328.0,246.0,2318.0
Jehanabad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,2.0,1.0,2.0,1.0,0.0,0.0,1.0,2.0,0.0,10.0
Jehanabad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,4.0
Jehanabad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jehanabad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,0.0,0.0,2.0,1.0,4.0,1.0,0.0,0.0,1.0,2.0,1.0,14.0
Jehanabad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,0.0,,,,,,0.0
Jehanabad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jehanabad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,0.0,,,,,,0.0
Jehanabad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,116.0,119.0,112.0,121.0,101.0,231.0,155.0,282.0,472.0,429.0,395.0,195.0,2728.0
Jehanabad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,4.0,3.0,0.0,5.0,9.0,15.0,13.0,7.0,18.0,11.0,11.0,96.0
Jehanabad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,18.0,10.0,2.0,11.0,14.0,10.0,13.0,37.0,34.0,24.0,30.0,14.0,217.0
Jehanabad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jehanabad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,134.0,133.0,117.0,132.0,120.0,250.0,183.0,332.0,513.0,471.0,436.0,220.0,3041.0
Jehanabad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,619.0,619.0
Jehanabad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,10.0,1.0,18.0,0.0,0.0,4.0,0.0,2.0,0.0,0.0,0.0,2.0,37.0
Jehanabad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Jehanabad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,8.0,58.0,5.0,2.0,6.0,9.0,8.0,8.0,3.0,5.0,4.0,1.0,117.0
Jehanabad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jehanabad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,21.0,59.0,23.0,2.0,6.0,13.0,8.0,10.0,3.0,5.0,4.0,3.0,157.0
Jehanabad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,0.0,,,,,,0.0
Jehanabad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,334.0,253.0,266.0,336.0,184.0,254.0,265.0,219.0,367.0,251.0,202.0,253.0,3184.0
Jehanabad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,308.0,196.0,181.0,667.0,144.0,211.0,176.0,181.0,272.0,194.0,207.0,184.0,2921.0
Jehanabad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,0.0,1.0,0.0,1.0,2.0,0.0,,0.0,1.0,0.0,0.0,7.0
Jehanabad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,17.0,31.0,15.0,29.0,10.0,14.0,7.0,9.0,16.0,10.0,17.0,12.0,187.0
Jehanabad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jehanabad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,661.0,480.0,463.0,1032.0,339.0,481.0,448.0,409.0,655.0,456.0,426.0,449.0,6299.0
Jehanabad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,55.0,25.0,67.0,184.0,54.0,75.0,43.0,91.0,105.0,105.0,130.0,95.0,1029.0
Jehanabad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,0.0,,,,,,0.0
Jehanabad,9.06,Number of IUCD removals,TOTAL,135.0,111.0,138.0,219.0,111.0,128.0,163.0,142.0,141.0,114.0,125.0,104.0,1631.0
Jehanabad,9.07,Number of Oral Pills cycles distributed,TOTAL,1064.0,904.0,992.0,1724.0,1091.0,1034.0,1113.0,1023.0,1354.0,1421.0,1111.0,1059.0,13890.0
Jehanabad,9.08,Number of Condom pieces distributed,TOTAL,7218.0,11171.0,7413.0,14148.0,8064.0,8611.0,8403.0,7807.0,7261.0,6805.0,7667.0,7032.0,101600.0
Jehanabad,9.09,Number of Centchroman (weekly) pills given,TOTAL,1.0,0.0,15.0,46.0,0.0,0.0,34.0,0.0,100.0,0.0,22.0,1.0,219.0
Jehanabad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,378.0,213.0,228.0,348.0,186.0,150.0,97.0,152.0,153.0,129.0,148.0,154.0,2336.0
Jehanabad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,6.0
Jehanabad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Jehanabad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,2.0,,,,,,-1.0
Jehanabad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1631.0,1739.0,1634.0,2015.0,2475.0,2999.0,2905.0,2786.0,2556.0,2351.0,2005.0,1694.0,26790.0
Jehanabad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1955.0,1765.0,1699.0,1807.0,1708.0,2073.0,2398.0,2908.0,2871.0,485.0,135.0,11.0,19815.0
Jehanabad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2554.0,2107.0,1648.0,1880.0,1859.0,1774.0,1935.0,2240.0,2958.0,2696.0,881.0,187.0,22719.0
Jehanabad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2965.0,2614.0,2022.0,1965.0,1875.0,1874.0,1796.0,1882.0,2272.0,2617.0,2364.0,1138.0,25384.0
Jehanabad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2169.0,2336.0,2194.0,6699.0
Jehanabad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1574.0,2377.0,3951.0
Jehanabad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,23.0,1365.0,1390.0
Jehanabad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1290.0,1417.0,1313.0,1716.0,2158.0,2408.0,2329.0,1888.0,2073.0,1858.0,1567.0,1317.0,21334.0
Jehanabad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1946.0,1768.0,1692.0,1791.0,1714.0,2074.0,2294.0,2663.0,2781.0,2601.0,2308.0,2177.0,25809.0
Jehanabad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2554.0,2112.0,1654.0,1863.0,1843.0,1778.0,1871.0,2098.0,2851.0,2704.0,2317.0,2524.0,26169.0
Jehanabad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2954.0,2603.0,2012.0,1967.0,1853.0,1875.0,1744.0,1720.0,2205.0,2555.0,2345.0,2388.0,26221.0
Jehanabad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,810.0,948.0,862.0,1143.0,1346.0,1325.0,1429.0,1361.0,1425.0,1181.0,895.0,803.0,13528.0
Jehanabad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1957.0,1766.0,1681.0,1769.0,1716.0,2076.0,2348.0,2910.0,2863.0,513.0,24.0,4.0,19627.0
Jehanabad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2542.0,2101.0,1649.0,1848.0,1851.0,1780.0,1951.0,2234.0,2935.0,2703.0,812.0,180.0,22586.0
Jehanabad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2970.0,2587.0,1990.0,1980.0,1846.0,1874.0,1848.0,1891.0,2257.0,2603.0,2364.0,1076.0,25286.0
Jehanabad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1703.0,2084.0,2254.0,2791.0,2690.0,2765.0,2165.0,2279.0,1370.0,1782.0,1531.0,597.0,24011.0
Jehanabad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2482.0,2088.0,1808.0,1500.0,1415.0,1134.0,1086.0,1360.0,1241.0,1502.0,1889.0,932.0,18437.0
Jehanabad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1375.0,1524.0,1659.0,1929.0,2055.0,1476.0,1614.0,1966.0,1453.0,1519.0,1389.0,1055.0,19014.0
Jehanabad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,929.0,1002.0,1144.0,1428.0,1375.0,1325.0,1117.0,1088.0,660.0,870.0,768.0,315.0,12021.0
Jehanabad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,754.0,953.0,1026.0,1204.0,1267.0,1258.0,976.0,1019.0,623.0,735.0,728.0,282.0,10825.0
Jehanabad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1683.0,1955.0,2170.0,2632.0,2642.0,2583.0,2093.0,2107.0,1283.0,1605.0,1496.0,597.0,22846.0
Jehanabad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2528.0,2078.0,1828.0,1769.0,1525.0,1356.0,1387.0,1419.0,1523.0,1723.0,2011.0,1920.0,21067.0
Jehanabad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2527.0,2072.0,1822.0,1774.0,1524.0,1357.0,1331.0,1283.0,1491.0,1701.0,2000.0,1907.0,20789.0
Jehanabad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,23.0,236.0,228.0,0.0,16.0,0.0,0.0,0.0,12.0,0.0,515.0
Jehanabad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,352.0,302.0,397.0,369.0,52.0,32.0,57.0,40.0,46.0,100.0,168.0,63.0,1978.0
Jehanabad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,289.0,289.0,391.0,324.0,38.0,39.0,42.0,50.0,45.0,107.0,118.0,68.0,1800.0
Jehanabad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,641.0,591.0,788.0,693.0,90.0,71.0,99.0,90.0,91.0,207.0,286.0,131.0,3778.0
Jehanabad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,32.0,4.0,87.0,65.0,89.0,117.0,116.0,118.0,73.0,88.0,195.0,984.0
Jehanabad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,835.0,777.0,801.0,857.0,779.0,842.0,951.0,768.0,713.0,681.0,750.0,709.0,9463.0
Jehanabad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1257.0,1198.0,1323.0,1283.0,1232.0,1297.0,1507.0,1341.0,1240.0,1150.0,1101.0,1109.0,15038.0
Jehanabad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,7.0
Jehanabad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,2.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,16.0
Jehanabad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1664.0,1643.0,1366.0,1518.0,1411.0,1353.0,1387.0,1326.0,1462.0,1353.0,1286.0,1247.0,17016.0
Jehanabad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1664.0,1643.0,1365.0,1517.0,1410.0,1353.0,1386.0,1325.0,1450.0,1347.0,1274.0,1245.0,16979.0
Jehanabad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1438.0,1433.0,1183.0,1339.0,1189.0,1207.0,1164.0,1136.0,1241.0,976.0,1114.0,1011.0,14431.0
Jehanabad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2048.0,1643.0,1423.0,1269.0,1207.0,964.0,1062.0,1095.0,1354.0,1380.0,1812.0,1830.0,17087.0
Jehanabad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,454.0,380.0,373.0,1475.0,1483.0,1349.0,704.0,525.0,327.0,92.0,68.0,16.0,7246.0
Jehanabad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,75.0,10.0,28.0,144.0,52.0,23.0,73.0,24.0,37.0,0.0,0.0,10.0,476.0
Jehanabad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,6.0,0.0,0.0,113.0,0.0,0.0,18.0,0.0,0.0,0.0,0.0,0.0,137.0
Jehanabad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,6.0
Jehanabad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,45.0,16.0,0.0,0.0,0.0,40.0,0.0,0.0,3.0,104.0
Jehanabad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1031.0,1170.0,1499.0,673.0,1432.0,702.0,497.0,770.0,580.0,622.0,644.0,527.0,10147.0
Jehanabad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,7.0,0.0,11.0,0.0,0.0,11.0,11.0,12.0,52.0
Jehanabad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Jehanabad,13.1,Number of Patients operated for cataract,TOTAL,55.0,0.0,114.0,61.0,69.0,72.0,82.0,87.0,314.0,264.0,207.0,266.0,1591.0
Jehanabad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,55.0,0.0,114.0,61.0,69.0,72.0,82.0,87.0,314.0,264.0,207.0,266.0,1591.0
Jehanabad,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,76.0,0.0,0.0,0.0,0.0,76.0
Jehanabad,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,2.0,,,,,,-1.0
Jehanabad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Jehanabad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,666.0,771.0,780.0,835.0,761.0,761.0,688.0,762.0,766.0,762.0,688.0,762.0,-1.0
Jehanabad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,2.0,,,,,,-1.0
Jehanabad,14.05,Number of RKS meetings held during the month,TOTAL,10.0,12.0,13.0,10.0,9.0,8.0,7.0,5.0,6.0,8.0,9.0,7.0,104.0
Jehanabad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,2.0,,,,,,-1.0
Jehanabad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1013.0,1160.0,844.0,223.0,692.0,1182.0,966.0,934.0,752.0,1173.0,870.0,891.0,10700.0
Jehanabad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,2.0,,,,,,-1.0
Jehanabad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,2.0,2.0,2.0,2.0,,1.0,1.0,2.0,2.0,2.0,1.0,-1.0
Jehanabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,264.0,605.0,396.0,470.0,507.0,773.0,653.0,692.0,600.0,727.0,506.0,461.0,6654.0
Jehanabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,531.0,860.0,724.0,1126.0,1258.0,1064.0,1175.0,1220.0,1063.0,977.0,1179.0,1136.0,12313.0
Jehanabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,272.0,926.0,443.0,381.0,507.0,746.0,1813.0,701.0,712.0,640.0,445.0,378.0,7964.0
Jehanabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1005.0,1838.0,1915.0,2577.0,2793.0,3309.0,1635.0,2673.0,2573.0,2300.0,1837.0,1893.0,26348.0
Jehanabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,536.0,1531.0,839.0,851.0,1014.0,1519.0,2466.0,1393.0,1312.0,1367.0,951.0,839.0,14618.0
Jehanabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1536.0,2698.0,2639.0,3703.0,4051.0,4373.0,2810.0,3893.0,3636.0,3277.0,3016.0,3029.0,38661.0
Jehanabad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,4.0,2.0,0.0,1.0,1.0,0.0,2.0,2.0,266.0,2.0,0.0,0.0,280.0
Jehanabad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,7.0
Jehanabad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6.0,3.0,0.0,2.0,2.0,1.0,3.0,2.0,266.0,2.0,0.0,0.0,287.0
Jehanabad,14.11,In-Patient Head Count at midnight,TOTAL,4464.0,4325.0,4236.0,3926.0,4650.0,4665.0,4232.0,4025.0,4416.0,3672.0,3172.0,2802.0,48585.0
Jehanabad,14.12.1,OPD attendance (All),TOTAL,115175.0,113921.0,125658.0,147820.0,132322.0,151285.0,122281.0,140180.0,103202.0,98497.0,107190.0,91692.0,1449223.0
Jehanabad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,269.0,333.0,152.0,263.0,333.0,439.0,804.0,427.0,795.0,721.0,587.0,624.0,5747.0
Jehanabad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,24.0,48.0,19.0,0.0,54.0,60.0,0.0,43.0,0.0,30.0,7.0,285.0
Jehanabad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2749.0,2840.0,3879.0,4508.0,4683.0,5058.0,3683.0,3805.0,2880.0,3331.0,2944.0,2265.0,42625.0
Jehanabad,14.14.a,Number of patients given AYUSH treatment,TOTAL,31947.0,30452.0,29279.0,35744.0,33326.0,36377.0,24506.0,29729.0,20341.0,23841.0,25909.0,18945.0,340396.0
Jehanabad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2324.0,1660.0,2375.0,2195.0,1154.0,1141.0,1035.0,1235.0,1830.0,1647.0,1921.0,2411.0,20928.0
Jehanabad,14.14.c,Number of Adolescents counselled,TOTAL,0.0,57.0,79.0,69.0,241.0,22.0,28.0,34.0,39.0,174.0,43.0,562.0,1348.0
Jehanabad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,822.0,950.0,1640.0,1430.0,2358.0,1751.0,1415.0,1498.0,1462.0,1754.0,1657.0,1606.0,18343.0
Jehanabad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,156.0,20.0,7.0,32.0,58.0,54.0,26.0,17.0,139.0,49.0,18.0,12.0,588.0
Jehanabad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,574.0,360.0,423.0,875.0,534.0,770.0,513.0,597.0,374.0,474.0,475.0,519.0,6488.0
Jehanabad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,3.0,1.0,1.0,2.0,3.0,0.0,2.0,2.0,0.0,0.0,0.0,16.0
Jehanabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1098.0,317.0,257.0,379.0,298.0,325.0,204.0,283.0,589.0,289.0,316.0,98.0,4453.0
Jehanabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,2.0,0.0,3.0,2.0,5.0,0.0,1.0,0.0,1.0,0.0,0.0,17.0
Jehanabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,657.0,119.0,501.0,633.0,693.0,782.0,194.0,702.0,385.0,380.0,447.0,193.0,5686.0
Jehanabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Jehanabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2329.0,796.0,1181.0,1887.0,1525.0,1877.0,911.0,1582.0,1348.0,1143.0,1238.0,810.0,16627.0
Jehanabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,5.0,3.0,4.0,4.0,8.0,1.0,3.0,2.0,1.0,0.0,0.0,36.0
Jehanabad,15.2,Number of Widal tests conducted,Number tested,8.0,0.0,0.0,0.0,10.0,1687.0,18.0,22.0,110.0,125.0,79.0,85.0,2144.0
Jehanabad,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,2.0,12.0,3.0,6.0,1.0,12.0,7.0,10.0,32.0,85.0
Jehanabad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,20.0,0.0,4.0,3.0,9.0,0.0,2.0,31.0,69.0
Jehanabad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,17.0,2.0,17.0,0.0,1.0,0.0,1.0,6.0,44.0
Jehanabad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,2.0,49.0,5.0,27.0,4.0,22.0,7.0,13.0,69.0,198.0
Jehanabad,15.4.1,Number of blood smears examined for Malaria,TOTAL,31.0,38.0,44.0,43.0,66.0,148.0,175.0,69.0,155.0,39.0,47.0,49.0,904.0
Jehanabad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0,0.0,14.0
Jehanabad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Jehanabad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1650.0,1550.0,950.0,950.0,1350.0,2100.0,1050.0,1110.0,1200.0,350.0,250.0,700.0,13210.0
Jehanabad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1500.0,500.0,1250.0,1000.0,2000.0,0.0,1000.0,500.0,750.0,500.0,1000.0,1000.0,11000.0
Jehanabad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1600.0,1100.0,1250.0,600.0,1250.0,1050.0,950.0,400.0,1600.0,600.0,550.0,600.0,11550.0
Jehanabad,16.1.1,Stock position of DPT vaccines,5. Total Stock,1550.0,950.0,950.0,1350.0,2100.0,1050.0,1100.0,1210.0,350.0,250.0,700.0,1100.0,12660.0
Jehanabad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1335.0,1000.0,2335.0
Jehanabad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2150.0,0.0,850.0,3000.0
Jehanabad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,815.0,335.0,1000.0,2150.0
Jehanabad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1335.0,1000.0,850.0,3185.0
Jehanabad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1555.0,1000.0,650.0,300.0,350.0,625.0,125.0,135.0,125.0,50.0,125.0,225.0,5265.0
Jehanabad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,500.0,500.0,500.0,700.0,1000.0,225.0,500.0,600.0,700.0,500.0,1000.0,1700.0,8425.0
Jehanabad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1055.0,850.0,500.0,650.0,725.0,725.0,490.0,610.0,775.0,425.0,900.0,775.0,8480.0
Jehanabad,16.1.2,Stock position of OPV vaccines,5. Total Stock,1000.0,650.0,650.0,350.0,625.0,125.0,135.0,125.0,50.0,125.0,225.0,1150.0,5210.0
Jehanabad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1750.0,2150.0,1150.0,1000.0,1150.0,1950.0,950.0,750.0,1050.0,300.0,400.0,800.0,13400.0
Jehanabad,16.1.3,Stock position of TT vaccines,2. Stocks Received,1500.0,,1000.0,1000.0,2000.0,0.0,1000.0,750.0,500.0,500.0,1000.0,1000.0,10250.0
Jehanabad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1100.0,1000.0,1150.0,850.0,1200.0,1000.0,1200.0,450.0,1250.0,400.0,600.0,800.0,11000.0
Jehanabad,16.1.3,Stock position of TT vaccines,5. Total Stock,2150.0,1150.0,1000.0,1150.0,1950.0,950.0,750.0,1050.0,300.0,400.0,800.0,1000.0,12650.0
Jehanabad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1150.0,1300.0,800.0,750.0,1150.0,690.0,900.0,400.0,200.0,75.0,220.0,70.0,7705.0
Jehanabad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,,500.0,0.0,300.0,1000.0,550.0,600.0,600.0,600.0,500.0,1300.0,6950.0
Jehanabad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,850.0,500.0,550.0,600.0,760.0,790.0,1050.0,800.0,725.0,455.0,650.0,520.0,8250.0
Jehanabad,16.1.5,Stock position of BCG vaccines,5. Total Stock,1300.0,800.0,750.0,150.0,690.0,900.0,400.0,200.0,75.0,220.0,70.0,850.0,6405.0
Jehanabad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1150.0,1450.0,950.0,1550.0,1650.0,480.0,300.0,250.0,50.0,50.0,120.0,30.0,8030.0
Jehanabad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,1000.0,2000.0,1500.0,400.0,750.0,800.0,1000.0,1200.0,1000.0,800.0,1550.0,14000.0
Jehanabad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1700.0,1500.0,1400.0,1400.0,1570.0,930.0,850.0,1200.0,1200.0,930.0,890.0,580.0,14150.0
Jehanabad,16.1.6,Stock position of Measles vaccines,5. Total Stock,1450.0,950.0,1550.0,1650.0,480.0,300.0,250.0,50.0,50.0,120.0,30.0,1000.0,7880.0
Jehanabad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,1150.0,1000.0,1050.0,1500.0,200.0,550.0,500.0,40.0,200.0,300.0,400.0,900.0,7790.0
Jehanabad,16.1.7,Stock position of JE vaccines,2. Stocks Received,2000.0,1500.0,1600.0,1200.0,900.0,1400.0,0.0,1500.0,2000.0,1000.0,1000.0,1300.0,15400.0
Jehanabad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2150.0,1450.0,1150.0,2500.0,550.0,1450.0,460.0,1340.0,1900.0,900.0,500.0,1000.0,15350.0
Jehanabad,16.1.7,Stock position of JE vaccines,5. Total Stock,1000.0,1050.0,1500.0,200.0,550.0,500.0,40.0,200.0,300.0,400.0,900.0,1200.0,7840.0
Jehanabad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,510.0,400.0,800.0,850.0,1300.0,1500.0,550.0,750.0,800.0,100.0,300.0,1000.0,8860.0
Jehanabad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000.0,1500.0,1500.0,1100.0,1200.0,0.0,1000.0,750.0,500.0,800.0,900.0,500.0,10750.0
Jehanabad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1110.0,1100.0,1450.0,650.0,1000.0,950.0,800.0,700.0,1200.0,600.0,700.0,1000.0,11260.0
Jehanabad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,400.0,800.0,850.0,1300.0,1500.0,550.0,750.0,800.0,100.0,300.0,500.0,500.0,8350.0
Jehanabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,50.0,50.0,500.0,500.0,50.0,1450.0,1300.0,700.0,100.0,100.0,100.0,50.0,4950.0
Jehanabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,1000.0,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,11330.0,16330.0
Jehanabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,550.0,0.0,450.0,2600.0,150.0,600.0,600.0,0.0,0.0,50.0,0.0,5000.0
Jehanabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,50.0,500.0,500.0,50.0,1450.0,1300.0,700.0,100.0,100.0,100.0,50.0,11380.0,16280.0
Jehanabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,20160.0,20160.0,15120.0,10080.0,10080.0,5040.0,5040.0,85680.0
Jehanabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,50000.0,0.0,0.0,0.0,0.0,0.0,0.0,93340.0,143340.0
Jehanabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,29840.0,0.0,5040.0,5040.0,0.0,5040.0,0.0,840.0,45800.0
Jehanabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,20160.0,20160.0,15120.0,10080.0,10080.0,5040.0,5040.0,97540.0,183220.0
Jehanabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,800.0,800.0,100.0,8700.0,8600.0,5400.0,2200.0,2200.0,2200.0,2100.0,33100.0
Jehanabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,1000.0,0.0,0.0,25000.0,0.0,0.0,0.0,0.0,0.0,0.0,18490.0,44490.0
Jehanabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,200.0,0.0,700.0,16400.0,100.0,3200.0,3200.0,0.0,0.0,100.0,200.0,24100.0
Jehanabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,800.0,800.0,100.0,8700.0,8600.0,5400.0,2200.0,2200.0,2200.0,2100.0,20390.0,53490.0
Jehanabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,300.0,300.0,0.0,0.0,0.0,1860.0,1860.0,1320.0,1080.0,1080.0,1080.0,1080.0,9960.0
Jehanabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,12660.0,18660.0
Jehanabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,300.0,0.0,0.0,4140.0,0.0,540.0,240.0,0.0,0.0,0.0,120.0,5340.0
Jehanabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,300.0,0.0,0.0,0.0,1860.0,1860.0,1320.0,1080.0,1080.0,1080.0,1080.0,13620.0,23280.0
Jehanabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,8100.0,4100.0,2000.0,8000.0,5900.0,5900.0,0.0,0.0,0.0,0.0,1700.0,1000.0,36700.0
Jehanabad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,0.0,0.0,10000.0
Jehanabad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,4000.0,2100.0,0.0,2100.0,0.0,5900.0,0.0,0.0,0.0,2300.0,700.0,0.0,17100.0
Jehanabad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,4100.0,2000.0,8000.0,5900.0,5900.0,0.0,0.0,0.0,0.0,1700.0,1000.0,1000.0,29600.0
Jehanabad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,11050.0,10050.0,9050.0,5550.0,5550.0,1550.0,50.0,0.0,0.0,0.0,11500.0,7000.0,61350.0
Jehanabad,16.3.02,Stock Position of Gloves,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,696.0,20000.0,0.0,200.0,20896.0
Jehanabad,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.02,Stock Position of Gloves,4. Stock Distributed,1000.0,1000.0,3500.0,0.0,4000.0,1500.0,50.0,0.0,696.0,8500.0,4500.0,1700.0,26446.0
Jehanabad,16.3.02,Stock Position of Gloves,5. Total Stock,10050.0,9050.0,5550.0,5550.0,1550.0,50.0,0.0,0.0,0.0,11500.0,7000.0,5500.0,55800.0
Jehanabad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,500.0,400.0,100.0,100.0,0.0,0.0,0.0,11500.0,7300.0,6300.0,5400.0,4000.0,35600.0
Jehanabad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,0.0,0.0,0.0,25000.0,0.0,0.0,0.0,0.0,0.0,25000.0
Jehanabad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,100.0,300.0,0.0,100.0,0.0,0.0,13500.0,4200.0,1000.0,900.0,1400.0,2400.0,23900.0
Jehanabad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,400.0,100.0,100.0,0.0,0.0,0.0,11500.0,7300.0,6300.0,5400.0,4000.0,1600.0,36700.0
Jehanabad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,105.0,105.0,105.0,55.0,55.0,55.0,55.0,0.0,0.0,25.0,25.0,25.0,610.0
Jehanabad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,50.0,0.0,0.0,0.0,50.0
Jehanabad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,50.0,0.0,0.0,55.0,55.0,0.0,25.0,0.0,0.0,0.0,185.0
Jehanabad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,105.0,105.0,55.0,55.0,55.0,0.0,0.0,0.0,25.0,25.0,25.0,25.0,475.0
Jehanabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,150000.0,110000.0,25200.0,5000.0,81000.0,25000.0,720000.0,625000.0,380000.0,300000.0,219800.0,219800.0,2860800.0
Jehanabad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,0.0,135000.0,0.0,1160000.0,5000.0,0.0,0.0,0.0,0.0,0.0,1300000.0
Jehanabad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,40000.0,84800.0,20200.0,59000.0,56000.0,465000.0,100000.0,245000.0,80000.0,80200.0,0.0,19800.0,1250000.0
Jehanabad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,110000.0,25200.0,5000.0,81000.0,25000.0,720000.0,625000.0,380000.0,300000.0,219800.0,219800.0,200000.0,2910800.0
Jehanabad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28656.0,0.0,80556.0,43256.0,36444.0,188912.0
Jehanabad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,0.0,0.0,0.0,0.0,64556.0,16000.0,80556.0,0.0,0.0,0.0,161112.0
Jehanabad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,0.0,0.0,0.0,0.0,35900.0,44656.0,0.0,37300.0,6812.0,10731.0,135399.0
Jehanabad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,28656.0,0.0,80556.0,43256.0,36444.0,25713.0,214625.0
Jehanabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,3048.0,3048.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6096.0
Jehanabad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,3048.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3048.0
Jehanabad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,0.0,3048.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3048.0
Jehanabad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,3048.0,3048.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6096.0
Jehanabad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,396.0,0.0,14500.0,3500.0,90900.0,68900.0,67900.0,62300.0,61300.0,59800.0,49800.0,61946.0,541242.0
Jehanabad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,100000.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,23558.0,0.0,133558.0
Jehanabad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,396.0,85500.0,0.0,0.0,22000.0,1000.0,5600.0,1000.0,1500.0,10000.0,11412.0,31548.0,169956.0
Jehanabad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,14500.0,14500.0,13500.0,68900.0,67900.0,62300.0,61300.0,59800.0,49800.0,61946.0,30398.0,504844.0
Jehanabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7600.0,9400.0,7600.0,8800.0,6800.0,7600.0,2400.0,1600.0,5100.0,6100.0,6700.0,6500.0,76200.0
Jehanabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,5000.0,,4000.0,0.0,4000.0,0.0,3000.0,6000.0,6000.0,3000.0,3000.0,5000.0,39000.0
Jehanabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3200.0,1800.0,2800.0,2000.0,3200.0,3200.0,3800.0,2500.0,5000.0,2400.0,3200.0,2000.0,35100.0
Jehanabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,9400.0,7600.0,8800.0,6800.0,7600.0,4400.0,1600.0,5100.0,6100.0,6700.0,6500.0,9500.0,80100.0
Jehanabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,26000.0,22000.0,46000.0,43000.0,24000.0,40400.0,11600.0,14400.0,12800.0,2800.0,4000.0,25400.0,272400.0
Jehanabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,48000.0,50000.0,30000.0,0.0,50000.0,0.0,30000.0,30000.0,30000.0,30000.0,50000.0,60000.0,408000.0
Jehanabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,52000.0,26000.0,33000.0,19000.0,33600.0,28800.0,27200.0,31600.0,40000.0,28800.0,28600.0,27400.0,376000.0
Jehanabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,22000.0,46000.0,43000.0,24000.0,40400.0,11600.0,14400.0,12800.0,2800.0,4000.0,25400.0,58000.0,304400.0
Jehanabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1900.0,1500.0,43400.0,54400.0,97900.0,82700.0,200.0,59750.0,49500.0,47900.0,30900.0,21800.0,491850.0
Jehanabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,3000.0,45000.0,15000.0,48000.0,3300.0,0.0,6000.0,4000.0,4000.0,4000.0,4000.0,4000.0,140300.0
Jehanabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jehanabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3400.0,3100.0,4000.0,4500.0,18500.0,19000.0,4000.0,14200.0,5600.0,21000.0,13100.0,6300.0,116700.0
Jehanabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1500.0,43400.0,54400.0,97900.0,82700.0,63700.0,2200.0,49550.0,47900.0,30900.0,21800.0,19500.0,515450.0
Jehanabad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Jehanabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jehanabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jehanabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Jehanabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jehanabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jehanabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Jehanabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jehanabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jehanabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Jehanabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jehanabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jehanabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Jehanabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jehanabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jehanabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Jehanabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jehanabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jehanabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Jehanabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jehanabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jehanabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Jehanabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jehanabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jehanabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Jehanabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Jehanabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Jehanabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Jehanabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Jehanabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Jehanabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Jehanabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Jehanabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,1.1,Total number of pregnant women Registered for ANC,TOTAL,3372.0,3874.0,3801.0,3463.0,3385.0,3301.0,2498.0,2382.0,2167.0,2239.0,3163.0,3601.0,37246.0
Kaimur Bhabua,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1556.0,1714.0,1708.0,1310.0,1107.0,1188.0,862.0,818.0,817.0,892.0,985.0,1288.0,14245.0
Kaimur Bhabua,1.2,Number of Pregnant women registered under JSY,TOTAL,3372.0,3874.0,3801.0,3463.0,3385.0,3301.0,2498.0,2382.0,2167.0,2239.0,3162.0,3601.0,37245.0
Kaimur Bhabua,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1322.0,1684.0,1692.0,1604.0,1663.0,1724.0,1508.0,1458.0,1430.0,1194.0,1215.0,1478.0,17972.0
Kaimur Bhabua,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2599.0,2747.0,2671.0,2496.0,2155.0,2124.0,1554.0,1510.0,1449.0,1368.0,2003.0,2312.0,24988.0
Kaimur Bhabua,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3260.0,3772.0,4135.0,3580.0,3535.0,3145.0,2910.0,2361.0,2174.0,1888.0,2302.0,3220.0,36282.0
Kaimur Bhabua,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,276.0,273.0,430.0,438.0,2562.0,1436.0,1171.0,337.0,990.0,832.0,726.0,690.0,10161.0
Kaimur Bhabua,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,67.0,34.0,247.0,292.0,102.0,92.0,282.0,31.0,37.0,53.0,34.0,28.0,1299.0
Kaimur Bhabua,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,9.0,2.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,16.0
Kaimur Bhabua,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,278.0,281.0,258.0,337.0,399.0,443.0,350.0,292.0,528.0,300.0,356.0,298.0,4120.0
Kaimur Bhabua,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,12.0,7.0,4.0,29.0,32.0,33.0,41.0,23.0,40.0,24.0,18.0,12.0,275.0
Kaimur Bhabua,1.8,Number of pregnancy test kits used at SC level,TOTAL,151.0,285.0,120.0,145.0,56.0,33.0,30.0,17.0,35.0,24.0,48.0,83.0,1027.0
Kaimur Bhabua,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,29.0,17.0,15.0,13.0,37.0,17.0,41.0,23.0,33.0,18.0,15.0,2.0,260.0
Kaimur Bhabua,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,147.0,164.0,144.0,189.0,201.0,189.0,191.0,292.0,244.0,173.0,203.0,125.0,2262.0
Kaimur Bhabua,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,176.0,181.0,159.0,202.0,238.0,206.0,232.0,315.0,277.0,191.0,218.0,127.0,2522.0
Kaimur Bhabua,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,176.0,146.0,152.0,202.0,234.0,206.0,229.0,315.0,277.0,191.0,218.0,126.0,2472.0
Kaimur Bhabua,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1515.0,1357.0,1431.0,1746.0,2333.0,2820.0,3002.0,2538.0,2204.0,1896.0,1613.0,1439.0,23894.0
Kaimur Bhabua,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1512.0,1355.0,1431.0,1744.0,2323.0,2820.0,3000.0,2528.0,2196.0,1886.0,1604.0,1436.0,23835.0
Kaimur Bhabua,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,669.0,365.0,1529.0,1238.0,1127.0,871.0,1.0,1345.0,2495.0,2536.0,2632.0,1598.0,16406.0
Kaimur Bhabua,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,666.0,122.0,998.0,423.0,1079.0,0.0,25.0,1156.0,2495.0,1061.0,1059.0,2778.0,11862.0
Kaimur Bhabua,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Kaimur Bhabua,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Kaimur Bhabua,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Kaimur Bhabua,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Kaimur Bhabua,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,3.0,2.0,0.0,2.0,10.0,0.0,2.0,10.0,5.0,10.0,9.0,4.0,57.0
Kaimur Bhabua,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kaimur Bhabua,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,3.0,2.0,0.0,2.0,10.0,0.0,2.0,10.0,5.0,10.0,9.0,4.0,57.0
Kaimur Bhabua,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Kaimur Bhabua,4.1.1.a,Number of male live births,TOTAL,876.0,883.0,785.0,999.0,1285.0,1474.0,1634.0,1426.0,1240.0,1052.0,935.0,797.0,13386.0
Kaimur Bhabua,4.1.1.b,Number of female live births,TOTAL,787.0,797.0,777.0,917.0,1225.0,1513.0,1571.0,1400.0,1221.0,1023.0,888.0,743.0,12862.0
Kaimur Bhabua,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1663.0,1680.0,1562.0,1916.0,2510.0,2987.0,3205.0,2826.0,2461.0,2075.0,1823.0,1540.0,26248.0
Kaimur Bhabua,4.1.2,Number of still births,TOTAL,34.0,26.0,29.0,32.0,46.0,41.0,39.0,27.0,37.0,16.0,12.0,26.0,365.0
Kaimur Bhabua,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,1.0,2.0,3.0,0.0,2.0,2.0,0.0,1.0,1.0,2.0,2.0,0.0,16.0
Kaimur Bhabua,4.2.1,Number of Newborns weighed at birth,TOTAL,1665.0,1673.0,1553.0,1926.0,2508.0,2987.0,3204.0,2826.0,2461.0,2075.0,1823.0,1540.0,26241.0
Kaimur Bhabua,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,160.0,120.0,122.0,165.0,190.0,257.0,231.0,133.0,207.0,141.0,105.0,126.0,1957.0
Kaimur Bhabua,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1662.0,1673.0,1562.0,1926.0,2508.0,2987.0,3204.0,2826.0,2456.0,2065.0,1814.0,1537.0,26220.0
Kaimur Bhabua,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,256.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,256.0
Kaimur Bhabua,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,6.0,3.0,2.0,10.0,0.0,10.0,15.0,,,,16.0,,62.0
Kaimur Bhabua,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kaimur Bhabua,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,6.0,3.0,2.0,10.0,256.0,10.0,15.0,0.0,0.0,0.0,16.0,0.0,318.0
Kaimur Bhabua,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Kaimur Bhabua,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,306.0,308.0,220.0,397.0,246.0,159.0,206.0,488.0,100.0,174.0,333.0,29.0,2966.0
Kaimur Bhabua,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,67.0,0.0,0.0,41.0,0.0,0.0,45.0,0.0,0.0,0.0,21.0,0.0,174.0
Kaimur Bhabua,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,254.0,385.0,212.0,480.0,351.0,307.0,343.0,422.0,10.0,24.0,103.0,29.0,2920.0
Kaimur Bhabua,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,8.0,3.0,1.0,3.0,1.0,0.0,7.0,9.0,13.0,4.0,7.0,8.0,64.0
Kaimur Bhabua,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1459.0,1333.0,1152.0,1370.0,1561.0,1262.0,3046.0,1334.0,1606.0,1927.0,1732.0,1368.0,19150.0
Kaimur Bhabua,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,690.0,468.0,677.0,769.0,1294.0,969.0,511.0,1583.0,1133.0,488.0,444.0,231.0,9257.0
Kaimur Bhabua,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,46.0,0.0,0.0,0.0,0.0,10.0,57.0
Kaimur Bhabua,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,360.0,15.0,0.0,0.0,375.0
Kaimur Bhabua,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,372.0,478.0,0.0,0.0,850.0
Kaimur Bhabua,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,732.0,493.0,0.0,0.0,1225.0
Kaimur Bhabua,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,118.0,0.0,0.0,0.0,118.0
Kaimur Bhabua,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,0.0,1.0,0.0,2.0,2.0,0.0,0.0,2.0,0.0,0.0,3.0,12.0
Kaimur Bhabua,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,2.0,,,,,,0.0,,0.0,0.0,0.0,2.0
Kaimur Bhabua,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.0,1.0,,,4.0
Kaimur Bhabua,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kaimur Bhabua,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,2.0,1.0,0.0,2.0,2.0,0.0,0.0,4.0,1.0,0.0,3.0,18.0
Kaimur Bhabua,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Kaimur Bhabua,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,16.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Kaimur Bhabua,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Kaimur Bhabua,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Kaimur Bhabua,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kaimur Bhabua,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,16.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Kaimur Bhabua,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Kaimur Bhabua,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,46.0,0.0,3.0,167.0,121.0,201.0,158.0,498.0,619.0,726.0,1014.0,364.0,3917.0
Kaimur Bhabua,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,10.0,157.0,,38.0,37.0,30.0,55.0,114.0,132.0,244.0,208.0,60.0,1085.0
Kaimur Bhabua,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,39.0,2.0,4.0,38.0,21.0,73.0,46.0,163.0,260.0,415.0,466.0,203.0,1730.0
Kaimur Bhabua,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kaimur Bhabua,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,95.0,159.0,7.0,243.0,179.0,304.0,259.0,775.0,1011.0,1385.0,1688.0,627.0,6732.0
Kaimur Bhabua,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,55.0,0.0,31.0,0.0,0.0,0.0,57.0,460.0,335.0,312.0,296.0,1278.0,2824.0
Kaimur Bhabua,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,,,,,,,0.0,,0.0,0.0,0.0,0.0
Kaimur Bhabua,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Kaimur Bhabua,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kaimur Bhabua,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Kaimur Bhabua,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,35.0,29.0,17.0,67.0,43.0,43.0,46.0,42.0,35.0,43.0,42.0,43.0,485.0
Kaimur Bhabua,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,210.0,21.0,56.0,106.0,75.0,305.0,141.0,42.0,123.0,59.0,63.0,164.0,1365.0
Kaimur Bhabua,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,7.0,109.0,4.0,,24.0,27.0,33.0,13.0,13.0,5.0,26.0,7.0,268.0
Kaimur Bhabua,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,28.0,110.0,103.0,86.0,37.0,34.0,18.0,23.0,69.0,6.0,77.0,124.0,715.0
Kaimur Bhabua,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kaimur Bhabua,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,280.0,269.0,180.0,259.0,179.0,409.0,238.0,120.0,240.0,113.0,208.0,338.0,2833.0
Kaimur Bhabua,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,2.0,6.0,9.0,121.0,10.0,79.0,60.0,0.0,97.0,0.0,115.0,77.0,576.0
Kaimur Bhabua,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,12.0,53.0,,,,,,21.0,,129.0,534.0,749.0
Kaimur Bhabua,9.06,Number of IUCD removals,TOTAL,23.0,42.0,77.0,36.0,82.0,37.0,71.0,19.0,30.0,160.0,22.0,19.0,618.0
Kaimur Bhabua,9.07,Number of Oral Pills cycles distributed,TOTAL,416.0,681.0,333.0,1048.0,962.0,429.0,869.0,1213.0,806.0,554.0,360.0,678.0,8349.0
Kaimur Bhabua,9.08,Number of Condom pieces distributed,TOTAL,3853.0,1247.0,2740.0,6253.0,2274.0,1783.0,2174.0,3516.0,3404.0,1313.0,3493.0,4696.0,36746.0
Kaimur Bhabua,9.09,Number of Centchroman (weekly) pills given,TOTAL,23.0,9.0,3.0,32.0,135.0,74.0,6.0,257.0,176.0,113.0,21.0,39.0,888.0
Kaimur Bhabua,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,135.0,96.0,97.0,111.0,322.0,314.0,318.0,188.0,414.0,317.0,336.0,209.0,2857.0
Kaimur Bhabua,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Kaimur Bhabua,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,1.0,,,,,,,-1.0
Kaimur Bhabua,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2364.0,2305.0,2268.0,2607.0,3028.0,3881.0,4085.0,4379.0,3719.0,3057.0,3255.0,2346.0,37294.0
Kaimur Bhabua,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2829.0,2396.0,2412.0,2467.0,2412.0,2746.0,3370.0,4207.0,4299.0,633.0,165.0,25.0,27961.0
Kaimur Bhabua,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3502.0,2892.0,2498.0,2556.0,2497.0,2440.0,2583.0,2908.0,3841.0,3816.0,1761.0,647.0,31941.0
Kaimur Bhabua,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3932.0,3658.0,2953.0,2747.0,2643.0,2582.0,2432.0,2507.0,2749.0,3283.0,3467.0,2408.0,35361.0
Kaimur Bhabua,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,52.0,0.0,1.0,0.0,0.0,0.0,0.0,3162.0,3456.0,3319.0,9990.0
Kaimur Bhabua,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,7.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,1787.0,3115.0,4915.0
Kaimur Bhabua,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,3.0,0.0,5.0,0.0,2.0,0.0,0.0,0.0,64.0,1243.0,1317.0
Kaimur Bhabua,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1252.0,1559.0,1174.0,1538.0,2124.0,2463.0,1553.0,1945.0,1801.0,1625.0,1566.0,1447.0,20047.0
Kaimur Bhabua,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2873.0,2379.0,2443.0,2449.0,2376.0,2672.0,1759.0,4397.0,4071.0,3756.0,3600.0,3410.0,36185.0
Kaimur Bhabua,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3622.0,2770.0,2524.0,2545.0,2464.0,2338.0,1345.0,2745.0,3647.0,3864.0,3384.0,3787.0,35035.0
Kaimur Bhabua,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3875.0,3544.0,2936.0,2718.0,2579.0,2481.0,1236.0,2366.0,2414.0,3177.0,3396.0,3587.0,34309.0
Kaimur Bhabua,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,901.0,1059.0,895.0,1118.0,1733.0,2172.0,2233.0,1770.0,1631.0,1498.0,1350.0,1023.0,17383.0
Kaimur Bhabua,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2777.0,2563.0,2390.0,2462.0,2426.0,2726.0,3230.0,4194.0,4311.0,729.0,200.0,63.0,28071.0
Kaimur Bhabua,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3512.0,2866.0,2583.0,2523.0,2474.0,2443.0,2564.0,2917.0,3858.0,3751.0,1734.0,814.0,32039.0
Kaimur Bhabua,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3838.0,3495.0,2931.0,2709.0,2617.0,2563.0,2417.0,2516.0,2765.0,3193.0,3246.0,2603.0,34893.0
Kaimur Bhabua,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2463.0,2952.0,3473.0,3892.0,3900.0,3530.0,3193.0,2933.0,2319.0,2030.0,2203.0,2104.0,34992.0
Kaimur Bhabua,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2788.0,2929.0,2780.0,2800.0,2185.0,2079.0,2072.0,2172.0,2487.0,2457.0,3309.0,3329.0,31387.0
Kaimur Bhabua,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Kaimur Bhabua,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1183.0,1490.0,1748.0,1899.0,1896.0,1850.0,1577.0,1563.0,1216.0,1159.0,1182.0,947.0,17710.0
Kaimur Bhabua,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1040.0,1315.0,1589.0,1945.0,1787.0,1587.0,1419.0,1395.0,1124.0,964.0,1043.0,839.0,16047.0
Kaimur Bhabua,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2223.0,2805.0,3337.0,3844.0,3683.0,3437.0,2996.0,2958.0,2340.0,2123.0,2225.0,1786.0,33757.0
Kaimur Bhabua,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3038.0,2933.0,2691.0,2698.0,2177.0,2108.0,1968.0,2198.0,2508.0,2550.0,3423.0,3347.0,31639.0
Kaimur Bhabua,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3120.0,2936.0,2691.0,2713.0,2164.0,2035.0,1496.0,2394.0,2363.0,2581.0,3410.0,3394.0,31297.0
Kaimur Bhabua,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,432.0,374.0,426.0,334.0,277.0,250.0,240.0,316.0,372.0,353.0,410.0,392.0,4176.0
Kaimur Bhabua,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,455.0,346.0,411.0,312.0,224.0,218.0,223.0,226.0,346.0,387.0,365.0,363.0,3876.0
Kaimur Bhabua,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,887.0,720.0,837.0,646.0,501.0,468.0,463.0,542.0,718.0,740.0,775.0,755.0,8052.0
Kaimur Bhabua,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,2.0,1.0,0.0,0.0,23.0,26.0,9.0,5.0,34.0,16.0,33.0,149.0
Kaimur Bhabua,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,286.0,242.0,292.0,332.0,283.0,347.0,298.0,266.0,305.0,324.0,306.0,305.0,3586.0
Kaimur Bhabua,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,417.0,406.0,402.0,474.0,529.0,529.0,528.0,418.0,479.0,504.0,512.0,469.0,5667.0
Kaimur Bhabua,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,19.0,6.0,7.0,22.0,0.0,2.0,1.0,0.0,9.0,66.0
Kaimur Bhabua,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,5.0,1.0,8.0,0.0,0.0,0.0,0.0,0.0,14.0
Kaimur Bhabua,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1612.0,1697.0,1622.0,1673.0,1639.0,1685.0,1698.0,1539.0,1656.0,1802.0,1568.0,1666.0,19857.0
Kaimur Bhabua,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1601.0,1695.0,1623.0,1672.0,1628.0,1583.0,1708.0,1513.0,1662.0,1784.0,1471.0,1642.0,19582.0
Kaimur Bhabua,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1494.0,1652.0,1457.0,1533.0,1568.0,1500.0,1551.0,1437.0,1594.0,1548.0,1375.0,1359.0,18068.0
Kaimur Bhabua,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kaimur Bhabua,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,46.0,0.0,62.0,24402.0,124.0,11.0,4.0,4.0,0.0,0.0,25.0,0.0,24678.0
Kaimur Bhabua,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,34.0,0.0,9.0,13912.0,309.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14264.0
Kaimur Bhabua,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,9.0,17029.0,38.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17076.0
Kaimur Bhabua,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Kaimur Bhabua,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,12.0,15.0,20.0,2.0,27.0,10.0,12.0,12.0,3.0,6.0,3.0,124.0
Kaimur Bhabua,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,203.0,199.0,275.0,262.0,237.0,240.0,204.0,130.0,159.0,169.0,56.0,60.0,2194.0
Kaimur Bhabua,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,11.0,10.0,18.0,1.0,0.0,0.0,3.0,0.0,9.0,10.0,62.0
Kaimur Bhabua,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kaimur Bhabua,13.1,Number of Patients operated for cataract,TOTAL,28.0,333.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,102.0,515.0,670.0,1668.0
Kaimur Bhabua,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,28.0,333.0,0.0,0.0,0.0,0.0,0.0,0.0,135.0,0.0,435.0,356.0,1287.0
Kaimur Bhabua,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Kaimur Bhabua,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Kaimur Bhabua,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Kaimur Bhabua,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,1.0,,,,,,,-1.0
Kaimur Bhabua,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1037.0,1032.0,1085.0,1136.0,1164.0,1123.0,1109.0,1122.0,1100.0,1105.0,1063.0,1091.0,-1.0
Kaimur Bhabua,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Kaimur Bhabua,14.05,Number of RKS meetings held during the month,TOTAL,4.0,7.0,5.0,6.0,4.0,3.0,3.0,2.0,6.0,5.0,5.0,4.0,54.0
Kaimur Bhabua,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,1.0,,,,,,,-1.0
Kaimur Bhabua,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,87.0,79.0,16.0,96.0,118.0,230.0,161.0,64.0,79.0,111.0,136.0,141.0,1318.0
Kaimur Bhabua,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Kaimur Bhabua,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Kaimur Bhabua,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,56.0,60.0,66.0,82.0,143.0,143.0,179.0,162.0,74.0,122.0,176.0,167.0,1430.0
Kaimur Bhabua,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,743.0,234.0,295.0,246.0,363.0,258.0,304.0,325.0,572.0,670.0,428.0,492.0,4930.0
Kaimur Bhabua,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,60.0,65.0,229.0,95.0,157.0,150.0,144.0,127.0,162.0,122.0,175.0,194.0,1680.0
Kaimur Bhabua,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3404.0,4352.0,4221.0,4881.0,3774.0,4558.0,5033.0,3452.0,3255.0,3238.0,2733.0,2142.0,45043.0
Kaimur Bhabua,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,116.0,125.0,295.0,177.0,300.0,293.0,323.0,289.0,236.0,244.0,351.0,361.0,3110.0
Kaimur Bhabua,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4147.0,4586.0,4516.0,5127.0,4137.0,4816.0,5337.0,3777.0,3827.0,3908.0,3161.0,2634.0,49973.0
Kaimur Bhabua,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,4.0,0.0,0.0,6.0
Kaimur Bhabua,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Kaimur Bhabua,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,4.0,0.0,0.0,7.0
Kaimur Bhabua,14.11,In-Patient Head Count at midnight,TOTAL,4916.0,5411.0,4250.0,4594.0,5011.0,5932.0,6561.0,5778.0,6228.0,5544.0,5033.0,4142.0,63400.0
Kaimur Bhabua,14.12.1,OPD attendance (All),TOTAL,79499.0,77236.0,88947.0,104964.0,107211.0,121368.0,92807.0,105766.0,77910.0,80290.0,83057.0,84880.0,1103935.0
Kaimur Bhabua,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,18.0,11.0,4.0,4.0,22.0,3.0,9.0,15.0,143.0,330.0,13.0,9.0,581.0
Kaimur Bhabua,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,229.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,232.0
Kaimur Bhabua,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1800.0,1600.0,1108.0,1070.0,1452.0,1672.0,1402.0,1788.0,1223.0,1279.0,2155.0,1534.0,18083.0
Kaimur Bhabua,14.14.a,Number of patients given AYUSH treatment,TOTAL,30565.0,17895.0,23272.0,31801.0,33204.0,41469.0,31760.0,39890.0,18582.0,29510.0,29276.0,24275.0,351499.0
Kaimur Bhabua,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1820.0,2542.0,865.0,1490.0,1389.0,1138.0,1338.0,2434.0,1020.0,1057.0,1211.0,553.0,16857.0
Kaimur Bhabua,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,822.0,0.0,0.0,822.0
Kaimur Bhabua,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,608.0,766.0,18.0,665.0,150.0,849.0,643.0,601.0,551.0,179.0,610.0,379.0,6019.0
Kaimur Bhabua,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,13.0,21.0,17.0,51.0,5.0,43.0,51.0,93.0,42.0,0.0,16.0,14.0,366.0
Kaimur Bhabua,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,219.0,523.0,485.0,373.0,174.0,68.0,519.0,223.0,397.0,434.0,159.0,494.0,4068.0
Kaimur Bhabua,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,0.0,4.0,1.0,1.0,0.0,1.0,1.0,0.0,7.0,1.0,7.0,26.0
Kaimur Bhabua,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,112.0,196.0,248.0,116.0,67.0,12.0,434.0,101.0,276.0,168.0,207.0,143.0,2080.0
Kaimur Bhabua,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,0.0,1.0,0.0,0.0,2.0,3.0,2.0,3.0,3.0,2.0,18.0
Kaimur Bhabua,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,465.0,417.0,451.0,465.0,258.0,23.0,88.0,410.0,426.0,358.0,472.0,426.0,4259.0
Kaimur Bhabua,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Kaimur Bhabua,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,796.0,1136.0,1184.0,954.0,499.0,103.0,1041.0,734.0,1099.0,960.0,838.0,1063.0,10407.0
Kaimur Bhabua,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,1.0,6.0,2.0,1.0,0.0,3.0,4.0,2.0,10.0,4.0,10.0,47.0
Kaimur Bhabua,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,56.0,326.0,207.0,0.0,0.0,16.0,92.0,0.0,697.0
Kaimur Bhabua,15.3.a,Number of VDRL tests conducted on males,Number tested,6.0,10.0,1.0,0.0,7.0,11.0,6.0,0.0,0.0,0.0,0.0,0.0,41.0
Kaimur Bhabua,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,60.0,118.0,9.0,0.0,11.0,50.0,45.0,43.0,61.0,51.0,56.0,78.0,582.0
Kaimur Bhabua,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,110.0,157.0,13.0,0.0,16.0,176.0,65.0,81.0,87.0,80.0,87.0,102.0,974.0
Kaimur Bhabua,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,176.0,285.0,23.0,0.0,34.0,237.0,116.0,124.0,148.0,131.0,143.0,180.0,1597.0
Kaimur Bhabua,15.4.1,Number of blood smears examined for Malaria,TOTAL,64.0,154.0,66.0,172.0,54.0,435.0,237.0,150.0,41.0,19.0,80.0,133.0,1605.0
Kaimur Bhabua,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,5.0,4.0,6.0,1.0,5.0,5.0,0.0,0.0,0.0,0.0,0.0,28.0
Kaimur Bhabua,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,2.0,2.0,4.0,0.0,3.0,4.0,0.0,0.0,0.0,0.0,0.0,17.0
Kaimur Bhabua,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,9675.0,92840.0,7850.0,8750.0,5800.0,10800.0,10050.0,2000.0,11950.0,9700.0,7400.0,10500.0,187315.0
Kaimur Bhabua,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,4000.0,2000.0,0.0,2000.0,1500.0,11500.0
Kaimur Bhabua,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3475.0,3400.0,3250.0,750.0,3400.0,3500.0,4800.0,1900.0,2000.0,4550.0,3500.0,3700.0,38225.0
Kaimur Bhabua,16.1.1,Stock position of DPT vaccines,5. Total Stock,6200.0,89440.0,4600.0,8000.0,2400.0,9300.0,5250.0,4100.0,11950.0,5150.0,5900.0,8300.0,160590.0
Kaimur Bhabua,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,0.0,500.0
Kaimur Bhabua,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,0.0,900.0,1400.0
Kaimur Bhabua,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,250.0,276.0,700.0,1226.0
Kaimur Bhabua,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,250.0,224.0,200.0,674.0
Kaimur Bhabua,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1200.0,301200.0,1100.0,1450.0,1200.0,600.0,0.0,200.0,500.0,0.0,1200.0,1400.0,310050.0
Kaimur Bhabua,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,600.0,0.0,500.0,500.0,2000.0,5600.0
Kaimur Bhabua,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,970.0,960.0,900.0,1025.0,900.0,600.0,1400.0,700.0,500.0,500.0,1400.0,1350.0,11205.0
Kaimur Bhabua,16.1.2,Stock position of OPV vaccines,5. Total Stock,230.0,300240.0,200.0,425.0,300.0,0.0,600.0,100.0,0.0,0.0,300.0,2050.0,304445.0
Kaimur Bhabua,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,5670.0,5670.0,5600.0,6820.0,6700.0,52300.0,5200.0,800.0,7800.0,6800.0,5400.0,5400.0,114160.0
Kaimur Bhabua,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0,2000.0,2000.0,0.0,500.0,1500.0,10000.0
Kaimur Bhabua,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.3,Stock position of TT vaccines,4. Stock Distributed,3700.0,23040.0,2240.0,900.0,3100.0,2300.0,3200.0,1400.0,2000.0,3500.0,3500.0,3524.0,52404.0
Kaimur Bhabua,16.1.3,Stock position of TT vaccines,5. Total Stock,1970.0,-17370.0,3360.0,5920.0,3600.0,52000.0,4000.0,1400.0,7800.0,3300.0,2400.0,3376.0,71756.0
Kaimur Bhabua,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1000.0,1000.0,1450.0,2500.0,900.0,1200.0,200.0,1000.0,2250.0,1500.0,200.0,500.0,13700.0
Kaimur Bhabua,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,400.0,900.0,500.0,500.0,500.0,500.0,1500.0,4800.0
Kaimur Bhabua,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,900.0,900.0,1180.0,1750.0,890.0,1300.0,800.0,1200.0,500.0,1400.0,700.0,1200.0,12720.0
Kaimur Bhabua,16.1.5,Stock position of BCG vaccines,5. Total Stock,100.0,100.0,270.0,750.0,10.0,300.0,300.0,300.0,2250.0,600.0,0.0,800.0,5780.0
Kaimur Bhabua,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4500.0,4525.0,4250.0,5650.0,2280.0,2800.0,2250.0,1700.0,2500.0,0.0,0.0,200.0,30655.0
Kaimur Bhabua,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,4000.0,3400.0,3500.0,0.0,900.0,3500.0,2000.0,17300.0
Kaimur Bhabua,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2300.0,1860.0,1890.0,3800.0,1287.0,2600.0,2800.0,2200.0,2500.0,900.0,3000.0,1800.0,26937.0
Kaimur Bhabua,16.1.6,Stock position of Measles vaccines,5. Total Stock,2200.0,2665.0,2360.0,1850.0,993.0,4200.0,2850.0,3000.0,0.0,0.0,500.0,400.0,21018.0
Kaimur Bhabua,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,900.0,1690.0,1500.0,2200.0,1490.0,1200.0,200.0,250.0,3400.0,1400.0,500.0,900.0,15630.0
Kaimur Bhabua,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,1500.0,2000.0,3000.0,1500.0,500.0,1500.0,2000.0,12000.0
Kaimur Bhabua,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,850.0,1130.0,1200.0,950.0,1230.0,1600.0,1800.0,1800.0,1500.0,900.0,1800.0,1800.0,16560.0
Kaimur Bhabua,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,50.0,560.0,300.0,1250.0,260.0,1100.0,400.0,1450.0,3400.0,1000.0,200.0,1100.0,11070.0
Kaimur Bhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Kaimur Bhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Kaimur Bhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.02,Stock Position of Gloves,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1400.0,16700.0,1400.0,10200.0,7200.0,10100.0,5800.0,1700.0,10500.0,11200.0,4000.0,1500.0,81700.0
Kaimur Bhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,10000.0,0.0,0.0,800.0,0.0,0.0,0.0,9600.0,3500.0,0.0,0.0,7500.0,31400.0
Kaimur Bhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5600.0,4000.0,3500.0,3600.0,3400.0,3500.0,3200.0,2300.0,3500.0,3500.0,3500.0,3500.0,43100.0
Kaimur Bhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5800.0,12700.0,-2100.0,7400.0,3800.0,6600.0,2600.0,9000.0,10500.0,7700.0,500.0,5500.0,70000.0
Kaimur Bhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,23000.0,92000.0,59000.0,0.0,59860.0,100800.0,69000.0,5800.0,108000.0,97800.0,100080.0,100082.0,815422.0
Kaimur Bhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,90000.0,0.0,0.0,108000.0,0.0,0.0,0.0,180000.0,0.0,0.0,0.0,0.0,378000.0
Kaimur Bhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,34000.0,34000.0,23500.0,45800.0,23670.0,39000.0,48000.0,38000.0,35000.0,42300.0,57000.0,5700.0,425970.0
Kaimur Bhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,79000.0,58000.0,35500.0,62200.0,36190.0,61800.0,21000.0,147800.0,73000.0,55500.0,43080.0,94382.0,767452.0
Kaimur Bhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,100.0,1700.0,100.0,0.0,100.0,4000.0,1700.0,100.0,1800.0,1500.0,1200.0,0.0,12300.0
Kaimur Bhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,0.0,0.0,4000.0,0.0,0.0,0.0,3500.0,0.0,0.0,0.0,1500.0,13000.0
Kaimur Bhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kaimur Bhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1700.0,1500.0,100.0,4000.0,100.0,2300.0,1500.0,1400.0,1800.0,1500.0,900.0,1300.0,18100.0
Kaimur Bhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2400.0,200.0,0.0,0.0,0.0,1700.0,200.0,2200.0,0.0,0.0,300.0,200.0,7200.0
Kaimur Bhabua,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Kaimur Bhabua,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kaimur Bhabua,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kaimur Bhabua,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kaimur Bhabua,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kaimur Bhabua,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kaimur Bhabua,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kaimur Bhabua,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kaimur Bhabua,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kaimur Bhabua,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kaimur Bhabua,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kaimur Bhabua,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kaimur Bhabua,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kaimur Bhabua,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kaimur Bhabua,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kaimur Bhabua,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kaimur Bhabua,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kaimur Bhabua,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Kaimur Bhabua,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Kaimur Bhabua,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Kaimur Bhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Katihar,1.1,Total number of pregnant women Registered for ANC,TOTAL,8472.0,7872.0,7482.0,6735.0,7871.0,7564.0,5251.0,7039.0,5981.0,6313.0,8153.0,9002.0,87735.0
Katihar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4489.0,3907.0,3774.0,3630.0,3507.0,3875.0,2639.0,3317.0,3515.0,4300.0,5158.0,5681.0,47792.0
Katihar,1.2,Number of Pregnant women registered under JSY,TOTAL,8410.0,7875.0,7453.0,6708.0,7871.0,7564.0,5241.0,7039.0,5981.0,6313.0,8153.0,9002.0,87610.0
Katihar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4579.0,4708.0,4863.0,5038.0,4921.0,5599.0,3825.0,4760.0,4333.0,4040.0,4961.0,5319.0,56946.0
Katihar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6908.0,6396.0,5931.0,5584.0,5999.0,5594.0,3165.0,4462.0,3942.0,4575.0,5516.0,6015.0,64087.0
Katihar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6750.0,7653.0,7211.0,6405.0,7390.0,8675.0,5057.0,6123.0,5307.0,4938.0,5649.0,6744.0,77902.0
Katihar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6244.0,7878.0,5690.0,4900.0,5433.0,4138.0,2759.0,2887.0,2614.0,4475.0,6129.0,5655.0,58802.0
Katihar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,219.0,83.0,494.0,70.0,54.0,196.0,218.0,197.0,195.0,149.0,52.0,37.0,1964.0
Katihar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,8.0,4.0,0.0,2.0,6.0,3.0,0.0,2.0,3.0,28.0
Katihar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,984.0,989.0,1984.0,1934.0,856.0,1284.0,784.0,911.0,978.0,1100.0,1217.0,1139.0,14160.0
Katihar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,30.0,37.0,16.0,13.0,27.0,14.0,12.0,0.0,0.0,9.0,158.0
Katihar,1.8,Number of pregnancy test kits used at SC level,TOTAL,269.0,238.0,133.0,145.0,127.0,178.0,321.0,726.0,751.0,1163.0,1534.0,1630.0,7215.0
Katihar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,445.0,341.0,325.0,293.0,407.0,442.0,287.0,451.0,360.0,311.0,352.0,323.0,4337.0
Katihar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1115.0,1179.0,1071.0,1303.0,1391.0,1535.0,1064.0,1544.0,1396.0,1687.0,1415.0,1362.0,16062.0
Katihar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1560.0,1520.0,1396.0,1596.0,1798.0,1977.0,1351.0,1995.0,1756.0,1998.0,1767.0,1685.0,20399.0
Katihar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1028.0,905.0,995.0,1201.0,1336.0,1630.0,1073.0,1465.0,1433.0,1434.0,1381.0,1100.0,14981.0
Katihar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,12.0,0.0,3.0,0.0,16.0,0.0,0.0,4.0,0.0,0.0,0.0,35.0
Katihar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3425.0,2677.0,3336.0,4615.0,5310.0,6009.0,5618.0,3773.0,4321.0,2711.0,3644.0,3150.0,48589.0
Katihar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3300.0,2281.0,3218.0,4489.0,5072.0,4987.0,4618.0,2752.0,3329.0,2616.0,3235.0,2828.0,42725.0
Katihar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1281.0,3346.0,2169.0,230.0,119.0,44.0,76.0,285.0,2922.0,898.0,18804.0,8682.0,38856.0
Katihar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,894.0,1524.0,1393.0,89.0,58.0,46.0,107.0,249.0,550.0,618.0,6244.0,4421.0,16193.0
Katihar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Katihar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Katihar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Katihar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Katihar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,1.0,0.0,0.0,2.0,2.0,4.0,5.0,3.0,5.0,2.0,4.0,0.0,28.0
Katihar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,77.0,0.0,58.0,66.0,46.0,103.0,105.0,80.0,84.0,,85.0,60.0,764.0
Katihar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katihar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,78.0,0.0,58.0,68.0,48.0,107.0,110.0,83.0,89.0,2.0,89.0,60.0,792.0
Katihar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Katihar,4.1.1.a,Number of male live births,TOTAL,2554.0,2186.0,2327.0,3026.0,3443.0,3988.0,3462.0,2827.0,2892.0,2479.0,2732.0,2407.0,34323.0
Katihar,4.1.1.b,Number of female live births,TOTAL,2390.0,1958.0,2310.0,3110.0,3547.0,3889.0,3440.0,2908.0,3139.0,2233.0,2681.0,2380.0,33985.0
Katihar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4944.0,4144.0,4637.0,6136.0,6990.0,7877.0,6902.0,5735.0,6031.0,4712.0,5413.0,4787.0,68308.0
Katihar,4.1.2,Number of still births,TOTAL,65.0,67.0,112.0,124.0,145.0,162.0,130.0,103.0,107.0,66.0,75.0,85.0,1241.0
Katihar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,26.0,18.0,28.0,21.0,17.0,17.0,9.0,18.0,22.0,18.0,14.0,23.0,231.0
Katihar,4.2.1,Number of Newborns weighed at birth,TOTAL,4107.0,3914.0,4381.0,5601.0,6899.0,7818.0,6840.0,5615.0,5997.0,4628.0,5318.0,4741.0,65859.0
Katihar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,313.0,207.0,232.0,866.0,594.0,592.0,448.0,725.0,213.0,132.0,758.0,653.0,5733.0
Katihar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4173.0,3965.0,4370.0,5613.0,6897.0,7834.0,6871.0,5617.0,6007.0,4629.0,5342.0,4701.0,66019.0
Katihar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6.0,5.0,6.0,11.0,30.0,9.0,0.0,18.0,27.0,6.0,1.0,3.0,122.0
Katihar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,9.0,7.0,134.0,142.0,115.0,189.0,197.0,136.0,146.0,,127.0,94.0,1296.0
Katihar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katihar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,15.0,12.0,140.0,153.0,145.0,198.0,197.0,154.0,173.0,6.0,128.0,97.0,1418.0
Katihar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Katihar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,125.0,47.0,394.0,1421.0,1223.0,1209.0,1316.0,1101.0,2095.0,80.0,1313.0,1411.0,11735.0
Katihar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,5.0,23.0,8.0,4.0,12.0,2.0,5.0,40.0,0.0,0.0,24.0,123.0
Katihar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,112.0,7.0,174.0,1063.0,1032.0,1072.0,1159.0,868.0,10.0,0.0,66.0,186.0,5749.0
Katihar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,10.0,12.0,19.0,71.0,27.0,14.0,12.0,0.0,10.0,9.0,184.0
Katihar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3052.0,2626.0,3623.0,3885.0,4555.0,6477.0,5534.0,4209.0,4488.0,3232.0,3268.0,3130.0,48079.0
Katihar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2118.0,2018.0,1888.0,2782.0,3290.0,4488.0,3406.0,3196.0,3365.0,3312.0,2819.0,2195.0,34877.0
Katihar,6.3,PNC maternal complications attended,TOTAL,12.0,1.0,18.0,20.0,2.0,4.0,15.0,1.0,0.0,0.0,2.0,0.0,75.0
Katihar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,17.0,0.0,10.0,12.0,3.0,1.0,2.0,8.0,10.0,4.0,9.0,7.0,83.0
Katihar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Katihar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,17.0,0.0,10.0,12.0,3.0,1.0,2.0,9.0,10.0,4.0,9.0,7.0,84.0
Katihar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,14.0,6.0,10.0,139.0,175.0,277.0,293.0,165.0,155.0,4.0,291.0,224.0,1753.0
Katihar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1285.0,18.0,14.0,520.0,526.0,805.0,1093.0,787.0,898.0,2.0,798.0,948.0,7694.0
Katihar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1299.0,24.0,24.0,659.0,701.0,1082.0,1386.0,952.0,1053.0,6.0,1089.0,1172.0,9447.0
Katihar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,19.0
Katihar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,,0.0,1.0,2.0
Katihar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katihar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,16.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,2.0,21.0
Katihar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,0.0,0.0,,,,,0.0,1.0,1.0
Katihar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,33.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,33.0
Katihar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katihar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,33.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33.0
Katihar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,0.0,0.0,,,,,,,0.0
Katihar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,145.0,143.0,71.0,256.0,172.0,217.0,368.0,1141.0,1700.0,1158.0,1620.0,1522.0,8513.0
Katihar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,2.0,4.0,3.0,61.0,26.0,23.0,25.0,192.0,220.0,149.0,160.0,110.0,975.0
Katihar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,205.0,65.0,133.0,158.0,66.0,147.0,75.0,70.0,174.0,,406.0,293.0,1792.0
Katihar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katihar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,352.0,212.0,207.0,475.0,264.0,387.0,468.0,1403.0,2094.0,1307.0,2186.0,1925.0,11280.0
Katihar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,1850.0,1345.0,42.0,124.0,41.0,60.0,212.0,245.0,216.0,,108.0,163.0,4406.0
Katihar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,10.0,10.0,1.0,0.0,0.0,0.0,0.0,0.0,59.0,5.0,9.0,10.0,104.0
Katihar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,6.0
Katihar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,7.0,0.0,16.0,16.0,15.0,43.0,20.0,25.0,30.0,,26.0,18.0,216.0
Katihar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katihar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,17.0,10.0,17.0,16.0,15.0,43.0,20.0,25.0,89.0,6.0,37.0,31.0,326.0
Katihar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,0.0,0.0,,,,,,,0.0
Katihar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,828.0,828.0,809.0,1226.0,681.0,846.0,661.0,1118.0,1211.0,1148.0,1177.0,1117.0,11650.0
Katihar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,241.0,298.0,262.0,669.0,397.0,406.0,332.0,391.0,343.0,188.0,235.0,181.0,3943.0
Katihar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,9.0,2.0,10.0,54.0,2.0,4.0,6.0,6.0,8.0,10.0,15.0,16.0,142.0
Katihar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,106.0,60.0,74.0,174.0,36.0,60.0,40.0,18.0,44.0,,52.0,50.0,714.0
Katihar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katihar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1184.0,1188.0,1155.0,2123.0,1116.0,1316.0,1039.0,1533.0,1606.0,1346.0,1479.0,1364.0,16449.0
Katihar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,58.0,63.0,106.0,296.0,208.0,280.0,99.0,102.0,154.0,22.0,93.0,123.0,1604.0
Katihar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,0.0,0.0,,,,,,,0.0
Katihar,9.06,Number of IUCD removals,TOTAL,458.0,371.0,625.0,564.0,465.0,637.0,423.0,461.0,423.0,473.0,607.0,609.0,6116.0
Katihar,9.07,Number of Oral Pills cycles distributed,TOTAL,1894.0,1607.0,1744.0,4267.0,2357.0,3214.0,2134.0,2670.0,2832.0,2701.0,3397.0,2638.0,31455.0
Katihar,9.08,Number of Condom pieces distributed,TOTAL,20726.0,17040.0,13975.0,16451.0,12453.0,16997.0,13007.0,13843.0,15980.0,14693.0,15020.0,14177.0,184362.0
Katihar,9.09,Number of Centchroman (weekly) pills given,TOTAL,75.0,58.0,31.0,19.0,28.0,61.0,34.0,237.0,150.0,49.0,43.0,239.0,1024.0
Katihar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,94.0,79.0,115.0,200.0,171.0,420.0,294.0,338.0,482.0,340.0,447.0,625.0,3605.0
Katihar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Katihar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Katihar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5845.0,6016.0,5684.0,6646.0,7159.0,7001.0,7011.0,8578.0,7359.0,7729.0,7595.0,7737.0,84360.0
Katihar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,7093.0,6245.0,5926.0,5362.0,5497.0,7134.0,5611.0,9837.0,8253.0,1469.0,579.0,169.0,63175.0
Katihar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,7071.0,6758.0,6567.0,6149.0,5743.0,5997.0,4499.0,7064.0,8050.0,7701.0,4385.0,2234.0,72218.0
Katihar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,7044.0,6555.0,6348.0,6470.0,6044.0,6349.0,4069.0,6071.0,6191.0,6932.0,7076.0,5157.0,74306.0
Katihar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,18.0,0.0,0.0,3.0,0.0,5.0,2.0,0.0,0.0,6200.0,6945.0,7498.0,20671.0
Katihar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,22.0,0.0,0.0,14.0,0.0,0.0,26.0,3755.0,5914.0,9731.0
Katihar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,23.0,0.0,0.0,17.0,0.0,0.0,45.0,5.0,2632.0,2722.0
Katihar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3203.0,3026.0,3783.0,4833.0,5444.0,5504.0,5152.0,3874.0,4870.0,3653.0,4173.0,3663.0,51178.0
Katihar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,5781.0,5760.0,6041.0,5494.0,5321.0,6907.0,5448.0,5185.0,8913.0,5976.0,6364.0,6805.0,73995.0
Katihar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5688.0,5851.0,6259.0,6122.0,5540.0,5669.0,4238.0,3710.0,7605.0,6500.0,5967.0,6891.0,70040.0
Katihar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5509.0,5774.0,6130.0,6438.0,5926.0,6119.0,3870.0,3165.0,6032.0,5528.0,6281.0,6534.0,67306.0
Katihar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2262.0,2125.0,2687.0,3648.0,4164.0,4308.0,3888.0,3457.0,3896.0,2576.0,3251.0,2656.0,38918.0
Katihar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,6461.0,6275.0,6063.0,5335.0,5747.0,7180.0,5610.0,9866.0,8335.0,1883.0,739.0,224.0,63718.0
Katihar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,6445.0,6660.0,6438.0,6134.0,5829.0,6076.0,4450.0,6988.0,7984.0,7552.0,4110.0,2145.0,70811.0
Katihar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,6258.0,6479.0,6318.0,6410.0,6042.0,6392.0,4012.0,5997.0,6350.0,6882.0,6495.0,5027.0,72662.0
Katihar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5033.0,5568.0,5636.0,6707.0,6063.0,5542.0,3876.0,8199.0,5858.0,5708.0,4193.0,4746.0,67129.0
Katihar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4496.0,3938.0,3170.0,3794.0,3234.0,2840.0,1743.0,3636.0,3775.0,4111.0,3808.0,4467.0,43012.0
Katihar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2587.0,2867.0,2961.0,3570.0,2900.0,2790.0,1957.0,4172.0,2949.0,2904.0,2150.0,2379.0,34186.0
Katihar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2346.0,2679.0,2804.0,3403.0,2744.0,2625.0,1869.0,3770.0,2663.0,2755.0,1850.0,2119.0,31627.0
Katihar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4933.0,5546.0,5765.0,6973.0,5644.0,5415.0,3826.0,7942.0,5612.0,5659.0,4000.0,4498.0,65813.0
Katihar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4931.0,4268.0,4055.0,4246.0,4103.0,3869.0,2547.0,4414.0,4032.0,4342.0,4730.0,5469.0,51006.0
Katihar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4592.0,3993.0,4019.0,4129.0,3961.0,3725.0,2481.0,2392.0,4035.0,3880.0,4419.0,5339.0,46965.0
Katihar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1182.0,992.0,894.0,901.0,786.0,697.0,472.0,754.0,861.0,934.0,741.0,832.0,10046.0
Katihar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,990.0,849.0,789.0,871.0,717.0,646.0,419.0,725.0,818.0,829.0,645.0,781.0,9079.0
Katihar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2172.0,1841.0,1683.0,1772.0,1503.0,1343.0,891.0,1479.0,1679.0,1763.0,1386.0,1613.0,19125.0
Katihar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,91.0,71.0,80.0,106.0,96.0,193.0,78.0,97.0,104.0,139.0,176.0,138.0,1369.0
Katihar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,805.0,804.0,724.0,686.0,749.0,858.0,1095.0,1033.0,813.0,1101.0,951.0,1346.0,10965.0
Katihar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1551.0,1389.0,1758.0,1115.0,1259.0,1615.0,2065.0,1737.0,1391.0,2500.0,1730.0,2272.0,20382.0
Katihar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,4.0,9.0,26.0,24.0,2.0,20.0,19.0,36.0,30.0,15.0,185.0
Katihar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,62.0,43.0,30.0,17.0,30.0,36.0,8.0,22.0,23.0,49.0,14.0,40.0,374.0
Katihar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3180.0,3308.0,3236.0,3146.0,3168.0,3449.0,2717.0,3290.0,3337.0,3201.0,3165.0,3439.0,38636.0
Katihar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3173.0,3301.0,3189.0,3136.0,3162.0,3445.0,2706.0,3270.0,3307.0,3193.0,3150.0,3425.0,38457.0
Katihar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2907.0,2942.0,2833.0,2845.0,2875.0,3193.0,2393.0,2997.0,2979.0,2865.0,2953.0,3123.0,34905.0
Katihar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Katihar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3507.0,3969.0,3716.0,4667.0,4099.0,3860.0,2787.0,5138.0,4929.0,4029.0,3195.0,3278.0,47174.0
Katihar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,544.0,515.0,678.0,2778.0,591.0,538.0,439.0,826.0,663.0,733.0,963.0,1040.0,10308.0
Katihar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,50.0,104.0,490.0,777.0,232.0,59.0,11.0,104.0,31.0,54.0,57.0,185.0,2154.0
Katihar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,2.0,0.0,1.0,0.0,3.0,0.0,0.0,2.0,9.0,7.0,17.0,43.0
Katihar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,327.0,428.0,392.0,388.0,429.0,467.0,127.0,196.0,237.0,117.0,129.0,196.0,3433.0
Katihar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,3.0,1.0,2.0,0.0,2.0,2.0,6.0,0.0,0.0,0.0,1.0,17.0
Katihar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,3.0,2.0,0.0,0.0,5.0,15.0,2.0,0.0,11.0,0.0,38.0
Katihar,13.1,Number of Patients operated for cataract,TOTAL,67.0,17.0,144.0,64.0,25.0,55.0,30.0,80.0,105.0,123.0,175.0,112.0,997.0
Katihar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,67.0,18.0,144.0,64.0,25.0,27.0,30.0,79.0,105.0,123.0,86.0,112.0,880.0
Katihar,13.3,Number of School children detected with Refractive errors,TOTAL,1.0,3.0,5.0,7.0,297.0,9.0,3.0,0.0,3.0,2.0,0.0,1.0,331.0
Katihar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Katihar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,2.0,1.0,,,,,,,1.0,,,-1.0
Katihar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,4.0,3.0,,,,,,,,1.0,,-1.0
Katihar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1970.0,2178.0,2137.0,1930.0,2005.0,2116.0,1601.0,2080.0,1985.0,2030.0,2008.0,2100.0,-1.0
Katihar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,1.0,1.0,,,,,,,1.0,,,-1.0
Katihar,14.05,Number of RKS meetings held during the month,TOTAL,10.0,11.0,11.0,14.0,10.0,14.0,7.0,10.0,12.0,9.0,10.0,10.0,128.0
Katihar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,4.0,5.0,2.0,,,,,,,1.0,1.0,,-1.0
Katihar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,731.0,622.0,782.0,906.0,771.0,907.0,824.0,601.0,827.0,831.0,887.0,965.0,9654.0
Katihar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,1.0,,,-1.0
Katihar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,2.0,1.0,2.0,3.0,1.0,1.0,1.0,0.0,1.0,1.0,-1.0
Katihar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,448.0,458.0,557.0,549.0,504.0,567.0,562.0,210.0,500.0,197.0,450.0,516.0,5518.0
Katihar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,515.0,523.0,1150.0,989.0,960.0,929.0,613.0,567.0,633.0,254.0,912.0,764.0,8809.0
Katihar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,540.0,407.0,527.0,747.0,765.0,723.0,699.0,394.0,590.0,221.0,442.0,644.0,6699.0
Katihar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3515.0,2922.0,4599.0,5865.0,6020.0,6623.0,6546.0,5114.0,6489.0,3979.0,6492.0,5210.0,63374.0
Katihar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,988.0,865.0,1084.0,1296.0,1269.0,1290.0,1261.0,604.0,1090.0,418.0,892.0,1160.0,12217.0
Katihar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4030.0,3445.0,5749.0,6854.0,6980.0,7552.0,7159.0,5681.0,7122.0,4233.0,7404.0,5974.0,72183.0
Katihar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,17.0,24.0,12.0,13.0,12.0,12.0,11.0,0.0,11.0,19.0,131.0
Katihar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,2.0,17.0,15.0,11.0,9.0,15.0,10.0,7.0,0.0,11.0,14.0,111.0
Katihar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,2.0,34.0,39.0,23.0,22.0,27.0,22.0,18.0,0.0,22.0,33.0,242.0
Katihar,14.11,In-Patient Head Count at midnight,TOTAL,4162.0,2759.0,6875.0,8109.0,7968.0,9513.0,8739.0,7141.0,8909.0,3710.0,8940.0,8003.0,84828.0
Katihar,14.12.1,OPD attendance (All),TOTAL,154383.0,127764.0,146618.0,188387.0,189378.0,195120.0,128697.0,139560.0,142028.0,122161.0,164865.0,174905.0,1873866.0
Katihar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,372.0,170.0,290.0,577.0,379.0,1338.0,614.0,1588.0,2106.0,1368.0,2386.0,2012.0,13200.0
Katihar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,1.0,0.0,216.0,94.0,0.0,0.0,12.0,0.0,0.0,1.0,324.0
Katihar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3678.0,2821.0,4371.0,5647.0,4903.0,4515.0,4573.0,3948.0,4050.0,2829.0,4213.0,3359.0,48907.0
Katihar,14.14.a,Number of patients given AYUSH treatment,TOTAL,16391.0,13949.0,15238.0,26314.0,24237.0,24574.0,17822.0,19500.0,11982.0,15777.0,20074.0,18855.0,224713.0
Katihar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,8500.0,6426.0,9415.0,12265.0,12145.0,11127.0,7553.0,6379.0,6568.0,5331.0,7855.0,8087.0,101651.0
Katihar,14.14.c,Number of Adolescents counselled,TOTAL,527.0,598.0,1012.0,588.0,418.0,767.0,74.0,261.0,320.0,161.0,283.0,279.0,5288.0
Katihar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3992.0,3797.0,5885.0,4587.0,4893.0,5415.0,3854.0,4943.0,5675.0,5023.0,6594.0,6849.0,61507.0
Katihar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,58.0,20.0,54.0,78.0,105.0,71.0,72.0,39.0,74.0,30.0,111.0,79.0,791.0
Katihar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,329.0,433.0,934.0,1209.0,1005.0,1085.0,964.0,1028.0,1040.0,335.0,276.0,1204.0,9842.0
Katihar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,1.0,17.0,8.0,18.0,15.0,3.0,10.0,6.0,1.0,509.0,11.0,604.0
Katihar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,361.0,492.0,1856.0,1794.0,1690.0,1804.0,1951.0,2277.0,2030.0,1446.0,860.0,2558.0,19119.0
Katihar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,4.0,14.0,8.0,8.0,13.0,9.0,13.0,1.0,0.0,798.0,8.0,879.0
Katihar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,661.0,468.0,1264.0,1168.0,788.0,1681.0,1314.0,964.0,729.0,724.0,630.0,1160.0,11551.0
Katihar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,7.0
Katihar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1351.0,1393.0,4054.0,4171.0,3483.0,4570.0,4229.0,4269.0,3799.0,2505.0,1766.0,4922.0,40512.0
Katihar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,5.0,32.0,17.0,26.0,29.0,13.0,24.0,7.0,2.0,1308.0,19.0,1490.0
Katihar,15.2,Number of Widal tests conducted,Number tested,51.0,46.0,113.0,138.0,52.0,88.0,42.0,1.0,77.0,119.0,118.0,348.0,1193.0
Katihar,15.3.a,Number of VDRL tests conducted on males,Number tested,12.0,0.0,0.0,1.0,0.0,0.0,0.0,61.0,0.0,0.0,152.0,1.0,227.0
Katihar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,5.0,0.0,2.0,0.0,0.0,0.0,0.0,28.0,1.0,0.0,0.0,15.0,51.0
Katihar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,10.0,12.0,65.0,0.0,0.0,0.0,0.0,39.0,1.0,0.0,0.0,0.0,127.0
Katihar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,27.0,12.0,67.0,1.0,0.0,0.0,0.0,128.0,2.0,0.0,152.0,16.0,405.0
Katihar,15.4.1,Number of blood smears examined for Malaria,TOTAL,94.0,106.0,180.0,263.0,259.0,352.0,355.0,196.0,140.0,142.0,201.0,219.0,2507.0
Katihar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,8.0,4.0,3.0,7.0,3.0,3.0,3.0,0.0,6.0,1.0,38.0
Katihar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,6.0,0.0,0.0,1.0,5.0,1.0,0.0,0.0,2.0,0.0,15.0
Katihar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,1827.0,112.0,712.0,3217.0,3301.0,3791.0,,,,2748.0,,15708.0
Katihar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4000.0,5032.0,2827.0,5862.0,4962.0,6217.0,4791.0,,,,3000.0,,36691.0
Katihar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Katihar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3250.0,3205.0,2715.0,5150.0,1745.0,2916.0,4791.0,,,,2135.0,,25907.0
Katihar,16.1.1,Stock position of DPT vaccines,5. Total Stock,750.0,3654.0,224.0,1424.0,6434.0,6602.0,3791.0,0.0,0.0,0.0,3613.0,0.0,26492.0
Katihar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,1160.0,,1160.0
Katihar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,2100.0,,2100.0
Katihar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,1775.0,,1775.0
Katihar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1485.0,0.0,1485.0
Katihar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,114.0,1570.0,10.0,20.0,510.0,229.0,235.0,,,,0.0,,2688.0
Katihar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2500.0,3475.0,2570.0,2910.0,2595.0,3010.0,1435.0,,,,2800.0,,21295.0
Katihar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Katihar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2025.0,1905.0,2560.0,2890.0,2085.0,2681.0,1435.0,,,,2630.0,,18211.0
Katihar,16.1.2,Stock position of OPV vaccines,5. Total Stock,589.0,3140.0,20.0,40.0,1020.0,558.0,235.0,0.0,0.0,0.0,170.0,0.0,5772.0
Katihar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,0.0,1004.0,4.0,226.0,1036.0,1452.0,1452.0,,,,1205.0,,6379.0
Katihar,16.1.3,Stock position of TT vaccines,2. Stocks Received,2814.0,2569.0,2504.0,4504.0,2726.0,4036.0,3052.0,,,,2000.0,,24205.0
Katihar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Katihar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2245.0,1565.0,1500.0,4277.0,1690.0,2584.0,3052.0,,,,1845.0,,18758.0
Katihar,16.1.3,Stock position of TT vaccines,5. Total Stock,569.0,2008.0,1008.0,453.0,2072.0,2904.0,1452.0,0.0,0.0,0.0,1360.0,0.0,11826.0
Katihar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Katihar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,1030.0,0.0,14.0,119.0,15.0,40.0,,,,0.0,,1218.0
Katihar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2500.0,3650.0,1530.0,2350.0,2014.0,1419.0,1340.0,,,,2500.0,,17303.0
Katihar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Katihar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1950.0,1620.0,1530.0,2336.0,1896.0,1404.0,1340.0,,,,1890.0,,13966.0
Katihar,16.1.5,Stock position of BCG vaccines,5. Total Stock,550.0,3060.0,0.0,28.0,237.0,30.0,40.0,0.0,0.0,0.0,610.0,0.0,4555.0
Katihar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5.0,1475.0,0.0,0.0,90.0,64.0,119.0,,,,,,1753.0
Katihar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3805.0,3245.0,2475.0,3500.0,2500.0,3090.0,2419.0,,,,,,21034.0
Katihar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3060.0,1770.0,2475.0,3500.0,2410.0,3026.0,2300.0,,,,,,18541.0
Katihar,16.1.6,Stock position of Measles vaccines,5. Total Stock,750.0,2950.0,0.0,0.0,180.0,128.0,238.0,0.0,0.0,0.0,0.0,0.0,4246.0
Katihar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Katihar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,1981.0,66.0,474.0,939.0,1609.0,1609.0,,,,,,6678.0
Katihar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3840.0,4871.0,2781.0,4066.0,2874.0,4339.0,3109.0,,,,,,25880.0
Katihar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Katihar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3040.0,2890.0,2715.0,3592.0,1935.0,2730.0,3109.0,,,,,,20011.0
Katihar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,800.0,3962.0,132.0,948.0,1878.0,3218.0,1609.0,0.0,0.0,0.0,0.0,0.0,12547.0
Katihar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Katihar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Katihar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Katihar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Katihar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katihar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Katihar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Katihar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Katihar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Katihar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Katihar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Katihar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Katihar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Katihar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Katihar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Katihar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Katihar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Katihar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Katihar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Katihar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Katihar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Katihar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Katihar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Katihar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Katihar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Katihar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Katihar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Katihar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Katihar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Katihar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Katihar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Katihar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Katihar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,,,,,,,,,,,1.0
Katihar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Katihar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Katihar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Katihar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Katihar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Katihar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,,,,,,,,,,1.0
Katihar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Katihar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Katihar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Katihar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Katihar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Katihar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Katihar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Katihar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Katihar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Katihar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Katihar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Katihar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Katihar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Katihar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Katihar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Katihar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Katihar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Katihar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Katihar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Katihar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Katihar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Katihar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Katihar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Katihar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Katihar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Katihar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Katihar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Katihar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Katihar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Katihar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Khagaria,1.1,Total number of pregnant women Registered for ANC,TOTAL,4517.0,4666.0,4483.0,4625.0,4714.0,4585.0,4005.0,3852.0,3993.0,4102.0,4424.0,5332.0,53298.0
Khagaria,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2798.0,2590.0,2704.0,3332.0,3294.0,3038.0,2677.0,2561.0,2637.0,3005.0,2987.0,3515.0,35138.0
Khagaria,1.2,Number of Pregnant women registered under JSY,TOTAL,4517.0,4666.0,4483.0,4625.0,4714.0,4585.0,4005.0,3852.0,3993.0,4102.0,4424.0,5332.0,53298.0
Khagaria,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2298.0,2530.0,2885.0,3621.0,3873.0,4166.0,3830.0,3447.0,3239.0,3135.0,3286.0,3421.0,39731.0
Khagaria,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2591.0,2652.0,2602.0,2665.0,2537.0,2495.0,2194.0,1943.0,2179.0,2288.0,2343.0,2876.0,29365.0
Khagaria,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4028.0,4380.0,4093.0,4353.0,4854.0,4582.0,4011.0,3630.0,3584.0,3662.0,3673.0,4832.0,49682.0
Khagaria,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,841.0,1350.0,2341.0,1698.0,1555.0,1915.0,2207.0,2070.0,2002.0,2338.0,2258.0,2549.0,23124.0
Khagaria,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,73.0,90.0,41.0,18.0,0.0,30.0,1.0,26.0,47.0,28.0,12.0,27.0,393.0
Khagaria,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,3.0
Khagaria,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,766.0,219.0,637.0,942.0,788.0,905.0,586.0,750.0,565.0,601.0,625.0,662.0,8046.0
Khagaria,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,4.0,2.0,3.0,1.0,0.0,0.0,2.0,6.0,5.0,23.0
Khagaria,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,270.0,699.0,643.0,545.0,281.0,767.0,815.0,1099.0,922.0,6041.0
Khagaria,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,243.0,192.0,256.0,346.0,360.0,241.0,208.0,261.0,299.0,321.0,268.0,178.0,3173.0
Khagaria,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,372.0,353.0,372.0,425.0,538.0,607.0,704.0,736.0,548.0,567.0,411.0,563.0,6196.0
Khagaria,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,615.0,545.0,628.0,771.0,898.0,848.0,912.0,997.0,847.0,888.0,679.0,741.0,9369.0
Khagaria,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,458.0,408.0,383.0,583.0,645.0,584.0,593.0,775.0,653.0,569.0,395.0,433.0,6479.0
Khagaria,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,7.0,11.0
Khagaria,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2347.0,2286.0,2064.0,2806.0,3762.0,3641.0,3691.0,3266.0,2955.0,2492.0,2353.0,2097.0,33760.0
Khagaria,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2338.0,2285.0,2064.0,2798.0,3756.0,3634.0,3690.0,3263.0,2943.0,2491.0,2332.0,1865.0,33459.0
Khagaria,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,496.0,49.0,1105.0,1081.0,21.0,1.0,1658.0,9.0,458.0,1627.0,1257.0,4439.0,12201.0
Khagaria,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,27.0,10.0,587.0,8.0,0.0,2.0,8.0,966.0,5.0,43.0,516.0,2172.0
Khagaria,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Khagaria,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Khagaria,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Khagaria,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Khagaria,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,9.0,1.0,0.0,6.0,6.0,7.0,1.0,3.0,1.0,1.0,1.0,0.0,36.0
Khagaria,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khagaria,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,9.0,1.0,0.0,6.0,6.0,7.0,1.0,3.0,1.0,1.0,1.0,0.0,36.0
Khagaria,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Khagaria,4.1.1.a,Number of male live births,TOTAL,1475.0,1500.0,1373.0,1863.0,2387.0,2345.0,2336.0,2116.0,1943.0,1725.0,1522.0,1465.0,22050.0
Khagaria,4.1.1.b,Number of female live births,TOTAL,1459.0,1305.0,1301.0,1691.0,2252.0,2111.0,2236.0,2114.0,1860.0,1627.0,1513.0,1358.0,20827.0
Khagaria,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2934.0,2805.0,2674.0,3554.0,4639.0,4456.0,4572.0,4230.0,3803.0,3352.0,3035.0,2823.0,42877.0
Khagaria,4.1.2,Number of still births,TOTAL,46.0,36.0,36.0,41.0,59.0,75.0,53.0,61.0,37.0,47.0,36.0,31.0,558.0
Khagaria,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,1.0,1.0,0.0,1.0,2.0,6.0,0.0,3.0,0.0,0.0,1.0,2.0,17.0
Khagaria,4.2.1,Number of Newborns weighed at birth,TOTAL,2632.0,2654.0,2394.0,3336.0,4152.0,3958.0,3967.0,3672.0,3397.0,2887.0,2675.0,2442.0,38166.0
Khagaria,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,150.0,153.0,169.0,124.0,218.0,125.0,368.0,369.0,270.0,120.0,128.0,124.0,2318.0
Khagaria,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2786.0,2211.0,2530.0,3455.0,4519.0,4158.0,4280.0,4047.0,3453.0,3220.0,2870.0,2680.0,40209.0
Khagaria,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Khagaria,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Khagaria,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,13.0,6.0,7.0,8.0,11.0,9.0,8.0,7.0,5.0,3.0,3.0,9.0,89.0
Khagaria,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khagaria,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,28.0,6.0,15.0,8.0,11.0,9.0,8.0,7.0,5.0,3.0,3.0,9.0,112.0
Khagaria,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Khagaria,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,9.0,1.0,7.0,6.0,6.0,9.0,8.0,48.0,32.0,3.0,3.0,9.0,141.0
Khagaria,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,9.0,1.0,7.0,6.0,6.0,9.0,8.0,2.0,0.0,3.0,3.0,9.0,63.0
Khagaria,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,9.0,1.0,345.0,6.0,6.0,409.0,308.0,6.0,2.0,178.0,103.0,309.0,1682.0
Khagaria,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,12.0,5.0,1.0,6.0,9.0,8.0,12.0,9.0,16.0,2.0,10.0,13.0,103.0
Khagaria,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2509.0,2409.0,2133.0,2974.0,3632.0,3559.0,3473.0,3260.0,2868.0,2483.0,2248.0,2250.0,33798.0
Khagaria,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1008.0,932.0,1275.0,1495.0,1621.0,1409.0,1655.0,1480.0,1105.0,1027.0,1211.0,1051.0,15269.0
Khagaria,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Khagaria,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,4.0,5.0,4.0,4.0,3.0,4.0,3.0,4.0,4.0,3.0,4.0,6.0,48.0
Khagaria,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,7.0,7.0,7.0,8.0,7.0,7.0,8.0,7.0,8.0,8.0,8.0,8.0,90.0
Khagaria,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,11.0,12.0,11.0,12.0,10.0,11.0,11.0,11.0,12.0,11.0,12.0,14.0,138.0
Khagaria,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,11.0
Khagaria,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,3.0
Khagaria,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khagaria,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,11.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,14.0
Khagaria,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,0.0,0.0
Khagaria,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khagaria,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,0.0,0.0
Khagaria,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,54.0,24.0,18.0,842.0,148.0,119.0,164.0,1073.0,1052.0,580.0,645.0,326.0,5045.0
Khagaria,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,15.0,15.0,14.0,277.0,16.0,30.0,12.0,230.0,315.0,209.0,166.0,107.0,1406.0
Khagaria,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,33.0,17.0,0.0,83.0,37.0,33.0,34.0,236.0,162.0,112.0,99.0,92.0,938.0
Khagaria,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khagaria,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,102.0,56.0,32.0,1202.0,201.0,182.0,210.0,1539.0,1529.0,901.0,910.0,525.0,7389.0
Khagaria,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,316.0,316.0
Khagaria,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Khagaria,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khagaria,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Khagaria,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,0.0,0.0
Khagaria,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,93.0,120.0,90.0,718.0,172.0,170.0,259.0,206.0,238.0,210.0,172.0,163.0,2611.0
Khagaria,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,356.0,334.0,25.0,565.0,72.0,66.0,70.0,74.0,85.0,46.0,39.0,72.0,1804.0
Khagaria,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,75.0,87.0,88.0,122.0,,,,25.0,66.0,15.0,18.0,20.0,516.0
Khagaria,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,81.0,78.0,62.0,104.0,6.0,4.0,6.0,8.0,3.0,7.0,6.0,6.0,371.0
Khagaria,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khagaria,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,605.0,619.0,265.0,1509.0,250.0,240.0,335.0,313.0,392.0,278.0,235.0,261.0,5302.0
Khagaria,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,130.0,148.0,125.0,265.0,134.0,64.0,51.0,72.0,120.0,72.0,74.0,116.0,1371.0
Khagaria,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,0.0,0.0
Khagaria,9.06,Number of IUCD removals,TOTAL,100.0,116.0,88.0,334.0,164.0,206.0,161.0,170.0,179.0,160.0,189.0,182.0,2049.0
Khagaria,9.07,Number of Oral Pills cycles distributed,TOTAL,522.0,182.0,285.0,1465.0,1344.0,1288.0,1031.0,1053.0,1075.0,964.0,1103.0,905.0,11217.0
Khagaria,9.08,Number of Condom pieces distributed,TOTAL,4436.0,4075.0,3527.0,9059.0,7624.0,9951.0,5073.0,5875.0,6318.0,5774.0,5867.0,4888.0,72467.0
Khagaria,9.09,Number of Centchroman (weekly) pills given,TOTAL,112.0,54.0,22.0,155.0,187.0,142.0,152.0,124.0,207.0,122.0,35.0,156.0,1468.0
Khagaria,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,20.0,30.0,11.0,262.0,128.0,88.0,81.0,61.0,49.0,79.0,79.0,65.0,953.0
Khagaria,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Khagaria,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Khagaria,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3645.0,3203.0,3219.0,4298.0,5186.0,5200.0,5430.0,5555.0,4426.0,4041.0,3648.0,3404.0,51255.0
Khagaria,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4241.0,3599.0,3466.0,3746.0,4049.0,4379.0,4220.0,5790.0,4929.0,707.0,0.0,4.0,39130.0
Khagaria,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4343.0,3927.0,3417.0,3785.0,4224.0,4032.0,3614.0,4486.0,5264.0,5286.0,2332.0,1034.0,45744.0
Khagaria,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4412.0,4145.0,3783.0,3959.0,4480.0,4226.0,3454.0,3968.0,4296.0,5113.0,4339.0,3063.0,49238.0
Khagaria,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,4672.0,4278.0,4514.0,13479.0
Khagaria,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,2438.0,4252.0,6700.0
Khagaria,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,21.0,2019.0,2045.0
Khagaria,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2331.0,2074.0,2443.0,3395.0,4520.0,3813.0,4137.0,3183.0,3455.0,2953.0,2825.0,2583.0,37712.0
Khagaria,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3915.0,3572.0,3441.0,3766.0,4051.0,3747.0,3769.0,3015.0,5542.0,5446.0,4668.0,4578.0,49510.0
Khagaria,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4329.0,3955.0,3415.0,3793.0,4232.0,3356.0,3221.0,2268.0,5045.0,5335.0,4634.0,5428.0,49011.0
Khagaria,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4471.0,4150.0,3747.0,3964.0,4483.0,3643.0,3110.0,1820.0,4125.0,4976.0,4603.0,5422.0,48514.0
Khagaria,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2017.0,1859.0,1790.0,2401.0,3334.0,3232.0,3336.0,3147.0,2833.0,2347.0,2171.0,1923.0,30390.0
Khagaria,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3985.0,3638.0,3489.0,3752.0,3995.0,4366.0,4669.0,5671.0,4904.0,629.0,8.0,0.0,39106.0
Khagaria,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,4231.0,4011.0,3425.0,3820.0,4232.0,4018.0,3982.0,4491.0,5149.0,5205.0,2072.0,983.0,45619.0
Khagaria,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4310.0,4195.0,3800.0,4006.0,4468.0,4197.0,3790.0,3835.0,4273.0,5028.0,4289.0,3134.0,49325.0
Khagaria,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2790.0,3693.0,3958.0,5029.0,5199.0,4993.0,4352.0,3833.0,3978.0,4074.0,3430.0,3577.0,48906.0
Khagaria,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3562.0,3602.0,3143.0,3625.0,3488.0,3287.0,3375.0,2756.0,3497.0,4148.0,3876.0,4523.0,42882.0
Khagaria,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,24.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0
Khagaria,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1396.0,1928.0,2100.0,2651.0,2770.0,2607.0,2319.0,1777.0,1919.0,1918.0,1568.0,1714.0,24667.0
Khagaria,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1243.0,1660.0,1781.0,2311.0,2345.0,2301.0,1935.0,1636.0,1637.0,1739.0,1343.0,1602.0,21533.0
Khagaria,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2639.0,3588.0,3881.0,4962.0,5115.0,4908.0,4254.0,3413.0,3556.0,3657.0,2911.0,3316.0,46200.0
Khagaria,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3455.0,3385.0,3177.0,3561.0,3520.0,3323.0,3018.0,3125.0,3474.0,4182.0,4160.0,4627.0,43007.0
Khagaria,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3662.0,3378.0,3178.0,3562.0,3520.0,2807.0,2743.0,1537.0,3480.0,4164.0,4227.0,4668.0,40926.0
Khagaria,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Khagaria,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,161.0,151.0,279.0,190.0,381.0,159.0,117.0,80.0,78.0,86.0,98.0,84.0,1864.0
Khagaria,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,179.0,117.0,248.0,164.0,327.0,144.0,98.0,88.0,69.0,68.0,106.0,70.0,1678.0
Khagaria,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,340.0,268.0,527.0,354.0,708.0,303.0,215.0,168.0,147.0,154.0,204.0,154.0,3542.0
Khagaria,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,190.0,169.0,266.0,272.0,328.0,345.0,280.0,311.0,444.0,299.0,437.0,446.0,3787.0
Khagaria,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,261.0,357.0,305.0,349.0,375.0,413.0,344.0,357.0,453.0,466.0,400.0,464.0,4544.0
Khagaria,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,439.0,510.0,484.0,559.0,538.0,589.0,563.0,626.0,665.0,603.0,640.0,808.0,7024.0
Khagaria,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Khagaria,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1944.0,1993.0,1888.0,2091.0,1678.0,1727.0,1681.0,1689.0,1688.0,1746.0,1634.0,1776.0,21535.0
Khagaria,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1939.0,1993.0,1884.0,2087.0,1661.0,1710.0,1675.0,1677.0,1685.0,1741.0,1582.0,1805.0,21439.0
Khagaria,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1798.0,1842.0,1683.0,1922.0,1448.0,1545.0,1461.0,1519.0,1468.0,1513.0,1412.0,1617.0,19228.0
Khagaria,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,146.0,198.0,197.0,5061.0,195.0,297.0,285.0,241.0,200.0,194.0,166.0,232.0,7412.0
Khagaria,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,48.0,26.0,16.0,3663.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3753.0
Khagaria,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,22.0,10.0,0.0,1884.0,0.0,0.0,0.0,37.0,0.0,0.0,0.0,0.0,1953.0
Khagaria,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,3.0,0.0,0.0,0.0,12.0,0.0,75.0,0.0,0.0,2.0,2.0,94.0
Khagaria,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2841.0,4944.0,5994.0,9910.0,10411.0,6606.0,5868.0,5999.0,5294.0,4243.0,4015.0,3905.0,70030.0
Khagaria,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,29.0,0.0,0.0,6.0,0.0,0.0,36.0
Khagaria,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Khagaria,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,144.0,163.0,206.0,513.0
Khagaria,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,144.0,160.0,206.0,510.0
Khagaria,13.3,Number of School children detected with Refractive errors,TOTAL,543.0,0.0,0.0,0.0,0.0,64.0,14.0,494.0,0.0,0.0,0.0,0.0,1115.0
Khagaria,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,41.0,14.0,53.0,0.0,0.0,0.0,0.0,108.0
Khagaria,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Khagaria,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Khagaria,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1554.0,1599.0,1551.0,1598.0,1530.0,1558.0,1591.0,1524.0,1445.0,1584.0,1360.0,1501.0,-1.0
Khagaria,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Khagaria,14.05,Number of RKS meetings held during the month,TOTAL,4.0,3.0,6.0,5.0,4.0,4.0,3.0,6.0,5.0,4.0,4.0,6.0,54.0
Khagaria,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Khagaria,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,467.0,490.0,375.0,489.0,325.0,590.0,325.0,569.0,819.0,566.0,556.0,466.0,6037.0
Khagaria,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Khagaria,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Khagaria,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,632.0,672.0,874.0,825.0,1076.0,981.0,967.0,795.0,786.0,682.0,556.0,596.0,9442.0
Khagaria,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,923.0,1043.0,872.0,1226.0,990.0,1177.0,901.0,1043.0,1027.0,753.0,592.0,732.0,11279.0
Khagaria,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,618.0,492.0,760.0,761.0,963.0,978.0,1005.0,798.0,724.0,728.0,569.0,514.0,8910.0
Khagaria,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2617.0,2489.0,2161.0,3856.0,4021.0,3855.0,3822.0,4008.0,3628.0,2782.0,2482.0,2278.0,37999.0
Khagaria,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1250.0,1164.0,1634.0,1586.0,2039.0,1959.0,1972.0,1593.0,1510.0,1410.0,1125.0,1110.0,18352.0
Khagaria,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3540.0,3532.0,3033.0,5082.0,5011.0,5032.0,4723.0,5051.0,4655.0,3535.0,3074.0,3010.0,49278.0
Khagaria,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,11.0,12.0,8.0,4.0,4.0,7.0,4.0,1.0,9.0,8.0,1.0,72.0
Khagaria,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,2.0,9.0,3.0,4.0,4.0,3.0,5.0,4.0,1.0,4.0,2.0,44.0
Khagaria,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6.0,13.0,21.0,11.0,8.0,8.0,10.0,9.0,5.0,10.0,12.0,3.0,116.0
Khagaria,14.11,In-Patient Head Count at midnight,TOTAL,4538.0,4567.0,4558.0,6389.0,6531.0,6662.0,6187.0,6259.0,5876.0,4849.0,4452.0,4240.0,65108.0
Khagaria,14.12.1,OPD attendance (All),TOTAL,99177.0,105338.0,102032.0,121357.0,122514.0,130491.0,101942.0,100991.0,93152.0,83981.0,91724.0,94809.0,1247508.0
Khagaria,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,634.0,585.0,752.0,1702.0,682.0,194.0,277.0,1605.0,1410.0,834.0,684.0,552.0,9911.0
Khagaria,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1074.0,1189.0,1686.0,1454.0,1558.0,1280.0,1189.0,1230.0,1245.0,1125.0,1031.0,1025.0,15086.0
Khagaria,14.14.a,Number of patients given AYUSH treatment,TOTAL,11572.0,15850.0,10791.0,10503.0,14345.0,13468.0,9351.0,11373.0,8176.0,12329.0,14272.0,11987.0,144017.0
Khagaria,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4611.0,4390.0,3222.0,3471.0,4101.0,4220.0,3031.0,3027.0,2519.0,2598.0,2593.0,2549.0,40332.0
Khagaria,14.14.c,Number of Adolescents counselled,TOTAL,106.0,115.0,0.0,102.0,136.0,141.0,55.0,109.0,77.0,80.0,113.0,137.0,1171.0
Khagaria,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1435.0,917.0,1100.0,1118.0,1192.0,1486.0,773.0,1252.0,858.0,856.0,1178.0,1142.0,13307.0
Khagaria,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0.0,3.0,8.0,9.0,8.0,24.0,13.0,8.0,2.0,14.0,1.0,7.0,97.0
Khagaria,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,295.0,302.0,489.0,345.0,484.0,432.0,276.0,276.0,364.0,392.0,108.0,144.0,3907.0
Khagaria,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,14.0,12.0,13.0,7.0,10.0,4.0,2.0,7.0,7.0,5.0,3.0,6.0,90.0
Khagaria,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,424.0,274.0,343.0,704.0,570.0,384.0,300.0,874.0,916.0,647.0,247.0,140.0,5823.0
Khagaria,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,11.0,6.0,6.0,7.0,6.0,3.0,5.0,5.0,3.0,7.0,1.0,0.0,60.0
Khagaria,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,490.0,476.0,628.0,756.0,869.0,727.0,658.0,467.0,775.0,507.0,297.0,251.0,6901.0
Khagaria,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,2.0,0.0,0.0,0.0,2.0,1.0,1.0,0.0,0.0,0.0,7.0
Khagaria,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1209.0,1052.0,1460.0,1805.0,1923.0,1543.0,1234.0,1617.0,2055.0,1546.0,652.0,535.0,16631.0
Khagaria,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,26.0,18.0,21.0,14.0,16.0,7.0,9.0,13.0,11.0,12.0,4.0,6.0,157.0
Khagaria,15.2,Number of Widal tests conducted,Number tested,9.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,11.0
Khagaria,15.3.a,Number of VDRL tests conducted on males,Number tested,51.0,0.0,0.0,92.0,35.0,35.0,12.0,0.0,29.0,0.0,1.0,0.0,255.0
Khagaria,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,64.0,9.0,18.0,164.0,40.0,40.0,10.0,0.0,33.0,28.0,20.0,8.0,434.0
Khagaria,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,41.0,34.0,35.0,0.0,0.0,0.0,0.0,63.0,15.0,16.0,0.0,70.0,274.0
Khagaria,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,156.0,43.0,53.0,256.0,75.0,75.0,22.0,63.0,77.0,44.0,21.0,78.0,963.0
Khagaria,15.4.1,Number of blood smears examined for Malaria,TOTAL,73.0,82.0,100.0,207.0,257.0,282.0,231.0,205.0,46.0,40.0,93.0,201.0,1817.0
Khagaria,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,500.0,80.0,650.0,1500.0,2375.0,200.0,0.0,0.0,2000.0,75.0,100.0,1100.0,8580.0
Khagaria,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,3000.0,3000.0,2000.0,0.0,2200.0,300.0,3000.0,0.0,2000.0,2000.0,0.0,17500.0
Khagaria,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,400.0,2430.0,2615.0,2015.0,2175.0,2200.0,,2625.0,1975.0,1975.0,975.0,775.0,20160.0
Khagaria,16.1.1,Stock position of DPT vaccines,5. Total Stock,100.0,650.0,1035.0,1485.0,200.0,200.0,300.0,375.0,25.0,100.0,1125.0,325.0,5920.0
Khagaria,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,474.0,474.0
Khagaria,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4150.0,4150.0,700.0,0.0,9000.0
Khagaria,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2900.0,3235.0,226.0,474.0,6835.0
Khagaria,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1250.0,915.0,474.0,0.0,2639.0
Khagaria,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1275.0,790.0,700.0,1200.0,1478.0,0.0,0.0,0.0,100.0,400.0,423.0,450.0,6816.0
Khagaria,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,2000.0,1300.0,1600.0,0.0,3000.0,1000.0,1000.0,1000.0,2200.0,2000.0,0.0,15100.0
Khagaria,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,475.0,2090.0,1322.0,1322.0,1478.0,3000.0,882.0,900.0,900.0,1977.0,1973.0,400.0,16719.0
Khagaria,16.1.2,Stock position of OPV vaccines,5. Total Stock,800.0,700.0,678.0,1478.0,0.0,0.0,118.0,100.0,200.0,623.0,450.0,50.0,5197.0
Khagaria,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1700.0,1388.0,650.0,1300.0,2962.0,1000.0,550.0,500.0,0.0,772.0,750.0,1600.0,13172.0
Khagaria,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,1000.0,2000.0,2000.0,0.0,2000.0,3000.0,2000.0,1700.0,1000.0,2000.0,0.0,16700.0
Khagaria,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.3,Stock position of TT vaccines,4. Stock Distributed,308.0,1738.0,1812.0,1812.0,1962.0,2000.0,1950.0,1370.0,920.0,1072.0,1072.0,100.0,16116.0
Khagaria,16.1.3,Stock position of TT vaccines,5. Total Stock,1392.0,650.0,838.0,1488.0,1000.0,1000.0,1600.0,1130.0,780.0,700.0,1678.0,1500.0,13756.0
Khagaria,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,475.0,240.0,450.0,1000.0,2750.0,1000.0,900.0,350.0,302.0,550.0,150.0,470.0,8637.0
Khagaria,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,2000.0,1400.0,2000.0,0.0,1500.0,900.0,1000.0,1000.0,1000.0,1000.0,0.0,11800.0
Khagaria,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,475.0,1990.0,1350.0,1350.0,1750.0,1500.0,1150.0,1048.0,1048.0,1200.0,680.0,420.0,13961.0
Khagaria,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,250.0,500.0,1650.0,1000.0,1000.0,650.0,302.0,254.0,350.0,470.0,50.0,6476.0
Khagaria,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1800.0,1375.0,100.0,800.0,2425.0,150.0,350.0,250.0,48.0,371.0,50.0,72.0,7791.0
Khagaria,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,1000.0,2000.0,3000.0,0.0,2500.0,1000.0,1000.0,2000.0,2000.0,2000.0,1000.0,17500.0
Khagaria,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,414.0,2275.0,1864.0,1864.0,2275.0,2500.0,1300.0,1202.0,1677.0,2121.0,2022.0,1072.0,20586.0
Khagaria,16.1.6,Stock position of Measles vaccines,5. Total Stock,1386.0,100.0,236.0,1936.0,150.0,150.0,50.0,48.0,371.0,250.0,28.0,0.0,4705.0
Khagaria,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,470.0,0.0,50.0,1400.0,2650.0,380.0,200.0,0.0,225.0,550.0,970.0,600.0,7495.0
Khagaria,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,3000.0,3000.0,3000.0,0.0,2500.0,2500.0,2000.0,1500.0,3000.0,2000.0,0.0,22500.0
Khagaria,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,470.0,2980.0,2620.0,2620.0,2270.0,0.0,2375.0,1775.0,1675.0,2218.0,2370.0,600.0,21973.0
Khagaria,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,20.0,430.0,1780.0,380.0,2880.0,325.0,225.0,50.0,1332.0,600.0,0.0,8022.0
Khagaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,350.0,6350.0,0.0,16700.0
Khagaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9270.0,9270.0
Khagaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,1700.0,0.0,0.0,0.0,535.0,0.0,2235.0
Khagaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,8300.0,0.0,0.0,350.0,5815.0,9270.0,23735.0
Khagaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,87224.0,0.0,85337.0,85337.0,83866.0,0.0,341764.0
Khagaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,132848.0,132848.0
Khagaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,844.0,0.0,1471.0,1417.0,1962.0,0.0,5694.0
Khagaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,86380.0,0.0,83866.0,83920.0,81904.0,132848.0,468918.0
Khagaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,28310.0,0.0,27345.0,27345.0,26922.0,0.0,109922.0
Khagaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15884.0,15884.0
Khagaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,362.0,0.0,423.0,423.0,920.0,0.0,2128.0
Khagaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,27948.0,0.0,26922.0,26922.0,26002.0,15884.0,123678.0
Khagaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,13413.0,0.0,16336.0,16336.0,16139.0,0.0,62224.0
Khagaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8664.0,8664.0
Khagaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,148.0,0.0,197.0,197.0,535.0,0.0,1077.0
Khagaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,13265.0,0.0,16139.0,16139.0,15604.0,8664.0,69811.0
Khagaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,30358.0,80058.0,70058.0,7330.0,66058.0,64058.0,57900.0,55700.0,49858.0,41700.0,41700.0,37700.0,602478.0
Khagaria,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,55700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,55700.0
Khagaria,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,10000.0,10000.0,2000.0,840.0,2000.0,0.0,2200.0,8000.0,8000.0,2000.0,4000.0,2000.0,51040.0
Khagaria,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,76058.0,70058.0,68058.0,6490.0,64058.0,64058.0,55700.0,47700.0,41858.0,39700.0,37700.0,35700.0,607138.0
Khagaria,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,72020.0,10000.0,8000.0,8000.0,7500.0,5500.0,4500.0,2500.0,2600.0,1000.0,1000.0,122620.0
Khagaria,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0
Khagaria,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,9500.0,1500.0,500.0,500.0,0.0,1000.0,2000.0,1500.0,800.0,500.0,500.0,18300.0
Khagaria,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,82520.0,8500.0,7500.0,7500.0,7500.0,4500.0,2500.0,1000.0,1800.0,500.0,500.0,124320.0
Khagaria,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,60000.0,25000.0,2000.0,10000.0,800.0,103800.0
Khagaria,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35000.0,23100.0,100.0,7000.0,800.0,66000.0
Khagaria,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,25000.0,1900.0,1900.0,3000.0,0.0,37800.0
Khagaria,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,180.0,0.0,0.0,0.0,180.0,180.0,180.0,200.0,180.0,180.0,180.0,180.0,1640.0
Khagaria,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,100.0,120.0
Khagaria,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,180.0,0.0,0.0,0.0,180.0,180.0,180.0,180.0,180.0,180.0,180.0,80.0,1520.0
Khagaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,687100.0,254950.0,38750.0,5450.0,350.0,750250.0,249950.0,129950.0,0.0,1000000.0,21300.0,0.0,3138050.0
Khagaria,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,750000.0,0.0,0.0,0.0,1000000.0,0.0,0.0,0.0,1750000.0
Khagaria,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,432150.0,216000.0,27000.0,5100.0,100.0,0.0,120000.0,110100.0,40000.0,800200.0,21300.0,0.0,1771950.0
Khagaria,16.3.07,Stock Position of IFA Tablets,5. Total Stock,254950.0,38950.0,11750.0,350.0,750250.0,750250.0,129950.0,19850.0,960000.0,199800.0,0.0,0.0,3116100.0
Khagaria,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,12040.0,0.0,504.0,238.0,188.0,8726.0,788.0,0.0,0.0,0.0,0.0,0.0,22484.0
Khagaria,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,12088.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12088.0
Khagaria,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,8440.0,0.0,144.0,100.0,3550.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,12734.0
Khagaria,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,3600.0,0.0,360.0,138.0,8726.0,8726.0,288.0,0.0,0.0,0.0,0.0,0.0,21838.0
Khagaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,6580.0,6580.0,330.0,0.0,0.0,0.0,20000.0,10000.0,10000.0,6000.0,0.0,0.0,59490.0
Khagaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,2000.0,6250.0,100.0,0.0,0.0,0.0,10000.0,2000.0,2000.0,2000.0,0.0,0.0,24350.0
Khagaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,4580.0,330.0,230.0,0.0,0.0,0.0,10000.0,8000.0,8000.0,4000.0,0.0,0.0,35140.0
Khagaria,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,5000.0,5000.0,5000.0,5000.0,5000.0,1004.0,1004.0,1004.0,1004.0,1004.0,1000.0,1000.0,32020.0
Khagaria,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,1000.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Khagaria,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,4000.0,4996.0,4996.0,0.0,0.0,4.0,4.0,4.0,1000.0,0.0,15004.0
Khagaria,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,5000.0,5000.0,1000.0,1004.0,1004.0,1004.0,1004.0,1000.0,1000.0,1000.0,0.0,1000.0,19016.0
Khagaria,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,156310.0,95310.0,206560.0,163733.0,31233.0,6093.0,24458.0,23258.0,14858.0,0.0,20568.0,10550.0,752931.0
Khagaria,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,61000.0,68200.0,79150.0,132500.0,25140.0,0.0,1200.0,8400.0,6100.0,0.0,9416.0,5450.0,396556.0
Khagaria,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,95310.0,27110.0,127410.0,31233.0,6093.0,6093.0,23258.0,14858.0,8758.0,0.0,11152.0,5100.0,356375.0
Khagaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8000.0,2000.0,200.0,1100.0,10300.0,4500.0,4000.0,1800.0,500.0,4000.0,700.0,2700.0,39800.0
Khagaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,10000.0,8000.0,1500.0,0.0,3000.0,6000.0,0.0,4500.0,0.0,6000.0,0.0,39000.0
Khagaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2600.0,6000.0,5800.0,5800.0,5800.0,3000.0,6300.0,1300.0,3000.0,2900.0,4000.0,2500.0,49000.0
Khagaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5400.0,6000.0,2400.0,-3200.0,4500.0,4500.0,3700.0,500.0,2000.0,1100.0,2700.0,200.0,29800.0
Khagaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,15000.0,5000.0,3800.0,4500.0,57700.0,8900.0,0.0,2500.0,100.0,1800.0,600.0,15500.0,115400.0
Khagaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,50000.0,50000.0,100000.0,0.0,50000.0,100000.0,0.0,6000.0,0.0,72800.0,0.0,428800.0
Khagaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khagaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,5000.0,54800.0,46800.0,46800.0,48800.0,45000.0,90400.0,2400.0,59600.0,1300.0,57900.0,13100.0,471900.0
Khagaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,10000.0,200.0,7000.0,57700.0,8900.0,13900.0,9600.0,100.0,-53500.0,500.0,15500.0,2400.0,72300.0
Khagaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,300.0,500.0,500.0,2100.0,4500.0,200.0,500.0,400.0,0.0,1000.0,200.0,0.0,10200.0
Khagaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,5000.0,5000.0,5000.0,0.0,5000.0,4000.0,0.0,2600.0,0.0,0.0,0.0,26600.0
Khagaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,4400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4400.0
Khagaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,300.0,5400.0,4400.0,2700.0,4300.0,4800.0,3900.0,400.0,2600.0,800.0,200.0,0.0,29800.0
Khagaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,100.0,1100.0,0.0,200.0,400.0,600.0,0.0,0.0,200.0,0.0,0.0,2600.0
Khagaria,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Khagaria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Khagaria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khagaria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Khagaria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Khagaria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khagaria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Khagaria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Khagaria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khagaria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Khagaria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Khagaria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khagaria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Khagaria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khagaria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khagaria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Khagaria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khagaria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khagaria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Khagaria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khagaria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khagaria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Khagaria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khagaria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khagaria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Khagaria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Khagaria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Khagaria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Khagaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Khagaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Khagaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Khagaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Khagaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Khagaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Khagaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Khagaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Khagaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Khagaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Khagaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Khagaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Khagaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Khagaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Khagaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Khagaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Khagaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Khagaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Khagaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Khagaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Khagaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Khagaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Khagaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Khagaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Khagaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Khagaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Khagaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Khagaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Khagaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Kishanganj,1.1,Total number of pregnant women Registered for ANC,TOTAL,5994.0,6329.0,5511.0,6633.0,6685.0,6755.0,5506.0,5748.0,5405.0,5256.0,5477.0,5408.0,70707.0
Kishanganj,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1904.0,2035.0,1781.0,2068.0,1980.0,1822.0,1792.0,1572.0,1471.0,1529.0,1736.0,1794.0,21484.0
Kishanganj,1.2,Number of Pregnant women registered under JSY,TOTAL,4304.0,4185.0,3613.0,4355.0,4674.0,4714.0,3727.0,3709.0,3279.0,3256.0,3820.0,3734.0,47370.0
Kishanganj,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2431.0,2324.0,2201.0,2517.0,2479.0,2741.0,2567.0,2494.0,2440.0,2222.0,2177.0,2291.0,28884.0
Kishanganj,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3633.0,3504.0,3107.0,3674.0,3547.0,3522.0,2651.0,2684.0,2467.0,2373.0,2550.0,2601.0,36313.0
Kishanganj,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3667.0,3948.0,3390.0,3844.0,4268.0,5151.0,4165.0,3875.0,3612.0,3332.0,3134.0,3788.0,46174.0
Kishanganj,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2057.0,1414.0,1263.0,1212.0,1213.0,820.0,2194.0,2145.0,2339.0,2114.0,1845.0,3297.0,21913.0
Kishanganj,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,125.0,174.0,97.0,113.0,158.0,67.0,113.0,188.0,89.0,93.0,37.0,183.0,1437.0
Kishanganj,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,23.0,19.0,10.0,5.0,4.0,6.0,12.0,9.0,6.0,4.0,1.0,15.0,114.0
Kishanganj,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1225.0,1127.0,1114.0,1634.0,1826.0,1646.0,1025.0,1071.0,1005.0,1142.0,929.0,1137.0,14881.0
Kishanganj,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,208.0,220.0,209.0,190.0,172.0,182.0,157.0,127.0,185.0,204.0,3.0,152.0,2009.0
Kishanganj,1.8,Number of pregnancy test kits used at SC level,TOTAL,424.0,446.0,493.0,854.0,1105.0,1066.0,868.0,652.0,1229.0,928.0,451.0,578.0,9094.0
Kishanganj,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,21.0,30.0,40.0,35.0,44.0,30.0,37.0,88.0,94.0,43.0,76.0,29.0,567.0
Kishanganj,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1076.0,1058.0,693.0,958.0,852.0,959.0,1005.0,1184.0,1124.0,1226.0,1117.0,1069.0,12321.0
Kishanganj,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1097.0,1088.0,733.0,993.0,896.0,989.0,1042.0,1272.0,1218.0,1269.0,1193.0,1098.0,12888.0
Kishanganj,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,410.0,428.0,244.0,401.0,253.0,342.0,331.0,505.0,489.0,469.0,496.0,420.0,4788.0
Kishanganj,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0,8.0,7.0,34.0
Kishanganj,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1587.0,1587.0,1273.0,1724.0,1821.0,1809.0,1918.0,1948.0,1957.0,1984.0,1888.0,1631.0,21127.0
Kishanganj,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1577.0,1560.0,1260.0,1690.0,1802.0,1789.0,1879.0,1931.0,1929.0,1950.0,1862.0,1611.0,20840.0
Kishanganj,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1312.0,1062.0,90.0,910.0,509.0,808.0,987.0,1852.0,2017.0,2733.0,2092.0,4106.0,18478.0
Kishanganj,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,675.0,636.0,100.0,631.0,630.0,644.0,338.0,581.0,739.0,784.0,1095.0,1371.0,8224.0
Kishanganj,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,,,,,,,,,,,,0.0
Kishanganj,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,,,,,,,,,,,0.0
Kishanganj,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,,,,,,,,,,,0.0
Kishanganj,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,,,,,,,,,,,,0.0
Kishanganj,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,10.0,17.0,13.0,13.0,19.0,20.0,17.0,17.0,16.0,20.0,15.0,9.0,186.0
Kishanganj,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kishanganj,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,10.0,17.0,13.0,13.0,19.0,20.0,17.0,17.0,16.0,20.0,15.0,9.0,186.0
Kishanganj,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,,,,,,,,,,,,0.0
Kishanganj,4.1.1.a,Number of male live births,TOTAL,1462.0,1499.0,1135.0,1547.0,1552.0,1591.0,1649.0,1819.0,1842.0,1784.0,1648.0,1564.0,19092.0
Kishanganj,4.1.1.b,Number of female live births,TOTAL,1302.0,1266.0,965.0,1415.0,1490.0,1499.0,1620.0,1728.0,1603.0,1659.0,1514.0,1490.0,17551.0
Kishanganj,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2764.0,2765.0,2100.0,2962.0,3042.0,3090.0,3269.0,3547.0,3445.0,3443.0,3162.0,3054.0,36643.0
Kishanganj,4.1.2,Number of still births,TOTAL,94.0,50.0,58.0,71.0,79.0,89.0,71.0,94.0,76.0,92.0,73.0,77.0,924.0
Kishanganj,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,35.0,83.0,59.0,68.0,68.0,61.0,55.0,59.0,51.0,29.0,50.0,43.0,661.0
Kishanganj,4.2.1,Number of Newborns weighed at birth,TOTAL,2098.0,2113.0,1570.0,2074.0,2251.0,2281.0,2271.0,2556.0,2627.0,2816.0,2404.0,2432.0,27493.0
Kishanganj,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,125.0,112.0,109.0,146.0,133.0,175.0,170.0,177.0,166.0,157.0,282.0,151.0,1903.0
Kishanganj,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2330.0,2530.0,1866.0,2538.0,2537.0,2684.0,2864.0,2933.0,3029.0,3138.0,3022.0,2730.0,32201.0
Kishanganj,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,6.0,3.0,1.0,2.0,0.0,4.0,0.0,2.0,2.0,0.0,21.0
Kishanganj,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,107.0,32.0,125.0,40.0,161.0,58.0,22.0,29.0,64.0,65.0,63.0,69.0,835.0
Kishanganj,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kishanganj,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,107.0,33.0,131.0,43.0,162.0,60.0,22.0,33.0,64.0,67.0,65.0,69.0,856.0
Kishanganj,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,,,,,,,,,,,,0.0
Kishanganj,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,272.0,123.0,135.0,143.0,78.0,399.0,147.0,161.0,218.0,201.0,184.0,406.0,2467.0
Kishanganj,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,41.0,19.0,32.0,30.0,9.0,13.0,23.0,24.0,24.0,30.0,28.0,27.0,300.0
Kishanganj,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,391.0,291.0,260.0,300.0,78.0,161.0,137.0,149.0,194.0,182.0,175.0,406.0,2724.0
Kishanganj,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,46.0,47.0,38.0,73.0,61.0,58.0,50.0,56.0,46.0,43.0,18.0,61.0,597.0
Kishanganj,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1510.0,1764.0,1342.0,2061.0,2150.0,2015.0,2276.0,2213.0,2208.0,2253.0,2044.0,2100.0,23936.0
Kishanganj,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1421.0,1096.0,929.0,1343.0,1415.0,1488.0,1481.0,1409.0,1307.0,1248.0,1135.0,1207.0,15479.0
Kishanganj,6.3,PNC maternal complications attended,TOTAL,14.0,1.0,1.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,72.0,41.0,133.0
Kishanganj,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,7.2,Number of MTPs conducted at Private Facilities,TOTAL,29.0,63.0,55.0,53.0,59.0,56.0,44.0,53.0,45.0,23.0,0.0,36.0,516.0
Kishanganj,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,98.0,0.0,130.0,176.0,0.0,56.0,0.0,0.0,75.0,0.0,0.0,79.0,614.0
Kishanganj,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,216.0,0.0,213.0,248.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,677.0
Kishanganj,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,314.0,0.0,343.0,424.0,0.0,56.0,0.0,0.0,75.0,0.0,0.0,79.0,1291.0
Kishanganj,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,1097.0,1508.0,1338.0,1350.0,820.0,47.0,1131.0,800.0,1474.0,1339.0,1832.0,1784.0,14520.0
Kishanganj,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,,,,,1.0,,,,0.0,0.0,0.0,1.0
Kishanganj,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kishanganj,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kishanganj,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,3.0,1.0,,,,,,,,,,4.0
Kishanganj,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42.0,0.0,0.0,0.0,0.0,42.0
Kishanganj,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,0.0,0.0
Kishanganj,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kishanganj,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42.0,0.0,0.0,0.0,0.0,42.0
Kishanganj,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,31.0,0.0,0.0,1.0,0.0,40.0,0.0,0.0,2.0,0.0,,7.0,81.0
Kishanganj,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,110.0,37.0,14.0,75.0,116.0,146.0,105.0,298.0,152.0,332.0,477.0,660.0,2522.0
Kishanganj,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,11.0,0.0,8.0,4.0,31.0,33.0,29.0,118.0
Kishanganj,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,40.0,22.0,7.0,3.0,5.0,10.0,9.0,32.0,22.0,44.0,54.0,65.0,313.0
Kishanganj,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kishanganj,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,150.0,59.0,21.0,78.0,123.0,167.0,114.0,338.0,178.0,407.0,564.0,754.0,2953.0
Kishanganj,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,48.0,72.0,69.0,28.0,75.0,35.0,57.0,28.0,49.0,0.0,103.0,,564.0
Kishanganj,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,11.0,2.0,3.0,3.0,3.0,22.0
Kishanganj,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kishanganj,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,2.0,3.0,3.0,3.0,22.0
Kishanganj,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,27.0,16.0,13.0,51.0,23.0,13.0,20.0,12.0,34.0,20.0,22.0,27.0,278.0
Kishanganj,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,234.0,252.0,232.0,1243.0,229.0,573.0,247.0,207.0,472.0,224.0,245.0,226.0,4384.0
Kishanganj,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,18.0,18.0,13.0,117.0,18.0,79.0,25.0,22.0,81.0,59.0,15.0,30.0,495.0
Kishanganj,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5.0,4.0,5.0,6.0,10.0,4.0,5.0,5.0,14.0,4.0,6.0,4.0,72.0
Kishanganj,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,121.0,105.0,87.0,151.0,119.0,91.0,53.0,67.0,79.0,82.0,71.0,31.0,1057.0
Kishanganj,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kishanganj,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,378.0,379.0,337.0,1517.0,376.0,747.0,330.0,301.0,646.0,369.0,337.0,291.0,6008.0
Kishanganj,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,68.0,74.0,15.0,15.0,17.0,0.0,9.0,18.0,36.0,86.0,66.0,73.0,477.0
Kishanganj,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,9.0,12.0,,10.0,13.0,,3.0,,4.0,,4.0,,55.0
Kishanganj,9.06,Number of IUCD removals,TOTAL,139.0,95.0,110.0,185.0,197.0,180.0,162.0,152.0,139.0,159.0,119.0,130.0,1767.0
Kishanganj,9.07,Number of Oral Pills cycles distributed,TOTAL,743.0,657.0,550.0,2476.0,678.0,958.0,1805.0,603.0,1175.0,576.0,656.0,481.0,11358.0
Kishanganj,9.08,Number of Condom pieces distributed,TOTAL,5127.0,2497.0,1270.0,11780.0,4257.0,4905.0,2401.0,12652.0,5741.0,2948.0,2884.0,2384.0,58846.0
Kishanganj,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,2.0,1.0,11.0
Kishanganj,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,198.0,73.0,58.0,165.0,108.0,93.0,84.0,94.0,436.0,58.0,70.0,99.0,1536.0
Kishanganj,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,20.0
Kishanganj,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,30.0,34.0
Kishanganj,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,4.0
Kishanganj,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Kishanganj,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3777.0,3643.0,2583.0,3763.0,3618.0,4189.0,3561.0,4496.0,4566.0,4583.0,4929.0,3782.0,47490.0
Kishanganj,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4552.0,3989.0,2811.0,3836.0,3032.0,4201.0,3613.0,4455.0,4035.0,812.0,73.0,62.0,35471.0
Kishanganj,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4843.0,4652.0,3226.0,4038.0,3436.0,3699.0,3369.0,3822.0,4443.0,4021.0,2761.0,937.0,43247.0
Kishanganj,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4250.0,4404.0,3412.0,4046.0,3664.0,3879.0,3413.0,3762.0,3838.0,3981.0,3902.0,2798.0,45349.0
Kishanganj,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3685.0,4698.0,4091.0,12474.0
Kishanganj,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0,1368.0,3178.0,4570.0
Kishanganj,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0,2.0,971.0,990.0
Kishanganj,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2164.0,2052.0,1561.0,2114.0,2192.0,2509.0,2478.0,2406.0,2796.0,2633.0,2467.0,2211.0,27583.0
Kishanganj,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4550.0,3974.0,2799.0,3747.0,2594.0,4183.0,3570.0,3993.0,3923.0,4285.0,4719.0,4207.0,46544.0
Kishanganj,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4849.0,4642.0,3218.0,3955.0,2949.0,3684.0,3257.0,3368.0,4234.0,4064.0,4008.0,4074.0,46302.0
Kishanganj,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4236.0,4431.0,3411.0,3996.0,3085.0,3888.0,3198.0,3297.0,3639.0,3997.0,3930.0,3715.0,44823.0
Kishanganj,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1493.0,1367.0,1111.0,1417.0,1385.0,1517.0,1530.0,1643.0,1837.0,1732.0,1572.0,1186.0,17790.0
Kishanganj,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4679.0,4042.0,2924.0,4060.0,3174.0,4103.0,3747.0,4436.0,4145.0,1008.0,216.0,124.0,36658.0
Kishanganj,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,4841.0,4640.0,3205.0,4047.0,3413.0,3605.0,3303.0,3767.0,4364.0,3921.0,2577.0,858.0,42541.0
Kishanganj,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4256.0,4433.0,3402.0,4063.0,3628.0,3772.0,3293.0,3693.0,3758.0,3841.0,3643.0,2818.0,44600.0
Kishanganj,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3452.0,3318.0,2446.0,3535.0,3313.0,4590.0,3255.0,4557.0,3180.0,4070.0,4866.0,3266.0,43848.0
Kishanganj,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3136.0,2728.0,1915.0,3199.0,2949.0,5530.0,3464.0,3856.0,2860.0,3645.0,5493.0,3769.0,42544.0
Kishanganj,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Kishanganj,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1683.0,1598.0,1187.0,1736.0,1587.0,2143.0,1556.0,2302.0,1552.0,1975.0,2118.0,1554.0,20991.0
Kishanganj,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1505.0,1454.0,1129.0,1471.0,1483.0,2036.0,1396.0,1919.0,1382.0,1782.0,2096.0,1419.0,19072.0
Kishanganj,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3188.0,3052.0,2316.0,3207.0,3070.0,4179.0,2952.0,4221.0,2934.0,3757.0,4214.0,2973.0,40063.0
Kishanganj,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3079.0,3095.0,2153.0,3458.0,3065.0,5106.0,3656.0,3345.0,3286.0,3430.0,4897.0,3687.0,42257.0
Kishanganj,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3060.0,3065.0,2150.0,3372.0,2683.0,4928.0,3380.0,3034.0,3081.0,3393.0,4875.0,3701.0,40722.0
Kishanganj,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,22.0,15.0,22.0,22.0,18.0,17.0,3.0,6.0,18.0,15.0,19.0,12.0,189.0
Kishanganj,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,733.0,581.0,303.0,702.0,582.0,1145.0,800.0,973.0,525.0,655.0,1072.0,737.0,8808.0
Kishanganj,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,630.0,541.0,276.0,701.0,528.0,1102.0,694.0,844.0,438.0,645.0,1134.0,671.0,8204.0
Kishanganj,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1363.0,1122.0,579.0,1403.0,1110.0,2247.0,1494.0,1817.0,963.0,1300.0,2206.0,1408.0,17012.0
Kishanganj,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,179.0,342.0,61.0,111.0,55.0,1739.0,1381.0,612.0,275.0,380.0,766.0,271.0,6172.0
Kishanganj,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,361.0,365.0,272.0,336.0,241.0,356.0,392.0,320.0,301.0,512.0,448.0,274.0,4178.0
Kishanganj,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,558.0,605.0,423.0,457.0,406.0,399.0,882.0,641.0,731.0,1710.0,862.0,487.0,8161.0
Kishanganj,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,21.0,3.0,10.0,6.0,21.0,28.0,4.0,10.0,0.0,103.0
Kishanganj,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,12.0,13.0,0.0,27.0,5.0,76.0,1.0,0.0,26.0,0.0,66.0,3.0,229.0
Kishanganj,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2598.0,2498.0,2435.0,2669.0,2389.0,2438.0,2441.0,2443.0,2477.0,2701.0,2629.0,2477.0,30195.0
Kishanganj,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2425.0,2395.0,2158.0,2509.0,2283.0,2370.0,2241.0,2310.0,2408.0,2313.0,2416.0,2313.0,28141.0
Kishanganj,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1775.0,1689.0,1450.0,1742.0,1480.0,1659.0,1588.0,1585.0,1729.0,1588.0,1596.0,1740.0,19621.0
Kishanganj,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3161.0,3041.0,2292.0,3417.0,3044.0,4422.0,3140.0,4333.0,3114.0,3833.0,4420.0,3175.0,41392.0
Kishanganj,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,952.0,1215.0,822.0,1231.0,1057.0,1911.0,948.0,1179.0,1231.0,815.0,1543.0,1222.0,14126.0
Kishanganj,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,15.0,65.0,44.0,62.0,43.0,70.0,157.0,64.0,115.0,50.0,76.0,65.0,826.0
Kishanganj,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,4.0,3.0,3.0,0.0,1.0,2.0,0.0,0.0,0.0,13.0
Kishanganj,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Kishanganj,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,2.0,3.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,9.0
Kishanganj,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,17.0,2.0,0.0,0.0,0.0,10.0,0.0,2.0,0.0,0.0,0.0,1.0,32.0
Kishanganj,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,192.0,251.0,294.0,510.0,633.0,674.0,552.0,751.0,674.0,540.0,547.0,549.0,6167.0
Kishanganj,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,33.0,30.0,8.0,6.0,0.0,0.0,0.0,0.0,0.0,77.0
Kishanganj,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,35.0,37.0,44.0,31.0,44.0,47.0,39.0,57.0,37.0,38.0,38.0,43.0,490.0
Kishanganj,13.1,Number of Patients operated for cataract,TOTAL,258.0,315.0,283.0,321.0,427.0,390.0,171.0,429.0,309.0,366.0,356.0,409.0,4034.0
Kishanganj,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,257.0,313.0,278.0,321.0,422.0,388.0,162.0,426.0,308.0,358.0,352.0,406.0,3991.0
Kishanganj,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,5.0,6.0,4.0,13.0,10.0,12.0,9.0,0.0,11.0,9.0,7.0,86.0
Kishanganj,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Kishanganj,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Kishanganj,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1128.0,1243.0,1159.0,1174.0,1230.0,1253.0,1264.0,1239.0,1259.0,1246.0,1191.0,1138.0,-1.0
Kishanganj,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Kishanganj,14.05,Number of RKS meetings held during the month,TOTAL,3.0,5.0,6.0,6.0,4.0,7.0,6.0,5.0,7.0,4.0,11.0,10.0,74.0
Kishanganj,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Kishanganj,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,906.0,888.0,627.0,584.0,542.0,853.0,554.0,664.0,891.0,905.0,797.0,697.0,8908.0
Kishanganj,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Kishanganj,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Kishanganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,762.0,933.0,916.0,982.0,1101.0,1071.0,807.0,917.0,944.0,919.0,908.0,2221.0,12481.0
Kishanganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2285.0,2309.0,2699.0,2831.0,2697.0,2759.0,2447.0,2605.0,2540.0,2790.0,2637.0,2772.0,31371.0
Kishanganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,604.0,670.0,635.0,837.0,814.0,758.0,619.0,748.0,716.0,712.0,707.0,650.0,8470.0
Kishanganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4065.0,3714.0,4071.0,4181.0,4583.0,4468.0,4437.0,5213.0,4959.0,5329.0,5157.0,3684.0,53861.0
Kishanganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1366.0,1603.0,1551.0,1819.0,1915.0,1829.0,1426.0,1665.0,1660.0,1631.0,1615.0,2871.0,20951.0
Kishanganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6350.0,6023.0,6770.0,7012.0,7280.0,7227.0,6884.0,7818.0,7499.0,8119.0,7794.0,6456.0,85232.0
Kishanganj,14.10.2.a,Number of death cases of Inpatient males,TOTAL,82.0,61.0,79.0,87.0,93.0,86.0,58.0,81.0,89.0,98.0,80.0,77.0,971.0
Kishanganj,14.10.2.b,Number of death cases of Inpatient females,TOTAL,49.0,46.0,50.0,56.0,51.0,48.0,46.0,62.0,52.0,50.0,40.0,46.0,596.0
Kishanganj,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,131.0,107.0,129.0,143.0,144.0,134.0,104.0,143.0,141.0,148.0,120.0,123.0,1567.0
Kishanganj,14.11,In-Patient Head Count at midnight,TOTAL,5018.0,5147.0,4649.0,5647.0,5229.0,5387.0,5306.0,5461.0,5317.0,5191.0,5077.0,5212.0,62641.0
Kishanganj,14.12.1,OPD attendance (All),TOTAL,113942.0,107421.0,104798.0,128041.0,128415.0,131616.0,106404.0,115610.0,108899.0,108673.0,110427.0,111334.0,1375580.0
Kishanganj,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1368.0,1384.0,1323.0,1581.0,1436.0,1456.0,1167.0,1848.0,1524.0,1856.0,1990.0,2156.0,19089.0
Kishanganj,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,224.0,27.0,167.0,60.0,75.0,47.0,42.0,93.0,141.0,206.0,261.0,92.0,1435.0
Kishanganj,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1811.0,2481.0,2357.0,2796.0,2707.0,2337.0,2005.0,2600.0,2324.0,2628.0,2613.0,2449.0,29108.0
Kishanganj,14.14.a,Number of patients given AYUSH treatment,TOTAL,11432.0,7581.0,10284.0,17336.0,15381.0,13456.0,9959.0,9793.0,4102.0,6825.0,8650.0,7664.0,122463.0
Kishanganj,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4044.0,5230.0,4979.0,2979.0,4429.0,4640.0,3588.0,3803.0,4628.0,4522.0,2645.0,4755.0,50242.0
Kishanganj,14.14.c,Number of Adolescents counselled,TOTAL,775.0,72.0,499.0,491.0,69.0,19.0,17.0,18.0,15.0,40.0,31.0,17.0,2063.0
Kishanganj,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6031.0,5917.0,4315.0,1247.0,4894.0,4301.0,3337.0,3788.0,4233.0,3631.0,4338.0,4536.0,50568.0
Kishanganj,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,802.0,647.0,513.0,42.0,598.0,688.0,446.0,568.0,675.0,585.0,644.0,738.0,6946.0
Kishanganj,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,794.0,668.0,790.0,881.0,1284.0,1105.0,1089.0,1234.0,1420.0,1578.0,976.0,697.0,12516.0
Kishanganj,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,25.0,16.0,9.0,15.0,15.0,21.0,12.0,14.0,12.0,11.0,23.0,14.0,187.0
Kishanganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,624.0,610.0,620.0,880.0,828.0,746.0,863.0,821.0,948.0,948.0,1085.0,994.0,9967.0
Kishanganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,19.0,8.0,6.0,16.0,10.0,18.0,6.0,13.0,13.0,16.0,10.0,8.0,143.0
Kishanganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1052.0,474.0,650.0,860.0,1311.0,1160.0,1084.0,1524.0,1672.0,1521.0,1365.0,807.0,13480.0
Kishanganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,5.0,0.0,1.0,3.0,1.0,4.0,3.0,0.0,18.0
Kishanganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2470.0,1752.0,2060.0,2621.0,3423.0,3011.0,3036.0,3579.0,4040.0,4047.0,3426.0,2498.0,35963.0
Kishanganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,45.0,24.0,15.0,31.0,30.0,39.0,19.0,30.0,26.0,31.0,36.0,22.0,348.0
Kishanganj,15.2,Number of Widal tests conducted,Number tested,237.0,6.0,43.0,175.0,0.0,103.0,123.0,61.0,29.0,38.0,226.0,259.0,1300.0
Kishanganj,15.3.a,Number of VDRL tests conducted on males,Number tested,1.0,377.0,126.0,0.0,0.0,0.0,0.0,0.0,0.0,40.0,0.0,0.0,544.0
Kishanganj,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,391.0,115.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,514.0
Kishanganj,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,3.0,449.0,98.0,2.0,0.0,35.0,16.0,39.0,38.0,40.0,14.0,5.0,739.0
Kishanganj,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,4.0,1217.0,339.0,2.0,8.0,35.0,16.0,39.0,38.0,80.0,14.0,5.0,1797.0
Kishanganj,15.4.1,Number of blood smears examined for Malaria,TOTAL,149.0,172.0,161.0,98.0,210.0,206.0,163.0,180.0,172.0,114.0,128.0,160.0,1913.0
Kishanganj,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,3.0,0.0,0.0,4.0,5.0,2.0,5.0,9.0,4.0,6.0,8.0,48.0
Kishanganj,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kishanganj,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1250.0,350.0,2000.0,980.0,1150.0,,2400.0,2350.0,1350.0,1400.0,1795.0,1650.0,16675.0
Kishanganj,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,4200.0,0.0,3200.0,2500.0,,2000.0,1000.0,1500.0,2000.0,1000.0,500.0,19900.0
Kishanganj,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2900.0,2200.0,1020.0,3030.0,2700.0,,2050.0,2000.0,1450.0,1605.0,1595.0,1000.0,21550.0
Kishanganj,16.1.1,Stock position of DPT vaccines,5. Total Stock,350.0,2350.0,980.0,1150.0,950.0,0.0,2350.0,1350.0,1400.0,1795.0,1200.0,1150.0,15025.0
Kishanganj,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,400.0,1717.0,2117.0
Kishanganj,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,600.0,600.0
Kishanganj,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Kishanganj,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,150.0,1900.0,2050.0
Kishanganj,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,250.0,417.0,667.0
Kishanganj,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1800.0,900.0,1200.0,330.0,355.0,,600.0,150.0,325.0,150.0,550.0,1050.0,7410.0
Kishanganj,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000.0,1900.0,0.0,1700.0,2200.0,,750.0,975.0,800.0,1625.0,1000.0,1000.0,12950.0
Kishanganj,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1900.0,1600.0,870.0,1675.0,1530.0,,1200.0,800.0,975.0,1225.0,1175.0,1750.0,14700.0
Kishanganj,16.1.2,Stock position of OPV vaccines,5. Total Stock,900.0,1200.0,330.0,355.0,1025.0,0.0,150.0,325.0,150.0,550.0,375.0,300.0,5660.0
Kishanganj,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,900.0,500.0,1300.0,650.0,900.0,,1250.0,1400.0,1350.0,1350.0,1005.0,1250.0,11855.0
Kishanganj,16.1.3,Stock position of TT vaccines,2. Stocks Received,1500.0,2300.0,0.0,2750.0,1750.0,,1200.0,1000.0,500.0,620.0,500.0,1000.0,13120.0
Kishanganj,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1900.0,1500.0,650.0,2500.0,1450.0,,1050.0,1050.0,500.0,965.0,705.0,1050.0,13320.0
Kishanganj,16.1.3,Stock position of TT vaccines,5. Total Stock,500.0,1300.0,650.0,900.0,1200.0,0.0,1400.0,1350.0,1350.0,1005.0,800.0,1200.0,11655.0
Kishanganj,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,2100.0,,,2100.0
Kishanganj,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,1700.0,,,1700.0
Kishanganj,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0,0.0,0.0,400.0
Kishanganj,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,800.0,600.0,1380.0,830.0,858.0,,1100.0,800.0,870.0,1150.0,1171.0,2271.0,11830.0
Kishanganj,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1100.0,2200.0,0.0,1300.0,1400.0,,800.0,1100.0,1150.0,1560.0,1500.0,1000.0,13110.0
Kishanganj,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1300.0,1420.0,550.0,1272.0,1258.0,,1100.0,1030.0,870.0,1539.0,900.0,1521.0,12760.0
Kishanganj,16.1.5,Stock position of BCG vaccines,5. Total Stock,600.0,1380.0,830.0,858.0,1000.0,0.0,800.0,870.0,1150.0,1171.0,1771.0,1750.0,12180.0
Kishanganj,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1850.0,650.0,700.0,30.0,430.0,,150.0,250.0,70.0,100.0,1050.0,300.0,5580.0
Kishanganj,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,1600.0,0.0,2700.0,2500.0,,1350.0,1800.0,1500.0,3500.0,2000.0,3000.0,20950.0
Kishanganj,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2200.0,1550.0,670.0,2300.0,1930.0,,1250.0,1980.0,1470.0,2550.0,2975.0,3100.0,21975.0
Kishanganj,16.1.6,Stock position of Measles vaccines,5. Total Stock,650.0,700.0,30.0,430.0,1000.0,0.0,250.0,70.0,100.0,1050.0,75.0,200.0,4555.0
Kishanganj,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,,0.0
Kishanganj,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1850.0,1330.0,2750.0,1770.0,2000.0,,1700.0,1200.0,700.0,650.0,643.0,993.0,15586.0
Kishanganj,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1500.0,3000.0,0.0,2400.0,900.0,,800.0,1000.0,1000.0,1600.0,1200.0,1000.0,14400.0
Kishanganj,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2020.0,1580.0,980.0,2170.0,1930.0,,1400.0,1500.0,1050.0,1607.0,550.0,943.0,15730.0
Kishanganj,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1330.0,2750.0,1770.0,2000.0,970.0,0.0,1100.0,700.0,650.0,643.0,1293.0,1050.0,14256.0
Kishanganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2495.0,2495.0,2495.0,2495.0,1295.0,1295.0,1295.0,995.0,2995.0,2995.0,2095.0,10815.0,33760.0
Kishanganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,2000.0,0.0,,,9270.0,11270.0
Kishanganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1200.0,1295.0,,300.0,0.0,0.0,900.0,500.0,5800.0,9995.0
Kishanganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2495.0,2495.0,2495.0,1295.0,0.0,1295.0,995.0,2995.0,2995.0,2095.0,1595.0,14285.0,35035.0
Kishanganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,20500.0,20500.0,17500.0,15500.0,57820.0,57820.0,57820.0,52780.0,47740.0,47740.0,47240.0,160034.0,602994.0
Kishanganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,80000.0,0.0,,0.0,0.0,0.0,,,,80000.0
Kishanganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,0.0
Kishanganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,18000.0,2000.0,37680.0,57820.0,,5040.0,5040.0,0.0,500.0,6300.0,128620.0,261000.0
Kishanganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,20500.0,2500.0,15500.0,57820.0,0.0,57820.0,52780.0,47740.0,47740.0,47240.0,40940.0,31414.0,421994.0
Kishanganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3100.0,3100.0,7100.0,5600.0,16800.0,16800.0,16800.0,,15300.0,15300.0,13100.0,30007.0,143007.0
Kishanganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,20000.0,0.0,,0.0,,0.0,,,,20000.0
Kishanganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0
Kishanganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1500.0,8800.0,16800.0,,500.0,,1200.0,2200.0,600.0,24600.0,56200.0
Kishanganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,3100.0,3100.0,5600.0,16800.0,0.0,16800.0,16300.0,0.0,14100.0,13100.0,12500.0,5407.0,106807.0
Kishanganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1248.0,1248.0,1648.0,1498.0,4848.0,4848.0,4848.0,,4198.0,4198.0,3898.0,14380.0,46860.0
Kishanganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,5000.0,0.0,,0.0,,0.0,,,,5000.0
Kishanganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0
Kishanganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,150.0,1650.0,4848.0,,200.0,,0.0,300.0,600.0,8300.0,16048.0
Kishanganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1248.0,1248.0,1498.0,4848.0,0.0,4848.0,4648.0,0.0,4198.0,3898.0,3298.0,6080.0,35812.0
Kishanganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,21.0,21.0,21.0,21.0,21.0,21.0,21.0,,21.0,,,,168.0
Kishanganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0
Kishanganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0
Kishanganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,21.0,,0.0,,0.0,,,,21.0
Kishanganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,21.0,21.0,21.0,21.0,0.0,21.0,21.0,0.0,21.0,0.0,0.0,0.0,147.0
Kishanganj,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,,,0.0,,,,,,,,0.0
Kishanganj,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kishanganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,12120.0,7820.0,15320.0,13420.0,8720.0,,11120.0,,12620.0,8220.0,9620.0,12820.0,111800.0
Kishanganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,12000.0,0.0,0.0,0.0,,0.0,,0.0,10000.0,,,22000.0
Kishanganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0
Kishanganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4300.0,4500.0,1900.0,4700.0,2100.0,,3300.0,,4400.0,8600.0,4700.0,8300.0,46800.0
Kishanganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,7820.0,15320.0,13420.0,8720.0,6620.0,0.0,7820.0,0.0,8220.0,9620.0,4920.0,4520.0,87000.0
Kishanganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,69568.0,13568.0,60768.0,50368.0,53368.0,,76668.0,,67268.0,28868.0,69068.0,78268.0,567780.0
Kishanganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,100000.0,0.0,43200.0,0.0,,0.0,,0.0,108000.0,,,251200.0
Kishanganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0
Kishanganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,56000.0,52800.0,10400.0,40200.0,34100.0,,48600.0,,38400.0,67800.0,37600.0,52600.0,438500.0
Kishanganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,13568.0,60768.0,50368.0,53368.0,19268.0,0.0,28068.0,0.0,28868.0,69068.0,31468.0,25668.0,380480.0
Kishanganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3253.0,553.0,2853.0,1453.0,3000.0,,4100.0,,5000.0,2900.0,4300.0,5100.0,32512.0
Kishanganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4800.0,0.0,5000.0,0.0,,0.0,,0.0,6000.0,,,15800.0
Kishanganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,,,0.0
Kishanganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2700.0,2500.0,1400.0,3453.0,2300.0,,2800.0,,2100.0,4600.0,2500.0,4400.0,28753.0
Kishanganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,553.0,2853.0,1453.0,3000.0,700.0,0.0,1300.0,0.0,2900.0,4300.0,1800.0,700.0,19559.0
Kishanganj,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Kishanganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kishanganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kishanganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Kishanganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kishanganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kishanganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Kishanganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kishanganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kishanganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Kishanganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kishanganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kishanganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Kishanganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kishanganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kishanganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Kishanganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kishanganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kishanganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kishanganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kishanganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kishanganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Kishanganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kishanganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kishanganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kishanganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Kishanganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Kishanganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Kishanganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Kishanganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Kishanganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Kishanganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Kishanganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Lakhisarai,1.1,Total number of pregnant women Registered for ANC,TOTAL,2085.0,1704.0,2352.0,2077.0,2290.0,2218.0,1979.0,2005.0,1985.0,2232.0,2475.0,2450.0,25852.0
Lakhisarai,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,714.0,703.0,767.0,837.0,1435.0,1409.0,1336.0,1453.0,1521.0,1833.0,2068.0,2155.0,16231.0
Lakhisarai,1.2,Number of Pregnant women registered under JSY,TOTAL,2085.0,1704.0,2352.0,2077.0,2290.0,2218.0,1979.0,2002.0,1985.0,2232.0,2475.0,2450.0,25849.0
Lakhisarai,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,997.0,964.0,1168.0,1354.0,1870.0,1987.0,1720.0,1845.0,1867.0,1885.0,2067.0,2216.0,19940.0
Lakhisarai,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1979.0,1597.0,2171.0,1881.0,1836.0,1883.0,1712.0,1748.0,1607.0,1992.0,2137.0,2162.0,22705.0
Lakhisarai,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1838.0,1742.0,1920.0,2120.0,2642.0,2306.0,2226.0,1875.0,1797.0,1958.0,2101.0,2305.0,24830.0
Lakhisarai,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,787.0,856.0,1084.0,1346.0,2110.0,2150.0,2004.0,1956.0,1998.0,2552.0,2558.0,2474.0,21875.0
Lakhisarai,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,14.0,22.0,54.0,66.0,99.0,62.0,7.0,24.0,58.0,25.0,0.0,1.0,432.0
Lakhisarai,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,4.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Lakhisarai,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,231.0,155.0,261.0,274.0,447.0,743.0,642.0,687.0,468.0,582.0,639.0,499.0,5628.0
Lakhisarai,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,4.0,2.0,2.0,8.0,15.0,22.0,35.0,11.0,4.0,7.0,6.0,117.0
Lakhisarai,1.8,Number of pregnancy test kits used at SC level,TOTAL,28.0,10.0,9.0,16.0,2.0,8.0,51.0,68.0,107.0,92.0,257.0,270.0,918.0
Lakhisarai,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,161.0,84.0,110.0,139.0,164.0,136.0,237.0,182.0,275.0,327.0,338.0,344.0,2497.0
Lakhisarai,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,203.0,169.0,217.0,282.0,415.0,479.0,434.0,552.0,540.0,385.0,340.0,269.0,4285.0
Lakhisarai,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,364.0,253.0,327.0,421.0,579.0,615.0,671.0,734.0,815.0,712.0,678.0,613.0,6782.0
Lakhisarai,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,237.0,196.0,248.0,314.0,443.0,523.0,476.0,548.0,458.0,479.0,580.0,579.0,5081.0
Lakhisarai,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,6.0
Lakhisarai,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1041.0,969.0,828.0,1188.0,1495.0,1510.0,1532.0,1456.0,1490.0,1211.0,1015.0,984.0,14719.0
Lakhisarai,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1038.0,966.0,818.0,1166.0,1494.0,1506.0,1527.0,1452.0,1442.0,1075.0,1015.0,979.0,14478.0
Lakhisarai,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,25.0,704.0,1025.0,1422.0,1389.0,1414.0,1263.0,1037.0,1619.0,1428.0,1084.0,2307.0,14717.0
Lakhisarai,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,141.0,1845.0,1479.0,966.0,1211.0,1068.0,970.0,1361.0,2023.0,937.0,899.0,12900.0
Lakhisarai,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Lakhisarai,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Lakhisarai,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Lakhisarai,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Lakhisarai,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,4.0,2.0,,9.0
Lakhisarai,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,3.0,3.0,1.0,3.0,1.0,4.0,4.0,4.0,1.0,6.0,4.0,3.0,37.0
Lakhisarai,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhisarai,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,3.0,3.0,1.0,3.0,1.0,6.0,5.0,4.0,1.0,10.0,6.0,3.0,46.0
Lakhisarai,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Lakhisarai,4.1.1.a,Number of male live births,TOTAL,720.0,587.0,574.0,854.0,1122.0,1155.0,1155.0,1117.0,1192.0,999.0,888.0,825.0,11188.0
Lakhisarai,4.1.1.b,Number of female live births,TOTAL,673.0,608.0,564.0,732.0,982.0,1067.0,1149.0,1079.0,1115.0,912.0,810.0,764.0,10455.0
Lakhisarai,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1393.0,1195.0,1138.0,1586.0,2104.0,2222.0,2304.0,2196.0,2307.0,1911.0,1698.0,1589.0,21643.0
Lakhisarai,4.1.2,Number of still births,TOTAL,22.0,32.0,18.0,30.0,15.0,42.0,34.0,34.0,27.0,27.0,23.0,21.0,325.0
Lakhisarai,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,3.0,5.0,1.0,2.0,6.0,5.0,3.0,4.0,3.0,5.0,1.0,5.0,43.0
Lakhisarai,4.2.1,Number of Newborns weighed at birth,TOTAL,1336.0,1157.0,1105.0,1548.0,2003.0,2147.0,2253.0,2029.0,2094.0,1789.0,1654.0,1583.0,20698.0
Lakhisarai,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,71.0,89.0,95.0,145.0,144.0,92.0,155.0,170.0,125.0,80.0,66.0,95.0,1327.0
Lakhisarai,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1362.0,1180.0,1118.0,1557.0,2063.0,2162.0,2277.0,2041.0,2089.0,1477.0,1657.0,1583.0,20566.0
Lakhisarai,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Lakhisarai,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,6.0,4.0,3.0,8.0,3.0,7.0,4.0,4.0,1.0,6.0,4.0,3.0,53.0
Lakhisarai,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhisarai,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,6.0,4.0,3.0,8.0,3.0,7.0,4.0,4.0,1.0,6.0,4.0,3.0,53.0
Lakhisarai,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Lakhisarai,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,1.0,8.0,1.0,4.0,4.0,4.0,1.0,0.0,4.0,3.0,30.0
Lakhisarai,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,6.0,4.0,1.0,5.0,2.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Lakhisarai,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,1.0,5.0,40.0,0.0,0.0,326.0,0.0,0.0,0.0,0.0,372.0
Lakhisarai,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1158.0,1062.0,895.0,983.0,1783.0,1801.0,1759.0,1638.0,1357.0,1316.0,1449.0,1393.0,16594.0
Lakhisarai,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,589.0,418.0,340.0,542.0,746.0,776.0,869.0,742.0,739.0,632.0,822.0,821.0,8036.0
Lakhisarai,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,4.0,9.0
Lakhisarai,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,99.0,113.0,137.0,153.0,100.0,152.0,151.0,91.0,0.0,0.0,47.0,1043.0
Lakhisarai,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0.0,182.0,145.0,148.0,141.0,137.0,98.0,187.0,85.0,0.0,0.0,67.0,1190.0
Lakhisarai,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,0.0,281.0,258.0,285.0,294.0,237.0,250.0,338.0,176.0,0.0,0.0,114.0,2233.0
Lakhisarai,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,3.0
Lakhisarai,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,,1.0,0.0,1.0,2.0,5.0,1.0,4.0,5.0,20.0
Lakhisarai,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,10.0,3.0,1.0,0.0,15.0
Lakhisarai,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhisarai,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,2.0,0.0,1.0,3.0,17.0,4.0,5.0,5.0,38.0
Lakhisarai,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0
Lakhisarai,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lakhisarai,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhisarai,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0
Lakhisarai,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,40.0,0.0,3.0,107.0,66.0,148.0,103.0,305.0,472.0,360.0,367.0,185.0,2156.0
Lakhisarai,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,9.0,0.0,1.0,30.0,13.0,31.0,15.0,122.0,132.0,116.0,144.0,71.0,684.0
Lakhisarai,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,28.0,10.0,7.0,32.0,19.0,54.0,34.0,144.0,357.0,105.0,147.0,90.0,1027.0
Lakhisarai,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhisarai,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,77.0,10.0,11.0,169.0,98.0,233.0,152.0,571.0,961.0,581.0,658.0,346.0,3867.0
Lakhisarai,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,9.0,0.0,0.0,0.0,8.0,0.0,,,435.0,452.0
Lakhisarai,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,36.0,38.0,29.0,15.0,121.0
Lakhisarai,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lakhisarai,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,2.0,0.0,4.0,1.0,1.0,5.0,5.0,3.0,1.0,23.0
Lakhisarai,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhisarai,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,1.0,2.0,2.0,4.0,1.0,2.0,41.0,43.0,32.0,16.0,144.0
Lakhisarai,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0
Lakhisarai,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,42.0,30.0,44.0,644.0,490.0,355.0,460.0,600.0,2197.0,1788.0,593.0,749.0,7992.0
Lakhisarai,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,16.0,9.0,13.0,219.0,175.0,285.0,257.0,309.0,366.0,313.0,193.0,134.0,2289.0
Lakhisarai,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,2.0,1.0,10.0,9.0,26.0,18.0,15.0,44.0,12.0,3.0,26.0,168.0
Lakhisarai,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,41.0,41.0,20.0,267.0,38.0,41.0,125.0,111.0,86.0,80.0,78.0,68.0,996.0
Lakhisarai,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lakhisarai,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,101.0,82.0,78.0,1140.0,712.0,707.0,860.0,1035.0,2693.0,2193.0,867.0,977.0,11445.0
Lakhisarai,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,31.0,37.0,16.0,47.0,34.0,41.0,79.0,10.0,62.0,62.0,67.0,71.0,557.0
Lakhisarai,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0
Lakhisarai,9.06,Number of IUCD removals,TOTAL,59.0,37.0,44.0,138.0,156.0,200.0,122.0,188.0,287.0,313.0,194.0,201.0,1939.0
Lakhisarai,9.07,Number of Oral Pills cycles distributed,TOTAL,405.0,103.0,279.0,1204.0,898.0,774.0,829.0,1030.0,5862.0,2592.0,2135.0,2193.0,18304.0
Lakhisarai,9.08,Number of Condom pieces distributed,TOTAL,3094.0,2764.0,3791.0,8959.0,10587.0,8188.0,8196.0,10496.0,22861.0,9318.0,13476.0,15170.0,116900.0
Lakhisarai,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,12.0,2.0,0.0,5.0,19.0,1.0,17.0,97.0,12.0,0.0,73.0,238.0
Lakhisarai,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,28.0,11.0,14.0,178.0,428.0,301.0,327.0,445.0,208.0,253.0,209.0,281.0,2683.0
Lakhisarai,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Lakhisarai,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1604.0,1197.0,1346.0,1801.0,2302.0,2606.0,2533.0,2558.0,2546.0,2210.0,1948.0,1826.0,24477.0
Lakhisarai,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1807.0,1239.0,1600.0,1650.0,1923.0,2229.0,2164.0,2623.0,2398.0,717.0,37.0,0.0,18387.0
Lakhisarai,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1977.0,1543.0,1618.0,1683.0,1956.0,1992.0,1988.0,2224.0,2456.0,2371.0,919.0,178.0,20905.0
Lakhisarai,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2073.0,1505.0,1720.0,1779.0,2012.0,2062.0,1968.0,1990.0,2093.0,2250.0,2123.0,1090.0,22665.0
Lakhisarai,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1701.0,2080.0,2036.0,5817.0
Lakhisarai,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1281.0,1955.0,3236.0
Lakhisarai,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,79.0,1215.0,1294.0
Lakhisarai,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1231.0,1090.0,1020.0,1440.0,1875.0,1985.0,1892.0,1644.0,1752.0,1348.0,1380.0,1632.0,18289.0
Lakhisarai,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1809.0,1221.0,1598.0,1632.0,1835.0,2230.0,1891.0,1489.0,2675.0,1759.0,2233.0,2064.0,22436.0
Lakhisarai,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1992.0,1486.0,1627.0,1689.0,1826.0,2012.0,1778.0,1293.0,2337.0,2074.0,2184.0,2282.0,22580.0
Lakhisarai,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2128.0,1433.0,1722.0,1762.0,1882.0,2013.0,1818.0,1163.0,2039.0,1813.0,2319.0,2295.0,22387.0
Lakhisarai,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1005.0,901.0,732.0,1088.0,1445.0,1465.0,1329.0,1328.0,1340.0,1056.0,1159.0,1479.0,14327.0
Lakhisarai,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1889.0,1250.0,1823.0,1601.0,1918.0,2242.0,2183.0,2759.0,2386.0,964.0,52.0,11.0,19078.0
Lakhisarai,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2143.0,1569.0,1673.0,1703.0,1970.0,1998.0,2003.0,2231.0,2433.0,2373.0,943.0,194.0,21233.0
Lakhisarai,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2332.0,1610.0,1831.0,1874.0,2078.0,2039.0,1959.0,2090.0,2092.0,2261.0,2127.0,1068.0,23361.0
Lakhisarai,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1358.0,1207.0,1778.0,1968.0,2232.0,1876.0,1865.0,2122.0,1385.0,1480.0,1596.0,1699.0,20566.0
Lakhisarai,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1493.0,953.0,1236.0,1339.0,1678.0,1481.0,1303.0,1387.0,993.0,1249.0,1234.0,1057.0,15403.0
Lakhisarai,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,70.0,12.0,0.0,0.0,85.0,58.0,823.0,1389.0,1232.0,1142.0,4811.0
Lakhisarai,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,769.0,649.0,898.0,1004.0,1169.0,951.0,945.0,956.0,709.0,774.0,844.0,941.0,10609.0
Lakhisarai,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,614.0,559.0,842.0,942.0,1022.0,923.0,919.0,910.0,632.0,686.0,728.0,754.0,9531.0
Lakhisarai,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1383.0,1208.0,1740.0,1946.0,2191.0,1874.0,1864.0,1866.0,1341.0,1460.0,1572.0,1695.0,20140.0
Lakhisarai,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1501.0,1040.0,1255.0,1278.0,1457.0,1451.0,1326.0,1108.0,1005.0,1214.0,1402.0,1459.0,15496.0
Lakhisarai,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1510.0,1009.0,1255.0,1261.0,1373.0,1434.0,1297.0,682.0,1043.0,1060.0,1417.0,1433.0,14774.0
Lakhisarai,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,508.0,322.0,380.0,481.0,506.0,359.0,319.0,407.0,288.0,386.0,343.0,248.0,4547.0
Lakhisarai,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,444.0,266.0,358.0,429.0,438.0,335.0,280.0,252.0,301.0,350.0,294.0,275.0,4022.0
Lakhisarai,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,952.0,588.0,738.0,910.0,944.0,694.0,599.0,659.0,589.0,736.0,637.0,523.0,8569.0
Lakhisarai,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,9.0,28.0,4.0,42.0
Lakhisarai,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,142.0,168.0,195.0,138.0,194.0,177.0,147.0,200.0,158.0,201.0,139.0,181.0,2040.0
Lakhisarai,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,235.0,201.0,296.0,205.0,312.0,281.0,218.0,302.0,313.0,310.0,284.0,243.0,3200.0
Lakhisarai,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,62.0,40.0,41.0,73.0,53.0,55.0,72.0,2.0,154.0,258.0,286.0,192.0,1288.0
Lakhisarai,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,186.0,191.0,189.0,569.0
Lakhisarai,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1242.0,1178.0,1160.0,1126.0,1120.0,1140.0,1193.0,1057.0,1080.0,1182.0,1128.0,1128.0,13734.0
Lakhisarai,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1227.0,1155.0,1128.0,1108.0,1116.0,1140.0,1189.0,1070.0,1078.0,1178.0,1115.0,1128.0,13632.0
Lakhisarai,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1173.0,1109.0,1056.0,1059.0,971.0,1081.0,1072.0,1007.0,1019.0,1030.0,1010.0,1014.0,12601.0
Lakhisarai,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,145.0,3.0,0.0,0.0,0.0,29.0,407.0,1024.0,840.0,773.0,3221.0
Lakhisarai,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,171.0,87.0,260.0,1353.0,396.0,377.0,367.0,477.0,298.0,343.0,751.0,729.0,5609.0
Lakhisarai,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,45.0,22.0,41.0,6289.0,66.0,42.0,45.0,83.0,100.0,98.0,153.0,111.0,7095.0
Lakhisarai,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,2.0,3.0,8221.0,13.0,21.0,11.0,30.0,11.0,28.0,65.0,109.0,8514.0
Lakhisarai,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,5.0,3.0,0.0,3.0,3.0,4.0,4.0,0.0,9.0,0.0,0.0,31.0
Lakhisarai,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,85.0,80.0,102.0,173.0,281.0,162.0,134.0,77.0,102.0,186.0,67.0,77.0,1526.0
Lakhisarai,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,2.0,0.0,2.0,2.0,4.0,0.0,2.0,0.0,0.0,0.0,0.0,14.0
Lakhisarai,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Lakhisarai,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Lakhisarai,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,570.0,567.0,562.0,575.0,580.0,575.0,575.0,539.0,573.0,576.0,575.0,575.0,-1.0
Lakhisarai,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Lakhisarai,14.05,Number of RKS meetings held during the month,TOTAL,2.0,4.0,7.0,7.0,6.0,5.0,4.0,6.0,4.0,3.0,5.0,555.0,608.0
Lakhisarai,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Lakhisarai,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,343.0,385.0,306.0,583.0,1038.0,1092.0,1083.0,1244.0,1425.0,929.0,862.0,1078.0,10368.0
Lakhisarai,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Lakhisarai,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Lakhisarai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,589.0,431.0,398.0,595.0,759.0,786.0,715.0,645.0,631.0,588.0,547.0,521.0,7205.0
Lakhisarai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,234.0,263.0,364.0,405.0,562.0,502.0,396.0,479.0,450.0,631.0,660.0,822.0,5768.0
Lakhisarai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,447.0,450.0,396.0,495.0,672.0,634.0,738.0,617.0,648.0,433.0,492.0,1329.0,7351.0
Lakhisarai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1200.0,1473.0,1195.0,1788.0,1829.0,2462.0,2142.0,2324.0,2632.0,2369.0,2426.0,1196.0,23036.0
Lakhisarai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1036.0,881.0,794.0,1090.0,1431.0,1420.0,1453.0,1262.0,1279.0,1021.0,1039.0,1850.0,14556.0
Lakhisarai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1434.0,1736.0,1559.0,2193.0,2391.0,2964.0,2538.0,2803.0,3082.0,3000.0,3086.0,2018.0,28804.0
Lakhisarai,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,6.0,0.0,4.0,1.0,2.0,1.0,0.0,5.0,2.0,1.0,5.0,30.0
Lakhisarai,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,1.0,0.0,1.0,1.0,2.0,1.0,1.0,2.0,0.0,1.0,1.0,12.0
Lakhisarai,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,4.0,7.0,0.0,5.0,2.0,4.0,2.0,1.0,7.0,2.0,2.0,6.0,42.0
Lakhisarai,14.11,In-Patient Head Count at midnight,TOTAL,1537.0,1602.0,1480.0,2476.0,3512.0,3653.0,3614.0,3746.0,4217.0,3750.0,3679.0,3461.0,36727.0
Lakhisarai,14.12.1,OPD attendance (All),TOTAL,45746.0,41094.0,49505.0,60500.0,80064.0,74679.0,68934.0,62649.0,61785.0,60837.0,61503.0,59851.0,727147.0
Lakhisarai,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,58.0,10.0,17.0,72.0,83.0,244.0,279.0,433.0,930.0,649.0,699.0,399.0,3873.0
Lakhisarai,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,3.0,3.0,1.0,3.0,1.0,7.0,2.0,4.0,1.0,10.0,4.0,3.0,42.0
Lakhisarai,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,342.0,411.0,593.0,794.0,1399.0,1429.0,1378.0,1611.0,1137.0,1463.0,1339.0,1563.0,13459.0
Lakhisarai,14.14.a,Number of patients given AYUSH treatment,TOTAL,6840.0,7571.0,7867.0,9265.0,12491.0,11208.0,12667.0,14910.0,5375.0,5733.0,6385.0,9517.0,109829.0
Lakhisarai,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1875.0,2001.0,2508.0,2604.0,2819.0,2885.0,2264.0,3088.0,2794.0,3091.0,2900.0,2645.0,31474.0
Lakhisarai,14.14.c,Number of Adolescents counselled,TOTAL,25.0,5.0,55.0,90.0,65.0,511.0,52.0,37.0,65.0,379.0,459.0,507.0,2250.0
Lakhisarai,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,591.0,1110.0,1021.0,1239.0,1514.0,1690.0,1434.0,1879.0,1885.0,2394.0,2035.0,1781.0,18573.0
Lakhisarai,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,12.0,12.0,21.0,6.0,25.0,40.0,32.0,49.0,24.0,17.0,17.0,13.0,268.0
Lakhisarai,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,680.0,562.0,593.0,651.0,632.0,198.0,575.0,581.0,577.0,549.0,302.0,766.0,6666.0
Lakhisarai,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,4.0,4.0,1.0,2.0,2.0,1.0,1.0,2.0,0.0,0.0,0.0,22.0
Lakhisarai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,754.0,407.0,388.0,581.0,253.0,315.0,591.0,1090.0,1401.0,1084.0,671.0,964.0,8499.0
Lakhisarai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,0.0,1.0,3.0,2.0,2.0,2.0,3.0,3.0,1.0,0.0,0.0,21.0
Lakhisarai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,869.0,654.0,599.0,754.0,345.0,488.0,947.0,842.0,882.0,712.0,444.0,806.0,8342.0
Lakhisarai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2303.0,1623.0,1580.0,1986.0,1230.0,1001.0,2113.0,2513.0,2860.0,2345.0,1417.0,2536.0,23507.0
Lakhisarai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,9.0,4.0,5.0,4.0,4.0,4.0,3.0,4.0,5.0,1.0,0.0,0.0,43.0
Lakhisarai,15.2,Number of Widal tests conducted,Number tested,0.0,11.0,6.0,54.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,91.0
Lakhisarai,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,36.0,47.0,73.0,87.0,56.0,52.0,55.0,14.0,0.0,0.0,40.0,460.0
Lakhisarai,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,52.0,46.0,46.0,49.0,47.0,46.0,43.0,8.0,0.0,0.0,57.0,394.0
Lakhisarai,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,18.0,10.0,82.0,34.0,31.0,40.0,0.0,0.0,0.0,88.0,303.0
Lakhisarai,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,88.0,111.0,129.0,218.0,137.0,129.0,138.0,22.0,0.0,0.0,185.0,1157.0
Lakhisarai,15.4.1,Number of blood smears examined for Malaria,TOTAL,139.0,202.0,445.0,733.0,490.0,693.0,557.0,320.0,384.0,172.0,186.0,436.0,4757.0
Lakhisarai,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,2.0,0.0,4.0,57.0,6.0,5.0,4.0,2.0,0.0,6.0,1.0,89.0
Lakhisarai,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,1.0,3.0,6.0,15.0,1.0,1.0,1.0,2.0,0.0,30.0
Lakhisarai,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1099.0,1344.0,1194.0,294.0,1744.0,1394.0,,1459.0,2494.0,1944.0,2034.0,1834.0,16834.0
Lakhisarai,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1500.0,0.0,0.0,2000.0,1000.0,2000.0,,1800.0,0.0,500.0,0.0,0.0,8800.0
Lakhisarai,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1255.0,150.0,900.0,550.0,1350.0,1315.0,,765.0,550.0,410.0,200.0,694.0,8139.0
Lakhisarai,16.1.1,Stock position of DPT vaccines,5. Total Stock,1344.0,1194.0,294.0,1744.0,1394.0,2079.0,0.0,2494.0,1944.0,2034.0,1834.0,1140.0,17495.0
Lakhisarai,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,760.0,1510.0,2270.0
Lakhisarai,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,1900.0,1100.0,0.0,3000.0
Lakhisarai,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,1140.0,350.0,750.0,2240.0
Lakhisarai,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,760.0,1510.0,760.0,3030.0
Lakhisarai,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,150.0,325.0,885.0,368.0,138.0,81.0,,0.0,75.0,25.0,0.0,0.0,2047.0
Lakhisarai,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1400.0,1110.0,600.0,700.0,1000.0,250.0,,425.0,425.0,200.0,500.0,800.0,7410.0
Lakhisarai,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1225.0,550.0,1117.0,930.0,1057.0,331.0,,350.0,475.0,225.0,500.0,800.0,7560.0
Lakhisarai,16.1.2,Stock position of OPV vaccines,5. Total Stock,325.0,885.0,368.0,138.0,81.0,0.0,0.0,75.0,25.0,0.0,0.0,0.0,1897.0
Lakhisarai,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,448.0,1948.0,1723.0,1023.0,1813.0,1838.0,,1628.0,2763.0,2363.0,2585.0,2335.0,20467.0
Lakhisarai,16.1.3,Stock position of TT vaccines,2. Stocks Received,2500.0,0.0,0.0,1200.0,1000.0,1000.0,,1800.0,0.0,500.0,0.0,0.0,8000.0
Lakhisarai,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Lakhisarai,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1000.0,225.0,700.0,410.0,975.0,760.0,,665.0,400.0,278.0,250.0,800.0,6463.0
Lakhisarai,16.1.3,Stock position of TT vaccines,5. Total Stock,1948.0,1723.0,1023.0,1813.0,1838.0,2078.0,0.0,2763.0,2363.0,2585.0,2335.0,1535.0,22004.0
Lakhisarai,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,300.0,276.0,226.0,550.0,1160.0,1120.0,1120.0,770.0,920.0,670.0,520.0,1020.0,8652.0
Lakhisarai,16.1.5,Stock position of BCG vaccines,2. Stocks Received,886.0,0.0,800.0,1000.0,800.0,800.0,500.0,700.0,500.0,500.0,1000.0,500.0,7986.0
Lakhisarai,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,910.0,50.0,476.0,390.0,840.0,800.0,850.0,550.0,750.0,650.0,500.0,770.0,7536.0
Lakhisarai,16.1.5,Stock position of BCG vaccines,5. Total Stock,276.0,226.0,550.0,1160.0,1120.0,1120.0,770.0,920.0,670.0,520.0,1020.0,750.0,9102.0
Lakhisarai,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,777.0,1317.0,1047.0,232.0,712.0,50.0,0.0,50.0,0.0,50.0,0.0,0.0,4235.0
Lakhisarai,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,0.0,200.0,1500.0,400.0,650.0,650.0,700.0,700.0,700.0,500.0,1150.0,9150.0
Lakhisarai,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1460.0,270.0,915.0,1020.0,1062.0,700.0,600.0,750.0,650.0,750.0,500.0,1070.0,9747.0
Lakhisarai,16.1.6,Stock position of Measles vaccines,5. Total Stock,1317.0,1047.0,332.0,712.0,50.0,0.0,50.0,0.0,50.0,0.0,0.0,80.0,3638.0
Lakhisarai,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,,0.0,,0.0,0.0,0.0,0.0,50.0,100.0,0.0,0.0,150.0
Lakhisarai,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,0.0,,0.0,0.0,0.0,400.0,1000.0,0.0,400.0,1100.0,2900.0
Lakhisarai,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,0.0,,0.0,0.0,0.0,350.0,950.0,100.0,400.0,960.0,2760.0
Lakhisarai,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,100.0,0.0,0.0,140.0,290.0
Lakhisarai,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5.0,760.0,430.0,480.0,1310.0,1065.0,965.0,1015.0,1680.0,1480.0,1430.0,1630.0,12250.0
Lakhisarai,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2400.0,0.0,700.0,1600.0,1000.0,1000.0,1000.0,1450.0,500.0,500.0,500.0,0.0,10650.0
Lakhisarai,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1645.0,330.0,650.0,770.0,1245.0,1120.0,950.0,785.0,700.0,550.0,300.0,550.0,9595.0
Lakhisarai,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,760.0,430.0,480.0,1310.0,1065.0,945.0,1015.0,1680.0,1480.0,1430.0,1630.0,1080.0,13305.0
Lakhisarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,1500.0,0.0,0.0,6200.0,6200.0,13900.0
Lakhisarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,3000.0,0.0,0.0,,0.0,0.0,10000.0,0.0,0.0,13000.0
Lakhisarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,3000.0,0.0,0.0,,1500.0,0.0,3800.0,0.0,0.0,8300.0
Lakhisarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6200.0,6200.0,6200.0,18600.0
Lakhisarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25000.0,0.0,0.0,24000.0,24000.0,73000.0
Lakhisarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,100000.0,0.0,0.0,100000.0,0.0,0.0,60000.0,0.0,0.0,260000.0
Lakhisarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,100000.0,0.0,0.0,90000.0,25000.0,0.0,36000.0,0.0,0.0,251000.0
Lakhisarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,24000.0,24000.0,24000.0,82000.0
Lakhisarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,0.0,0.0,6500.0,6500.0,13500.0
Lakhisarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,6000.0,0.0,0.0,13000.0,0.0,0.0,15000.0,0.0,0.0,34000.0
Lakhisarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,6000.0,0.0,0.0,11750.0,500.0,0.0,8500.0,0.0,0.0,26750.0
Lakhisarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1250.0,0.0,0.0,6500.0,6500.0,6500.0,20750.0
Lakhisarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,1500.0
Lakhisarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,2000.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,7000.0
Lakhisarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,2000.0,0.0,0.0,4300.0,1500.0,0.0,0.0,0.0,0.0,7800.0
Lakhisarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,700.0,0.0,0.0,0.0,0.0,0.0,700.0
Lakhisarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,2250.0,1150.0,1050.0,1050.0,50.0,0.0,0.0,8000.0,2000.0,1500.0,1500.0,1500.0,20050.0
Lakhisarai,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,0.0,0.0,0.0,0.0,0.0,8000.0
Lakhisarai,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,1100.0,0.0,1000.0,1000.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,200.0,8300.0
Lakhisarai,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,1150.0,1150.0,50.0,50.0,50.0,0.0,8000.0,3000.0,2000.0,1500.0,1500.0,1300.0,19750.0
Lakhisarai,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,40000.0,8000.0,19000.0,400.0,15500.0,8000.0,8000.0,6000.0,104900.0
Lakhisarai,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,40000.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,41000.0
Lakhisarai,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,18000.0,0.0,0.0,0.0,0.0,0.0,2000.0,500.0,20500.0
Lakhisarai,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,40000.0,22000.0,8000.0,19000.0,400.0,16500.0,8000.0,6000.0,5500.0,125400.0
Lakhisarai,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,2200.0,0.0,5800.0,5800.0,2300.0,500.0,500.0,38700.0,12700.0,12700.0,12700.0,12700.0,106600.0
Lakhisarai,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,10000.0,0.0,0.0,0.0,0.0,38500.0,0.0,0.0,0.0,0.0,0.0,48500.0
Lakhisarai,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,2200.0,200.0,2000.0,3500.0,1800.0,0.0,300.0,25000.0,0.0,0.0,5000.0,5000.0,45000.0
Lakhisarai,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,9800.0,3800.0,2300.0,500.0,500.0,38700.0,13700.0,12700.0,12700.0,7700.0,7700.0,110100.0
Lakhisarai,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1000.0,261000.0,241000.0,121000.0,61000.0,190000.0,64800.0,606650.0,45500.0,0.0,135000.0,135000.0,1861950.0
Lakhisarai,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,260000.0,60000.0,0.0,0.0,0.0,0.0,570000.0,695000.0,0.0,0.0,0.0,0.0,1585000.0
Lakhisarai,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,120000.0,60000.0,60000.0,125200.0,28000.0,500000.0,0.0,0.0,80000.0,120000.0,1093200.0
Lakhisarai,16.3.07,Stock Position of IFA Tablets,5. Total Stock,261000.0,321000.0,121000.0,61000.0,1000.0,64800.0,606800.0,801650.0,45500.0,0.0,55000.0,15000.0,2353750.0
Lakhisarai,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,996.0,46.0,49.0,49.0,46.0,1186.0
Lakhisarai,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,1000.0
Lakhisarai,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,4.0,800.0,0.0,0.0,3.0,0.0,807.0
Lakhisarai,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,996.0,196.0,46.0,49.0,46.0,46.0,1379.0
Lakhisarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,2800.0,2200.0,1400.0,200.0,10.0,2723.0,2723.0,5223.0,1505.0,1505.0,1505.0,1505.0,23299.0
Lakhisarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,2500.0,0.0,0.0,0.0,0.0,0.0,2500.0
Lakhisarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,600.0,0.0,1200.0,190.0,0.0,0.0,,2800.0,0.0,0.0,0.0,0.0,4790.0
Lakhisarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,2200.0,2200.0,200.0,10.0,10.0,2723.0,5223.0,2423.0,1505.0,1505.0,1505.0,1505.0,21009.0
Lakhisarai,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,140.0,76.0,76.0,2778.0,38.0,28.0,,6.0,0.0,0.0,0.0,0.0,3142.0
Lakhisarai,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,2712.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,2712.0
Lakhisarai,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,64.0,10.0,10.0,2740.0,10.0,12.0,,6.0,0.0,0.0,0.0,0.0,2852.0
Lakhisarai,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,2788.0,66.0,66.0,38.0,28.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,3002.0
Lakhisarai,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,207500.0,41000.0,72897.0,73294.0,56897.0,46797.0,,46797.0,46697.0,46697.0,57543.0,46997.0,743116.0
Lakhisarai,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,41897.0,397.0,0.0,0.0,0.0,,0.0,0.0,10846.0,0.0,10846.0,63986.0
Lakhisarai,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,166500.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,20000.0,20000.0,216500.0
Lakhisarai,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,41000.0,82897.0,73294.0,73294.0,46897.0,46797.0,0.0,46797.0,46697.0,57543.0,37543.0,37843.0,590602.0
Lakhisarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7700.0,4300.0,3600.0,1700.0,8000.0,3600.0,1400.0,100.0,6800.0,4000.0,2500.0,0.0,43700.0
Lakhisarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,8000.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,10000.0,28000.0
Lakhisarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3400.0,700.0,1900.0,1700.0,4400.0,2200.0,1300.0,3300.0,2800.0,1500.0,2500.0,5000.0,30700.0
Lakhisarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4300.0,3600.0,1700.0,8000.0,3600.0,1400.0,100.0,6800.0,4000.0,2500.0,0.0,5000.0,41000.0
Lakhisarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,54000.0,18000.0,12000.0,41600.0,77200.0,40800.0,25800.0,6600.0,30800.0,4200.0,200.0,0.0,311200.0
Lakhisarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,37600.0,40000.0,0.0,0.0,0.0,50000.0,0.0,0.0,0.0,50000.0,177600.0
Lakhisarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lakhisarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,36000.0,6000.0,8000.0,4400.0,36400.0,0.0,19800.0,25800.0,26600.0,4000.0,250.0,38000.0,205250.0
Lakhisarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,18000.0,12000.0,41600.0,77200.0,40800.0,40800.0,6000.0,30800.0,4200.0,200.0,-50.0,12000.0,283550.0
Lakhisarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2733.0,433.0,0.0,5100.0,8100.0,5400.0,4800.0,4800.0,4300.0,2800.0,1700.0,1600.0,41766.0
Lakhisarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,5100.0,3000.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,4000.0,14100.0
Lakhisarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0
Lakhisarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2300.0,433.0,0.0,0.0,2700.0,600.0,0.0,2500.0,1500.0,1100.0,100.0,3500.0,14733.0
Lakhisarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,433.0,0.0,5100.0,8100.0,5400.0,4200.0,4800.0,4300.0,2800.0,1700.0,1600.0,2100.0,40533.0
Lakhisarai,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Lakhisarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lakhisarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lakhisarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Lakhisarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lakhisarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lakhisarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Lakhisarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lakhisarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lakhisarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Lakhisarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lakhisarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lakhisarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Lakhisarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lakhisarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lakhisarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Lakhisarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lakhisarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lakhisarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Lakhisarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lakhisarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lakhisarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Lakhisarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lakhisarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lakhisarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Lakhisarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Lakhisarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Lakhisarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Lakhisarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Lakhisarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Lakhisarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Lakhisarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Madhepura,1.1,Total number of pregnant women Registered for ANC,TOTAL,7334.0,7427.0,6360.0,5872.0,5786.0,5384.0,4611.0,4762.0,4970.0,5024.0,5605.0,6423.0,69558.0
Madhepura,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3797.0,3494.0,3344.0,2810.0,3042.0,3050.0,2547.0,2779.0,2882.0,2930.0,3407.0,3855.0,37937.0
Madhepura,1.2,Number of Pregnant women registered under JSY,TOTAL,7326.0,7361.0,6341.0,5843.0,5730.0,5349.0,4555.0,4661.0,4970.0,4985.0,5597.0,6423.0,69141.0
Madhepura,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3335.0,3168.0,3491.0,3340.0,3500.0,3252.0,3106.0,3263.0,3241.0,3164.0,3501.0,3579.0,39940.0
Madhepura,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4015.0,3903.0,3507.0,3065.0,2949.0,2910.0,2342.0,2471.0,2544.0,2626.0,3094.0,3482.0,36908.0
Madhepura,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5266.0,5758.0,5480.0,5311.0,5190.0,4754.0,4409.0,4215.0,4114.0,4191.0,4862.0,5164.0,58714.0
Madhepura,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4495.0,3255.0,3833.0,3157.0,6385.0,3110.0,5976.0,3820.0,2733.0,3646.0,2717.0,2851.0,45978.0
Madhepura,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,11.0,20.0,10.0,50.0,30.0,38.0,17.0,19.0,9.0,46.0,70.0,29.0,349.0
Madhepura,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,13.0,10.0,17.0,10.0,27.0,8.0,11.0,8.0,10.0,8.0,7.0,131.0
Madhepura,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,21.0,6.0,7.0,56.0,76.0,155.0,74.0,127.0,110.0,62.0,97.0,45.0,836.0
Madhepura,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,0.0,4.0,8.0,12.0,8.0,3.0,3.0,4.0,2.0,3.0,3.0,52.0
Madhepura,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,20.0,0.0,21.0,443.0,221.0,966.0,759.0,796.0,3226.0
Madhepura,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,21.0,33.0,15.0,33.0,45.0,25.0,28.0,33.0,15.0,5.0,21.0,8.0,282.0
Madhepura,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,959.0,887.0,1059.0,882.0,1011.0,1275.0,1548.0,1780.0,1692.0,1499.0,1272.0,1141.0,15005.0
Madhepura,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,980.0,920.0,1074.0,915.0,1056.0,1300.0,1576.0,1813.0,1707.0,1504.0,1293.0,1149.0,15287.0
Madhepura,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,185.0,269.0,293.0,144.0,171.0,200.0,340.0,326.0,473.0,523.0,438.0,270.0,3632.0
Madhepura,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,6.0,1.0,0.0,11.0,0.0,0.0,0.0,0.0,0.0,18.0
Madhepura,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2421.0,2382.0,2174.0,2778.0,4177.0,4762.0,5079.0,3957.0,3222.0,2580.0,2405.0,2092.0,38029.0
Madhepura,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2417.0,2374.0,2159.0,2744.0,3826.0,4746.0,5055.0,3928.0,3211.0,2549.0,2317.0,2081.0,37407.0
Madhepura,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1525.0,892.0,3128.0,2919.0,4165.0,4549.0,5117.0,3449.0,3138.0,2885.0,2376.0,2491.0,36634.0
Madhepura,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,972.0,508.0,2743.0,2951.0,6843.0,3053.0,4014.0,2529.0,3378.0,2405.0,2332.0,2883.0,34611.0
Madhepura,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Madhepura,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,14.0,5.0,10.0,34.0,20.0,22.0,14.0,16.0,11.0,20.0,19.0,10.0,195.0
Madhepura,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhepura,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,14.0,5.0,10.0,34.0,20.0,22.0,14.0,16.0,11.0,20.0,19.0,10.0,195.0
Madhepura,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,4.1.1.a,Number of male live births,TOTAL,1760.0,1686.0,1667.0,1938.0,2688.0,3052.0,3411.0,2906.0,2462.0,2086.0,1841.0,1699.0,27196.0
Madhepura,4.1.1.b,Number of female live births,TOTAL,1600.0,1575.0,1533.0,1758.0,2491.0,2932.0,3158.0,2827.0,2393.0,2005.0,1817.0,1521.0,25610.0
Madhepura,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3360.0,3261.0,3200.0,3696.0,5179.0,5984.0,6569.0,5733.0,4855.0,4091.0,3658.0,3220.0,52806.0
Madhepura,4.1.2,Number of still births,TOTAL,50.0,53.0,48.0,66.0,94.0,117.0,116.0,72.0,74.0,34.0,49.0,35.0,808.0
Madhepura,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,4.2.1,Number of Newborns weighed at birth,TOTAL,2984.0,3022.0,2921.0,3400.0,4756.0,5426.0,6097.0,4895.0,4286.0,3653.0,3356.0,2904.0,47700.0
Madhepura,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,109.0,144.0,104.0,189.0,222.0,254.0,227.0,191.0,124.0,112.0,106.0,95.0,1877.0
Madhepura,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3163.0,3171.0,3127.0,3603.0,5002.0,5644.0,6320.0,5253.0,4619.0,3859.0,3517.0,3120.0,50398.0
Madhepura,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,230.0,252.0,402.0,419.0,286.0,140.0,223.0,109.0,240.0,204.0,247.0,255.0,3007.0
Madhepura,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Madhepura,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,81.0,75.0,81.0,108.0,130.0,92.0,120.0,199.0,97.0,52.0,38.0,103.0,1176.0
Madhepura,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhepura,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,311.0,327.0,483.0,527.0,416.0,232.0,343.0,308.0,337.0,256.0,285.0,358.0,4183.0
Madhepura,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,229.0,255.0,237.0,240.0,418.0,224.0,261.0,314.0,290.0,211.0,215.0,334.0,3228.0
Madhepura,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,13.0,10.0,19.0,10.0,23.0,54.0,13.0,8.0,8.0,8.0,103.0,271.0
Madhepura,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,258.0,348.0,444.0,798.0,457.0,276.0,324.0,314.0,329.0,222.0,275.0,209.0,4254.0
Madhepura,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,4.0,0.0,7.0,19.0,18.0,0.0,21.0,8.0,6.0,4.0,11.0,3.0,101.0
Madhepura,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2177.0,2189.0,2247.0,2759.0,3331.0,4242.0,4893.0,3654.0,3021.0,2743.0,2238.0,1830.0,35324.0
Madhepura,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,979.0,1099.0,1329.0,1124.0,776.0,1274.0,1630.0,1644.0,2532.0,1363.0,1405.0,1631.0,16786.0
Madhepura,6.3,PNC maternal complications attended,TOTAL,2.0,0.0,4.0,2.0,0.0,0.0,0.0,0.0,14.0,0.0,399.0,0.0,421.0
Madhepura,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,32.0,45.0,38.0,50.0,50.0,30.0,60.0,48.0,50.0,60.0,60.0,50.0,573.0
Madhepura,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,218.0,200.0,212.0,150.0,200.0,210.0,280.0,232.0,250.0,320.0,250.0,360.0,2882.0
Madhepura,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,250.0,245.0,250.0,200.0,250.0,240.0,340.0,280.0,300.0,380.0,310.0,410.0,3455.0
Madhepura,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Madhepura,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Madhepura,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Madhepura,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhepura,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0
Madhepura,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Madhepura,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhepura,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,52.0,47.0,40.0,936.0,160.0,340.0,283.0,801.0,2056.0,1426.0,1523.0,846.0,8510.0
Madhepura,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Madhepura,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,42.0,25.0,5.0,22.0,44.0,89.0,94.0,134.0,192.0,203.0,238.0,138.0,1226.0
Madhepura,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhepura,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,94.0,72.0,45.0,958.0,204.0,429.0,377.0,935.0,2248.0,1629.0,1761.0,984.0,9736.0
Madhepura,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,11.0,15.0,107.0,36.0,45.0,41.0,68.0,323.0,545.0,575.0,655.0,2421.0
Madhepura,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Madhepura,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Madhepura,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,7.0,2.0,2.0,7.0,4.0,10.0,8.0,5.0,3.0,12.0,7.0,5.0,72.0
Madhepura,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhepura,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,7.0,2.0,5.0,7.0,4.0,10.0,8.0,5.0,3.0,12.0,7.0,5.0,75.0
Madhepura,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,159.0,95.0,117.0,377.0,228.0,175.0,146.0,267.0,246.0,321.0,287.0,214.0,2632.0
Madhepura,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,48.0,58.0,61.0,126.0,53.0,69.0,57.0,55.0,81.0,90.0,92.0,75.0,865.0
Madhepura,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Madhepura,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,14.0,5.0,4.0,22.0,6.0,5.0,8.0,4.0,6.0,2.0,5.0,2.0,83.0
Madhepura,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhepura,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,221.0,158.0,182.0,525.0,287.0,249.0,211.0,326.0,333.0,413.0,384.0,291.0,3580.0
Madhepura,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,154.0,82.0,96.0,169.0,172.0,177.0,172.0,79.0,125.0,164.0,188.0,236.0,1814.0
Madhepura,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Madhepura,9.06,Number of IUCD removals,TOTAL,86.0,71.0,50.0,140.0,149.0,144.0,93.0,101.0,156.0,118.0,110.0,106.0,1324.0
Madhepura,9.07,Number of Oral Pills cycles distributed,TOTAL,1629.0,1205.0,1711.0,2448.0,2646.0,2186.0,2498.0,3320.0,3040.0,2415.0,2806.0,2473.0,28377.0
Madhepura,9.08,Number of Condom pieces distributed,TOTAL,8062.0,5734.0,6119.0,13695.0,11064.0,9451.0,10234.0,9500.0,10820.0,10627.0,11340.0,10219.0,116865.0
Madhepura,9.09,Number of Centchroman (weekly) pills given,TOTAL,107.0,103.0,102.0,120.0,715.0,153.0,128.0,138.0,136.0,89.0,20.0,296.0,2107.0
Madhepura,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,66.0,29.0,2.0,28.0,94.0,135.0,145.0,20.0,2.0,27.0,40.0,4.0,592.0
Madhepura,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Madhepura,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4148.0,4175.0,4136.0,4447.0,6110.0,7025.0,7783.0,7053.0,6073.0,5159.0,4609.0,4177.0,64895.0
Madhepura,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4701.0,4481.0,4319.0,4339.0,4283.0,4850.0,5353.0,7263.0,7315.0,1489.0,0.0,0.0,48393.0
Madhepura,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,5288.0,4925.0,4228.0,4161.0,4258.0,4378.0,4080.0,5051.0,6364.0,6798.0,3667.0,1420.0,54618.0
Madhepura,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,5645.0,5397.0,4795.0,4480.0,4422.0,4590.0,4107.0,4404.0,4835.0,5822.0,5505.0,4326.0,58328.0
Madhepura,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5204.0,5762.0,4653.0,15619.0
Madhepura,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,2845.0,4835.0,7696.0
Madhepura,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,2273.0,2282.0
Madhepura,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3588.0,3231.0,3378.0,3597.0,4966.0,5705.0,6010.0,4910.0,4325.0,3730.0,3254.0,2908.0,49602.0
Madhepura,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4689.0,4481.0,4319.0,4339.0,4283.0,4850.0,5326.0,7263.0,7315.0,5802.0,5378.0,4584.0,62629.0
Madhepura,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5288.0,4925.0,4228.0,4161.0,4258.0,4378.0,4073.0,5078.0,6364.0,6712.0,5939.0,5938.0,61342.0
Madhepura,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5669.0,5397.0,4795.0,4480.0,4422.0,4590.0,4083.0,4404.0,4819.0,5772.0,5213.0,6242.0,59886.0
Madhepura,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2640.0,2465.0,2479.0,2689.0,4082.0,4459.0,4757.0,3689.0,3153.0,2588.0,2253.0,2021.0,37275.0
Madhepura,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4668.0,4477.0,4287.0,4339.0,4283.0,4834.0,5353.0,7243.0,7348.0,1236.0,95.0,0.0,48163.0
Madhepura,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,5267.0,4912.0,4232.0,4164.0,4258.0,4387.0,4080.0,5106.0,6394.0,6826.0,3843.0,1490.0,54959.0
Madhepura,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,5673.0,5373.0,4807.0,4490.0,4431.0,4561.0,4111.0,4397.0,4856.0,5842.0,5513.0,4310.0,58364.0
Madhepura,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4263.0,4706.0,5218.0,5710.0,5291.0,3928.0,4195.0,5005.0,4647.0,4487.0,4269.0,3754.0,55473.0
Madhepura,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4615.0,4160.0,3266.0,3463.0,2896.0,2292.0,2445.0,3002.0,3307.0,3938.0,4429.0,4488.0,42301.0
Madhepura,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2185.0,2453.0,2748.0,2960.0,2763.0,1976.0,2204.0,2545.0,2296.0,2234.0,2170.0,1871.0,28405.0
Madhepura,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2026.0,2214.0,2455.0,2666.0,2382.0,1844.0,1961.0,2253.0,2148.0,2108.0,1911.0,1741.0,25709.0
Madhepura,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4211.0,4667.0,5203.0,5626.0,5145.0,3820.0,4165.0,4798.0,4444.0,4342.0,4081.0,3612.0,54114.0
Madhepura,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4635.0,4477.0,3276.0,3515.0,2847.0,3046.0,2775.0,3239.0,3434.0,4195.0,4685.0,4893.0,45017.0
Madhepura,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4635.0,4477.0,3276.0,3515.0,2830.0,3046.0,2774.0,3244.0,3434.0,4141.0,4594.0,4926.0,44892.0
Madhepura,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,7.0,0.0,18.0,0.0,0.0,26.0,9.0,0.0,60.0
Madhepura,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,463.0,532.0,317.0,395.0,377.0,331.0,378.0,551.0,620.0,717.0,1126.0,1204.0,7011.0
Madhepura,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,424.0,483.0,281.0,375.0,343.0,364.0,336.0,540.0,616.0,694.0,1019.0,1073.0,6548.0
Madhepura,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,887.0,1015.0,598.0,770.0,720.0,695.0,714.0,1091.0,1236.0,1411.0,2145.0,2277.0,13559.0
Madhepura,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,0.0,0.0,77.0,146.0,215.0,243.0,356.0,447.0,411.0,359.0,495.0,2749.0
Madhepura,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,434.0,423.0,431.0,485.0,615.0,602.0,623.0,630.0,692.0,681.0,829.0,762.0,7207.0
Madhepura,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,722.0,713.0,695.0,784.0,828.0,911.0,978.0,1034.0,1060.0,916.0,1013.0,1006.0,10660.0
Madhepura,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,4.0,1.0,0.0,7.0
Madhepura,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1702.0,1701.0,1717.0,1737.0,1723.0,1733.0,1732.0,1706.0,1723.0,1677.0,1662.0,1668.0,20481.0
Madhepura,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1661.0,1705.0,1657.0,1722.0,1704.0,1730.0,1695.0,1649.0,1702.0,1680.0,1620.0,1626.0,20151.0
Madhepura,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1472.0,1518.0,1506.0,1544.0,1522.0,1509.0,1529.0,1498.0,1525.0,1553.0,1510.0,1533.0,18219.0
Madhepura,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4194.0,4692.0,5206.0,5410.0,5094.0,3822.0,4119.0,4930.0,4601.0,4452.0,4191.0,3749.0,54460.0
Madhepura,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1346.0,1589.0,1063.0,909.0,807.0,771.0,870.0,1043.0,850.0,915.0,1273.0,1219.0,12655.0
Madhepura,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3.0,7.0,16.0,20.0,10.0,3.0,6.0,4.0,7.0,60.0,4.0,0.0,140.0
Madhepura,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,10.0,4.0,0.0,0.0,5.0,0.0,0.0,19.0
Madhepura,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,914.0,1291.0,1005.0,1095.0,2134.0,1615.0,1341.0,1009.0,947.0,710.0,938.0,1013.0,14012.0
Madhepura,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,513.0,13.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,531.0
Madhepura,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,19.0,0.0,0.0,0.0,22.0
Madhepura,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,47.0,30.0,118.0,0.0,56.0,0.0,22.0,31.0,0.0,0.0,39.0,58.0,401.0
Madhepura,13.3,Number of School children detected with Refractive errors,TOTAL,8.0,7.0,7.0,8.0,6.0,65.0,7.0,13.0,9.0,9.0,0.0,0.0,139.0
Madhepura,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Madhepura,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Madhepura,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1443.0,1478.0,1463.0,1471.0,1474.0,1489.0,1479.0,1470.0,1481.0,1480.0,1448.0,1448.0,-1.0
Madhepura,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Madhepura,14.05,Number of RKS meetings held during the month,TOTAL,7.0,6.0,6.0,6.0,6.0,5.0,3.0,6.0,8.0,133.0,7.0,8.0,201.0
Madhepura,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Madhepura,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,503.0,433.0,671.0,543.0,543.0,626.0,821.0,632.0,864.0,791.0,712.0,527.0,7666.0
Madhepura,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Madhepura,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Madhepura,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,332.0,339.0,373.0,439.0,572.0,447.0,479.0,473.0,398.0,382.0,348.0,424.0,5006.0
Madhepura,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,735.0,786.0,712.0,933.0,887.0,884.0,1759.0,755.0,853.0,641.0,599.0,702.0,10246.0
Madhepura,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,271.0,298.0,342.0,290.0,618.0,359.0,423.0,381.0,367.0,311.0,296.0,411.0,4367.0
Madhepura,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2621.0,2643.0,2550.0,3950.0,4355.0,5229.0,4654.0,4925.0,5070.0,4124.0,4286.0,3207.0,47614.0
Madhepura,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,603.0,637.0,715.0,729.0,1190.0,806.0,902.0,854.0,765.0,693.0,644.0,835.0,9373.0
Madhepura,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3356.0,3429.0,3262.0,4883.0,5242.0,6113.0,6413.0,5680.0,5923.0,4765.0,4885.0,3909.0,57860.0
Madhepura,14.10.2.a,Number of death cases of Inpatient males,TOTAL,4.0,9.0,6.0,6.0,14.0,9.0,7.0,7.0,10.0,6.0,5.0,5.0,88.0
Madhepura,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,7.0,6.0,8.0,11.0,7.0,5.0,6.0,8.0,6.0,6.0,6.0,83.0
Madhepura,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,11.0,16.0,12.0,14.0,25.0,16.0,12.0,13.0,18.0,12.0,11.0,11.0,171.0
Madhepura,14.11,In-Patient Head Count at midnight,TOTAL,6427.0,5916.0,6366.0,8748.0,8476.0,9292.0,9783.0,9018.0,8874.0,8065.0,7920.0,7195.0,96080.0
Madhepura,14.12.1,OPD attendance (All),TOTAL,144280.0,138695.0,138193.0,158433.0,171284.0,185417.0,157119.0,152864.0,140794.0,139004.0,148100.0,150982.0,1825165.0
Madhepura,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,187.0,69.0,114.0,1054.0,261.0,482.0,405.0,977.0,1982.0,1314.0,1609.0,762.0,9216.0
Madhepura,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,51.0,0.0,0.0,0.0,0.0,0.0,23.0,0.0,0.0,108.0,44.0,226.0
Madhepura,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,696.0,879.0,809.0,1278.0,1166.0,961.0,844.0,974.0,1135.0,1100.0,1115.0,760.0,11717.0
Madhepura,14.14.a,Number of patients given AYUSH treatment,TOTAL,16277.0,19228.0,16084.0,19000.0,20734.0,25442.0,22397.0,18270.0,10679.0,18063.0,19178.0,19870.0,225222.0
Madhepura,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,6251.0,5618.0,5609.0,7265.0,8974.0,7003.0,5620.0,8046.0,7478.0,6402.0,5297.0,7363.0,80926.0
Madhepura,14.14.c,Number of Adolescents counselled,TOTAL,10.0,15.0,15.0,45.0,0.0,0.0,0.0,0.0,10.0,30.0,0.0,24.0,149.0
Madhepura,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,561.0,464.0,505.0,222.0,457.0,654.0,1006.0,1026.0,1294.0,1445.0,1163.0,858.0,9655.0
Madhepura,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,7.0,0.0,0.0,8.0,12.0,17.0,9.0,15.0,5.0,171.0,26.0,101.0,371.0
Madhepura,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,374.0,271.0,326.0,364.0,224.0,401.0,311.0,360.0,387.0,365.0,282.0,334.0,3999.0
Madhepura,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,2.0,1.0,5.0,1.0,3.0,2.0,1.0,2.0,1.0,2.0,1.0,22.0
Madhepura,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,426.0,239.0,502.0,569.0,493.0,641.0,569.0,619.0,750.0,765.0,710.0,628.0,6911.0
Madhepura,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,1.0,4.0,1.0,4.0,1.0,1.0,1.0,0.0,2.0,0.0,17.0
Madhepura,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,380.0,401.0,380.0,380.0,258.0,259.0,330.0,298.0,351.0,353.0,320.0,353.0,4063.0
Madhepura,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,3.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Madhepura,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1180.0,911.0,1208.0,1313.0,975.0,1301.0,1210.0,1277.0,1488.0,1483.0,1312.0,1315.0,14973.0
Madhepura,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,6.0,2.0,9.0,4.0,7.0,3.0,2.0,3.0,1.0,4.0,1.0,44.0
Madhepura,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,50.0
Madhepura,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0,150.0
Madhepura,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,200.0
Madhepura,15.4.1,Number of blood smears examined for Malaria,TOTAL,32.0,23.0,34.0,72.0,57.0,39.0,164.0,168.0,104.0,89.0,74.0,115.0,971.0
Madhepura,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0
Madhepura,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,850.0,550.0,550.0,1550.0,2850.0,3050.0,2150.0,1900.0,2900.0,3050.0,2150.0,1800.0,23350.0
Madhepura,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,2250.0,2500.0,3500.0,2000.0,1000.0,0.0,3000.0,2000.0,1000.0,1000.0,1000.0,21250.0
Madhepura,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2300.0,2250.0,1500.0,2200.0,1800.0,1900.0,2250.0,2000.0,1850.0,1900.0,1350.0,1500.0,22800.0
Madhepura,16.1.1,Stock position of DPT vaccines,5. Total Stock,550.0,550.0,1550.0,2850.0,3050.0,2150.0,-100.0,2900.0,3050.0,2150.0,1800.0,1300.0,21800.0
Madhepura,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2450.0,2450.0
Madhepura,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4800.0,,0.0,4800.0
Madhepura,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Madhepura,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0,,1150.0,2650.0
Madhepura,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3300.0,0.0,1300.0,4600.0
Madhepura,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1100.0,796.0,936.0,1336.0,1586.0,1386.0,1304.0,857.0,688.0,137.0,1280.0,643.0,12049.0
Madhepura,16.1.2,Stock position of OPV vaccines,2. Stocks Received,32400.0,1700.0,32500.0,2000.0,1200.0,1300.0,1650.0,32075.0,0.0,31539.0,33322.0,0.0,169686.0
Madhepura,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,32754.0,1700.0,32100.0,1750.0,1400.0,1475.0,2097.0,32405.0,650.0,31065.0,33245.0,0.0,170641.0
Madhepura,16.1.2,Stock position of OPV vaccines,5. Total Stock,746.0,796.0,1336.0,1586.0,1386.0,1211.0,857.0,527.0,38.0,611.0,1357.0,643.0,11094.0
Madhepura,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,550.0,700.0,1150.0,1550.0,2550.0,2150.0,2050.0,1300.0,1150.0,2100.0,2100.0,2350.0,19700.0
Madhepura,16.1.3,Stock position of TT vaccines,2. Stocks Received,1500.0,2200.0,1500.0,2500.0,1000.0,1200.0,800.0,1200.0,2000.0,1000.0,1000.0,1000.0,16900.0
Madhepura,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1350.0,1750.0,1100.0,1500.0,1400.0,1300.0,1550.0,1350.0,1050.0,1000.0,750.0,250.0,14350.0
Madhepura,16.1.3,Stock position of TT vaccines,5. Total Stock,700.0,1150.0,1550.0,2550.0,2150.0,2050.0,1300.0,1150.0,2100.0,2100.0,2350.0,3100.0,22250.0
Madhepura,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,300.0,800.0,700.0,1450.0,2050.0,2300.0,1192.0,1772.0,800.0,1000.0,1850.0,2200.0,16414.0
Madhepura,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1500.0,1100.0,1500.0,1500.0,1000.0,0.0,1700.0,1100.0,1150.0,1800.0,1000.0,1000.0,14350.0
Madhepura,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1000.0,1200.0,750.0,900.0,750.0,1108.0,1120.0,2072.0,950.0,950.0,2200.0,950.0,13950.0
Madhepura,16.1.5,Stock position of BCG vaccines,5. Total Stock,800.0,700.0,1450.0,2050.0,2300.0,1192.0,1772.0,800.0,1000.0,1850.0,650.0,2250.0,16814.0
Madhepura,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1450.0,800.0,350.0,350.0,125.0,30.0,0.0,1500.0,710.0,650.0,500.0,250.0,6715.0
Madhepura,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1500.0,1800.0,2000.0,1600.0,2000.0,700.0,3100.0,1600.0,1750.0,1500.0,2000.0,1000.0,20550.0
Madhepura,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2150.0,2250.0,2000.0,1825.0,2095.0,730.0,1600.0,2390.0,1810.0,1650.0,2250.0,1250.0,22000.0
Madhepura,16.1.6,Stock position of Measles vaccines,5. Total Stock,800.0,350.0,350.0,125.0,30.0,0.0,1500.0,710.0,650.0,500.0,250.0,0.0,5265.0
Madhepura,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,600.0,290.0,240.0,1090.0,1620.0,1620.0,2220.0,1870.0,770.0,620.0,570.0,400.0,11910.0
Madhepura,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2000.0,2000.0,2400.0,2800.0,2000.0,2400.0,1500.0,1250.0,1500.0,1500.0,1200.0,800.0,21350.0
Madhepura,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2310.0,2050.0,1550.0,2270.0,2000.0,1300.0,1850.0,2350.0,1650.0,1550.0,1370.0,800.0,21050.0
Madhepura,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,290.0,240.0,1090.0,1620.0,1620.0,2720.0,1870.0,770.0,620.0,570.0,400.0,400.0,12210.0
Madhepura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15450.0,35450.0
Madhepura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7450.0,27450.0
Madhepura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,8000.0
Madhepura,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,160014.0,260014.0
Madhepura,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,75000.0,175000.0
Madhepura,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,85014.0,85014.0
Madhepura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22797.0,42797.0
Madhepura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10337.0,30337.0
Madhepura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12460.0,12460.0
Madhepura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13722.0,13722.0
Madhepura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3922.0,3922.0
Madhepura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9800.0,9800.0
Madhepura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,10000.0,7500.0,2400.0,,940.0,0.0,0.0,,0.0,2600.0,0.0,0.0,23440.0
Madhepura,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,4000.0,,0.0,0.0,0.0,0.0,4000.0
Madhepura,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,2500.0,5100.0,1200.0,,940.0,0.0,4000.0,,0.0,2000.0,0.0,0.0,15740.0
Madhepura,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,7500.0,2400.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,11700.0
Madhepura,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,36050.0,26250.0,15050.0,,11650.0,6450.0,4400.0,,300.0,300.0,0.0,73150.0,173600.0
Madhepura,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.02,Stock Position of Gloves,4. Stock Distributed,9800.0,11200.0,15050.0,,5200.0,2700.0,3600.0,,0.0,0.0,0.0,5400.0,52950.0
Madhepura,16.3.02,Stock Position of Gloves,5. Total Stock,26250.0,15050.0,0.0,0.0,6450.0,3750.0,800.0,0.0,300.0,300.0,0.0,67750.0,120650.0
Madhepura,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,40000.0,29000.0,,7300.0,1500.0,0.0,,0.0,0.0,0.0,31500.0,109300.0
Madhepura,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,3000.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,20797.0,23797.0
Madhepura,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,11000.0,12000.0,,0.0,1500.0,0.0,,0.0,0.0,0.0,40000.0,64500.0
Madhepura,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,3000.0,29000.0,17000.0,0.0,7300.0,0.0,0.0,0.0,0.0,0.0,0.0,12297.0,68597.0
Madhepura,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,428400.0,328400.0,80900.0,,254130.0,187040.0,40.0,,0.0,0.0,0.0,1464000.0,2742910.0
Madhepura,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,128600.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,128600.0
Madhepura,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,100000.0,126000.0,58500.0,,82090.0,187400.0,0.0,,0.0,0.0,0.0,624000.0,1177990.0
Madhepura,16.3.07,Stock Position of IFA Tablets,5. Total Stock,457000.0,202400.0,22400.0,0.0,172040.0,-360.0,40.0,0.0,0.0,0.0,0.0,840000.0,1693520.0
Madhepura,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,3176.0,0.0,,5000.0,3092.0,542.0,,0.0,0.0,0.0,0.0,11810.0
Madhepura,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,5000.0,0.0,0.0,5000.0
Madhepura,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,2496.0,0.0,,1408.0,2552.0,0.0,,0.0,0.0,0.0,0.0,6456.0
Madhepura,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,680.0,0.0,0.0,3592.0,540.0,542.0,0.0,0.0,5000.0,0.0,0.0,10354.0
Madhepura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,10500.0,0.0,,1600.0,0.0,0.0,,0.0,0.0,0.0,0.0,12100.0
Madhepura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,5800.0,0.0,,1600.0,0.0,0.0,,0.0,0.0,0.0,0.0,7400.0
Madhepura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,4700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4700.0
Madhepura,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,614.0,0.0,1705.0,,,949.0,949.0,,649.0,649.0,0.0,449.0,5964.0
Madhepura,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,1410.0,0.0,,,0.0,0.0,,0.0,0.0,0.0,0.0,1410.0
Madhepura,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,30.0,,,0.0,100.0,,0.0,25.0,0.0,225.0,380.0
Madhepura,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,614.0,1410.0,1675.0,0.0,0.0,949.0,849.0,0.0,649.0,624.0,0.0,224.0,6994.0
Madhepura,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,5000.0,0.0,353411.0,,17500.0,17500.0,7000.0,,4450.0,42450.0,0.0,31459.0,478770.0
Madhepura,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,358411.0,0.0,,0.0,10000.0,0.0,,40000.0,41800.0,0.0,0.0,450211.0
Madhepura,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,230000.0,,0.0,20500.0,2500.0,,0.0,0.0,0.0,18000.0,271000.0
Madhepura,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,5000.0,358411.0,123411.0,0.0,17500.0,7000.0,4500.0,0.0,44450.0,84250.0,0.0,13459.0,657981.0
Madhepura,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,9400.0,4300.0,7300.0,3100.0,31400.0,26000.0,18400.0,21600.0,10400.0,15300.0,9100.0,4300.0,160600.0
Madhepura,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,8000.0,0.0,33000.0,0.0,0.0,10000.0,0.0,12000.0,0.0,0.0,12000.0,75000.0
Madhepura,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5100.0,500.0,4200.0,4700.0,5400.0,7600.0,6800.0,11200.0,7100.0,6200.0,4300.0,6200.0,69300.0
Madhepura,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4300.0,11800.0,3100.0,31400.0,26000.0,18400.0,21600.0,10400.0,15300.0,9100.0,4800.0,10100.0,166300.0
Madhepura,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,78000.0,16000.0,188000.0,140000.0,174000.0,134000.0,78000.0,96000.0,17200.0,108000.0,40800.0,0.0,1070000.0
Madhepura,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,226000.0,0.0,100000.0,0.0,0.0,60000.0,0.0,124800.0,0.0,0.0,100000.0,610800.0
Madhepura,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,6200.0,54000.0,48000.0,66000.0,40000.0,56000.0,42000.0,78800.0,34000.0,67200.0,0.0,50400.0,542600.0
Madhepura,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,71800.0,188000.0,140000.0,174000.0,134000.0,78000.0,96000.0,17200.0,108000.0,40800.0,40800.0,49600.0,1138200.0
Madhepura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2500.0,0.0,7000.0,4700.0,8100.0,5400.0,2200.0,5100.0,1000.0,5800.0,2900.0,500.0,45200.0
Madhepura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,500.0,10000.0,0.0,8000.0,0.0,0.0,5600.0,0.0,6800.0,0.0,0.0,6000.0,36900.0
Madhepura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Madhepura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3000.0,3000.0,2300.0,4600.0,2700.0,2200.0,2700.0,4100.0,2000.0,2900.0,500.0,3100.0,33100.0
Madhepura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,7000.0,4700.0,8100.0,5400.0,3200.0,5100.0,1000.0,5800.0,2900.0,2400.0,3400.0,49000.0
Madhepura,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Madhepura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Madhepura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Madhepura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Madhepura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Madhepura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Madhepura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Madhepura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Madhepura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Madhepura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Madhepura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Madhepura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Madhepura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Madhepura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Madhepura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Madhepura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Madhepura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Madhepura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Madhepura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Madhepura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Madhepura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Madhepura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Madhepura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Madhepura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Madhepura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Madhepura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Madhepura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Madhepura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Madhepura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Madhepura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Madhepura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Madhepura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Madhepura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Madhepura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Madhepura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Madhepura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Madhepura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Madhepura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Madhepura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Madhepura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Madhepura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Madhepura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Madhepura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Madhepura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Madhepura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Madhepura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Madhepura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Madhepura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Madhepura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Madhepura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Madhepura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Madhepura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Madhepura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Madhepura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Madhepura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Madhepura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Madhepura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Madhubani,1.1,Total number of pregnant women Registered for ANC,TOTAL,8371.0,8842.0,8543.0,8420.0,9005.0,8645.0,6423.0,6573.0,6068.0,6126.0,6750.0,7786.0,91552.0
Madhubani,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4087.0,4432.0,4193.0,4094.0,4266.0,4007.0,3308.0,3386.0,3020.0,3492.0,3726.0,4086.0,46097.0
Madhubani,1.2,Number of Pregnant women registered under JSY,TOTAL,8352.0,8825.0,8446.0,8370.0,8974.0,8387.0,6307.0,6523.0,5977.0,6050.0,6619.0,7703.0,90533.0
Madhubani,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4883.0,5237.0,5137.0,5339.0,5331.0,5649.0,5034.0,4780.0,4185.0,3932.0,3789.0,4333.0,57629.0
Madhubani,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,7337.0,7809.0,7665.0,7473.0,7809.0,7434.0,5600.0,5597.0,5012.0,5211.0,5649.0,6621.0,79217.0
Madhubani,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,7706.0,7940.0,7397.0,8128.0,9038.0,8921.0,7581.0,6236.0,5843.0,5500.0,5195.0,6912.0,86397.0
Madhubani,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4454.0,4768.0,4691.0,5255.0,4912.0,4713.0,3599.0,3164.0,2815.0,2155.0,1925.0,1610.0,44061.0
Madhubani,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,241.0,227.0,328.0,242.0,270.0,434.0,298.0,266.0,239.0,148.0,200.0,235.0,3128.0
Madhubani,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,0.0,5.0,1.0,0.0,0.0,0.0,2.0,3.0,2.0,4.0,2.0,21.0
Madhubani,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,645.0,515.0,916.0,1098.0,1133.0,1148.0,1098.0,1443.0,1216.0,1021.0,1306.0,1416.0,12955.0
Madhubani,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,15.0,13.0,34.0,39.0,43.0,43.0,43.0,36.0,19.0,13.0,26.0,27.0,351.0
Madhubani,1.8,Number of pregnancy test kits used at SC level,TOTAL,311.0,321.0,162.0,316.0,387.0,264.0,312.0,322.0,317.0,414.0,511.0,747.0,4384.0
Madhubani,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,600.0,583.0,542.0,672.0,677.0,751.0,655.0,705.0,859.0,842.0,618.0,653.0,8157.0
Madhubani,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1411.0,1556.0,1496.0,1478.0,1878.0,2047.0,2064.0,2440.0,2392.0,2110.0,1934.0,1684.0,22490.0
Madhubani,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2011.0,2139.0,2038.0,2150.0,2555.0,2798.0,2719.0,3145.0,3251.0,2952.0,2552.0,2337.0,30647.0
Madhubani,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1199.0,1115.0,1064.0,1174.0,1262.0,1389.0,1232.0,1428.0,1806.0,1855.0,1479.0,1468.0,16471.0
Madhubani,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,12.0,16.0,0.0,2.0,21.0,0.0,4.0,0.0,28.0,28.0,36.0,147.0
Madhubani,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3265.0,2964.0,2937.0,4116.0,5438.0,5076.0,4927.0,5306.0,5165.0,4757.0,3934.0,3154.0,51039.0
Madhubani,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3292.0,2974.0,2788.0,3798.0,4998.0,4612.0,4237.0,4423.0,4782.0,4716.0,3660.0,3179.0,47459.0
Madhubani,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1161.0,602.0,1255.0,1564.0,3087.0,2393.0,1363.0,2217.0,2519.0,5809.0,4257.0,3102.0,29329.0
Madhubani,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,505.0,372.0,807.0,1011.0,923.0,1741.0,532.0,1105.0,1084.0,2984.0,1617.0,4258.0,16939.0
Madhubani,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Madhubani,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Madhubani,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Madhubani,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Madhubani,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,4.0,0.0,0.0,0.0,6.0
Madhubani,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Madhubani,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,2.0,4.0,2.0,2.0,6.0,7.0,0.0,4.0,0.0,3.0,3.0,1.0,34.0
Madhubani,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhubani,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,2.0,4.0,2.0,2.0,6.0,7.0,0.0,6.0,4.0,3.0,3.0,1.0,40.0
Madhubani,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Madhubani,4.1.1.a,Number of male live births,TOTAL,2882.0,2794.0,2813.0,3274.0,4259.0,4200.0,4077.0,4559.0,4328.0,3993.0,3516.0,2964.0,43659.0
Madhubani,4.1.1.b,Number of female live births,TOTAL,2649.0,2467.0,2428.0,3025.0,3914.0,3823.0,3777.0,4170.0,3988.0,3699.0,3228.0,2767.0,39935.0
Madhubani,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5531.0,5261.0,5241.0,6299.0,8173.0,8023.0,7854.0,8729.0,8316.0,7692.0,6744.0,5731.0,83594.0
Madhubani,4.1.2,Number of still births,TOTAL,61.0,58.0,67.0,324.0,112.0,115.0,362.0,79.0,351.0,89.0,55.0,58.0,1731.0
Madhubani,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,36.0,36.0,110.0,41.0,27.0,22.0,24.0,34.0,19.0,12.0,16.0,19.0,396.0
Madhubani,4.2.1,Number of Newborns weighed at birth,TOTAL,4951.0,4688.0,4519.0,5726.0,7333.0,7068.0,6833.0,7470.0,7383.0,6867.0,5901.0,5111.0,73850.0
Madhubani,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,149.0,143.0,228.0,233.0,188.0,220.0,524.0,258.0,260.0,258.0,197.0,183.0,2841.0
Madhubani,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,5084.0,4992.0,4970.0,6082.0,7719.0,7223.0,6862.0,7940.0,7994.0,7036.0,6375.0,5338.0,77615.0
Madhubani,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,4.0,3.0,0.0,2.0,1.0,0.0,15.0,25.0
Madhubani,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Madhubani,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,22.0,18.0,17.0,27.0,29.0,24.0,281.0,3.0,12.0,6.0,6.0,4.0,449.0
Madhubani,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhubani,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,22.0,18.0,17.0,27.0,29.0,28.0,284.0,3.0,14.0,7.0,6.0,19.0,474.0
Madhubani,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Madhubani,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,506.0,462.0,512.0,676.0,908.0,766.0,764.0,763.0,787.0,824.0,648.0,512.0,8128.0
Madhubani,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,137.0,104.0,96.0,164.0,182.0,188.0,202.0,0.0,169.0,2.0,161.0,28.0,1433.0
Madhubani,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,367.0,459.0,479.0,668.0,815.0,756.0,757.0,1277.0,1377.0,1059.0,1013.0,865.0,9892.0
Madhubani,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,26.0,22.0,44.0,31.0,24.0,13.0,19.0,27.0,22.0,31.0,20.0,21.0,300.0
Madhubani,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2580.0,2615.0,2435.0,3401.0,3593.0,3566.0,3836.0,4344.0,3634.0,3596.0,2885.0,3122.0,39607.0
Madhubani,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1678.0,11810.0,1929.0,2223.0,2401.0,2854.0,2415.0,2954.0,2738.0,3085.0,2381.0,2211.0,38679.0
Madhubani,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,32.0,77.0,4.0,5.0,4.0,4.0,129.0
Madhubani,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,21.0,32.0,41.0,32.0,28.0,136.0,27.0,123.0,37.0,59.0,175.0,27.0,738.0
Madhubani,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5.0,7.0,7.0,0.0,9.0,80.0,8.0,89.0,7.0,34.0,13.0,12.0,271.0
Madhubani,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,26.0,39.0,48.0,32.0,37.0,216.0,35.0,212.0,44.0,93.0,188.0,39.0,1009.0
Madhubani,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1161.0,658.0,553.0,1421.0,1643.0,1689.0,1207.0,911.0,500.0,612.0,640.0,539.0,11534.0
Madhubani,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1480.0,1270.0,1090.0,2070.0,2032.0,2054.0,1566.0,1297.0,1021.0,1107.0,1133.0,999.0,17119.0
Madhubani,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,2641.0,1928.0,1643.0,3491.0,3675.0,3743.0,2773.0,2208.0,1521.0,1719.0,1773.0,1538.0,28653.0
Madhubani,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,2.0,7.0,0.0,0.0,0.0,0.0,165.0,0.0,2.0,0.0,176.0
Madhubani,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,1.0,2.0,1.0,1.0,0.0,0.0,2.0,3.0,0.0,0.0,10.0
Madhubani,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,0.0,0.0,,,0.0,,0.0,0.0
Madhubani,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0,3.0,1.0,0.0,8.0,16.0
Madhubani,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhubani,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,4.0,1.0,1.0,0.0,2.0,5.0,4.0,0.0,8.0,26.0
Madhubani,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,1.0,,,,,1.0
Madhubani,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,0.0,,,0.0,,0.0,0.0
Madhubani,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,48.0,0.0,51.0
Madhubani,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhubani,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,48.0,0.0,51.0
Madhubani,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Madhubani,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,74.0,67.0,72.0,715.0,151.0,430.0,208.0,1157.0,4256.0,3256.0,1853.0,932.0,13171.0
Madhubani,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,1.0,4.0,,17.0,12.0,28.0,19.0,37.0,206.0,219.0,105.0,23.0,671.0
Madhubani,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,12.0,16.0,11.0,9.0,14.0,21.0,16.0,91.0,120.0,91.0,31.0,37.0,469.0
Madhubani,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhubani,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,87.0,87.0,83.0,741.0,177.0,479.0,243.0,1285.0,4582.0,3566.0,1989.0,992.0,14311.0
Madhubani,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,26.0,25.0,18.0,,24.0,34.0,,150.0,174.0,202.0,159.0,8752.0,9564.0
Madhubani,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1.0,1.0,0.0,1.0,18.0,0.0,2.0,8.0,77.0,46.0,36.0,112.0,302.0
Madhubani,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,1.0,0.0,1.0,2.0,0.0,,0.0,3.0,0.0,7.0
Madhubani,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,49.0,0.0,0.0,0.0,96.0,17.0,163.0
Madhubani,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhubani,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,1.0,0.0,3.0,18.0,1.0,53.0,8.0,77.0,46.0,135.0,129.0,472.0
Madhubani,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Madhubani,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,447.0,465.0,499.0,918.0,479.0,574.0,445.0,443.0,455.0,496.0,480.0,607.0,6308.0
Madhubani,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,210.0,276.0,290.0,846.0,304.0,625.0,232.0,303.0,348.0,229.0,272.0,784.0,4719.0
Madhubani,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,7.0,13.0,3.0,4.0,3.0,,5.0,2.0,4.0,3.0,44.0
Madhubani,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,109.0,103.0,124.0,114.0,56.0,63.0,42.0,70.0,40.0,48.0,53.0,40.0,862.0
Madhubani,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Madhubani,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,766.0,844.0,920.0,1891.0,842.0,1266.0,722.0,816.0,848.0,775.0,809.0,1434.0,11933.0
Madhubani,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,138.0,103.0,244.0,212.0,218.0,211.0,97.0,201.0,150.0,163.0,170.0,163.0,2070.0
Madhubani,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,4.0,8.0,5.0,,6.0,6.0,,34.0,,5.0,11.0,11.0,90.0
Madhubani,9.06,Number of IUCD removals,TOTAL,252.0,260.0,247.0,306.0,235.0,293.0,307.0,267.0,271.0,253.0,218.0,280.0,3189.0
Madhubani,9.07,Number of Oral Pills cycles distributed,TOTAL,4846.0,4215.0,3602.0,4062.0,4009.0,4306.0,3954.0,3291.0,3462.0,3401.0,2680.0,2792.0,44620.0
Madhubani,9.08,Number of Condom pieces distributed,TOTAL,23133.0,20323.0,19151.0,31415.0,26973.0,28553.0,18684.0,20930.0,19939.0,21618.0,19193.0,20102.0,270014.0
Madhubani,9.09,Number of Centchroman (weekly) pills given,TOTAL,64.0,78.0,100.0,102.0,99.0,243.0,662.0,203.0,152.0,48.0,1933.0,78.0,3762.0
Madhubani,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,364.0,371.0,388.0,402.0,303.0,274.0,269.0,341.0,382.0,348.0,314.0,283.0,4039.0
Madhubani,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Madhubani,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,6232.0,6680.0,6224.0,7356.0,9965.0,10407.0,9801.0,11595.0,9925.0,9360.0,7770.0,10791.0,106106.0
Madhubani,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,8562.0,7595.0,6437.0,6149.0,6183.0,8096.0,8423.0,10520.0,9764.0,1600.0,20.0,3509.0,76858.0
Madhubani,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,9183.0,9009.0,7112.0,7098.0,6835.0,6971.0,6947.0,8588.0,9936.0,9276.0,3961.0,6412.0,91328.0
Madhubani,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,9204.0,8985.0,7672.0,7869.0,7513.0,7698.0,6304.0,7269.0,7982.0,8535.0,7583.0,10441.0,97055.0
Madhubani,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,75.0,0.0,24.0,14.0,24.0,23.0,0.0,0.0,0.0,7985.0,9211.0,10352.0,27708.0
Madhubani,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,31.0,7.0,15.0,23.0,0.0,0.0,0.0,19.0,4516.0,8796.0,13407.0
Madhubani,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,24.0,14.0,5.0,8.0,23.0,0.0,0.0,0.0,27.0,34.0,3822.0,3957.0
Madhubani,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3794.0,3328.0,3545.0,5101.0,6907.0,5747.0,3870.0,5219.0,4362.0,4733.0,3702.0,6076.0,56384.0
Madhubani,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,8268.0,6416.0,6188.0,5940.0,6250.0,6831.0,4943.0,7096.0,6628.0,8618.0,4893.0,12934.0,85005.0
Madhubani,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,8701.0,7533.0,6642.0,6924.0,6668.0,5769.0,4041.0,5247.0,5270.0,8111.0,4650.0,13141.0,82697.0
Madhubani,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,8753.0,7519.0,7034.0,7448.0,7571.0,6372.0,3794.0,4428.0,4335.0,6725.0,4555.0,13191.0,81725.0
Madhubani,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2696.0,2651.0,2397.0,3616.0,4752.0,4300.0,4163.0,4636.0,4236.0,3385.0,2981.0,2880.0,42693.0
Madhubani,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,6536.0,6727.0,8410.0,6274.0,6558.0,7920.0,8157.0,10222.0,9189.0,2099.0,292.0,3921.0,76305.0
Madhubani,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,6869.0,7330.0,6977.0,10117.0,7155.0,7156.0,6767.0,8366.0,9212.0,7937.0,4456.0,7030.0,89372.0
Madhubani,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,6803.0,7327.0,7305.0,7589.0,8197.0,7878.0,6491.0,7230.0,7633.0,7902.0,7364.0,12121.0,93840.0
Madhubani,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,6225.0,7076.0,7189.0,7008.0,7918.0,6882.0,6797.0,8735.0,5277.0,5446.0,6766.0,10495.0,85814.0
Madhubani,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4515.0,3817.0,4119.0,3790.0,4134.0,4406.0,3629.0,4364.0,3006.0,3359.0,5154.0,8857.0,53150.0
Madhubani,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,7.0,9.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,18.0
Madhubani,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3124.0,3628.0,3700.0,3640.0,4187.0,3663.0,3423.0,4059.0,2425.0,2364.0,3720.0,5865.0,43798.0
Madhubani,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2816.0,3272.0,3393.0,3319.0,3692.0,3249.0,3107.0,3642.0,2174.0,2106.0,2763.0,6228.0,39761.0
Madhubani,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5940.0,6900.0,7093.0,6959.0,7879.0,6912.0,6530.0,7701.0,4599.0,4470.0,6483.0,12093.0,83559.0
Madhubani,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6590.0,6325.0,5675.0,5990.0,5687.0,5749.0,4697.0,5472.0,5091.0,4915.0,6131.0,9992.0,72314.0
Madhubani,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6327.0,5778.0,5430.0,5727.0,5510.0,5218.0,3409.0,4064.0,3408.0,4545.0,4241.0,8971.0,62628.0
Madhubani,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,426.0,521.0,305.0,509.0,469.0,257.0,166.0,54.0,38.0,16.0,95.0,19.0,2875.0
Madhubani,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1798.0,1648.0,1541.0,1634.0,1486.0,1525.0,1070.0,1221.0,1035.0,967.0,1382.0,1389.0,16696.0
Madhubani,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1677.0,1479.0,1404.0,1537.0,1359.0,1340.0,984.0,1127.0,888.0,902.0,1234.0,1192.0,15123.0
Madhubani,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3475.0,3127.0,2945.0,3171.0,2845.0,2865.0,2054.0,2348.0,1923.0,1869.0,2616.0,2581.0,31819.0
Madhubani,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1110.0,1353.0,1082.0,1367.0,1040.0,1488.0,1327.0,1233.0,1237.0,1215.0,1032.0,1077.0,14561.0
Madhubani,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1229.0,1267.0,1049.0,1207.0,1161.0,1762.0,1706.0,1304.0,1449.0,1148.0,1210.0,1147.0,15639.0
Madhubani,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2154.0,2254.0,1875.0,2054.0,2097.0,2819.0,2754.0,2294.0,2603.0,2280.0,2115.0,2128.0,27427.0
Madhubani,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,14.0,0.0,7.0,26.0,9.0,0.0,2.0,13.0,30.0,101.0
Madhubani,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3603.0,3533.0,3300.0,3495.0,3526.0,3475.0,3520.0,3574.0,3578.0,3486.0,3566.0,3463.0,42119.0
Madhubani,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3367.0,3489.0,3238.0,3425.0,3449.0,3442.0,3456.0,3512.0,3535.0,3308.0,3346.0,3365.0,40932.0
Madhubani,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2928.0,3073.0,2826.0,2982.0,2994.0,3043.0,3028.0,3010.0,3062.0,2873.0,2980.0,2958.0,35757.0
Madhubani,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Madhubani,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5682.0,6864.0,6758.0,7579.0,7439.0,6437.0,6302.0,8154.0,5858.0,4894.0,5991.0,6039.0,77997.0
Madhubani,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1518.0,1806.0,1729.0,38557.0,1438.0,1533.0,1388.0,1898.0,34364.0,1436.0,1903.0,2082.0,89652.0
Madhubani,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,230.0,305.0,156.0,1588.0,144.0,140.0,126.0,51.0,230.0,77.0,90.0,122.0,3259.0
Madhubani,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,14.0,6.0,6.0,17.0,2.0,17.0,3.0,0.0,2.0,7.0,21.0,28.0,123.0
Madhubani,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,475.0,722.0,527.0,393.0,308.0,259.0,387.0,265.0,471.0,394.0,434.0,541.0,5176.0
Madhubani,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,4.0,4.0,9.0,13.0,14.0,25.0,8.0,26.0,106.0,91.0,82.0,9.0,391.0
Madhubani,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,11.0,0.0,0.0,0.0,1.0,0.0,1.0,8.0,21.0
Madhubani,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,61.0,255.0,0.0,0.0,42.0,362.0,720.0
Madhubani,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,61.0,146.0,0.0,0.0,42.0,65.0,314.0
Madhubani,13.3,Number of School children detected with Refractive errors,TOTAL,122.0,61.0,44.0,75.0,77.0,77.0,129.0,67.0,156.0,305.0,45.0,25.0,1183.0
Madhubani,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,162.0,0.0,0.0,162.0
Madhubani,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Madhubani,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Madhubani,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2625.0,2620.0,2502.0,2566.0,2563.0,2670.0,2741.0,2748.0,2570.0,2555.0,2597.0,2719.0,-1.0
Madhubani,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Madhubani,14.05,Number of RKS meetings held during the month,TOTAL,10.0,11.0,14.0,12.0,14.0,12.0,11.0,12.0,14.0,10.0,16.0,12.0,148.0
Madhubani,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Madhubani,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,745.0,320.0,369.0,514.0,524.0,191.0,219.0,831.0,773.0,453.0,529.0,430.0,5898.0
Madhubani,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Madhubani,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Madhubani,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1458.0,1502.0,1584.0,1660.0,1748.0,1398.0,1409.0,1339.0,1343.0,1243.0,922.0,1134.0,16740.0
Madhubani,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3188.0,2678.0,2393.0,2573.0,2810.0,2820.0,2779.0,2738.0,2723.0,2269.0,2323.0,2210.0,31504.0
Madhubani,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1450.0,1633.0,1591.0,1646.0,1605.0,1422.0,1547.0,1337.0,1504.0,1385.0,1133.0,1254.0,17507.0
Madhubani,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4366.0,4282.0,4236.0,5264.0,6242.0,6094.0,5969.0,6631.0,7760.0,7277.0,5770.0,4366.0,68257.0
Madhubani,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2908.0,3135.0,3175.0,3306.0,3353.0,2820.0,2956.0,2676.0,2847.0,2628.0,2055.0,2388.0,34247.0
Madhubani,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7554.0,6960.0,6629.0,7837.0,9052.0,8914.0,8748.0,9369.0,10483.0,9546.0,8093.0,6576.0,99761.0
Madhubani,14.10.2.a,Number of death cases of Inpatient males,TOTAL,13.0,12.0,5.0,8.0,14.0,10.0,7.0,4.0,12.0,8.0,7.0,8.0,108.0
Madhubani,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,2.0,5.0,12.0,6.0,10.0,4.0,7.0,9.0,11.0,5.0,5.0,82.0
Madhubani,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,19.0,14.0,10.0,20.0,20.0,20.0,11.0,11.0,21.0,19.0,12.0,13.0,190.0
Madhubani,14.11,In-Patient Head Count at midnight,TOTAL,8428.0,7315.0,7187.0,8620.0,12604.0,8571.0,8228.0,8542.0,10230.0,10109.0,6794.0,7276.0,103904.0
Madhubani,14.12.1,OPD attendance (All),TOTAL,224216.0,240311.0,221102.0,261853.0,263193.0,288926.0,224298.0,229285.0,207414.0,209291.0,213972.0,229873.0,2813734.0
Madhubani,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,341.0,99.0,221.0,1739.0,429.0,717.0,1060.0,1666.0,3962.0,4383.0,2227.0,968.0,17812.0
Madhubani,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,302.0,97.0,0.0,14.0,6.0,0.0,377.0,0.0,176.0,0.0,0.0,0.0,972.0
Madhubani,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4094.0,4649.0,4923.0,3441.0,5420.0,5488.0,4115.0,5759.0,5182.0,5674.0,5320.0,5111.0,59176.0
Madhubani,14.14.a,Number of patients given AYUSH treatment,TOTAL,38653.0,41854.0,38361.0,45857.0,49601.0,46065.0,37659.0,30366.0,22348.0,35064.0,34378.0,36799.0,457005.0
Madhubani,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,8637.0,7675.0,9358.0,11400.0,10045.0,13369.0,10385.0,10820.0,9584.0,9409.0,10612.0,8385.0,119679.0
Madhubani,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,6.0
Madhubani,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2225.0,2456.0,2656.0,2585.0,2622.0,2635.0,2724.0,3071.0,3169.0,3724.0,3431.0,3221.0,34519.0
Madhubani,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,42.0,32.0,66.0,56.0,54.0,107.0,164.0,59.0,31.0,41.0,55.0,56.0,763.0
Madhubani,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,970.0,870.0,933.0,1021.0,1130.0,779.0,1146.0,967.0,947.0,1189.0,556.0,966.0,11474.0
Madhubani,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,39.0,35.0,33.0,32.0,30.0,47.0,54.0,23.0,27.0,30.0,17.0,23.0,390.0
Madhubani,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,845.0,952.0,686.0,1071.0,1055.0,807.0,1169.0,1619.0,1868.0,1829.0,1190.0,1161.0,14252.0
Madhubani,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,36.0,35.0,31.0,16.0,31.0,29.0,18.0,28.0,14.0,18.0,13.0,24.0,293.0
Madhubani,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1610.0,1597.0,1623.0,2501.0,2465.0,1700.0,2397.0,2082.0,1893.0,1603.0,1204.0,2072.0,22747.0
Madhubani,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,5.0,3.0,1.0,6.0,1.0,2.0,2.0,2.0,2.0,3.0,1.0,1.0,29.0
Madhubani,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3425.0,3419.0,3242.0,4593.0,4650.0,3286.0,4712.0,4668.0,4708.0,4621.0,2950.0,4199.0,48473.0
Madhubani,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,80.0,73.0,65.0,54.0,62.0,78.0,74.0,53.0,43.0,51.0,31.0,48.0,712.0
Madhubani,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,314.0,343.0,343.0,61.0,0.0,0.0,1061.0
Madhubani,15.3.a,Number of VDRL tests conducted on males,Number tested,86.0,23.0,48.0,35.0,58.0,0.0,0.0,0.0,0.0,10.0,12.0,3.0,275.0
Madhubani,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,190.0,148.0,179.0,210.0,168.0,13.0,0.0,0.0,0.0,179.0,134.0,112.0,1333.0
Madhubani,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,747.0,814.0,609.0,872.0,859.0,119.0,283.0,30.0,102.0,570.0,441.0,780.0,6226.0
Madhubani,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1023.0,985.0,836.0,1117.0,1085.0,132.0,283.0,30.0,102.0,759.0,587.0,895.0,7834.0
Madhubani,15.4.1,Number of blood smears examined for Malaria,TOTAL,192.0,89.0,77.0,122.0,142.0,231.0,230.0,172.0,113.0,127.0,64.0,108.0,1667.0
Madhubani,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,5.0,0.0,1.0,3.0,0.0,11.0,2.0,2.0,0.0,2.0,0.0,1.0,27.0
Madhubani,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,0.0,0.0,0.0,4.0,4.0,2.0,0.0,0.0,1.0,0.0,0.0,12.0
Madhubani,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,900.0,850.0,0.0,500.0,1300.0,650.0,500.0,450.0,1850.0,500.0,886.0,86.0,8472.0
Madhubani,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4000.0,5000.0,4000.0,8000.0,1000.0,6000.0,2000.0,3000.0,1000.0,2886.0,0.0,4000.0,40886.0
Madhubani,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Madhubani,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4050.0,5850.0,3500.0,7200.0,1650.0,6150.0,2050.0,1600.0,2250.0,2500.0,800.0,3100.0,40700.0
Madhubani,16.1.1,Stock position of DPT vaccines,5. Total Stock,850.0,0.0,500.0,1300.0,650.0,500.0,450.0,1850.0,600.0,886.0,86.0,986.0,8658.0
Madhubani,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,0.0,,,,,,,,0.0,2000.0,1050.0,3050.0
Madhubani,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,0.0,,,,,,,,6000.0,0.0,3000.0,9000.0
Madhubani,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,0.0,,,,,,,,,0.0,,0.0
Madhubani,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,,,,,,,,4000.0,950.0,1900.0,6850.0
Madhubani,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,1050.0,2150.0,5200.0
Madhubani,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,225.0,175.0,375.0,575.0,0.0,0.0,25.0,225.0,0.0,0.0,0.0,0.0,1600.0
Madhubani,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,3000.0,3000.0,3000.0,2000.0,1400.0,2000.0,0.0,1400.0,1500.0,0.0,2800.0,22100.0
Madhubani,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Madhubani,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2050.0,2800.0,2600.0,3575.0,2000.0,1375.0,1800.0,225.0,1400.0,1500.0,0.0,2025.0,21350.0
Madhubani,16.1.2,Stock position of OPV vaccines,5. Total Stock,175.0,375.0,775.0,0.0,0.0,25.0,225.0,0.0,0.0,0.0,0.0,775.0,2350.0
Madhubani,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,500.0,750.0,250.0,650.0,350.0,200.0,0.0,600.0,1100.0,350.0,,950.0,5700.0
Madhubani,16.1.3,Stock position of TT vaccines,2. Stocks Received,3000.0,3000.0,3000.0,4000.0,1000.0,4600.0,2000.0,2000.0,1200.0,5000.0,,2000.0,30800.0
Madhubani,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,,,0.0
Madhubani,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2750.0,3500.0,2950.0,4300.0,1150.0,4800.0,1400.0,1500.0,1950.0,2550.0,,850.0,27700.0
Madhubani,16.1.3,Stock position of TT vaccines,5. Total Stock,750.0,250.0,300.0,350.0,200.0,0.0,600.0,1100.0,350.0,2800.0,0.0,2100.0,8800.0
Madhubani,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Madhubani,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Madhubani,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Madhubani,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Madhubani,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,100.0,350.0,400.0,1000.0,1050.0,400.0,1150.0,650.0,1400.0,1150.0,1950.0,250.0,9850.0
Madhubani,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,2400.0,2000.0,4100.0,0.0,2900.0,2000.0,2000.0,2000.0,3000.0,0.0,3000.0,25400.0
Madhubani,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Madhubani,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1750.0,2350.0,1400.0,4050.0,650.0,2150.0,2500.0,1250.0,2250.0,2200.0,1700.0,2250.0,24500.0
Madhubani,16.1.5,Stock position of BCG vaccines,5. Total Stock,350.0,400.0,1000.0,1050.0,400.0,1150.0,650.0,1400.0,1150.0,1950.0,250.0,1000.0,10750.0
Madhubani,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1150.0,200.0,50.0,100.0,75.0,0.0,450.0,700.0,900.0,0.0,3200.0,0.0,6825.0
Madhubani,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,4000.0,3000.0,3500.0,2500.0,4100.0,3000.0,3000.0,200.0,6000.0,0.0,3500.0,35800.0
Madhubani,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Madhubani,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3950.0,4150.0,2950.0,3525.0,2575.0,3650.0,2750.0,2800.0,1100.0,2800.0,3200.0,3500.0,36950.0
Madhubani,16.1.6,Stock position of Measles vaccines,5. Total Stock,200.0,50.0,100.0,75.0,0.0,450.0,700.0,900.0,0.0,3200.0,0.0,0.0,5675.0
Madhubani,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,,,,,,,0.0,,,,0.0
Madhubani,16.1.7,Stock position of JE vaccines,2. Stocks Received,,0.0,,,,,,,0.0,,,,0.0
Madhubani,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,,,,,,,0.0,,,,0.0
Madhubani,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,0.0,,,,,,,0.0,,,,0.0
Madhubani,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,240.0,430.0,455.0,500.0,0.0,950.0,850.0,1700.0,100.0,2600.0,150.0,7975.0
Madhubani,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,3000.0,3000.0,4000.0,2010.0,4500.0,3000.0,3000.0,1000.0,4450.0,0.0,3800.0,34760.0
Madhubani,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Madhubani,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2760.0,2810.0,3175.0,3955.0,2510.0,3550.0,3100.0,2150.0,2600.0,1950.0,2500.0,2650.0,33710.0
Madhubani,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,240.0,430.0,255.0,500.0,0.0,950.0,850.0,1700.0,100.0,2600.0,100.0,1300.0,9025.0
Madhubani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,0.0,,,,1806.0,1705.0,905.0,,,,,4416.0
Madhubani,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,,,,0.0,0.0,0.0,,,,,0.0
Madhubani,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,,,,,0.0
Madhubani,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,,,,101.0,820.0,150.0,,,,,1071.0
Madhubani,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,1705.0,885.0,755.0,0.0,0.0,0.0,0.0,3345.0
Madhubani,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Madhubani,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Madhubani,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Madhubani,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Madhubani,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Madhubani,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,12950.0,4050.0,14550.0,5150.0,14850.0,8000.0,16850.0,5150.0,25850.0,12600.0,300.0,6800.0,127100.0
Madhubani,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,20000.0,0.0,20000.0,0.0,22000.0,0.0,26000.0,0.0,0.0,14000.0,25000.0,127000.0
Madhubani,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Madhubani,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,8900.0,9500.0,9400.0,10300.0,6850.0,13150.0,11700.0,5300.0,13250.0,12300.0,7500.0,8200.0,116350.0
Madhubani,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4050.0,14550.0,5150.0,14850.0,8000.0,16850.0,5150.0,25850.0,12600.0,300.0,6800.0,23600.0,137750.0
Madhubani,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,122200.0,38200.0,153200.0,55400.0,310200.0,236600.0,341400.0,240200.0,145600.0,319400.0,225800.0,29500.0,2217700.0
Madhubani,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,240000.0,0.0,375000.0,0.0,228000.0,0.0,260000.0,260000.0,0.0,,100000.0,1463000.0
Madhubani,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,,,0.0
Madhubani,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,84000.0,125000.0,97800.0,120200.0,73600.0,123200.0,101200.0,94600.0,86200.0,93600.0,,36750.0,1036150.0
Madhubani,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,38200.0,153200.0,55400.0,310200.0,236600.0,341400.0,240200.0,405600.0,319400.0,225800.0,225800.0,92750.0,2644550.0
Madhubani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1900.0,100.0,6000.0,3900.0,6800.0,3700.0,6600.0,2100.0,100.0,9600.0,4900.0,3200.0,48900.0
Madhubani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,10000.0,0.0,8000.0,0.0,8000.0,0.0,14000.0,14000.0,0.0,3600.0,18000.0,75600.0
Madhubani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Madhubani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1800.0,4100.0,2100.0,5100.0,3100.0,5100.0,4500.0,2000.0,4500.0,4700.0,5300.0,2700.0,45000.0
Madhubani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,100.0,6000.0,3900.0,6800.0,3700.0,6600.0,2100.0,14100.0,9600.0,4900.0,3200.0,18500.0,79500.0
Madhubani,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Madhubani,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Madhubani,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Madhubani,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Madhubani,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Madhubani,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Madhubani,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Madhubani,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Madhubani,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Madhubani,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Madhubani,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Madhubani,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Madhubani,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Madhubani,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Madhubani,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Madhubani,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Madhubani,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Madhubani,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Madhubani,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Madhubani,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Madhubani,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Madhubani,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Madhubani,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Madhubani,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Madhubani,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Madhubani,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Madhubani,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Madhubani,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Madhubani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Madhubani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Madhubani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Madhubani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Madhubani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Madhubani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Madhubani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Madhubani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Madhubani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Madhubani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Madhubani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Madhubani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Madhubani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Madhubani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Madhubani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Madhubani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Madhubani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Madhubani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Madhubani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Madhubani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Madhubani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Madhubani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Madhubani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Madhubani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Madhubani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Madhubani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Madhubani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Madhubani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Madhubani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Munger,1.1,Total number of pregnant women Registered for ANC,TOTAL,2669.0,2844.0,2890.0,2681.0,2498.0,2228.0,1599.0,1989.0,1761.0,1987.0,2208.0,2725.0,28079.0
Munger,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1077.0,1248.0,1071.0,996.0,939.0,825.0,598.0,731.0,697.0,782.0,867.0,1069.0,10900.0
Munger,1.2,Number of Pregnant women registered under JSY,TOTAL,2669.0,2844.0,2890.0,2681.0,2498.0,2228.0,1599.0,1989.0,1761.0,1987.0,2208.0,2725.0,28079.0
Munger,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1200.0,1238.0,1510.0,1364.0,1572.0,1485.0,1331.0,1352.0,1072.0,1138.0,1114.0,1350.0,15726.0
Munger,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1910.0,1982.0,2012.0,1870.0,1667.0,1465.0,1042.0,1330.0,1144.0,1349.0,1478.0,1793.0,19042.0
Munger,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2490.0,2559.0,2623.0,2593.0,2751.0,2390.0,2008.0,1702.0,1823.0,1727.0,1690.0,2435.0,26791.0
Munger,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1359.0,1437.0,1514.0,1528.0,1562.0,1493.0,1142.0,1180.0,1098.0,1169.0,1209.0,1365.0,16056.0
Munger,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,1.0,0.0,31.0,16.0,0.0,11.0,7.0,12.0,1.0,79.0
Munger,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,9.0,1.0,0.0,1.0,0.0,5.0,3.0,1.0,0.0,0.0,2.0,22.0
Munger,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,131.0,221.0,255.0,192.0,300.0,199.0,184.0,316.0,236.0,344.0,316.0,402.0,3096.0
Munger,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,13.0,5.0,13.0,8.0,7.0,9.0,8.0,8.0,14.0,9.0,9.0,25.0,128.0
Munger,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,9.0,0.0,0.0,17.0,0.0,0.0,0.0,0.0,3.0,2.0,5.0,36.0
Munger,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,48.0,57.0,36.0,73.0,74.0,89.0,72.0,75.0,86.0,77.0,76.0,75.0,838.0
Munger,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,81.0,103.0,89.0,87.0,129.0,158.0,234.0,189.0,196.0,162.0,118.0,107.0,1653.0
Munger,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,129.0,160.0,125.0,160.0,203.0,247.0,306.0,264.0,282.0,239.0,194.0,182.0,2491.0
Munger,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,98.0,134.0,103.0,137.0,171.0,199.0,247.0,170.0,164.0,148.0,99.0,132.0,1802.0
Munger,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Munger,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1390.0,1280.0,1334.0,1759.0,2157.0,2297.0,2318.0,1965.0,1858.0,1721.0,1406.0,1275.0,20760.0
Munger,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1384.0,1269.0,1307.0,1752.0,2148.0,2293.0,2312.0,1961.0,1855.0,1707.0,1400.0,1199.0,20587.0
Munger,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,17.0,1311.0,307.0,380.0,2220.0,2320.0,846.0,1686.0,2154.0,1466.0,1312.0,1147.0,15166.0
Munger,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,213.0,411.0,864.0,905.0,1109.0,526.0,804.0,1372.0,1685.0,1633.0,1987.0,11509.0
Munger,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Munger,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Munger,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Munger,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Munger,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Munger,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,6.0,13.0,5.0,7.0,9.0,4.0,6.0,4.0,3.0,3.0,6.0,4.0,70.0
Munger,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Munger,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,6.0,13.0,5.0,7.0,9.0,4.0,6.0,4.0,3.0,3.0,6.0,4.0,70.0
Munger,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Munger,4.1.1.a,Number of male live births,TOTAL,781.0,734.0,736.0,1026.0,1213.0,1280.0,1282.0,1143.0,1055.0,981.0,797.0,714.0,11742.0
Munger,4.1.1.b,Number of female live births,TOTAL,709.0,678.0,696.0,862.0,1102.0,1217.0,1312.0,1053.0,1061.0,942.0,778.0,651.0,11061.0
Munger,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1490.0,1412.0,1432.0,1888.0,2315.0,2497.0,2594.0,2196.0,2116.0,1923.0,1575.0,1365.0,22803.0
Munger,4.1.2,Number of still births,TOTAL,29.0,31.0,28.0,38.0,52.0,60.0,41.0,38.0,33.0,40.0,29.0,21.0,440.0
Munger,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,7.0,1.0,5.0,9.0,4.0,0.0,3.0,2.0,4.0,10.0,2.0,0.0,47.0
Munger,4.2.1,Number of Newborns weighed at birth,TOTAL,1487.0,1403.0,1417.0,1881.0,2307.0,2487.0,2543.0,2159.0,2040.0,1866.0,1565.0,1336.0,22491.0
Munger,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,87.0,85.0,113.0,141.0,186.0,150.0,186.0,136.0,127.0,103.0,425.0,82.0,1821.0
Munger,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1462.0,1375.0,1401.0,1852.0,2279.0,2466.0,2536.0,2164.0,2084.0,1890.0,1555.0,1344.0,22408.0
Munger,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Munger,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,22.0,83.0,28.0,55.0,50.0,53.0,33.0,33.0,37.0,25.0,36.0,27.0,482.0
Munger,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Munger,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,22.0,83.0,28.0,55.0,50.0,53.0,33.0,33.0,37.0,25.0,36.0,27.0,482.0
Munger,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Munger,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,9.0,54.0,18.0,5.0,29.0,35.0,13.0,18.0,20.0,17.0,18.0,17.0,253.0
Munger,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,7.0,20.0,6.0,30.0,13.0,17.0,7.0,3.0,5.0,3.0,9.0,4.0,124.0
Munger,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,13.0,6.0,20.0,10.0,3.0,7.0,13.0,6.0,6.0,10.0,5.0,99.0
Munger,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,13.0,7.0,14.0,8.0,7.0,9.0,8.0,6.0,9.0,7.0,6.0,9.0,103.0
Munger,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1506.0,1417.0,1423.0,1884.0,2320.0,2493.0,2508.0,2083.0,1962.0,1795.0,1496.0,1301.0,22188.0
Munger,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,421.0,396.0,365.0,495.0,778.0,694.0,698.0,640.0,514.0,511.0,479.0,376.0,6367.0
Munger,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3.0,0.0,3.0,2.0,0.0,0.0,2.0,2.0,2.0,0.0,1.0,2.0,17.0
Munger,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,11.0
Munger,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3.0,0.0,6.0,2.0,0.0,0.0,2.0,2.0,2.0,8.0,1.0,2.0,28.0
Munger,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,223.0,225.0,308.0,390.0,305.0,295.0,255.0,333.0,388.0,230.0,244.0,293.0,3489.0
Munger,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,405.0,405.0,322.0,310.0,326.0,326.0,278.0,303.0,229.0,208.0,261.0,302.0,3675.0
Munger,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,628.0,630.0,630.0,700.0,631.0,621.0,533.0,636.0,617.0,438.0,505.0,595.0,7164.0
Munger,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,7.0,0.0,8.0
Munger,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Munger,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,6.0
Munger,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Munger,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,5.0,0.0,7.0,0.0,14.0
Munger,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,1.0,0.0,,,1.0
Munger,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Munger,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Munger,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,5.0,6.0,11.0,5.0,9.0,5.0,7.0,16.0,44.0,42.0,15.0,14.0,179.0
Munger,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,75.0,5.0,7.0,87.0,48.0,101.0,130.0,384.0,586.0,595.0,689.0,446.0,3153.0
Munger,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Munger,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,31.0,15.0,8.0,7.0,16.0,18.0,20.0,84.0,92.0,101.0,136.0,74.0,602.0
Munger,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Munger,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,106.0,20.0,15.0,94.0,64.0,119.0,150.0,468.0,678.0,696.0,825.0,520.0,3755.0
Munger,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,27.0,15.0,26.0,28.0,31.0,25.0,25.0,89.0,55.0,52.0,68.0,1010.0,1451.0
Munger,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,3.0,0.0,4.0,14.0,22.0
Munger,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Munger,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,3.0,3.0,5.0,0.0,1.0,2.0,1.0,3.0,5.0,9.0,3.0,36.0
Munger,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Munger,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,3.0,3.0,5.0,0.0,1.0,3.0,1.0,6.0,5.0,13.0,17.0,58.0
Munger,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Munger,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,52.0,80.0,50.0,163.0,47.0,72.0,59.0,60.0,70.0,54.0,49.0,56.0,812.0
Munger,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,26.0,18.0,19.0,49.0,18.0,18.0,19.0,35.0,31.0,26.0,22.0,46.0,327.0
Munger,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Munger,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,59.0,51.0,16.0,57.0,6.0,18.0,6.0,9.0,14.0,13.0,8.0,21.0,278.0
Munger,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Munger,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,137.0,149.0,85.0,269.0,71.0,108.0,84.0,104.0,115.0,93.0,79.0,123.0,1417.0
Munger,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,29.0,17.0,23.0,35.0,58.0,49.0,52.0,32.0,56.0,351.0
Munger,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,2.0,5.0,5.0,4.0,3.0,2.0,3.0,,1.0,1.0,2.0,6.0,34.0
Munger,9.06,Number of IUCD removals,TOTAL,41.0,49.0,62.0,40.0,42.0,46.0,55.0,63.0,33.0,29.0,39.0,35.0,534.0
Munger,9.07,Number of Oral Pills cycles distributed,TOTAL,867.0,1016.0,774.0,921.0,746.0,546.0,560.0,647.0,538.0,629.0,558.0,633.0,8435.0
Munger,9.08,Number of Condom pieces distributed,TOTAL,7586.0,7583.0,7223.0,7569.0,6537.0,5282.0,4973.0,4902.0,4488.0,4818.0,5746.0,3605.0,70312.0
Munger,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,11.0,3.0,14.0,0.0,2.0,1.0,2.0,2.0,1.0,5.0,80.0,121.0
Munger,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2.0,14.0,36.0,43.0,33.0,41.0,33.0,20.0,16.0,13.0,23.0,45.0,319.0
Munger,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Munger,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Munger,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1877.0,1910.0,1621.0,2281.0,2693.0,3278.0,3135.0,3221.0,2750.0,2444.0,2084.0,1910.0,29204.0
Munger,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2345.0,2127.0,1977.0,1662.0,1948.0,2362.0,2351.0,3526.0,3033.0,451.0,0.0,0.0,21782.0
Munger,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2732.0,2175.0,2116.0,1992.0,1932.0,2061.0,1972.0,2419.0,3023.0,2837.0,1101.0,456.0,24816.0
Munger,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2915.0,2436.0,2132.0,1971.0,2190.0,2185.0,1765.0,2099.0,2234.0,2782.0,2254.0,1893.0,26856.0
Munger,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2274.0,2395.0,2616.0,7285.0
Munger,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,1178.0,2300.0,3484.0
Munger,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,26.0,845.0,876.0
Munger,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1423.0,1484.0,1396.0,1785.0,2244.0,2452.0,2495.0,2108.0,1997.0,1776.0,1387.0,1244.0,21791.0
Munger,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2347.0,2142.0,1975.0,1665.0,1953.0,2375.0,2379.0,3554.0,3050.0,2820.0,2617.0,2710.0,29587.0
Munger,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2715.0,2198.0,2104.0,2004.0,1929.0,2078.0,2009.0,2439.0,3022.0,2702.0,2370.0,2856.0,28426.0
Munger,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2951.0,2469.0,2123.0,1985.0,2198.0,2188.0,1805.0,2105.0,2221.0,2606.0,2307.0,2765.0,27723.0
Munger,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1138.0,1166.0,1119.0,1603.0,1805.0,2013.0,1993.0,1731.0,1656.0,1521.0,1122.0,1009.0,17876.0
Munger,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2477.0,2130.0,1985.0,1668.0,1938.0,2360.0,2336.0,3485.0,3022.0,430.0,349.0,1.0,22181.0
Munger,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2825.0,2207.0,2125.0,2002.0,1930.0,2060.0,1991.0,2460.0,3021.0,2835.0,1095.0,450.0,25001.0
Munger,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3067.0,2503.0,2171.0,1998.0,2197.0,2202.0,1784.0,2043.0,2220.0,2747.0,2230.0,1913.0,27075.0
Munger,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1742.0,2056.0,2506.0,2555.0,2731.0,2782.0,626.0,3145.0,1779.0,1450.0,1261.0,1729.0,24362.0
Munger,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2761.0,2204.0,1908.0,1663.0,1762.0,1645.0,386.0,2122.0,1761.0,1744.0,1850.0,2765.0,22571.0
Munger,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,865.0,1095.0,1403.0,1344.0,1432.0,1406.0,314.0,1600.0,872.0,766.0,659.0,907.0,12663.0
Munger,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,852.0,960.0,1101.0,1198.0,1301.0,1354.0,286.0,1472.0,882.0,641.0,575.0,794.0,11416.0
Munger,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1717.0,2055.0,2504.0,2542.0,2733.0,2760.0,600.0,3072.0,1754.0,1407.0,1234.0,1701.0,24079.0
Munger,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2560.0,2160.0,1880.0,1629.0,1745.0,1562.0,1100.0,1828.0,1835.0,1902.0,2193.0,2728.0,23122.0
Munger,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2589.0,2165.0,1877.0,1634.0,1745.0,1564.0,1092.0,1829.0,1828.0,1800.0,2224.0,2734.0,23081.0
Munger,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,7.0
Munger,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,142.0,102.0,130.0,129.0,145.0,160.0,44.0,201.0,143.0,193.0,148.0,180.0,1717.0
Munger,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,117.0,98.0,100.0,100.0,122.0,178.0,69.0,190.0,134.0,177.0,129.0,156.0,1570.0
Munger,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,259.0,200.0,230.0,229.0,267.0,338.0,113.0,391.0,277.0,370.0,277.0,336.0,3287.0
Munger,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,132.0,128.0,77.0,91.0,182.0,169.0,150.0,219.0,131.0,191.0,131.0,157.0,1758.0
Munger,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,430.0,206.0,279.0,317.0,403.0,322.0,1030.0,330.0,220.0,492.0,220.0,255.0,4504.0
Munger,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1063.0,382.0,401.0,752.0,698.0,562.0,2010.0,561.0,363.0,1308.0,441.0,439.0,8980.0
Munger,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Munger,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,5.0
Munger,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1509.0,1524.0,1484.0,1466.0,1459.0,1455.0,1490.0,1472.0,1479.0,1454.0,1442.0,1463.0,17697.0
Munger,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1493.0,1486.0,1448.0,1463.0,1458.0,1454.0,1486.0,1459.0,1479.0,1429.0,1386.0,1463.0,17504.0
Munger,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1060.0,1094.0,1067.0,1143.0,1122.0,1122.0,1173.0,1106.0,1122.0,1096.0,1075.0,1158.0,13338.0
Munger,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,187.0,245.0,127.0,236.0,248.0,98.0,34.0,195.0,122.0,159.0,139.0,150.0,1940.0
Munger,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,18.0,27.0,18.0,34.0,20.0,1.0,1.0,55.0,58.0,65.0,20.0,2.0,319.0
Munger,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Munger,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,58.0,102.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,160.0
Munger,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,355.0,689.0,1332.0,1807.0,1693.0,1613.0,1636.0,1306.0,859.0,943.0,919.0,1163.0,14315.0
Munger,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,6.0,3.0,0.0,0.0,0.0,0.0,0.0,28.0,0.0,37.0
Munger,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,17.0,26.0,26.0,63.0,56.0,46.0,88.0,44.0,63.0,45.0,0.0,55.0,529.0
Munger,13.1,Number of Patients operated for cataract,TOTAL,114.0,88.0,87.0,120.0,92.0,76.0,109.0,327.0,266.0,175.0,316.0,805.0,2575.0
Munger,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,114.0,88.0,87.0,120.0,92.0,76.0,109.0,327.0,266.0,175.0,316.0,805.0,2575.0
Munger,13.3,Number of School children detected with Refractive errors,TOTAL,12.0,7.0,14.0,5.0,16.0,18.0,28.0,39.0,14.0,5.0,15.0,31.0,204.0
Munger,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0,17.0
Munger,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,,,,,,,,,,1.0,-1.0
Munger,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,1.0,,-1.0
Munger,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,833.0,830.0,821.0,839.0,745.0,852.0,855.0,864.0,856.0,846.0,804.0,857.0,-1.0
Munger,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,1.0,-1.0
Munger,14.05,Number of RKS meetings held during the month,TOTAL,5.0,5.0,5.0,4.0,9.0,4.0,1.0,3.0,5.0,5.0,53.0,5.0,104.0
Munger,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,1.0,,,,,,,,,,1.0,-1.0
Munger,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,743.0,541.0,628.0,766.0,918.0,902.0,526.0,626.0,616.0,657.0,613.0,566.0,8102.0
Munger,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Munger,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,0.0,-1.0
Munger,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,245.0,314.0,323.0,265.0,322.0,297.0,266.0,202.0,223.0,193.0,179.0,189.0,3018.0
Munger,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,453.0,887.0,755.0,723.0,818.0,699.0,588.0,591.0,420.0,461.0,222.0,474.0,7091.0
Munger,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,200.0,215.0,224.0,335.0,241.0,238.0,252.0,278.0,236.0,149.0,429.0,181.0,2978.0
Munger,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1876.0,1395.0,1759.0,2281.0,2649.0,3091.0,2955.0,2459.0,2520.0,2448.0,2304.0,2042.0,27779.0
Munger,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,445.0,529.0,547.0,600.0,563.0,535.0,518.0,480.0,459.0,342.0,608.0,370.0,5996.0
Munger,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2329.0,2282.0,2514.0,3004.0,3467.0,3790.0,3543.0,3050.0,2940.0,2909.0,2526.0,2516.0,34870.0
Munger,14.10.2.a,Number of death cases of Inpatient males,TOTAL,14.0,14.0,14.0,15.0,24.0,16.0,16.0,15.0,12.0,17.0,11.0,13.0,181.0
Munger,14.10.2.b,Number of death cases of Inpatient females,TOTAL,9.0,15.0,20.0,12.0,14.0,7.0,12.0,11.0,8.0,12.0,6.0,4.0,130.0
Munger,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,23.0,29.0,34.0,27.0,38.0,23.0,28.0,26.0,20.0,29.0,17.0,17.0,311.0
Munger,14.11,In-Patient Head Count at midnight,TOTAL,4353.0,4258.0,4100.0,4807.0,4814.0,5185.0,5238.0,4934.0,4664.0,4984.0,4617.0,4307.0,56261.0
Munger,14.12.1,OPD attendance (All),TOTAL,81716.0,83580.0,93173.0,108157.0,106710.0,118439.0,87690.0,95653.0,81905.0,77926.0,87372.0,83118.0,1105439.0
Munger,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,136.0,65.0,37.0,123.0,105.0,147.0,183.0,411.0,590.0,611.0,831.0,536.0,3775.0
Munger,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,90.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,90.0
Munger,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1418.0,1342.0,1458.0,1450.0,1641.0,1711.0,1476.0,1545.0,1312.0,1292.0,1407.0,1256.0,17308.0
Munger,14.14.a,Number of patients given AYUSH treatment,TOTAL,12875.0,13383.0,13717.0,20601.0,18253.0,17357.0,9979.0,12050.0,5223.0,11918.0,12141.0,14541.0,162038.0
Munger,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2926.0,2625.0,3841.0,2871.0,3947.0,4749.0,3162.0,2292.0,2166.0,3134.0,2927.0,2447.0,37087.0
Munger,14.14.c,Number of Adolescents counselled,TOTAL,87.0,199.0,34.0,257.0,166.0,739.0,752.0,708.0,751.0,777.0,608.0,525.0,5603.0
Munger,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,715.0,756.0,646.0,812.0,662.0,645.0,705.0,830.0,931.0,959.0,1040.0,1172.0,9873.0
Munger,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,43.0,33.0,56.0,96.0,43.0,31.0,63.0,41.0,55.0,50.0,61.0,56.0,628.0
Munger,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,278.0,306.0,329.0,517.0,193.0,275.0,355.0,450.0,664.0,429.0,359.0,447.0,4602.0
Munger,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,4.0,3.0,3.0,7.0,3.0,3.0,1.0,1.0,0.0,5.0,0.0,34.0
Munger,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,180.0,177.0,134.0,242.0,80.0,150.0,217.0,330.0,361.0,363.0,343.0,337.0,2914.0
Munger,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,3.0,2.0,2.0,0.0,1.0,0.0,2.0,0.0,90.0,2.0,104.0
Munger,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,796.0,469.0,820.0,580.0,654.0,244.0,709.0,745.0,841.0,875.0,781.0,765.0,8279.0
Munger,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0
Munger,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1254.0,952.0,1283.0,1339.0,927.0,669.0,1281.0,1525.0,1866.0,1667.0,1483.0,1549.0,15795.0
Munger,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,5.0,6.0,7.0,9.0,3.0,4.0,1.0,3.0,0.0,95.0,4.0,143.0
Munger,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,13.0,29.0,50.0
Munger,15.3.a,Number of VDRL tests conducted on males,Number tested,2.0,4.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,190.0,0.0,0.0,198.0
Munger,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,1.0,5.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,150.0,0.0,0.0,159.0
Munger,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Munger,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3.0,29.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,340.0,0.0,0.0,377.0
Munger,15.4.1,Number of blood smears examined for Malaria,TOTAL,58.0,55.0,61.0,62.0,126.0,149.0,571.0,418.0,162.0,108.0,176.0,252.0,2198.0
Munger,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,5.0,5.0,6.0,2.0,3.0,4.0,27.0
Munger,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,1.0,7.0,12.0,25.0,11.0,2.0,1.0,3.0,62.0
Munger,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,390.0,890.0,1140.0,1430.0,1080.0,630.0,730.0,570.0,,,,496.0,7356.0
Munger,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000.0,1500.0,1500.0,500.0,1000.0,2000.0,0.0,2000.0,,,,800.0,10300.0
Munger,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,500.0,1250.0,1210.0,850.0,1450.0,1900.0,160.0,1000.0,,,,950.0,9270.0
Munger,16.1.1,Stock position of DPT vaccines,5. Total Stock,890.0,1140.0,1430.0,1080.0,630.0,730.0,570.0,1570.0,0.0,0.0,0.0,346.0,8386.0
Munger,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,450.0,450.0
Munger,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Munger,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Munger,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,200.0,200.0
Munger,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,250.0,250.0
Munger,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,800.0,350.0,400.0,650.0,675.0,175.0,445.0,,,,60.0,3555.0
Munger,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,1000.0,1000.0,1000.0,1500.0,600.0,600.0,600.0,,,,1400.0,9700.0
Munger,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1200.0,1450.0,950.0,750.0,1475.0,1100.0,330.0,866.0,,,,1360.0,9481.0
Munger,16.1.2,Stock position of OPV vaccines,5. Total Stock,800.0,350.0,400.0,650.0,675.0,175.0,445.0,179.0,0.0,0.0,0.0,100.0,3774.0
Munger,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,745.0,1495.0,645.0,790.0,740.0,815.0,940.0,885.0,,,,684.0,7739.0
Munger,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000.0,,1000.0,500.0,1000.0,1500.0,0.0,1500.0,,,,1600.0,8100.0
Munger,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.1.3,Stock position of TT vaccines,4. Stock Distributed,250.0,850.0,855.0,550.0,925.0,1375.0,55.0,1270.0,,,,400.0,6530.0
Munger,16.1.3,Stock position of TT vaccines,5. Total Stock,1495.0,645.0,790.0,740.0,815.0,940.0,885.0,1115.0,0.0,0.0,0.0,1884.0,9309.0
Munger,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Munger,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Munger,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Munger,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Munger,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,140.0,640.0,740.0,1380.0,1430.0,680.0,615.0,555.0,,,,690.0,6870.0
Munger,16.1.5,Stock position of BCG vaccines,2. Stocks Received,900.0,900.0,900.0,500.0,0.0,900.0,0.0,1200.0,,,,1100.0,6400.0
Munger,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,400.0,800.0,260.0,450.0,750.0,965.0,60.0,1225.0,,,,450.0,5360.0
Munger,16.1.5,Stock position of BCG vaccines,5. Total Stock,640.0,740.0,1380.0,1430.0,680.0,615.0,555.0,530.0,0.0,0.0,0.0,1340.0,7910.0
Munger,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,140.0,400.0,435.0,675.0,200.0,50.0,0.0,180.0,,,,25.0,2105.0
Munger,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1500.0,3000.0,1000.0,1000.0,1080.0,900.0,950.0,1500.0,,,,2400.0,13330.0
Munger,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1240.0,2965.0,760.0,1475.0,1230.0,950.0,770.0,1485.0,,,,2105.0,12980.0
Munger,16.1.6,Stock position of Measles vaccines,5. Total Stock,400.0,435.0,675.0,200.0,50.0,0.0,180.0,195.0,0.0,0.0,0.0,320.0,2455.0
Munger,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,,0.0,,,,,0.0
Munger,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,0.0,0.0,0.0,0.0,,0.0,,,,,0.0
Munger,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,,0.0,,,,,0.0
Munger,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,0.0,0.0,0.0,0.0,,0.0,,,,,0.0
Munger,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,240.0,589.0,569.0,699.0,950.0,650.0,750.0,450.0,,,,260.0,5157.0
Munger,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1300.0,1300.0,1300.0,1000.0,1250.0,1600.0,0.0,2000.0,,,,800.0,10550.0
Munger,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,951.0,1320.0,1170.0,749.0,1550.0,1500.0,300.0,1180.0,,,,650.0,9370.0
Munger,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,589.0,569.0,699.0,950.0,650.0,750.0,450.0,1270.0,0.0,0.0,0.0,410.0,6337.0
Munger,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3550.0,3250.0,3250.0,3250.0,2400.0,2400.0,1800.0,1700.0,,,,1100.0,22700.0
Munger,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,300.0,0.0,0.0,850.0,0.0,600.0,100.0,100.0,,,,0.0,1950.0
Munger,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3250.0,3250.0,3250.0,2400.0,2400.0,1800.0,1700.0,1600.0,0.0,0.0,0.0,1100.0,20750.0
Munger,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,3000.0
Munger,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,3000.0
Munger,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,474.0,474.0
Munger,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,474.0,474.0
Munger,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,2819.0,2819.0
Munger,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2819.0,2819.0
Munger,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,,,,0.0,56.0
Munger,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,0.0,0.0,0.0,0.0,56.0
Munger,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,13900.0,0.0,0.0,0.0,4000.0,500.0,500.0,500.0,,,,3200.0,22600.0
Munger,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,0.0,9000.0,0.0,0.0,0.0,0.0,,,,0.0,9000.0
Munger,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,13900.0,0.0,0.0,5000.0,3500.0,0.0,0.0,0.0,,,,200.0,22600.0
Munger,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,4000.0,500.0,500.0,500.0,500.0,0.0,0.0,0.0,3000.0,9000.0
Munger,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,11900.0,11900.0,8400.0,4885.0,9600.0,18914.0,15714.0,,,,0.0,81313.0
Munger,16.3.02,Stock Position of Gloves,2. Stocks Received,15000.0,0.0,0.0,100.0,6000.0,10000.0,0.0,0.0,,,,1225.0,32325.0
Munger,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.02,Stock Position of Gloves,4. Stock Distributed,3100.0,3500.0,3500.0,3615.0,1285.0,686.0,3200.0,2700.0,,,,1200.0,22786.0
Munger,16.3.02,Stock Position of Gloves,5. Total Stock,11900.0,8400.0,8400.0,4885.0,9600.0,18914.0,15714.0,13014.0,0.0,0.0,0.0,25.0,90852.0
Munger,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,0.0,0.0,40000.0,49800.0,41800.0,33300.0,32000.0,,,,55000.0,251900.0
Munger,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,40000.0,40000.0,29000.0,0.0,0.0,0.0,0.0,,,,,109000.0
Munger,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,0.0,0.0,19200.0,8000.0,8500.0,1300.0,5000.0,,,,5000.0,47000.0
Munger,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,40000.0,40000.0,49800.0,41800.0,33300.0,32000.0,27000.0,0.0,0.0,0.0,50000.0,313900.0
Munger,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,55.0,55.0,55.0,55.0,55.0,55.0,55.0,55.0,,,,55.0,495.0
Munger,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,55.0,55.0,55.0,55.0,55.0,55.0,55.0,55.0,0.0,0.0,0.0,55.0,495.0
Munger,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Munger,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1265150.0,975150.0,975150.0,782150.0,281550.0,135350.0,115350.0,1133750.0,,,,223950.0,5887550.0
Munger,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,1150000.0,60000.0,,,,0.0,1210000.0
Munger,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,290000.0,193000.0,193000.0,500600.0,146200.0,20000.0,131600.0,263950.0,,,,12000.0,1750350.0
Munger,16.3.07,Stock Position of IFA Tablets,5. Total Stock,975150.0,782150.0,782150.0,281550.0,135350.0,115350.0,1133750.0,929800.0,0.0,0.0,0.0,211950.0,5347200.0
Munger,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,15630.0,11630.0,11630.0,7590.0,3750.0,1230.0,260.0,210.0,,,,0.0,51930.0
Munger,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,4000.0,4040.0,4040.0,3840.0,2520.0,970.0,50.0,210.0,,,,0.0,19670.0
Munger,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,11630.0,7590.0,7590.0,3750.0,1230.0,260.0,210.0,0.0,0.0,0.0,0.0,0.0,32260.0
Munger,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,4850.0,4650.0,4650.0,1625.0,2865.0,1840.0,1440.0,240.0,,,,0.0,22160.0
Munger,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,0.0,0.0,5340.0,2000.0,0.0,0.0,0.0,,,,0.0,7340.0
Munger,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,200.0,3025.0,3025.0,4100.0,3025.0,400.0,1200.0,240.0,,,,0.0,15215.0
Munger,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,4650.0,1625.0,1625.0,2865.0,1840.0,1440.0,240.0,0.0,0.0,0.0,0.0,0.0,14285.0
Munger,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,100.0,100.0,,,,0.0,200.0
Munger,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,0.0,0.0,100.0,100.0,0.0,0.0,,,,0.0,200.0
Munger,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,50.0,,,,0.0,50.0
Munger,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,100.0,100.0,100.0,50.0,0.0,0.0,0.0,0.0,350.0
Munger,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,33400.0,30400.0,30400.0,20100.0,117940.0,183520.0,153020.0,151170.0,,,,12900.0,732850.0
Munger,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,5000.0,0.0,0.0,173440.0,123600.0,500.0,0.0,0.0,,,,0.0,302540.0
Munger,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,8000.0,10300.0,10300.0,75600.0,58020.0,31000.0,1850.0,3000.0,,,,1010.0,199080.0
Munger,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,30400.0,20100.0,20100.0,117940.0,183520.0,153020.0,151170.0,148170.0,0.0,0.0,0.0,11890.0,836310.0
Munger,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1900.0,4200.0,3200.0,10050.0,10050.0,7050.0,6050.0,5000.0,,,,9500.0,57000.0
Munger,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,10000.0,,10000.0,0.0,0.0,6000.0,0.0,8000.0,,,,0.0,34000.0
Munger,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,7700.0,1000.0,3150.0,0.0,3000.0,7000.0,1050.0,3900.0,,,,4800.0,31600.0
Munger,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4200.0,3200.0,10050.0,10050.0,7050.0,6050.0,5000.0,9100.0,0.0,0.0,0.0,4700.0,59400.0
Munger,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6800.0,13400.0,400.0,36600.0,19000.0,0.0,22400.0,19050.0,,,,51850.0,169500.0
Munger,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,50000.0,,75000.0,0.0,0.0,75000.0,0.0,75000.0,,,,0.0,275000.0
Munger,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,43400.0,13000.0,38800.0,17600.0,19000.0,52600.0,3350.0,39000.0,,,,42800.0,269550.0
Munger,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,13400.0,400.0,36600.0,19000.0,0.0,22400.0,19050.0,55050.0,0.0,0.0,0.0,9050.0,174950.0
Munger,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,480.0,780.0,80.0,2460.0,2160.0,1100.0,1500.0,1480.0,,,,880.0,10920.0
Munger,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2500.0,,5000.0,0.0,0.0,4000.0,0.0,5000.0,,,,0.0,16500.0
Munger,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Munger,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2200.0,700.0,2620.0,300.0,1060.0,3600.0,20.0,1700.0,,,,0.0,12200.0
Munger,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,780.0,80.0,2460.0,2160.0,1100.0,1500.0,1480.0,4780.0,0.0,0.0,0.0,880.0,15220.0
Munger,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Munger,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Munger,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Munger,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Munger,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Munger,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Munger,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Munger,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Munger,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Munger,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Munger,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Munger,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Munger,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Munger,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Munger,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Munger,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Munger,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Munger,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Munger,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Munger,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Munger,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Munger,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Munger,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Munger,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Munger,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Munger,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Munger,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,2.0,2.0
Munger,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,2.0,2.0
Munger,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Munger,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Munger,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Munger,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Munger,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Munger,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Munger,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Munger,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Munger,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Munger,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Munger,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Munger,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Munger,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Munger,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Munger,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Munger,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Munger,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Munger,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Munger,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Munger,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Munger,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Munger,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Munger,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Munger,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Munger,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Munger,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Munger,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Munger,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Munger,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Munger,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Munger,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Munger,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Munger,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Munger,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Munger,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Muzaffarpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,10551.0,9455.0,9548.0,11880.0,10646.0,11631.0,9190.0,8956.0,8998.0,7813.0,9877.0,10264.0,118809.0
Muzaffarpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4035.0,3616.0,3792.0,4890.0,4043.0,4700.0,3739.0,4065.0,3767.0,3473.0,4089.0,3833.0,48042.0
Muzaffarpur,1.2,Number of Pregnant women registered under JSY,TOTAL,10541.0,8378.0,9484.0,11836.0,10650.0,11573.0,9179.0,8900.0,8968.0,7785.0,9775.0,10128.0,117197.0
Muzaffarpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5199.0,4970.0,4895.0,5953.0,5599.0,6022.0,5386.0,5293.0,5446.0,4480.0,4873.0,5342.0,63458.0
Muzaffarpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,8626.0,7482.0,8021.0,10125.0,8181.0,9215.0,6823.0,6997.0,6991.0,6002.0,7397.0,7506.0,93366.0
Muzaffarpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,8219.0,7926.0,7675.0,9271.0,8823.0,9539.0,8521.0,7396.0,7548.0,6483.0,7292.0,9431.0,98124.0
Muzaffarpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3856.0,3389.0,3485.0,3893.0,3227.0,2862.0,2708.0,2726.0,2547.0,3124.0,3141.0,2933.0,37891.0
Muzaffarpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,327.0,249.0,293.0,341.0,373.0,1432.0,389.0,366.0,793.0,296.0,264.0,136.0,5259.0
Muzaffarpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,25.0,14.0,18.0,13.0,15.0,10.0,19.0,17.0,16.0,25.0,12.0,10.0,194.0
Muzaffarpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,195.0,174.0,210.0,219.0,247.0,220.0,244.0,246.0,204.0,195.0,139.0,201.0,2494.0
Muzaffarpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,33.0,29.0,38.0,26.0,42.0,38.0,39.0,42.0,52.0,66.0,57.0,53.0,515.0
Muzaffarpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,510.0,402.0,535.0,736.0,719.0,770.0,564.0,747.0,870.0,658.0,875.0,884.0,8270.0
Muzaffarpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,216.0,256.0,288.0,315.0,358.0,365.0,422.0,448.0,357.0,443.0,285.0,237.0,3990.0
Muzaffarpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,2808.0,2324.0,2147.0,2765.0,2546.0,2967.0,2484.0,2901.0,3223.0,2820.0,2674.0,2261.0,31920.0
Muzaffarpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,3024.0,2580.0,2435.0,3080.0,2904.0,3332.0,2906.0,3349.0,3580.0,3263.0,2959.0,2498.0,35910.0
Muzaffarpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1449.0,1288.0,1156.0,1385.0,1394.0,1604.0,1319.0,1654.0,1684.0,1743.0,1545.0,1468.0,17689.0
Muzaffarpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,15.0,20.0,5.0,21.0,23.0,16.0,6.0,46.0,16.0,23.0,16.0,35.0,242.0
Muzaffarpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3535.0,3197.0,3332.0,4597.0,5461.0,4799.0,4332.0,4224.0,4125.0,3913.0,3598.0,2824.0,47937.0
Muzaffarpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3830.0,3538.0,3505.0,4782.0,5679.0,5094.0,4177.0,4764.0,4604.0,3828.0,3681.0,2707.0,50189.0
Muzaffarpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3928.0,3642.0,3358.0,4772.0,2399.0,141.0,1511.0,3409.0,2725.0,6794.0,3693.0,4063.0,40435.0
Muzaffarpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2911.0,2376.0,2220.0,3303.0,1969.0,663.0,1538.0,2062.0,1768.0,5426.0,4439.0,2994.0,31669.0
Muzaffarpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Muzaffarpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Muzaffarpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Muzaffarpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Muzaffarpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Muzaffarpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,3.0,2.0,1.0,0.0,2.0,2.0,0.0,1.0,0.0,0.0,0.0,1.0,12.0
Muzaffarpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muzaffarpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,8.0,2.0,1.0,0.0,2.0,2.0,0.0,1.0,0.0,0.0,0.0,1.0,17.0
Muzaffarpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Muzaffarpur,4.1.1.a,Number of male live births,TOTAL,3737.0,3278.0,3268.0,4323.0,4885.0,4558.0,4329.0,4364.0,4546.0,4402.0,3887.0,3187.0,48764.0
Muzaffarpur,4.1.1.b,Number of female live births,TOTAL,3486.0,3094.0,3048.0,4176.0,4442.0,4471.0,3795.0,4052.0,4312.0,4220.0,3571.0,2886.0,45553.0
Muzaffarpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,7223.0,6372.0,6316.0,8499.0,9327.0,9029.0,8124.0,8416.0,8858.0,8622.0,7458.0,6073.0,94317.0
Muzaffarpur,4.1.2,Number of still births,TOTAL,103.0,86.0,94.0,139.0,116.0,107.0,88.0,115.0,106.0,99.0,75.0,85.0,1213.0
Muzaffarpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,15.0,12.0,8.0,12.0,15.0,13.0,15.0,12.0,13.0,9.0,7.0,12.0,143.0
Muzaffarpur,4.2.1,Number of Newborns weighed at birth,TOTAL,4688.0,4296.0,4439.0,5931.0,6879.0,6369.0,5660.0,5738.0,5993.0,6847.0,5977.0,4994.0,67811.0
Muzaffarpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,826.0,454.0,550.0,849.0,793.0,685.0,615.0,526.0,471.0,669.0,311.0,366.0,7115.0
Muzaffarpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4925.0,4645.0,4693.0,6089.0,7239.0,6774.0,6122.0,6136.0,6133.0,6967.0,6114.0,4532.0,70369.0
Muzaffarpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,5.0,5.0,0.0,4.0,23.0
Muzaffarpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,3.0,0.0,3.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Muzaffarpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muzaffarpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,3.0,0.0,3.0,10.0,0.0,9.0,0.0,0.0,5.0,5.0,0.0,4.0,39.0
Muzaffarpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Muzaffarpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1778.0,1532.0,58.0,1388.0,1876.0,2717.0,2273.0,2298.0,2175.0,1785.0,1977.0,1488.0,21345.0
Muzaffarpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,350.0,112.0,238.0,182.0,210.0,66.0,228.0,120.0,210.0,89.0,99.0,64.0,1968.0
Muzaffarpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1483.0,1345.0,358.0,1995.0,2276.0,2291.0,2013.0,2066.0,1803.0,1515.0,1375.0,1031.0,19551.0
Muzaffarpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,72.0,84.0,96.0,85.0,90.0,83.0,88.0,91.0,80.0,67.0,71.0,108.0,1015.0
Muzaffarpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2594.0,2598.0,2021.0,2434.0,2988.0,3145.0,2694.0,2418.0,2720.0,2648.0,2247.0,1871.0,30378.0
Muzaffarpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1820.0,1489.0,988.0,1209.0,1319.0,1535.0,1358.0,1530.0,1366.0,1487.0,1549.0,1308.0,16958.0
Muzaffarpur,6.3,PNC maternal complications attended,TOTAL,215.0,198.0,216.0,289.0,351.0,363.0,363.0,273.0,304.0,228.0,226.0,156.0,3182.0
Muzaffarpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Muzaffarpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,8.0,8.0,11.0,6.0,6.0,7.0,2.0,6.0,3.0,2.0,4.0,8.0,71.0
Muzaffarpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,10.0,8.0,11.0,6.0,6.0,7.0,2.0,6.0,3.0,2.0,4.0,8.0,73.0
Muzaffarpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,210.0,32.0,237.0,150.0,212.0,187.0,67.0,232.0,266.0,316.0,244.0,75.0,2228.0
Muzaffarpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,363.0,213.0,600.0,301.0,330.0,250.0,166.0,312.0,433.0,300.0,257.0,130.0,3655.0
Muzaffarpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,573.0,245.0,837.0,451.0,542.0,437.0,233.0,544.0,699.0,616.0,501.0,205.0,5883.0
Muzaffarpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Muzaffarpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,7.0,1.0,1.0,4.0,1.0,0.0,5.0,4.0,12.0,9.0,1.0,45.0
Muzaffarpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Muzaffarpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,5.0
Muzaffarpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muzaffarpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,8.0,2.0,1.0,4.0,1.0,0.0,5.0,5.0,13.0,9.0,1.0,51.0
Muzaffarpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,1.0,,,,,,,,,,1.0
Muzaffarpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muzaffarpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Muzaffarpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,157.0,15.0,6.0,899.0,221.0,649.0,238.0,1662.0,1637.0,1311.0,2009.0,1083.0,9887.0
Muzaffarpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,22.0,0.0,10.0,73.0,14.0,35.0,12.0,173.0,205.0,117.0,169.0,91.0,921.0
Muzaffarpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,43.0,19.0,11.0,10.0,9.0,12.0,6.0,52.0,100.0,81.0,113.0,75.0,531.0
Muzaffarpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muzaffarpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,222.0,34.0,27.0,982.0,244.0,696.0,256.0,1887.0,1942.0,1509.0,2291.0,1249.0,11339.0
Muzaffarpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,163.0,185.0,117.0,259.0,323.0,365.0,317.0,654.0,780.0,453.0,989.0,733.0,5338.0
Muzaffarpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.0,4.0
Muzaffarpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,3.0,0.0,2.0,2.0,0.0,0.0,2.0,8.0,17.0,12.0,14.0,7.0,67.0
Muzaffarpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,3.0,1.0,1.0,1.0,9.0,0.0,0.0,0.0,13.0,2.0,10.0,7.0,47.0
Muzaffarpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muzaffarpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,6.0,1.0,3.0,3.0,9.0,0.0,2.0,8.0,30.0,15.0,26.0,15.0,118.0
Muzaffarpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Muzaffarpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,410.0,475.0,326.0,511.0,601.0,636.0,493.0,486.0,482.0,369.0,464.0,402.0,5655.0
Muzaffarpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,144.0,126.0,97.0,380.0,239.0,190.0,262.0,300.0,342.0,289.0,306.0,523.0,3198.0
Muzaffarpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,8.0,,9.0,52.0,8.0,12.0,13.0,8.0,67.0,6.0,8.0,7.0,198.0
Muzaffarpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,176.0,164.0,188.0,347.0,299.0,375.0,230.0,244.0,198.0,298.0,280.0,169.0,2968.0
Muzaffarpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muzaffarpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,738.0,765.0,620.0,1290.0,1147.0,1213.0,998.0,1038.0,1089.0,962.0,1058.0,1101.0,12019.0
Muzaffarpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,92.0,64.0,128.0,225.0,221.0,251.0,218.0,179.0,144.0,174.0,183.0,141.0,2020.0
Muzaffarpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,12.0,16.0,13.0,5.0,13.0,8.0,9.0,9.0,8.0,8.0,9.0,10.0,120.0
Muzaffarpur,9.06,Number of IUCD removals,TOTAL,275.0,237.0,243.0,254.0,243.0,352.0,263.0,340.0,247.0,223.0,221.0,201.0,3099.0
Muzaffarpur,9.07,Number of Oral Pills cycles distributed,TOTAL,1639.0,1783.0,1686.0,2563.0,2268.0,4924.0,1821.0,1744.0,1600.0,1573.0,1855.0,1888.0,25344.0
Muzaffarpur,9.08,Number of Condom pieces distributed,TOTAL,11732.0,13217.0,10971.0,15223.0,19589.0,17030.0,15800.0,13233.0,14471.0,14997.0,12599.0,8747.0,167609.0
Muzaffarpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,404.0,464.0,177.0,237.0,241.0,409.0,360.0,249.0,208.0,240.0,144.0,133.0,3266.0
Muzaffarpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,209.0,322.0,118.0,268.0,112.0,319.0,183.0,212.0,192.0,188.0,141.0,303.0,2567.0
Muzaffarpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,8.0,14.0,0.0,41.0,16.0,0.0,0.0,8.0,0.0,0.0,0.0,11.0,98.0
Muzaffarpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,6.0,13.0,0.0,31.0,12.0,0.0,0.0,7.0,4.0,0.0,0.0,5.0,78.0
Muzaffarpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,41.0,10.0,0.0,0.0,8.0,0.0,6.0,0.0,3.0,68.0
Muzaffarpur,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,37.0,4.0,0.0,0.0,7.0,0.0,0.0,0.0,6.0,55.0
Muzaffarpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,8.0
Muzaffarpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,8.0
Muzaffarpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,2.0,2.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,-1.0
Muzaffarpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,9839.0,7563.0,7906.0,10522.0,10094.0,11675.0,9383.0,10731.0,10213.0,9613.0,10455.0,8388.0,116382.0
Muzaffarpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,9958.0,7967.0,8232.0,9368.0,7763.0,10321.0,9655.0,10533.0,10576.0,3339.0,562.0,715.0,88989.0
Muzaffarpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,9802.0,8575.0,8203.0,9711.0,8152.0,9059.0,8732.0,9607.0,10861.0,9257.0,6054.0,3102.0,101115.0
Muzaffarpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,9258.0,8269.0,8484.0,9710.0,8084.0,9246.0,8101.0,8428.0,9596.0,9009.0,9444.0,6626.0,104255.0
Muzaffarpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1.0,1.0,0.0,0.0,0.0,18.0,0.0,0.0,4.0,6084.0,9954.0,9434.0,25496.0
Muzaffarpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,13.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,37.0,4085.0,7930.0,12067.0
Muzaffarpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,22.0,0.0,0.0,0.0,0.0,23.0,0.0,0.0,3.0,0.0,123.0,3518.0,3689.0
Muzaffarpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,6626.0,5298.0,5795.0,7248.0,7800.0,7773.0,6308.0,7436.0,7075.0,6413.0,8691.0,5523.0,81986.0
Muzaffarpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,10032.0,8080.0,8226.0,9788.0,7807.0,9228.0,8955.0,9394.0,9458.0,6418.0,9364.0,9192.0,105942.0
Muzaffarpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,9732.0,8614.0,8182.0,9650.0,8078.0,8372.0,7868.0,8267.0,9360.0,8382.0,9052.0,9736.0,105293.0
Muzaffarpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,9398.0,8496.0,8525.0,9751.0,8032.0,8315.0,7353.0,7483.0,8461.0,7881.0,9318.0,8818.0,101831.0
Muzaffarpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3107.0,2766.0,3044.0,4246.0,4850.0,4141.0,3773.0,3784.0,3957.0,3763.0,3137.0,2406.0,42974.0
Muzaffarpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,9339.0,7714.0,7856.0,8900.0,7558.0,9533.0,9292.0,10567.0,10199.0,3117.0,440.0,188.0,84703.0
Muzaffarpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,9245.0,8317.0,7981.0,9421.0,7961.0,8627.0,8261.0,9250.0,10381.0,8807.0,5633.0,2505.0,96389.0
Muzaffarpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,8887.0,8004.0,8346.0,9487.0,7940.0,8821.0,7725.0,8288.0,9247.0,8505.0,8942.0,6079.0,100271.0
Muzaffarpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7322.0,7324.0,7999.0,9804.0,8340.0,8152.0,6650.0,6887.0,5379.0,7228.0,8613.0,8290.0,91988.0
Muzaffarpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2818.0,3756.0,3957.0,5108.0,4197.0,4260.0,3485.0,3285.0,3283.0,4401.0,5871.0,7107.0,51528.0
Muzaffarpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3954.0,3727.0,5764.0,5774.0,4766.0,5595.0,4689.0,4435.0,5149.0,5600.0,6312.0,6170.0,61935.0
Muzaffarpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4013.0,3935.0,4250.0,5234.0,4559.0,4304.0,3560.0,3700.0,3792.0,3934.0,4424.0,4948.0,50653.0
Muzaffarpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3579.0,3519.0,3837.0,4680.0,4011.0,3875.0,3142.0,3300.0,3335.0,3379.0,3980.0,4386.0,45023.0
Muzaffarpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,7592.0,7454.0,8087.0,9914.0,8570.0,8179.0,6702.0,7000.0,7127.0,7313.0,8404.0,9334.0,95676.0
Muzaffarpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6725.0,5929.0,6237.0,7619.0,5663.0,6448.0,5355.0,5515.0,6192.0,5873.0,7412.0,7701.0,76669.0
Muzaffarpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6512.0,5820.0,6275.0,7553.0,5642.0,6047.0,5082.0,4946.0,5571.0,5461.0,7471.0,7740.0,74120.0
Muzaffarpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,91.0,38.0,44.0,55.0,68.0,27.0,41.0,58.0,261.0,58.0,14.0,15.0,770.0
Muzaffarpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1569.0,1398.0,1494.0,1527.0,1554.0,1447.0,1166.0,1203.0,1038.0,1271.0,1514.0,1725.0,16906.0
Muzaffarpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1333.0,1211.0,1313.0,1296.0,1420.0,1249.0,1063.0,996.0,909.0,1155.0,1344.0,1559.0,14848.0
Muzaffarpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2902.0,2609.0,2807.0,2823.0,2974.0,2696.0,2229.0,2199.0,1947.0,2426.0,2858.0,3284.0,31754.0
Muzaffarpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,497.0,220.0,412.0,502.0,450.0,215.0,265.0,276.0,176.0,465.0,563.0,787.0,4828.0
Muzaffarpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2566.0,2343.0,2364.0,2611.0,2436.0,2257.0,2616.0,2256.0,2349.0,2119.0,2169.0,2281.0,28367.0
Muzaffarpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,3841.0,3006.0,3299.0,3431.0,3427.0,3435.0,3424.0,3124.0,3093.0,3080.0,3143.0,3405.0,39708.0
Muzaffarpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,6.0,0.0,21.0,33.0
Muzaffarpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,5.0,7.0,4.0,19.0
Muzaffarpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,4141.0,4108.0,3678.0,4211.0,3978.0,4034.0,4083.0,3984.0,3791.0,3705.0,3670.0,3865.0,47248.0
Muzaffarpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,4059.0,3980.0,3507.0,4056.0,3896.0,3997.0,4057.0,3916.0,3772.0,3581.0,3645.0,3855.0,46321.0
Muzaffarpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3685.0,3700.0,3616.0,3701.0,3677.0,3721.0,3754.0,3584.0,3484.0,3284.0,3400.0,3624.0,43230.0
Muzaffarpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2113.0,2363.0,3615.0,3639.0,2983.0,4195.0,3426.0,3007.0,4449.0,4239.0,5915.0,6654.0,46598.0
Muzaffarpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4780.0,4583.0,5589.0,8756.0,6309.0,6024.0,5127.0,5156.0,4688.0,5428.0,5736.0,5757.0,67933.0
Muzaffarpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1298.0,1227.0,1320.0,3677.0,1309.0,1510.0,1246.0,1336.0,1554.0,1503.0,1679.0,2051.0,19710.0
Muzaffarpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,416.0,474.0,387.0,1779.0,349.0,439.0,365.0,319.0,334.0,268.0,444.0,398.0,5972.0
Muzaffarpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,7.0
Muzaffarpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Muzaffarpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,7.0,17.0,24.0,8.0,5.0,0.0,0.0,0.0,0.0,0.0,13.0,3.0,77.0
Muzaffarpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,125.0,251.0,215.0,277.0,253.0,177.0,168.0,168.0,296.0,213.0,307.0,133.0,2583.0
Muzaffarpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,5.0,935.0,38.0,0.0,0.0,0.0,10.0,80.0,4.0,0.0,4.0,1076.0
Muzaffarpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,0.0,16.0
Muzaffarpur,13.1,Number of Patients operated for cataract,TOTAL,1458.0,762.0,1313.0,1120.0,2189.0,2320.0,2086.0,3288.0,4039.0,4329.0,5536.0,8526.0,36966.0
Muzaffarpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,1423.0,743.0,1343.0,1149.0,2153.0,2262.0,2115.0,3232.0,4001.0,4280.0,5470.0,8480.0,36651.0
Muzaffarpur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,4.0,155.0,15.0,37.0,20.0,0.0,0.0,0.0,0.0,0.0,231.0
Muzaffarpur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,56.0,8.0,22.0,0.0,0.0,0.0,0.0,0.0,0.0,86.0
Muzaffarpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Muzaffarpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,,,-1.0
Muzaffarpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2860.0,2984.0,2965.0,2623.0,2854.0,2862.0,2899.0,2771.0,2965.0,2890.0,2729.0,2965.0,-1.0
Muzaffarpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Muzaffarpur,14.05,Number of RKS meetings held during the month,TOTAL,9.0,9.0,10.0,10.0,13.0,10.0,7.0,8.0,9.0,10.0,420.0,8.0,523.0
Muzaffarpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,1.0,2.0,2.0,2.0,2.0,2.0,1.0,,1.0,1.0,1.0,-1.0
Muzaffarpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,819.0,822.0,878.0,877.0,1124.0,579.0,944.0,686.0,1351.0,910.0,855.0,810.0,10655.0
Muzaffarpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Muzaffarpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Muzaffarpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,807.0,815.0,1443.0,1161.0,1082.0,1088.0,1028.0,787.0,666.0,769.0,653.0,591.0,10890.0
Muzaffarpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1877.0,1911.0,1698.0,1710.0,1755.0,1736.0,1685.0,1707.0,1476.0,1503.0,1534.0,1743.0,20335.0
Muzaffarpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,709.0,753.0,1343.0,1264.0,1444.0,1200.0,932.0,927.0,918.0,586.0,614.0,535.0,11225.0
Muzaffarpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4870.0,4461.0,5196.0,5903.0,7228.0,6497.0,5687.0,6033.0,5497.0,5771.0,6444.0,4804.0,68391.0
Muzaffarpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1516.0,1568.0,2786.0,2425.0,2526.0,2288.0,1960.0,1714.0,1584.0,1355.0,1267.0,1126.0,22115.0
Muzaffarpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6747.0,6372.0,6894.0,7613.0,8983.0,8233.0,7372.0,7740.0,6973.0,7274.0,7978.0,6547.0,88726.0
Muzaffarpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,110.0,109.0,181.0,128.0,124.0,90.0,111.0,222.0,71.0,73.0,82.0,88.0,1389.0
Muzaffarpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,66.0,66.0,137.0,79.0,78.0,65.0,59.0,199.0,49.0,58.0,46.0,57.0,959.0
Muzaffarpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,176.0,175.0,318.0,207.0,202.0,155.0,170.0,421.0,120.0,131.0,128.0,145.0,2348.0
Muzaffarpur,14.11,In-Patient Head Count at midnight,TOTAL,6891.0,5086.0,5468.0,6835.0,6866.0,6155.0,6242.0,5784.0,5558.0,5289.0,5241.0,4158.0,69573.0
Muzaffarpur,14.12.1,OPD attendance (All),TOTAL,286228.0,290382.0,328127.0,345131.0,339476.0,352625.0,298983.0,299126.0,256621.0,260460.0,270800.0,273337.0,3601296.0
Muzaffarpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,521.0,7235.0,471.0,1080.0,1637.0,929.0,800.0,1761.0,2030.0,1588.0,2374.0,2543.0,22969.0
Muzaffarpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,89.0,31.0,46.0,229.0,57.0,62.0,6.0,115.0,357.0,48.0,223.0,140.0,1403.0
Muzaffarpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3835.0,3733.0,3976.0,3420.0,3871.0,4085.0,3191.0,3743.0,3082.0,2974.0,3520.0,2489.0,41919.0
Muzaffarpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,50091.0,45504.0,55124.0,48661.0,54975.0,60488.0,49017.0,49300.0,30270.0,38004.0,46775.0,37844.0,566053.0
Muzaffarpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,6977.0,7647.0,8424.0,10461.0,7270.0,9136.0,6130.0,7954.0,5784.0,5501.0,6765.0,5755.0,87804.0
Muzaffarpur,14.14.c,Number of Adolescents counselled,TOTAL,0.0,21.0,382.0,22.0,111.0,43.0,0.0,0.0,110.0,0.0,74.0,36.0,799.0
Muzaffarpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3655.0,3542.0,3053.0,2690.0,3050.0,2721.0,2071.0,2862.0,2795.0,2637.0,3430.0,3884.0,36390.0
Muzaffarpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,246.0,190.0,209.0,126.0,159.0,107.0,57.0,165.0,211.0,110.0,168.0,137.0,1885.0
Muzaffarpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,818.0,740.0,686.0,732.0,659.0,544.0,519.0,550.0,570.0,458.0,450.0,527.0,7253.0
Muzaffarpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,46.0,35.0,41.0,44.0,34.0,36.0,3.0,5.0,35.0,31.0,36.0,35.0,381.0
Muzaffarpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,858.0,639.0,472.0,922.0,623.0,811.0,765.0,1411.0,1564.0,986.0,1090.0,854.0,10995.0
Muzaffarpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,34.0,28.0,31.0,27.0,4.0,25.0,1.0,1.0,24.0,23.0,25.0,27.0,250.0
Muzaffarpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2001.0,1652.0,1429.0,2066.0,1800.0,1835.0,822.0,1012.0,1279.0,1146.0,1227.0,1104.0,17373.0
Muzaffarpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,10.0,0.0,1.0,3.0,7.0,6.0,4.0,1.0,3.0,2.0,1.0,0.0,38.0
Muzaffarpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3677.0,3031.0,2587.0,3720.0,3082.0,3190.0,2106.0,2973.0,3413.0,2590.0,2767.0,2485.0,35621.0
Muzaffarpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,90.0,63.0,73.0,74.0,45.0,67.0,8.0,7.0,62.0,56.0,62.0,62.0,669.0
Muzaffarpur,15.2,Number of Widal tests conducted,Number tested,135.0,115.0,106.0,158.0,232.0,245.0,0.0,0.0,64.0,54.0,636.0,183.0,1928.0
Muzaffarpur,15.3.a,Number of VDRL tests conducted on males,Number tested,109.0,50.0,41.0,0.0,95.0,0.0,0.0,108.0,3.0,65.0,78.0,121.0,670.0
Muzaffarpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,263.0,249.0,187.0,0.0,201.0,0.0,0.0,215.0,5.0,7.0,266.0,195.0,1588.0
Muzaffarpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,320.0,302.0,350.0,0.0,301.0,0.0,0.0,0.0,0.0,17.0,258.0,343.0,1891.0
Muzaffarpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,692.0,601.0,578.0,0.0,597.0,0.0,0.0,323.0,8.0,89.0,602.0,659.0,4149.0
Muzaffarpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,411.0,136.0,292.0,145.0,183.0,235.0,138.0,148.0,164.0,27.0,33.0,159.0,2071.0
Muzaffarpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,8.0,4.0,9.0,0.0,82.0,8.0,0.0,0.0,0.0,1.0,0.0,0.0,112.0
Muzaffarpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,10.0,1.0,11.0,0.0,5.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,32.0
Muzaffarpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,5034.0,3979.0,7189.0,1284.0,7549.0,11823.0,8908.0,13758.0,9488.0,1438.0,4288.0,6631.0,81369.0
Muzaffarpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,12000.0,0.0,5000.0,9000.0,3000.0,11000.0,,,5000.0,3800.0,,58800.0
Muzaffarpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,11055.0,8790.0,5905.0,6284.0,4726.0,5915.0,6150.0,4310.0,8050.0,2150.0,1457.0,2805.0,67597.0
Muzaffarpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,3979.0,7189.0,1284.0,0.0,11823.0,8908.0,13758.0,9448.0,1438.0,4288.0,6631.0,3826.0,72572.0
Muzaffarpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,9815.0,,9815.0
Muzaffarpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,2402.0,,2402.0
Muzaffarpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7413.0,0.0,7413.0
Muzaffarpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3234.0,2019.0,4502.0,752.0,2417.0,651.0,891.0,1091.0,1888.0,388.0,978.0,117.0,18928.0
Muzaffarpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,6400.0,9003.0,0.0,9500.0,2000.0,2000.0,2750.0,2000.0,2200.0,53050.0,1600.0,6350.0,96853.0
Muzaffarpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7615.0,6520.0,3750.0,7835.0,3766.0,1760.0,2550.0,1203.0,3750.0,52460.0,2461.0,4460.0,98130.0
Muzaffarpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,2019.0,4502.0,752.0,2417.0,651.0,891.0,1091.0,1888.0,338.0,978.0,117.0,2007.0,17651.0
Muzaffarpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2730.0,6685.0,10310.0,5944.0,2004.0,2453.0,983.0,14458.0,11435.0,4985.0,6835.0,7750.0,76572.0
Muzaffarpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,10000.0,0.0,3000.0,4100.0,3000.0,16000.0,,,3500.0,3000.0,0.0,52600.0
Muzaffarpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6045.0,6375.0,4366.0,6940.0,3651.0,4470.0,2525.0,3023.0,6450.0,1650.0,2085.0,3450.0,51030.0
Muzaffarpur,16.1.3,Stock position of TT vaccines,5. Total Stock,6685.0,10310.0,5944.0,2004.0,2453.0,983.0,14458.0,11435.0,4985.0,6835.0,7750.0,4300.0,78142.0
Muzaffarpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3605.0,2225.0,5135.0,1765.0,2647.0,656.0,691.0,441.0,2281.0,1226.0,1536.0,928.0,23136.0
Muzaffarpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,8000.0,0.0,8500.0,0.0,2000.0,2250.0,4100.0,2035.0,2450.0,2100.0,5350.0,41785.0
Muzaffarpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6380.0,5090.0,3370.0,5618.0,1991.0,1875.0,2500.0,1819.0,2900.0,2140.0,2708.0,3360.0,39751.0
Muzaffarpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,2225.0,5135.0,1765.0,4647.0,656.0,781.0,441.0,2722.0,1416.0,1536.0,928.0,2918.0,25170.0
Muzaffarpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,683.0,558.0,3070.0,1158.0,2118.0,0.0,950.0,1690.0,1917.0,1540.0,2400.0,443.0,16527.0
Muzaffarpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,8500.0,10500.0,2000.0,8000.0,1000.0,3050.0,2850.0,3400.0,3400.0,3000.0,2750.0,5700.0,54150.0
Muzaffarpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,8625.0,7988.0,3912.0,7040.0,3118.0,2100.0,2110.0,3173.0,3777.0,2140.0,4357.0,5145.0,53485.0
Muzaffarpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,558.0,3070.0,1158.0,2118.0,0.0,950.0,1690.0,1917.0,1540.0,2400.0,793.0,998.0,17192.0
Muzaffarpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,911.0,71.0,1469.0,400.0,6420.0,2689.0,989.0,210.0,2410.0,2700.0,2440.0,2167.0,22876.0
Muzaffarpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,4000.0,19300.0,10000.0,0.0,3400.0,1300.0,5500.0,5000.0,3500.0,3000.0,7000.0,62000.0
Muzaffarpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,840.0,2602.0,20369.0,3980.0,3731.0,5100.0,2079.0,3300.0,4710.0,3760.0,3263.0,6320.0,60054.0
Muzaffarpur,16.1.7,Stock position of JE vaccines,5. Total Stock,71.0,1469.0,400.0,6420.0,2689.0,989.0,210.0,2410.0,2700.0,2440.0,2177.0,2847.0,24822.0
Muzaffarpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2334.0,5539.0,5004.0,950.0,3640.0,558.0,328.0,8618.0,4768.0,1018.0,3068.0,,35825.0
Muzaffarpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,10000.0,8000.0,0.0,12500.0,0.0,3000.0,12100.0,,,3500.0,1250.0,,50350.0
Muzaffarpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,6795.0,8535.0,5004.0,7610.0,3082.0,3430.0,3810.0,3850.0,3750.0,1450.0,4311.0,,51627.0
Muzaffarpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5539.0,5004.0,0.0,5840.0,558.0,128.0,8618.0,4768.0,1018.0,3068.0,7.0,0.0,34548.0
Muzaffarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Muzaffarpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Muzaffarpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Muzaffarpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muzaffarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7730.0,12530.0,530.0,16830.0,15230.0,3330.0,14430.0,700.0,2308.0,3308.0,5108.0,1772.0,83806.0
Muzaffarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,16000.0,0.0,20000.0,15000.0,0.0,21000.0,0.0,10000.0,12000.0,13000.0,8000.0,15000.0,130000.0
Muzaffarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,11200.0,12000.0,3700.0,16600.0,11900.0,9900.0,13730.0,8392.0,11000.0,11200.0,11330.0,10450.0,131402.0
Muzaffarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,12530.0,530.0,16830.0,15230.0,3330.0,14430.0,700.0,2308.0,3308.0,5108.0,1778.0,6322.0,82404.0
Muzaffarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,64430.0,55430.0,430.0,63830.0,96830.0,19330.0,123730.0,18530.0,12430.0,17430.0,29580.0,52780.0,554760.0
Muzaffarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000.0,0.0,156200.0,112000.0,0.0,225000.0,0.0,80000.0,100000.0,100000.0,100000.0,100000.0,1073200.0
Muzaffarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,100900.0,55000.0,92800.0,79000.0,77500.0,120600.0,105200.0,86100.0,95000.0,87850.0,76800.0,98650.0,1075400.0
Muzaffarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,63530.0,430.0,63830.0,96830.0,19330.0,123730.0,18530.0,12430.0,17430.0,29580.0,52780.0,54130.0,552560.0
Muzaffarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10808.0,8950.0,3550.0,21500.0,16400.0,9450.0,10550.0,3050.0,1050.0,450.0,1290.0,190.0,87238.0
Muzaffarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,5000.0,0.0,25300.0,4500.0,0.0,10000.0,0.0,5000.0,5000.0,5000.0,,5000.0,64800.0
Muzaffarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Muzaffarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,6850.0,5400.0,7350.0,9900.0,6950.0,8400.0,7600.0,7000.0,5600.0,4160.0,1100.0,5050.0,75360.0
Muzaffarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,8958.0,3550.0,21500.0,16100.0,9450.0,11050.0,2950.0,1050.0,450.0,1290.0,190.0,140.0,76678.0
Muzaffarpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Muzaffarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Muzaffarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Muzaffarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Muzaffarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Muzaffarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Muzaffarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Muzaffarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Muzaffarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Muzaffarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Muzaffarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Muzaffarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Muzaffarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Muzaffarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Muzaffarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Muzaffarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Muzaffarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Muzaffarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Muzaffarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Muzaffarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Muzaffarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Muzaffarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Muzaffarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Muzaffarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Muzaffarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Muzaffarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Muzaffarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Muzaffarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Muzaffarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Muzaffarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Muzaffarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Nalanda,1.1,Total number of pregnant women Registered for ANC,TOTAL,6145.0,6426.0,6730.0,7559.0,6346.0,6280.0,4706.0,4471.0,4086.0,4589.0,4899.0,5834.0,68071.0
Nalanda,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2814.0,3200.0,2970.0,3245.0,2718.0,2582.0,1935.0,2110.0,2262.0,2767.0,2704.0,2880.0,32187.0
Nalanda,1.2,Number of Pregnant women registered under JSY,TOTAL,5761.0,6311.0,6609.0,7457.0,6072.0,6261.0,4583.0,4125.0,3759.0,4411.0,4891.0,5696.0,65936.0
Nalanda,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3528.0,3866.0,4043.0,4212.0,4317.0,4199.0,3687.0,3277.0,3299.0,3148.0,3431.0,3308.0,44315.0
Nalanda,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5367.0,5406.0,5261.0,6017.0,4833.0,4680.0,3546.0,3679.0,3080.0,3512.0,3926.0,4949.0,54256.0
Nalanda,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5487.0,6053.0,5600.0,7266.0,6769.0,6383.0,5604.0,4530.0,4233.0,4037.0,3933.0,8342.0,68237.0
Nalanda,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,5697.0,8714.0,33659.0,14592.0,14533.0,15802.0,8472.0,6427.0,7795.0,7149.0,4827.0,26956.0,154623.0
Nalanda,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,257.0,307.0,267.0,526.0,307.0,164.0,204.0,242.0,157.0,192.0,1204.0,243.0,4070.0
Nalanda,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,4.0,2.0,12.0,9.0,5.0,5.0,10.0,4.0,10.0,0.0,5.0,70.0
Nalanda,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1491.0,1702.0,1665.0,1715.0,3184.0,2945.0,2848.0,1072.0,1367.0,1297.0,1223.0,2158.0,22667.0
Nalanda,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,21.0,34.0,16.0,42.0,219.0,195.0,214.0,5.0,23.0,23.0,26.0,60.0,878.0
Nalanda,1.8,Number of pregnancy test kits used at SC level,TOTAL,298.0,224.0,268.0,274.0,554.0,570.0,420.0,431.0,530.0,786.0,604.0,788.0,5747.0
Nalanda,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,142.0,241.0,230.0,406.0,385.0,416.0,317.0,400.0,370.0,295.0,235.0,207.0,3644.0
Nalanda,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,215.0,307.0,326.0,294.0,483.0,511.0,424.0,432.0,495.0,411.0,304.0,220.0,4422.0
Nalanda,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,357.0,548.0,556.0,700.0,868.0,927.0,741.0,832.0,865.0,706.0,539.0,427.0,8066.0
Nalanda,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,621.0,814.0,756.0,934.0,813.0,1645.0,1047.0,1271.0,1206.0,1140.0,1163.0,720.0,12130.0
Nalanda,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,25.0,98.0,27.0,51.0,19.0,77.0,33.0,24.0,10.0,0.0,4.0,10.0,378.0
Nalanda,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2693.0,2897.0,2793.0,3808.0,4300.0,4770.0,4631.0,4005.0,3953.0,3215.0,2750.0,2906.0,42721.0
Nalanda,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2101.0,2707.0,2501.0,3254.0,3522.0,4117.0,3644.0,3356.0,3177.0,3127.0,2461.0,2739.0,36706.0
Nalanda,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1750.0,2714.0,2101.0,1577.0,3348.0,4377.0,4147.0,2440.0,4340.0,3295.0,2668.0,2787.0,35544.0
Nalanda,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,578.0,732.0,1642.0,1349.0,1889.0,2329.0,2183.0,648.0,3579.0,2824.0,2521.0,2686.0,22960.0
Nalanda,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Nalanda,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Nalanda,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Nalanda,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Nalanda,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,1.0,13.0,134.0,4.0,19.0,6.0,7.0,6.0,12.0,10.0,6.0,5.0,223.0
Nalanda,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,0.0,,,,,,,,,,,0.0
Nalanda,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,160.0,117.0,142.0,153.0,200.0,161.0,149.0,156.0,175.0,156.0,137.0,149.0,1855.0
Nalanda,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalanda,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,161.0,130.0,276.0,157.0,219.0,167.0,156.0,162.0,187.0,166.0,143.0,154.0,2078.0
Nalanda,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Nalanda,4.1.1.a,Number of male live births,TOTAL,1535.0,1681.0,1729.0,2316.0,2598.0,2945.0,2773.0,2411.0,2427.0,2107.0,1749.0,1515.0,25786.0
Nalanda,4.1.1.b,Number of female live births,TOTAL,1276.0,1714.0,1660.0,2119.0,2416.0,2737.0,2556.0,2302.0,2284.0,1924.0,1577.0,1410.0,23975.0
Nalanda,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2811.0,3395.0,3389.0,4435.0,5014.0,5682.0,5329.0,4713.0,4711.0,4031.0,3326.0,2925.0,49761.0
Nalanda,4.1.2,Number of still births,TOTAL,76.0,116.0,66.0,100.0,100.0,123.0,294.0,100.0,107.0,67.0,599.0,45.0,1793.0
Nalanda,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,27.0,34.0,29.0,14.0,15.0,15.0,20.0,8.0,174.0,81.0,63.0,35.0,515.0
Nalanda,4.2.1,Number of Newborns weighed at birth,TOTAL,2621.0,3167.0,3191.0,4297.0,4777.0,5529.0,4860.0,4138.0,4469.0,3917.0,3216.0,2630.0,46812.0
Nalanda,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,160.0,240.0,185.0,231.0,237.0,322.0,320.0,265.0,230.0,187.0,211.0,396.0,2984.0
Nalanda,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2548.0,3076.0,3182.0,4163.0,4598.0,5509.0,5070.0,4503.0,4128.0,3901.0,2971.0,2639.0,46288.0
Nalanda,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,25.0,30.0,1.0,65.0,7.0,4.0,4.0,29.0,19.0,14.0,2.0,127.0,327.0
Nalanda,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,0.0,,,,,,,,,,,0.0
Nalanda,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,152.0,111.0,141.0,148.0,196.0,156.0,149.0,154.0,170.0,148.0,130.0,146.0,1801.0
Nalanda,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalanda,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,177.0,141.0,142.0,213.0,203.0,160.0,153.0,183.0,189.0,162.0,132.0,273.0,2128.0
Nalanda,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Nalanda,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,510.0,402.0,553.0,730.0,693.0,861.0,699.0,728.0,726.0,708.0,606.0,352.0,7568.0
Nalanda,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,11.0,2.0,6.0,12.0,74.0,74.0,12.0,142.0,187.0,84.0,5.0,611.0
Nalanda,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,521.0,706.0,810.0,1153.0,1086.0,1190.0,1228.0,738.0,1073.0,1077.0,1029.0,718.0,11329.0
Nalanda,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,5.0,12.0,4.0,6.0,11.0,12.0,14.0,13.0,10.0,12.0,10.0,7.0,116.0
Nalanda,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1450.0,1597.0,1813.0,1755.0,2793.0,3191.0,2467.0,2131.0,2419.0,2088.0,2161.0,1512.0,25377.0
Nalanda,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1518.0,1737.0,1459.0,1997.0,2111.0,2797.0,2022.0,1890.0,1713.0,1434.0,1938.0,1407.0,22023.0
Nalanda,6.3,PNC maternal complications attended,TOTAL,11.0,0.0,27.0,81.0,97.0,9.0,23.0,13.0,136.0,77.0,0.0,37.0,511.0
Nalanda,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,28.0,55.0,25.0,9.0,9.0,12.0,14.0,8.0,39.0,31.0,32.0,46.0,308.0
Nalanda,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,2.0,1.0,0.0,12.0
Nalanda,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,28.0,55.0,25.0,9.0,9.0,12.0,14.0,8.0,48.0,33.0,33.0,46.0,320.0
Nalanda,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,278.0,70.0,427.0,331.0,263.0,291.0,306.0,384.0,461.0,498.0,507.0,446.0,4262.0
Nalanda,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,238.0,70.0,437.0,269.0,213.0,295.0,301.0,349.0,454.0,435.0,506.0,403.0,3970.0
Nalanda,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,516.0,140.0,864.0,600.0,476.0,586.0,607.0,733.0,915.0,933.0,1013.0,849.0,8232.0
Nalanda,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,3.0,0.0,0.0,0.0,0.0,162.0,0.0,0.0,486.0,0.0,518.0,0.0,1169.0
Nalanda,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,10.0,9.0,33.0,21.0,62.0,13.0,110.0,45.0,64.0,6.0,39.0,60.0,472.0
Nalanda,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,0.0,,,,,,,,,,,0.0
Nalanda,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,23.0,1.0,5.0,1.0,1.0,6.0,3.0,2.0,3.0,46.0
Nalanda,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalanda,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,11.0,9.0,33.0,44.0,63.0,18.0,111.0,46.0,70.0,9.0,41.0,63.0,518.0
Nalanda,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,0.0,,0.0,28.0,,,,,28.0
Nalanda,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,18.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,8.0,37.0,0.0,0.0,67.0
Nalanda,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,0.0,,,,,,,,,,,0.0
Nalanda,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,4.0,0.0,5.0,0.0,0.0,21.0,0.0,30.0
Nalanda,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalanda,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,18.0,0.0,0.0,0.0,0.0,4.0,0.0,9.0,8.0,37.0,21.0,0.0,97.0
Nalanda,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,0.0,,0.0,,,,,,0.0
Nalanda,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,299.0,406.0,284.0,666.0,366.0,677.0,474.0,722.0,1150.0,734.0,759.0,476.0,7013.0
Nalanda,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,0.0,,,,,,,,,,,0.0
Nalanda,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,92.0,88.0,98.0,209.0,165.0,213.0,159.0,111.0,257.0,145.0,60.0,136.0,1733.0
Nalanda,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalanda,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,391.0,494.0,382.0,875.0,531.0,890.0,633.0,833.0,1407.0,879.0,819.0,612.0,8746.0
Nalanda,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,35.0,,,150.0,,20.0,577.0,,,,593.0,1375.0
Nalanda,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,34.0,12.0,18.0,79.0,27.0,34.0,59.0,42.0,138.0,57.0,141.0,54.0,695.0
Nalanda,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,0.0,,,,,,,,,,,0.0
Nalanda,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,31.0,35.0,0.0,40.0,48.0,44.0,31.0,46.0,55.0,84.0,80.0,90.0,584.0
Nalanda,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalanda,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,65.0,47.0,18.0,119.0,75.0,78.0,90.0,88.0,193.0,141.0,221.0,144.0,1279.0
Nalanda,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nalanda,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,738.0,762.0,964.0,1354.0,890.0,910.0,844.0,981.0,837.0,620.0,750.0,810.0,10460.0
Nalanda,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,320.0,317.0,292.0,1028.0,325.0,241.0,329.0,243.0,306.0,267.0,281.0,261.0,4210.0
Nalanda,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Nalanda,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,140.0,110.0,59.0,156.0,93.0,84.0,81.0,72.0,116.0,119.0,109.0,102.0,1241.0
Nalanda,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nalanda,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1198.0,1189.0,1315.0,2538.0,1308.0,1235.0,1254.0,1296.0,1259.0,1006.0,1140.0,1173.0,15911.0
Nalanda,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,109.0,303.0,103.0,157.0,97.0,82.0,97.0,91.0,187.0,211.0,318.0,279.0,2034.0
Nalanda,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nalanda,9.06,Number of IUCD removals,TOTAL,609.0,511.0,620.0,803.0,702.0,612.0,555.0,564.0,602.0,477.0,508.0,647.0,7210.0
Nalanda,9.07,Number of Oral Pills cycles distributed,TOTAL,3899.0,2281.0,2616.0,4455.0,3638.0,2297.0,2840.0,1982.0,2293.0,2454.0,2222.0,2482.0,33459.0
Nalanda,9.08,Number of Condom pieces distributed,TOTAL,27170.0,25034.0,25579.0,39169.0,27871.0,27769.0,26509.0,24717.0,24609.0,20539.0,19935.0,26812.0,315713.0
Nalanda,9.09,Number of Centchroman (weekly) pills given,TOTAL,439.0,645.0,683.0,447.0,378.0,309.0,375.0,357.0,305.0,358.0,144.0,194.0,4634.0
Nalanda,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,340.0,411.0,422.0,574.0,523.0,414.0,593.0,340.0,309.0,334.0,445.0,358.0,5063.0
Nalanda,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,4.0,7.0,2.0,0.0,2.0,5.0,0.0,0.0,10.0,2.0,32.0
Nalanda,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,6.0,0.0,6.0,15.0,16.0,1.0,1.0,2.0,10.0,8.0,4.0,4.0,73.0
Nalanda,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Nalanda,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,2.0,0.0,0.0,1.0,0.0,18.0,0.0,3.0,1.0,0.0,25.0
Nalanda,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Nalanda,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Nalanda,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,,1.0,,,1.0,1.0,1.0,,,,-1.0
Nalanda,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3349.0,3994.0,3735.0,4908.0,6020.0,7047.0,6536.0,6675.0,5964.0,5181.0,4778.0,10167.0,68354.0
Nalanda,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4710.0,3871.0,3711.0,5023.0,4618.0,5943.0,6566.0,8233.0,7566.0,1805.0,611.0,5826.0,58483.0
Nalanda,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,5526.0,4601.0,3739.0,4554.0,4570.0,4845.0,5445.0,6447.0,7410.0,7642.0,2830.0,6447.0,64056.0
Nalanda,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,5856.0,5411.0,4206.0,4531.0,4256.0,4874.0,4635.0,5455.0,5875.0,7373.0,6069.0,8115.0,66656.0
Nalanda,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,75.0,74.0,13.0,15.0,34.0,0.0,13.0,244.0,33.0,6028.0,6209.0,5118.0,17856.0
Nalanda,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,122.0,142.0,17.0,0.0,38.0,0.0,9.0,33.0,0.0,35.0,3414.0,5332.0,9142.0
Nalanda,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,107.0,124.0,19.0,0.0,24.0,0.0,9.0,25.0,0.0,0.0,75.0,2133.0,2516.0
Nalanda,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2763.0,3144.0,2719.0,3614.0,4639.0,5125.0,4834.0,4389.0,4358.0,3775.0,3076.0,2949.0,45385.0
Nalanda,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4605.0,3924.0,3641.0,4936.0,4615.0,5823.0,6546.0,8177.0,7557.0,5733.0,5597.0,5603.0,66757.0
Nalanda,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5604.0,4606.0,3709.0,4481.0,4558.0,5067.0,5457.0,6410.0,7407.0,7683.0,5575.0,7417.0,67974.0
Nalanda,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5867.0,5408.0,4192.0,4424.0,4408.0,4868.0,4642.0,5448.0,5858.0,7499.0,6083.0,8082.0,66779.0
Nalanda,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2163.0,2176.0,2024.0,2849.0,3409.0,4982.0,3227.0,3397.0,3409.0,2953.0,2305.0,2171.0,35065.0
Nalanda,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4515.0,3854.0,3774.0,5028.0,4603.0,5874.0,6584.0,8217.0,7552.0,1825.0,718.0,5576.0,58120.0
Nalanda,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,5465.0,4545.0,3760.0,4570.0,4543.0,4874.0,5471.0,6470.0,7412.0,7959.0,2768.0,6396.0,64233.0
Nalanda,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,5751.0,5452.0,4237.0,4531.0,4271.0,4863.0,4619.0,5464.0,5846.0,7435.0,6108.0,7720.0,66297.0
Nalanda,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3965.0,4614.0,4951.0,6472.0,6463.0,7046.0,5749.0,5032.0,5288.0,4743.0,4537.0,12005.0,70865.0
Nalanda,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4228.0,3726.0,3486.0,3577.0,3346.0,3936.0,3152.0,3197.0,3708.0,3961.0,4758.0,4882.0,45957.0
Nalanda,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3965.0,2603.0,3384.0,4683.0,3992.0,4947.0,4541.0,3777.0,4649.0,3864.0,4202.0,3925.0,48532.0
Nalanda,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2118.0,2378.0,2621.0,3203.0,3448.0,3482.0,2952.0,2833.0,2782.0,2329.0,2167.0,2733.0,33046.0
Nalanda,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1863.0,2201.0,2373.0,2960.0,3033.0,3367.0,2787.0,2528.0,2556.0,2161.0,2016.0,2328.0,30173.0
Nalanda,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3981.0,4579.0,4994.0,6163.0,6481.0,6849.0,5739.0,5361.0,5338.0,4490.0,4183.0,5061.0,63219.0
Nalanda,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5386.0,4746.0,3984.0,4281.0,3773.0,4271.0,3996.0,3579.0,4330.0,4388.0,5060.0,5959.0,53753.0
Nalanda,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5497.0,4770.0,3964.0,4196.0,3765.0,8259.0,3994.0,3571.0,4320.0,4395.0,5057.0,5985.0,57773.0
Nalanda,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,1190.0,1810.0,1342.0,1337.0,1210.0,1225.0,1206.0,1129.0,914.0,1096.0,717.0,1211.0,14387.0
Nalanda,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,942.0,1021.0,826.0,667.0,753.0,701.0,765.0,589.0,911.0,1224.0,1291.0,1241.0,10931.0
Nalanda,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1312.0,844.0,784.0,631.0,707.0,723.0,702.0,555.0,821.0,962.0,1151.0,1091.0,10283.0
Nalanda,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2254.0,1865.0,1610.0,1298.0,1460.0,1424.0,1467.0,1144.0,1732.0,2186.0,2442.0,2332.0,21214.0
Nalanda,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,778.0,884.0,706.0,746.0,834.0,1163.0,933.0,897.0,916.0,935.0,849.0,830.0,10471.0
Nalanda,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1077.0,1152.0,1104.0,1120.0,1212.0,1271.0,1277.0,1155.0,2292.0,1150.0,1056.0,1088.0,14954.0
Nalanda,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1115.0,1364.0,1135.0,1419.0,1380.0,1494.0,1451.0,1212.0,1367.0,1259.0,1135.0,1256.0,15587.0
Nalanda,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,22.0,18.0,14.0,30.0,95.0,58.0,142.0,56.0,74.0,136.0,117.0,71.0,833.0
Nalanda,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,24.0,30.0,33.0,118.0,437.0,421.0,553.0,570.0,830.0,697.0,411.0,347.0,4471.0
Nalanda,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3337.0,3560.0,3057.0,3486.0,3416.0,3386.0,3510.0,3316.0,3603.0,3699.0,3635.0,3280.0,41285.0
Nalanda,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3355.0,3548.0,2922.0,3460.0,3332.0,3373.0,3478.0,3105.0,3544.0,3679.0,3607.0,3301.0,40704.0
Nalanda,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3005.0,3185.0,2427.0,3074.0,2823.0,2798.0,3012.0,2771.0,3238.0,3018.0,3114.0,2830.0,35295.0
Nalanda,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2216.0,2603.0,3466.0,2022.0,6642.0,2945.0,3090.0,2640.0,3793.0,3744.0,4673.0,4958.0,42792.0
Nalanda,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1610.0,1662.0,1494.0,3213.0,3554.0,3419.0,2568.0,2403.0,2040.0,1912.0,1578.0,1834.0,27287.0
Nalanda,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,425.0,373.0,192.0,334.0,372.0,332.0,268.0,258.0,322.0,265.0,357.0,373.0,3871.0
Nalanda,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,110.0,86.0,68.0,188.0,137.0,71.0,70.0,540.0,85.0,67.0,64.0,94.0,1580.0
Nalanda,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Nalanda,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,173.0,0.0,0.0,41.0,28.0,0.0,0.0,0.0,242.0
Nalanda,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,202.0,0.0,0.0,41.0,28.0,0.0,0.0,0.0,271.0
Nalanda,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Nalanda,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,47.0,65.0,32.0,25.0,42.0,1.0,79.0,53.0,102.0,10.0,43.0,16.0,515.0
Nalanda,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,244.0,392.0,1948.0,3579.0,3682.0,3034.0,3492.0,3297.0,2291.0,3221.0,3227.0,7755.0,36162.0
Nalanda,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,30.0,18.0,35.0,42.0,37.0,31.0,36.0,38.0,32.0,22.0,153.0,476.0
Nalanda,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,37.0,4.0,4.0,30.0,89.0,2.0,11.0,4.0,9.0,4.0,10.0,114.0,318.0
Nalanda,13.1,Number of Patients operated for cataract,TOTAL,0.0,906.0,258.0,284.0,0.0,12.0,555.0,697.0,2773.0,8.0,4.0,6.0,5503.0
Nalanda,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,12.0,381.0,0.0,549.0,0.0,831.0,8.0,5.0,6.0,1792.0
Nalanda,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,707.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,707.0
Nalanda,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,,1.0,1.0,,,,,,-1.0
Nalanda,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Nalanda,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2469.0,2470.0,2440.0,2457.0,2463.0,2465.0,2527.0,2578.0,2466.0,2605.0,2640.0,2477.0,-1.0
Nalanda,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,1.0,1.0,1.0,,1.0,1.0,,,,,,-1.0
Nalanda,14.05,Number of RKS meetings held during the month,TOTAL,14.0,24.0,13.0,23.0,175.0,140.0,12.0,15.0,36.0,20.0,24.0,16.0,512.0
Nalanda,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,1.0,1.0,1.0,,1.0,1.0,,,,,,-1.0
Nalanda,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,435.0,510.0,399.0,737.0,771.0,755.0,849.0,635.0,952.0,680.0,983.0,896.0,8602.0
Nalanda,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,,1.0,1.0,,,,,,-1.0
Nalanda,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Nalanda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,3108.0,2658.0,20754.0,3580.0,3529.0,3660.0,3515.0,3331.0,3338.0,3903.0,4829.0,2348.0,58553.0
Nalanda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3955.0,4357.0,4062.0,4374.0,4554.0,4632.0,4368.0,5196.0,5083.0,4565.0,5812.0,3277.0,54235.0
Nalanda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2428.0,2880.0,2994.0,3297.0,3302.0,3288.0,3349.0,3009.0,3753.0,3914.0,5219.0,3446.0,40879.0
Nalanda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,7088.0,7320.0,6463.0,7318.0,7541.0,7996.0,8343.0,7429.0,6894.0,7916.0,6798.0,7436.0,88542.0
Nalanda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,5536.0,5538.0,23748.0,6877.0,6831.0,6948.0,6864.0,6340.0,7091.0,7817.0,10048.0,5794.0,99432.0
Nalanda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,11043.0,11677.0,10525.0,11692.0,12095.0,12628.0,12711.0,12625.0,11977.0,12481.0,12610.0,10713.0,142777.0
Nalanda,14.10.2.a,Number of death cases of Inpatient males,TOTAL,121.0,224.0,9.0,10.0,206.0,7.0,5.0,579.0,2.0,4.0,197.0,143.0,1507.0
Nalanda,14.10.2.b,Number of death cases of Inpatient females,TOTAL,69.0,196.0,4.0,1.0,2324.0,6.0,5.0,1.0,1.0,3.0,1.0,98.0,2709.0
Nalanda,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,190.0,420.0,13.0,11.0,2530.0,13.0,10.0,580.0,3.0,7.0,198.0,241.0,4216.0
Nalanda,14.11,In-Patient Head Count at midnight,TOTAL,16159.0,17167.0,16464.0,17794.0,18777.0,19582.0,18518.0,19620.0,18550.0,17048.0,17879.0,16461.0,214019.0
Nalanda,14.12.1,OPD attendance (All),TOTAL,185576.0,198262.0,203325.0,233384.0,214871.0,233029.0,206292.0,200218.0,189545.0,191524.0,188818.0,185606.0,2430450.0
Nalanda,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,637.0,565.0,684.0,1445.0,2218.0,1524.0,953.0,1231.0,1837.0,1271.0,2494.0,1042.0,15901.0
Nalanda,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,188.0,320.0,1581.0,654.0,118.0,595.0,6.0,31.0,274.0,0.0,21.0,174.0,3962.0
Nalanda,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4422.0,4732.0,6461.0,6654.0,4890.0,5199.0,5180.0,5172.0,5700.0,5517.0,4638.0,3932.0,62497.0
Nalanda,14.14.a,Number of patients given AYUSH treatment,TOTAL,33734.0,38431.0,30157.0,36232.0,37114.0,45490.0,36125.0,36789.0,23015.0,33565.0,38148.0,37420.0,426220.0
Nalanda,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1934.0,2757.0,5409.0,5244.0,5500.0,5828.0,4806.0,4487.0,2857.0,4557.0,4830.0,3357.0,51566.0
Nalanda,14.14.c,Number of Adolescents counselled,TOTAL,633.0,473.0,298.0,641.0,195.0,250.0,189.0,211.0,349.0,1399.0,54.0,331.0,5023.0
Nalanda,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6095.0,6148.0,5752.0,6955.0,4648.0,5558.0,3614.0,3761.0,4390.0,4252.0,3910.0,3915.0,58998.0
Nalanda,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1026.0,1206.0,1065.0,782.0,887.0,865.0,104.0,96.0,254.0,88.0,201.0,213.0,6787.0
Nalanda,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,171.0,206.0,322.0,242.0,432.0,199.0,149.0,182.0,374.0,110.0,102.0,372.0,2861.0
Nalanda,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,3.0,17.0,0.0,2.0,2.0,0.0,1.0,2.0,0.0,1.0,1.0,30.0
Nalanda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,151.0,175.0,400.0,344.0,376.0,279.0,260.0,379.0,588.0,356.0,226.0,374.0,3908.0
Nalanda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,1.0,32.0,5.0,4.0,5.0,0.0,0.0,4.0,1.0,49.0,0.0,103.0
Nalanda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,391.0,375.0,294.0,612.0,654.0,421.0,511.0,652.0,536.0,718.0,333.0,297.0,5794.0
Nalanda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,15.0,1.0,0.0,6.0,0.0,0.0,0.0,1.0,0.0,1.0,25.0
Nalanda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,713.0,756.0,1016.0,1198.0,1462.0,899.0,920.0,1213.0,1498.0,1184.0,661.0,1043.0,12563.0
Nalanda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,4.0,64.0,6.0,6.0,13.0,0.0,1.0,6.0,2.0,50.0,2.0,158.0
Nalanda,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,17.0,15.0,47.0
Nalanda,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,202.0,202.0
Nalanda,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,120.0,120.0
Nalanda,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,183.0,183.0
Nalanda,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,505.0,505.0
Nalanda,15.4.1,Number of blood smears examined for Malaria,TOTAL,250.0,447.0,501.0,542.0,426.0,497.0,434.0,363.0,256.0,463.0,449.0,514.0,5142.0
Nalanda,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,14.0,0.0,0.0,0.0,0.0,7.0,1.0,0.0,0.0,0.0,36.0,58.0
Nalanda,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Nalanda,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1550.0,2300.0,4950.0,2500.0,3500.0,6200.0,4400.0,4200.0,2350.0,,,2000.0,33950.0
Nalanda,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4000.0,6000.0,,5000.0,5000.0,1000.0,2000.0,1000.0,2500.0,,,3000.0,29500.0
Nalanda,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3250.0,3350.0,2450.0,4000.0,2300.0,2800.0,2200.0,2850.0,2200.0,,,3450.0,28850.0
Nalanda,16.1.1,Stock position of DPT vaccines,5. Total Stock,2300.0,4950.0,2500.0,3500.0,6200.0,4400.0,4200.0,2350.0,2650.0,0.0,0.0,1550.0,34600.0
Nalanda,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,5900.0,,,,5900.0
Nalanda,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5900.0,0.0,0.0,0.0,5900.0
Nalanda,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1075.0,1725.0,2250.0,1503.0,1410.0,1375.0,103.0,685.0,170.0,,,900.0,11196.0
Nalanda,16.1.2,Stock position of OPV vaccines,2. Stocks Received,3500.0,3000.0,973.0,2800.0,2000.0,625.0,3000.0,1000.0,2200.0,,,2000.0,21098.0
Nalanda,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2850.0,2475.0,1720.0,2843.0,2035.0,1897.0,2418.0,1515.0,2130.0,,,1825.0,21708.0
Nalanda,16.1.2,Stock position of OPV vaccines,5. Total Stock,1725.0,2250.0,1503.0,1460.0,1375.0,103.0,685.0,170.0,240.0,0.0,0.0,1075.0,10586.0
Nalanda,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2550.0,2350.0,4600.0,3035.0,3050.0,5950.0,4850.0,3950.0,3150.0,,,4000.0,37485.0
Nalanda,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,5000.0,,3937.0,5000.0,1000.0,1000.0,1000.0,3500.0,,,1000.0,23437.0
Nalanda,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2200.0,2750.0,1565.0,3922.0,2100.0,2100.0,1900.0,1800.0,2350.0,,,2450.0,23137.0
Nalanda,16.1.3,Stock position of TT vaccines,5. Total Stock,2350.0,4600.0,3035.0,3050.0,5950.0,4850.0,3950.0,3150.0,4300.0,0.0,0.0,2550.0,37785.0
Nalanda,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,770.0,1500.0,1500.0,805.0,1460.0,520.0,520.0,940.0,1230.0,,,90.0,9335.0
Nalanda,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,1000.0,,2000.0,200.0,2000.0,1500.0,1500.0,1500.0,,,2000.0,13700.0
Nalanda,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1270.0,1000.0,695.0,1345.0,1140.0,2000.0,1080.0,1210.0,2000.0,,,1320.0,13060.0
Nalanda,16.1.5,Stock position of BCG vaccines,5. Total Stock,1500.0,1500.0,805.0,1460.0,520.0,520.0,940.0,1230.0,730.0,0.0,0.0,770.0,9975.0
Nalanda,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1450.0,2400.0,5150.0,2630.0,2500.0,950.0,400.0,770.0,850.0,,,3950.0,21050.0
Nalanda,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000.0,6000.0,,4535.0,500.0,3000.0,3200.0,3000.0,2500.0,,,1000.0,27735.0
Nalanda,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3050.0,3250.0,2520.0,4665.0,2050.0,3550.0,2830.0,2920.0,3000.0,,,1450.0,29285.0
Nalanda,16.1.6,Stock position of Measles vaccines,5. Total Stock,2400.0,5150.0,2630.0,2500.0,950.0,400.0,770.0,850.0,350.0,0.0,0.0,3500.0,19500.0
Nalanda,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,20900.0,19750.0,400.0,2000.0,550.0,110.0,55.0,30.0,530.0,,,21500.0,65825.0
Nalanda,16.1.7,Stock position of JE vaccines,2. Stocks Received,,1000.0,8520.0,1000.0,200.0,2500.0,2000.0,3000.0,4000.0,,,500.0,22720.0
Nalanda,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.1.7,Stock position of JE vaccines,4. Stock Distributed,1150.0,20350.0,6920.0,2450.0,640.0,2555.0,2025.0,2500.0,3870.0,,,1100.0,43560.0
Nalanda,16.1.7,Stock position of JE vaccines,5. Total Stock,19750.0,400.0,2000.0,550.0,110.0,55.0,30.0,530.0,660.0,0.0,0.0,20900.0,44985.0
Nalanda,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,900.0,2100.0,3400.0,1530.0,2580.0,4060.0,2600.0,4600.0,2350.0,,,800.0,24920.0
Nalanda,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,4000.0,4000.0,,3990.0,4000.0,1500.0,4000.0,1000.0,2500.0,,,3000.0,27990.0
Nalanda,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2800.0,2700.0,1870.0,2940.0,2520.0,2960.0,2000.0,3250.0,2750.0,,,2900.0,26690.0
Nalanda,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2100.0,3400.0,1530.0,2580.0,4060.0,2600.0,4600.0,2350.0,2100.0,0.0,0.0,900.0,26220.0
Nalanda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Nalanda,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Nalanda,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Nalanda,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nalanda,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,11400.0,4400.0,13100.0,10100.0,12100.0,16100.0,7500.0,10600.0,7900.0,,,11805.0,105005.0
Nalanda,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,12000.0,,10000.0,10000.0,,10000.0,5600.0,10000.0,,,6000.0,63600.0
Nalanda,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,7000.0,3300.0,3000.0,8000.0,6000.0,8600.0,6900.0,8300.0,8700.0,,,6405.0,66205.0
Nalanda,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4400.0,13100.0,10100.0,12100.0,16100.0,7500.0,10600.0,7900.0,9200.0,0.0,0.0,11400.0,102400.0
Nalanda,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,170800.0,48000.0,84000.0,34900.0,55300.0,27200.0,40800.0,96000.0,70200.0,,,170800.0,798000.0
Nalanda,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,100000.0,50000.0,79200.0,36000.0,96000.0,125000.0,70000.0,60000.0,,,60000.0,676200.0
Nalanda,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,122800.0,64000.0,99100.0,58800.0,64100.0,82400.0,69800.0,95800.0,89000.0,,,60000.0,805800.0
Nalanda,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,48000.0,84000.0,34900.0,55300.0,27200.0,40800.0,96000.0,70200.0,41200.0,0.0,0.0,170800.0,668400.0
Nalanda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10600.0,7400.0,8800.0,10389.0,9800.0,12000.0,4200.0,7200.0,4400.0,,,10500.0,85289.0
Nalanda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,5000.0,16000.0,3000.0,8000.0,,8000.0,5000.0,10000.0,,,3000.0,58000.0
Nalanda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Nalanda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3200.0,3600.0,14411.0,3589.0,5800.0,7800.0,5000.0,7600.0,7600.0,,,2900.0,61500.0
Nalanda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,7400.0,8800.0,10389.0,9800.0,12000.0,4200.0,7200.0,4600.0,6800.0,0.0,0.0,10600.0,81789.0
Nalanda,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,2.0,,,6.0,3.0,16.0,,27.0
Nalanda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,2.0,,,,,,2.0
Nalanda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,2.0,,,,1.0,,3.0
Nalanda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,4.0,,,,1.0,,5.0
Nalanda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,1.0,,2.0
Nalanda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,1.0,,,,2.0
Nalanda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,,,,1.0,1.0,1.0,,4.0
Nalanda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,,,,,,,1.0,,,,2.0
Nalanda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,1.0,,1.0,,3.0
Nalanda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,2.0,,,,,,,2.0,,1.0,,5.0
Nalanda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,1.0,1.0,2.0,1.0,4.0,,,9.0
Nalanda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,1.0,,4.0,6.0,,,,,11.0
Nalanda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,1.0,1.0,5.0,8.0,1.0,4.0,,,20.0
Nalanda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,3.0,,,,,,,1.0,,,4.0
Nalanda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nalanda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,3.0,,,,,,,1.0,,,4.0
Nalanda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nalanda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Nalanda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,1.0,,,,,,,,1.0
Nalanda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,,,,,,1.0
Nalanda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nalanda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,,,,,,,,1.0
Nalanda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nalanda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nalanda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Nalanda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,1.0,,1.0,2.0,,4.0
Nalanda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,2.0,,1.0,1.0,,4.0
Nalanda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,3.0,,2.0,3.0,,8.0
Nalanda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Nalanda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Nalanda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,3.0,,,,,3.0
Nalanda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,3.0,,,,,3.0
Nalanda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Nalanda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Nalanda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,1.0,,,,,1.0
Nalanda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,2.0,,,,,,,,2.0
Nalanda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,2.0,,,,,,,,2.0
Nalanda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,1.0,,,,,2.0,3.0
Nalanda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,2.0,2.0
Nalanda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,1.0,,,,,4.0,5.0
Nalanda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Nalanda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Nalanda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Nalanda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Nalanda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Nalanda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Nalanda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Nalanda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Nalanda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Nalanda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Nalanda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Nalanda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,2.0,,,,,,,,2.0
Nalanda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Nalanda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,2.0,,,,,,,,2.0
Nalanda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,1.0,,1.0,1.0,,,,,3.0
Nalanda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,5.0,,,,5.0
Nalanda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,1.0,,1.0,1.0,5.0,,,,8.0
Nalanda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Nalanda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,1.0,,,,,,,,1.0
Nalanda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Nalanda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,,,,,2.0,,3.0
Nalanda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,2.0,,,,,2.0,,4.0
Nalanda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Nalanda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Nalanda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Nalanda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,1.0,,,,1.0
Nalanda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,20.0,1.0,,,,,,21.0
Nalanda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Nalanda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,3.0,1.0,1.0,,,,5.0
Nalanda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,20.0,5.0,1.0,1.0,,,,27.0
Nalanda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,1.0,1.0,,,,,2.0
Nalanda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,1.0,2.0,2.0,8.0,6.0,,2.0,,21.0
Nalanda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,4.0,3.0,16.0,14.0,13.0,,12.0,1.0,63.0
Nalanda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,5.0,5.0,19.0,23.0,19.0,,14.0,1.0,86.0
Nawada,1.1,Total number of pregnant women Registered for ANC,TOTAL,4451.0,4713.0,5019.0,5783.0,4349.0,4525.0,3466.0,3142.0,3206.0,3537.0,3766.0,4197.0,50154.0
Nawada,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2286.0,2408.0,2444.0,2725.0,2114.0,2223.0,1812.0,1683.0,1830.0,1888.0,2046.0,2368.0,25827.0
Nawada,1.2,Number of Pregnant women registered under JSY,TOTAL,4414.0,4692.0,5025.0,5738.0,4349.0,4470.0,3393.0,3142.0,3199.0,3537.0,3766.0,4197.0,49922.0
Nawada,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2253.0,2188.0,2308.0,2572.0,2463.0,2469.0,2036.0,1888.0,1929.0,2076.0,2118.0,2338.0,26638.0
Nawada,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3835.0,4093.0,4303.0,4927.0,3706.0,3680.0,2872.0,2613.0,2748.0,2807.0,3075.0,3285.0,41944.0
Nawada,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4252.0,4268.0,4222.0,5246.0,4908.0,4865.0,4086.0,3078.0,3081.0,3154.0,3291.0,3699.0,48150.0
Nawada,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3210.0,3505.0,3265.0,4285.0,3988.0,7889.0,2586.0,1893.0,2255.0,2772.0,1623.0,1627.0,38898.0
Nawada,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,86.0,244.0,168.0,123.0,169.0,151.0,134.0,97.0,85.0,68.0,136.0,41.0,1502.0
Nawada,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,35.0,10.0,3.0,3.0,8.0,2.0,0.0,0.0,2.0,4.0,2.0,0.0,69.0
Nawada,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,644.0,950.0,690.0,868.0,92.0,203.0,69.0,44.0,56.0,248.0,207.0,200.0,4271.0
Nawada,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,21.0,24.0,17.0,27.0,12.0,10.0,0.0,0.0,2.0,12.0,22.0,12.0,159.0
Nawada,1.8,Number of pregnancy test kits used at SC level,TOTAL,259.0,268.0,187.0,474.0,421.0,321.0,304.0,254.0,257.0,167.0,339.0,352.0,3603.0
Nawada,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,26.0,23.0,2.0,13.0,25.0,9.0,8.0,12.0,64.0,6.0,3.0,5.0,196.0
Nawada,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,607.0,629.0,647.0,745.0,736.0,814.0,823.0,872.0,696.0,716.0,727.0,684.0,8696.0
Nawada,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,633.0,652.0,649.0,758.0,761.0,823.0,831.0,884.0,760.0,722.0,730.0,689.0,8892.0
Nawada,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,455.0,549.0,561.0,630.0,612.0,713.0,612.0,552.0,539.0,536.0,597.0,528.0,6884.0
Nawada,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,2.0,10.0,0.0,11.0,0.0,3.0,2.0,0.0,3.0,1.0,33.0
Nawada,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1848.0,2079.0,2046.0,2587.0,3000.0,3068.0,2933.0,2789.0,2878.0,2420.0,1980.0,1606.0,29234.0
Nawada,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1819.0,2062.0,2034.0,2359.0,2803.0,2810.0,2576.0,2758.0,2834.0,2396.0,1961.0,1588.0,28000.0
Nawada,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,464.0,343.0,1006.0,1599.0,1578.0,1253.0,860.0,1649.0,2673.0,9350.0,3397.0,7018.0,31190.0
Nawada,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,95.0,642.0,646.0,631.0,1138.0,432.0,1000.0,1149.0,5006.0,2082.0,5471.0,18292.0
Nawada,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Nawada,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Nawada,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Nawada,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Nawada,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,27.0,20.0,11.0,25.0,28.0,35.0,34.0,31.0,52.0,24.0,19.0,18.0,324.0
Nawada,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawada,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,27.0,20.0,11.0,25.0,28.0,35.0,34.0,31.0,52.0,24.0,19.0,18.0,324.0
Nawada,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Nawada,4.1.1.a,Number of male live births,TOTAL,1262.0,1385.0,1346.0,1710.0,1887.0,1974.0,1916.0,1838.0,1815.0,1554.0,1394.0,1188.0,19269.0
Nawada,4.1.1.b,Number of female live births,TOTAL,1153.0,1274.0,1311.0,1575.0,1829.0,1856.0,1819.0,1806.0,1805.0,1545.0,1309.0,1080.0,18362.0
Nawada,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2415.0,2659.0,2657.0,3285.0,3716.0,3830.0,3735.0,3644.0,3620.0,3099.0,2703.0,2268.0,37631.0
Nawada,4.1.2,Number of still births,TOTAL,47.0,52.0,52.0,72.0,267.0,84.0,59.0,63.0,52.0,65.0,40.0,30.0,883.0
Nawada,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,93.0,89.0,96.0,92.0,7.0,1.0,2.0,11.0,4.0,0.0,14.0,4.0,413.0
Nawada,4.2.1,Number of Newborns weighed at birth,TOTAL,2302.0,2588.0,2601.0,3132.0,3560.0,3643.0,3411.0,3644.0,3578.0,3099.0,2703.0,2268.0,36529.0
Nawada,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,88.0,79.0,71.0,121.0,144.0,155.0,200.0,128.0,273.0,234.0,155.0,165.0,1813.0
Nawada,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2291.0,2575.0,2524.0,2476.0,3487.0,3594.0,3619.0,3625.0,3535.0,3075.0,2691.0,2250.0,35742.0
Nawada,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,9.0,5.0,1.0,20.0,0.0,8.0,3.0,0.0,166.0,0.0,5.0,218.0
Nawada,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,36.0,27.0,18.0,25.0,34.0,35.0,34.0,0.0,0.0,0.0,19.0,18.0,246.0
Nawada,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawada,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,37.0,36.0,23.0,26.0,54.0,35.0,42.0,3.0,0.0,166.0,19.0,23.0,464.0
Nawada,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Nawada,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1113.0,1065.0,1710.0,5236.0,1801.0,2412.0,2406.0,2401.0,2681.0,2182.0,1760.0,1901.0,26668.0
Nawada,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,25.0,16.0,30.0,51.0,194.0,281.0,306.0,289.0,347.0,71.0,30.0,31.0,1671.0
Nawada,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,653.0,669.0,2818.0,3526.0,2085.0,3997.0,2946.0,2584.0,3886.0,2511.0,2302.0,1939.0,29916.0
Nawada,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,11.0,4.0,4.0,10.0,14.0,11.0,8.0,10.0,4.0,18.0,22.0,30.0,146.0
Nawada,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1722.0,1901.0,1871.0,2281.0,2402.0,2423.0,2467.0,2379.0,2330.0,2049.0,1955.0,1574.0,25354.0
Nawada,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,801.0,976.0,726.0,1480.0,1223.0,1084.0,1301.0,956.0,1075.0,925.0,954.0,801.0,12302.0
Nawada,6.3,PNC maternal complications attended,TOTAL,13.0,3.0,0.0,25.0,4.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,61.0
Nawada,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,89.0,87.0,101.0,94.0,4.0,6.0,2.0,13.0,3.0,3.0,3.0,3.0,408.0
Nawada,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,5.0,1.0,0.0,0.0,2.0,3.0,0.0,0.0,0.0,11.0
Nawada,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,89.0,87.0,101.0,99.0,5.0,6.0,2.0,15.0,6.0,3.0,3.0,3.0,419.0
Nawada,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,25.0,19.0,13.0,0.0,0.0,10.0,7.0,0.0,0.0,0.0,0.0,74.0
Nawada,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,128.0,94.0,50.0,158.0,370.0,324.0,122.0,94.0,124.0,0.0,0.0,47.0,1511.0
Nawada,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,445.0,424.0,445.0,287.0,139.0,506.0,281.0,354.0,340.0,0.0,0.0,260.0,3481.0
Nawada,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,573.0,518.0,495.0,445.0,509.0,830.0,403.0,448.0,464.0,0.0,0.0,307.0,4992.0
Nawada,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,5.0,5.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0
Nawada,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,4.0,2.0,19.0,4.0,3.0,3.0,6.0,8.0,16.0,7.0,17.0,90.0
Nawada,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,2.0,0.0,1.0,8.0
Nawada,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawada,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,4.0,2.0,19.0,4.0,3.0,3.0,7.0,11.0,18.0,7.0,18.0,98.0
Nawada,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,4.0,2.0,1.0,2.0,,0.0,1.0,2.0,0.0,0.0,3.0,15.0
Nawada,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Nawada,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawada,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Nawada,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,290.0,223.0,193.0,928.0,437.0,739.0,517.0,644.0,1030.0,966.0,843.0,696.0,7506.0
Nawada,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,9.0,6.0,8.0,3.0,3.0,7.0,7.0,10.0,14.0,18.0,38.0,38.0,161.0
Nawada,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawada,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,299.0,229.0,201.0,931.0,440.0,746.0,524.0,654.0,1044.0,984.0,881.0,734.0,7667.0
Nawada,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,23.0,32.0,29.0,28.0,29.0,,26.0,28.0,24.0,20.0,23.0,108.0,370.0
Nawada,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,5.0,21.0,0.0,41.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,71.0
Nawada,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,2.0,2.0,3.0,4.0,7.0,6.0,5.0,9.0,6.0,5.0,4.0,55.0
Nawada,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawada,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,7.0,23.0,3.0,45.0,7.0,10.0,5.0,9.0,6.0,5.0,4.0,126.0
Nawada,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,0.0
Nawada,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,424.0,387.0,400.0,600.0,403.0,392.0,363.0,334.0,376.0,332.0,400.0,369.0,4780.0
Nawada,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,314.0,214.0,256.0,444.0,255.0,228.0,218.0,235.0,211.0,222.0,226.0,151.0,2974.0
Nawada,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,63.0,71.0,66.0,96.0,60.0,44.0,31.0,40.0,39.0,29.0,29.0,13.0,581.0
Nawada,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawada,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,801.0,672.0,722.0,1140.0,718.0,664.0,612.0,609.0,626.0,583.0,655.0,533.0,8335.0
Nawada,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,85.0,143.0,127.0,179.0,161.0,122.0,7.0,6.0,9.0,26.0,6.0,47.0,918.0
Nawada,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,6.0,16.0,9.0,8.0,4.0,,4.0,4.0,0.0,1.0,4.0,0.0,56.0
Nawada,9.06,Number of IUCD removals,TOTAL,177.0,165.0,168.0,216.0,202.0,276.0,187.0,190.0,371.0,201.0,191.0,186.0,2530.0
Nawada,9.07,Number of Oral Pills cycles distributed,TOTAL,1891.0,1284.0,1303.0,2567.0,1294.0,1291.0,1240.0,1153.0,1246.0,1227.0,1042.0,1027.0,16565.0
Nawada,9.08,Number of Condom pieces distributed,TOTAL,14909.0,13302.0,13694.0,22758.0,15180.0,16526.0,14902.0,12476.0,13257.0,10823.0,11963.0,12456.0,172246.0
Nawada,9.09,Number of Centchroman (weekly) pills given,TOTAL,129.0,50.0,5.0,57.0,1.0,71.0,10.0,11.0,11.0,48.0,1.0,17.0,411.0
Nawada,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,102.0,94.0,137.0,342.0,187.0,152.0,141.0,62.0,86.0,96.0,123.0,104.0,1626.0
Nawada,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,5.0,0.0,0.0,0.0,1.0,5.0,2.0,0.0,0.0,0.0,0.0,0.0,13.0
Nawada,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Nawada,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Nawada,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,1.0,1.0,1.0,-1.0
Nawada,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3383.0,3603.0,3406.0,4308.0,4330.0,5144.0,4526.0,4703.0,4824.0,4165.0,4130.0,3374.0,49896.0
Nawada,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4225.0,3603.0,3742.0,4223.0,3939.0,4477.0,4601.0,5184.0,5121.0,914.0,156.0,43.0,40228.0
Nawada,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4939.0,4362.0,3684.0,4102.0,3790.0,4165.0,4137.0,4348.0,5214.0,4854.0,2481.0,1007.0,47083.0
Nawada,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4734.0,4513.0,3765.0,4162.0,3670.0,4094.0,3864.0,3848.0,4420.0,4640.0,4182.0,2905.0,48797.0
Nawada,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4019.0,4796.0,4540.0,13361.0
Nawada,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,18.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2700.0,4205.0,6923.0
Nawada,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,26.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,40.0,2256.0,2325.0
Nawada,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2283.0,2470.0,2388.0,2895.0,3287.0,3485.0,3312.0,2707.0,2985.0,2513.0,2242.0,1987.0,32554.0
Nawada,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4144.0,3546.0,3458.0,4198.0,3944.0,4391.0,4316.0,2339.0,2385.0,2960.0,4465.0,4534.0,44680.0
Nawada,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4953.0,4302.0,3650.0,4094.0,3751.0,4095.0,3854.0,1890.0,2228.0,2983.0,4198.0,5019.0,45017.0
Nawada,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4787.0,4486.0,3715.0,4118.0,3624.0,4022.0,3600.0,1662.0,1817.0,2790.0,3924.0,4506.0,43051.0
Nawada,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2002.0,2112.0,2044.0,2532.0,2972.0,3120.0,2795.0,2503.0,2980.0,2245.0,2007.0,1690.0,29002.0
Nawada,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4181.0,3625.0,3492.0,4227.0,3938.0,4447.0,4600.0,5185.0,5090.0,1089.0,227.0,58.0,40159.0
Nawada,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,4885.0,4360.0,3678.0,4109.0,3785.0,4119.0,4566.0,4338.0,5202.0,4819.0,2481.0,1056.0,47398.0
Nawada,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4744.0,4566.0,3809.0,4161.0,3680.0,4067.0,3869.0,3844.0,4393.0,4647.0,4194.0,2924.0,48898.0
Nawada,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3161.0,3306.0,3572.0,4270.0,3972.0,4823.0,4359.0,3950.0,2672.0,2900.0,3740.0,3552.0,44277.0
Nawada,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3391.0,3135.0,3003.0,3337.0,2881.0,3146.0,2850.0,2739.0,2078.0,2197.0,3483.0,3481.0,35721.0
Nawada,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2201.0,2653.0,3184.0,3171.0,3409.0,4347.0,3842.0,3251.0,2106.0,1200.0,3525.0,3310.0,36199.0
Nawada,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1620.0,1613.0,1806.0,2148.0,1982.0,2283.0,2257.0,2011.0,1309.0,1452.0,2023.0,1869.0,22373.0
Nawada,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1457.0,1422.0,1656.0,2018.0,1789.0,2195.0,1986.0,1801.0,1189.0,1267.0,1785.0,1714.0,20279.0
Nawada,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3077.0,3035.0,3462.0,4166.0,3771.0,4478.0,4243.0,3812.0,2498.0,2719.0,3808.0,3583.0,42652.0
Nawada,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3730.0,3426.0,3165.0,3434.0,2794.0,3073.0,2834.0,2764.0,2720.0,2769.0,3570.0,3593.0,37872.0
Nawada,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3720.0,3399.0,3129.0,3445.0,2790.0,3032.0,2747.0,1472.0,1254.0,1933.0,3559.0,3638.0,34118.0
Nawada,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,123.0,85.0,79.0,78.0,72.0,90.0,54.0,62.0,58.0,10.0,0.0,93.0,804.0
Nawada,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1237.0,1092.0,1092.0,1138.0,928.0,1116.0,1077.0,945.0,791.0,953.0,1437.0,1471.0,13277.0
Nawada,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1172.0,1040.0,1002.0,1048.0,830.0,993.0,986.0,877.0,739.0,818.0,1441.0,1345.0,12291.0
Nawada,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2409.0,2132.0,2094.0,2186.0,1758.0,2109.0,2063.0,1822.0,1530.0,1771.0,2878.0,2816.0,25568.0
Nawada,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,335.0,104.0,183.0,184.0,193.0,278.0,515.0,357.0,476.0,533.0,441.0,461.0,4060.0
Nawada,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1184.0,1238.0,1235.0,1216.0,1234.0,1222.0,1341.0,1259.0,1392.0,1443.0,1398.0,1355.0,15517.0
Nawada,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1341.0,1434.0,1367.0,1336.0,1324.0,1371.0,1338.0,1440.0,1540.0,1623.0,1444.0,1631.0,17189.0
Nawada,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,12.0,13.0,15.0,25.0,12.0,17.0,12.0,11.0,45.0,12.0,4.0,16.0,194.0
Nawada,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,8.0,12.0,37.0,10.0,9.0,5.0,15.0,12.0,29.0,9.0,2.0,12.0,160.0
Nawada,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2201.0,2190.0,1985.0,2082.0,2055.0,2045.0,2142.0,2035.0,2076.0,2075.0,2002.0,2032.0,24920.0
Nawada,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2155.0,2137.0,1929.0,2062.0,1986.0,2036.0,2120.0,2028.0,2072.0,2067.0,1962.0,2081.0,24635.0
Nawada,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2071.0,1983.0,1815.0,1949.0,1869.0,1944.0,2032.0,1859.0,1981.0,1938.0,1868.0,1867.0,23176.0
Nawada,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2125.0,2449.0,5186.0,3437.0,2508.0,2997.0,2577.0,2447.0,1818.0,1032.0,3383.0,3472.0,33431.0
Nawada,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2306.0,2730.0,2864.0,3513.0,2907.0,3481.0,3441.0,3035.0,5383.0,1968.0,2717.0,2665.0,37010.0
Nawada,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,871.0,962.0,1053.0,1603.0,1065.0,1119.0,1068.0,875.0,13526.0,700.0,980.0,1262.0,25084.0
Nawada,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,184.0,178.0,306.0,466.0,236.0,174.0,194.0,219.0,586.0,356.0,294.0,351.0,3544.0
Nawada,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Nawada,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,10.0
Nawada,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,9.0,0.0,5.0,2.0,0.0,0.0,0.0,16.0
Nawada,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,115.0,158.0,83.0,169.0,135.0,107.0,81.0,131.0,170.0,390.0,349.0,342.0,2230.0
Nawada,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,24.0,0.0,19.0,183.0,0.0,180.0,3.0,35.0,78.0,67.0,162.0,751.0
Nawada,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,28.0,21.0,11.0,12.0,78.0
Nawada,13.1,Number of Patients operated for cataract,TOTAL,29.0,0.0,0.0,6.0,0.0,0.0,0.0,104.0,165.0,19.0,9.0,603.0,935.0
Nawada,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,29.0,0.0,0.0,0.0,188.0,0.0,0.0,104.0,165.0,19.0,9.0,603.0,1117.0
Nawada,13.3,Number of School children detected with Refractive errors,TOTAL,202.0,242.0,235.0,193.0,50.0,387.0,142.0,0.0,0.0,146.0,120.0,171.0,1888.0
Nawada,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,50.0,103.0,0.0,0.0,0.0,0.0,0.0,30.0,183.0
Nawada,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Nawada,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,1.0,,,,,,,,,,,-1.0
Nawada,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1439.0,1388.0,1308.0,1433.0,1361.0,1481.0,1488.0,1163.0,1485.0,1322.0,1428.0,1482.0,-1.0
Nawada,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Nawada,14.05,Number of RKS meetings held during the month,TOTAL,6.0,6.0,6.0,6.0,6.0,7.0,8.0,7.0,6.0,6.0,4.0,5.0,73.0
Nawada,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,1.0,,,,,,,,,,,-1.0
Nawada,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,49.0,60.0,36.0,64.0,188.0,169.0,544.0,682.0,735.0,867.0,627.0,695.0,4716.0
Nawada,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Nawada,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Nawada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,586.0,691.0,530.0,524.0,518.0,618.0,559.0,456.0,380.0,423.0,533.0,487.0,6305.0
Nawada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1050.0,1417.0,1599.0,1156.0,945.0,1849.0,1483.0,1676.0,1182.0,1229.0,871.0,1143.0,15600.0
Nawada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,516.0,580.0,480.0,505.0,440.0,568.0,480.0,558.0,458.0,393.0,582.0,500.0,6060.0
Nawada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2167.0,2417.0,2232.0,3306.0,2895.0,4096.0,3725.0,3861.0,4442.0,3840.0,3616.0,3036.0,39633.0
Nawada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1102.0,1271.0,1010.0,1029.0,958.0,1186.0,1039.0,1014.0,838.0,816.0,1115.0,987.0,12365.0
Nawada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3217.0,3834.0,3831.0,4462.0,3840.0,5945.0,5208.0,5537.0,5624.0,5069.0,4487.0,4179.0,55233.0
Nawada,14.10.2.a,Number of death cases of Inpatient males,TOTAL,14.0,16.0,21.0,22.0,17.0,6.0,13.0,8.0,11.0,12.0,11.0,10.0,161.0
Nawada,14.10.2.b,Number of death cases of Inpatient females,TOTAL,16.0,14.0,14.0,7.0,10.0,1.0,6.0,6.0,5.0,8.0,4.0,5.0,96.0
Nawada,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,30.0,30.0,35.0,29.0,27.0,7.0,19.0,14.0,16.0,20.0,15.0,15.0,257.0
Nawada,14.11,In-Patient Head Count at midnight,TOTAL,2756.0,2900.0,2977.0,4270.0,3289.0,4975.0,4734.0,4958.0,4366.0,3218.0,2993.0,3071.0,44507.0
Nawada,14.12.1,OPD attendance (All),TOTAL,92356.0,96998.0,99596.0,109680.0,96886.0,112226.0,89511.0,90665.0,76964.0,77029.0,78982.0,70946.0,1091839.0
Nawada,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,291.0,518.0,347.0,928.0,558.0,845.0,588.0,887.0,1245.0,1216.0,896.0,835.0,9154.0
Nawada,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,508.0,0.0,0.0,0.0,41.0,38.0,34.0,28.0,30.0,0.0,5.0,8.0,692.0
Nawada,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,951.0,1730.0,1902.0,1752.0,1763.0,2010.0,1472.0,1846.0,1352.0,1752.0,1263.0,1642.0,19435.0
Nawada,14.14.a,Number of patients given AYUSH treatment,TOTAL,19337.0,22686.0,20287.0,25521.0,20955.0,27542.0,22018.0,20732.0,11392.0,18410.0,17376.0,23072.0,249328.0
Nawada,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5007.0,5004.0,5293.0,5870.0,6314.0,7415.0,5550.0,5067.0,6153.0,6303.0,6491.0,4589.0,69056.0
Nawada,14.14.c,Number of Adolescents counselled,TOTAL,533.0,386.0,674.0,381.0,780.0,846.0,278.0,395.0,432.0,436.0,315.0,467.0,5923.0
Nawada,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1299.0,1748.0,1548.0,1825.0,1305.0,1485.0,1457.0,1213.0,1882.0,1734.0,1744.0,1628.0,18868.0
Nawada,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,22.0,28.0,13.0,32.0,695.0,77.0,38.0,39.0,871.0,39.0,33.0,52.0,1939.0
Nawada,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,316.0,385.0,311.0,375.0,183.0,345.0,307.0,125.0,260.0,296.0,275.0,203.0,3381.0
Nawada,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,4.0,2.0,2.0,0.0,9.0,1.0,1.0,5.0,1.0,3.0,2.0,37.0
Nawada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,194.0,122.0,163.0,122.0,94.0,181.0,157.0,132.0,218.0,236.0,168.0,127.0,1914.0
Nawada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,5.0,2.0,5.0,0.0,0.0,7.0,1.0,6.0,3.0,1.0,2.0,3.0,35.0
Nawada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,639.0,777.0,586.0,513.0,217.0,519.0,434.0,394.0,420.0,322.0,322.0,358.0,5501.0
Nawada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Nawada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1149.0,1284.0,1060.0,1010.0,494.0,1045.0,898.0,651.0,898.0,854.0,765.0,688.0,10796.0
Nawada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,13.0,7.0,7.0,3.0,0.0,17.0,2.0,7.0,8.0,2.0,5.0,5.0,76.0
Nawada,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,22.0,26.0,27.0,6.0,636.0,6.0,6.0,2.0,8.0,739.0
Nawada,15.3.a,Number of VDRL tests conducted on males,Number tested,25.0,6.0,3.0,4.0,34.0,67.0,15.0,9.0,8.0,21.0,6.0,22.0,220.0
Nawada,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,15.0,10.0,31.0,21.0,31.0,13.0,0.0,28.0,126.0,275.0
Nawada,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,11.0,34.0,27.0,2.0,51.0,129.0,20.0,4.0,0.0,172.0,95.0,181.0,726.0
Nawada,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,36.0,40.0,30.0,21.0,95.0,227.0,56.0,44.0,21.0,193.0,129.0,329.0,1221.0
Nawada,15.4.1,Number of blood smears examined for Malaria,TOTAL,628.0,617.0,594.0,806.0,759.0,847.0,955.0,708.0,609.0,717.0,686.0,598.0,8524.0
Nawada,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,0.0,0.0,10.0,16.0,20.0,18.0,13.0,3.0,5.0,5.0,8.0,99.0
Nawada,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,1.0,16.0,16.0,7.0,14.0,10.0,5.0,9.0,3.0,5.0,86.0
Nawada,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1200.0,2200.0,2100.0,2950.0,1300.0,2145.0,1895.0,2465.0,1840.0,1865.0,1485.0,1315.0,22760.0
Nawada,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3000.0,2500.0,2000.0,1500.0,2000.0,2000.0,2500.0,2000.0,1500.0,1000.0,1000.0,1000.0,22000.0
Nawada,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2000.0,2600.0,1150.0,3150.0,1155.0,2250.0,1930.0,2625.0,1475.0,1380.0,1170.0,850.0,21735.0
Nawada,16.1.1,Stock position of DPT vaccines,5. Total Stock,2200.0,2100.0,2950.0,1300.0,2145.0,1895.0,2465.0,1840.0,1865.0,1485.0,1315.0,1465.0,23025.0
Nawada,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,3703.0,2658.0,6361.0
Nawada,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,4300.0,0.0,0.0,4300.0
Nawada,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Nawada,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,597.0,1045.0,1425.0,3067.0
Nawada,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3703.0,2658.0,1233.0,7594.0
Nawada,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,592.0,546.0,468.0,975.0,35.0,29.0,17.0,33.0,8.0,68.0,73.0,912.0,3756.0
Nawada,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1400.0,1500.0,2000.0,1500.0,800.0,1500.0,1000.0,400.0,600.0,500.0,2072.0,2500.0,15772.0
Nawada,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1446.0,1578.0,1493.0,2440.0,806.0,1512.0,984.0,425.0,540.0,495.0,1233.0,1455.0,14407.0
Nawada,16.1.2,Stock position of OPV vaccines,5. Total Stock,546.0,468.0,975.0,35.0,29.0,17.0,33.0,8.0,68.0,73.0,912.0,1957.0,5121.0
Nawada,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1800.0,2475.0,1875.0,1600.0,512.0,362.0,1062.0,1250.0,1462.0,2422.0,2022.0,1952.0,18794.0
Nawada,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,1500.0,1500.0,1500.0,500.0,3000.0,2000.0,2000.0,2000.0,500.0,1000.0,1000.0,18500.0
Nawada,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Nawada,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1325.0,2100.0,1775.0,2588.0,650.0,2300.0,1812.0,1788.0,1040.0,900.0,1070.0,1475.0,18823.0
Nawada,16.1.3,Stock position of TT vaccines,5. Total Stock,2475.0,1875.0,1600.0,512.0,362.0,1062.0,1250.0,1462.0,2422.0,2022.0,1952.0,1477.0,18471.0
Nawada,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nawada,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Nawada,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nawada,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nawada,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,207.0,1684.0,1810.0,2040.0,1832.0,2248.0,1435.0,1412.0,1352.0,1837.0,1807.0,2002.0,19666.0
Nawada,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,1000.0,1000.0,1000.0,1000.0,200.0,1000.0,1000.0,1100.0,1000.0,1000.0,1000.0,12300.0
Nawada,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,523.0,874.0,770.0,1208.0,584.0,1013.0,1023.0,1060.0,615.0,1030.0,805.0,1075.0,10580.0
Nawada,16.1.5,Stock position of BCG vaccines,5. Total Stock,1684.0,1810.0,2040.0,1832.0,2248.0,1435.0,1412.0,1352.0,1837.0,1807.0,2002.0,1927.0,21386.0
Nawada,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,617.0,1692.0,1292.0,1392.0,266.0,1521.0,1222.0,400.0,137.0,0.0,20.0,219.0,8778.0
Nawada,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,2000.0,2000.0,2000.0,2465.0,2250.0,1235.0,2000.0,200.0,1600.0,2470.0,1500.0,22720.0
Nawada,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Nawada,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1925.0,2400.0,1900.0,3126.0,1210.0,2549.0,2057.0,2263.0,337.0,1580.0,2271.0,1705.0,23323.0
Nawada,16.1.6,Stock position of Measles vaccines,5. Total Stock,1692.0,1292.0,1392.0,266.0,1521.0,1222.0,400.0,137.0,0.0,20.0,219.0,14.0,8175.0
Nawada,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,11705.0,9540.0,1410.0,2720.0,35.0,15.0,590.0,60.0,35.0,40.0,40.0,50.0,26240.0
Nawada,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,2000.0,0.0,1000.0,2000.0,1000.0,2000.0,500.0,500.0,2300.0,2600.0,13900.0
Nawada,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2165.0,8130.0,690.0,2685.0,1020.0,1425.0,1530.0,2025.0,495.0,500.0,2290.0,2495.0,25450.0
Nawada,16.1.7,Stock position of JE vaccines,5. Total Stock,9540.0,1410.0,2720.0,35.0,15.0,590.0,60.0,35.0,40.0,40.0,50.0,155.0,14690.0
Nawada,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,16.0,1244.0,1352.0,1658.0,574.0,1267.0,359.0,1042.0,812.0,1252.0,1152.0,1122.0,11850.0
Nawada,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,2000.0,2000.0,1500.0,1980.0,1000.0,2500.0,2000.0,2000.0,1500.0,1000.0,600.0,21080.0
Nawada,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1772.0,1892.0,1694.0,2584.0,1287.0,1908.0,1817.0,2230.0,1560.0,1600.0,1030.0,525.0,19899.0
Nawada,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1244.0,1352.0,1658.0,574.0,1267.0,359.0,1042.0,812.0,1252.0,1152.0,1122.0,1197.0,13031.0
Nawada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2553.0,1953.0,1353.0,1353.0,1853.0,1253.0,1253.0,,,,,,11571.0
Nawada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,,4000.0,,,,,,,,,4000.0
Nawada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Nawada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,600.0,0.0,3500.0,600.0,,,,,,,,5300.0
Nawada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1953.0,1353.0,1353.0,1853.0,1253.0,1253.0,1253.0,0.0,0.0,0.0,0.0,0.0,10271.0
Nawada,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,50000.0,50000.0,50000.0,50000.0,2000.0,1000.0,1000.0,,,,,,204000.0
Nawada,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Nawada,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Nawada,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,48000.0,1000.0,,,,,,,,49000.0
Nawada,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,50000.0,50000.0,50000.0,2000.0,1000.0,1000.0,1000.0,0.0,0.0,0.0,0.0,0.0,155000.0
Nawada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nawada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nawada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nawada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nawada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,940.0,,,,4000.0,4000.0,4000.0,,,,,,12940.0
Nawada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,4000.0,,,,,,,,,4000.0
Nawada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Nawada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,300.0,,,,,,,,,,,,300.0
Nawada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,640.0,0.0,0.0,4000.0,4000.0,4000.0,4000.0,0.0,0.0,0.0,0.0,0.0,16640.0
Nawada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Nawada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nawada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nawada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Nawada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,12900.0,12900.0,11100.0,8700.0,3700.0,1100.0,200.0,,,,,,50600.0
Nawada,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Nawada,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Nawada,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,1800.0,2400.0,5000.0,2600.0,900.0,200.0,,,,,,12900.0
Nawada,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,12900.0,11100.0,8700.0,3700.0,1100.0,200.0,0.0,0.0,0.0,0.0,0.0,0.0,37700.0
Nawada,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,17200.0,17200.0,13200.0,11200.0,7200.0,6600.0,4500.0,,,,,,77100.0
Nawada,16.3.02,Stock Position of Gloves,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Nawada,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Nawada,16.3.02,Stock Position of Gloves,4. Stock Distributed,,4000.0,2000.0,4000.0,600.0,2100.0,500.0,,,,,,13200.0
Nawada,16.3.02,Stock Position of Gloves,5. Total Stock,17200.0,13200.0,11200.0,7200.0,6600.0,4500.0,4000.0,0.0,0.0,0.0,0.0,0.0,63900.0
Nawada,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Nawada,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Nawada,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Nawada,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Nawada,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Nawada,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Nawada,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Nawada,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Nawada,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Nawada,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Nawada,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Nawada,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Nawada,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Nawada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Nawada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Nawada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Nawada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,181740.0,151740.0,79740.0,7740.0,1000.0,0.0,,,,,,,421960.0
Nawada,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Nawada,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Nawada,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,30000.0,72000.0,72000.0,6740.0,1000.0,,,,,,,,181740.0
Nawada,16.3.07,Stock Position of IFA Tablets,5. Total Stock,151740.0,79740.0,7740.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,240220.0
Nawada,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,22173.0,15149.0,11157.0,8421.0,7053.0,3525.0,,,,,,,67478.0
Nawada,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Nawada,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Nawada,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,7024.0,3992.0,2736.0,1368.0,3528.0,3525.0,,,,,,,22173.0
Nawada,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,15149.0,11157.0,8421.0,7053.0,3525.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45305.0
Nawada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,31600.0,21600.0,6100.0,100.0,212.0,112.0,112.0,,,,,,59836.0
Nawada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,,6012.0,,,,,,,,,6012.0
Nawada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,,0.0,,,,,,,,,0.0
Nawada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,10000.0,15500.0,6000.0,5900.0,100.0,,,,,,,,37500.0
Nawada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,21600.0,6100.0,100.0,212.0,112.0,112.0,112.0,0.0,0.0,0.0,0.0,0.0,28348.0
Nawada,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,231.0,31.0,0.0,,,0.0,,,,,,,262.0
Nawada,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Nawada,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Nawada,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,200.0,31.0,0.0,,,,,,,,,,231.0
Nawada,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,31.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0
Nawada,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,140429.0,86929.0,159929.0,142429.0,115529.0,71429.0,60429.0,,,,,,777103.0
Nawada,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,99500.0,,3600.0,400.0,,,,,,,,103500.0
Nawada,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Nawada,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,53500.0,26500.0,17500.0,30500.0,44500.0,11000.0,3500.0,,,,,,187000.0
Nawada,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,86929.0,159929.0,142429.0,115529.0,71429.0,60429.0,56929.0,0.0,0.0,0.0,0.0,0.0,693603.0
Nawada,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1226.0,2866.0,2266.0,2616.0,293.0,3653.0,1693.0,1663.0,1163.0,1963.0,1853.0,3053.0,24308.0
Nawada,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6000.0,4000.0,4000.0,4000.0,6000.0,5000.0,5000.0,4000.0,5000.0,6000.0,6000.0,6000.0,61000.0
Nawada,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4360.0,4600.0,3650.0,6323.0,2640.0,6960.0,5030.0,4500.0,4200.0,6110.0,4800.0,5300.0,58473.0
Nawada,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2866.0,2266.0,2616.0,293.0,3653.0,1693.0,1663.0,1163.0,1963.0,1853.0,3053.0,3753.0,26835.0
Nawada,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,47260.0,64850.0,55650.0,50100.0,24200.0,63260.0,35800.0,54950.0,44200.0,43550.0,41010.0,42710.0,567540.0
Nawada,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,60000.0,50000.0,50000.0,50000.0,80000.0,50000.0,80000.0,50000.0,60000.0,60000.0,60000.0,60000.0,710000.0
Nawada,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,42410.0,59200.0,55550.0,75900.0,40940.0,77460.0,60850.0,60750.0,60650.0,62540.0,58300.0,56700.0,711250.0
Nawada,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,64850.0,55650.0,50100.0,24200.0,63260.0,35800.0,54950.0,44200.0,43550.0,41010.0,42710.0,46010.0,566290.0
Nawada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3965.0,3556.0,3856.0,3656.0,3100.0,4263.0,3163.0,3139.0,1019.0,1619.0,3919.0,6219.0,41474.0
Nawada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,2500.0,3500.0,3000.0,4000.0,5000.0,5000.0,4000.0,5000.0,6000.0,6000.0,6000.0,52000.0
Nawada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2409.0,2200.0,3700.0,3556.0,2837.0,6100.0,5024.0,6120.0,4400.0,3700.0,3700.0,5100.0,48846.0
Nawada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3556.0,3856.0,3656.0,3100.0,4263.0,3163.0,3139.0,1019.0,1619.0,3919.0,6219.0,7119.0,44628.0
Nawada,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Nawada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Nawada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nawada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Nawada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Nawada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nawada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Nawada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Nawada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nawada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Nawada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Nawada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nawada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Nawada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nawada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nawada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Nawada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nawada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nawada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Nawada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nawada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nawada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Nawada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nawada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nawada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Nawada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Nawada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Nawada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Nawada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Nawada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Nawada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Nawada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Nawada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Nawada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Nawada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Nawada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Nawada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Nawada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Nawada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Nawada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Nawada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Nawada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Nawada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Nawada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Nawada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Nawada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Nawada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Nawada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Nawada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Nawada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Nawada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Nawada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Nawada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Nawada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Nawada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Nawada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Nawada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Nawada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Nawada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Nawada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Nawada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Nawada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Nawada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Patna,1.1,Total number of pregnant women Registered for ANC,TOTAL,14807.0,12004.0,13184.0,13870.0,11658.0,11232.0,8886.0,9528.0,7250.0,8420.0,9386.0,10596.0,130821.0
Patna,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5250.0,35197.0,6580.0,14724.0,5226.0,11437.0,5208.0,4728.0,3083.0,3281.0,6959.0,6251.0,107924.0
Patna,1.2,Number of Pregnant women registered under JSY,TOTAL,9343.0,10148.0,11667.0,12046.0,10051.0,9376.0,8204.0,7188.0,6612.0,7912.0,8006.0,9863.0,110416.0
Patna,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,8588.0,5055.0,4765.0,5253.0,4334.0,4315.0,4108.0,3840.0,3593.0,3527.0,3565.0,4012.0,54955.0
Patna,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,7855.0,6578.0,7525.0,8301.0,6306.0,6583.0,4750.0,5333.0,3916.0,5284.0,6131.0,6631.0,75193.0
Patna,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,9005.0,8432.0,8797.0,10972.0,10570.0,9198.0,7326.0,6528.0,5478.0,6517.0,8616.0,10638.0,102077.0
Patna,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,8122.0,5476.0,10930.0,8415.0,7209.0,6655.0,5505.0,4029.0,5310.0,4404.0,6680.0,4929.0,77664.0
Patna,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,46.0,155.0,181.0,250.0,244.0,153.0,142.0,3241.0,67.0,69.0,83.0,40.0,4671.0
Patna,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,18.0,14.0,82.0,31.0,33.0,43.0,0.0,30.0,22.0,9.0,12.0,298.0
Patna,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,876.0,967.0,1059.0,1198.0,2184.0,1254.0,1524.0,1264.0,1069.0,1167.0,1282.0,1651.0,15495.0
Patna,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,36.0,26.0,59.0,52.0,34.0,46.0,45.0,57.0,23.0,356.0,80.0,38.0,852.0
Patna,1.8,Number of pregnancy test kits used at SC level,TOTAL,247.0,167.0,93.0,484.0,455.0,429.0,376.0,346.0,235.0,256.0,258.0,331.0,3677.0
Patna,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,65.0,32.0,72.0,64.0,75.0,84.0,111.0,85.0,47.0,37.0,3.0,16.0,691.0
Patna,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,116.0,158.0,152.0,167.0,181.0,252.0,214.0,257.0,272.0,171.0,137.0,132.0,2209.0
Patna,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,181.0,190.0,224.0,231.0,256.0,336.0,325.0,342.0,319.0,208.0,140.0,148.0,2900.0
Patna,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,157.0,144.0,108.0,171.0,151.0,277.0,282.0,237.0,228.0,81.0,79.0,84.0,1999.0
Patna,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Patna,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3219.0,3813.0,3527.0,4168.0,5274.0,5902.0,6100.0,5317.0,4512.0,3986.0,3646.0,2737.0,52201.0
Patna,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2991.0,2934.0,3109.0,4488.0,5349.0,5762.0,6478.0,5640.0,4242.0,4090.0,4204.0,3405.0,52692.0
Patna,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2917.0,3352.0,3736.0,2475.0,1699.0,1799.0,1075.0,1432.0,1403.0,2778.0,2955.0,6086.0,31707.0
Patna,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1593.0,1185.0,968.0,1557.0,299.0,650.0,71.0,88.0,246.0,1114.0,756.0,4643.0,13170.0
Patna,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Patna,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Patna,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Patna,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Patna,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Patna,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,19.0,33.0,18.0,20.0,16.0,27.0,21.0,23.0,28.0,11.0,23.0,8.0,247.0
Patna,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patna,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,19.0,33.0,18.0,20.0,16.0,27.0,21.0,23.0,28.0,11.0,23.0,8.0,247.0
Patna,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Patna,4.1.1.a,Number of male live births,TOTAL,2287.0,2379.0,2232.0,2693.0,3360.0,3691.0,3873.0,3382.0,2695.0,2447.0,2379.0,2072.0,33490.0
Patna,4.1.1.b,Number of female live births,TOTAL,2016.0,2010.0,2102.0,2221.0,3138.0,3452.0,3535.0,3297.0,2586.0,2338.0,2182.0,1773.0,30650.0
Patna,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4303.0,4389.0,4334.0,4914.0,6498.0,7143.0,7408.0,6679.0,5281.0,4785.0,4561.0,3845.0,64140.0
Patna,4.1.2,Number of still births,TOTAL,84.0,107.0,85.0,242.0,123.0,124.0,146.0,130.0,87.0,107.0,82.0,80.0,1397.0
Patna,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,59.0,44.0,52.0,42.0,0.0,26.0,44.0,35.0,36.0,38.0,43.0,0.0,419.0
Patna,4.2.1,Number of Newborns weighed at birth,TOTAL,3155.0,3146.0,2768.0,4048.0,5186.0,6051.0,5793.0,4927.0,4447.0,4454.0,4545.0,3667.0,52187.0
Patna,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,480.0,553.0,503.0,657.0,803.0,1008.0,495.0,302.0,196.0,212.0,755.0,154.0,6118.0
Patna,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2972.0,3078.0,3038.0,3951.0,5288.0,5967.0,5837.0,4460.0,4158.0,4853.0,4541.0,3652.0,51795.0
Patna,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,18.0,16.0,26.0,35.0,17.0,10.0,16.0,0.0,23.0,6.0,6.0,0.0,173.0
Patna,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Patna,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,9.0,19.0,15.0,18.0,16.0,25.0,19.0,27.0,21.0,25.0,22.0,16.0,232.0
Patna,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patna,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,27.0,35.0,41.0,53.0,33.0,35.0,35.0,27.0,44.0,31.0,28.0,16.0,405.0
Patna,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Patna,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,6116.0,5778.0,5389.0,7483.0,783.0,6778.0,6617.0,6192.0,492.0,4747.0,3462.0,4832.0,58669.0
Patna,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,205.0,269.0,189.0,87.0,6025.0,635.0,430.0,501.0,310.0,86.0,8.0,31.0,8776.0
Patna,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1270.0,1067.0,528.0,1010.0,522.0,1205.0,1720.0,2013.0,437.0,517.0,391.0,491.0,11171.0
Patna,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,790.0,1680.0,206.0,23.0,6.0,1508.0,65.0,0.0,0.0,16.0,62.0,0.0,4356.0
Patna,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2088.0,2435.0,2246.0,3149.0,3815.0,5493.0,5855.0,4279.0,3872.0,4026.0,3465.0,3105.0,43828.0
Patna,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1939.0,1307.0,1423.0,1763.0,1509.0,1716.0,2055.0,2007.0,1884.0,2123.0,1748.0,1434.0,20908.0
Patna,6.3,PNC maternal complications attended,TOTAL,0.0,24.0,10.0,22.0,25.0,27.0,29.0,22.0,24.0,6.0,0.0,8.0,197.0
Patna,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,14.0,19.0,16.0,21.0,10.0,223.0,21.0,32.0,7.0,33.0,26.0,34.0,456.0
Patna,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,2.0,0.0,0.0,589.0,0.0,0.0,0.0,16.0,2.0,0.0,609.0
Patna,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,14.0,19.0,18.0,21.0,10.0,812.0,21.0,32.0,7.0,49.0,28.0,34.0,1065.0
Patna,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,15.0,19.0,15.0,25.0,2.0,4.0,4.0,0.0,0.0,5.0,1.0,14.0,104.0
Patna,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,39.0,25.0,35.0,10.0,5.0,14.0,7.0,0.0,2.0,11.0,4.0,38.0,190.0
Patna,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,54.0,44.0,50.0,35.0,7.0,18.0,11.0,0.0,2.0,16.0,5.0,52.0,294.0
Patna,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,4.0,0.0,3.0,2.0,4.0,3.0,1.0,5.0,6.0,3.0,6.0,4.0,41.0
Patna,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Patna,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,1.0,3.0,0.0,1.0,0.0,0.0,2.0,4.0,1.0,2.0,16.0
Patna,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patna,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,5.0,1.0,4.0,5.0,4.0,4.0,1.0,5.0,8.0,7.0,7.0,6.0,57.0
Patna,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Patna,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,41.0,0.0,0.0,0.0,41.0
Patna,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Patna,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,5.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0,0.0,50.0
Patna,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patna,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,5.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,41.0,0.0,37.0,0.0,91.0
Patna,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Patna,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,428.0,316.0,424.0,994.0,419.0,887.0,310.0,1285.0,1518.0,1740.0,1470.0,1814.0,11605.0
Patna,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,11.0,15.0,8.0,,,34.0
Patna,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,108.0,48.0,44.0,69.0,41.0,37.0,55.0,211.0,237.0,170.0,161.0,905.0,2086.0
Patna,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patna,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,536.0,364.0,468.0,1063.0,460.0,924.0,365.0,1507.0,1770.0,1918.0,1631.0,2719.0,13725.0
Patna,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,98.0,29.0,185.0,,,220.0,316.0,,,,22893.0,23741.0
Patna,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,18.0,0.0,0.0,24.0,1.0,2.0,1.0,1.0,15.0,13.0,106.0,46.0,227.0
Patna,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Patna,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,15.0,14.0,10.0,3.0,5.0,10.0,11.0,18.0,11.0,16.0,17.0,8.0,138.0
Patna,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patna,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,33.0,14.0,10.0,27.0,6.0,12.0,12.0,19.0,26.0,29.0,123.0,54.0,365.0
Patna,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,178.0,,8.0,,,,,,186.0
Patna,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,342.0,396.0,374.0,592.0,335.0,433.0,324.0,352.0,402.0,288.0,398.0,389.0,4625.0
Patna,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,373.0,219.0,200.0,490.0,193.0,249.0,204.0,180.0,196.0,234.0,203.0,194.0,2935.0
Patna,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,17.0,,17.0,13.0,1.0,5.0,3.0,,9.0,7.0,5.0,10.0,87.0
Patna,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,72.0,78.0,91.0,57.0,60.0,58.0,47.0,63.0,45.0,30.0,49.0,2560.0,3210.0
Patna,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patna,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,804.0,693.0,682.0,1152.0,589.0,745.0,578.0,595.0,652.0,559.0,655.0,3153.0,10857.0
Patna,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,110.0,26.0,35.0,67.0,41.0,70.0,178.0,75.0,13.0,105.0,97.0,133.0,950.0
Patna,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,101.0,,197.0,,,215.0,,,,,16426.0,16939.0
Patna,9.06,Number of IUCD removals,TOTAL,260.0,213.0,200.0,274.0,203.0,187.0,161.0,170.0,164.0,178.0,200.0,183.0,2393.0
Patna,9.07,Number of Oral Pills cycles distributed,TOTAL,2804.0,2581.0,3992.0,3783.0,3128.0,2946.0,3263.0,2729.0,2528.0,2502.0,3005.0,3676.0,36937.0
Patna,9.08,Number of Condom pieces distributed,TOTAL,12542.0,13028.0,13408.0,15878.0,11450.0,12991.0,11081.0,10778.0,10440.0,9268.0,10833.0,16698.0,148395.0
Patna,9.09,Number of Centchroman (weekly) pills given,TOTAL,107.0,30.0,93.0,80.0,223.0,49.0,10.0,24.0,86.0,67.0,153.0,29.0,951.0
Patna,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,202.0,297.0,786.0,489.0,314.0,439.0,323.0,287.0,161.0,324.0,624.0,1674.0,5920.0
Patna,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Patna,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,9.12,Number of Institutions having NSV trained doctors,TOTAL,,1.0,,,,,1.0,,,1.0,1.0,1.0,-1.0
Patna,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,9777.0,7813.0,9068.0,11096.0,9750.0,12496.0,12805.0,13204.0,8938.0,10236.0,9515.0,7534.0,122232.0
Patna,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,10427.0,8377.0,8598.0,11208.0,8098.0,10313.0,10702.0,12927.0,10461.0,3433.0,1237.0,478.0,96259.0
Patna,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,11932.0,9121.0,9020.0,10986.0,9673.0,9485.0,9231.0,10735.0,10039.0,12593.0,5938.0,2471.0,111224.0
Patna,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,12120.0,9865.0,9379.0,11330.0,9662.0,9390.0,9143.0,9603.0,8356.0,11841.0,10281.0,7327.0,118297.0
Patna,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,7.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,10017.0,9800.0,9495.0,29328.0
Patna,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,5916.0,9307.0,15224.0
Patna,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,53.0,4777.0,4830.0
Patna,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,6849.0,5751.0,6931.0,7625.0,9054.0,9629.0,9338.0,8740.0,5860.0,6383.0,6446.0,4912.0,87518.0
Patna,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,10556.0,8378.0,8858.0,11420.0,9315.0,10406.0,10634.0,11925.0,10369.0,11785.0,10381.0,9910.0,123937.0
Patna,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,11925.0,9076.0,9193.0,10967.0,9687.0,9433.0,9226.0,9779.0,9940.0,12590.0,10436.0,11188.0,123440.0
Patna,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,12148.0,9878.0,9577.0,10998.0,9731.0,9442.0,9146.0,8761.0,8184.0,11918.0,10135.0,11022.0,120940.0
Patna,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,4048.0,3808.0,3784.0,4498.0,5962.0,5746.0,6589.0,5094.0,4103.0,4112.0,3602.0,2705.0,54051.0
Patna,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,10334.0,8206.0,8391.0,10506.0,9455.0,9839.0,10739.0,12380.0,10354.0,4868.0,1036.0,569.0,96677.0
Patna,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,11658.0,9068.0,8619.0,10260.0,9255.0,8899.0,9076.0,10284.0,9978.0,12301.0,5475.0,2493.0,107366.0
Patna,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,11132.0,9790.0,8928.0,10385.0,9408.0,8989.0,8848.0,9106.0,8288.0,11626.0,9974.0,7391.0,113865.0
Patna,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,8063.0,8314.0,10093.0,12987.0,11845.0,11200.0,9072.0,10920.0,6116.0,9286.0,9070.0,7253.0,114219.0
Patna,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,8426.0,7791.0,6518.0,7820.0,5973.0,6423.0,5232.0,6639.0,5068.0,7023.0,8171.0,8254.0,83338.0
Patna,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,6892.0,7804.0,8592.0,11673.0,10008.0,10113.0,8554.0,9622.0,6258.0,8392.0,7961.0,6983.0,102852.0
Patna,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4056.0,4225.0,5214.0,6876.0,5837.0,5743.0,4734.0,5114.0,3021.0,4500.0,4445.0,3605.0,57370.0
Patna,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3433.0,3625.0,4499.0,6087.0,5200.0,5199.0,4351.0,4342.0,2624.0,4069.0,4056.0,3193.0,50678.0
Patna,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,7489.0,7850.0,9713.0,12963.0,11037.0,10942.0,9085.0,9456.0,5645.0,8569.0,8501.0,6798.0,108048.0
Patna,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,9718.0,8312.0,8885.0,10018.0,8124.0,7718.0,6945.0,7154.0,5867.0,8082.0,9379.0,9151.0,99353.0
Patna,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,9710.0,8290.0,8840.0,9861.0,8038.0,7680.0,6958.0,6703.0,5853.0,8071.0,9392.0,9234.0,98630.0
Patna,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,178.0,252.0,27.0,0.0,133.0,119.0,0.0,5.0,38.0,0.0,18.0,770.0
Patna,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2484.0,2732.0,2187.0,3060.0,2206.0,2403.0,3064.0,3286.0,1422.0,1876.0,3072.0,2708.0,30500.0
Patna,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2008.0,2432.0,1825.0,2565.0,1920.0,2043.0,2496.0,2611.0,1190.0,1581.0,2707.0,2361.0,25739.0
Patna,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,4492.0,5164.0,4012.0,5625.0,4126.0,4446.0,5560.0,5897.0,2612.0,3457.0,5779.0,5069.0,56239.0
Patna,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1231.0,1115.0,1095.0,1373.0,1332.0,1538.0,1313.0,1507.0,1382.0,1599.0,3086.0,1641.0,18212.0
Patna,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2176.0,2129.0,1987.0,2586.0,2178.0,2139.0,2285.0,2089.0,1974.0,2256.0,2023.0,1956.0,25778.0
Patna,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,3181.0,3290.0,2629.0,3738.0,3390.0,3252.0,3264.0,3141.0,2754.0,3267.0,2850.0,3027.0,37783.0
Patna,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,28.0,48.0,44.0,35.0,33.0,97.0,211.0,251.0,247.0,291.0,246.0,219.0,1750.0
Patna,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,20.0,44.0,56.0,83.0,78.0,307.0,390.0,636.0,865.0,886.0,679.0,836.0,4880.0
Patna,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,4964.0,4886.0,4772.0,5416.0,5100.0,4824.0,4979.0,5048.0,4698.0,5128.0,4938.0,5221.0,59974.0
Patna,10.4.2,Number of Immunisation sessions held during the month,TOTAL,4920.0,4872.0,4564.0,5390.0,5015.0,4808.0,4925.0,4954.0,4677.0,5105.0,4821.0,5185.0,59236.0
Patna,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3331.0,3536.0,3137.0,3555.0,3224.0,3273.0,3306.0,3216.0,3376.0,3395.0,3245.0,3378.0,39972.0
Patna,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,8587.0,7854.0,7820.0,9429.0,8007.0,7741.0,6129.0,6650.0,5539.0,7313.0,8129.0,8278.0,91476.0
Patna,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5878.0,7070.0,7303.0,10246.0,8722.0,8448.0,7052.0,8269.0,5140.0,6747.0,6967.0,4778.0,86620.0
Patna,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2119.0,3331.0,3372.0,3904.0,2626.0,2759.0,2800.0,3198.0,2017.0,2696.0,3580.0,2436.0,34838.0
Patna,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,745.0,885.0,1073.0,902.0,787.0,816.0,652.0,1119.0,543.0,890.0,1348.0,517.0,10277.0
Patna,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0
Patna,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,4.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,1.0,4.0,15.0
Patna,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,36.0,62.0,1373.0,481.0,916.0,625.0,495.0,327.0,143.0,346.0,466.0,303.0,5573.0
Patna,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,6.0,1.0,2.0,1.0,9.0,8.0,6.0,0.0,0.0,0.0,33.0
Patna,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,2.0,0.0,115.0,63.0,52.0,75.0,1.0,1.0,5.0,0.0,0.0,7.0,321.0
Patna,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,2131.0,132.0,136.0,82.0,147.0,119.0,19820.0,180.0,85.0,202.0,23034.0
Patna,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,70.0,38.0,2181.0,174.0,173.0,177.0,116.0,119.0,260.0,288.0,385.0,396.0,4377.0
Patna,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,75.0,250.0,66.0,142.0,200.0,305.0,528.0,453.0,2019.0
Patna,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Patna,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Patna,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2704.0,2800.0,2604.0,2833.0,2612.0,2581.0,2534.0,2561.0,2566.0,2460.0,2568.0,2521.0,-1.0
Patna,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,1.0,1.0,-1.0
Patna,14.05,Number of RKS meetings held during the month,TOTAL,13.0,11.0,20.0,22.0,14.0,15.0,16.0,18.0,13.0,16.0,13.0,18.0,189.0
Patna,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Patna,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,275.0,391.0,319.0,527.0,467.0,456.0,323.0,441.0,281.0,170.0,245.0,468.0,4363.0
Patna,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Patna,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,1.0,1.0,-1.0
Patna,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1790.0,1632.0,1923.0,1930.0,551.0,2494.0,2035.0,1766.0,775.0,1583.0,1761.0,1679.0,19919.0
Patna,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,6135.0,5852.0,7297.0,7287.0,1057.0,6756.0,6393.0,6884.0,582.0,5057.0,5643.0,5213.0,64156.0
Patna,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1388.0,1183.0,1363.0,1155.0,730.0,1579.0,1394.0,1217.0,753.0,1195.0,1113.0,1100.0,14170.0
Patna,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,10093.0,8269.0,10452.0,11665.0,6047.0,11543.0,10639.0,10079.0,5772.0,8298.0,8240.0,8427.0,109524.0
Patna,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,3178.0,2815.0,3286.0,3085.0,1281.0,4073.0,3429.0,2983.0,1528.0,2778.0,2874.0,2779.0,34089.0
Patna,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,16228.0,14121.0,17749.0,18952.0,7104.0,18299.0,17032.0,16963.0,6354.0,13355.0,13883.0,13640.0,173680.0
Patna,14.10.2.a,Number of death cases of Inpatient males,TOTAL,447.0,569.0,9.0,587.0,537.0,501.0,529.0,606.0,505.0,523.0,428.0,490.0,5731.0
Patna,14.10.2.b,Number of death cases of Inpatient females,TOTAL,319.0,330.0,6.0,350.0,357.0,326.0,394.0,328.0,262.0,331.0,240.0,294.0,3537.0
Patna,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,766.0,899.0,15.0,937.0,894.0,827.0,923.0,934.0,767.0,854.0,668.0,784.0,9268.0
Patna,14.11,In-Patient Head Count at midnight,TOTAL,3983.0,3749.0,4749.0,5147.0,4948.0,11244.0,7145.0,7390.0,7536.0,6752.0,4793.0,7085.0,74521.0
Patna,14.12.1,OPD attendance (All),TOTAL,321940.0,315338.0,377838.0,414794.0,348993.0,386845.0,290850.0,333293.0,217556.0,258855.0,289216.0,300929.0,3856447.0
Patna,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,264.0,2594.0,2749.0,3166.0,2686.0,1614.0,2541.0,2787.0,2653.0,2923.0,3192.0,2922.0,30091.0
Patna,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2337.0,19.0,0.0,6.0,424.0,0.0,0.0,118.0,83.0,78.0,0.0,0.0,3065.0
Patna,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,669.0,2931.0,3761.0,4671.0,3097.0,2309.0,3300.0,2814.0,2478.0,2777.0,3326.0,2919.0,35052.0
Patna,14.14.a,Number of patients given AYUSH treatment,TOTAL,31086.0,30688.0,29780.0,34732.0,41262.0,38682.0,26360.0,34329.0,16063.0,24927.0,26932.0,29882.0,364723.0
Patna,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4190.0,3713.0,5000.0,4355.0,4067.0,4699.0,3174.0,4380.0,3434.0,4384.0,4179.0,4971.0,50546.0
Patna,14.14.c,Number of Adolescents counselled,TOTAL,11.0,141.0,8.0,37.0,5.0,5.0,5.0,3.0,3.0,2.0,42.0,2.0,264.0
Patna,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,10625.0,11612.0,7926.0,12076.0,13838.0,12420.0,9913.0,12788.0,8901.0,9609.0,12444.0,13100.0,135252.0
Patna,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,241.0,332.0,300.0,375.0,331.0,337.0,331.0,288.0,282.0,278.0,310.0,163.0,3568.0
Patna,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2350.0,3203.0,2655.0,1628.0,1534.0,1151.0,376.0,1465.0,2156.0,2249.0,2385.0,2496.0,23648.0
Patna,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,3.0,8.0,13.0,4.0,5.0,3.0,7.0,1.0,11.0,9.0,10.0,76.0
Patna,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1906.0,1936.0,2109.0,1240.0,965.0,779.0,386.0,1689.0,1949.0,1943.0,2208.0,2271.0,19381.0
Patna,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,3.0,2.0,0.0,1.0,1.0,1.0,3.0,22.0,6.0,30.0,70.0
Patna,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,933.0,775.0,1011.0,1213.0,619.0,1075.0,918.0,1107.0,378.0,987.0,1223.0,1167.0,11406.0
Patna,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4.0,1.0,3.0,2.0,2.0,3.0,4.0,0.0,1.0,1.0,1.0,38.0,60.0
Patna,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5189.0,5914.0,5775.0,4081.0,3118.0,3005.0,1680.0,4261.0,4483.0,5179.0,5816.0,5934.0,54435.0
Patna,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,5.0,14.0,17.0,6.0,9.0,8.0,8.0,5.0,34.0,16.0,78.0,206.0
Patna,15.2,Number of Widal tests conducted,Number tested,3346.0,92.0,73.0,42.0,24.0,32.0,14.0,229.0,57.0,0.0,10.0,59.0,3978.0
Patna,15.3.a,Number of VDRL tests conducted on males,Number tested,1.0,0.0,0.0,26.0,320.0,0.0,0.0,0.0,3.0,10.0,12.0,4.0,376.0
Patna,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,1.0,470.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,476.0
Patna,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,4.0,0.0,206.0,9.0,0.0,1.0,50.0,0.0,0.0,59.0,39.0,59.0,427.0
Patna,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,5.0,0.0,206.0,36.0,790.0,1.0,50.0,0.0,3.0,74.0,51.0,63.0,1279.0
Patna,15.4.1,Number of blood smears examined for Malaria,TOTAL,417.0,428.0,603.0,529.0,367.0,573.0,361.0,1217.0,667.0,797.0,722.0,837.0,7518.0
Patna,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,8.0,0.0,7.0,7.0,0.0,1.0,1.0,4.0,0.0,6.0,2.0,2.0,38.0
Patna,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,1.0,5.0,0.0,1.0,0.0,0.0,9.0
Patna,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1413.0,,3579.0,,1076.0,,4946.0,1851.0,,1556.0,1556.0,,15977.0
Patna,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,,4000.0,,8000.0,,2000.0,4000.0,,,1500.0,,19500.0
Patna,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,,,,,,0.0,0.0,,,,,0.0
Patna,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,0.0,,4200.0,,3830.0,,5095.0,4840.0,,,2750.0,,20715.0
Patna,16.1.1,Stock position of DPT vaccines,5. Total Stock,1413.0,0.0,3379.0,0.0,5246.0,0.0,1851.0,1011.0,0.0,1556.0,306.0,0.0,14762.0
Patna,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,,,,,,0.0,,,1830.0,1830.0,,3660.0
Patna,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,,,,,0.0,,,,0.0,,0.0
Patna,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,,,,,0.0,,,,,,0.0
Patna,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,,,,,0.0,,,,810.0,,810.0
Patna,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1830.0,1020.0,0.0,2850.0
Patna,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,5291.0,,511.0,,1845.0,,160.0,123.0,,1468.0,1468.0,,10866.0
Patna,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,,3000.0,,2000.0,,3500.0,2400.0,,,1000.0,,11900.0
Patna,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,,,,,,0.0,0.0,,,,,0.0
Patna,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,0.0,,2650.0,,3485.0,,3537.0,1735.0,,,1975.0,,13382.0
Patna,16.1.2,Stock position of OPV vaccines,5. Total Stock,5291.0,0.0,861.0,0.0,360.0,0.0,123.0,788.0,0.0,1468.0,493.0,0.0,9384.0
Patna,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2618.0,,568.0,,1905.0,,2145.0,1842.0,,1429.0,1429.0,,11936.0
Patna,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,,3000.0,,40000.0,,3000.0,3000.0,,,1500.0,,50500.0
Patna,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,,,,,,0.0,0.0,,,,,0.0
Patna,16.1.3,Stock position of TT vaccines,4. Stock Distributed,0.0,,2505.0,,3460.0,,3303.0,3285.0,,,2155.0,,14708.0
Patna,16.1.3,Stock position of TT vaccines,5. Total Stock,2618.0,0.0,1063.0,0.0,38445.0,0.0,1842.0,1557.0,0.0,1429.0,774.0,0.0,47728.0
Patna,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,0.0,,0.0,,,,,,0.0
Patna,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,0.0,,0.0,,,,0.0,,0.0
Patna,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,0.0,,0.0,,,,,,0.0
Patna,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,0.0,,0.0,,,,,,0.0
Patna,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,740.0,,615.0,,1980.0,,1160.0,609.0,,1658.0,1658.0,,8420.0
Patna,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,,3000.0,,2500.0,,3000.0,3500.0,,,2250.0,,14250.0
Patna,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,,,,,,0.0,0.0,,,,,0.0
Patna,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,0.0,,2615.0,,3120.0,,3551.0,3345.0,,,3070.0,,15701.0
Patna,16.1.5,Stock position of BCG vaccines,5. Total Stock,740.0,0.0,1000.0,0.0,1360.0,0.0,609.0,764.0,0.0,1658.0,838.0,0.0,6969.0
Patna,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,761.0,,786.0,,656.0,,31.0,955.0,,1267.0,1267.0,,5723.0
Patna,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,,4000.0,,4750.0,,5100.0,4400.0,,,3500.0,,21750.0
Patna,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,,,,,0.0,0.0,,,,,0.0
Patna,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,0.0,,4530.0,,5175.0,,4176.0,5145.0,,,4732.0,,23758.0
Patna,16.1.6,Stock position of Measles vaccines,5. Total Stock,761.0,0.0,256.0,0.0,231.0,0.0,955.0,210.0,0.0,1267.0,35.0,0.0,3715.0
Patna,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,1250.0,,641.0,,3351.0,,641.0,5.0,,1601.0,1601.0,,9090.0
Patna,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,4000.0,,4000.0,,3000.0,6000.0,,,3500.0,,20500.0
Patna,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,,,,,0.0,0.0,,,,,0.0
Patna,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,4020.0,,6210.0,,3640.0,5474.0,,,4688.0,,24032.0
Patna,16.1.7,Stock position of JE vaccines,5. Total Stock,1250.0,0.0,621.0,0.0,1141.0,0.0,1.0,531.0,0.0,1601.0,413.0,0.0,5558.0
Patna,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,340.0,,1690.0,,947.0,,1702.0,1164.0,,1936.0,1936.0,,9715.0
Patna,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,,3000.0,,5000.0,,3000.0,5000.0,,,1500.0,,17500.0
Patna,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,,,,,,0.0,0.0,,,,,0.0
Patna,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,,3305.0,,3945.0,,3538.0,4300.0,,,2540.0,,17628.0
Patna,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,340.0,0.0,1385.0,0.0,2002.0,0.0,1164.0,1864.0,0.0,1936.0,896.0,0.0,9587.0
Patna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,20675.0,,,,,20675.0
Patna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,350.0,,,,,350.0
Patna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20325.0,0.0,0.0,0.0,0.0,20325.0
Patna,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,24250.0,,,,,24250.0
Patna,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,600.0,,,,,600.0
Patna,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23650.0,0.0,0.0,0.0,0.0,23650.0
Patna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,24750.0,,,,,24750.0
Patna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,1300.0,,,,,1300.0
Patna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23450.0,0.0,0.0,0.0,0.0,23450.0
Patna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,11600.0,,,,,11600.0
Patna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,8000.0,,,,,8000.0
Patna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3600.0,0.0,0.0,0.0,0.0,3600.0
Patna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,69.0,,69.0,,,,,0.0,,,,,138.0
Patna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,,,,,,,0.0,,,,,0.0
Patna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,0.0,,,,,0.0
Patna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,,,,,,,0.0,,,,,0.0
Patna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,69.0,0.0,69.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,138.0
Patna,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,16550.0,16550.0,9150.0,,,,,0.0,,,,,42250.0
Patna,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,,,,,,0.0,,,,,0.0
Patna,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,,,,,,0.0,,,,,0.0
Patna,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,3500.0,3500.0,1150.0,,,,,0.0,,,,,8150.0
Patna,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,13050.0,13050.0,8000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34100.0
Patna,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,8615.0,,,,,22800.0,,,,,31415.0
Patna,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,615.0,,,,,3200.0,,,,,3815.0
Patna,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,8000.0,0.0,0.0,0.0,0.0,19600.0,0.0,0.0,0.0,0.0,27600.0
Patna,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Patna,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Patna,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Patna,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,192000.0,,,,,192000.0
Patna,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,16950.0,,,,,16950.0
Patna,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,175050.0,0.0,0.0,0.0,0.0,175050.0
Patna,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Patna,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Patna,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Patna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Patna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,3998000.0,3998000.0,,,,,,0.0,,,,,7996000.0
Patna,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,,,,,,0.0,,,,,0.0
Patna,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,,,,,,0.0,,,,,0.0
Patna,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,351000.0,351000.0,,,,,,0.0,,,,,702000.0
Patna,16.3.07,Stock Position of IFA Tablets,5. Total Stock,3647000.0,3647000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7294000.0
Patna,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Patna,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Patna,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Patna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Patna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patna,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1426.0,,5856.0,,,,,0.0,,,,,7282.0
Patna,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,4988.0,,,,,0.0,,,,,4988.0
Patna,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1426.0,0.0,868.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2294.0
Patna,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,12558.0,,98900.0,,,,,233800.0,,,,,345258.0
Patna,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Patna,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Patna,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,17050.0,,,,,12600.0,,,,,29650.0
Patna,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,12558.0,0.0,81850.0,0.0,0.0,0.0,0.0,221200.0,0.0,0.0,0.0,0.0,315608.0
Patna,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,13800.0,,17050.0,,17650.0,,14600.0,10600.0,,12000.0,12000.0,,97700.0
Patna,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,15000.0,,10000.0,,18000.0,10000.0,,,14000.0,,67000.0
Patna,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,0.0,0.0,,,,,0.0
Patna,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,7600.0,,12150.0,,22000.0,12700.0,,,12700.0,,67150.0
Patna,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,13800.0,0.0,24450.0,0.0,15500.0,0.0,10600.0,7900.0,0.0,12000.0,13300.0,0.0,97550.0
Patna,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,65000.0,,43130.0,,23530.0,,47130.0,57530.0,,56030.0,56030.0,,348380.0
Patna,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,100000.0,,140000.0,,140000.0,100000.0,,,150000.0,,630000.0
Patna,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,0.0,0.0,,,,,0.0
Patna,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,84100.0,,112000.0,,129600.0,126400.0,,,121300.0,,573400.0
Patna,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,65000.0,0.0,59030.0,0.0,51530.0,0.0,57530.0,31130.0,0.0,56030.0,84730.0,0.0,404980.0
Patna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,500.0,,981.0,,81.0,,1481.0,4700.0,,5850.0,5850.0,,19443.0
Patna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,8000.0,,10000.0,,10000.0,8500.0,,,12500.0,,49000.0
Patna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,0.0,0.0,,,,,0.0
Patna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,6150.0,,8000.0,,8481.0,10750.0,,,11800.0,,45181.0
Patna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,500.0,0.0,2831.0,0.0,2081.0,0.0,3000.0,2450.0,0.0,5850.0,6550.0,0.0,23262.0
Patna,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Patna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Patna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Patna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Patna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Patna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Patna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Patna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Patna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Patna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Patna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Patna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Patna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Patna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Patna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Patna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Patna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Patna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Patna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Patna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Patna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Patna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Patna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Patna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Patna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Patna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Patna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Patna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Patna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Patna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Patna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Patna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Patna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Patna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Patna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Patna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Patna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Patna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Patna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Patna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Patna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Patna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Patna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Patna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Patna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Patna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Patna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Patna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Patna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Patna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Patna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Patna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Patna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Patna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Patna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Patna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Patna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Patna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Patna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Patna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Patna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Patna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Patna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Purnia,1.1,Total number of pregnant women Registered for ANC,TOTAL,9827.0,9284.0,8877.0,7560.0,8696.0,8072.0,6257.0,7335.0,6734.0,7857.0,8682.0,9835.0,99016.0
Purnia,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4475.0,4184.0,3802.0,3283.0,3554.0,3385.0,2810.0,3005.0,2840.0,3420.0,4040.0,4648.0,43446.0
Purnia,1.2,Number of Pregnant women registered under JSY,TOTAL,9898.0,9062.0,8869.0,7549.0,8696.0,8072.0,6257.0,7335.0,6734.0,7845.0,8682.0,9834.0,98833.0
Purnia,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5330.0,5388.0,5271.0,5304.0,6050.0,5520.0,5438.0,5352.0,4846.0,4961.0,5281.0,5820.0,64561.0
Purnia,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,8215.0,7803.0,7565.0,6323.0,6808.0,6280.0,4696.0,5089.0,4610.0,5299.0,6026.0,7028.0,75742.0
Purnia,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,9306.0,9627.0,9477.0,8868.0,9703.0,9213.0,7828.0,7070.0,6899.0,7188.0,7463.0,9259.0,101901.0
Purnia,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,9246.0,8561.0,7699.0,4380.0,3936.0,4359.0,3842.0,5279.0,5305.0,6583.0,6581.0,7019.0,72790.0
Purnia,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,54.0,90.0,9.0,25.0,25.0,15.0,5.0,33.0,55.0,84.0,114.0,26.0,535.0
Purnia,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,7.0,12.0,15.0,9.0,11.0,11.0,19.0,30.0,19.0,18.0,5.0,9.0,165.0
Purnia,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,185.0,242.0,135.0,356.0,204.0,155.0,309.0,441.0,287.0,421.0,214.0,327.0,3276.0
Purnia,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,2.0,5.0,7.0,2.0,4.0,21.0,58.0,21.0,78.0,22.0,50.0,272.0
Purnia,1.8,Number of pregnancy test kits used at SC level,TOTAL,567.0,568.0,322.0,220.0,361.0,309.0,88.0,247.0,154.0,105.0,42.0,301.0,3284.0
Purnia,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,151.0,162.0,192.0,160.0,196.0,264.0,255.0,343.0,209.0,271.0,236.0,204.0,2643.0
Purnia,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1222.0,1236.0,1132.0,1246.0,1575.0,1773.0,1762.0,2344.0,1596.0,1838.0,1574.0,1365.0,18663.0
Purnia,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1373.0,1398.0,1324.0,1406.0,1771.0,2037.0,2017.0,2687.0,1805.0,2109.0,1810.0,1569.0,21306.0
Purnia,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,802.0,823.0,826.0,813.0,1086.0,1016.0,1143.0,1371.0,1004.0,1231.0,1018.0,992.0,12125.0
Purnia,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,3.0,0.0,11.0,0.0,0.0,1.0,0.0,0.0,0.0,8.0,10.0,35.0
Purnia,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,5032.0,5218.0,4327.0,5453.0,7486.0,8456.0,8322.0,7003.0,5941.0,5321.0,4602.0,4177.0,71338.0
Purnia,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,4548.0,4683.0,3897.0,4882.0,6713.0,7587.0,7784.0,6506.0,5370.0,4856.0,3867.0,3818.0,64511.0
Purnia,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2719.0,4520.0,2484.0,1640.0,750.0,789.0,674.0,503.0,1411.0,2848.0,3376.0,3180.0,24894.0
Purnia,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2462.0,3413.0,2286.0,1726.0,1359.0,1054.0,674.0,503.0,1233.0,1859.0,2614.0,2327.0,21510.0
Purnia,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Purnia,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Purnia,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Purnia,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Purnia,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,5.0,10.0,5.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,8.0,29.0
Purnia,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,118.0,117.0,92.0,123.0,152.0,160.0,133.0,132.0,137.0,112.0,63.0,57.0,1396.0
Purnia,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purnia,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,123.0,127.0,97.0,123.0,152.0,160.0,133.0,132.0,138.0,112.0,63.0,65.0,1425.0
Purnia,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Purnia,4.1.1.a,Number of male live births,TOTAL,3183.0,3366.0,2903.0,3372.0,4572.0,5241.0,5336.0,4873.0,3929.0,3724.0,3222.0,2957.0,46678.0
Purnia,4.1.1.b,Number of female live births,TOTAL,3071.0,3123.0,2638.0,3326.0,4505.0,5058.0,4822.0,4671.0,3666.0,3596.0,3085.0,2709.0,44270.0
Purnia,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,6254.0,6489.0,5541.0,6698.0,9077.0,10299.0,10158.0,9544.0,7595.0,7320.0,6307.0,5666.0,90948.0
Purnia,4.1.2,Number of still births,TOTAL,151.0,127.0,116.0,165.0,187.0,211.0,186.0,158.0,158.0,140.0,111.0,101.0,1811.0
Purnia,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,11.0,12.0,14.0,18.0,8.0,12.0,7.0,17.0,31.0,6.0,14.0,13.0,163.0
Purnia,4.2.1,Number of Newborns weighed at birth,TOTAL,6036.0,6315.0,5398.0,6620.0,8981.0,10145.0,9857.0,9225.0,7515.0,7045.0,6177.0,5504.0,88818.0
Purnia,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,175.0,191.0,232.0,268.0,311.0,343.0,449.0,337.0,225.0,202.0,124.0,164.0,3021.0
Purnia,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,5915.0,6126.0,5215.0,6488.0,8837.0,9759.0,9681.0,9090.0,7334.0,6985.0,6162.0,5458.0,87050.0
Purnia,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,5.0,0.0,143.0,98.0,44.0,120.0,23.0,21.0,23.0,24.0,19.0,523.0
Purnia,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,164.0,178.0,117.0,186.0,182.0,216.0,304.0,262.0,137.0,112.0,63.0,138.0,2059.0
Purnia,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purnia,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,167.0,183.0,117.0,329.0,280.0,260.0,424.0,285.0,158.0,135.0,87.0,157.0,2582.0
Purnia,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Purnia,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,341.0,1310.0,117.0,335.0,219.0,216.0,401.0,265.0,79.0,121.0,77.0,94.0,3575.0
Purnia,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,89.0,133.0,13.0,17.0,14.0,11.0,21.0,41.0,19.0,60.0,11.0,16.0,445.0
Purnia,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,455.0,482.0,117.0,314.0,280.0,260.0,342.0,191.0,149.0,135.0,67.0,76.0,2868.0
Purnia,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,164.0,180.0,92.0,136.0,155.0,140.0,264.0,236.0,37.0,55.0,60.0,138.0,1657.0
Purnia,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2981.0,3682.0,2934.0,4055.0,6163.0,6020.0,5639.0,5035.0,4047.0,3469.0,2796.0,3107.0,49928.0
Purnia,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2129.0,2176.0,1830.0,2616.0,3982.0,3833.0,3557.0,3469.0,2948.0,2656.0,3108.0,2355.0,34659.0
Purnia,6.3,PNC maternal complications attended,TOTAL,40.0,30.0,50.0,30.0,30.0,35.0,30.0,26.0,37.0,27.0,58.0,28.0,421.0
Purnia,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,0.0,0.0,0.0,8.0,0.0,7.0,17.0,31.0,6.0,13.0,11.0,94.0
Purnia,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,2.0,2.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Purnia,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1.0,2.0,2.0,0.0,8.0,12.0,7.0,17.0,31.0,6.0,13.0,11.0,110.0
Purnia,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,359.0,380.0,395.0,710.0,675.0,595.0,498.0,428.0,576.0,503.0,410.0,407.0,5936.0
Purnia,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1091.0,934.0,1039.0,840.0,1009.0,989.0,1032.0,1091.0,1055.0,1035.0,1101.0,1191.0,12407.0
Purnia,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1450.0,1314.0,1434.0,1550.0,1684.0,1584.0,1530.0,1519.0,1631.0,1538.0,1511.0,1598.0,18343.0
Purnia,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,1.0,9.0,3.0,0.0,2.0,8.0,4.0,3.0,9.0,6.0,46.0
Purnia,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,1.0,2.0,2.0,1.0,2.0,0.0,2.0,1.0,2.0,1.0,1.0,17.0
Purnia,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purnia,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,1.0,3.0,11.0,4.0,2.0,2.0,10.0,5.0,5.0,10.0,7.0,63.0
Purnia,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Purnia,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Purnia,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purnia,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Purnia,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,429.0,96.0,57.0,473.0,281.0,415.0,394.0,1835.0,2117.0,1505.0,3076.0,1267.0,11945.0
Purnia,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,11.0,4.0,21.0,26.0,72.0,117.0,152.0,679.0,131.0,107.0,130.0,70.0,1520.0
Purnia,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,31.0,44.0,42.0,58.0,82.0,20.0,39.0,118.0,148.0,89.0,97.0,226.0,994.0
Purnia,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purnia,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,471.0,144.0,120.0,557.0,435.0,552.0,585.0,2632.0,2396.0,1701.0,3303.0,1563.0,14459.0
Purnia,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Purnia,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,189.0,48.0,61.0,181.0,90.0,139.0,153.0,632.0,352.0,512.0,138.0,94.0,2589.0
Purnia,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,12.0,19.0,17.0,0.0,0.0,0.0,0.0,1.0,49.0
Purnia,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,34.0,16.0,0.0,0.0,0.0,57.0,43.0,45.0,51.0,48.0,27.0,21.0,342.0
Purnia,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purnia,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,223.0,64.0,61.0,181.0,102.0,215.0,213.0,677.0,403.0,560.0,165.0,116.0,2980.0
Purnia,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Purnia,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1011.0,1165.0,1122.0,2045.0,1104.0,1021.0,1283.0,1426.0,1393.0,1397.0,1369.0,1529.0,15865.0
Purnia,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,423.0,440.0,343.0,566.0,322.0,418.0,335.0,198.0,181.0,258.0,309.0,475.0,4268.0
Purnia,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,4.0,,0.0,52.0,56.0,16.0,48.0,18.0,11.0,13.0,12.0,18.0,248.0
Purnia,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,21.0,15.0,195.0,241.0,16.0,215.0,186.0,229.0,177.0,238.0,165.0,185.0,1883.0
Purnia,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purnia,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1459.0,1620.0,1660.0,2904.0,1498.0,1670.0,1852.0,1871.0,1762.0,1906.0,1855.0,2207.0,22264.0
Purnia,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,392.0,445.0,281.0,539.0,473.0,427.0,310.0,295.0,319.0,298.0,316.0,276.0,4371.0
Purnia,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Purnia,9.06,Number of IUCD removals,TOTAL,614.0,407.0,380.0,476.0,450.0,490.0,481.0,570.0,540.0,566.0,562.0,612.0,6148.0
Purnia,9.07,Number of Oral Pills cycles distributed,TOTAL,2726.0,2513.0,2416.0,3105.0,2256.0,2340.0,2706.0,2789.0,2954.0,3122.0,2921.0,3220.0,33068.0
Purnia,9.08,Number of Condom pieces distributed,TOTAL,31268.0,31259.0,23298.0,26712.0,19849.0,20145.0,21317.0,23865.0,25393.0,21222.0,22555.0,25467.0,292350.0
Purnia,9.09,Number of Centchroman (weekly) pills given,TOTAL,92.0,160.0,168.0,200.0,24.0,114.0,130.0,87.0,76.0,185.0,146.0,166.0,1548.0
Purnia,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,407.0,411.0,343.0,630.0,567.0,569.0,553.0,589.0,591.0,784.0,1119.0,1149.0,7712.0
Purnia,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,9.0
Purnia,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,1.0,10.0,17.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,41.0
Purnia,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Purnia,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Purnia,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,6746.0,7296.0,6425.0,7515.0,9984.0,11449.0,10729.0,12363.0,9101.0,8944.0,7980.0,7106.0,105638.0
Purnia,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,8327.0,7187.0,6706.0,6960.0,6792.0,7969.0,9161.0,12804.0,11688.0,1331.0,0.0,642.0,79567.0
Purnia,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,9635.0,8314.0,7148.0,7200.0,7595.0,7358.0,7261.0,9152.0,11740.0,11922.0,5426.0,2590.0,95341.0
Purnia,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,10353.0,9351.0,7994.0,7872.0,7813.0,8099.0,7081.0,7547.0,8832.0,11329.0,10124.0,7735.0,104130.0
Purnia,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8448.0,9003.0,8493.0,25944.0
Purnia,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4795.0,8259.0,13054.0
Purnia,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4126.0,4126.0
Purnia,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,5589.0,6130.0,5347.0,6729.0,8829.0,9843.0,9327.0,9687.0,7389.0,6895.0,5976.0,5440.0,87181.0
Purnia,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,8334.0,7182.0,6709.0,6959.0,6782.0,7977.0,9044.0,12615.0,11676.0,9711.0,8689.0,9144.0,104822.0
Purnia,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,9626.0,8315.0,7148.0,7204.0,7594.0,7380.0,7187.0,9008.0,11740.0,11693.0,8995.0,10473.0,106363.0
Purnia,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,10346.0,9352.0,7983.0,7870.0,7816.0,8091.0,6967.0,7430.0,8822.0,11156.0,9767.0,11171.0,106771.0
Purnia,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,4108.0,4360.0,3564.0,4679.0,6312.0,7096.0,6882.0,6763.0,5184.0,4741.0,4026.0,3871.0,61586.0
Purnia,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,8249.0,7134.0,6728.0,6906.0,6797.0,7967.0,9162.0,12750.0,11672.0,1310.0,0.0,634.0,79309.0
Purnia,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,9569.0,8237.0,7160.0,7216.0,7625.0,7356.0,7302.0,9094.0,11727.0,11816.0,5447.0,2457.0,95006.0
Purnia,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,10270.0,9266.0,8004.0,7875.0,7836.0,8091.0,7077.0,7507.0,8820.0,11307.0,10104.0,7784.0,103941.0
Purnia,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7001.0,7743.0,8710.0,9986.0,10350.0,9866.0,7671.0,9392.0,8132.0,7268.0,7051.0,7438.0,100608.0
Purnia,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4275.0,3685.0,3935.0,4343.0,4294.0,4219.0,3490.0,5209.0,5014.0,5392.0,6179.0,6431.0,56466.0
Purnia,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3711.0,4048.0,4597.0,5250.0,5328.0,5058.0,3953.0,4931.0,4183.0,3784.0,3724.0,4000.0,52567.0
Purnia,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3290.0,3695.0,4113.0,4736.0,5022.0,4808.0,3718.0,4430.0,3949.0,3484.0,3328.0,3440.0,48013.0
Purnia,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,7001.0,7743.0,8710.0,9986.0,10350.0,9866.0,7671.0,9361.0,8132.0,7268.0,7052.0,7440.0,100580.0
Purnia,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6548.0,5522.0,5378.0,5574.0,5536.0,5210.0,4383.0,6216.0,5801.0,6464.0,7191.0,7798.0,71621.0
Purnia,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6540.0,5531.0,5377.0,5559.0,5528.0,5193.0,4345.0,6139.0,5803.0,6374.0,7036.0,7808.0,71233.0
Purnia,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,11.0
Purnia,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1126.0,824.0,725.0,1173.0,1193.0,1104.0,851.0,820.0,788.0,1003.0,1118.0,1164.0,11889.0
Purnia,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1123.0,758.0,648.0,1040.0,1042.0,1082.0,835.0,787.0,752.0,951.0,1122.0,1140.0,11280.0
Purnia,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2249.0,1582.0,1373.0,2213.0,2235.0,2186.0,1686.0,1607.0,1540.0,1954.0,2240.0,2304.0,23169.0
Purnia,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,65.0,114.0,111.0,116.0,114.0,115.0,151.0,174.0,166.0,194.0,214.0,240.0,1774.0
Purnia,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1560.0,1687.0,1674.0,1703.0,1649.0,1538.0,1541.0,1602.0,1545.0,1426.0,1538.0,1506.0,18969.0
Purnia,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2586.0,2610.0,2768.0,2600.0,2605.0,2450.0,2499.0,2468.0,2404.0,2280.0,2320.0,2309.0,29899.0
Purnia,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,2.0,5.0,10.0
Purnia,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,5.0
Purnia,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3461.0,3470.0,3182.0,3469.0,3484.0,3470.0,3531.0,3494.0,3376.0,3484.0,3478.0,3492.0,41391.0
Purnia,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3481.0,3463.0,3176.0,3468.0,3484.0,3470.0,3518.0,3485.0,3375.0,3491.0,3479.0,3496.0,41386.0
Purnia,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3203.0,3111.0,2821.0,3178.0,3157.0,3136.0,3108.0,3158.0,3031.0,3127.0,3118.0,3179.0,37327.0
Purnia,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1818.0,2312.0,1499.0,21689.0,2363.0,1716.0,1063.0,2099.0,21612.0,1789.0,1433.0,1079.0,60472.0
Purnia,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,794.0,653.0,506.0,44963.0,610.0,474.0,333.0,795.0,37249.0,769.0,840.0,736.0,88722.0
Purnia,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,245.0,216.0,68.0,4847.0,236.0,150.0,82.0,453.0,539.0,299.0,231.0,123.0,7489.0
Purnia,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Purnia,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Purnia,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,7.0,0.0,27.0,0.0,2.0,0.0,0.0,0.0,6.0,8.0,9.0,62.0
Purnia,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,232.0,362.0,161.0,276.0,708.0,605.0,508.0,794.0,575.0,747.0,799.0,748.0,6515.0
Purnia,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,5.0,3.0,10.0,13.0,0.0,1.0,1.0,4.0,14.0,5.0,15.0,0.0,71.0
Purnia,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,3.0,57.0,35.0,63.0,45.0,52.0,58.0,46.0,39.0,32.0,42.0,40.0,512.0
Purnia,13.1,Number of Patients operated for cataract,TOTAL,238.0,247.0,100.0,6.0,169.0,118.0,80.0,131.0,90.0,140.0,164.0,147.0,1630.0
Purnia,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,238.0,247.0,100.0,6.0,169.0,118.0,80.0,131.0,90.0,65.0,164.0,147.0,1555.0
Purnia,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Purnia,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Purnia,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2641.0,2441.0,2438.0,2217.0,2640.0,2437.0,2563.0,2630.0,2446.0,2635.0,2632.0,2640.0,-1.0
Purnia,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Purnia,14.05,Number of RKS meetings held during the month,TOTAL,26.0,22.0,22.0,25.0,22.0,24.0,22.0,22.0,19.0,22.0,20.0,17.0,263.0
Purnia,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Purnia,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1355.0,1658.0,1124.0,1422.0,1131.0,1061.0,1178.0,1657.0,1603.0,1221.0,1072.0,1295.0,15777.0
Purnia,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Purnia,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,,2.0,1.0,,,,,,,,,-1.0
Purnia,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,833.0,1763.0,772.0,892.0,979.0,823.0,831.0,1031.0,923.0,785.0,557.0,830.0,11019.0
Purnia,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2034.0,2893.0,1618.0,1686.0,1816.0,1679.0,1450.0,1595.0,1193.0,1168.0,921.0,1313.0,19366.0
Purnia,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1244.0,2202.0,1223.0,1297.0,1162.0,1211.0,1135.0,1548.0,976.0,1029.0,797.0,1025.0,14849.0
Purnia,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,8233.0,13310.0,7664.0,9162.0,9891.0,12354.0,12178.0,9805.0,10122.0,8547.0,8237.0,8282.0,117785.0
Purnia,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2077.0,3965.0,1995.0,2189.0,2141.0,2034.0,1966.0,2579.0,1899.0,1814.0,1354.0,1855.0,25868.0
Purnia,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,10267.0,16203.0,9282.0,10848.0,11707.0,14033.0,13628.0,11400.0,11315.0,9715.0,9158.0,9595.0,137151.0
Purnia,14.10.2.a,Number of death cases of Inpatient males,TOTAL,64.0,52.0,64.0,83.0,66.0,58.0,65.0,77.0,59.0,60.0,48.0,43.0,739.0
Purnia,14.10.2.b,Number of death cases of Inpatient females,TOTAL,46.0,59.0,40.0,65.0,49.0,64.0,61.0,54.0,47.0,31.0,25.0,45.0,586.0
Purnia,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,110.0,111.0,104.0,148.0,115.0,122.0,126.0,131.0,106.0,91.0,73.0,88.0,1325.0
Purnia,14.11,In-Patient Head Count at midnight,TOTAL,16716.0,17811.0,17113.0,17974.0,20851.0,21425.0,20422.0,18072.0,18331.0,15699.0,13438.0,14081.0,211933.0
Purnia,14.12.1,OPD attendance (All),TOTAL,258488.0,262846.0,205001.0,239516.0,246191.0,288165.0,225859.0,200955.0,198566.0,197034.0,206266.0,229636.0,2758523.0
Purnia,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,669.0,1115.0,194.0,1218.0,371.0,510.0,407.0,1522.0,1306.0,690.0,692.0,795.0,9489.0
Purnia,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,13.0,6.0,3.0,5.0,7.0,3.0,3.0,6.0,9.0,435.0,6.0,4.0,500.0
Purnia,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1639.0,2805.0,2403.0,2350.0,2234.0,2245.0,2054.0,1980.0,1746.0,1966.0,1796.0,2124.0,25342.0
Purnia,14.14.a,Number of patients given AYUSH treatment,TOTAL,24317.0,48248.0,24759.0,24322.0,25931.0,32731.0,22745.0,22987.0,20466.0,23126.0,43431.0,24176.0,337239.0
Purnia,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,10025.0,11489.0,10955.0,10428.0,12917.0,10618.0,9726.0,10201.0,9357.0,9594.0,12468.0,10048.0,127826.0
Purnia,14.14.c,Number of Adolescents counselled,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,37.0,1.0,1.0,1.0,1.0,1.0,48.0
Purnia,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6275.0,6695.0,6488.0,6600.0,7899.0,7589.0,5880.0,7972.0,7121.0,7818.0,7653.0,8048.0,86038.0
Purnia,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,81.0,91.0,90.0,88.0,104.0,81.0,47.0,85.0,98.0,57.0,62.0,60.0,944.0
Purnia,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1148.0,888.0,1220.0,1229.0,1385.0,833.0,245.0,733.0,1069.0,433.0,314.0,1347.0,10844.0
Purnia,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,10.0,21.0,17.0,11.0,10.0,11.0,1.0,9.0,7.0,2.0,9.0,6.0,114.0
Purnia,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1262.0,1070.0,538.0,702.0,716.0,1072.0,202.0,599.0,689.0,187.0,99.0,639.0,7775.0
Purnia,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,6.0,14.0,13.0,15.0,4.0,8.0,0.0,8.0,8.0,6.0,4.0,9.0,95.0
Purnia,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2476.0,2444.0,2356.0,2552.0,2371.0,1665.0,1002.0,2231.0,2237.0,1150.0,1170.0,2241.0,23895.0
Purnia,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,4.0,3.0,1.0,2.0,1.0,0.0,0.0,3.0,0.0,1.0,2.0,19.0
Purnia,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4886.0,4402.0,4114.0,4483.0,4472.0,3570.0,1449.0,3563.0,3995.0,1770.0,1583.0,4227.0,42514.0
Purnia,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,18.0,39.0,33.0,27.0,16.0,20.0,1.0,17.0,18.0,8.0,14.0,17.0,228.0
Purnia,15.2,Number of Widal tests conducted,Number tested,143.0,309.0,460.0,686.0,1809.0,1508.0,1171.0,1081.0,685.0,530.0,572.0,1072.0,10026.0
Purnia,15.3.a,Number of VDRL tests conducted on males,Number tested,36.0,19.0,75.0,57.0,22.0,20.0,14.0,19.0,28.0,7.0,0.0,0.0,297.0
Purnia,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,15.0,75.0,21.0,10.0,0.0,0.0,15.0,12.0,0.0,5.0,0.0,0.0,153.0
Purnia,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,84.0,52.0,44.0,132.0,26.0,22.0,4.0,34.0,28.0,10.0,0.0,0.0,436.0
Purnia,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,135.0,146.0,140.0,199.0,48.0,42.0,33.0,65.0,56.0,22.0,0.0,0.0,886.0
Purnia,15.4.1,Number of blood smears examined for Malaria,TOTAL,285.0,317.0,261.0,375.0,404.0,659.0,740.0,740.0,562.0,370.0,502.0,654.0,5869.0
Purnia,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,5.0,6.0,4.0,8.0,9.0,17.0,13.0,15.0,11.0,43.0,9.0,3.0,143.0
Purnia,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,2.0,6.0,2.0,0.0,2.0,6.0,2.0,2.0,1.0,1.0,25.0
Purnia,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1450.0,400.0,400.0,1000.0,2850.0,550.0,950.0,1150.0,1050.0,1950.0,3050.0,200.0,15000.0
Purnia,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3350.0,3750.0,4350.0,6000.0,1500.0,4000.0,4000.0,3000.0,4500.0,4000.0,250.0,3000.0,41700.0
Purnia,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,0.0,,,0.0
Purnia,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4400.0,3750.0,3650.0,4150.0,3800.0,3600.0,3800.0,3100.0,3600.0,2900.0,3100.0,2250.0,42100.0
Purnia,16.1.1,Stock position of DPT vaccines,5. Total Stock,400.0,400.0,1100.0,2850.0,550.0,950.0,1150.0,1050.0,1950.0,3050.0,200.0,950.0,14600.0
Purnia,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,,,,,,,,0.0,5550.0,3950.0,9500.0
Purnia,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,,,,,,,,7300.0,0.0,0.0,7300.0
Purnia,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,,,,,,,,0.0,,,0.0
Purnia,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,,,,,,,,1750.0,1600.0,2750.0,6100.0
Purnia,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5550.0,3950.0,1200.0,10700.0
Purnia,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,425.0,200.0,231.0,331.0,321.0,196.0,1146.0,1171.0,2175.0,636.0,1061.0,25.0,7918.0
Purnia,16.1.2,Stock position of OPV vaccines,2. Stocks Received,3050.0,3720.0,53000.0,4240.0,3000.0,4400.0,3650.0,53175.0,2236.0,52350.0,51300.0,2625.0,236746.0
Purnia,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,0.0,,,0.0
Purnia,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3425.0,3689.0,52900.0,4250.0,3275.0,3450.0,3625.0,52171.0,3775.0,51925.0,52336.0,2550.0,237371.0
Purnia,16.1.2,Stock position of OPV vaccines,5. Total Stock,50.0,231.0,331.0,321.0,46.0,1146.0,1171.0,2175.0,636.0,1061.0,25.0,100.0,7293.0
Purnia,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1250.0,200.0,400.0,700.0,2400.0,1050.0,950.0,1000.0,1000.0,1650.0,2700.0,1000.0,14300.0
Purnia,16.1.3,Stock position of TT vaccines,2. Stocks Received,1800.0,2800.0,3200.0,5000.0,1500.0,2500.0,2400.0,2000.0,2600.0,3000.0,0.0,2000.0,28800.0
Purnia,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,0.0,,,0.0
Purnia,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2850.0,2600.0,2900.0,3300.0,2850.0,2600.0,2350.0,2000.0,1950.0,1950.0,1700.0,1950.0,29000.0
Purnia,16.1.3,Stock position of TT vaccines,5. Total Stock,200.0,400.0,700.0,2400.0,1050.0,950.0,1000.0,1000.0,1650.0,2700.0,1000.0,1050.0,14100.0
Purnia,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,0.0,,,0.0
Purnia,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Purnia,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,50.0,550.0,200.0,800.0,650.0,150.0,800.0,900.0,500.0,1050.0,2550.0,400.0,8600.0
Purnia,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2900.0,2200.0,3000.0,2500.0,2000.0,2900.0,2500.0,2500.0,3300.0,4000.0,0.0,2500.0,30300.0
Purnia,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,0.0,,,0.0
Purnia,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2400.0,2550.0,2400.0,2650.0,2500.0,2250.0,2400.0,2900.0,2750.0,2500.0,2150.0,2000.0,29450.0
Purnia,16.1.5,Stock position of BCG vaccines,5. Total Stock,550.0,200.0,800.0,650.0,150.0,800.0,900.0,500.0,1050.0,2550.0,400.0,900.0,9450.0
Purnia,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,100.0,150.0,400.0,0.0,0.0,1300.0,1900.0,900.0,2600.0,1637.0,37.0,9024.0
Purnia,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000.0,2800.0,4000.0,4450.0,4500.0,5400.0,4150.0,3500.0,5000.0,2750.0,2500.0,3900.0,46950.0
Purnia,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,0.0,,,0.0
Purnia,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3900.0,2750.0,3750.0,4850.0,4500.0,4100.0,3550.0,4500.0,3300.0,3713.0,4100.0,3900.0,46913.0
Purnia,16.1.6,Stock position of Measles vaccines,5. Total Stock,100.0,150.0,400.0,0.0,0.0,1300.0,1900.0,900.0,2600.0,1637.0,37.0,37.0,9061.0
Purnia,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,0.0,,,0.0
Purnia,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Purnia,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1050.0,310.0,450.0,1150.0,1500.0,350.0,750.0,1300.0,560.0,850.0,900.0,300.0,9470.0
Purnia,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3380.0,3500.0,4500.0,4400.0,2400.0,3500.0,4000.0,2293.0,4000.0,2200.0,2400.0,2400.0,38973.0
Purnia,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,0.0,,,0.0
Purnia,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,4120.0,3360.0,3800.0,4050.0,3550.0,3100.0,3450.0,3033.0,3710.0,2150.0,3000.0,1450.0,38773.0
Purnia,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,310.0,450.0,1150.0,1500.0,350.0,750.0,1300.0,560.0,850.0,900.0,300.0,1250.0,9670.0
Purnia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,5000.0,4950.0,3300.0,2000.0,100.0,100.0,7300.0,4900.0,3700.0,2100.0,1900.0,1300.0,36650.0
Purnia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,50.0,0.0,0.0,,0.0,15000.0,0.0,,0.0,0.0,0.0,,15050.0
Purnia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,0.0,,0.0,0.0,0.0,,0.0
Purnia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,4950.0,1650.0,1300.0,1900.0,0.0,7800.0,2400.0,1200.0,1600.0,200.0,600.0,450.0,24050.0
Purnia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,100.0,3300.0,2000.0,100.0,100.0,7300.0,4900.0,3700.0,2100.0,1900.0,1300.0,850.0,27650.0
Purnia,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,5500.0,5500.0,2500.0,1500.0,500.0,0.0,154640.0,115820.0,75500.0,45260.0,20060.0,9980.0,436760.0
Purnia,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,0.0,200000.0,0.0,,0.0,0.0,0.0,,200000.0
Purnia,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,0.0,,0.0,0.0,0.0,,0.0
Purnia,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,5500.0,3000.0,1000.0,1000.0,500.0,45360.0,38820.0,40320.0,30240.0,25200.0,10080.0,5460.0,206480.0
Purnia,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,2500.0,1500.0,500.0,0.0,154640.0,115820.0,75500.0,45260.0,20060.0,9980.0,4520.0,430280.0
Purnia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3000.0,1500.0,500.0,200.0,200.0,100.0,7100.0,3900.0,1500.0,1500.0,0.0,,19500.0
Purnia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,1500.0,0.0,0.0,,0.0,15000.0,0.0,,0.0,0.0,0.0,,16500.0
Purnia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,0.0,,0.0,0.0,0.0,,0.0
Purnia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1500.0,1000.0,300.0,0.0,100.0,8000.0,3200.0,2400.0,0.0,1500.0,0.0,,18000.0
Purnia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,3000.0,500.0,200.0,200.0,100.0,7100.0,3900.0,1500.0,1500.0,0.0,0.0,0.0,18000.0
Purnia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,15360.0,15300.0,15300.0,6480.0,4980.0,4980.0,13780.0,13780.0,13780.0,12840.0,6060.0,1620.0,124260.0
Purnia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,60.0,0.0,0.0,,0.0,10000.0,0.0,,0.0,0.0,0.0,,10060.0
Purnia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,0.0,,0.0,0.0,0.0,,0.0
Purnia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,15300.0,0.0,8820.0,1500.0,0.0,1200.0,0.0,0.0,940.0,6780.0,4440.0,180.0,39160.0
Purnia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,120.0,15300.0,6480.0,4980.0,4980.0,13780.0,13780.0,13780.0,12840.0,6060.0,1620.0,1440.0,95160.0
Purnia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,59500.0,49500.0,41500.0,25500.0,14500.0,6200.0,3700.0,3700.0,6000.0,1200.0,1800.0,300.0,213400.0
Purnia,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,10000.0,0.0,,,0.0,28300.0,0.0,10000.0,0.0,2000.0,0.0,100000.0,150300.0
Purnia,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,,,,,0.0,,0.0,0.0,0.0,,0.0
Purnia,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,49500.0,8000.0,16000.0,11000.0,8300.0,30800.0,2500.0,7700.0,4800.0,1400.0,1500.0,200.0,141700.0
Purnia,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,20000.0,41500.0,25500.0,14500.0,6200.0,3700.0,1200.0,6000.0,1200.0,1800.0,300.0,100100.0,222000.0
Purnia,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,34200.0,12400.0,77600.0,54400.0,36700.0,21500.0,6500.0,5000.0,100.0,3900.0,78400.0,63000.0,393700.0
Purnia,16.3.02,Stock Position of Gloves,2. Stocks Received,21800.0,80000.0,,,0.0,,3000.0,,6500.0,100500.0,0.0,55000.0,266800.0
Purnia,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,,,,,0.0,,0.0,0.0,0.0,,0.0
Purnia,16.3.02,Stock Position of Gloves,4. Stock Distributed,12400.0,14800.0,2350.0,17400.0,15200.0,15000.0,4500.0,4900.0,800.0,26000.0,15400.0,7000.0,135750.0
Purnia,16.3.02,Stock Position of Gloves,5. Total Stock,43600.0,77600.0,75250.0,37000.0,21500.0,6500.0,5000.0,100.0,5800.0,78400.0,63000.0,111000.0,524750.0
Purnia,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,0.0,,0.0
Purnia,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,0.0,,0.0
Purnia,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,0.0,,0.0
Purnia,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,2000.0,199300.0,172103.0,373403.0
Purnia,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,,,,,,,10000.0,20000.0,20003.0,,50003.0
Purnia,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,0.0,,0.0
Purnia,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,,,,,,,8000.0,2700.0,47200.0,12000.0,69900.0
Purnia,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,19300.0,172103.0,160103.0,353506.0
Purnia,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,1500.0,1475.0,75.0,75.0,75.0,75.0,75.0,5075.0,4075.0,12500.0
Purnia,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,5000.0,,,,0.0,,0.0,5000.0,0.0,,10000.0
Purnia,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,,,,,0.0,,0.0,0.0,0.0,,0.0
Purnia,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,3500.0,25.0,1400.0,75.0,0.0,0.0,0.0,0.0,1000.0,4075.0,10075.0
Purnia,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,1500.0,1475.0,75.0,0.0,75.0,75.0,75.0,5075.0,4075.0,0.0,12425.0
Purnia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,0.0,,0.0
Purnia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,0.0,,0.0
Purnia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,532000.0,232000.0,72000.0,,0.0,0.0,930250.0,410050.0,147800.0,517050.0,181050.0,36050.0,3058250.0
Purnia,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,300000.0,0.0,,,469850.0,1530250.0,0.0,,469750.0,0.0,0.0,200000.0,2969850.0
Purnia,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,,,,,0.0,,0.0,0.0,0.0,,0.0
Purnia,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,232000.0,160000.0,72000.0,,40000.0,600000.0,520200.0,262250.0,100500.0,336000.0,145000.0,29000.0,2496950.0
Purnia,16.3.07,Stock Position of IFA Tablets,5. Total Stock,600000.0,72000.0,0.0,0.0,429850.0,930250.0,410050.0,147800.0,517050.0,181050.0,36050.0,207050.0,3531150.0
Purnia,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,0.0,0.0,,0.0
Purnia,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,0.0,,0.0
Purnia,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,,,,,,,0.0,0.0,0.0,,0.0
Purnia,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purnia,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,,,,,,8032.0,,0.0,,8032.0
Purnia,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,,,,,,,6300.0,,0.0,,6300.0
Purnia,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1732.0,0.0,0.0,0.0,1732.0
Purnia,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,13484.0,9084.0,2500.0,81500.0,33500.0,332400.0,394800.0,460800.0,428400.0,414150.0,408150.0,427446.0,3006214.0
Purnia,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,4400.0,0.0,100000.0,,391600.0,530400.0,132000.0,,0.0,,34296.0,,1192696.0
Purnia,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,,,,,,,0.0,,0.0,,0.0
Purnia,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,9084.0,6584.0,21000.0,48000.0,92700.0,135600.0,66000.0,32400.0,14250.0,6000.0,15000.0,393400.0,840018.0
Purnia,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,8800.0,2500.0,81500.0,33500.0,332400.0,727200.0,460800.0,428400.0,414150.0,408150.0,427446.0,34046.0,3358892.0
Purnia,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,200.0,,4900.0,2600.0,1300.0,3700.0,300.0,13900.0,3100.0,800.0,30800.0
Purnia,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,12000.0,,10000.0,10000.0,15000.0,10000.0,22000.0,,8500.0,15000.0,102500.0
Purnia,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,9200.0,,12300.0,11300.0,12600.0,13400.0,8400.0,10800.0,10800.0,8000.0,96800.0
Purnia,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,3000.0,0.0,2600.0,1300.0,3700.0,300.0,13900.0,3100.0,800.0,7800.0,36500.0
Purnia,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,11000.0,,4000.0,10200.0,23600.0,0.0,56200.0,139600.0,28600.0,46000.0,319200.0
Purnia,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,100000.0,,110000.0,110000.0,50000.0,150000.0,180000.0,,120000.0,110000.0,930000.0
Purnia,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,100000.0,,103800.0,96600.0,73600.0,93800.0,96600.0,111000.0,102600.0,86200.0,864200.0
Purnia,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,11000.0,0.0,10200.0,23600.0,0.0,56200.0,139600.0,28600.0,46000.0,69800.0,385000.0
Purnia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1600.0,200.0,200.0,42200.0,10000.0,42700.0,25600.0,15400.0,5900.0,10500.0,166000.0,237700.0,558000.0
Purnia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,1400.0,0.0,100000.0,,233200.0,14500.0,10000.0,5000.0,13000.0,20600.0,126000.0,8400.0,532100.0
Purnia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,,,,,,,,,0.0,,0.0
Purnia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,200.0,0.0,58000.0,32200.0,65600.0,19500.0,20200.0,14500.0,6900.0,45100.0,54300.0,22100.0,338600.0
Purnia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2800.0,200.0,42200.0,10000.0,177600.0,37700.0,15400.0,5900.0,12000.0,-14000.0,237700.0,224000.0,751500.0
Purnia,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Purnia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Purnia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Purnia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Purnia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Purnia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Purnia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Purnia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Purnia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Purnia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Purnia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Purnia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Purnia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Purnia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Purnia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Purnia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Purnia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Purnia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Purnia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Purnia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Purnia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Purnia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Purnia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Purnia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Purnia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Purnia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Purnia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Purnia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Purnia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Purnia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Purnia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Purnia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Purnia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Purnia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Purnia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Purnia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Purnia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Purnia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Purnia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Purnia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Purnia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Purnia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Purnia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Purnia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Purnia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Purnia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Purnia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Purnia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Purnia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Purnia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Purnia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Purnia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Purnia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Purnia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Purnia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Purnia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Purnia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Purnia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Purnia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Purnia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Purnia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Purnia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Purnia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Rohtas,1.1,Total number of pregnant women Registered for ANC,TOTAL,6014.0,5816.0,6156.0,6611.0,6176.0,6181.0,5211.0,5487.0,5137.0,4705.0,5667.0,6354.0,69515.0
Rohtas,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2340.0,2082.0,2675.0,3071.0,3541.0,3624.0,3191.0,3159.0,3078.0,2823.0,3474.0,4078.0,37136.0
Rohtas,1.2,Number of Pregnant women registered under JSY,TOTAL,6014.0,5816.0,6156.0,6611.0,6176.0,6181.0,5211.0,5487.0,5137.0,4705.0,5667.0,6354.0,69515.0
Rohtas,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4902.0,4636.0,4915.0,5327.0,5445.0,5889.0,5485.0,5140.0,4873.0,4017.0,4419.0,5000.0,60048.0
Rohtas,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3966.0,4037.0,4184.0,4713.0,4463.0,4557.0,3972.0,3849.0,3602.0,3285.0,3932.0,4145.0,48705.0
Rohtas,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5096.0,5318.0,5521.0,5902.0,6263.0,5909.0,5258.0,5143.0,5074.0,4422.0,4791.0,5929.0,64626.0
Rohtas,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1823.0,1636.0,1647.0,1461.0,1248.0,1377.0,1487.0,1047.0,1628.0,1647.0,846.0,1821.0,17668.0
Rohtas,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,134.0,34.0,56.0,78.0,2.0,6.0,24.0,92.0,107.0,114.0,81.0,85.0,813.0
Rohtas,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,490.0,520.0,607.0,583.0,527.0,401.0,459.0,386.0,515.0,343.0,353.0,855.0,6039.0
Rohtas,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,2.0,0.0,4.0,5.0,0.0,0.0,2.0,0.0,1.0,14.0
Rohtas,1.8,Number of pregnancy test kits used at SC level,TOTAL,228.0,343.0,356.0,345.0,292.0,263.0,200.0,129.0,157.0,180.0,80.0,53.0,2626.0
Rohtas,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,34.0,42.0,32.0,54.0,65.0,44.0,49.0,74.0,46.0,21.0,60.0,62.0,583.0
Rohtas,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,350.0,315.0,321.0,345.0,417.0,444.0,396.0,461.0,427.0,353.0,411.0,406.0,4646.0
Rohtas,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,384.0,357.0,353.0,399.0,482.0,488.0,445.0,535.0,473.0,374.0,471.0,468.0,5229.0
Rohtas,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,188.0,151.0,200.0,221.0,242.0,249.0,263.0,276.0,267.0,183.0,268.0,249.0,2757.0
Rohtas,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0
Rohtas,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1981.0,1916.0,1878.0,2265.0,2768.0,3015.0,3253.0,2989.0,2782.0,2367.0,1963.0,1558.0,28735.0
Rohtas,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1954.0,1894.0,1868.0,2251.0,2826.0,2998.0,3237.0,2975.0,2777.0,2365.0,1887.0,1415.0,28447.0
Rohtas,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,743.0,1107.0,236.0,681.0,1950.0,1403.0,247.0,1205.0,2936.0,1976.0,2657.0,1709.0,16850.0
Rohtas,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,582.0,701.0,375.0,1769.0,1602.0,1226.0,149.0,1234.0,2535.0,1810.0,2288.0,1794.0,16065.0
Rohtas,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Rohtas,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Rohtas,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Rohtas,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Rohtas,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0
Rohtas,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rohtas,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0
Rohtas,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Rohtas,4.1.1.a,Number of male live births,TOTAL,1196.0,1159.0,1105.0,1347.0,1695.0,1770.0,1897.0,1820.0,1669.0,1416.0,1285.0,1032.0,17391.0
Rohtas,4.1.1.b,Number of female live births,TOTAL,1125.0,1095.0,1092.0,1298.0,1590.0,1697.0,1756.0,1679.0,1553.0,1295.0,1124.0,957.0,16261.0
Rohtas,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2321.0,2254.0,2197.0,2645.0,3285.0,3467.0,3653.0,3499.0,3222.0,2711.0,2409.0,1989.0,33652.0
Rohtas,4.1.2,Number of still births,TOTAL,43.0,28.0,41.0,36.0,67.0,57.0,60.0,47.0,44.0,48.0,38.0,26.0,535.0
Rohtas,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,5.0
Rohtas,4.2.1,Number of Newborns weighed at birth,TOTAL,2290.0,2213.0,2154.0,2601.0,3217.0,3403.0,3611.0,3441.0,3201.0,2668.0,2323.0,1882.0,33004.0
Rohtas,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,148.0,135.0,122.0,175.0,252.0,270.0,259.0,207.0,158.0,129.0,188.0,95.0,2138.0
Rohtas,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2272.0,2172.0,2135.0,2615.0,3235.0,3395.0,3197.0,3411.0,3196.0,2662.0,2319.0,1875.0,32484.0
Rohtas,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,2.0,3.0,2.0,3.0,0.0,2.0,1.0,1.0,0.0,1.0,1.0,17.0
Rohtas,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,5.0,6.0,16.0,25.0,3.0,0.0,3.0,3.0,5.0,3.0,0.0,69.0
Rohtas,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rohtas,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1.0,7.0,9.0,18.0,28.0,3.0,2.0,4.0,4.0,5.0,4.0,1.0,86.0
Rohtas,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Rohtas,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1.0,2.0,3.0,2.0,3.0,2.0,5.0,3.0,3.0,3.0,1.0,1.0,29.0
Rohtas,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,3.0,2.0,4.0,125.0,1.0,5.0,1.0,1.0,1.0,1.0,0.0,144.0
Rohtas,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2021.0,1701.0,1544.0,2329.0,2455.0,3233.0,2966.0,3327.0,3166.0,2611.0,2092.0,1591.0,29036.0
Rohtas,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1694.0,1689.0,1584.0,2060.0,1996.0,2209.0,2051.0,1991.0,2022.0,2201.0,1765.0,1449.0,22711.0
Rohtas,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,2.0,8.0
Rohtas,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,110.0,121.0,155.0,238.0,263.0,260.0,332.0,396.0,226.0,193.0,9.0,241.0,2544.0
Rohtas,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,435.0,425.0,637.0,567.0,552.0,492.0,424.0,546.0,432.0,234.0,145.0,365.0,5254.0
Rohtas,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,545.0,546.0,792.0,805.0,815.0,752.0,756.0,942.0,658.0,427.0,154.0,606.0,7798.0
Rohtas,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,3.0,2.0,0.0,6.0,2.0,5.0,54.0,12.0,10.0,8.0,10.0,8.0,120.0
Rohtas,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,1.0,2.0,0.0,2.0,0.0,1.0,0.0,2.0,0.0,1.0,10.0
Rohtas,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,2.0,2.0,0.0,0.0,0.0,8.0,0.0,10.0,5.0,5.0,32.0
Rohtas,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rohtas,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,2.0,3.0,10.0,2.0,7.0,54.0,21.0,10.0,20.0,15.0,14.0,162.0
Rohtas,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Rohtas,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rohtas,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Rohtas,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,68.0,22.0,26.0,118.0,135.0,261.0,213.0,422.0,416.0,634.0,555.0,444.0,3314.0
Rohtas,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,15.0,2.0,9.0,23.0,2.0,39.0,37.0,105.0,145.0,84.0,159.0,78.0,698.0
Rohtas,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,81.0,17.0,31.0,82.0,86.0,133.0,68.0,233.0,277.0,298.0,419.0,351.0,2076.0
Rohtas,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rohtas,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,164.0,41.0,66.0,223.0,223.0,433.0,318.0,760.0,838.0,1016.0,1133.0,873.0,6088.0
Rohtas,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,71.0,101.0,168.0,163.0,134.0,135.0,234.0,328.0,1579.0,2913.0
Rohtas,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,6.0
Rohtas,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,6.0
Rohtas,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rohtas,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,4.0,0.0,12.0
Rohtas,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Rohtas,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,578.0,518.0,769.0,1413.0,888.0,862.0,891.0,750.0,546.0,608.0,762.0,873.0,9458.0
Rohtas,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,224.0,215.0,328.0,951.0,308.0,325.0,263.0,198.0,145.0,152.0,213.0,219.0,3541.0
Rohtas,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,7.0,9.0,8.0,28.0,19.0,18.0,2.0,7.0,3.0,2.0,5.0,3.0,111.0
Rohtas,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,9.0,11.0,16.0,64.0,15.0,7.0,57.0,7.0,9.0,5.0,6.0,15.0,221.0
Rohtas,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rohtas,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,818.0,753.0,1121.0,2456.0,1230.0,1212.0,1213.0,962.0,703.0,767.0,986.0,1110.0,13331.0
Rohtas,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,5.0,12.0,30.0,27.0,19.0,29.0,22.0,13.0,25.0,10.0,22.0,41.0,255.0
Rohtas,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Rohtas,9.06,Number of IUCD removals,TOTAL,378.0,370.0,412.0,489.0,450.0,489.0,472.0,516.0,327.0,312.0,451.0,520.0,5186.0
Rohtas,9.07,Number of Oral Pills cycles distributed,TOTAL,701.0,537.0,669.0,1906.0,823.0,800.0,764.0,933.0,710.0,628.0,928.0,1399.0,10798.0
Rohtas,9.08,Number of Condom pieces distributed,TOTAL,2859.0,2098.0,2428.0,7635.0,4424.0,2841.0,2830.0,2121.0,1373.0,987.0,1712.0,1879.0,33187.0
Rohtas,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,10.0,0.0,16.0
Rohtas,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,8.0,0.0,17.0,60.0,78.0,61.0,161.0,282.0,667.0
Rohtas,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Rohtas,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Rohtas,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4220.0,4093.0,4203.0,4976.0,5670.0,6366.0,6231.0,6861.0,6117.0,5323.0,5178.0,4613.0,63851.0
Rohtas,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,5656.0,4981.0,5111.0,5273.0,5245.0,5936.0,5854.0,7118.0,6722.0,1529.0,236.0,33.0,53694.0
Rohtas,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,6209.0,5603.0,5048.0,5211.0,5356.0,5460.0,5341.0,5747.0,6450.0,6090.0,3047.0,1088.0,60650.0
Rohtas,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,6504.0,5706.0,5631.0,5496.0,5637.0,5591.0,5118.0,5497.0,5604.0,6110.0,5790.0,3483.0,66167.0
Rohtas,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,5358.0,6152.0,5977.0,17497.0
Rohtas,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3668.0,5719.0,9387.0
Rohtas,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,162.0,3167.0,3329.0
Rohtas,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2984.0,2763.0,2914.0,3639.0,4377.0,3485.0,2440.0,4334.0,3913.0,3405.0,3097.0,3486.0,40837.0
Rohtas,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,5666.0,4785.0,4924.0,5363.0,5005.0,4011.0,3119.0,7004.0,6583.0,5649.0,6322.0,6035.0,64466.0
Rohtas,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,6237.0,5444.0,4880.0,5242.0,5108.0,3722.0,2588.0,4902.0,6310.0,5904.0,6570.0,7025.0,63932.0
Rohtas,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6575.0,5524.0,5420.0,5585.0,5338.0,3803.0,2572.0,4764.0,5093.0,5468.0,6360.0,6762.0,63264.0
Rohtas,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2293.0,2072.0,2158.0,2508.0,3188.0,3049.0,3054.0,3116.0,3026.0,2485.0,1883.0,1675.0,30507.0
Rohtas,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,5578.0,5069.0,5217.0,5293.0,5214.0,5898.0,5923.0,7008.0,6599.0,1683.0,426.0,150.0,54058.0
Rohtas,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,6176.0,5741.0,5239.0,5363.0,5429.0,5427.0,5842.0,5936.0,6382.0,5985.0,3150.0,1258.0,61928.0
Rohtas,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,6583.0,6067.0,5929.0,5786.0,5775.0,5701.0,5084.0,5458.0,5556.0,6018.0,5628.0,3575.0,67160.0
Rohtas,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4840.0,4979.0,5401.0,6243.0,6336.0,6385.0,4855.0,6172.0,4061.0,4452.0,4786.0,4435.0,62945.0
Rohtas,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4648.0,4382.0,3476.0,4253.0,3838.0,3666.0,2543.0,3459.0,2927.0,3449.0,4053.0,3752.0,44446.0
Rohtas,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,5.0
Rohtas,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2509.0,2515.0,2870.0,3287.0,3338.0,3402.0,2625.0,3131.0,2130.0,2313.0,2486.0,2304.0,32910.0
Rohtas,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2106.0,2154.0,2413.0,2884.0,3017.0,2983.0,2220.0,2793.0,1799.0,2041.0,2161.0,1989.0,28560.0
Rohtas,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4615.0,4669.0,5283.0,6171.0,6355.0,6385.0,4845.0,5924.0,3929.0,4354.0,4647.0,4293.0,61470.0
Rohtas,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5573.0,4928.0,4278.0,4779.0,4209.0,3967.0,3278.0,3837.0,3752.0,3837.0,4549.0,4929.0,51916.0
Rohtas,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5535.0,4844.0,4200.0,4773.0,4065.0,2728.0,1943.0,3386.0,3695.0,3604.0,4688.0,4968.0,48429.0
Rohtas,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,53.0,0.0,3.0,4.0,0.0,0.0,60.0
Rohtas,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,317.0,355.0,275.0,178.0,156.0,133.0,128.0,210.0,162.0,194.0,347.0,270.0,2725.0
Rohtas,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,178.0,326.0,264.0,129.0,134.0,116.0,99.0,173.0,139.0,161.0,323.0,248.0,2290.0
Rohtas,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,495.0,681.0,539.0,307.0,290.0,249.0,227.0,383.0,301.0,355.0,670.0,518.0,5015.0
Rohtas,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,251.0,251.0,227.0,264.0,245.0,333.0,280.0,246.0,276.0,208.0,308.0,311.0,3200.0
Rohtas,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,917.0,1138.0,1147.0,1243.0,1305.0,1281.0,1326.0,1326.0,1161.0,945.0,1022.0,1172.0,13983.0
Rohtas,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1385.0,1510.0,1584.0,1901.0,1905.0,1875.0,1583.0,1640.0,1556.0,1215.0,1463.0,1520.0,19137.0
Rohtas,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,2.0,6.0
Rohtas,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,2.0,0.0,0.0,2.0,2.0,0.0,0.0,5.0,4.0,0.0,5.0,20.0
Rohtas,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2927.0,2879.0,2855.0,2907.0,2895.0,2820.0,2822.0,2800.0,2845.0,2609.0,2829.0,2812.0,34000.0
Rohtas,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2931.0,2868.0,2825.0,2896.0,2894.0,2819.0,2822.0,2779.0,2815.0,2606.0,2775.0,2820.0,33850.0
Rohtas,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2544.0,2537.0,2473.0,2501.0,2481.0,2354.0,2462.0,2381.0,2450.0,2315.0,2374.0,2439.0,29311.0
Rohtas,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Rohtas,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4079.0,4200.0,4415.0,5496.0,5399.0,5503.0,4073.0,5185.0,3294.0,3572.0,3921.0,3678.0,52815.0
Rohtas,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2182.0,1859.0,1571.0,1887.0,1685.0,1279.0,926.0,1244.0,1174.0,1190.0,1401.0,1396.0,17794.0
Rohtas,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,27.0,18.0,51.0,91.0,56.0,64.0,22.0,40.0,44.0,27.0,46.0,52.0,538.0
Rohtas,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,11.0
Rohtas,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,264.0,52.0,285.0,183.0,72.0,2.0,0.0,0.0,23.0,1.0,3.0,27.0,912.0
Rohtas,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,2.0,4.0,3.0,4.0,0.0,0.0,2.0,10.0,1.0,8.0,2.0,36.0
Rohtas,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Rohtas,13.1,Number of Patients operated for cataract,TOTAL,14.0,0.0,0.0,0.0,6.0,0.0,2.0,0.0,0.0,0.0,0.0,77.0,99.0
Rohtas,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,14.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,148.0,166.0
Rohtas,13.3,Number of School children detected with Refractive errors,TOTAL,5.0,8.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,500.0,532.0
Rohtas,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Rohtas,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Rohtas,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1941.0,1897.0,1902.0,1977.0,1933.0,1993.0,1906.0,1897.0,1814.0,1845.0,1879.0,1889.0,-1.0
Rohtas,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Rohtas,14.05,Number of RKS meetings held during the month,TOTAL,21.0,22.0,24.0,17.0,26.0,24.0,17.0,16.0,21.0,18.0,16.0,24.0,246.0
Rohtas,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Rohtas,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,39.0,2.0,23.0,66.0,2.0,52.0,44.0,28.0,44.0,11.0,25.0,97.0,433.0
Rohtas,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Rohtas,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,4.0,1.0,2.0,3.0,2.0,,,,,,,-1.0
Rohtas,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1056.0,1216.0,1388.0,1604.0,1609.0,1393.0,1915.0,1589.0,1307.0,1201.0,1081.0,1046.0,16405.0
Rohtas,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2164.0,1695.0,1973.0,2179.0,2205.0,2006.0,2609.0,2190.0,2239.0,1557.0,1844.0,1678.0,24339.0
Rohtas,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1011.0,846.0,935.0,1167.0,1521.0,1467.0,1642.0,1357.0,1189.0,1126.0,1318.0,887.0,14466.0
Rohtas,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3283.0,3186.0,3371.0,4342.0,4434.0,4957.0,5510.0,5503.0,4241.0,4386.0,3395.0,3978.0,50586.0
Rohtas,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2067.0,2062.0,2323.0,2771.0,3130.0,2860.0,3557.0,2946.0,2496.0,2327.0,2399.0,1933.0,30871.0
Rohtas,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5447.0,4881.0,5344.0,6521.0,6639.0,6963.0,8119.0,7693.0,6480.0,5943.0,5239.0,5656.0,74925.0
Rohtas,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0,1.0,1.0,1.0,2.0,10.0
Rohtas,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,3.0
Rohtas,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,5.0,1.0,1.0,2.0,3.0,13.0
Rohtas,14.11,In-Patient Head Count at midnight,TOTAL,5098.0,4434.0,5195.0,6876.0,6662.0,7580.0,8912.0,8764.0,6968.0,6363.0,6787.0,6340.0,79979.0
Rohtas,14.12.1,OPD attendance (All),TOTAL,180950.0,174731.0,188012.0,229076.0,224446.0,234229.0,197301.0,193818.0,164005.0,150371.0,165507.0,169747.0,2272193.0
Rohtas,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,173.0,48.0,59.0,185.0,239.0,436.0,327.0,719.0,1246.0,1050.0,1140.0,853.0,6475.0
Rohtas,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,56.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,56.0
Rohtas,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3676.0,3637.0,3919.0,3740.0,4154.0,4161.0,3866.0,3745.0,3459.0,3542.0,3180.0,3732.0,44811.0
Rohtas,14.14.a,Number of patients given AYUSH treatment,TOTAL,42191.0,42112.0,42373.0,48806.0,52888.0,50436.0,40522.0,37423.0,22699.0,28582.0,28019.0,30260.0,466311.0
Rohtas,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,912.0,821.0,1027.0,1123.0,1231.0,1222.0,658.0,1535.0,1401.0,1180.0,1401.0,1416.0,13927.0
Rohtas,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2431.0,2328.0,2817.0,2762.0,3062.0,2672.0,2056.0,2590.0,2369.0,2569.0,2685.0,2418.0,30759.0
Rohtas,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,37.0,29.0,76.0,45.0,48.0,59.0,29.0,55.0,20.0,37.0,40.0,60.0,535.0
Rohtas,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,579.0,606.0,551.0,728.0,454.0,399.0,335.0,386.0,391.0,293.0,341.0,354.0,5417.0
Rohtas,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,9.0,5.0,5.0,6.0,8.0,6.0,5.0,1.0,1.0,0.0,0.0,5.0,51.0
Rohtas,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,354.0,176.0,159.0,275.0,209.0,195.0,184.0,285.0,271.0,231.0,306.0,445.0,3090.0
Rohtas,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,3.0,4.0,4.0,3.0,2.0,4.0,1.0,4.0,0.0,1.0,4.0,34.0
Rohtas,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,556.0,554.0,656.0,740.0,619.0,564.0,379.0,476.0,368.0,291.0,392.0,571.0,6166.0
Rohtas,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,4.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,6.0
Rohtas,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1489.0,1336.0,1366.0,1743.0,1282.0,1158.0,898.0,1147.0,1030.0,815.0,1039.0,1370.0,14673.0
Rohtas,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,13.0,9.0,13.0,10.0,11.0,8.0,10.0,2.0,5.0,0.0,1.0,9.0,91.0
Rohtas,15.2,Number of Widal tests conducted,Number tested,0.0,1.0,0.0,22.0,0.0,0.0,12.0,5.0,6.0,4.0,18.0,110.0,178.0
Rohtas,15.3.a,Number of VDRL tests conducted on males,Number tested,18.0,13.0,21.0,8.0,8.0,3.0,2.0,10.0,1.0,10.0,11.0,6.0,111.0
Rohtas,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,112.0,15.0,58.0,36.0,30.0,10.0,3.0,6.0,1.0,2.0,4.0,5.0,282.0
Rohtas,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,251.0,251.0,549.0,421.0,308.0,190.0,240.0,282.0,229.0,106.0,150.0,7.0,2984.0
Rohtas,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,381.0,279.0,628.0,465.0,346.0,203.0,245.0,298.0,231.0,118.0,165.0,18.0,3377.0
Rohtas,15.4.1,Number of blood smears examined for Malaria,TOTAL,693.0,483.0,873.0,1250.0,1291.0,1294.0,809.0,661.0,379.0,590.0,561.0,623.0,9507.0
Rohtas,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,4.0,9.0,8.0,29.0,35.0,51.0,8.0,72.0,2.0,0.0,0.0,4.0,222.0
Rohtas,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,0.0,0.0,23.0,20.0,2.0,1.0,4.0,1.0,1.0,0.0,1.0,54.0
Rohtas,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1175.0,1175.0,1825.0,1625.0,775.0,3675.0,1275.0,4025.0,1900.0,,1150.0,1550.0,20150.0
Rohtas,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3000.0,3000.0,2000.0,1500.0,5000.0,0.0,5000.0,0.0,1500.0,,1400.0,1000.0,23400.0
Rohtas,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,0.0,2200.0,2350.0,2000.0,2400.0,2250.0,2125.0,1450.0,,1000.0,1000.0,16775.0
Rohtas,16.1.1,Stock position of DPT vaccines,5. Total Stock,4175.0,4175.0,1625.0,775.0,3775.0,1275.0,4025.0,1900.0,1950.0,0.0,1550.0,1550.0,26775.0
Rohtas,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,450.0,1350.0,1800.0
Rohtas,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2100.0,1800.0,3900.0
Rohtas,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,1200.0,1600.0,2800.0
Rohtas,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1350.0,1550.0,2900.0
Rohtas,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,0.0,125.0,200.0,0.0,0.0,0.0,150.0,,575.0,1125.0,2175.0
Rohtas,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,2000.0,2500.0,1200.0,775.0,1300.0,1300.0,1300.0,,2000.0,1650.0,14025.0
Rohtas,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,1875.0,2425.0,1400.0,775.0,1300.0,1150.0,1450.0,,1450.0,1800.0,13625.0
Rohtas,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,125.0,200.0,0.0,0.0,0.0,150.0,0.0,0.0,1125.0,975.0,2575.0
Rohtas,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,985.0,985.0,1500.0,1500.0,1250.0,1000.0,1160.0,2860.0,1050.0,,1050.0,1500.0,14840.0
Rohtas,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,2000.0,2000.0,1500.0,1500.0,2000.0,3000.0,0.0,1500.0,,1000.0,1000.0,17500.0
Rohtas,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1485.0,1485.0,2000.0,1750.0,1750.0,1840.0,1300.0,1810.0,800.0,,550.0,1050.0,15820.0
Rohtas,16.1.3,Stock position of TT vaccines,5. Total Stock,1500.0,1500.0,1500.0,1250.0,1000.0,1160.0,2860.0,1050.0,1750.0,0.0,1500.0,1450.0,16520.0
Rohtas,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,630.0,630.0,1280.0,1830.0,1080.0,1580.0,1410.0,1460.0,1400.0,,1400.0,1200.0,13900.0
Rohtas,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,2000.0,1500.0,1000.0,1800.0,1300.0,1450.0,0.0,1000.0,,900.0,2000.0,14950.0
Rohtas,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1350.0,1350.0,950.0,1750.0,1300.0,1470.0,1400.0,1500.0,1300.0,,1100.0,1200.0,14670.0
Rohtas,16.1.5,Stock position of BCG vaccines,5. Total Stock,1280.0,1280.0,1830.0,1080.0,1580.0,1410.0,1460.0,-40.0,1100.0,0.0,1200.0,2000.0,14180.0
Rohtas,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1875.0,1875.0,1725.0,975.0,85.0,485.0,100.0,20.0,150.0,,150.0,800.0,8240.0
Rohtas,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,3000.0,2000.0,2000.0,3000.0,2300.0,2000.0,2100.0,2000.0,,2900.0,2500.0,26800.0
Rohtas,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3150.0,3150.0,2750.0,2890.0,2600.0,2685.0,2080.0,1970.0,2050.0,,2250.0,2700.0,28275.0
Rohtas,16.1.6,Stock position of Measles vaccines,5. Total Stock,1725.0,1725.0,975.0,85.0,485.0,100.0,20.0,150.0,100.0,0.0,800.0,600.0,6765.0
Rohtas,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,,680.0,430.0,1430.0,1260.0,2060.0,1850.0,,1450.0,1750.0,10910.0
Rohtas,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3770.0,3770.0,2000.0,2500.0,3000.0,2000.0,2500.0,2000.0,1000.0,,1200.0,0.0,23740.0
Rohtas,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3160.0,3160.0,1930.0,2750.0,2000.0,2170.0,1700.0,2210.0,1400.0,,900.0,775.0,22155.0
Rohtas,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,610.0,610.0,70.0,430.0,1430.0,1260.0,2060.0,1850.0,1450.0,0.0,1750.0,975.0,12495.0
Rohtas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Rohtas,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Rohtas,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Rohtas,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Rohtas,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rohtas,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2400.0,2400.0,0.0,6600.0,3100.0,6200.0,10000.0,4700.0,10100.0,,0.0,600.0,46100.0
Rohtas,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,15000.0,15000.0,15000.0,0.0,10000.0,10000.0,0.0,10000.0,0.0,,7000.0,0.0,82000.0
Rohtas,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2400.0,2400.0,8400.0,3500.0,6900.0,6200.0,5300.0,4600.0,7700.0,,6400.0,600.0,54400.0
Rohtas,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,15000.0,15000.0,6600.0,3100.0,6200.0,10000.0,4700.0,10100.0,2400.0,0.0,600.0,0.0,73700.0
Rohtas,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,18000.0,18000.0,0.0,16000.0,0.0,22200.0,120400.0,24800.0,120000.0,,2400.0,30000.0,371800.0
Rohtas,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000.0,100000.0,100000.0,0.0,120000.0,120000.0,0.0,12000.0,0.0,,120000.0,0.0,672000.0
Rohtas,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,18000.0,18000.0,84000.0,16000.0,97800.0,29000.0,95600.0,4600.0,84000.0,,92400.0,24000.0,563400.0
Rohtas,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,100000.0,100000.0,16000.0,0.0,22200.0,113200.0,24800.0,32200.0,36000.0,0.0,30000.0,6000.0,480400.0
Rohtas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,1600.0,200.0,1000.0,5000.0,900.0,5500.0,,0.0,500.0,14700.0
Rohtas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,8000.0,8000.0,8000.0,0.0,4500.0,5000.0,0.0,5500.0,0.0,,5000.0,0.0,44000.0
Rohtas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Rohtas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,6400.0,1400.0,3700.0,1200.0,4100.0,900.0,4000.0,,4500.0,500.0,26700.0
Rohtas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,8000.0,8000.0,1600.0,200.0,1000.0,4800.0,900.0,5500.0,1500.0,0.0,500.0,0.0,32000.0
Rohtas,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Rohtas,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rohtas,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rohtas,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Rohtas,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rohtas,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rohtas,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Rohtas,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rohtas,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rohtas,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Rohtas,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rohtas,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rohtas,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Rohtas,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rohtas,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rohtas,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Rohtas,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rohtas,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rohtas,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Rohtas,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rohtas,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rohtas,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Rohtas,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rohtas,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rohtas,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Rohtas,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Rohtas,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Rohtas,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Rohtas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Rohtas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Rohtas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Rohtas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Rohtas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Rohtas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Rohtas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Rohtas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Rohtas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Rohtas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Rohtas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Rohtas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Rohtas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Rohtas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Rohtas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Rohtas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Rohtas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Rohtas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Rohtas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Rohtas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Rohtas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Rohtas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Rohtas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Rohtas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Rohtas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Rohtas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Rohtas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Rohtas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Rohtas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Saharsa,1.1,Total number of pregnant women Registered for ANC,TOTAL,6743.0,6840.0,5860.0,5852.0,5680.0,6042.0,5040.0,4810.0,4527.0,4530.0,4931.0,5291.0,66146.0
Saharsa,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2991.0,2874.0,2564.0,2851.0,2343.0,2347.0,2124.0,1898.0,2069.0,2007.0,2404.0,2414.0,28886.0
Saharsa,1.2,Number of Pregnant women registered under JSY,TOTAL,6082.0,6235.0,5329.0,5237.0,5102.0,5480.0,4473.0,4356.0,4527.0,4530.0,4931.0,5285.0,61567.0
Saharsa,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2762.0,2924.0,2810.0,3187.0,2639.0,2665.0,2235.0,2396.0,2098.0,1921.0,2124.0,2229.0,29990.0
Saharsa,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3319.0,3588.0,2894.0,2594.0,2436.0,2539.0,1994.0,1977.0,1865.0,1854.0,2246.0,2397.0,29703.0
Saharsa,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5126.0,5393.0,4766.0,4713.0,4380.0,4476.0,3791.0,3386.0,3213.0,3036.0,3349.0,3872.0,49501.0
Saharsa,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3136.0,3536.0,2569.0,2457.0,2133.0,1883.0,1764.0,2284.0,1785.0,2169.0,2248.0,2890.0,28854.0
Saharsa,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,354.0,287.0,77.0,59.0,74.0,86.0,101.0,103.0,62.0,168.0,175.0,126.0,1672.0
Saharsa,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,39.0,33.0,24.0,7.0,32.0,7.0,8.0,8.0,7.0,9.0,11.0,10.0,195.0
Saharsa,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,164.0,206.0,178.0,188.0,187.0,157.0,207.0,100.0,186.0,455.0,690.0,603.0,3321.0
Saharsa,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,20.0,17.0,21.0,19.0,17.0,16.0,12.0,8.0,16.0,23.0,26.0,32.0,227.0
Saharsa,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,2.0,0.0,63.0,0.0,0.0,16.0,0.0,0.0,0.0,9.0,38.0,128.0
Saharsa,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,67.0,53.0,37.0,29.0,55.0,70.0,95.0,82.0,46.0,51.0,37.0,37.0,659.0
Saharsa,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,309.0,298.0,276.0,223.0,204.0,317.0,322.0,431.0,387.0,324.0,338.0,265.0,3694.0
Saharsa,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,376.0,351.0,313.0,252.0,259.0,387.0,417.0,513.0,433.0,375.0,375.0,302.0,4353.0
Saharsa,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,268.0,241.0,214.0,202.0,173.0,212.0,290.0,389.0,340.0,255.0,245.0,196.0,3025.0
Saharsa,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,7.0,2.0,0.0,0.0,1.0,0.0,0.0,10.0
Saharsa,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2653.0,2676.0,2073.0,2961.0,3954.0,4342.0,4870.0,4129.0,3537.0,2526.0,2677.0,1883.0,38281.0
Saharsa,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1702.0,1735.0,1307.0,1828.0,2603.0,2835.0,3170.0,2741.0,2343.0,1947.0,1654.0,1066.0,24931.0
Saharsa,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,234.0,184.0,586.0,791.0,495.0,1557.0,1087.0,2508.0,625.0,1803.0,4743.0,2072.0,16685.0
Saharsa,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,350.0,0.0,30.0,609.0,420.0,1473.0,107.0,1012.0,836.0,318.0,5427.0,2179.0,12761.0
Saharsa,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,0.0,0.0,,,0.0,,,,0.0,,0.0,0.0
Saharsa,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,0.0,,,0.0,,,,,,0.0,0.0
Saharsa,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,0.0,,,0.0,,,,,,0.0,0.0
Saharsa,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,0.0,,,0.0,,,,,,0.0,0.0
Saharsa,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Saharsa,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,67.0,58.0,56.0,60.0,42.0,53.0,62.0,44.0,47.0,56.0,0.0,40.0,585.0
Saharsa,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saharsa,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,67.0,58.0,56.0,60.0,42.0,53.0,62.0,44.0,47.0,56.0,0.0,40.0,585.0
Saharsa,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,0.0,0.0,,,0.0,,,,,,0.0,0.0
Saharsa,4.1.1.a,Number of male live births,TOTAL,1581.0,1589.0,1220.0,1589.0,2101.0,2394.0,2615.0,2318.0,1936.0,1422.0,1469.0,1070.0,21304.0
Saharsa,4.1.1.b,Number of female live births,TOTAL,1437.0,1433.0,1134.0,1603.0,2047.0,2264.0,2634.0,2240.0,1978.0,1397.0,1539.0,1071.0,20777.0
Saharsa,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3018.0,3022.0,2354.0,3192.0,4148.0,4658.0,5249.0,4558.0,3914.0,2819.0,3008.0,2141.0,42081.0
Saharsa,4.1.2,Number of still births,TOTAL,51.0,92.0,49.0,73.0,79.0,83.0,99.0,96.0,73.0,42.0,50.0,41.0,828.0
Saharsa,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,17.0,12.0,18.0,21.0,5.0,7.0,6.0,12.0,11.0,9.0,9.0,12.0,139.0
Saharsa,4.2.1,Number of Newborns weighed at birth,TOTAL,2947.0,2920.0,2205.0,3100.0,4126.0,4514.0,5013.0,4418.0,3564.0,2742.0,2873.0,2130.0,40552.0
Saharsa,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,261.0,220.0,225.0,180.0,263.0,269.0,306.0,284.0,408.0,122.0,136.0,141.0,2815.0
Saharsa,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2946.0,2906.0,2212.0,3100.0,4095.0,4556.0,5095.0,4356.0,3814.0,2728.0,2907.0,2084.0,40799.0
Saharsa,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,44.0,15.0,18.0,27.0,16.0,35.0,27.0,22.0,23.0,57.0,60.0,48.0,392.0
Saharsa,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Saharsa,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,102.0,9.0,7.0,6.0,11.0,10.0,9.0,4.0,8.0,7.0,6.0,7.0,186.0
Saharsa,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saharsa,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,146.0,24.0,25.0,33.0,27.0,45.0,36.0,26.0,31.0,64.0,66.0,55.0,578.0
Saharsa,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,0.0,0.0,,,0.0,,,,0.0,,0.0,0.0
Saharsa,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,201.0,256.0,361.0,356.0,684.0,444.0,648.0,216.0,259.0,253.0,181.0,164.0,4023.0
Saharsa,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,21.0,22.0,16.0,12.0,29.0,30.0,26.0,30.0,32.0,26.0,26.0,26.0,296.0
Saharsa,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,545.0,623.0,556.0,610.0,845.0,1117.0,1295.0,1055.0,773.0,652.0,529.0,454.0,9054.0
Saharsa,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,9.0,13.0,9.0,19.0,16.0,16.0,14.0,12.0,16.0,12.0,19.0,16.0,171.0
Saharsa,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2334.0,2043.0,1771.0,2154.0,3355.0,3735.0,4192.0,2084.0,3114.0,2146.0,2608.0,1895.0,31431.0
Saharsa,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,921.0,1248.0,1163.0,1115.0,1097.0,1092.0,1554.0,1672.0,1438.0,933.0,1607.0,1006.0,14846.0
Saharsa,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,748.0,0.0,0.0,0.0,0.0,748.0
Saharsa,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,16.0,12.0,10.0,18.0,5.0,7.0,5.0,10.0,11.0,8.0,9.0,11.0,122.0
Saharsa,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Saharsa,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,16.0,12.0,10.0,18.0,5.0,7.0,5.0,12.0,11.0,8.0,9.0,11.0,124.0
Saharsa,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,204.0,404.0,204.0,203.0,441.0,460.0,463.0,103.0,308.0,374.0,2.0,67.0,3233.0
Saharsa,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,251.0,408.0,104.0,305.0,108.0,102.0,119.0,205.0,310.0,413.0,3.0,27.0,2355.0
Saharsa,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,455.0,812.0,308.0,508.0,549.0,562.0,582.0,308.0,618.0,787.0,5.0,94.0,5588.0
Saharsa,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Saharsa,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,4.0,2.0,1.0,0.0,9.0
Saharsa,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Saharsa,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,1.0,1.0,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.0
Saharsa,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saharsa,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,1.0,2.0,1.0,0.0,0.0,0.0,4.0,2.0,1.0,1.0,13.0
Saharsa,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,0.0,0.0,,,0.0,,,,0.0,,1.0,1.0
Saharsa,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Saharsa,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saharsa,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,0.0,0.0,,,0.0,,,,,,,0.0
Saharsa,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,70.0,89.0,32.0,739.0,143.0,340.0,305.0,720.0,1736.0,904.0,1188.0,749.0,7015.0
Saharsa,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Saharsa,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,58.0,40.0,25.0,26.0,,41.0,47.0,2.0,127.0,100.0,156.0,110.0,732.0
Saharsa,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saharsa,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,128.0,129.0,57.0,765.0,143.0,381.0,352.0,722.0,1863.0,1004.0,1344.0,859.0,7747.0
Saharsa,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,32.0,32.0,,,85.0,,,,1000.0,174.0,111.0,1434.0
Saharsa,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,16.0,17.0,32.0,15.0,86.0
Saharsa,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Saharsa,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,16.0,19.0,12.0,14.0,14.0,75.0
Saharsa,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saharsa,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,6.0,0.0,0.0,0.0,0.0,16.0,35.0,29.0,46.0,29.0,161.0
Saharsa,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,0.0,0.0,,,0.0,,,,,,,0.0
Saharsa,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,148.0,125.0,87.0,135.0,129.0,114.0,97.0,116.0,138.0,133.0,66.0,70.0,1358.0
Saharsa,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,69.0,48.0,89.0,75.0,54.0,53.0,82.0,54.0,81.0,26.0,55.0,27.0,713.0
Saharsa,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Saharsa,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,189.0,138.0,78.0,105.0,,162.0,120.0,74.0,84.0,131.0,131.0,66.0,1278.0
Saharsa,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saharsa,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,406.0,311.0,254.0,315.0,183.0,329.0,299.0,244.0,303.0,290.0,252.0,163.0,3349.0
Saharsa,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,9.0,114.0,69.0,107.0,29.0,160.0,177.0,98.0,123.0,182.0,138.0,85.0,1291.0
Saharsa,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,6.0,,,5.0,3.0,,,,8.0,15.0,6.0,43.0
Saharsa,9.06,Number of IUCD removals,TOTAL,108.0,92.0,88.0,97.0,83.0,80.0,50.0,79.0,69.0,61.0,63.0,42.0,912.0
Saharsa,9.07,Number of Oral Pills cycles distributed,TOTAL,413.0,389.0,300.0,432.0,236.0,368.0,531.0,218.0,425.0,325.0,620.0,190.0,4447.0
Saharsa,9.08,Number of Condom pieces distributed,TOTAL,4366.0,4497.0,3164.0,4825.0,3145.0,3939.0,2172.0,1468.0,1520.0,2220.0,1068.0,1112.0,33496.0
Saharsa,9.09,Number of Centchroman (weekly) pills given,TOTAL,227.0,10.0,0.0,27.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,1.0,269.0
Saharsa,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,6.0,0.0,0.0,3.0,5.0,7.0,21.0,34.0,7.0,10.0,93.0
Saharsa,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Saharsa,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4158.0,4137.0,3292.0,3903.0,3712.0,5864.0,6532.0,6696.0,4962.0,4538.0,4489.0,2981.0,55264.0
Saharsa,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4458.0,3962.0,3260.0,3340.0,2874.0,4038.0,4689.0,6291.0,6513.0,917.0,174.0,7.0,40523.0
Saharsa,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,5427.0,4564.0,3406.0,3469.0,3275.0,3596.0,3674.0,4559.0,5453.0,5736.0,2484.0,1140.0,46783.0
Saharsa,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,5487.0,5289.0,3630.0,3764.0,3437.0,3706.0,3372.0,3650.0,4108.0,4734.0,4590.0,3664.0,49431.0
Saharsa,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,4666.0,4697.0,4229.0,13600.0
Saharsa,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,12.0,0.0,0.0,0.0,16.0,0.0,4.0,0.0,7.0,2544.0,4122.0,6705.0
Saharsa,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,12.0,0.0,3.0,0.0,3.0,16.0,1530.0,1564.0
Saharsa,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3099.0,3069.0,2334.0,3161.0,3149.0,4910.0,5457.0,4595.0,4045.0,2840.0,2676.0,1982.0,41317.0
Saharsa,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4481.0,3923.0,3260.0,3356.0,2898.0,4060.0,4728.0,5337.0,6531.0,4454.0,3580.0,4321.0,50929.0
Saharsa,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5414.0,4544.0,3382.0,3476.0,3282.0,3531.0,3606.0,3786.0,5379.0,4926.0,3638.0,4839.0,49803.0
Saharsa,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5461.0,5290.0,3720.0,3758.0,3435.0,3737.0,3354.0,3100.0,3972.0,4046.0,3548.0,4558.0,47979.0
Saharsa,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2348.0,2285.0,1804.0,2605.0,2565.0,3735.0,4170.0,3674.0,3112.0,2349.0,2380.0,1602.0,32629.0
Saharsa,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4161.0,4009.0,3330.0,3364.0,2877.0,4044.0,4685.0,6277.0,6494.0,930.0,93.0,28.0,40292.0
Saharsa,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,5075.0,4621.0,3552.0,3552.0,3323.0,3563.0,3581.0,4574.0,5446.0,5648.0,2565.0,1083.0,46583.0
Saharsa,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,5064.0,5190.0,3847.0,3867.0,3505.0,3788.0,3400.0,3702.0,4108.0,4637.0,4513.0,3613.0,49234.0
Saharsa,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3480.0,3893.0,4201.0,4625.0,4344.0,4843.0,4461.0,4530.0,4109.0,3269.0,3205.0,2491.0,47451.0
Saharsa,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3703.0,3521.0,2932.0,2778.0,2116.0,2628.0,2338.0,2661.0,3152.0,3222.0,3491.0,3256.0,35798.0
Saharsa,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1718.0,1857.0,2176.0,2230.0,2251.0,2382.0,2262.0,2309.0,2059.0,1615.0,1593.0,1251.0,23703.0
Saharsa,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1498.0,1663.0,1809.0,2209.0,2046.0,2287.0,2055.0,1979.0,1783.0,1460.0,1417.0,1137.0,21343.0
Saharsa,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3216.0,3520.0,3985.0,4439.0,4297.0,4669.0,4317.0,4288.0,3842.0,3075.0,3010.0,2388.0,45046.0
Saharsa,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3809.0,3607.0,2860.0,2738.0,2222.0,2634.0,2410.0,2668.0,3209.0,3308.0,3849.0,3688.0,37002.0
Saharsa,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3764.0,3562.0,2853.0,2758.0,2215.0,2626.0,2428.0,2268.0,3092.0,2893.0,2917.0,3510.0,34886.0
Saharsa,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,6.0,0.0,14.0,0.0,0.0,0.0,6.0,0.0,26.0
Saharsa,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,343.0,532.0,460.0,433.0,367.0,413.0,344.0,414.0,508.0,478.0,503.0,580.0,5375.0
Saharsa,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,326.0,485.0,397.0,389.0,355.0,372.0,318.0,372.0,452.0,493.0,475.0,515.0,4949.0
Saharsa,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,669.0,1017.0,857.0,822.0,722.0,785.0,662.0,786.0,960.0,971.0,978.0,1095.0,10324.0
Saharsa,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,12.0,24.0,43.0,59.0,54.0,48.0,75.0,58.0,40.0,45.0,77.0,27.0,562.0
Saharsa,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,568.0,357.0,339.0,491.0,359.0,497.0,615.0,413.0,378.0,834.0,477.0,314.0,5642.0
Saharsa,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1056.0,676.0,665.0,1142.0,852.0,804.0,1487.0,942.0,995.0,2042.0,1253.0,907.0,12821.0
Saharsa,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,5.0,0.0,7.0
Saharsa,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Saharsa,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1957.0,1929.0,1681.0,1827.0,1813.0,1921.0,1872.0,1945.0,1941.0,1608.0,1878.0,1657.0,22029.0
Saharsa,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1969.0,1945.0,1603.0,1801.0,1669.0,1769.0,1705.0,1845.0,1890.0,1594.0,1772.0,1613.0,21175.0
Saharsa,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1469.0,1467.0,1309.0,1438.0,1419.0,1359.0,1317.0,1427.0,1460.0,1355.0,1441.0,1310.0,16771.0
Saharsa,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1359.0,1418.0,1158.0,15599.0,1283.0,2040.0,2108.0,2139.0,2798.0,1165.0,1514.0,1332.0,33913.0
Saharsa,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,76.0,66.0,46.0,172.0,63.0,125.0,96.0,108.0,174.0,153.0,127.0,45.0,1251.0
Saharsa,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,4.0,14.0,0.0,80.0,2.0,24.0,11.0,9.0,118.0,15.0,2.0,6.0,285.0
Saharsa,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,4.0
Saharsa,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Saharsa,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2064.0,2215.0,2197.0,1748.0,1929.0,1743.0,1613.0,1103.0,1170.0,1029.0,1158.0,1421.0,19390.0
Saharsa,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,8.0
Saharsa,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,690.0,588.0,142.0,455.0,327.0,394.0,122.0,106.0,172.0,503.0,63.0,208.0,3770.0
Saharsa,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,785.0,1.0,0.0,786.0
Saharsa,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,3.0
Saharsa,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,5.0,4.0,4.0,5.0,6.0,3.0,6.0,5.0,7.0,6.0,0.0,51.0
Saharsa,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Saharsa,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Saharsa,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Saharsa,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Saharsa,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1448.0,1320.0,1192.0,1424.0,1218.0,1303.0,1279.0,1324.0,1337.0,1225.0,1402.0,1205.0,-1.0
Saharsa,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Saharsa,14.05,Number of RKS meetings held during the month,TOTAL,3.0,14.0,1.0,4.0,4.0,3.0,2.0,3.0,2.0,5.0,3.0,2.0,46.0
Saharsa,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Saharsa,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,211.0,480.0,477.0,392.0,431.0,632.0,370.0,622.0,760.0,717.0,1013.0,636.0,6741.0
Saharsa,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Saharsa,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Saharsa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2643.0,1999.0,1876.0,2078.0,1459.0,2736.0,2746.0,2580.0,2203.0,1347.0,1523.0,1289.0,24479.0
Saharsa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2059.0,2021.0,1926.0,2197.0,1330.0,2143.0,2027.0,2324.0,2066.0,1959.0,1820.0,1352.0,23224.0
Saharsa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1955.0,1673.0,1581.0,2024.0,1490.0,2504.0,2691.0,2495.0,2194.0,1480.0,1663.0,1340.0,23090.0
Saharsa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3050.0,3363.0,3037.0,3995.0,3392.0,4528.0,5083.0,5070.0,4784.0,3331.0,4267.0,3040.0,46940.0
Saharsa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,4598.0,3672.0,3457.0,4102.0,2949.0,5240.0,5437.0,5075.0,4397.0,2827.0,3186.0,2629.0,47569.0
Saharsa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5109.0,5384.0,4963.0,6192.0,4722.0,6671.0,7110.0,7394.0,6850.0,5290.0,6087.0,4392.0,70164.0
Saharsa,14.10.2.a,Number of death cases of Inpatient males,TOTAL,13.0,16.0,16.0,32.0,0.0,12.0,19.0,26.0,19.0,13.0,15.0,15.0,196.0
Saharsa,14.10.2.b,Number of death cases of Inpatient females,TOTAL,10.0,13.0,12.0,17.0,0.0,17.0,18.0,18.0,0.0,13.0,8.0,12.0,138.0
Saharsa,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,23.0,29.0,28.0,49.0,0.0,29.0,37.0,44.0,19.0,26.0,23.0,27.0,334.0
Saharsa,14.11,In-Patient Head Count at midnight,TOTAL,9205.0,8409.0,8029.0,9725.0,7322.0,11451.0,11392.0,11688.0,10545.0,4859.0,8414.0,6724.0,107763.0
Saharsa,14.12.1,OPD attendance (All),TOTAL,107251.0,106470.0,89976.0,116314.0,92500.0,128010.0,104277.0,95015.0,68891.0,67863.0,96735.0,84980.0,1158282.0
Saharsa,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,164.0,192.0,132.0,891.0,147.0,509.0,385.0,840.0,1826.0,1011.0,1328.0,827.0,8252.0
Saharsa,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,71.0,6.0,2.0,1.0,0.0,0.0,3.0,2.0,47.0,280.0,7.0,7.0,426.0
Saharsa,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3541.0,3750.0,3660.0,2670.0,2469.0,4640.0,2574.0,2441.0,3871.0,2896.0,3350.0,2910.0,38772.0
Saharsa,14.14.a,Number of patients given AYUSH treatment,TOTAL,33404.0,34183.0,30212.0,40063.0,47099.0,55761.0,54327.0,44528.0,25065.0,27724.0,32101.0,28800.0,453267.0
Saharsa,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2758.0,3323.0,2057.0,3032.0,2590.0,3982.0,2727.0,2664.0,2318.0,2802.0,3253.0,2996.0,34502.0
Saharsa,14.14.c,Number of Adolescents counselled,TOTAL,481.0,849.0,303.0,503.0,0.0,555.0,576.0,592.0,0.0,15.0,9.0,125.0,4008.0
Saharsa,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,671.0,833.0,1067.0,942.0,327.0,984.0,726.0,707.0,710.0,770.0,1090.0,855.0,9682.0
Saharsa,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,21.0,30.0,25.0,35.0,0.0,46.0,46.0,34.0,46.0,33.0,27.0,42.0,385.0
Saharsa,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,540.0,480.0,357.0,503.0,0.0,203.0,203.0,325.0,305.0,301.0,5.0,508.0,3730.0
Saharsa,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,1.0,1.0,1.0,0.0,1.0,1.0,2.0,0.0,1.0,0.0,3.0,13.0
Saharsa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,140.0,125.0,148.0,142.0,0.0,100.0,117.0,76.0,113.0,128.0,129.0,130.0,1348.0
Saharsa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,6.0
Saharsa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,476.0,430.0,330.0,440.0,0.0,350.0,346.0,336.0,294.0,296.0,248.0,336.0,3882.0
Saharsa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Saharsa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1156.0,1035.0,835.0,1085.0,0.0,653.0,666.0,737.0,712.0,725.0,382.0,974.0,8960.0
Saharsa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,2.0,1.0,1.0,0.0,2.0,3.0,2.0,0.0,1.0,0.0,6.0,21.0
Saharsa,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,13.0,11.0,26.0
Saharsa,15.3.a,Number of VDRL tests conducted on males,Number tested,201.0,401.0,201.0,201.0,0.0,201.0,203.0,101.0,305.0,226.0,347.0,345.0,2732.0
Saharsa,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,251.0,406.0,102.0,302.0,0.0,301.0,302.0,203.0,294.0,296.0,126.0,126.0,2709.0
Saharsa,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,452.0,807.0,303.0,503.0,0.0,502.0,505.0,304.0,599.0,522.0,473.0,471.0,5441.0
Saharsa,15.4.1,Number of blood smears examined for Malaria,TOTAL,0.0,0.0,52.0,50.0,0.0,98.0,93.0,93.0,41.0,78.0,147.0,88.0,740.0
Saharsa,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,5.0,8.0
Saharsa,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,4.0,5.0,11.0
Saharsa,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,270.0,0.0,880.0,1650.0,,,3615.0,,,,,,6415.0
Saharsa,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2200.0,3250.0,2000.0,4000.0,,,1500.0,,,,,,12950.0
Saharsa,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,880.0,1650.0,2982.0,,,4735.0,,,,,,10247.0
Saharsa,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2470.0,2370.0,1230.0,2668.0,,,360.0,,,,,,9098.0
Saharsa,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,20.0
Saharsa,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,916.0,663.0,55.0,1141.0,,,1064.0,,,,,,3839.0
Saharsa,16.1.2,Stock position of OPV vaccines,2. Stocks Received,30300.0,2000.0,1500.0,2000.0,,,2825.0,,,,,,38625.0
Saharsa,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,663.0,235.0,270.0,1331.0,,,749.0,,,,,,3248.0
Saharsa,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,30553.0,2428.0,1185.0,1810.0,,,3140.0,,,,,,39116.0
Saharsa,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Saharsa,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,941.0,661.0,1031.0,1341.0,,,1600.0,,,,,,5574.0
Saharsa,16.1.3,Stock position of TT vaccines,2. Stocks Received,1500.0,1600.0,1000.0,2000.0,,,1300.0,,,,,,7400.0
Saharsa,16.1.3,Stock position of TT vaccines,3. Unusable Stock,661.0,1031.0,1421.0,1217.0,,,2525.0,,,,,,6855.0
Saharsa,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1780.0,1230.0,610.0,2124.0,,,375.0,,,,,,6119.0
Saharsa,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,568.0,298.0,653.0,973.0,,,1225.0,,,,,,3717.0
Saharsa,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1100.0,1600.0,1000.0,1500.0,,,800.0,,,,,,6000.0
Saharsa,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,298.0,653.0,973.0,1106.0,,,1355.0,,,,,,4385.0
Saharsa,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1370.0,1245.0,680.0,1367.0,,,670.0,,,,,,5332.0
Saharsa,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,344.0,204.0,114.0,289.0,,,613.0,,,,,,1564.0
Saharsa,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,1800.0,2000.0,2500.0,,,1700.0,,,,,,10000.0
Saharsa,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,204.0,653.0,389.0,144.0,,,1160.0,,,,,,2550.0
Saharsa,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2140.0,1245.0,1725.0,2645.0,,,1153.0,,,,,,8908.0
Saharsa,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,106.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,106.0
Saharsa,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Saharsa,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,520.0,210.0,690.0,1020.0,,,2675.0,,,,,,5115.0
Saharsa,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2010.0,3000.0,2000.0,2800.0,,,400.0,,,,,,10210.0
Saharsa,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,210.0,690.0,1240.0,1297.0,,,2447.0,,,,,,5884.0
Saharsa,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2320.0,2520.0,1450.0,2523.0,,,628.0,,,,,,9441.0
Saharsa,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2950.0,2950.0,2950.0,2950.0,,,,,,,,,11800.0
Saharsa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,2950.0,2950.0,2950.0,2950.0,,,,,,,,,11800.0
Saharsa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,11000.0,11000.0,11000.0,11000.0,,,,,,,,,44000.0
Saharsa,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,8440.0,8440.0,8440.0,8440.0,,,,,,,,,33760.0
Saharsa,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,2560.0,2560.0,2560.0,2560.0,,,,,,,,,10240.0
Saharsa,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1200.0,1200.0,1200.0,1200.0,,,,,,,,,4800.0
Saharsa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,1200.0,1200.0,1200.0,1200.0,,,,,,,,,4800.0
Saharsa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,580.0,580.0,580.0,580.0,,,,,,,,,2320.0
Saharsa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,580.0,580.0,580.0,580.0,,,,,,,,,2320.0
Saharsa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Saharsa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Saharsa,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Saharsa,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Saharsa,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Saharsa,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Saharsa,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Saharsa,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Saharsa,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Saharsa,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Saharsa,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Saharsa,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Saharsa,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Saharsa,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Saharsa,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Saharsa,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Saharsa,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Saharsa,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Saharsa,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Saharsa,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Saharsa,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Saharsa,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Saharsa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Saharsa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Saharsa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Saharsa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,0.0,,,,,,0.0
Saharsa,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,0.0,,,,,,0.0
Saharsa,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Saharsa,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,0.0,,,,,,0.0
Saharsa,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,0.0,,,,,,0.0
Saharsa,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,0.0,,,,,,0.0
Saharsa,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Saharsa,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,0.0,,,,,,0.0
Saharsa,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Saharsa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Saharsa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Saharsa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Saharsa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,1801.0,,,,,,1801.0
Saharsa,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,0.0,,,,,,0.0
Saharsa,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,1776.0,,,,,,1776.0
Saharsa,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,25.0,,,,,,25.0
Saharsa,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Saharsa,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Saharsa,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Saharsa,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Saharsa,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2480.0,50.0,3590.0,0.0,,,4600.0,,,,,,10720.0
Saharsa,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,10000.0,600.0,11400.0,,,0.0,,,,,,22000.0
Saharsa,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,50.0,3590.0,0.0,5825.0,,,3500.0,,,,,,12965.0
Saharsa,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2430.0,6460.0,4190.0,5575.0,,,1100.0,,,,,,19755.0
Saharsa,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,123105.0,64505.0,92805.0,57505.0,,,66805.0,,,,,,404725.0
Saharsa,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,100000.0,0.0,90000.0,,,0.0,,,,,,190000.0
Saharsa,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,64505.0,92805.0,97505.0,87605.0,,,38805.0,,,,,,381225.0
Saharsa,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,58600.0,71700.0,54300.0,59000.0,,,28000.0,,,,,,271600.0
Saharsa,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,-59000.0,900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-58100.0
Saharsa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1050.0,125.0,1305.0,105.0,,,2550.0,,,,,,5135.0
Saharsa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,1000.0,5000.0,1000.0,5000.0,,,0.0,,,,,,12000.0
Saharsa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,125.0,1305.0,105.0,2395.0,,,50.0,,,,,,3980.0
Saharsa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1925.0,3820.0,2200.0,2710.0,,,2500.0,,,,,,13155.0
Saharsa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saharsa,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Saharsa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Saharsa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saharsa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Saharsa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Saharsa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saharsa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Saharsa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Saharsa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saharsa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Saharsa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Saharsa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saharsa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Saharsa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saharsa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saharsa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Saharsa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saharsa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saharsa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Saharsa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saharsa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saharsa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Saharsa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saharsa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saharsa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Saharsa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Saharsa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Saharsa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Saharsa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Saharsa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Saharsa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Saharsa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Saharsa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Saharsa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Saharsa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Saharsa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Saharsa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Saharsa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Saharsa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Saharsa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Saharsa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Saharsa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Saharsa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Saharsa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Saharsa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Saharsa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Saharsa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Saharsa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Saharsa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Saharsa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Saharsa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Saharsa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Saharsa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Saharsa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Saharsa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Saharsa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Saharsa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Samastipur,1.1,Total number of pregnant women Registered for ANC,TOTAL,9879.0,9253.0,8953.0,10032.0,9938.0,8945.0,8004.0,8350.0,7564.0,7999.0,8385.0,9554.0,106856.0
Samastipur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3983.0,3710.0,3865.0,4180.0,4569.0,3763.0,3895.0,3412.0,3269.0,3863.0,3727.0,4159.0,46395.0
Samastipur,1.2,Number of Pregnant women registered under JSY,TOTAL,9879.0,9253.0,8953.0,10032.0,9938.0,8945.0,8004.0,8338.0,7560.0,7999.0,8385.0,9554.0,106840.0
Samastipur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5318.0,5466.0,5450.0,5720.0,6865.0,6297.0,6002.0,6075.0,5744.0,5311.0,4809.0,5543.0,68600.0
Samastipur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6649.0,6238.0,6043.0,6841.0,6026.0,5472.0,4523.0,4638.0,4528.0,5081.0,5388.0,6011.0,67438.0
Samastipur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,9610.0,9111.0,8088.0,9574.0,9518.0,9037.0,8045.0,7135.0,6946.0,7113.0,6891.0,8894.0,99962.0
Samastipur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6472.0,6431.0,6508.0,6480.0,6272.0,5006.0,4567.0,4791.0,4269.0,4149.0,4503.0,4077.0,63525.0
Samastipur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,208.0,73.0,25.0,194.0,221.0,206.0,111.0,68.0,118.0,187.0,89.0,119.0,1619.0
Samastipur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,1.0,0.0,0.0,4.0,2.0,0.0,2.0,0.0,0.0,0.0,2.0,12.0
Samastipur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,880.0,1018.0,690.0,903.0,1145.0,1322.0,1148.0,1057.0,1498.0,1052.0,800.0,1083.0,12596.0
Samastipur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,0.0,0.0,0.0,5.0,7.0,2.0,2.0,0.0,5.0,1.0,10.0,33.0
Samastipur,1.8,Number of pregnancy test kits used at SC level,TOTAL,312.0,560.0,506.0,613.0,1247.0,1482.0,1809.0,1853.0,1454.0,1562.0,1786.0,1997.0,15181.0
Samastipur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,107.0,88.0,99.0,106.0,106.0,125.0,139.0,121.0,135.0,143.0,105.0,94.0,1368.0
Samastipur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,771.0,822.0,780.0,967.0,1044.0,1005.0,988.0,1047.0,1047.0,1062.0,913.0,729.0,11175.0
Samastipur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,878.0,910.0,879.0,1073.0,1150.0,1130.0,1127.0,1168.0,1182.0,1205.0,1018.0,823.0,12543.0
Samastipur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,464.0,507.0,447.0,611.0,676.0,586.0,654.0,677.0,654.0,760.0,555.0,507.0,7098.0
Samastipur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,5.0,3.0,4.0,0.0,0.0,7.0,4.0,0.0,6.0,0.0,0.0,0.0,29.0
Samastipur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,6305.0,5526.0,5754.0,7204.0,9776.0,8578.0,8538.0,7654.0,7923.0,7452.0,6142.0,5446.0,86298.0
Samastipur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,4794.0,3987.0,4294.0,5641.0,7783.0,7173.0,6095.0,6227.0,6477.0,6393.0,5151.0,4345.0,68360.0
Samastipur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2570.0,1649.0,3311.0,814.0,733.0,170.0,306.0,1362.0,25948.0,5428.0,18287.0,11361.0,71939.0
Samastipur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1545.0,948.0,845.0,208.0,2034.0,591.0,879.0,1090.0,8573.0,3587.0,14703.0,21351.0,56354.0
Samastipur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,,0.0,0.0,0.0,,,,,0.0,,,0.0
Samastipur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,0.0,0.0,0.0,,,,,0.0,,,0.0
Samastipur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,0.0,0.0,0.0,,,,,0.0,,,0.0
Samastipur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,,0.0,0.0,0.0,,,,,0.0,,,0.0
Samastipur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,27.0,0.0,30.0,0.0,25.0,17.0,19.0,18.0,24.0,20.0,20.0,9.0,209.0
Samastipur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Samastipur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,27.0,0.0,30.0,0.0,25.0,17.0,19.0,18.0,24.0,20.0,20.0,9.0,209.0
Samastipur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,,,0.0,0.0,,,,,0.0,,,0.0
Samastipur,4.1.1.a,Number of male live births,TOTAL,3718.0,3346.0,3381.0,4407.0,5491.0,4872.0,4819.0,4490.0,4668.0,4400.0,3762.0,3226.0,50580.0
Samastipur,4.1.1.b,Number of female live births,TOTAL,3405.0,3032.0,3188.0,3836.0,5317.0,4712.0,4778.0,4262.0,4349.0,4161.0,3325.0,2987.0,47352.0
Samastipur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,7123.0,6378.0,6569.0,8243.0,10808.0,9584.0,9597.0,8752.0,9017.0,8561.0,7087.0,6213.0,97932.0
Samastipur,4.1.2,Number of still births,TOTAL,84.0,75.0,90.0,77.0,152.0,124.0,119.0,111.0,109.0,108.0,89.0,81.0,1219.0
Samastipur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,5.0,5.0,15.0,9.0,6.0,4.0,8.0,7.0,6.0,4.0,5.0,4.0,78.0
Samastipur,4.2.1,Number of Newborns weighed at birth,TOTAL,6758.0,6117.0,6292.0,7919.0,10421.0,9281.0,9092.0,8532.0,8755.0,8369.0,6888.0,6076.0,94500.0
Samastipur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,820.0,736.0,851.0,886.0,1501.0,1343.0,1487.0,1206.0,1007.0,893.0,859.0,684.0,12273.0
Samastipur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,6996.0,6238.0,6428.0,8171.0,9831.0,9496.0,9282.0,7905.0,8430.0,8523.0,7519.0,6157.0,94976.0
Samastipur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,17.0,27.0,14.0,19.0,13.0,28.0,26.0,16.0,11.0,9.0,11.0,11.0,202.0
Samastipur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,2.0,6.0,4.0,3.0,5.0,3.0,1.0,5.0,5.0,2.0,4.0,44.0
Samastipur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,1.0,0.0,1.0,0.0,1.0,4.0,8.0,7.0,5.0,12.0,7.0,5.0,51.0
Samastipur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Samastipur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,22.0,29.0,21.0,23.0,17.0,37.0,37.0,24.0,21.0,26.0,20.0,20.0,297.0
Samastipur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,,,0.0,0.0,,,,,0.0,,,0.0
Samastipur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,16.0,29.0,34.0,23.0,17.0,80.0,37.0,28.0,27.0,22.0,30.0,20.0,363.0
Samastipur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,8.0,5.0,5.0,20.0
Samastipur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,1.0,0.0,1.0,12.0,19.0,18.0,11.0,10.0,509.0,7.0,588.0
Samastipur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1653.0,1450.0,1735.0,2075.0,2877.0,2755.0,2686.0,2228.0,1989.0,2808.0,1807.0,1961.0,26024.0
Samastipur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1476.0,1300.0,1351.0,2164.0,2317.0,2473.0,2476.0,2020.0,2225.0,2323.0,1757.0,1678.0,23560.0
Samastipur,6.3,PNC maternal complications attended,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Samastipur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,243.0,10.0,20.0,0.0,40.0,31.0,5.0,28.0,38.0,53.0,8.0,48.0,524.0
Samastipur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,157.0,5.0,311.0,0.0,20.0,331.0,215.0,310.0,23.0,313.0,268.0,291.0,2244.0
Samastipur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,400.0,15.0,331.0,0.0,60.0,362.0,220.0,338.0,61.0,366.0,276.0,339.0,2768.0
Samastipur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,3.0,3.0,6.0,6.0,6.0,7.0,3.0,6.0,0.0,41.0
Samastipur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Samastipur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,3.0,0.0,1.0,2.0,5.0,1.0,2.0,3.0,18.0
Samastipur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Samastipur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,0.0,0.0,3.0,6.0,6.0,7.0,8.0,12.0,4.0,9.0,3.0,60.0
Samastipur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0
Samastipur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Samastipur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0
Samastipur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,322.0,95.0,90.0,765.0,381.0,522.0,301.0,3244.0,3081.0,1529.0,1691.0,898.0,12919.0
Samastipur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,52.0,11.0,17.0,43.0,32.0,63.0,31.0,403.0,276.0,166.0,183.0,129.0,1406.0
Samastipur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,111.0,27.0,22.0,187.0,61.0,173.0,87.0,790.0,885.0,487.0,604.0,361.0,3795.0
Samastipur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Samastipur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,485.0,133.0,129.0,995.0,474.0,758.0,419.0,4437.0,4242.0,2182.0,2478.0,1388.0,18120.0
Samastipur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,102.0,58.0,27.0,22.0,19.0,52.0,33.0,197.0,167.0,101.0,116.0,64.0,958.0
Samastipur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,42.0,19.0,34.0,24.0,129.0
Samastipur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,1.0,4.0
Samastipur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,5.0,6.0,6.0,2.0,20.0
Samastipur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Samastipur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,48.0,25.0,42.0,27.0,153.0
Samastipur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0
Samastipur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,708.0,712.0,827.0,1643.0,1192.0,1187.0,1187.0,1146.0,1393.0,1104.0,922.0,1186.0,13207.0
Samastipur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,212.0,125.0,257.0,528.0,231.0,250.0,299.0,255.0,238.0,215.0,183.0,184.0,2977.0
Samastipur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,4.0,7.0,5.0,28.0,,2.0,3.0,1.0,2.0,5.0,4.0,5.0,66.0
Samastipur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,94.0,32.0,84.0,93.0,61.0,107.0,74.0,74.0,76.0,72.0,89.0,98.0,954.0
Samastipur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Samastipur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1018.0,876.0,1173.0,2292.0,1484.0,1546.0,1563.0,1476.0,1709.0,1396.0,1198.0,1473.0,17204.0
Samastipur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,82.0,144.0,70.0,65.0,88.0,39.0,70.0,21.0,46.0,62.0,106.0,196.0,989.0
Samastipur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,,0.0,0.0,0.0,,,0.0,,0.0,,0.0
Samastipur,9.06,Number of IUCD removals,TOTAL,348.0,281.0,277.0,395.0,333.0,364.0,281.0,326.0,318.0,239.0,243.0,353.0,3758.0
Samastipur,9.07,Number of Oral Pills cycles distributed,TOTAL,2570.0,3227.0,2524.0,3623.0,3647.0,4693.0,3921.0,3847.0,3570.0,3284.0,3069.0,2993.0,40968.0
Samastipur,9.08,Number of Condom pieces distributed,TOTAL,23458.0,27326.0,23395.0,33819.0,34229.0,25807.0,29069.0,34247.0,34804.0,34726.0,33970.0,25453.0,360303.0
Samastipur,9.09,Number of Centchroman (weekly) pills given,TOTAL,499.0,58.0,231.0,400.0,210.0,449.0,127.0,29.0,170.0,21.0,125.0,40.0,2359.0
Samastipur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,142.0,172.0,100.0,381.0,349.0,800.0,380.0,339.0,275.0,212.0,198.0,221.0,3569.0
Samastipur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,2.0,0.0,4.0,0.0,0.0,0.0,0.0,8.0
Samastipur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Samastipur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Samastipur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,8820.0,6791.0,6841.0,9096.0,11743.0,11426.0,10367.0,11108.0,10835.0,10267.0,9266.0,7953.0,114513.0
Samastipur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,10066.0,8827.0,7878.0,8056.0,8253.0,9558.0,9960.0,11812.0,10157.0,1177.0,59.0,7.0,85810.0
Samastipur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,11066.0,9635.0,8364.0,8898.0,8385.0,8184.0,8214.0,9680.0,10661.0,10509.0,4033.0,1829.0,99458.0
Samastipur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,10974.0,10337.0,8823.0,9089.0,8628.0,8334.0,7734.0,8279.0,8841.0,10329.0,8218.0,6198.0,105784.0
Samastipur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,53.0,0.0,0.0,0.0,0.0,10064.0,9123.0,9595.0,28835.0
Samastipur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,64.0,0.0,0.0,0.0,0.0,10.0,4727.0,8705.0,13506.0
Samastipur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,152.0,0.0,0.0,0.0,0.0,3.0,22.0,3534.0,3711.0
Samastipur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,6495.0,5771.0,5912.0,7356.0,9537.0,8911.0,7032.0,7142.0,8180.0,8030.0,7344.0,6132.0,87842.0
Samastipur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,9566.0,8750.0,8025.0,8025.0,7667.0,8625.0,7639.0,6815.0,11199.0,9650.0,9614.0,8722.0,104297.0
Samastipur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,10697.0,9443.0,8346.0,8704.0,7797.0,7330.0,6339.0,5306.0,9673.0,9693.0,8651.0,9687.0,101666.0
Samastipur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,10890.0,10052.0,8790.0,9037.0,8054.0,7450.0,6011.0,4756.0,7817.0,7963.0,7956.0,8675.0,97451.0
Samastipur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,5710.0,4836.0,5175.0,6439.0,8247.0,7963.0,7387.0,6823.0,8011.0,7556.0,6337.0,5526.0,80010.0
Samastipur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,10465.0,8957.0,7850.0,7970.0,8047.0,9582.0,10050.0,11458.0,10285.0,1260.0,131.0,36.0,86091.0
Samastipur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,10986.0,9776.0,8302.0,8948.0,8392.0,8100.0,8220.0,9346.0,10462.0,10474.0,4144.0,1737.0,98887.0
Samastipur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,11091.0,10181.0,8777.0,9304.0,8822.0,8543.0,7773.0,8177.0,8718.0,10301.0,8009.0,6393.0,106089.0
Samastipur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7994.0,8867.0,8828.0,10059.0,9318.0,8788.0,8734.0,8887.0,8302.0,7365.0,7285.0,5085.0,99512.0
Samastipur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,7259.0,6444.0,4738.0,5971.0,5095.0,4337.0,3991.0,4235.0,5005.0,5190.0,6529.0,4992.0,63786.0
Samastipur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,5130.0,5805.0,6385.0,7032.0,6486.0,1800.0,3791.0,2605.0,7276.0,6415.0,5269.0,6127.0,64121.0
Samastipur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3956.0,4538.0,4372.0,5117.0,4783.0,4350.0,4455.0,4525.0,4166.0,3829.0,3779.0,2601.0,50471.0
Samastipur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3688.0,4032.0,4018.0,4618.0,4242.0,3812.0,3974.0,4034.0,3828.0,3338.0,3357.0,2270.0,45211.0
Samastipur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,7644.0,8570.0,8390.0,9735.0,9025.0,8162.0,8429.0,8559.0,7994.0,7167.0,7136.0,4871.0,95682.0
Samastipur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,9150.0,7992.0,6761.0,7113.0,5553.0,5629.0,4958.0,5413.0,6148.0,7049.0,7664.0,8346.0,81776.0
Samastipur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,8893.0,7831.0,6741.0,6873.0,5221.0,4974.0,3978.0,3478.0,5799.0,5947.0,7334.0,7344.0,74413.0
Samastipur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1310.0,789.0,711.0,499.0,424.0,603.0,359.0,403.0,360.0,388.0,786.0,424.0,7056.0
Samastipur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1199.0,665.0,667.0,435.0,357.0,511.0,294.0,321.0,309.0,346.0,725.0,389.0,6218.0
Samastipur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2509.0,1454.0,1378.0,934.0,781.0,1114.0,653.0,724.0,669.0,734.0,1511.0,813.0,13274.0
Samastipur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1101.0,892.0,855.0,876.0,834.0,1113.0,1086.0,1145.0,1270.0,1290.0,1380.0,1293.0,13135.0
Samastipur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,777.0,734.0,808.0,900.0,913.0,1009.0,1097.0,1057.0,1133.0,1054.0,998.0,1095.0,11575.0
Samastipur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1165.0,1014.0,962.0,1142.0,1222.0,1418.0,1474.0,1574.0,1713.0,1741.0,1593.0,1498.0,16516.0
Samastipur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,0.0,2.0,0.0,0.0,0.0,1.0,3.0,16.0,0.0,0.0,3.0,28.0
Samastipur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,8.0,15.0,7.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0
Samastipur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,4561.0,4468.0,4220.0,4520.0,3938.0,3799.0,3921.0,3937.0,3928.0,3980.0,3770.0,3941.0,48983.0
Samastipur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,4530.0,4466.0,4216.0,4508.0,3920.0,3796.0,3919.0,3936.0,3927.0,3979.0,3762.0,3940.0,48899.0
Samastipur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,4236.0,4153.0,3864.0,4248.0,3680.0,3547.0,3744.0,3692.0,3744.0,3778.0,3593.0,3750.0,46029.0
Samastipur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,3018.0,1644.0,1396.0,2959.0,2551.0,839.0,2052.0,1053.0,3923.0,4301.0,4374.0,6439.0,34549.0
Samastipur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3533.0,3868.0,3050.0,4339.0,3355.0,3196.0,3947.0,3877.0,4046.0,3151.0,2732.0,2324.0,41418.0
Samastipur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,644.0,445.0,487.0,710.0,347.0,407.0,283.0,288.0,508.0,459.0,467.0,605.0,5650.0
Samastipur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,19.0,2.0,16.0,265.0,3.0,18.0,44.0,70.0,31.0,1.0,15.0,70.0,554.0
Samastipur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,26.0,2.0,6.0,10.0,4.0,0.0,0.0,1.0,0.0,0.0,10.0,3.0,62.0
Samastipur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,3250.0,3145.0,3883.0,3512.0,4755.0,6444.0,3598.0,3992.0,3807.0,3494.0,2696.0,2779.0,45355.0
Samastipur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Samastipur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,168.0,208.0,4.0,253.0,141.0,99.0,2.0,3.0,3.0,2.0,126.0,34.0,1043.0
Samastipur,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,210.0,395.0,615.0
Samastipur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,210.0,464.0,684.0
Samastipur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Samastipur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Samastipur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,3103.0,3119.0,3111.0,3018.0,3090.0,3005.0,3103.0,3099.0,3114.0,3113.0,2859.0,3095.0,-1.0
Samastipur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Samastipur,14.05,Number of RKS meetings held during the month,TOTAL,18.0,9.0,13.0,12.0,22.0,17.0,14.0,15.0,16.0,13.0,15.0,16.0,180.0
Samastipur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Samastipur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,828.0,1124.0,1188.0,1503.0,1964.0,1647.0,1269.0,1646.0,2840.0,2438.0,1686.0,1866.0,19999.0
Samastipur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Samastipur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,4.0,3.0,,,,,,,,,,-1.0
Samastipur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2758.0,2284.0,2418.0,2872.0,3317.0,2911.0,3867.0,3641.0,3672.0,3538.0,3718.0,2767.0,37763.0
Samastipur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1339.0,983.0,1572.0,777.0,1229.0,1833.0,2588.0,2208.0,2185.0,2188.0,2407.0,2020.0,21329.0
Samastipur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2635.0,2030.0,2431.0,2722.0,3348.0,3238.0,3910.0,3603.0,3515.0,3304.0,3263.0,2619.0,36618.0
Samastipur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,7640.0,5761.0,6992.0,8245.0,9738.0,8872.0,9784.0,12050.0,12026.0,10032.0,8635.0,7675.0,107450.0
Samastipur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,5393.0,4314.0,4849.0,5594.0,6665.0,6149.0,7777.0,7244.0,7187.0,6842.0,6981.0,5386.0,74381.0
Samastipur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,8979.0,6744.0,8564.0,9022.0,10967.0,10705.0,12372.0,14258.0,14211.0,12220.0,11042.0,9695.0,128779.0
Samastipur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,2.0,4.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,14.0
Samastipur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,2.0,4.0,0.0,1.0,0.0,2.0,1.0,0.0,1.0,2.0,1.0,15.0
Samastipur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2.0,4.0,8.0,0.0,1.0,1.0,3.0,2.0,1.0,2.0,3.0,2.0,29.0
Samastipur,14.11,In-Patient Head Count at midnight,TOTAL,8762.0,6984.0,9120.0,8048.0,10119.0,11668.0,11778.0,13831.0,12926.0,10647.0,11882.0,9892.0,125657.0
Samastipur,14.12.1,OPD attendance (All),TOTAL,254362.0,227520.0,239664.0,260055.0,293370.0,337732.0,283235.0,285769.0,241731.0,243767.0,241083.0,251681.0,3159969.0
Samastipur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,554.0,94.0,228.0,966.0,477.0,927.0,459.0,4415.0,4173.0,2293.0,2399.0,1700.0,18685.0
Samastipur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,84.0,2.0,2.0,0.0,0.0,24.0,2.0,0.0,2.0,0.0,0.0,0.0,116.0
Samastipur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4971.0,3642.0,4779.0,4278.0,4870.0,6901.0,6571.0,8062.0,7735.0,6567.0,6852.0,5795.0,71023.0
Samastipur,14.14.a,Number of patients given AYUSH treatment,TOTAL,53029.0,55187.0,49203.0,60763.0,78462.0,82662.0,66996.0,57135.0,36324.0,49401.0,47728.0,54061.0,690951.0
Samastipur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,13426.0,9666.0,12071.0,10913.0,14115.0,15584.0,11495.0,9105.0,11911.0,10520.0,11317.0,9326.0,139449.0
Samastipur,14.14.c,Number of Adolescents counselled,TOTAL,36.0,55.0,679.0,659.0,85.0,142.0,0.0,72.0,87.0,195.0,189.0,87.0,2286.0
Samastipur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1828.0,2019.0,2362.0,2575.0,3154.0,3700.0,3260.0,4173.0,3676.0,3360.0,3342.0,4322.0,37771.0
Samastipur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,26.0,5.0,44.0,31.0,78.0,193.0,20.0,21.0,243.0,134.0,9.0,41.0,845.0
Samastipur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,604.0,586.0,633.0,208.0,305.0,379.0,578.0,410.0,362.0,126.0,206.0,311.0,4708.0
Samastipur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,8.0,11.0,10.0,2.0,7.0,4.0,16.0,6.0,10.0,3.0,10.0,20.0,107.0
Samastipur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,504.0,480.0,549.0,131.0,198.0,217.0,388.0,983.0,977.0,355.0,517.0,511.0,5810.0
Samastipur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,9.0,7.0,14.0,2.0,5.0,3.0,16.0,8.0,17.0,5.0,10.0,20.0,116.0
Samastipur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,702.0,713.0,905.0,284.0,459.0,506.0,1042.0,1195.0,1323.0,308.0,275.0,682.0,8394.0
Samastipur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,7.0
Samastipur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1810.0,1779.0,2087.0,623.0,962.0,1102.0,2008.0,2588.0,2662.0,789.0,998.0,1504.0,18912.0
Samastipur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,17.0,18.0,24.0,4.0,13.0,8.0,33.0,15.0,28.0,8.0,21.0,41.0,230.0
Samastipur,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,72.0,81.0,33.0,0.0,0.0,0.0,0.0,0.0,0.0,62.0,248.0
Samastipur,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,11.0,0.0,3.0,24.0
Samastipur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,52.0,282.0,0.0,0.0,0.0,281.0,0.0,1.0,616.0
Samastipur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0,37.0
Samastipur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,52.0,292.0,0.0,0.0,0.0,292.0,0.0,41.0,677.0
Samastipur,15.4.1,Number of blood smears examined for Malaria,TOTAL,16.0,17.0,6.0,11.0,11.0,11.0,10.0,2.0,1.0,1.0,1.0,0.0,87.0
Samastipur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2143.0,754.0,3327.0,2633.0,4222.0,4185.0,2583.0,4600.0,4450.0,6150.0,,1250.0,36297.0
Samastipur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4000.0,8000.0,4000.0,5000.0,3000.0,2000.0,5000.0,4000.0,6000.0,0.0,,3000.0,44000.0
Samastipur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,5389.0,5427.0,4694.0,3411.0,3037.0,3602.0,2983.0,4150.0,4300.0,3500.0,,2350.0,42843.0
Samastipur,16.1.1,Stock position of DPT vaccines,5. Total Stock,754.0,3327.0,2633.0,4222.0,4185.0,2583.0,4600.0,4450.0,6150.0,2650.0,0.0,1900.0,37454.0
Samastipur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,0.0,,0.0,,0.0,,0.0,,,6000.0,6000.0
Samastipur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,0.0,,0.0,,0.0,,0.0,,,0.0,0.0
Samastipur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,0.0,,0.0,,0.0,,0.0,,,0.0,0.0
Samastipur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,0.0,,0.0,,0.0,,0.0,,,2800.0,2800.0
Samastipur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3200.0,3200.0
Samastipur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1465.0,41.0,717.0,393.0,58.0,1185.0,129.0,325.0,175.0,175.0,,0.0,4663.0
Samastipur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,4500.0,3000.0,3000.0,4000.0,1500.0,2200.0,2100.0,2300.0,1000.0,,3000.0,28600.0
Samastipur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3424.0,3824.0,3324.0,3335.0,2873.0,2556.0,2004.0,2250.0,2300.0,775.0,,3000.0,29665.0
Samastipur,16.1.2,Stock position of OPV vaccines,5. Total Stock,41.0,717.0,393.0,58.0,1185.0,129.0,325.0,175.0,175.0,400.0,0.0,0.0,3598.0
Samastipur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,759.0,1405.0,981.0,1666.0,1986.0,1873.0,2367.0,5117.0,3667.0,2712.0,,2167.0,24700.0
Samastipur,16.1.3,Stock position of TT vaccines,2. Stocks Received,3000.0,3000.0,3000.0,3000.0,2000.0,3000.0,5000.0,1000.0,1000.0,2000.0,,2000.0,28000.0
Samastipur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2354.0,3424.0,2315.0,2680.0,2113.0,2506.0,2250.0,2450.0,1955.0,2500.0,,2450.0,26997.0
Samastipur,16.1.3,Stock position of TT vaccines,5. Total Stock,1405.0,981.0,1666.0,1986.0,1873.0,2367.0,5117.0,3667.0,2712.0,2212.0,0.0,1717.0,25703.0
Samastipur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,509.0,571.0,1075.0,1414.0,2044.0,1919.0,1370.0,1500.0,1450.0,1800.0,,1250.0,14902.0
Samastipur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,2500.0,2000.0,2000.0,1500.0,1500.0,2000.0,2000.0,2000.0,2000.0,,2000.0,21500.0
Samastipur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1938.0,1996.0,1661.0,1370.0,1625.0,2049.0,1870.0,2050.0,1650.0,1750.0,,2450.0,20409.0
Samastipur,16.1.5,Stock position of BCG vaccines,5. Total Stock,571.0,1075.0,1414.0,2044.0,1919.0,1370.0,1500.0,1450.0,1800.0,2050.0,0.0,800.0,15993.0
Samastipur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3209.0,321.0,1298.0,1017.0,785.0,1543.0,1757.0,2250.0,1100.0,0.0,,1050.0,14330.0
Samastipur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,5500.0,4500.0,4000.0,5000.0,4400.0,3300.0,3000.0,2000.0,5500.0,,1000.0,40200.0
Samastipur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4888.0,4523.0,4781.0,4232.0,4242.0,4186.0,2817.0,4150.0,3100.0,3300.0,,2050.0,42269.0
Samastipur,16.1.6,Stock position of Measles vaccines,5. Total Stock,321.0,1298.0,1017.0,785.0,1543.0,1757.0,2240.0,1100.0,0.0,2200.0,0.0,0.0,12261.0
Samastipur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,7273.0,6107.0,7574.0,1170.0,1314.0,24.0,361.0,0.0,1400.0,400.0,,2900.0,28523.0
Samastipur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,3200.0,0.0,3000.0,1300.0,2000.0,1000.0,3500.0,3000.0,2000.0,,3000.0,22000.0
Samastipur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,14403.0,1733.0,6404.0,2856.0,2590.0,1655.0,1361.0,2100.0,4000.0,2400.0,,5550.0,45052.0
Samastipur,16.1.7,Stock position of JE vaccines,5. Total Stock,-7130.0,7574.0,1170.0,1314.0,24.0,369.0,0.0,1400.0,400.0,0.0,0.0,350.0,5471.0
Samastipur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1535.0,145.0,408.0,513.0,1323.0,3864.0,2972.0,2042.0,2662.0,3162.0,,2712.0,21338.0
Samastipur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,4500.0,3000.0,5000.0,6000.0,3510.0,2000.0,4500.0,4000.0,2500.0,,2000.0,40010.0
Samastipur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,4390.0,4237.0,2895.0,4190.0,3459.0,4402.0,2930.0,3880.0,3500.0,3150.0,,2000.0,39033.0
Samastipur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,145.0,408.0,513.0,1323.0,3864.0,2972.0,2042.0,2662.0,3162.0,2512.0,0.0,2712.0,22315.0
Samastipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Samastipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Samastipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Samastipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Samastipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Samastipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Samastipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Samastipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Samastipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Samastipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Samastipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Samastipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Samastipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Samastipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Samastipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Samastipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Samastipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Samastipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Samastipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Samastipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Samastipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,0.0,11000.0,11000.0,,2100.0,2100.0,1100.0,100.0,0.0,,0.0,27400.0
Samastipur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,11000.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,11000.0
Samastipur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,0.0,0.0,7900.0,,0.0,1000.0,1000.0,100.0,0.0,,0.0,10000.0
Samastipur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,11000.0,11000.0,3100.0,0.0,2100.0,1100.0,100.0,0.0,0.0,0.0,0.0,28400.0
Samastipur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,0.0,0.0,0.0,,450.0,0.0,0.0,0.0,10100.0,,2400.0,12950.0
Samastipur,16.3.02,Stock Position of Gloves,2. Stocks Received,,0.0,0.0,5000.0,,0.0,0.0,0.0,15000.0,0.0,,4000.0,24000.0
Samastipur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,0.0,0.0,2050.0,,450.0,0.0,0.0,4900.0,3700.0,,1500.0,12600.0
Samastipur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,2950.0,0.0,0.0,0.0,0.0,10100.0,6400.0,0.0,4900.0,24350.0
Samastipur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,0.0,0.0,0.0,,0.0,0.0,0.0,5000.0,0.0,,0.0,5000.0
Samastipur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,5500.0,0.0,0.0,,0.0,5500.0
Samastipur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,0.0,0.0,0.0,,0.0,0.0,500.0,5000.0,0.0,,0.0,5500.0
Samastipur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,5000.0
Samastipur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,0.0,0.0,,2000.0,2000.0,2000.0,2000.0,2000.0,,2000.0,12000.0
Samastipur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,0.0,2000.0,,0.0,0.0,0.0,0.0,0.0,,0.0,2000.0
Samastipur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,2000.0,,0.0,2000.0
Samastipur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,2000.0,0.0,2000.0,2000.0,2000.0,2000.0,0.0,0.0,2000.0,12000.0
Samastipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Samastipur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,372800.0,242800.0,172300.0,,2000.0,820000.0,319800.0,819800.0,319800.0,,0.0,3069300.0
Samastipur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,0.0,0.0,,1200000.0,0.0,800000.0,0.0,0.0,,2140000.0,4140000.0
Samastipur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,130000.0,70500.0,170300.0,,382000.0,500200.0,300000.0,500000.0,240000.0,,40600.0,2333600.0
Samastipur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,242800.0,172300.0,2000.0,0.0,820000.0,319800.0,819800.0,319800.0,79800.0,0.0,2099400.0,4875700.0
Samastipur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,3099.0,2499.0,879.0,,22100.0,26200.0,19000.0,13200.0,3400.0,,0.0,90377.0
Samastipur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,0.0,15000.0,,20100.0,0.0,0.0,0.0,0.0,,18100.0,53200.0
Samastipur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,600.0,1620.0,5779.0,,16000.0,7200.0,5800.0,9800.0,3400.0,,4025.0,54224.0
Samastipur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,2499.0,879.0,10100.0,0.0,26200.0,19000.0,13200.0,3400.0,0.0,0.0,14075.0,89353.0
Samastipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,0.0,1000.0,500.0,,0.0,0.0,0.0,0.0,0.0,,0.0,1500.0
Samastipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,1000.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,3500.0,4500.0
Samastipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,0.0,500.0,500.0,,0.0,0.0,0.0,0.0,0.0,,300.0,1300.0
Samastipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,1000.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3200.0,4700.0
Samastipur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,0.0,4900.0,4890.0,,292.0,292.0,292.0,0.0,0.0,,0.0,10666.0
Samastipur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,5000.0,0.0,6543.0,,0.0,0.0,0.0,0.0,0.0,,0.0,11543.0
Samastipur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,100.0,10.0,11031.0,,0.0,0.0,0.0,0.0,0.0,,0.0,11141.0
Samastipur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,4900.0,4890.0,402.0,0.0,292.0,292.0,292.0,0.0,0.0,0.0,0.0,11068.0
Samastipur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,97550.0,49550.0,37350.0,,0.0,105956.0,88848.0,86148.0,62816.0,,95614.0,623832.0
Samastipur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,0.0,0.0,95450.0,,200000.0,0.0,0.0,0.0,0.0,,0.0,295450.0
Samastipur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,48000.0,12200.0,123700.0,,94044.0,17108.0,2700.0,23332.0,0.0,,57778.0,378862.0
Samastipur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,49550.0,37350.0,9100.0,0.0,105956.0,88848.0,86148.0,62816.0,62816.0,0.0,37836.0,540420.0
Samastipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,17209.0,2806.0,13805.0,5695.0,14695.0,5695.0,4395.0,4495.0,2195.0,4595.0,,3095.0,78680.0
Samastipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,20000.0,0.0,20000.0,0.0,11000.0,10000.0,11000.0,13000.0,20000.0,,16600.0,121600.0
Samastipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,14403.0,9001.0,8110.0,11000.0,9000.0,12300.0,9900.0,13300.0,10600.0,11800.0,,10700.0,120114.0
Samastipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2806.0,13805.0,5695.0,14695.0,5695.0,4395.0,4495.0,2195.0,4595.0,12795.0,0.0,8995.0,80166.0
Samastipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,186204.0,54066.0,34453.0,14326.0,100007.0,45038.0,16588.0,23988.0,15538.0,4938.0,,1138.0,496284.0
Samastipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,100000.0,100000.0,200000.0,50000.0,100000.0,100000.0,100000.0,100000.0,200000.0,,210000.0,1260000.0
Samastipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,132138.0,119613.0,120127.0,114319.0,104971.0,128450.0,92600.0,108450.0,110600.0,115000.0,,120000.0,1266268.0
Samastipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,54066.0,34453.0,14326.0,100007.0,45036.0,16588.0,23988.0,15538.0,4938.0,89938.0,0.0,91138.0,490016.0
Samastipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,17901.0,7805.0,8249.0,49.0,6585.0,318.0,4098.0,3498.0,2298.0,3748.0,,6298.0,60847.0
Samastipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,6000.0,0.0,14500.0,0.0,10000.0,4000.0,6000.0,8600.0,16000.0,,12000.0,77100.0
Samastipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Samastipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,10096.0,5556.0,8200.0,7964.0,6267.0,6220.0,4600.0,7200.0,7100.0,7600.0,,8600.0,79403.0
Samastipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,7805.0,8249.0,49.0,6585.0,318.0,4098.0,3498.0,2298.0,3798.0,12148.0,0.0,9698.0,58544.0
Samastipur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Samastipur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Samastipur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Samastipur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Samastipur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Samastipur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Samastipur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Samastipur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Samastipur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Samastipur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Samastipur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Samastipur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Samastipur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Samastipur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Samastipur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Samastipur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Samastipur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Samastipur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Samastipur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Samastipur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Samastipur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Samastipur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Samastipur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Samastipur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Samastipur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Samastipur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Samastipur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Samastipur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Samastipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Samastipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Samastipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Samastipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Samastipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Samastipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Samastipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Samastipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Samastipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Samastipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Samastipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Samastipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Samastipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Samastipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Samastipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Samastipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Samastipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Samastipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Samastipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Samastipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Samastipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Samastipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Samastipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Samastipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Samastipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Samastipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Samastipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Samastipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Samastipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Saran,1.1,Total number of pregnant women Registered for ANC,TOTAL,7464.0,6895.0,6110.0,7332.0,7633.0,7488.0,6086.0,6711.0,6204.0,6680.0,6871.0,7375.0,82849.0
Saran,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2934.0,3049.0,2732.0,3276.0,3463.0,3299.0,2870.0,3030.0,3002.0,3421.0,3433.0,3765.0,38274.0
Saran,1.2,Number of Pregnant women registered under JSY,TOTAL,7465.0,6872.0,6013.0,7331.0,7628.0,7484.0,6079.0,6668.0,6179.0,6649.0,6889.0,7319.0,82576.0
Saran,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4807.0,4957.0,4605.0,5025.0,5320.0,5509.0,5649.0,5726.0,5407.0,5278.0,4964.0,5319.0,62566.0
Saran,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6356.0,5816.0,5192.0,6249.0,6582.0,6288.0,5067.0,5562.0,5051.0,5288.0,5533.0,5843.0,68827.0
Saran,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6645.0,6422.0,6056.0,6791.0,7323.0,7664.0,7176.0,6974.0,6291.0,6169.0,5949.0,7151.0,80611.0
Saran,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4600.0,4445.0,4744.0,4892.0,4610.0,5636.0,4696.0,4995.0,4562.0,4551.0,4326.0,3876.0,55933.0
Saran,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,595.0,11.0,37.0,84.0,234.0,232.0,114.0,85.0,97.0,59.0,673.0,37.0,2258.0
Saran,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,1.0,2.0,5.0,7.0,3.0,0.0,0.0,0.0,0.0,518.0,0.0,537.0
Saran,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,196.0,156.0,151.0,140.0,176.0,63.0,79.0,104.0,195.0,65.0,126.0,65.0,1516.0
Saran,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,17.0,25.0,50.0,44.0,44.0,37.0,23.0,37.0,26.0,27.0,22.0,20.0,372.0
Saran,1.8,Number of pregnancy test kits used at SC level,TOTAL,75.0,197.0,19.0,27.0,43.0,157.0,176.0,190.0,276.0,250.0,322.0,277.0,2009.0
Saran,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,333.0,363.0,216.0,545.0,577.0,454.0,508.0,384.0,329.0,410.0,412.0,396.0,4927.0
Saran,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,784.0,698.0,791.0,829.0,1094.0,1073.0,1261.0,1553.0,1318.0,1281.0,1178.0,1039.0,12899.0
Saran,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1117.0,1061.0,1007.0,1374.0,1671.0,1527.0,1769.0,1937.0,1647.0,1691.0,1590.0,1435.0,17826.0
Saran,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,331.0,287.0,426.0,418.0,709.0,817.0,707.0,864.0,689.0,752.0,745.0,689.0,7434.0
Saran,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,4.0,0.0,2.0,6.0,0.0,0.0,17.0,34.0,21.0,12.0,0.0,96.0
Saran,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3523.0,3805.0,3478.0,4499.0,5701.0,4814.0,4990.0,4529.0,4154.0,3883.0,3943.0,3240.0,50559.0
Saran,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3194.0,3440.0,2574.0,3439.0,4677.0,4580.0,4142.0,4195.0,3842.0,3861.0,3879.0,2901.0,44724.0
Saran,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,525.0,1965.0,1110.0,591.0,725.0,1555.0,670.0,1797.0,448.0,2801.0,8959.0,2926.0,24072.0
Saran,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,236.0,1148.0,973.0,792.0,1250.0,869.0,562.0,1470.0,275.0,1554.0,3786.0,2352.0,15267.0
Saran,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,20.0,28.0,16.0,37.0,41.0,34.0,26.0,20.0,15.0,11.0,16.0,16.0,280.0
Saran,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saran,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,20.0,28.0,16.0,37.0,41.0,34.0,26.0,20.0,15.0,11.0,16.0,16.0,280.0
Saran,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,4.1.1.a,Number of male live births,TOTAL,2650.0,2485.0,2378.0,3105.0,3481.0,3290.0,3532.0,3322.0,3002.0,2904.0,2799.0,2382.0,35330.0
Saran,4.1.1.b,Number of female live births,TOTAL,2281.0,2313.0,2096.0,2751.0,3535.0,3009.0,3195.0,3143.0,2698.0,2540.0,2663.0,2186.0,32410.0
Saran,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4931.0,4798.0,4474.0,5856.0,7016.0,6299.0,6727.0,6465.0,5700.0,5444.0,5462.0,4568.0,67740.0
Saran,4.1.2,Number of still births,TOTAL,49.0,70.0,70.0,77.0,94.0,73.0,83.0,75.0,58.0,71.0,55.0,61.0,836.0
Saran,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,1.0,8.0,1.0,6.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,3.0,28.0
Saran,4.2.1,Number of Newborns weighed at birth,TOTAL,4753.0,4539.0,4295.0,5524.0,6952.0,6058.0,6393.0,6235.0,5435.0,5362.0,5293.0,4564.0,65403.0
Saran,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,109.0,109.0,127.0,132.0,134.0,106.0,160.0,89.0,91.0,65.0,49.0,63.0,1234.0
Saran,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4804.0,4701.0,4347.0,5719.0,7130.0,6196.0,6513.0,6361.0,5619.0,5473.0,5376.0,4675.0,66914.0
Saran,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,334.0,0.0,0.0,0.0,0.0,0.0,334.0
Saran,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,78.0,443.0,1.0,44.0,55.0,143.0,130.0,118.0,97.0,47.0,53.0,112.0,1321.0
Saran,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saran,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,78.0,443.0,1.0,44.0,55.0,143.0,464.0,118.0,97.0,47.0,53.0,112.0,1655.0
Saran,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,606.0,454.0,382.0,530.0,65.0,108.0,107.0,437.0,67.0,47.0,62.0,81.0,2946.0
Saran,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,10.0,0.0,0.0,40.0,0.0,0.0,0.0,0.0,0.0,9.0,4.0,68.0
Saran,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,459.0,456.0,386.0,522.0,38.0,126.0,113.0,107.0,87.0,64.0,77.0,96.0,2531.0
Saran,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,3.0,2.0,20.0,19.0,6.0,6.0,3.0,4.0,4.0,1.0,3.0,73.0
Saran,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2325.0,3079.0,2601.0,3892.0,4081.0,3659.0,3788.0,4204.0,3695.0,3173.0,3481.0,3059.0,41037.0
Saran,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2062.0,2733.0,2246.0,3380.0,3968.0,3539.0,4239.0,3472.0,3578.0,3118.0,3164.0,2634.0,38133.0
Saran,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,180.0,0.0,0.0,0.0,0.0,0.0,301.0,0.0,16.0,497.0
Saran,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Saran,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Saran,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1.0,1.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Saran,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,91.0,84.0,82.0,91.0,90.0,21.0,13.0,24.0,13.0,15.0,16.0,13.0,553.0
Saran,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,214.0,184.0,173.0,159.0,157.0,25.0,22.0,25.0,15.0,25.0,26.0,13.0,1038.0
Saran,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,305.0,268.0,255.0,250.0,247.0,46.0,35.0,49.0,28.0,40.0,42.0,26.0,1591.0
Saran,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,2.0,0.0,5.0
Saran,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,4.0,2.0,0.0,0.0,4.0,2.0,10.0,0.0,1.0,0.0,0.0,0.0,23.0
Saran,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,12.0,0.0,15.0
Saran,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saran,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,4.0,0.0,0.0,4.0,2.0,10.0,3.0,1.0,1.0,14.0,0.0,43.0
Saran,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,44.0,0.0,0.0,0.0,151.0,0.0,0.0,0.0,0.0,195.0
Saran,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saran,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,44.0,0.0,0.0,0.0,151.0,0.0,0.0,0.0,0.0,195.0
Saran,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,538.0,286.0,269.0,543.0,375.0,361.0,398.0,706.0,998.0,796.0,2583.0,1058.0,8911.0
Saran,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,195.0,174.0,12.0,185.0,37.0,99.0,33.0,338.0,488.0,353.0,931.0,230.0,3075.0
Saran,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,42.0,16.0,13.0,45.0,58.0,92.0,24.0,437.0,196.0,38.0,283.0,114.0,1358.0
Saran,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saran,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,775.0,476.0,294.0,773.0,470.0,552.0,455.0,1481.0,1682.0,1187.0,3797.0,1402.0,13344.0
Saran,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,26.0,16.0,,20.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25439.0,25501.0
Saran,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,163.0,0.0,0.0,0.0,0.0,0.0,0.0,163.0
Saran,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,14.0,0.0,0.0,0.0,2.0,6.0,6.0,5.0,34.0
Saran,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,15.0,8.0,13.0,3.0,0.0,4.0,0.0,0.0,0.0,4.0,3.0,7.0,57.0
Saran,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saran,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,15.0,8.0,14.0,3.0,14.0,167.0,0.0,0.0,2.0,10.0,9.0,12.0,254.0
Saran,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,611.0,527.0,577.0,638.0,652.0,700.0,719.0,755.0,752.0,786.0,768.0,844.0,8329.0
Saran,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,196.0,163.0,145.0,301.0,217.0,309.0,306.0,225.0,239.0,240.0,162.0,288.0,2791.0
Saran,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,1.0,,,82.0,11.0,29.0,6.0,1.0,21.0,20.0,23.0,12.0,206.0
Saran,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,139.0,59.0,39.0,61.0,49.0,65.0,35.0,81.0,84.0,12.0,52.0,88.0,764.0
Saran,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saran,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,947.0,749.0,761.0,1082.0,929.0,1103.0,1066.0,1062.0,1096.0,1058.0,1005.0,1232.0,12090.0
Saran,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,39.0,10.0,27.0,92.0,96.0,63.0,115.0,73.0,60.0,136.0,91.0,127.0,929.0
Saran,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,4.0,4.0
Saran,9.06,Number of IUCD removals,TOTAL,248.0,196.0,227.0,197.0,233.0,320.0,336.0,255.0,354.0,405.0,654.0,422.0,3847.0
Saran,9.07,Number of Oral Pills cycles distributed,TOTAL,2014.0,2645.0,2245.0,2121.0,2224.0,2250.0,2842.0,2446.0,3093.0,2989.0,5039.0,3257.0,33165.0
Saran,9.08,Number of Condom pieces distributed,TOTAL,18750.0,17717.0,14983.0,15514.0,17716.0,17540.0,20169.0,17399.0,20897.0,19777.0,24833.0,18648.0,223943.0
Saran,9.09,Number of Centchroman (weekly) pills given,TOTAL,96.0,141.0,56.0,16.0,98.0,97.0,149.0,19.0,145.0,97.0,26.0,104.0,1044.0
Saran,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,12.0,124.0,109.0,83.0,28.0,242.0,134.0,106.0,238.0,447.0,356.0,419.0,2298.0
Saran,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,3.0
Saran,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,3.0,0.0,0.0,14.0,26.0,2.0,0.0,2.0,0.0,0.0,0.0,47.0
Saran,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Saran,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Saran,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,6911.0,6264.0,5908.0,6904.0,8023.0,6907.0,7975.0,10630.0,8569.0,8207.0,8359.0,7350.0,92007.0
Saran,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,7711.0,7078.0,5872.0,6510.0,7080.0,7610.0,8163.0,9721.0,9041.0,1828.0,355.0,156.0,71125.0
Saran,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,7564.0,7337.0,6326.0,6611.0,7119.0,6984.0,7289.0,8554.0,9081.0,9300.0,4114.0,1931.0,82210.0
Saran,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,7427.0,7256.0,6249.0,6764.0,7829.0,7239.0,7014.0,7726.0,8134.0,9021.0,7746.0,5579.0,87984.0
Saran,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,36.0,0.0,0.0,0.0,0.0,0.0,7038.0,7044.0,7395.0,21513.0
Saran,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,13.0,0.0,44.0,0.0,0.0,0.0,0.0,0.0,4.0,3690.0,6015.0,9766.0
Saran,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,15.0,0.0,54.0,0.0,0.0,0.0,0.0,0.0,1.0,33.0,2775.0,2878.0
Saran,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,5542.0,4995.0,4782.0,5152.0,6972.0,6049.0,6007.0,6992.0,5213.0,5105.0,5171.0,4427.0,66407.0
Saran,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7667.0,7092.0,5856.0,6504.0,7089.0,7447.0,7444.0,9149.0,8874.0,7821.0,6876.0,7309.0,89128.0
Saran,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7502.0,7336.0,6314.0,6613.0,7130.0,6904.0,6677.0,7969.0,8965.0,9209.0,7187.0,7511.0,89317.0
Saran,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,7364.0,7190.0,6216.0,6762.0,7429.0,7106.0,6481.0,7258.0,8044.0,8948.0,7882.0,7934.0,88614.0
Saran,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2979.0,2877.0,2630.0,3507.0,4209.0,3548.0,4178.0,4352.0,3063.0,2353.0,3013.0,2876.0,39585.0
Saran,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,7677.0,7094.0,5810.0,6335.0,7066.0,7540.0,8174.0,9736.0,8795.0,2582.0,435.0,248.0,71492.0
Saran,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7595.0,7333.0,6326.0,6565.0,7061.0,6967.0,7250.0,8534.0,8923.0,8974.0,4316.0,1976.0,81820.0
Saran,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,7344.0,7208.0,6236.0,6780.0,7434.0,7202.0,6978.0,7727.0,8013.0,8780.0,7712.0,5523.0,86937.0
Saran,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5966.0,6497.0,6263.0,7172.0,7743.0,6955.0,6968.0,6597.0,7746.0,7348.0,6704.0,6463.0,82422.0
Saran,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4814.0,4653.0,3905.0,4047.0,4572.0,4827.0,4382.0,4197.0,4693.0,4950.0,5922.0,6109.0,57071.0
Saran,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1194.0,3971.0,5541.0,6286.0,6522.0,23516.0
Saran,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3167.0,3687.0,3162.0,3762.0,4190.0,3742.0,3635.0,3491.0,4127.0,3995.0,3564.0,3515.0,44037.0
Saran,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2771.0,2927.0,2862.0,3326.0,3604.0,3326.0,3171.0,3017.0,3600.0,3494.0,3158.0,3181.0,38437.0
Saran,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5938.0,6614.0,6024.0,7088.0,7794.0,7068.0,6806.0,6508.0,7727.0,7489.0,6722.0,6696.0,82474.0
Saran,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6215.0,5812.0,5042.0,4944.0,5780.0,5737.0,4832.0,5303.0,5700.0,5850.0,6461.0,6686.0,68362.0
Saran,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6190.0,5815.0,5064.0,4944.0,5728.0,5721.0,4662.0,5330.0,5659.0,5814.0,6427.0,6406.0,67760.0
Saran,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,22.0,12.0,0.0,23.0,14.0,40.0,0.0,2.0,3.0,14.0,0.0,0.0,130.0
Saran,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1567.0,1624.0,1263.0,1388.0,1570.0,1497.0,1463.0,1445.0,1684.0,1426.0,1772.0,1804.0,18503.0
Saran,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1469.0,1414.0,1214.0,1243.0,1370.0,1352.0,1281.0,1236.0,1450.0,1262.0,1548.0,1695.0,16534.0
Saran,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3036.0,3038.0,2477.0,2631.0,2940.0,2849.0,2744.0,2681.0,3134.0,2688.0,3320.0,3499.0,35037.0
Saran,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,655.0,790.0,780.0,877.0,772.0,1150.0,803.0,1117.0,1463.0,1399.0,1472.0,1351.0,12629.0
Saran,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1890.0,1995.0,1801.0,1615.0,1764.0,1901.0,2043.0,2006.0,2243.0,2420.0,2291.0,2572.0,24541.0
Saran,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2996.0,2984.0,2628.0,2419.0,2695.0,2922.0,3233.0,3389.0,3619.0,3596.0,3339.0,4019.0,37839.0
Saran,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,7.0,0.0,3.0,15.0,0.0,0.0,36.0,1.0,0.0,1.0,0.0,66.0
Saran,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,5.0,0.0,4.0,4.0,4.0,0.0,4.0,4.0,0.0,25.0
Saran,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3444.0,3625.0,3565.0,3397.0,3624.0,3381.0,3628.0,3657.0,3640.0,3672.0,3631.0,3308.0,42572.0
Saran,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3340.0,3531.0,3274.0,3223.0,3517.0,3356.0,3452.0,3629.0,3612.0,3568.0,3490.0,3232.0,41224.0
Saran,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2814.0,2937.0,2763.0,2693.0,2942.0,2796.0,2834.0,2952.0,2977.0,2995.0,2933.0,2656.0,34292.0
Saran,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,322.0,9.0,0.0,2.0,493.0,1837.0,3749.0,4986.0,6022.0,17420.0
Saran,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5148.0,5686.0,5178.0,6691.0,7121.0,6758.0,6666.0,5934.0,6615.0,6121.0,5436.0,5209.0,72563.0
Saran,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,3586.0,2713.0,2478.0,2956.0,2686.0,2466.0,2639.0,2862.0,2790.0,2728.0,3098.0,3270.0,34272.0
Saran,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,586.0,404.0,718.0,1545.0,798.0,848.0,863.0,954.0,929.0,766.0,959.0,812.0,10182.0
Saran,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,0.0,7.0,0.0,20.0,39.0
Saran,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,18.0,25.0
Saran,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,2.0,7.0
Saran,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,1.0,14.0,2.0,55.0,5.0,17.0,1.0,0.0,0.0,8.0,0.0,105.0
Saran,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,606.0,915.0,1118.0,1256.0,1693.0,1453.0,1069.0,1142.0,1280.0,1366.0,1346.0,1530.0,14774.0
Saran,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,4.0,0.0,10.0,6.0,178.0,35.0,7.0,1.0,0.0,10.0,14.0,5.0,270.0
Saran,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Saran,13.1,Number of Patients operated for cataract,TOTAL,236.0,130.0,0.0,0.0,0.0,0.0,0.0,500.0,503.0,329.0,0.0,743.0,2441.0
Saran,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,329.0,0.0,0.0,329.0
Saran,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Saran,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Saran,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2675.0,2733.0,2674.0,2586.0,2818.0,2650.0,2716.0,2780.0,2678.0,2754.0,2741.0,2478.0,-1.0
Saran,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Saran,14.05,Number of RKS meetings held during the month,TOTAL,11.0,10.0,8.0,15.0,10.0,16.0,8.0,9.0,202.0,11.0,16.0,10.0,326.0
Saran,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Saran,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,5.0,167.0,40.0,169.0,594.0,318.0,307.0,253.0,87.0,268.0,190.0,95.0,2493.0
Saran,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Saran,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Saran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2735.0,2476.0,2389.0,3156.0,3573.0,2935.0,3114.0,2748.0,2853.0,2489.0,2073.0,2003.0,32544.0
Saran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1915.0,2279.0,2922.0,2962.0,3002.0,3036.0,2701.0,3326.0,2458.0,2127.0,1864.0,1913.0,30505.0
Saran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2532.0,2434.0,2580.0,2967.0,3425.0,3038.0,3189.0,3150.0,2428.0,2281.0,2037.0,2226.0,32287.0
Saran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4927.0,5479.0,4403.0,5766.0,6487.0,6434.0,5972.0,5154.0,4872.0,4113.0,5764.0,4534.0,63905.0
Saran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,5267.0,4910.0,4969.0,6123.0,6998.0,5973.0,6303.0,5898.0,5281.0,4770.0,4110.0,4229.0,64831.0
Saran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6842.0,7758.0,7325.0,8728.0,9489.0,9470.0,8673.0,8480.0,7330.0,6240.0,7628.0,6447.0,94410.0
Saran,14.10.2.a,Number of death cases of Inpatient males,TOTAL,14.0,24.0,27.0,19.0,21.0,12.0,1.0,28.0,10.0,10.0,17.0,12.0,195.0
Saran,14.10.2.b,Number of death cases of Inpatient females,TOTAL,17.0,12.0,14.0,13.0,17.0,10.0,1.0,18.0,11.0,11.0,20.0,5.0,149.0
Saran,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,31.0,36.0,41.0,32.0,38.0,22.0,2.0,46.0,21.0,21.0,37.0,17.0,344.0
Saran,14.11,In-Patient Head Count at midnight,TOTAL,9932.0,9577.0,9248.0,11121.0,12323.0,11262.0,11464.0,11177.0,10875.0,8831.0,9299.0,9361.0,124470.0
Saran,14.12.1,OPD attendance (All),TOTAL,254419.0,245785.0,259293.0,313458.0,265905.0,260711.0,254182.0,257121.0,238453.0,242050.0,243957.0,251607.0,3086941.0
Saran,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,476.0,432.0,387.0,730.0,567.0,743.0,417.0,1463.0,1325.0,893.0,1919.0,1452.0,10804.0
Saran,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,6.0,6.0,64.0,7.0,2815.0,0.0,1.0,0.0,2899.0
Saran,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,5866.0,8221.0,7119.0,7833.0,7584.0,7090.0,6891.0,8301.0,4405.0,5294.0,5642.0,6479.0,80725.0
Saran,14.14.a,Number of patients given AYUSH treatment,TOTAL,39779.0,30156.0,41347.0,45010.0,44483.0,36169.0,38788.0,33681.0,26259.0,42850.0,39146.0,37915.0,455583.0
Saran,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,14755.0,13799.0,13413.0,15550.0,13813.0,13959.0,13248.0,14139.0,12809.0,12458.0,13482.0,9927.0,161352.0
Saran,14.14.c,Number of Adolescents counselled,TOTAL,192.0,151.0,461.0,1342.0,101.0,181.0,281.0,326.0,318.0,113.0,107.0,202.0,3775.0
Saran,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1679.0,1942.0,1659.0,1277.0,1664.0,1811.0,1355.0,2556.0,2405.0,1925.0,1895.0,2330.0,22498.0
Saran,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,15.0,27.0,135.0,116.0,48.0,101.0,23.0,39.0,26.0,27.0,24.0,22.0,603.0
Saran,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,201.0,186.0,164.0,231.0,201.0,0.0,1.0,406.0,466.0,173.0,300.0,450.0,2779.0
Saran,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,32.0,39.0,29.0,43.0,36.0,0.0,0.0,17.0,15.0,22.0,28.0,18.0,279.0
Saran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,243.0,185.0,255.0,232.0,279.0,28.0,0.0,176.0,51.0,100.0,246.0,54.0,1849.0
Saran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,31.0,26.0,17.0,26.0,19.0,0.0,0.0,7.0,9.0,51.0,12.0,0.0,198.0
Saran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,443.0,392.0,591.0,501.0,466.0,98.0,138.0,443.0,244.0,208.0,227.0,297.0,4048.0
Saran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,3.0,1.0,1.0,1.0,0.0,0.0,4.0,1.0,0.0,0.0,0.0,12.0
Saran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,887.0,763.0,1010.0,964.0,946.0,126.0,139.0,1025.0,761.0,481.0,773.0,801.0,8676.0
Saran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,64.0,68.0,47.0,70.0,56.0,0.0,0.0,28.0,25.0,73.0,40.0,18.0,489.0
Saran,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,16.0,0.0,43.0,58.0,10.0,0.0,0.0,0.0,127.0
Saran,15.3.a,Number of VDRL tests conducted on males,Number tested,2.0,3.0,0.0,0.0,10.0,0.0,172.0,0.0,0.0,0.0,0.0,0.0,187.0
Saran,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,2.0,2.0,0.0,0.0,5.0,0.0,126.0,0.0,0.0,0.0,0.0,0.0,135.0
Saran,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,1.0,0.0,279.0,565.0,534.0,774.0,1.0,841.0,2995.0
Saran,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,4.0,5.0,0.0,0.0,16.0,0.0,577.0,565.0,534.0,774.0,1.0,841.0,3317.0
Saran,15.4.1,Number of blood smears examined for Malaria,TOTAL,169.0,38.0,69.0,35.0,74.0,118.0,82.0,775.0,537.0,779.0,9.0,911.0,3596.0
Saran,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Saran,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,7200.0,2200.0,204.0,454.0,454.0,404.0,2354.0,804.0,154.0,12500.0,54.0,54.0,26836.0
Saran,16.1.1,Stock position of DPT vaccines,2. Stocks Received,6000.0,14000.0,2500.0,4500.0,3000.0,6500.0,2000.0,2000.0,3500.0,6000.0,2900.0,2000.0,54900.0
Saran,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Saran,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,11000.0,9500.0,2550.0,4491.0,3050.0,2354.0,804.0,2000.0,3500.0,2500.0,2846.0,1400.0,45995.0
Saran,16.1.1,Stock position of DPT vaccines,5. Total Stock,2200.0,6700.0,154.0,463.0,404.0,4550.0,3550.0,804.0,154.0,16000.0,108.0,654.0,35741.0
Saran,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,0.0,0.0,6300.0,5350.0,11650.0
Saran,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,0.0,220000.0,0.0,0.0,220000.0
Saran,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,0.0,,,,0.0
Saran,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,0.0,210000.0,950.0,,210950.0
Saran,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,5350.0,5350.0,20700.0
Saran,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,4700.0,800.0,184.0,484.0,159.0,0.0,725.0,675.0,1300.0,0.0,50.0,75.0,9152.0
Saran,16.1.2,Stock position of OPV vaccines,2. Stocks Received,3000.0,7000.0,2100.0,2400.0,3100.0,2900.0,1700.0,1900.0,1900.0,4500.0,2500.0,3800.0,36800.0
Saran,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Saran,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,6900.0,5900.0,1800.0,2725.0,3259.0,725.0,675.0,1900.0,1900.0,1100.0,2475.0,3775.0,33134.0
Saran,16.1.2,Stock position of OPV vaccines,5. Total Stock,800.0,1900.0,484.0,159.0,0.0,2175.0,1750.0,675.0,1300.0,3400.0,75.0,100.0,12818.0
Saran,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,5850.0,1400.0,18.0,18.0,180.0,180.0,1230.0,730.0,80.0,1153.0,30.0,80.0,10949.0
Saran,16.1.3,Stock position of TT vaccines,2. Stocks Received,4000.0,12000.0,3000.0,3400.0,3100.0,5500.0,2000.0,2300.0,3050.0,12000.0,2200.0,4200.0,56750.0
Saran,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Saran,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8450.0,7300.0,3000.0,5182.0,3100.0,,730.0,2300.0,3050.0,2200.0,2150.0,4200.0,41662.0
Saran,16.1.3,Stock position of TT vaccines,5. Total Stock,1400.0,6100.0,18.0,-1764.0,180.0,5680.0,2500.0,730.0,80.0,10953.0,80.0,80.0,26037.0
Saran,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Saran,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Saran,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Saran,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Saran,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4400.0,1100.0,532.0,532.0,82.0,0.0,1300.0,900.0,1150.0,0.0,0.0,50.0,10046.0
Saran,16.1.5,Stock position of BCG vaccines,2. Stocks Received,4000.0,5000.0,1900.0,2200.0,1300.0,3450.0,2000.0,2900.0,1900.0,7700.0,2700.0,3400.0,38450.0
Saran,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Saran,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7300.0,4600.0,1900.0,2650.0,1382.0,1300.0,900.0,2900.0,1900.0,2400.0,2650.0,3450.0,33332.0
Saran,16.1.5,Stock position of BCG vaccines,5. Total Stock,1100.0,1500.0,532.0,82.0,0.0,2150.0,2400.0,900.0,1150.0,5300.0,50.0,0.0,15164.0
Saran,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4550.0,550.0,139.0,139.0,139.0,139.0,1489.0,1039.0,739.0,0.0,0.0,50.0,8973.0
Saran,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000.0,12000.0,2500.0,3100.0,3200.0,,2500.0,1700.0,2700.0,9000.0,3200.0,3900.0,47800.0
Saran,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Saran,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,8000.0,6500.0,2500.0,3100.0,3200.0,1489.0,1039.0,1700.0,2700.0,2900.0,3150.0,3950.0,40228.0
Saran,16.1.6,Stock position of Measles vaccines,5. Total Stock,550.0,6050.0,139.0,139.0,139.0,-1350.0,2950.0,1039.0,739.0,6100.0,50.0,0.0,16545.0
Saran,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,12000.0,9500.0,0.0,0.0,0.0,0.0,2400.0,1400.0,1200.0,2000.0,300.0,0.0,28800.0
Saran,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,1700.0,2500.0,6000.0,3200.0,4350.0,20750.0
Saran,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Saran,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2500.0,8000.0,0.0,0.0,0.0,2400.0,1400.0,1700.0,2500.0,2500.0,3500.0,,24500.0
Saran,16.1.7,Stock position of JE vaccines,5. Total Stock,9500.0,1500.0,0.0,0.0,0.0,600.0,1000.0,1400.0,1200.0,5500.0,0.0,4350.0,25050.0
Saran,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,4300.0,700.0,30.0,70.0,20.0,20.0,1170.0,670.0,70.0,0.0,98.0,148.0,7296.0
Saran,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,4000.0,8000.0,2200.0,2680.0,3000.0,5000.0,2000.0,2200.0,2330.0,8998.0,2300.0,1850.0,44558.0
Saran,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Saran,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,7600.0,6200.0,2160.0,2730.0,3000.0,1170.0,670.0,2200.0,2400.0,2498.0,2250.0,,32878.0
Saran,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,700.0,2500.0,70.0,20.0,20.0,3850.0,2500.0,670.0,0.0,6500.0,148.0,1998.0,18976.0
Saran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,1150.0,850.0,850.0,750.0,450.0,9848.0,8984.0,8088.0,1784.0,1584.0,,34338.0
Saran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Saran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,,,,,,,,,0.0
Saran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,300.0,0.0,100.0,300.0,450.0,864.0,896.0,6304.0,200.0,0.0,,9414.0
Saran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,850.0,850.0,750.0,450.0,0.0,8984.0,8088.0,1784.0,1584.0,1584.0,0.0,24924.0
Saran,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,6000.0,1000.0,1000.0,1000.0,1000.0,264654.0,237654.0,209654.0,12654.0,6654.0,,741270.0
Saran,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Saran,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,,,,,,,,,0.0
Saran,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,5000.0,0.0,0.0,,1000.0,27000.0,28000.0,197000.0,6000.0,0.0,,264000.0
Saran,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,1000.0,1000.0,1000.0,1000.0,0.0,237654.0,209654.0,12654.0,6654.0,6654.0,0.0,477270.0
Saran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,1000.0,500.0,500.0,500.0,500.0,17832.0,,15082.0,5232.0,,,41146.0
Saran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,,0.0,,,,0.0
Saran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,,,,,,,,,0.0
Saran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,500.0,0.0,0.0,,500.0,1350.0,,9850.0,200.0,,,12400.0
Saran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,500.0,500.0,500.0,500.0,0.0,16482.0,0.0,5232.0,5032.0,0.0,0.0,28746.0
Saran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,,,,,6579.0,6012.0,5424.0,1287.0,1187.0,,20489.0
Saran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,0.0
Saran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Saran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,,,,,567.0,588.0,4137.0,100.0,0.0,,5392.0
Saran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,6012.0,5424.0,1287.0,1187.0,1187.0,0.0,15097.0
Saran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,0.0,,,,,,,,,1953.0,,1953.0
Saran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,,,,,,,,,0.0,,0.0
Saran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Saran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,0.0,,,,,,,,,0.0,,0.0
Saran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1953.0,0.0,1953.0
Saran,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,1200.0,1200.0,,600.0,600.0,200.0,200.0,0.0,0.0,,4000.0
Saran,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Saran,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Saran,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,200.0,400.0,,0.0,400.0,200.0,200.0,0.0,0.0,,1400.0
Saran,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,1000.0,800.0,0.0,600.0,200.0,0.0,0.0,0.0,0.0,0.0,2600.0
Saran,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,8500.0,8500.0,8500.0,4600.0,2500.0,1600.0,2600.0,2100.0,1600.0,,40500.0
Saran,16.3.02,Stock Position of Gloves,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,,2000.0
Saran,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Saran,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,1000.0,1500.0,1400.0,2100.0,900.0,1000.0,500.0,500.0,950.0,,9850.0
Saran,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,7500.0,7000.0,7100.0,2500.0,1600.0,2600.0,2100.0,1600.0,650.0,0.0,32650.0
Saran,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Saran,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Saran,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Saran,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Saran,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,1000.0,1000.0,1000.0,1000.0,23500.0,45300.0,28200.0,21000.0,12000.0,,134000.0
Saran,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,0.0,0.0,25000.0,50000.0,0.0,0.0,0.0,0.0,,75000.0
Saran,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,0.0,,,,,,,,,,0.0
Saran,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,0.0,0.0,0.0,2500.0,28200.0,17100.0,7200.0,9000.0,1500.0,,65500.0
Saran,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,1000.0,1000.0,1000.0,23500.0,45300.0,28200.0,21000.0,12000.0,10500.0,0.0,143500.0
Saran,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,3000.0,3000.0,3000.0,3000.0,3000.0,3000.0,3000.0,0.0,0.0,,21000.0
Saran,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Saran,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,0.0,,,,,,,,,,0.0
Saran,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,3000.0,3000.0,0.0,0.0,,6000.0
Saran,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,3000.0,3000.0,3000.0,3000.0,3000.0,0.0,0.0,0.0,0.0,0.0,15000.0
Saran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Saran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Saran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Saran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Saran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saran,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,72875.0,72875.0,72875.0,251875.0,320000.0,190000.0,120000.0,79000.0,35000.0,,1214500.0
Saran,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,0.0,0.0,300000.0,200000.0,0.0,0.0,0.0,0.0,0.0,,500000.0
Saran,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Saran,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,49000.0,13000.0,59000.0,131875.0,130000.0,70000.0,41000.0,44000.0,22000.0,,559875.0
Saran,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,23875.0,59875.0,313875.0,320000.0,190000.0,120000.0,79000.0,35000.0,13000.0,0.0,1154625.0
Saran,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,5760.0,5760.0,5760.0,13596.0,9996.0,22000.0,16500.0,12000.0,10696.0,,102068.0
Saran,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,0.0,0.0,17600.0,0.0,21000.0,0.0,0.0,0.0,0.0,,38600.0
Saran,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Saran,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,5616.0,72.0,4076.0,3600.0,8996.0,5500.0,4500.0,1304.0,3696.0,,37360.0
Saran,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,144.0,5688.0,19284.0,9996.0,22000.0,16500.0,12000.0,10696.0,7000.0,0.0,103308.0
Saran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,14200.0,14200.0,14200.0,6700.0,5600.0,4200.0,2700.0,1900.0,1700.0,,65400.0
Saran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Saran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Saran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,2800.0,2500.0,2200.0,1100.0,900.0,1500.0,400.0,200.0,700.0,,12300.0
Saran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,11400.0,11700.0,12000.0,5600.0,4700.0,2700.0,2300.0,1700.0,1000.0,0.0,53100.0
Saran,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,287.0,287.0,287.0,437.0,437.0,437.0,437.0,337.0,337.0,,3283.0
Saran,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,12000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,12000.0
Saran,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Saran,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,100.0,11750.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,,11950.0
Saran,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,187.0,537.0,287.0,437.0,437.0,437.0,337.0,337.0,337.0,0.0,3333.0
Saran,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,127500.0,127500.0,,87153.0,82000.0,227000.0,222000.0,211940.0,184817.0,,1269910.0
Saran,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,0.0,73153.0,,0.0,145000.0,0.0,0.0,0.0,262604.0,,480757.0
Saran,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Saran,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,34000.0,51500.0,,5153.0,0.0,5000.0,10060.0,27123.0,41050.0,,173886.0
Saran,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,93500.0,149153.0,0.0,82000.0,227000.0,222000.0,211940.0,184817.0,406371.0,0.0,1576781.0
Saran,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,100.0,200.0,800.0,6300.0,6400.0,20.0,5900.0,9500.0,0.0,9400.0,0.0,,38620.0
Saran,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,10000.0,9000.0,10000.0,10000.0,0.0,12000.0,10000.0,0.0,24000.0,0.0,20500.0,,105500.0
Saran,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Saran,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,9900.0,8400.0,4500.0,9900.0,6400.0,5900.0,9500.0,,9400.0,0.0,8800.0,,72700.0
Saran,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,200.0,800.0,6300.0,6400.0,0.0,6120.0,6400.0,9500.0,14600.0,9400.0,11700.0,0.0,71420.0
Saran,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,23200.0,24600.0,17800.0,87200.0,22800.0,57400.0,55000.0,59800.0,0.0,133600.0,35200.0,,516600.0
Saran,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000.0,74000.0,100000.0,0.0,119200.0,86400.0,72000.0,0.0,23200.0,0.0,132000.0,,706800.0
Saran,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Saran,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,98600.0,84800.0,30600.0,64400.0,84600.0,55000.0,59800.0,,133600.0,35200.0,28000.0,,674600.0
Saran,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,24600.0,13800.0,87200.0,22800.0,57400.0,88800.0,67200.0,59800.0,-110400.0,98400.0,139200.0,0.0,548800.0
Saran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2000.0,200.0,400.0,3400.0,5900.0,10400.0,5800.0,8000.0,1700.0,6900.0,1100.0,,45800.0
Saran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,3000.0,3000.0,4500.0,5000.0,12100.0,5000.0,8000.0,0.0,16000.0,0.0,13600.0,,70200.0
Saran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Saran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3000.0,2800.0,1500.0,2500.0,7600.0,5800.0,7800.0,,6900.0,1100.0,7700.0,,46700.0
Saran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2000.0,400.0,3400.0,5900.0,10400.0,9600.0,6000.0,8000.0,10800.0,5800.0,7000.0,0.0,69300.0
Saran,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Saran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Saran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Saran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Saran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Saran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Saran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Saran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Saran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Saran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Saran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Saran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Saran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Saran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Saran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Saran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Saran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Saran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Saran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Saran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Saran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Saran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Saran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Saran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Saran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Saran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Saran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Saran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Saran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Saran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Saran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Saran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Saran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Saran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Saran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Saran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Saran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Saran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Saran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Saran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Saran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Saran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Saran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Saran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Saran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Saran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Saran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Saran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Saran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Saran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Saran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Sheikhpura,1.1,Total number of pregnant women Registered for ANC,TOTAL,1342.0,1084.0,1766.0,1584.0,1448.0,1349.0,1104.0,1074.0,1098.0,1238.0,1428.0,1473.0,15988.0
Sheikhpura,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,667.0,546.0,898.0,819.0,745.0,901.0,768.0,573.0,698.0,635.0,724.0,826.0,8800.0
Sheikhpura,1.2,Number of Pregnant women registered under JSY,TOTAL,1322.0,1084.0,1766.0,1584.0,1448.0,1349.0,1104.0,1074.0,1098.0,1238.0,1428.0,1473.0,15968.0
Sheikhpura,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,745.0,745.0,901.0,912.0,1050.0,1003.0,1190.0,911.0,790.0,705.0,717.0,761.0,10430.0
Sheikhpura,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1229.0,1030.0,1629.0,1467.0,1290.0,1244.0,984.0,961.0,994.0,1029.0,1250.0,1287.0,14394.0
Sheikhpura,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1262.0,1062.0,1247.0,1546.0,1567.0,1543.0,1335.0,988.0,951.0,980.0,1031.0,1327.0,14839.0
Sheikhpura,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,510.0,563.0,658.0,858.0,933.0,992.0,1120.0,857.0,714.0,690.0,691.0,716.0,9302.0
Sheikhpura,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,6.0
Sheikhpura,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,5.0,20.0,13.0,77.0,167.0,102.0,90.0,46.0,62.0,82.0,39.0,66.0,769.0
Sheikhpura,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Sheikhpura,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,28.0,0.0,0.0,2.0,0.0,7.0,0.0,0.0,37.0
Sheikhpura,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,32.0,25.0,86.0,123.0,171.0,175.0,177.0,181.0,178.0,208.0,148.0,152.0,1656.0
Sheikhpura,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,89.0,69.0,40.0,5.0,10.0,2.0,5.0,16.0,11.0,4.0,9.0,23.0,283.0
Sheikhpura,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,121.0,94.0,126.0,128.0,181.0,177.0,182.0,197.0,189.0,212.0,157.0,175.0,1939.0
Sheikhpura,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,123.0,85.0,122.0,125.0,173.0,177.0,174.0,190.0,189.0,211.0,153.0,170.0,1892.0
Sheikhpura,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,704.0,753.0,790.0,1100.0,1393.0,1510.0,1456.0,1192.0,1253.0,1074.0,901.0,684.0,12810.0
Sheikhpura,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,175.0,202.0,226.0,327.0,399.0,421.0,339.0,308.0,852.0,765.0,578.0,215.0,4807.0
Sheikhpura,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,25.0,240.0,70.0,182.0,1097.0,2003.0,842.0,1159.0,1183.0,1052.0,874.0,666.0,9393.0
Sheikhpura,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,21.0,223.0,45.0,75.0,442.0,253.0,44.0,316.0,396.0,291.0,725.0,592.0,3423.0
Sheikhpura,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0
Sheikhpura,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Sheikhpura,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sheikhpura,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sheikhpura,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Sheikhpura,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,1.0,3.0,1.0,0.0,0.0,3.0,3.0,0.0,0.0,11.0
Sheikhpura,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Sheikhpura,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,2.0,5.0,10.0,15.0,22.0,16.0,23.0,20.0,11.0,12.0,22.0,11.0,169.0
Sheikhpura,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheikhpura,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,2.0,5.0,10.0,16.0,25.0,17.0,23.0,20.0,14.0,15.0,22.0,11.0,180.0
Sheikhpura,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Sheikhpura,4.1.1.a,Number of male live births,TOTAL,416.0,456.0,494.0,624.0,782.0,864.0,809.0,716.0,738.0,643.0,547.0,436.0,7525.0
Sheikhpura,4.1.1.b,Number of female live births,TOTAL,399.0,386.0,415.0,583.0,776.0,810.0,808.0,650.0,687.0,637.0,496.0,418.0,7065.0
Sheikhpura,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,815.0,842.0,909.0,1207.0,1558.0,1674.0,1617.0,1366.0,1425.0,1280.0,1043.0,854.0,14590.0
Sheikhpura,4.1.2,Number of still births,TOTAL,11.0,11.0,16.0,28.0,24.0,24.0,28.0,29.0,24.0,7.0,21.0,9.0,232.0
Sheikhpura,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Sheikhpura,4.2.1,Number of Newborns weighed at birth,TOTAL,796.0,841.0,905.0,1202.0,1556.0,1674.0,1605.0,1365.0,1423.0,1280.0,1040.0,849.0,14536.0
Sheikhpura,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,51.0,119.0,129.0,176.0,261.0,246.0,245.0,107.0,88.0,39.0,110.0,110.0,1681.0
Sheikhpura,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,822.0,835.0,904.0,1183.0,1529.0,1657.0,1594.0,1346.0,1419.0,1280.0,1040.0,849.0,14458.0
Sheikhpura,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,1.0,4.0,1.0,0.0,0.0,0.0,3.0,0.0,0.0,9.0
Sheikhpura,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Sheikhpura,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,2.0,12.0,10.0,15.0,22.0,16.0,23.0,20.0,11.0,12.0,,11.0,154.0
Sheikhpura,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheikhpura,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,2.0,12.0,10.0,16.0,26.0,17.0,23.0,20.0,11.0,15.0,0.0,11.0,163.0
Sheikhpura,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Sheikhpura,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,2.0,0.0,0.0,16.0,22.0,322.0,23.0,20.0,178.0,12.0,0.0,234.0,829.0
Sheikhpura,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,5.0,10.0,15.0,597.0,644.0,23.0,20.0,230.0,253.0,0.0,0.0,1797.0
Sheikhpura,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,2.0,0.0,3.0,4.0,1.0,0.0,12.0,0.0,,0.0,22.0
Sheikhpura,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,570.0,475.0,657.0,695.0,848.0,964.0,1127.0,964.0,978.0,996.0,372.0,276.0,8922.0
Sheikhpura,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,12.0,23.0,36.0,81.0,109.0,94.0,37.0,49.0,39.0,261.0,93.0,59.0,893.0
Sheikhpura,6.3,PNC maternal complications attended,TOTAL,0.0,12.0,0.0,0.0,22.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34.0
Sheikhpura,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,80.0,36.0,51.0,65.0,57.0,43.0,36.0,27.0,34.0,0.0,33.0,32.0,494.0
Sheikhpura,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,150.0,238.0,206.0,177.0,278.0,236.0,198.0,238.0,326.0,0.0,212.0,224.0,2483.0
Sheikhpura,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,230.0,274.0,257.0,242.0,335.0,279.0,234.0,265.0,360.0,0.0,245.0,256.0,2977.0
Sheikhpura,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0,1.0,0.0,5.0
Sheikhpura,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Sheikhpura,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0,2.0,0.0,6.0
Sheikhpura,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,58.0,28.0,20.0,141.0,64.0,203.0,159.0,267.0,221.0,314.0,299.0,254.0,2028.0
Sheikhpura,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,5.0,0.0,5.0,2.0,7.0,13.0,14.0,5.0,8.0,14.0,12.0,23.0,108.0
Sheikhpura,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,63.0,28.0,25.0,143.0,71.0,216.0,173.0,272.0,229.0,328.0,311.0,277.0,2136.0
Sheikhpura,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,3.0,0.0,0.0,1.0,1.0,0.0,0.0,6.0,6.0,19.0,16.0,52.0
Sheikhpura,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,4.0,4.0,1.0,5.0,4.0,7.0,5.0,,0.0,2.0,0.0,33.0
Sheikhpura,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,7.0,4.0,1.0,6.0,5.0,7.0,5.0,6.0,6.0,21.0,16.0,85.0
Sheikhpura,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,72.0,68.0,95.0,155.0,106.0,134.0,94.0,76.0,143.0,104.0,137.0,116.0,1300.0
Sheikhpura,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,36.0,46.0,39.0,387.0,60.0,141.0,36.0,45.0,161.0,71.0,56.0,143.0,1221.0
Sheikhpura,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,2.0,4.0,4.0,4.0,6.0,6.0,6.0,2.0,3.0,,1.0,2.0,40.0
Sheikhpura,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,110.0,118.0,138.0,546.0,172.0,281.0,136.0,123.0,307.0,175.0,194.0,261.0,2561.0
Sheikhpura,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,21.0,17.0,93.0,130.0,119.0,87.0,61.0,46.0,38.0,50.0,46.0,35.0,743.0
Sheikhpura,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheikhpura,9.06,Number of IUCD removals,TOTAL,32.0,30.0,38.0,63.0,28.0,38.0,23.0,46.0,30.0,72.0,47.0,54.0,501.0
Sheikhpura,9.07,Number of Oral Pills cycles distributed,TOTAL,254.0,105.0,39.0,111.0,57.0,132.0,24.0,110.0,84.0,285.0,400.0,313.0,1914.0
Sheikhpura,9.08,Number of Condom pieces distributed,TOTAL,934.0,862.0,904.0,1944.0,778.0,1152.0,460.0,411.0,544.0,1090.0,1149.0,804.0,11032.0
Sheikhpura,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,2.0,4.0,0.0,35.0,23.0,8.0,74.0
Sheikhpura,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,7.0,4.0,5.0,0.0,0.0,1.0,2.0,0.0,15.0,46.0,34.0,30.0,144.0
Sheikhpura,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Sheikhpura,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Sheikhpura,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Sheikhpura,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Sheikhpura,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,973.0,851.0,1085.0,1358.0,1747.0,2002.0,1880.0,1704.0,1743.0,1553.0,1346.0,1088.0,17330.0
Sheikhpura,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1177.0,758.0,1015.0,954.0,959.0,1291.0,1438.0,1767.0,1556.0,402.0,53.0,0.0,11370.0
Sheikhpura,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1346.0,972.0,987.0,917.0,1008.0,1027.0,1197.0,1255.0,1527.0,1548.0,565.0,278.0,12627.0
Sheikhpura,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1430.0,990.0,1078.0,959.0,1002.0,1078.0,1082.0,1124.0,1137.0,1478.0,1294.0,818.0,13470.0
Sheikhpura,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1213.0,1409.0,1338.0,3960.0
Sheikhpura,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,812.0,1284.0,2096.0
Sheikhpura,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,9.0,598.0,608.0
Sheikhpura,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,764.0,764.0,829.0,1114.0,1478.0,1651.0,1504.0,1340.0,1334.0,1060.0,934.0,747.0,13519.0
Sheikhpura,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1179.0,758.0,1015.0,954.0,959.0,1291.0,1438.0,1767.0,1556.0,1407.0,1268.0,1320.0,14912.0
Sheikhpura,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1357.0,972.0,985.0,915.0,1008.0,1027.0,1197.0,1255.0,1527.0,1559.0,1207.0,1476.0,14485.0
Sheikhpura,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1426.0,990.0,1076.0,959.0,1002.0,1078.0,1072.0,1124.0,1137.0,1472.0,1308.0,1385.0,14029.0
Sheikhpura,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,686.0,679.0,710.0,1028.0,1333.0,1517.0,1390.0,1121.0,1208.0,887.0,790.0,621.0,11970.0
Sheikhpura,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1178.0,757.0,1016.0,951.0,959.0,1290.0,1438.0,1767.0,1556.0,657.0,32.0,0.0,11601.0
Sheikhpura,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1347.0,973.0,986.0,920.0,1005.0,1027.0,1197.0,1255.0,1497.0,1528.0,560.0,225.0,12520.0
Sheikhpura,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1440.0,993.0,1098.0,973.0,1007.0,1081.0,1072.0,1124.0,1137.0,1441.0,1249.0,764.0,13379.0
Sheikhpura,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,957.0,817.0,1212.0,1279.0,1324.0,1080.0,1295.0,1234.0,1200.0,1012.0,840.0,923.0,13173.0
Sheikhpura,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1206.0,749.0,943.0,743.0,711.0,595.0,682.0,710.0,787.0,904.0,952.0,1112.0,10094.0
Sheikhpura,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,55.0,0.0,0.0,0.0,0.0,0.0,773.0,1029.0,750.0,754.0,3361.0
Sheikhpura,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,501.0,457.0,619.0,710.0,719.0,561.0,670.0,681.0,625.0,544.0,455.0,494.0,7036.0
Sheikhpura,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,456.0,373.0,593.0,569.0,605.0,519.0,625.0,552.0,575.0,468.0,375.0,429.0,6139.0
Sheikhpura,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,957.0,830.0,1212.0,1279.0,1324.0,1080.0,1295.0,1233.0,1200.0,1012.0,830.0,923.0,13175.0
Sheikhpura,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1214.0,790.0,992.0,788.0,713.0,604.0,682.0,710.0,797.0,904.0,972.0,1112.0,10278.0
Sheikhpura,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1219.0,790.0,992.0,788.0,713.0,604.0,682.0,710.0,797.0,904.0,972.0,1112.0,10283.0
Sheikhpura,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Sheikhpura,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,662.0,394.0,523.0,389.0,382.0,313.0,355.0,379.0,420.0,473.0,510.0,582.0,5382.0
Sheikhpura,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,580.0,360.0,453.0,389.0,331.0,282.0,327.0,331.0,378.0,429.0,455.0,530.0,4845.0
Sheikhpura,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1242.0,754.0,976.0,778.0,713.0,595.0,682.0,710.0,798.0,902.0,965.0,1112.0,10227.0
Sheikhpura,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,99.0,34.0,69.0,54.0,61.0,98.0,64.0,217.0,225.0,172.0,147.0,194.0,1434.0
Sheikhpura,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1092.0,136.0,280.0,209.0,120.0,114.0,158.0,250.0,160.0,162.0,188.0,189.0,3058.0
Sheikhpura,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,598.0,186.0,237.0,232.0,166.0,160.0,170.0,281.0,178.0,185.0,242.0,179.0,2814.0
Sheikhpura,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,8.0
Sheikhpura,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0
Sheikhpura,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,647.0,566.0,608.0,612.0,589.0,590.0,667.0,686.0,663.0,640.0,658.0,657.0,7583.0
Sheikhpura,10.4.2,Number of Immunisation sessions held during the month,TOTAL,636.0,555.0,597.0,602.0,581.0,590.0,665.0,677.0,654.0,638.0,650.0,648.0,7493.0
Sheikhpura,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,625.0,544.0,589.0,591.0,565.0,580.0,598.0,604.0,574.0,563.0,565.0,540.0,6938.0
Sheikhpura,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,77.0,0.0,0.0,0.0,0.0,0.0,510.0,873.0,758.0,897.0,3115.0
Sheikhpura,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,27.0,32.0,15.0,687.0,92.0,168.0,273.0,126.0,84.0,246.0,106.0,92.0,1948.0
Sheikhpura,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,7.0,9.0,2.0,791.0,16.0,2.0,25.0,13.0,9.0,3.0,62.0,24.0,963.0
Sheikhpura,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,7.0,5.0,3.0,571.0,13.0,0.0,7.0,5.0,4.0,2.0,13.0,7.0,637.0
Sheikhpura,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,0.0,10.0,51.0,11.0,84.0
Sheikhpura,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,84.0,104.0,974.0,1389.0,1189.0,1215.0,877.0,601.0,414.0,438.0,599.0,865.0,8749.0
Sheikhpura,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,16.0
Sheikhpura,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,13.1,Number of Patients operated for cataract,TOTAL,11.0,3.0,2.0,0.0,9.0,11.0,7.0,474.0,230.0,310.0,185.0,176.0,1418.0
Sheikhpura,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,11.0,3.0,2.0,0.0,9.0,11.0,7.0,474.0,230.0,310.0,0.0,176.0,1233.0
Sheikhpura,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Sheikhpura,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sheikhpura,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Sheikhpura,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Sheikhpura,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Sheikhpura,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,407.0,406.0,415.0,418.0,421.0,434.0,541.0,546.0,547.0,519.0,445.0,547.0,-1.0
Sheikhpura,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Sheikhpura,14.05,Number of RKS meetings held during the month,TOTAL,11.0,15.0,9.0,10.0,8.0,12.0,11.0,9.0,4.0,2.0,6.0,10.0,107.0
Sheikhpura,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,1.0,,,,,,,,-1.0
Sheikhpura,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,121.0,231.0,326.0,347.0,466.0,466.0,377.0,389.0,712.0,384.0,596.0,276.0,4691.0
Sheikhpura,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Sheikhpura,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Sheikhpura,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,274.0,226.0,193.0,207.0,209.0,217.0,278.0,256.0,127.0,201.0,65.0,67.0,2320.0
Sheikhpura,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,424.0,499.0,203.0,444.0,509.0,502.0,430.0,483.0,380.0,582.0,149.0,143.0,4748.0
Sheikhpura,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,131.0,165.0,133.0,178.0,207.0,192.0,259.0,397.0,159.0,149.0,164.0,92.0,2226.0
Sheikhpura,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,872.0,976.0,921.0,1589.0,1796.0,2076.0,1627.0,1696.0,1366.0,1191.0,592.0,613.0,15315.0
Sheikhpura,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,405.0,391.0,326.0,385.0,416.0,409.0,537.0,653.0,286.0,350.0,229.0,159.0,4546.0
Sheikhpura,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1296.0,1475.0,1124.0,2033.0,2305.0,2578.0,2057.0,2179.0,1746.0,1773.0,741.0,756.0,20063.0
Sheikhpura,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Sheikhpura,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,2.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0
Sheikhpura,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,1.0,2.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,6.0
Sheikhpura,14.11,In-Patient Head Count at midnight,TOTAL,2193.0,2093.0,1888.0,2797.0,3434.0,3395.0,3299.0,3904.0,2740.0,3044.0,3545.0,2402.0,34734.0
Sheikhpura,14.12.1,OPD attendance (All),TOTAL,49900.0,45943.0,58950.0,71033.0,64423.0,77423.0,56064.0,58255.0,44700.0,46692.0,57616.0,51189.0,682188.0
Sheikhpura,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,50.0,51.0,38.0,162.0,122.0,251.0,217.0,751.0,238.0,269.0,361.0,300.0,2810.0
Sheikhpura,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,0.0,17.0
Sheikhpura,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1135.0,1021.0,1037.0,1050.0,1078.0,1397.0,1171.0,1216.0,659.0,841.0,967.0,525.0,12097.0
Sheikhpura,14.14.a,Number of patients given AYUSH treatment,TOTAL,11135.0,12846.0,14640.0,15825.0,12791.0,16010.0,12965.0,14019.0,5329.0,10292.0,12926.0,10965.0,149743.0
Sheikhpura,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1435.0,1243.0,1301.0,1427.0,1421.0,1249.0,908.0,1325.0,559.0,1507.0,1430.0,1426.0,15231.0
Sheikhpura,14.14.c,Number of Adolescents counselled,TOTAL,5.0,0.0,40.0,25.0,48.0,174.0,28.0,66.0,14.0,0.0,0.0,0.0,400.0
Sheikhpura,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,165.0,135.0,248.0,335.0,285.0,392.0,321.0,237.0,229.0,379.0,541.0,426.0,3693.0
Sheikhpura,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0.0,2.0,0.0,8.0,9.0,11.0,16.0,2.0,3.0,3.0,1.0,9.0,64.0
Sheikhpura,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,129.0,94.0,100.0,227.0,136.0,88.0,85.0,136.0,1.0,124.0,102.0,158.0,1380.0
Sheikhpura,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,4.0,1.0,3.0,2.0,0.0,1.0,1.0,0.0,3.0,2.0,1.0,19.0
Sheikhpura,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,211.0,205.0,211.0,286.0,226.0,200.0,217.0,270.0,0.0,101.0,231.0,368.0,2526.0
Sheikhpura,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,2.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,3.0,2.0,12.0
Sheikhpura,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,295.0,183.0,180.0,178.0,251.0,146.0,83.0,179.0,0.0,283.0,280.0,172.0,2230.0
Sheikhpura,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,7.0
Sheikhpura,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,635.0,482.0,491.0,691.0,613.0,434.0,385.0,585.0,1.0,508.0,613.0,698.0,6136.0
Sheikhpura,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,5.0,3.0,3.0,5.0,0.0,2.0,1.0,0.0,8.0,5.0,3.0,38.0
Sheikhpura,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Sheikhpura,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Sheikhpura,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Sheikhpura,15.4.1,Number of blood smears examined for Malaria,TOTAL,4.0,6.0,9.0,32.0,36.0,43.0,45.0,23.0,0.0,6.0,4.0,53.0,261.0
Sheikhpura,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Sheikhpura,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1050.0,750.0,1500.0,800.0,1300.0,1950.0,800.0,1600.0,1450.0,600.0,1090.0,870.0,13760.0
Sheikhpura,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000.0,1000.0,0.0,1200.0,1000.0,0.0,1000.0,,0.0,1000.0,0.0,0.0,6200.0
Sheikhpura,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1300.0,250.0,700.0,700.0,350.0,1150.0,200.0,150.0,850.0,510.0,220.0,250.0,6630.0
Sheikhpura,16.1.1,Stock position of DPT vaccines,5. Total Stock,750.0,1500.0,800.0,1300.0,1950.0,800.0,1600.0,1450.0,600.0,1090.0,870.0,620.0,13330.0
Sheikhpura,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,1450.0,730.0,530.0,2710.0
Sheikhpura,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,1450.0,0.0,0.0,0.0,1450.0
Sheikhpura,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,0.0,720.0,200.0,310.0,1230.0
Sheikhpura,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1450.0,730.0,530.0,220.0,2930.0
Sheikhpura,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,900.0,450.0,575.0,125.0,425.0,1100.0,325.0,275.0,575.0,365.0,475.0,325.0,5915.0
Sheikhpura,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,500.0,0.0,1000.0,1000.0,0.0,0.0,325.0,440.0,610.0,0.0,600.0,4475.0
Sheikhpura,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,450.0,375.0,450.0,700.0,325.0,775.0,100.0,25.0,650.0,500.0,150.0,10.0,4510.0
Sheikhpura,16.1.2,Stock position of OPV vaccines,5. Total Stock,450.0,575.0,125.0,425.0,1100.0,325.0,225.0,575.0,365.0,475.0,325.0,915.0,5880.0
Sheikhpura,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,750.0,650.0,1100.0,250.0,650.0,1450.0,900.0,700.0,1350.0,750.0,950.0,700.0,10200.0
Sheikhpura,16.1.3,Stock position of TT vaccines,2. Stocks Received,500.0,500.0,0.0,1000.0,1000.0,0.0,0.0,1000.0,0.0,550.0,0.0,50.0,4600.0
Sheikhpura,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.1.3,Stock position of TT vaccines,4. Stock Distributed,600.0,50.0,850.0,600.0,200.0,550.0,200.0,350.0,600.0,350.0,250.0,0.0,4600.0
Sheikhpura,16.1.3,Stock position of TT vaccines,5. Total Stock,650.0,1100.0,250.0,650.0,1450.0,900.0,700.0,1350.0,750.0,950.0,700.0,750.0,10200.0
Sheikhpura,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sheikhpura,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Sheikhpura,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sheikhpura,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sheikhpura,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,900.0,950.0,1600.0,1300.0,1750.0,1350.0,500.0,300.0,340.0,290.0,500.0,400.0,10180.0
Sheikhpura,16.1.5,Stock position of BCG vaccines,2. Stocks Received,500.0,1000.0,0.0,1000.0,0.0,0.0,0.0,290.0,0.0,500.0,300.0,750.0,4340.0
Sheikhpura,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,450.0,350.0,300.0,550.0,400.0,850.0,200.0,250.0,50.0,290.0,400.0,0.0,4090.0
Sheikhpura,16.1.5,Stock position of BCG vaccines,5. Total Stock,950.0,1600.0,1300.0,1750.0,1350.0,500.0,300.0,340.0,290.0,500.0,400.0,1150.0,10430.0
Sheikhpura,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,730.0,645.0,1195.0,445.0,495.0,350.0,245.0,435.0,565.0,600.0,365.0,445.0,6515.0
Sheikhpura,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,1000.0,0.0,1000.0,0.0,500.0,600.0,1230.0,785.0,190.0,500.0,70.0,6875.0
Sheikhpura,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1085.0,450.0,750.0,950.0,145.0,605.0,410.0,1100.0,750.0,425.0,420.0,0.0,7090.0
Sheikhpura,16.1.6,Stock position of Measles vaccines,5. Total Stock,645.0,1195.0,445.0,495.0,350.0,245.0,435.0,565.0,600.0,365.0,445.0,515.0,6300.0
Sheikhpura,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,565.0,500.0,550.0,1615.0
Sheikhpura,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,1135.0,315.0,500.0,160.0,2110.0
Sheikhpura,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,570.0,380.0,450.0,0.0,1400.0
Sheikhpura,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,565.0,500.0,550.0,710.0,2325.0
Sheikhpura,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,640.0,750.0,1300.0,600.0,950.0,1600.0,700.0,850.0,2200.0,1710.0,1210.0,860.0,13370.0
Sheikhpura,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000.0,1000.0,0.0,1000.0,1000.0,0.0,400.0,1600.0,0.0,0.0,0.0,0.0,6000.0
Sheikhpura,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,890.0,450.0,700.0,650.0,350.0,900.0,250.0,250.0,490.0,500.0,350.0,350.0,6130.0
Sheikhpura,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,750.0,1300.0,600.0,950.0,1600.0,700.0,850.0,2200.0,1710.0,1210.0,860.0,510.0,13240.0
Sheikhpura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,655.0,655.0,335.0,35.0,,,,,,,,0.0,1680.0
Sheikhpura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,123.0,123.0
Sheikhpura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,0.0,0.0
Sheikhpura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,320.0,300.0,0.0,,,,,,,,0.0,620.0
Sheikhpura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,655.0,335.0,35.0,35.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,123.0,1183.0
Sheikhpura,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,0.0,0.0
Sheikhpura,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,1000.0,1000.0
Sheikhpura,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Sheikhpura,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Sheikhpura,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,1000.0
Sheikhpura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,0.0,0.0
Sheikhpura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,800.0,800.0
Sheikhpura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Sheikhpura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Sheikhpura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,800.0,800.0
Sheikhpura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,0.0,0.0
Sheikhpura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,500.0,500.0
Sheikhpura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Sheikhpura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Sheikhpura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,500.0
Sheikhpura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,18.0,,,,0.0,18.0
Sheikhpura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,10.0,10.0
Sheikhpura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Sheikhpura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,18.0,,,,0.0,18.0
Sheikhpura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0
Sheikhpura,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,8600.0,8600.0,7300.0,6300.0,4300.0,3800.0,600.0,200.0,,,,,39700.0
Sheikhpura,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,200.0,,,,200.0
Sheikhpura,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0
Sheikhpura,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,1300.0,1000.0,2000.0,500.0,3200.0,400.0,200.0,200.0,,,,8800.0
Sheikhpura,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,8600.0,7300.0,6300.0,4300.0,3800.0,600.0,200.0,0.0,0.0,0.0,0.0,0.0,31100.0
Sheikhpura,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,6000.0,4000.0,10000.0,7000.0,3000.0,1500.0,1500.0,500.0,,,,,33500.0
Sheikhpura,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,,500.0,,,,6500.0
Sheikhpura,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0
Sheikhpura,16.3.02,Stock Position of Gloves,4. Stock Distributed,2000.0,0.0,3000.0,4000.0,1500.0,0.0,1000.0,500.0,500.0,,,,12500.0
Sheikhpura,16.3.02,Stock Position of Gloves,5. Total Stock,4000.0,10000.0,7000.0,3000.0,1500.0,1500.0,500.0,0.0,0.0,0.0,0.0,0.0,27500.0
Sheikhpura,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Sheikhpura,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Sheikhpura,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Sheikhpura,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Sheikhpura,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,0.0,15000.0,,,,0.0,15000.0
Sheikhpura,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,15000.0,,15000.0,,,20000.0,50000.0
Sheikhpura,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,0.0,,0.0,,,,0.0
Sheikhpura,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,0.0,15000.0,15000.0,,,,30000.0
Sheikhpura,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,0.0,0.0,0.0,0.0,20000.0,35000.0
Sheikhpura,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Sheikhpura,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Sheikhpura,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Sheikhpura,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Sheikhpura,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Sheikhpura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Sheikhpura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Sheikhpura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Sheikhpura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,404200.0,404200.0,334200.0,244200.0,100000.0,50000.0,69800.0,69800.0,10000.0,,,,1686400.0
Sheikhpura,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,50000.0,0.0,,0.0,,,,50000.0
Sheikhpura,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0
Sheikhpura,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,70000.0,90000.0,144200.0,50000.0,30200.0,0.0,59800.0,10000.0,,,,454200.0
Sheikhpura,16.3.07,Stock Position of IFA Tablets,5. Total Stock,404200.0,334200.0,244200.0,100000.0,50000.0,69800.0,69800.0,10000.0,0.0,0.0,0.0,0.0,1282200.0
Sheikhpura,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,3100.0,3100.0,2100.0,0.0,,,0.0,9880.0,5048.0,272.0,,,23500.0
Sheikhpura,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,,,9880.0,,0.0,0.0,,,9880.0
Sheikhpura,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,0.0
Sheikhpura,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,1000.0,2100.0,0.0,,,0.0,4832.0,4776.0,272.0,,,12980.0
Sheikhpura,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,3100.0,2100.0,0.0,0.0,0.0,0.0,9880.0,5048.0,272.0,0.0,0.0,0.0,20400.0
Sheikhpura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,500.0,500.0,2500.0,2300.0,2300.0,2300.0,1800.0,1800.0,7800.0,1800.0,1800.0,1800.0,27200.0
Sheikhpura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,8200.0,0.0,0.0,0.0,0.0,10200.0
Sheikhpura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,200.0,0.0,0.0,500.0,0.0,2200.0,6000.0,0.0,0.0,0.0,8900.0
Sheikhpura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,500.0,2500.0,2300.0,2300.0,2300.0,1800.0,1800.0,7800.0,1800.0,1800.0,1800.0,1800.0,28500.0
Sheikhpura,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Sheikhpura,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Sheikhpura,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Sheikhpura,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Sheikhpura,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheikhpura,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,2000.0,279401.0,182424.0,173420.0,131424.0,118424.0,110424.0,110425.0,80425.0,20425.0,5425.0,5425.0,1219642.0
Sheikhpura,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,278401.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,13305.0,291706.0
Sheikhpura,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,4.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,4.0
Sheikhpura,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,1000.0,96977.0,9000.0,41996.0,13000.0,8000.0,0.0,30000.0,60000.0,15000.0,0.0,,274973.0
Sheikhpura,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,279401.0,182424.0,173420.0,131424.0,118424.0,110424.0,110424.0,80425.0,20425.0,5425.0,5425.0,18730.0,1236371.0
Sheikhpura,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2400.0,8600.0,17800.0,16000.0,14000.0,12200.0,9900.0,15900.0,12800.0,11300.0,8700.0,,129600.0
Sheikhpura,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,8000.0,10000.0,0.0,0.0,0.0,0.0,8000.0,,0.0,0.0,0.0,,26000.0
Sheikhpura,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Sheikhpura,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1800.0,800.0,1800.0,2000.0,1800.0,2300.0,2000.0,3100.0,1500.0,2600.0,2100.0,,21800.0
Sheikhpura,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8600.0,17800.0,16000.0,14000.0,12200.0,9900.0,15900.0,12800.0,11300.0,8700.0,6600.0,0.0,133800.0
Sheikhpura,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,900.0,16700.0,44300.0,31900.0,19900.0,11900.0,1900.0,40900.0,22100.0,51900.0,32100.0,,274500.0
Sheikhpura,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,40000.0,30000.0,0.0,0.0,0.0,0.0,40000.0,,29800.0,0.0,0.0,,139800.0
Sheikhpura,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Sheikhpura,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,24200.0,2400.0,12400.0,12000.0,8000.0,10000.0,1000.0,18800.0,0.0,19800.0,17000.0,,125600.0
Sheikhpura,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,16700.0,44300.0,31900.0,19900.0,11900.0,1900.0,40900.0,22100.0,51900.0,32100.0,15100.0,0.0,288700.0
Sheikhpura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1400.0,1200.0,6200.0,6200.0,6000.0,5600.0,5600.0,5600.0,3600.0,5700.0,4900.0,,52000.0
Sheikhpura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,5000.0,0.0,0.0,0.0,0.0,0.0,,2100.0,0.0,0.0,,9100.0
Sheikhpura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Sheikhpura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2200.0,0.0,0.0,200.0,400.0,0.0,0.0,2000.0,0.0,800.0,2000.0,,7600.0
Sheikhpura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1200.0,6200.0,6200.0,6000.0,5600.0,5600.0,5600.0,3600.0,5700.0,4900.0,2900.0,0.0,53500.0
Sheikhpura,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Sheikhpura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sheikhpura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sheikhpura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Sheikhpura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sheikhpura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sheikhpura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Sheikhpura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sheikhpura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sheikhpura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Sheikhpura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sheikhpura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sheikhpura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Sheikhpura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheikhpura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheikhpura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Sheikhpura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheikhpura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheikhpura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Sheikhpura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheikhpura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheikhpura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Sheikhpura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheikhpura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheikhpura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sheikhpura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheikhpura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheikhpura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Sheikhpura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Sheikhpura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Sheikhpura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Sheikhpura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Sheohar,1.1,Total number of pregnant women Registered for ANC,TOTAL,1858.0,1851.0,1803.0,2078.0,1670.0,1713.0,1394.0,1534.0,1485.0,1574.0,1688.0,1770.0,20418.0
Sheohar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,749.0,772.0,704.0,1048.0,881.0,928.0,647.0,905.0,1009.0,981.0,1047.0,1186.0,10857.0
Sheohar,1.2,Number of Pregnant women registered under JSY,TOTAL,1858.0,1851.0,1803.0,2078.0,1671.0,1713.0,1394.0,1534.0,1485.0,1574.0,1688.0,1770.0,20419.0
Sheohar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,951.0,1052.0,994.0,1290.0,1391.0,1378.0,1043.0,986.0,1095.0,1061.0,1095.0,1190.0,13526.0
Sheohar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1858.0,1813.0,1803.0,2078.0,1471.0,1522.0,1214.0,1331.0,1269.0,1351.0,1414.0,1471.0,18595.0
Sheohar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1475.0,1527.0,1295.0,1757.0,1846.0,1658.0,1480.0,1303.0,1417.0,1300.0,1385.0,1659.0,18102.0
Sheohar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,555.0,694.0,619.0,778.0,830.0,972.0,705.0,666.0,747.0,852.0,918.0,829.0,9165.0
Sheohar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,4.0
Sheohar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Sheohar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,3.0,4.0,0.0,11.0
Sheohar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,251.0,269.0,212.0,151.0,126.0,98.0,87.0,91.0,67.0,79.0,92.0,59.0,1582.0
Sheohar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,613.0,574.0,392.0,411.0,378.0,446.0,386.0,417.0,361.0,366.0,335.0,248.0,4927.0
Sheohar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,864.0,843.0,604.0,562.0,504.0,544.0,473.0,508.0,428.0,445.0,427.0,307.0,6509.0
Sheohar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,151.0,117.0,188.0,302.0,338.0,470.0,394.0,433.0,362.0,380.0,392.0,272.0,3799.0
Sheohar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,690.0,636.0,552.0,778.0,942.0,925.0,915.0,851.0,841.0,661.0,700.0,433.0,8924.0
Sheohar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,650.0,615.0,548.0,778.0,942.0,925.0,915.0,855.0,841.0,635.0,678.0,375.0,8757.0
Sheohar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,48.0,0.0,717.0,104.0,119.0,650.0,186.0,560.0,578.0,228.0,3190.0
Sheohar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,138.0,101.0,110.0,141.0,108.0,152.0,106.0,1938.0,2794.0
Sheohar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Sheohar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sheohar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sheohar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Sheohar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Sheohar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheohar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Sheohar,4.1.1.a,Number of male live births,TOTAL,886.0,762.0,603.0,708.0,746.0,763.0,723.0,659.0,648.0,586.0,585.0,382.0,8051.0
Sheohar,4.1.1.b,Number of female live births,TOTAL,750.0,698.0,543.0,602.0,689.0,702.0,668.0,670.0,590.0,505.0,514.0,356.0,7287.0
Sheohar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1636.0,1460.0,1146.0,1310.0,1435.0,1465.0,1391.0,1329.0,1238.0,1091.0,1099.0,738.0,15338.0
Sheohar,4.1.2,Number of still births,TOTAL,12.0,12.0,9.0,19.0,25.0,16.0,8.0,8.0,16.0,7.0,16.0,7.0,155.0
Sheohar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,4.2.1,Number of Newborns weighed at birth,TOTAL,1421.0,1400.0,1081.0,1202.0,1357.0,1361.0,1334.0,1273.0,1190.0,1023.0,1062.0,714.0,14418.0
Sheohar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,98.0,131.0,140.0,161.0,194.0,205.0,191.0,217.0,176.0,143.0,120.0,101.0,1877.0
Sheohar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1636.0,1472.0,1142.0,1310.0,1430.0,1463.0,1385.0,1328.0,1238.0,1088.0,1096.0,737.0,15325.0
Sheohar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Sheohar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Sheohar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheohar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Sheohar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Sheohar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,123.0,111.0,81.0,158.0,146.0,169.0,165.0,131.0,139.0,0.0,68.0,5.0,1296.0
Sheohar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,5.0,79.0,0.0,146.0,169.0,165.0,131.0,0.0,0.0,0.0,2.0,698.0
Sheohar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,123.0,20.0,82.0,158.0,146.0,169.0,165.0,7.0,139.0,0.0,28.0,0.0,1037.0
Sheohar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,248.0,252.0,172.0,365.0,436.0,475.0,432.0,485.0,513.0,392.0,417.0,285.0,4472.0
Sheohar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,688.0,780.0,485.0,392.0,356.0,73.0,70.0,54.0,149.0,55.0,69.0,43.0,3214.0
Sheohar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,40.0,45.0,30.0,49.0,57.0,85.0,74.0,58.0,53.0,45.0,28.0,30.0,594.0
Sheohar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,144.0,179.0,82.0,95.0,103.0,132.0,136.0,142.0,147.0,175.0,166.0,178.0,1679.0
Sheohar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,184.0,224.0,112.0,144.0,160.0,217.0,210.0,200.0,200.0,220.0,194.0,208.0,2273.0
Sheohar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Sheohar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sheohar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheohar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Sheohar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheohar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sheohar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheohar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheohar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,18.0,0.0,0.0,198.0,20.0,91.0,31.0,375.0,537.0,294.0,281.0,226.0,2071.0
Sheohar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sheohar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,13.0,87.0,64.0,42.0,0.0,207.0
Sheohar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheohar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,18.0,0.0,0.0,199.0,20.0,91.0,31.0,388.0,624.0,358.0,323.0,226.0,2278.0
Sheohar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheohar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sheohar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheohar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheohar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,146.0,91.0,98.0,147.0,120.0,116.0,78.0,78.0,69.0,85.0,165.0,85.0,1278.0
Sheohar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,29.0,28.0,55.0,408.0,64.0,135.0,28.0,52.0,80.0,46.0,66.0,43.0,1034.0
Sheohar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sheohar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4.0,2.0,1.0,6.0,7.0,3.0,3.0,3.0,1.0,2.0,7.0,6.0,45.0
Sheohar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheohar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,179.0,121.0,154.0,561.0,191.0,254.0,109.0,133.0,150.0,133.0,238.0,134.0,2357.0
Sheohar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,7.0,8.0,4.0,45.0,14.0,12.0,20.0,5.0,11.0,5.0,9.0,25.0,165.0
Sheohar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheohar,9.06,Number of IUCD removals,TOTAL,47.0,38.0,43.0,54.0,47.0,62.0,29.0,36.0,30.0,31.0,57.0,36.0,510.0
Sheohar,9.07,Number of Oral Pills cycles distributed,TOTAL,440.0,278.0,305.0,413.0,494.0,567.0,419.0,462.0,623.0,459.0,730.0,570.0,5760.0
Sheohar,9.08,Number of Condom pieces distributed,TOTAL,2803.0,2536.0,2121.0,2355.0,2571.0,2893.0,2481.0,2283.0,1963.0,1956.0,3397.0,3260.0,30619.0
Sheohar,9.09,Number of Centchroman (weekly) pills given,TOTAL,61.0,83.0,28.0,12.0,34.0,73.0,55.0,79.0,51.0,4.0,5.0,14.0,499.0
Sheohar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,191.0,149.0,223.0,196.0,162.0,195.0,174.0,170.0,162.0,187.0,207.0,233.0,2249.0
Sheohar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,33.0,0.0,13.0,0.0,30.0,77.0,22.0,0.0,6.0,181.0
Sheohar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Sheohar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Sheohar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1697.0,1662.0,1428.0,1407.0,1718.0,2202.0,1868.0,2120.0,1808.0,1801.0,1895.0,1418.0,21024.0
Sheohar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1953.0,1719.0,1420.0,1928.0,1414.0,1673.0,1655.0,2037.0,1860.0,386.0,20.0,5.0,16070.0
Sheohar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2014.0,1859.0,1435.0,1682.0,1534.0,1599.0,1478.0,1647.0,1916.0,1907.0,949.0,508.0,18528.0
Sheohar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1919.0,1811.0,1526.0,1862.0,1509.0,1626.0,1443.0,1439.0,1636.0,1820.0,1569.0,1151.0,19311.0
Sheohar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1440.0,1744.0,1627.0,4811.0
Sheohar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,51.0,806.0,1431.0,2288.0
Sheohar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,27.0,660.0,689.0
Sheohar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1283.0,1308.0,1197.0,1157.0,1322.0,1743.0,1400.0,1365.0,1425.0,1328.0,1524.0,989.0,16041.0
Sheohar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1947.0,1711.0,1419.0,1917.0,1232.0,1706.0,1570.0,1690.0,1729.0,1003.0,1456.0,1411.0,18791.0
Sheohar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2009.0,1859.0,1439.0,1670.0,1270.0,1605.0,1436.0,1412.0,1779.0,1561.0,1453.0,1789.0,19282.0
Sheohar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1915.0,1811.0,1528.0,1851.0,1255.0,1629.0,1370.0,1229.0,1493.0,1512.0,1529.0,1717.0,18839.0
Sheohar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,732.0,744.0,775.0,575.0,805.0,851.0,747.0,803.0,730.0,749.0,1008.0,677.0,9196.0
Sheohar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1973.0,1733.0,1419.0,1715.0,1404.0,1658.0,1646.0,2026.0,1844.0,348.0,54.0,5.0,15825.0
Sheohar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2015.0,1867.0,1438.0,1632.0,1504.0,1576.0,1484.0,1645.0,1898.0,1841.0,1014.0,515.0,18429.0
Sheohar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1930.0,1817.0,1526.0,1827.0,1489.0,1606.0,1426.0,1434.0,1610.0,1775.0,1567.0,1146.0,19153.0
Sheohar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1468.0,1585.0,1435.0,2120.0,1539.0,1746.0,1509.0,1592.0,1297.0,1034.0,1283.0,1344.0,17952.0
Sheohar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1534.0,1327.0,1137.0,1412.0,1067.0,1193.0,1112.0,1186.0,1077.0,952.0,1302.0,1391.0,14690.0
Sheohar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Sheohar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,776.0,872.0,793.0,1104.0,826.0,901.0,780.0,851.0,705.0,545.0,673.0,712.0,9538.0
Sheohar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,675.0,690.0,627.0,981.0,680.0,800.0,724.0,691.0,554.0,472.0,563.0,579.0,8036.0
Sheohar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1451.0,1562.0,1420.0,2085.0,1506.0,1701.0,1504.0,1542.0,1259.0,1017.0,1236.0,1291.0,17574.0
Sheohar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1648.0,1596.0,1228.0,1601.0,1076.0,1189.0,1122.0,1199.0,1201.0,1182.0,1345.0,1556.0,15943.0
Sheohar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1648.0,1596.0,1228.0,1601.0,985.0,1189.0,1083.0,1069.0,1175.0,1061.0,1332.0,1523.0,15490.0
Sheohar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,8.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,0.0,22.0
Sheohar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,523.0,491.0,408.0,563.0,459.0,506.0,483.0,505.0,417.0,333.0,479.0,471.0,5638.0
Sheohar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,468.0,393.0,337.0,418.0,393.0,420.0,412.0,451.0,360.0,290.0,400.0,393.0,4735.0
Sheohar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,991.0,884.0,745.0,981.0,852.0,926.0,895.0,956.0,777.0,623.0,879.0,864.0,10373.0
Sheohar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,21.0,20.0,19.0,9.0,53.0,81.0,50.0,56.0,98.0,102.0,34.0,116.0,659.0
Sheohar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,163.0,217.0,175.0,218.0,163.0,160.0,152.0,123.0,138.0,164.0,131.0,130.0,1934.0
Sheohar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,339.0,319.0,298.0,448.0,279.0,298.0,275.0,235.0,236.0,244.0,242.0,245.0,3458.0
Sheohar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Sheohar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Sheohar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,943.0,954.0,912.0,1021.0,916.0,961.0,944.0,909.0,974.0,940.0,938.0,927.0,11339.0
Sheohar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,919.0,932.0,809.0,997.0,903.0,959.0,931.0,887.0,954.0,906.0,846.0,868.0,10911.0
Sheohar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,570.0,727.0,677.0,774.0,698.0,733.0,720.0,721.0,723.0,748.0,721.0,725.0,8537.0
Sheohar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1402.0,1497.0,1366.0,2093.0,1539.0,1721.0,1488.0,1565.0,1291.0,1010.0,1259.0,1303.0,17534.0
Sheohar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,153.0,229.0,236.0,347.0,230.0,308.0,287.0,331.0,273.0,249.0,312.0,237.0,3192.0
Sheohar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,108.0,64.0,26.0,69.0,20.0,13.0,50.0,34.0,157.0,32.0,46.0,74.0,693.0
Sheohar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0,0.0,0.0,0.0,18.0
Sheohar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,611.0,673.0,911.0,1116.0,1108.0,1311.0,1014.0,799.0,644.0,542.0,607.0,702.0,10038.0
Sheohar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,94.0,78.0,177.0,45.0,394.0
Sheohar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,94.0,78.0,177.0,45.0,394.0
Sheohar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,30.0,20.0,45.0,30.0,0.0,0.0,25.0,0.0,150.0
Sheohar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0,150.0
Sheohar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Sheohar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Sheohar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,472.0,479.0,472.0,479.0,484.0,487.0,486.0,483.0,486.0,413.0,471.0,467.0,-1.0
Sheohar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Sheohar,14.05,Number of RKS meetings held during the month,TOTAL,3.0,2.0,5.0,3.0,6.0,2.0,2.0,1.0,4.0,3.0,1.0,4.0,36.0
Sheohar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Sheohar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,256.0,152.0,175.0,238.0,175.0,116.0,69.0,120.0,273.0,391.0,399.0,264.0,2628.0
Sheohar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Sheohar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Sheohar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,96.0,114.0,133.0,86.0,98.0,119.0,94.0,68.0,85.0,74.0,49.0,201.0,1217.0
Sheohar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,421.0,496.0,400.0,291.0,379.0,324.0,329.0,235.0,224.0,190.0,186.0,104.0,3579.0
Sheohar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,69.0,76.0,77.0,88.0,98.0,171.0,51.0,53.0,49.0,43.0,35.0,405.0,1215.0
Sheohar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,794.0,767.0,699.0,906.0,1008.0,1009.0,991.0,1063.0,1110.0,817.0,897.0,225.0,10286.0
Sheohar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,165.0,190.0,210.0,174.0,196.0,290.0,145.0,121.0,134.0,117.0,84.0,606.0,2432.0
Sheohar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1215.0,1263.0,1099.0,1197.0,1387.0,1333.0,1320.0,1298.0,1334.0,1007.0,1083.0,329.0,13865.0
Sheohar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,5.0,6.0,4.0,5.0,4.0,5.0,5.0,5.0,1.0,1.0,2.0,46.0
Sheohar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,1.0,3.0,3.0,5.0,0.0,2.0,3.0,2.0,2.0,2.0,1.0,27.0
Sheohar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6.0,6.0,9.0,7.0,10.0,4.0,7.0,8.0,7.0,3.0,3.0,3.0,73.0
Sheohar,14.11,In-Patient Head Count at midnight,TOTAL,1186.0,1204.0,1068.0,1222.0,1453.0,548.0,1295.0,1348.0,1354.0,1006.0,1175.0,880.0,13739.0
Sheohar,14.12.1,OPD attendance (All),TOTAL,42876.0,42125.0,42402.0,46031.0,44730.0,50544.0,34372.0,35636.0,34557.0,34498.0,37767.0,36540.0,482078.0
Sheohar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,19.0,0.0,1.0,137.0,20.0,95.0,31.0,355.0,610.0,350.0,214.0,102.0,1934.0
Sheohar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,279.0,356.0,440.0,414.0,430.0,406.0,322.0,320.0,217.0,236.0,249.0,271.0,3940.0
Sheohar,14.14.a,Number of patients given AYUSH treatment,TOTAL,5194.0,5798.0,6373.0,7392.0,6028.0,8360.0,4327.0,4882.0,4755.0,4724.0,4843.0,5489.0,68165.0
Sheohar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1235.0,1333.0,1676.0,1822.0,2523.0,2366.0,1643.0,2072.0,1713.0,1148.0,1505.0,1440.0,20476.0
Sheohar,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9.0,39.0,0.0,134.0,0.0,36.0,0.0,204.0,311.0,250.0,146.0,117.0,1246.0
Sheohar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1.0,6.0,0.0,5.0,0.0,2.0,0.0,2.0,9.0,0.0,0.0,0.0,25.0
Sheohar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,115.0,98.0,226.0,191.0,182.0,217.0,109.0,128.0,91.0,78.0,92.0,106.0,1633.0
Sheohar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,0.0,1.0,4.0,3.0,3.0,2.0,3.0,2.0,1.0,2.0,7.0,30.0
Sheohar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,41.0,23.0,54.0,245.0,92.0,147.0,76.0,404.0,545.0,460.0,387.0,311.0,2785.0
Sheohar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,0.0,3.0,1.0,1.0,0.0,2.0,3.0,4.0,2.0,4.0,4.0,26.0
Sheohar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,199.0,103.0,211.0,141.0,128.0,135.0,96.0,74.0,44.0,57.0,213.0,163.0,1564.0
Sheohar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,3.0
Sheohar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,355.0,224.0,491.0,577.0,402.0,499.0,281.0,606.0,680.0,595.0,692.0,580.0,5982.0
Sheohar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,0.0,4.0,6.0,5.0,3.0,4.0,6.0,6.0,4.0,6.0,11.0,59.0
Sheohar,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0,30.0,58.0
Sheohar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,133.0,69.0,202.0
Sheohar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33.0,109.0,142.0
Sheohar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,194.0,208.0,402.0
Sheohar,15.4.1,Number of blood smears examined for Malaria,TOTAL,43.0,13.0,20.0,11.0,9.0,30.0,2.0,10.0,3.0,13.0,13.0,27.0,194.0
Sheohar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Sheohar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Sheohar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Sheohar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Sheohar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheohar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Sheohar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sheohar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sheohar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Sheohar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sheohar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sheohar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Sheohar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sheohar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sheohar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Sheohar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sheohar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sheohar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Sheohar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheohar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheohar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Sheohar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheohar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheohar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Sheohar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheohar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheohar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Sheohar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheohar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheohar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sheohar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheohar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheohar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Sheohar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Sheohar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Sheohar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Sheohar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Sheohar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Sheohar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sheohar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Sheohar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Sheohar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sheohar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sheohar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sheohar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Sheohar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sheohar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Sheohar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sheohar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Sheohar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sheohar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sheohar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Sheohar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sheohar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Sheohar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Sheohar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Sheohar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Sheohar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Sheohar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Sheohar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Sheohar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Sheohar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Sitamarhi,1.1,Total number of pregnant women Registered for ANC,TOTAL,9104.0,9261.0,9582.0,9165.0,8120.0,7229.0,6013.0,6627.0,6393.0,6756.0,7193.0,8204.0,93647.0
Sitamarhi,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4587.0,4583.0,4511.0,4279.0,4124.0,3643.0,3215.0,3612.0,3536.0,4112.0,4558.0,4983.0,49743.0
Sitamarhi,1.2,Number of Pregnant women registered under JSY,TOTAL,9104.0,9271.0,9582.0,9165.0,8120.0,7234.0,6013.0,6625.0,6394.0,6756.0,7190.0,8194.0,93648.0
Sitamarhi,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5114.0,5557.0,5579.0,5393.0,5357.0,5452.0,4999.0,5449.0,5455.0,5472.0,5526.0,5870.0,65223.0
Sitamarhi,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,7372.0,8031.0,7773.0,7634.0,6548.0,5684.0,4891.0,5211.0,4873.0,5247.0,5687.0,6143.0,75094.0
Sitamarhi,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6851.0,7492.0,7292.0,8097.0,7626.0,6949.0,6176.0,5545.0,5590.0,5634.0,5669.0,6926.0,79847.0
Sitamarhi,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3369.0,4509.0,2723.0,2112.0,1281.0,927.0,748.0,878.0,748.0,1663.0,2947.0,3106.0,25011.0
Sitamarhi,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,69.0,18.0,6.0,20.0,8.0,13.0,9.0,10.0,13.0,20.0,9.0,3.0,198.0
Sitamarhi,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,9.0,1.0,4.0,0.0,5.0,10.0,8.0,6.0,10.0,3.0,0.0,62.0
Sitamarhi,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,634.0,842.0,1008.0,1039.0,1366.0,1174.0,999.0,1067.0,831.0,1499.0,1126.0,1120.0,12705.0
Sitamarhi,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,28.0,31.0,34.0,38.0,36.0,28.0,26.0,31.0,28.0,18.0,16.0,19.0,333.0
Sitamarhi,1.8,Number of pregnancy test kits used at SC level,TOTAL,54.0,54.0,74.0,49.0,35.0,81.0,68.0,50.0,32.0,34.0,34.0,82.0,647.0
Sitamarhi,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,152.0,179.0,186.0,186.0,173.0,148.0,172.0,182.0,233.0,234.0,161.0,158.0,2164.0
Sitamarhi,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,965.0,929.0,905.0,914.0,985.0,1148.0,1104.0,1248.0,1199.0,1145.0,1142.0,997.0,12681.0
Sitamarhi,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1117.0,1108.0,1091.0,1100.0,1158.0,1296.0,1276.0,1430.0,1432.0,1379.0,1303.0,1155.0,14845.0
Sitamarhi,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,371.0,441.0,406.0,330.0,387.0,456.0,568.0,611.0,595.0,469.0,513.0,390.0,5537.0
Sitamarhi,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,15.0,0.0,5.0,0.0,5.0,0.0,0.0,0.0,12.0,37.0
Sitamarhi,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3406.0,2948.0,2569.0,3489.0,4547.0,4974.0,4357.0,4620.0,4840.0,3890.0,3264.0,2676.0,45580.0
Sitamarhi,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3373.0,2893.0,2540.0,3462.0,4495.0,4939.0,4145.0,4563.0,4742.0,3806.0,3179.0,2667.0,44804.0
Sitamarhi,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1396.0,1175.0,1670.0,3074.0,4567.0,4667.0,3441.0,4796.0,2459.0,4564.0,3568.0,4058.0,39435.0
Sitamarhi,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,835.0,1319.0,1810.0,2614.0,3712.0,4007.0,3040.0,4160.0,2109.0,2998.0,3827.0,5815.0,36246.0
Sitamarhi,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,22.0,18.0,27.0,27.0,30.0,23.0,21.0,25.0,24.0,21.0,25.0,22.0,285.0
Sitamarhi,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sitamarhi,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,22.0,18.0,27.0,27.0,30.0,23.0,21.0,25.0,24.0,21.0,25.0,22.0,285.0
Sitamarhi,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,4.1.1.a,Number of male live births,TOTAL,2340.0,2084.0,1872.0,2305.0,2870.0,3108.0,2802.0,3045.0,3276.0,2594.0,2353.0,1924.0,30573.0
Sitamarhi,4.1.1.b,Number of female live births,TOTAL,2136.0,1891.0,1780.0,2228.0,2789.0,3107.0,2785.0,2960.0,2957.0,2619.0,2220.0,1903.0,29375.0
Sitamarhi,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4476.0,3975.0,3652.0,4533.0,5659.0,6215.0,5587.0,6005.0,6233.0,5213.0,4573.0,3827.0,59948.0
Sitamarhi,4.1.2,Number of still births,TOTAL,75.0,65.0,66.0,90.0,391.0,94.0,77.0,85.0,92.0,71.0,68.0,29.0,1203.0
Sitamarhi,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,7.0,4.0,5.0,11.0,8.0,3.0,6.0,4.0,0.0,6.0,7.0,7.0,68.0
Sitamarhi,4.2.1,Number of Newborns weighed at birth,TOTAL,3827.0,3443.0,3075.0,3952.0,5052.0,5492.0,5016.0,5384.0,5492.0,4492.0,3930.0,3186.0,52341.0
Sitamarhi,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,548.0,435.0,462.0,722.0,758.0,790.0,704.0,676.0,768.0,509.0,435.0,361.0,7168.0
Sitamarhi,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4097.0,3684.0,3297.0,4171.0,5317.0,5777.0,5249.0,5573.0,5793.0,4732.0,4167.0,3438.0,55295.0
Sitamarhi,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,268.0,29.0,19.0,43.0,29.0,100.0,77.0,69.0,64.0,19.0,59.0,28.0,804.0
Sitamarhi,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,18.0,13.0,20.0,21.0,16.0,21.0,10.0,27.0,22.0,13.0,13.0,14.0,208.0
Sitamarhi,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sitamarhi,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,286.0,42.0,39.0,64.0,45.0,121.0,87.0,96.0,86.0,32.0,72.0,42.0,1012.0
Sitamarhi,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,39.0,36.0,33.0,40.0,41.0,70.0,53.0,60.0,41.0,23.0,40.0,27.0,503.0
Sitamarhi,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,6.0,7.0,7.0,13.0,13.0,8.0,9.0,8.0,8.0,11.0,7.0,8.0,105.0
Sitamarhi,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,51.0,38.0,99.0,62.0,39.0,100.0,68.0,86.0,84.0,22.0,60.0,134.0,843.0
Sitamarhi,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,3.0,3.0,1.0,3.0,3.0,1.0,5.0,2.0,3.0,2.0,2.0,30.0
Sitamarhi,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3183.0,2509.0,2442.0,3439.0,4458.0,4685.0,4091.0,4817.0,4656.0,3997.0,3269.0,2749.0,44295.0
Sitamarhi,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1476.0,1306.0,1159.0,1260.0,1451.0,1640.0,1493.0,1683.0,1294.0,1672.0,1374.0,1098.0,16906.0
Sitamarhi,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,25.0,87.0,0.0,22.0,30.0,0.0,164.0
Sitamarhi,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,37.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0
Sitamarhi,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,37.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0
Sitamarhi,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,8.0,17.0,9.0,20.0,17.0,16.0,62.0,100.0,85.0,24.0,98.0,69.0,525.0
Sitamarhi,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,628.0,448.0,705.0,679.0,596.0,446.0,741.0,981.0,1041.0,602.0,682.0,664.0,8213.0
Sitamarhi,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,636.0,465.0,714.0,699.0,613.0,462.0,803.0,1081.0,1126.0,626.0,780.0,733.0,8738.0
Sitamarhi,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,2.0,0.0,21.0,5.0,6.0,1.0,9.0,16.0,45.0,6.0,3.0,114.0
Sitamarhi,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,1.0,3.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,7.0
Sitamarhi,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sitamarhi,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,2.0,1.0,22.0,8.0,6.0,1.0,9.0,17.0,46.0,6.0,3.0,121.0
Sitamarhi,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,2.0,0.0,10.0
Sitamarhi,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sitamarhi,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,0.0,0.0,0.0,21.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Sitamarhi,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,130.0,10.0,14.0,746.0,105.0,236.0,101.0,1759.0,2770.0,1906.0,1449.0,520.0,9746.0
Sitamarhi,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,3.0,7.0,0.0,145.0,241.0,177.0,186.0,96.0,856.0
Sitamarhi,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sitamarhi,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,130.0,10.0,14.0,747.0,108.0,243.0,101.0,1904.0,3011.0,2083.0,1635.0,616.0,10602.0
Sitamarhi,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,14.0,6.0,8.0,0.0,0.0,0.0,0.0,69.0,108.0,71.0,73.0,29.0,378.0
Sitamarhi,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,4.0,0.0,30.0,9.0,28.0,0.0,2.0,5.0,4.0,11.0,10.0,103.0
Sitamarhi,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,3.0,5.0,4.0,7.0,10.0,4.0,4.0,5.0,7.0,4.0,5.0,3.0,61.0
Sitamarhi,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sitamarhi,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,3.0,9.0,4.0,37.0,19.0,32.0,4.0,7.0,12.0,8.0,16.0,13.0,164.0
Sitamarhi,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,0.0,3.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,3.0
Sitamarhi,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,703.0,653.0,677.0,1509.0,643.0,781.0,616.0,788.0,840.0,806.0,885.0,868.0,9769.0
Sitamarhi,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,404.0,459.0,366.0,1563.0,362.0,552.0,372.0,445.0,527.0,364.0,396.0,358.0,6168.0
Sitamarhi,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Sitamarhi,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,25.0,22.0,13.0,28.0,38.0,66.0,45.0,18.0,28.0,21.0,19.0,25.0,348.0
Sitamarhi,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sitamarhi,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1132.0,1134.0,1056.0,3100.0,1043.0,1399.0,1033.0,1251.0,1395.0,1191.0,1300.0,1251.0,16285.0
Sitamarhi,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,21.0,45.0,32.0,27.0,24.0,75.0,76.0,44.0,87.0,40.0,21.0,40.0,532.0
Sitamarhi,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,0.0,0.0,0.0,0.0
Sitamarhi,9.06,Number of IUCD removals,TOTAL,370.0,376.0,283.0,334.0,348.0,326.0,297.0,373.0,347.0,285.0,304.0,272.0,3915.0
Sitamarhi,9.07,Number of Oral Pills cycles distributed,TOTAL,2525.0,2380.0,2132.0,3800.0,2039.0,2834.0,1909.0,2141.0,3251.0,2094.0,2174.0,2436.0,29715.0
Sitamarhi,9.08,Number of Condom pieces distributed,TOTAL,12159.0,11110.0,9050.0,24492.0,9192.0,12758.0,9440.0,9159.0,11664.0,9190.0,9343.0,11444.0,139001.0
Sitamarhi,9.09,Number of Centchroman (weekly) pills given,TOTAL,60.0,163.0,320.0,188.0,206.0,222.0,151.0,98.0,118.0,133.0,41.0,225.0,1925.0
Sitamarhi,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,580.0,502.0,471.0,820.0,458.0,674.0,431.0,414.0,592.0,460.0,463.0,576.0,6441.0
Sitamarhi,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Sitamarhi,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,7002.0,6355.0,6033.0,6766.0,7786.0,9529.0,7921.0,9786.0,9202.0,9258.0,7524.0,7017.0,94179.0
Sitamarhi,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,8017.0,6793.0,6374.0,6195.0,5489.0,7220.0,7636.0,9187.0,9199.0,1757.0,417.0,206.0,68490.0
Sitamarhi,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,8099.0,7435.0,6333.0,6599.0,5789.0,5938.0,6017.0,7506.0,8309.0,8804.0,3783.0,2066.0,76678.0
Sitamarhi,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,8054.0,7455.0,6514.0,6545.0,5987.0,6029.0,5500.0,6202.0,6704.0,7990.0,7195.0,5020.0,79195.0
Sitamarhi,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,45.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7605.0,7893.0,7237.0,22785.0
Sitamarhi,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,4055.0,6966.0,11026.0
Sitamarhi,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,99.0,3145.0,3244.0
Sitamarhi,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3075.0,2821.0,2745.0,3120.0,4381.0,4891.0,3870.0,4176.0,4652.0,4430.0,4034.0,3271.0,45466.0
Sitamarhi,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7939.0,6711.0,6236.0,6059.0,5407.0,7070.0,7016.0,7205.0,7483.0,8234.0,7574.0,7132.0,84066.0
Sitamarhi,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7980.0,7371.0,6314.0,6559.0,5675.0,5846.0,5535.0,5852.0,6433.0,8525.0,6879.0,7898.0,80867.0
Sitamarhi,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,7953.0,7402.0,6385.0,6475.0,5867.0,5976.0,5133.0,4956.0,5252.0,7462.0,6661.0,7044.0,76566.0
Sitamarhi,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1428.0,1216.0,1306.0,1466.0,2191.0,2608.0,2012.0,2288.0,2786.0,2435.0,2358.0,2044.0,24138.0
Sitamarhi,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,7668.0,6466.0,6350.0,5847.0,5435.0,6704.0,7667.0,9155.0,9228.0,2421.0,393.0,83.0,67417.0
Sitamarhi,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7942.0,7023.0,6199.0,6370.0,5738.0,5510.0,6045.0,7424.0,8314.0,8666.0,3969.0,2113.0,75313.0
Sitamarhi,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,7674.0,7084.0,6515.0,6312.0,5963.0,5630.0,5528.0,6088.0,6726.0,7873.0,6713.0,5170.0,77276.0
Sitamarhi,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5896.0,6415.0,6927.0,7424.0,6401.0,3892.0,6680.0,7544.0,5449.0,7054.0,6036.0,5922.0,75640.0
Sitamarhi,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5118.0,4446.0,4321.0,4778.0,3609.0,1950.0,2768.0,3226.0,3021.0,3890.0,3976.0,4424.0,45527.0
Sitamarhi,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,11.0
Sitamarhi,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2956.0,3242.0,3561.0,3723.0,3247.0,2009.0,3389.0,3998.0,2837.0,3716.0,3176.0,2998.0,38852.0
Sitamarhi,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2727.0,2944.0,3136.0,3338.0,2967.0,1765.0,3084.0,3396.0,2508.0,3255.0,2778.0,2819.0,34717.0
Sitamarhi,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5683.0,6186.0,6697.0,7061.0,6214.0,3774.0,6473.0,7394.0,5345.0,6971.0,5954.0,5817.0,73569.0
Sitamarhi,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5531.0,4990.0,4732.0,5066.0,3952.0,3417.0,3242.0,3564.0,4014.0,4592.0,4718.0,5312.0,53130.0
Sitamarhi,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5612.0,5021.0,4679.0,5067.0,3740.0,3387.0,3069.0,3041.0,3373.0,4414.0,4705.0,5207.0,51315.0
Sitamarhi,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,38.0,0.0,7.0,5.0,0.0,0.0,5.0,0.0,11.0,0.0,0.0,10.0,76.0
Sitamarhi,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1218.0,1056.0,1190.0,1259.0,857.0,695.0,753.0,793.0,855.0,1069.0,881.0,1066.0,11692.0
Sitamarhi,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1023.0,943.0,990.0,1127.0,743.0,595.0,663.0,655.0,730.0,868.0,722.0,856.0,9915.0
Sitamarhi,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2241.0,1999.0,2180.0,2386.0,1600.0,1290.0,1416.0,1448.0,1585.0,1937.0,1603.0,1922.0,21607.0
Sitamarhi,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,330.0,452.0,320.0,334.0,243.0,382.0,264.0,354.0,363.0,422.0,411.0,339.0,4214.0
Sitamarhi,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,798.0,741.0,777.0,750.0,649.0,684.0,676.0,591.0,790.0,961.0,836.0,996.0,9249.0
Sitamarhi,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2037.0,1676.0,1595.0,2297.0,1561.0,1489.0,2527.0,1783.0,2109.0,2690.0,1804.0,2305.0,23873.0
Sitamarhi,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,5.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Sitamarhi,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,11.0,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0
Sitamarhi,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2972.0,2970.0,2896.0,3043.0,3014.0,2900.0,2809.0,2876.0,2984.0,2969.0,2916.0,2958.0,35307.0
Sitamarhi,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2977.0,2953.0,2895.0,2958.0,2854.0,2850.0,2771.0,2811.0,2942.0,2913.0,2845.0,2890.0,34659.0
Sitamarhi,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2363.0,2341.0,2318.0,2384.0,2331.0,2310.0,2235.0,2279.0,2390.0,2383.0,2319.0,2316.0,27969.0
Sitamarhi,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Sitamarhi,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1827.0,2039.0,2211.0,4454.0,3517.0,1760.0,2524.0,3062.0,7297.0,2338.0,1978.0,1834.0,34841.0
Sitamarhi,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,635.0,493.0,561.0,6029.0,6168.0,417.0,485.0,588.0,23427.0,497.0,698.0,561.0,40559.0
Sitamarhi,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,12.0,56.0,57.0,3977.0,2575.0,55.0,66.0,26.0,5565.0,27.0,45.0,28.0,12489.0
Sitamarhi,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,17.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0
Sitamarhi,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,17.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0
Sitamarhi,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,10.0,6.0,2.0,0.0,0.0,2.0,0.0,0.0,48.0,5.0,0.0,76.0
Sitamarhi,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1915.0,1962.0,2442.0,2013.0,3079.0,1875.0,1497.0,1487.0,1546.0,1916.0,2336.0,2319.0,24387.0
Sitamarhi,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,6.0,8.0,0.0,0.0,0.0,0.0,6.0,12.0,10.0,7.0,4.0,2.0,55.0
Sitamarhi,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,13.1,Number of Patients operated for cataract,TOTAL,5.0,0.0,8.0,2.0,0.0,6.0,55.0,0.0,282.0,289.0,538.0,471.0,1656.0
Sitamarhi,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,153.0,0.0,0.0,0.0,0.0,153.0
Sitamarhi,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,5.0,0.0,36.0,0.0,0.0,8.0,0.0,0.0,0.0,49.0
Sitamarhi,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,250.0,36.0,0.0,286.0
Sitamarhi,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,1.0,-1.0
Sitamarhi,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Sitamarhi,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2182.0,2139.0,2176.0,2147.0,2072.0,2198.0,2183.0,2207.0,2220.0,2182.0,2134.0,2185.0,-1.0
Sitamarhi,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,1.0,-1.0
Sitamarhi,14.05,Number of RKS meetings held during the month,TOTAL,14.0,11.0,11.0,14.0,11.0,12.0,10.0,14.0,11.0,13.0,10.0,10.0,141.0
Sitamarhi,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,1.0,-1.0
Sitamarhi,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,750.0,673.0,541.0,1070.0,1110.0,1270.0,1299.0,1436.0,1169.0,1048.0,961.0,892.0,12219.0
Sitamarhi,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Sitamarhi,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,,,,,1.0,,0.0,,0.0,-1.0
Sitamarhi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1284.0,1337.0,1224.0,1351.0,1582.0,1557.0,1615.0,1467.0,1395.0,1181.0,1078.0,1107.0,16178.0
Sitamarhi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1532.0,1421.0,1651.0,1667.0,2040.0,1660.0,1615.0,1341.0,1455.0,1344.0,1312.0,1703.0,18741.0
Sitamarhi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1644.0,1595.0,1547.0,1639.0,1589.0,2027.0,1719.0,1596.0,2490.0,1581.0,1498.0,1681.0,20606.0
Sitamarhi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3853.0,3390.0,3453.0,4496.0,4968.0,4961.0,4025.0,6213.0,5583.0,5518.0,4553.0,3401.0,54414.0
Sitamarhi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2928.0,2932.0,2771.0,2990.0,3171.0,3584.0,3334.0,3063.0,3885.0,2762.0,2576.0,2788.0,36784.0
Sitamarhi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5385.0,4811.0,5104.0,6163.0,7008.0,6621.0,5640.0,7554.0,7038.0,6862.0,5865.0,5104.0,73155.0
Sitamarhi,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,9.0,10.0,3.0,6.0,8.0,13.0,13.0,3.0,4.0,5.0,5.0,84.0
Sitamarhi,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,7.0,7.0,12.0,10.0,12.0,3.0,9.0,7.0,5.0,7.0,1.0,87.0
Sitamarhi,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,16.0,17.0,15.0,16.0,20.0,16.0,22.0,10.0,9.0,12.0,6.0,171.0
Sitamarhi,14.11,In-Patient Head Count at midnight,TOTAL,6086.0,5549.0,5386.0,6829.0,7201.0,7726.0,6408.0,8161.0,8390.0,7428.0,6703.0,7177.0,83044.0
Sitamarhi,14.12.1,OPD attendance (All),TOTAL,185521.0,182099.0,178064.0,185801.0,169928.0,205472.0,162595.0,170439.0,139820.0,153728.0,154684.0,156836.0,2044987.0
Sitamarhi,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,171.0,50.0,62.0,775.0,166.0,315.0,102.0,1956.0,3070.0,2121.0,1687.0,721.0,11196.0
Sitamarhi,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,360.0,0.0,0.0,0.0,0.0,0.0,381.0,606.0,0.0,0.0,0.0,1347.0
Sitamarhi,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,6370.0,6347.0,6926.0,6385.0,6945.0,7415.0,6379.0,6939.0,6666.0,6834.0,6837.0,5888.0,79931.0
Sitamarhi,14.14.a,Number of patients given AYUSH treatment,TOTAL,40287.0,43502.0,38662.0,36331.0,40394.0,43331.0,42921.0,40621.0,23532.0,43569.0,41198.0,42201.0,476549.0
Sitamarhi,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4001.0,3706.0,4422.0,5675.0,4087.0,5036.0,3290.0,3915.0,3698.0,3533.0,3122.0,3092.0,47577.0
Sitamarhi,14.14.c,Number of Adolescents counselled,TOTAL,195.0,222.0,277.0,384.0,286.0,163.0,176.0,124.0,66.0,74.0,311.0,507.0,2785.0
Sitamarhi,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1193.0,1331.0,1667.0,2098.0,1375.0,1747.0,1431.0,1907.0,1764.0,1707.0,1627.0,1999.0,19846.0
Sitamarhi,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,31.0,34.0,37.0,35.0,39.0,36.0,34.0,62.0,44.0,24.0,19.0,44.0,439.0
Sitamarhi,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,816.0,624.0,644.0,1031.0,633.0,253.0,862.0,995.0,1071.0,712.0,406.0,1166.0,9213.0
Sitamarhi,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,31.0,33.0,22.0,28.0,20.0,17.0,24.0,21.0,26.0,4.0,12.0,10.0,248.0
Sitamarhi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1004.0,556.0,720.0,1517.0,712.0,276.0,817.0,1688.0,2308.0,1392.0,833.0,1502.0,13325.0
Sitamarhi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,16.0,22.0,13.0,22.0,16.0,11.0,13.0,16.0,17.0,2.0,7.0,6.0,161.0
Sitamarhi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1810.0,1417.0,1643.0,2255.0,1665.0,707.0,909.0,1573.0,1464.0,1052.0,395.0,1284.0,16174.0
Sitamarhi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,2.0,2.0,5.0,3.0,0.0,1.0,1.0,3.0,3.0,0.0,1.0,22.0
Sitamarhi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3630.0,2597.0,3007.0,4803.0,3010.0,1236.0,2588.0,4256.0,4843.0,3156.0,1634.0,3952.0,38712.0
Sitamarhi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,48.0,57.0,37.0,55.0,39.0,28.0,38.0,38.0,46.0,9.0,19.0,17.0,431.0
Sitamarhi,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,434.0,0.0,0.0,0.0,0.0,434.0
Sitamarhi,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,38.0,41.0,90.0
Sitamarhi,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,246.0,355.0,197.0,798.0
Sitamarhi,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,245.0,112.0,122.0,479.0
Sitamarhi,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,502.0,505.0,360.0,1367.0
Sitamarhi,15.4.1,Number of blood smears examined for Malaria,TOTAL,363.0,245.0,509.0,438.0,463.0,443.0,285.0,334.0,270.0,239.0,344.0,341.0,4274.0
Sitamarhi,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Sitamarhi,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,2910.0,4230.0,3266.0,,,,,,,,10406.0
Sitamarhi,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,3000.0,3000.0,10000.0,,,,,,,,16000.0
Sitamarhi,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,1680.0,3914.0,3752.0,,,,,,,,9346.0
Sitamarhi,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,4230.0,3316.0,9514.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17060.0
Sitamarhi,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Sitamarhi,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Sitamarhi,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Sitamarhi,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Sitamarhi,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,2122.0,2017.0,1916.0,,,,,,,,6055.0
Sitamarhi,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,1500.0,3000.0,2000.0,,,,,,,,6500.0
Sitamarhi,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,1231.0,3001.0,2175.0,,,,,,,,6407.0
Sitamarhi,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,2391.0,2016.0,1741.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6148.0
Sitamarhi,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,2295.0,3064.0,1464.0,,,,,,,,6823.0
Sitamarhi,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,2000.0,2000.0,500.0,,,,,,,,4500.0
Sitamarhi,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,0.0,0.0,125.0,,,,,,,,125.0
Sitamarhi,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,1231.0,3450.0,1425.0,,,,,,,,6106.0
Sitamarhi,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,3064.0,1614.0,414.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5092.0
Sitamarhi,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,1561.0,2533.0,2310.0,,,,,,,,6404.0
Sitamarhi,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,2000.0,2000.0,1500.0,,,,,,,,5500.0
Sitamarhi,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,1028.0,2123.0,1467.0,,,,,,,,4618.0
Sitamarhi,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,2533.0,2410.0,2343.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7286.0
Sitamarhi,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,3774.0,3162.0,730.0,,,,,,,,7666.0
Sitamarhi,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,1500.0,1500.0,1000.0,,,,,,,,4000.0
Sitamarhi,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,2117.0,3882.0,1526.0,,,,,,,,7525.0
Sitamarhi,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,3157.0,780.0,204.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4141.0
Sitamarhi,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,1655.0,1530.0,1686.0,,,,,,,,4871.0
Sitamarhi,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,1500.0,3000.0,1200.0,,,,,,,,5700.0
Sitamarhi,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,1625.0,2744.0,1725.0,,,,,,,,6094.0
Sitamarhi,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,1530.0,1786.0,1161.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4477.0
Sitamarhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,9900.0,,,,,,,,,,9900.0
Sitamarhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,0.0,,,,,,,,,,0.0
Sitamarhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,0.0,,,,,,,,,,0.0
Sitamarhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,4500.0,,,,,,,,,,4500.0
Sitamarhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,5400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5400.0
Sitamarhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,23980.0,,,,,,,,,,23980.0
Sitamarhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,0.0,,,,,,,,,,0.0
Sitamarhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,0.0,,,,,,,,,,0.0
Sitamarhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,10000.0,,,,,,,,,,10000.0
Sitamarhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,13980.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13980.0
Sitamarhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,11600.0,,,,,,,,,,11600.0
Sitamarhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,11600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11600.0
Sitamarhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Sitamarhi,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Sitamarhi,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Sitamarhi,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,0.0,,,,,,,,0.0
Sitamarhi,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Sitamarhi,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Sitamarhi,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sitamarhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,9090.0,14781.0,3756.0,,,,,,,,27627.0
Sitamarhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,15000.0,0.0,10000.0,,,,,,,,25000.0
Sitamarhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,9309.0,10825.0,8600.0,,,,,,,,28734.0
Sitamarhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,14781.0,3956.0,5156.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23893.0
Sitamarhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,47657.0,109302.0,18036.0,,,,,,,,174995.0
Sitamarhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,125000.0,0.0,170000.0,,,,,,,,295000.0
Sitamarhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,63355.0,90466.0,64304.0,,,,,,,,218125.0
Sitamarhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,109302.0,18836.0,123732.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,251870.0
Sitamarhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,6324.0,7915.0,2437.0,,,,,,,,16676.0
Sitamarhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,6000.0,0.0,8000.0,,,,,,,,14000.0
Sitamarhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,,0.0
Sitamarhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,4409.0,5278.0,5000.0,,,,,,,,14687.0
Sitamarhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,7915.0,2637.0,5437.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15989.0
Sitamarhi,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Sitamarhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sitamarhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sitamarhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Sitamarhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sitamarhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sitamarhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Sitamarhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sitamarhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sitamarhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Sitamarhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sitamarhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sitamarhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Sitamarhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sitamarhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sitamarhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Sitamarhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sitamarhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sitamarhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Sitamarhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sitamarhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sitamarhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Sitamarhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sitamarhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sitamarhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sitamarhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Sitamarhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Sitamarhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Sitamarhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Sitamarhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Sitamarhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Sitamarhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Siwan,1.1,Total number of pregnant women Registered for ANC,TOTAL,7351.0,6999.0,7195.0,7731.0,7516.0,7523.0,6693.0,7303.0,6850.0,6665.0,7167.0,7665.0,86658.0
Siwan,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3484.0,3280.0,3588.0,3687.0,3906.0,3685.0,3530.0,4087.0,4168.0,4195.0,4372.0,4431.0,46413.0
Siwan,1.2,Number of Pregnant women registered under JSY,TOTAL,7351.0,6997.0,7195.0,7731.0,7516.0,7523.0,6693.0,7303.0,6850.0,6665.0,7166.0,7664.0,86654.0
Siwan,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5421.0,5548.0,5771.0,5588.0,5909.0,6218.0,5926.0,6129.0,5726.0,5418.0,5336.0,5646.0,68636.0
Siwan,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6407.0,6093.0,6244.0,6607.0,6588.0,6530.0,5901.0,6302.0,5966.0,5848.0,6274.0,6711.0,75471.0
Siwan,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6748.0,6785.0,6342.0,6877.0,7269.0,7147.0,6984.0,6376.0,6512.0,5895.0,5962.0,7250.0,80147.0
Siwan,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,5014.0,4819.0,5122.0,3915.0,3865.0,4541.0,4707.0,4814.0,4617.0,4698.0,4715.0,5044.0,55871.0
Siwan,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,166.0,193.0,156.0,166.0,219.0,34.0,37.0,150.0,25.0,84.0,149.0,24.0,1403.0
Siwan,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,3.0,20.0,30.0,18.0,1.0,3.0,2.0,3.0,4.0,0.0,0.0,89.0
Siwan,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2273.0,2465.0,2337.0,2426.0,2367.0,2352.0,1951.0,2203.0,2246.0,2195.0,2305.0,2575.0,27695.0
Siwan,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,14.0,0.0,0.0,23.0,0.0,38.0
Siwan,1.8,Number of pregnancy test kits used at SC level,TOTAL,1443.0,1299.0,1508.0,1443.0,1227.0,1396.0,1356.0,1348.0,1899.0,1768.0,2084.0,2497.0,19268.0
Siwan,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,456.0,413.0,410.0,506.0,613.0,519.0,515.0,512.0,498.0,518.0,443.0,485.0,5888.0
Siwan,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,576.0,553.0,581.0,698.0,786.0,750.0,651.0,691.0,749.0,647.0,587.0,561.0,7830.0
Siwan,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1032.0,966.0,991.0,1204.0,1399.0,1269.0,1166.0,1203.0,1247.0,1165.0,1030.0,1046.0,13718.0
Siwan,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,417.0,411.0,470.0,522.0,601.0,530.0,483.0,496.0,508.0,490.0,458.0,414.0,5800.0
Siwan,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,6.0,0.0,0.0,4.0,0.0,6.0,0.0,0.0,0.0,4.0,2.0,22.0
Siwan,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2918.0,3095.0,2813.0,3761.0,4415.0,4064.0,3480.0,3457.0,3280.0,3403.0,3332.0,2818.0,40836.0
Siwan,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2782.0,2919.0,2559.0,3553.0,4106.0,3817.0,3271.0,3264.0,3136.0,3211.0,3164.0,2658.0,38440.0
Siwan,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2901.0,2649.0,308.0,673.0,1488.0,2251.0,994.0,1584.0,1943.0,2597.0,4399.0,3710.0,25497.0
Siwan,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,752.0,1319.0,1192.0,1475.0,1234.0,1054.0,601.0,228.0,1104.0,1675.0,2772.0,3284.0,16690.0
Siwan,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Siwan,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Siwan,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Siwan,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Siwan,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,3.0,0.0,2.0,1.0,0.0,2.0,0.0,0.0,0.0,1.0,3.0,12.0
Siwan,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,22.0,16.0,12.0,13.0,25.0,11.0,8.0,21.0,18.0,5.0,6.0,7.0,164.0
Siwan,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Siwan,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,22.0,19.0,12.0,15.0,26.0,11.0,10.0,21.0,18.0,5.0,7.0,10.0,176.0
Siwan,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Siwan,4.1.1.a,Number of male live births,TOTAL,2025.0,2064.0,1986.0,2555.0,2992.0,2735.0,2407.0,2437.0,2394.0,2366.0,2313.0,2011.0,28285.0
Siwan,4.1.1.b,Number of female live births,TOTAL,1906.0,1971.0,1802.0,2391.0,2789.0,2562.0,2173.0,2175.0,2113.0,2158.0,2006.0,1835.0,25881.0
Siwan,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3931.0,4035.0,3788.0,4946.0,5781.0,5297.0,4580.0,4612.0,4507.0,4524.0,4319.0,3846.0,54166.0
Siwan,4.1.2,Number of still births,TOTAL,47.0,64.0,57.0,89.0,100.0,99.0,75.0,70.0,70.0,57.0,51.0,56.0,835.0
Siwan,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,50.0,45.0,22.0,49.0,51.0,48.0,37.0,47.0,78.0,65.0,79.0,86.0,657.0
Siwan,4.2.1,Number of Newborns weighed at birth,TOTAL,3778.0,3928.0,3638.0,4782.0,5651.0,5078.0,4492.0,4414.0,4312.0,4203.0,4207.0,3686.0,52169.0
Siwan,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,76.0,81.0,76.0,126.0,161.0,122.0,66.0,136.0,110.0,97.0,93.0,96.0,1240.0
Siwan,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3773.0,3969.0,3689.0,4751.0,5679.0,4934.0,4533.0,4474.0,4356.0,4386.0,4211.0,3693.0,52448.0
Siwan,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,203.0,140.0,80.0,47.0,113.0,220.0,206.0,201.0,225.0,193.0,199.0,175.0,2002.0
Siwan,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,9.0,6.0,8.0,10.0,5.0,7.0,5.0,4.0,6.0,8.0,8.0,80.0
Siwan,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,110.0,90.0,70.0,98.0,86.0,84.0,125.0,109.0,65.0,56.0,67.0,71.0,1031.0
Siwan,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Siwan,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,317.0,239.0,156.0,153.0,209.0,309.0,338.0,315.0,294.0,255.0,274.0,254.0,3113.0
Siwan,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Siwan,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,31.0,136.0,124.0,203.0,218.0,208.0,38.0,196.0,218.0,186.0,192.0,168.0,1918.0
Siwan,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,4.0,4.0,3.0,3.0,9.0,3.0,2.0,2.0,2.0,2.0,2.0,41.0
Siwan,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,174.0,115.0,46.0,153.0,123.0,171.0,184.0,161.0,177.0,154.0,163.0,143.0,1764.0
Siwan,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,110.0,90.0,70.0,98.0,86.0,84.0,125.0,109.0,65.0,56.0,67.0,71.0,1031.0
Siwan,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1724.0,1623.0,1638.0,2084.0,1992.0,2022.0,1898.0,2041.0,2064.0,1892.0,2071.0,1584.0,22633.0
Siwan,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1748.0,1961.0,1809.0,2165.0,2398.0,2263.0,2072.0,2222.0,2062.0,1936.0,1888.0,1750.0,24274.0
Siwan,6.3,PNC maternal complications attended,TOTAL,0.0,3.0,4.0,4.0,4.0,5.0,0.0,6.0,0.0,5.0,2.0,2.0,35.0
Siwan,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Siwan,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Siwan,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Siwan,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,80.0,74.0,76.0,75.0,71.0,68.0,49.0,56.0,54.0,57.0,62.0,154.0,876.0
Siwan,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,172.0,154.0,175.0,185.0,179.0,196.0,161.0,194.0,196.0,204.0,174.0,185.0,2175.0
Siwan,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,252.0,228.0,251.0,260.0,250.0,264.0,210.0,250.0,250.0,261.0,236.0,339.0,3051.0
Siwan,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,54.0,54.0,36.0,88.0,76.0,84.0,0.0,62.0,59.0,325.0,68.0,46.0,952.0
Siwan,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,1.0,0.0,0.0,1.0,3.0,1.0,2.0,1.0,0.0,2.0,2.0,13.0
Siwan,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,1.0,0.0,0.0,1.0,0.0,2.0
Siwan,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Siwan,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,0.0,0.0,1.0,3.0,1.0,3.0,1.0,0.0,3.0,2.0,15.0
Siwan,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,2.0,0.0,1.0,1.0,1.0,0.0,2.0,3.0,3.0,1.0,3.0,2.0,19.0
Siwan,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Siwan,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,,,0.0,,0.0,,0.0,,,0.0,0.0,0.0
Siwan,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Siwan,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Siwan,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,179.0,84.0,79.0,335.0,229.0,575.0,154.0,857.0,960.0,809.0,1113.0,870.0,6244.0
Siwan,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,45.0,26.0,31.0,64.0,49.0,121.0,62.0,176.0,248.0,193.0,323.0,149.0,1487.0
Siwan,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,22.0,21.0,11.0,14.0,14.0,22.0,16.0,70.0,48.0,44.0,84.0,43.0,409.0
Siwan,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Siwan,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,246.0,131.0,121.0,413.0,292.0,718.0,232.0,1103.0,1256.0,1046.0,1520.0,1062.0,8140.0
Siwan,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,50.0,52.0,41.0,40.0,35.0,23.0,21.0,56.0,26.0,39.0,47.0,50.0,480.0
Siwan,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,1.0,5.0,0.0,9.0
Siwan,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,10.0,6.0,2.0,1.0,6.0,3.0,0.0,4.0,4.0,1.0,2.0,2.0,41.0
Siwan,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Siwan,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,10.0,6.0,2.0,3.0,6.0,3.0,0.0,4.0,5.0,2.0,7.0,2.0,50.0
Siwan,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Siwan,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1150.0,1076.0,1360.0,1590.0,1457.0,1574.0,1539.0,1708.0,1877.0,1561.0,1536.0,1616.0,18044.0
Siwan,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,223.0,210.0,268.0,488.0,332.0,456.0,321.0,336.0,413.0,360.0,339.0,313.0,4059.0
Siwan,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,20.0,27.0,34.0,112.0,63.0,89.0,47.0,50.0,80.0,45.0,47.0,24.0,638.0
Siwan,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,50.0,51.0,43.0,109.0,54.0,59.0,21.0,21.0,19.0,36.0,50.0,44.0,557.0
Siwan,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Siwan,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1443.0,1364.0,1705.0,2299.0,1906.0,2178.0,1928.0,2115.0,2389.0,2002.0,1972.0,1997.0,23298.0
Siwan,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,37.0,45.0,37.0,136.0,140.0,95.0,45.0,36.0,87.0,86.0,144.0,111.0,999.0
Siwan,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,2.0,8.0,7.0,5.0,6.0,4.0,3.0,5.0,3.0,4.0,3.0,13.0,63.0
Siwan,9.06,Number of IUCD removals,TOTAL,426.0,441.0,445.0,553.0,488.0,508.0,534.0,574.0,593.0,550.0,579.0,544.0,6235.0
Siwan,9.07,Number of Oral Pills cycles distributed,TOTAL,3002.0,3242.0,3593.0,4464.0,3822.0,3720.0,3871.0,3292.0,4541.0,3357.0,3492.0,4113.0,44509.0
Siwan,9.08,Number of Condom pieces distributed,TOTAL,33126.0,37810.0,39657.0,39129.0,33273.0,37435.0,31419.0,29239.0,40392.0,35551.0,33507.0,35503.0,426041.0
Siwan,9.09,Number of Centchroman (weekly) pills given,TOTAL,1.0,24.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,28.0
Siwan,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,495.0,520.0,571.0,910.0,782.0,765.0,1014.0,869.0,1107.0,996.0,1403.0,1477.0,10909.0
Siwan,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Siwan,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5650.0,5722.0,5460.0,6735.0,7655.0,7637.0,6261.0,6740.0,6303.0,6379.0,5860.0,5462.0,75864.0
Siwan,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,6658.0,6185.0,5840.0,6314.0,6040.0,7001.0,7497.0,7690.0,6814.0,1077.0,146.0,38.0,61300.0
Siwan,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,6869.0,6743.0,5940.0,6254.0,6415.0,6276.0,6654.0,7041.0,7250.0,6463.0,2856.0,1032.0,69793.0
Siwan,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,7145.0,6927.0,6362.0,6815.0,6572.0,6496.0,6378.0,6638.0,6771.0,6708.0,5808.0,3975.0,76595.0
Siwan,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5425.0,5905.0,6467.0,17797.0
Siwan,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44.0,3319.0,5952.0,9315.0
Siwan,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,57.0,12.0,2942.0,3011.0
Siwan,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3933.0,3949.0,3719.0,5010.0,5560.0,4821.0,4298.0,3849.0,4266.0,4094.0,3796.0,3538.0,50833.0
Siwan,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,6539.0,6059.0,5459.0,6275.0,5862.0,4754.0,6713.0,5628.0,7141.0,5827.0,5227.0,6159.0,71643.0
Siwan,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,6752.0,6597.0,5540.0,6155.0,6195.0,4177.0,5789.0,5046.0,7216.0,6235.0,5182.0,6700.0,71584.0
Siwan,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,7114.0,6746.0,5921.0,6739.0,6322.0,4270.0,5645.0,4633.0,6696.0,6326.0,5366.0,6627.0,72405.0
Siwan,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2766.0,2817.0,2687.0,3558.0,3971.0,3803.0,3037.0,3056.0,3169.0,3113.0,2929.0,2362.0,37268.0
Siwan,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,6954.0,6339.0,6036.0,6449.0,6063.0,6974.0,7445.0,7730.0,6708.0,1259.0,441.0,84.0,62482.0
Siwan,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7009.0,7086.0,6239.0,6544.0,6511.0,6349.0,6725.0,7189.0,7174.0,6399.0,2842.0,1112.0,71179.0
Siwan,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,7014.0,7146.0,6687.0,7255.0,6763.0,6634.0,6488.0,6747.0,6671.0,6689.0,5823.0,4053.0,77970.0
Siwan,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5448.0,6563.0,6165.0,7686.0,7262.0,4540.0,7444.0,4850.0,6649.0,4913.0,4058.0,4653.0,70231.0
Siwan,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5133.0,5225.0,4149.0,5484.0,4806.0,3371.0,4640.0,3342.0,4640.0,3929.0,3737.0,4024.0,52480.0
Siwan,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,4831.0,5886.0,4740.0,6525.0,5399.0,4400.0,6807.0,4438.0,5718.0,3971.0,1894.0,4181.0,58790.0
Siwan,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2876.0,3424.0,3257.0,3948.0,3805.0,2434.0,3886.0,2464.0,3440.0,2615.0,2155.0,2595.0,36899.0
Siwan,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2547.0,3061.0,2896.0,3720.0,3390.0,2117.0,3359.0,2129.0,3189.0,2273.0,1897.0,2223.0,32801.0
Siwan,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5423.0,6485.0,6153.0,7668.0,7195.0,4551.0,7245.0,4593.0,6629.0,4888.0,4052.0,4818.0,69700.0
Siwan,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5900.0,5584.0,4954.0,5984.0,5245.0,5277.0,4908.0,4710.0,5149.0,5001.0,5527.0,5832.0,64071.0
Siwan,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5929.0,5485.0,4712.0,5923.0,5131.0,3705.0,4374.0,3632.0,5227.0,4719.0,5104.0,5814.0,59755.0
Siwan,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1274.0,1170.0,1041.0,1537.0,1026.0,1009.0,962.0,835.0,918.0,831.0,856.0,1005.0,12464.0
Siwan,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1199.0,1035.0,1016.0,1202.0,896.0,886.0,868.0,722.0,858.0,717.0,793.0,902.0,11094.0
Siwan,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2473.0,2205.0,2057.0,2739.0,1922.0,1895.0,1830.0,1557.0,1776.0,1548.0,1649.0,1907.0,23558.0
Siwan,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2239.0,2041.0,1841.0,2344.0,1949.0,2240.0,2361.0,2102.0,2091.0,1988.0,2073.0,2355.0,25624.0
Siwan,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1517.0,1672.0,1616.0,1861.0,1645.0,1712.0,1932.0,1725.0,1644.0,1631.0,1651.0,1871.0,20477.0
Siwan,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2514.0,2587.0,2299.0,2764.0,2500.0,2747.0,2948.0,2689.0,2694.0,2594.0,2804.0,2900.0,32040.0
Siwan,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,381.0,240.0,173.0,323.0,274.0,305.0,280.0,298.0,314.0,219.0,283.0,217.0,3307.0
Siwan,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1009.0,798.0,760.0,836.0,803.0,888.0,780.0,989.0,809.0,833.0,910.0,920.0,10335.0
Siwan,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,4220.0,4284.0,3718.0,4100.0,4085.0,3770.0,4274.0,3762.0,3900.0,3852.0,3647.0,3758.0,47370.0
Siwan,10.4.2,Number of Immunisation sessions held during the month,TOTAL,4101.0,4247.0,3620.0,4045.0,3993.0,3731.0,4139.0,3667.0,3864.0,3660.0,3411.0,3665.0,46143.0
Siwan,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3382.0,3627.0,3097.0,3395.0,3315.0,3133.0,3499.0,3148.0,3231.0,3147.0,2907.0,3087.0,38968.0
Siwan,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,4347.0,4395.0,2732.0,4958.0,3867.0,4143.0,4635.0,3467.0,4268.0,3665.0,1923.0,3785.0,46185.0
Siwan,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5299.0,6014.0,5573.0,7161.0,6534.0,4490.0,7088.0,4747.0,6156.0,4663.0,3712.0,4437.0,65874.0
Siwan,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1619.0,1893.0,1366.0,1726.0,1307.0,1535.0,1614.0,1498.0,1750.0,1366.0,1622.0,1594.0,18890.0
Siwan,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,708.0,763.0,733.0,927.0,743.0,849.0,931.0,930.0,1173.0,629.0,890.0,895.0,10171.0
Siwan,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,8.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Siwan,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Siwan,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,4.0,5.0,2.0,0.0,0.0,1.0,0.0,7.0,2.0,10.0,2.0,2.0,35.0
Siwan,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,867.0,914.0,870.0,1354.0,1387.0,1202.0,976.0,1288.0,1757.0,1684.0,1610.0,1820.0,15729.0
Siwan,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35.0,0.0,0.0,0.0,25.0,60.0
Siwan,13.1,Number of Patients operated for cataract,TOTAL,0.0,104.0,242.0,378.0,269.0,170.0,130.0,724.0,634.0,340.0,577.0,322.0,3890.0
Siwan,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,104.0,242.0,378.0,269.0,170.0,130.0,724.0,634.0,340.0,577.0,322.0,3890.0
Siwan,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Siwan,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Siwan,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Siwan,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Siwan,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2288.0,2289.0,2278.0,2277.0,2274.0,2297.0,2288.0,2292.0,2172.0,2152.0,2256.0,2268.0,-1.0
Siwan,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Siwan,14.05,Number of RKS meetings held during the month,TOTAL,10.0,16.0,9.0,10.0,11.0,10.0,17.0,10.0,11.0,10.0,11.0,10.0,135.0
Siwan,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Siwan,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,909.0,956.0,840.0,989.0,1456.0,939.0,598.0,940.0,720.0,1050.0,1364.0,1564.0,12325.0
Siwan,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Siwan,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,2.0,3.0,3.0,2.0,3.0,,,,1.0,1.0,1.0,-1.0
Siwan,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1101.0,1277.0,1438.0,1467.0,1342.0,1436.0,1451.0,1272.0,1088.0,1342.0,1162.0,1454.0,15830.0
Siwan,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1697.0,1865.0,1830.0,1811.0,1755.0,1899.0,1703.0,1837.0,1377.0,1508.0,1566.0,1970.0,20818.0
Siwan,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1150.0,1065.0,1847.0,1276.0,1545.0,1339.0,1250.0,1114.0,1200.0,1310.0,1188.0,1027.0,15311.0
Siwan,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4198.0,3557.0,3693.0,4941.0,5494.0,5573.0,4368.0,5204.0,5619.0,5112.0,5451.0,4312.0,57522.0
Siwan,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2251.0,2342.0,3285.0,2743.0,2887.0,2775.0,2701.0,2386.0,2288.0,2652.0,2350.0,2481.0,31141.0
Siwan,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5895.0,5422.0,5523.0,6752.0,7249.0,7472.0,6071.0,7041.0,6996.0,6620.0,7017.0,6282.0,78340.0
Siwan,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,7.0,4.0,5.0,8.0,3.0,9.0,7.0,2.0,10.0,1.0,2.0,63.0
Siwan,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,1.0,5.0,9.0,8.0,3.0,5.0,6.0,2.0,1.0,0.0,2.0,44.0
Siwan,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,7.0,8.0,9.0,14.0,16.0,6.0,14.0,13.0,4.0,11.0,1.0,4.0,107.0
Siwan,14.11,In-Patient Head Count at midnight,TOTAL,5975.0,5799.0,6518.0,7180.0,8050.0,8064.0,6908.0,7447.0,7663.0,7472.0,7661.0,6983.0,85720.0
Siwan,14.12.1,OPD attendance (All),TOTAL,211409.0,199413.0,210361.0,228032.0,217298.0,239357.0,198217.0,214494.0,190289.0,179127.0,194544.0,195008.0,2477549.0
Siwan,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,919.0,109.0,92.0,247.0,166.0,372.0,170.0,613.0,749.0,557.0,834.0,634.0,5462.0
Siwan,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,21.0,0.0,0.0,0.0,23.0
Siwan,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1200.0,1591.0,1629.0,1905.0,1907.0,1865.0,1773.0,1984.0,1835.0,1853.0,1812.0,1848.0,21202.0
Siwan,14.14.a,Number of patients given AYUSH treatment,TOTAL,33707.0,32538.0,36080.0,36462.0,35434.0,42496.0,33725.0,39684.0,27650.0,28412.0,27214.0,31290.0,404692.0
Siwan,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4467.0,4334.0,3970.0,5531.0,4120.0,4269.0,3425.0,3632.0,3811.0,2522.0,2865.0,3019.0,45965.0
Siwan,14.14.c,Number of Adolescents counselled,TOTAL,502.0,439.0,460.0,356.0,414.0,531.0,646.0,517.0,440.0,516.0,354.0,386.0,5561.0
Siwan,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3128.0,3240.0,3808.0,3638.0,3527.0,3521.0,2928.0,3696.0,3681.0,3376.0,3897.0,3589.0,42029.0
Siwan,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,39.0,19.0,60.0,32.0,48.0,37.0,34.0,35.0,34.0,25.0,24.0,31.0,418.0
Siwan,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,209.0,188.0,281.0,337.0,393.0,296.0,135.0,139.0,844.0,158.0,182.0,147.0,3309.0
Siwan,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,11.0,12.0,11.0,10.0,15.0,17.0,13.0,21.0,35.0,19.0,23.0,17.0,204.0
Siwan,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,306.0,259.0,321.0,443.0,357.0,445.0,214.0,665.0,755.0,756.0,944.0,624.0,6089.0
Siwan,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,10.0,11.0,13.0,7.0,11.0,12.0,6.0,9.0,14.0,9.0,11.0,8.0,121.0
Siwan,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,747.0,697.0,945.0,869.0,792.0,835.0,449.0,745.0,659.0,543.0,696.0,446.0,8423.0
Siwan,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,0.0,2.0,2.0,4.0,2.0,0.0,0.0,0.0,2.0,1.0,1.0,16.0
Siwan,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1262.0,1144.0,1547.0,1649.0,1542.0,1576.0,798.0,1549.0,2258.0,1457.0,1822.0,1217.0,17821.0
Siwan,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,23.0,23.0,26.0,19.0,30.0,31.0,19.0,30.0,49.0,30.0,35.0,26.0,341.0
Siwan,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,15.3.a,Number of VDRL tests conducted on males,Number tested,80.0,102.0,0.0,75.0,71.0,68.0,49.0,56.0,54.0,87.0,62.0,50.0,754.0
Siwan,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,172.0,164.0,0.0,191.0,179.0,196.0,161.0,194.0,196.0,206.0,174.0,180.0,2013.0
Siwan,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,579.0,434.0,0.0,546.0,520.0,560.0,410.0,340.0,361.0,210.0,285.0,135.0,4380.0
Siwan,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,831.0,700.0,0.0,812.0,770.0,824.0,620.0,590.0,611.0,503.0,521.0,365.0,7147.0
Siwan,15.4.1,Number of blood smears examined for Malaria,TOTAL,717.0,696.0,1328.0,747.0,780.0,845.0,828.0,806.0,960.0,851.0,830.0,807.0,10195.0
Siwan,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,3.0
Siwan,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2413.0,3063.0,2098.0,3223.0,2490.0,2940.0,2000.0,0.0,2250.0,2400.0,1000.0,1200.0,25077.0
Siwan,16.1.1,Stock position of DPT vaccines,2. Stocks Received,5000.0,2500.0,4000.0,3000.0,3000.0,4000.0,0.0,4000.0,2000.0,1000.0,2000.0,4000.0,34500.0
Siwan,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,3063.0,2098.0,3223.0,2490.0,3240.0,3000.0,1100.0,2250.0,2400.0,1000.0,1200.0,750.0,25814.0
Siwan,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4350.0,3465.0,2875.0,3733.0,2250.0,3940.0,900.0,1750.0,1850.0,2400.0,1800.0,4450.0,33763.0
Siwan,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,0.0,3850.0,3400.0,7250.0
Siwan,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,7500.0,0.0,0.0,7500.0
Siwan,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,3850.0,3400.0,1600.0,8850.0
Siwan,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,3650.0,450.0,1800.0,5900.0
Siwan,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,371.0,0.0,19.0,145.0,410.0,0.0,925.0,25.0,800.0,150.0,0.0,525.0,3370.0
Siwan,16.1.2,Stock position of OPV vaccines,2. Stocks Received,3000.0,1200.0,2000.0,3500.0,1500.0,1300.0,1500.0,1600.0,1500.0,400.0,2000.0,3500.0,23000.0
Siwan,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,716.0,19.0,145.0,412.0,63.0,25.0,24.0,800.0,150.0,0.0,525.0,1250.0,4129.0
Siwan,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2655.0,1181.0,1874.0,3233.0,1847.0,1275.0,2400.0,825.0,2150.0,550.0,1475.0,2775.0,22240.0
Siwan,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Siwan,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2690.0,3275.0,1950.0,2925.0,1550.0,1400.0,2450.0,1350.0,0.0,1700.0,1400.0,1850.0,22540.0
Siwan,16.1.3,Stock position of TT vaccines,2. Stocks Received,3500.0,1500.0,3600.0,2500.0,3000.0,5000.0,0.0,4000.0,2000.0,2000.0,2000.0,3000.0,32100.0
Siwan,16.1.3,Stock position of TT vaccines,3. Unusable Stock,3275.0,1950.0,2925.0,1550.0,1750.0,2650.0,1350.0,4000.0,1700.0,1400.0,1850.0,550.0,24950.0
Siwan,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2915.0,2825.0,2625.0,3875.0,2800.0,3750.0,1100.0,1350.0,300.0,2300.0,1550.0,4300.0,29690.0
Siwan,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Siwan,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Siwan,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Siwan,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Siwan,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,806.0,1793.0,382.0,818.0,270.0,0.0,50.0,0.0,700.0,550.0,350.0,350.0,6069.0
Siwan,16.1.5,Stock position of BCG vaccines,2. Stocks Received,3500.0,1000.0,1600.0,2500.0,400.0,3000.0,0.0,2800.0,1600.0,1500.0,1500.0,2900.0,22300.0
Siwan,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,1793.0,382.0,818.0,270.0,39.0,200.0,0.0,700.0,550.0,450.0,350.0,750.0,6302.0
Siwan,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2513.0,2411.0,1164.0,3048.0,631.0,2800.0,50.0,2100.0,1750.0,1600.0,1500.0,2500.0,22067.0
Siwan,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,758.0,1054.0,10.0,520.0,1050.0,0.0,0.0,0.0,700.0,210.0,180.0,50.0,4532.0
Siwan,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3500.0,2000.0,2800.0,5000.0,1200.0,3250.0,2000.0,1800.0,2400.0,2000.0,1500.0,2500.0,29950.0
Siwan,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,1054.0,10.0,520.0,1050.0,90.0,430.0,0.0,700.0,210.0,180.0,50.0,200.0,4494.0
Siwan,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3204.0,3044.0,2290.0,4470.0,2160.0,2820.0,2000.0,1100.0,2890.0,2030.0,1630.0,2350.0,29988.0
Siwan,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,8635.0,6645.0,250.0,200.0,300.0,0.0,2900.0,0.0,400.0,100.0,0.0,50.0,19480.0
Siwan,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,2000.0,1000.0,2000.0,1000.0,6000.0,400.0,2300.0,2000.0,300.0,600.0,4400.0,22000.0
Siwan,16.1.7,Stock position of JE vaccines,3. Unusable Stock,7055.0,6895.0,200.0,300.0,0.0,600.0,0.0,400.0,100.0,0.0,50.0,750.0,16350.0
Siwan,16.1.7,Stock position of JE vaccines,4. Stock Distributed,1580.0,1750.0,1050.0,1900.0,1300.0,5400.0,3300.0,1900.0,2300.0,400.0,550.0,3700.0,25130.0
Siwan,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1105.0,1111.0,416.0,650.0,1071.0,107.0,350.0,100.0,1650.0,100.0,850.0,1450.0,8960.0
Siwan,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3200.0,2000.0,2000.0,4000.0,1500.0,5000.0,0.0,5000.0,0.0,2000.0,2000.0,1500.0,28200.0
Siwan,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,1111.0,416.0,650.0,1071.0,217.0,900.0,100.0,1650.0,100.0,850.0,1450.0,1350.0,9865.0
Siwan,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3194.0,2695.0,1766.0,3579.0,2354.0,4207.0,250.0,3450.0,1550.0,1250.0,1400.0,1600.0,27295.0
Siwan,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3950.0,3450.0,2700.0,2000.0,4000.0,3000.0,2400.0,900.0,5900.0,4000.0,1600.0,800.0,34700.0
Siwan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,8000.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,13000.0
Siwan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,3450.0,2700.0,2000.0,4000.0,3000.0,900.0,1500.0,5900.0,4000.0,1600.0,800.0,800.0,30650.0
Siwan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,500.0,750.0,700.0,6000.0,1000.0,2100.0,900.0,0.0,1900.0,2400.0,800.0,0.0,17050.0
Siwan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,27500.0,22500.0,6000.0,6000.0,20420.0,1920.0,1500.0,1500.0,105500.0,64220.0,31720.0,20720.0,309500.0
Siwan,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,110000.0,0.0,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,210000.0
Siwan,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,22500.0,6000.0,6000.0,20420.0,1920.0,420.0,0.0,101500.0,69260.0,30220.0,19220.0,15720.0,293180.0
Siwan,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,5000.0,16500.0,0.0,95580.0,18500.0,1500.0,1500.0,0.0,36240.0,34000.0,12500.0,5000.0,226320.0
Siwan,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,4700.0,4200.0,2000.0,1200.0,8800.0,5500.0,4900.0,1800.0,5800.0,2200.0,1600.0,1600.0,44300.0
Siwan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,20000.0,0.0,0.0,0.0,7000.0,0.0,0.0,0.0,0.0,27000.0
Siwan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,4200.0,2000.0,1200.0,8800.0,5500.0,0.0,3100.0,8800.0,2200.0,1600.0,1600.0,1600.0,40600.0
Siwan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,500.0,2200.0,800.0,12400.0,3300.0,5500.0,1800.0,0.0,3600.0,600.0,0.0,0.0,30700.0
Siwan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,6550.0,6050.0,2700.0,4670.0,38020.0,34120.0,33620.0,13920.0,13920.0,7440.0,3120.0,1680.0,165810.0
Siwan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,40000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,40000.0
Siwan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,6050.0,5570.0,2000.0,38020.0,34120.0,500.0,2700.0,13920.0,7440.0,3120.0,1680.0,680.0,115800.0
Siwan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,500.0,480.0,700.0,6650.0,3900.0,33620.0,30920.0,0.0,6480.0,4320.0,1440.0,1000.0,90010.0
Siwan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Siwan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Siwan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Siwan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Siwan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,45000.0,39700.0,33500.0,33500.0,12800.0,2800.0,2300.0,1800.0,1500.0,1000.0,173900.0
Siwan,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,50000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50000.0
Siwan,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,41500.0,39700.0,33500.0,22800.0,12800.0,2800.0,2300.0,1800.0,1500.0,1000.0,300.0,160000.0
Siwan,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,8500.0,5300.0,6200.0,10700.0,20700.0,10000.0,500.0,500.0,300.0,500.0,700.0,63900.0
Siwan,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,9500.0,6000.0,5000.0,2000.0,1000.0,0.0,0.0,0.0,0.0,46000.0,40500.0,32000.0,142000.0
Siwan,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50000.0,0.0,0.0,0.0,50000.0
Siwan,16.3.02,Stock Position of Gloves,3. Unusable Stock,3500.0,4500.0,2000.0,0.0,0.0,0.0,0.0,0.0,47000.0,40500.0,32000.0,25000.0,154500.0
Siwan,16.3.02,Stock Position of Gloves,4. Stock Distributed,6000.0,1500.0,3000.0,2000.0,1000.0,0.0,0.0,0.0,3000.0,5500.0,8500.0,7000.0,37500.0
Siwan,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,10000.0,1000.0,800.0,0.0,0.0,191000.0,163000.0,119000.0,83000.0,68000.0,56000.0,691800.0
Siwan,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,10000.0,0.0,0.0,0.0,0.0,200000.0,0.0,0.0,0.0,0.0,0.0,0.0,210000.0
Siwan,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,8000.0,1000.0,800.0,0.0,0.0,191000.0,163000.0,119000.0,83000.0,68000.0,56000.0,31000.0,720800.0
Siwan,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,2080.0,9000.0,200.0,800.0,0.0,9000.0,28000.0,44000.0,36000.0,15000.0,12000.0,25000.0,181080.0
Siwan,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,-80.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-80.0
Siwan,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,19600.0,0.0,0.0,420000.0,285000.0,165000.0,1790000.0,1380000.0,0.0,710000.0,4769600.0
Siwan,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,50600.0,0.0,10000.0,500000.0,200000.0,0.0,1790000.0,0.0,0.0,0.0,0.0,2550600.0
Siwan,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,19600.0,0.0,0.0,360000.0,305000.0,145000.0,1790000.0,1380000.0,1020000.0,0.0,399700.0,5419300.0
Siwan,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,31000.0,19600.0,10000.0,140000.0,315000.0,40000.0,165000.0,410000.0,360000.0,0.0,310300.0,1800900.0
Siwan,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,100000.0
Siwan,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,4500.0,4500.0,3000.0,3000.0,11000.0,0.0,5500.0,4000.0,4000.0,4000.0,3400.0,3000.0,49900.0
Siwan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Siwan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,4000.0,3000.0,0.0,11000.0,10000.0,0.0,4000.0,4000.0,4000.0,3400.0,3000.0,1500.0,47900.0
Siwan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,500.0,1000.0,3000.0,2000.0,1000.0,0.0,1500.0,0.0,0.0,600.0,400.0,1500.0,11500.0
Siwan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0
Siwan,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,210.0,160.0,160.0,160.0,160.0,110.0,100.0,1060.0
Siwan,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,,0.0,9000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0
Siwan,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,0.0,210.0,0.0,160.0,160.0,160.0,110.0,160.0,100.0,0.0,1060.0
Siwan,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,,0.0,8790.0,0.0,50.0,0.0,0.0,50.0,0.0,10.0,100.0,9000.0
Siwan,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,100000.0,65000.0,57500.0,33300.0,117100.0,187900.0,,124800.0,44900.0,44900.0,43.0,775443.0
Siwan,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,100200.0,99800.0,0.0,,0.0,0.0,34768.0,0.0,234768.0
Siwan,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,63500.0,57500.0,33300.0,117100.0,182900.0,156900.0,,44900.0,43700.0,78468.0,43.0,778311.0
Siwan,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,36500.0,7500.0,24200.0,16200.0,34000.0,31000.0,,79900.0,1200.0,1200.0,0.0,231700.0
Siwan,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0
Siwan,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4500.0,8800.0,800.0,6300.0,8400.0,1700.0,8500.0,1400.0,9000.0,2200.0,8500.0,1500.0,61600.0
Siwan,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,10000.0,0.0,12000.0,12000.0,0.0,12000.0,0.0,12000.0,0.0,12000.0,0.0,12000.0,82000.0
Siwan,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,8600.0,800.0,6300.0,8000.0,1700.0,8500.0,1400.0,9000.0,2200.0,8500.0,1500.0,6600.0,63100.0
Siwan,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5900.0,8000.0,6500.0,10300.0,6700.0,5200.0,7100.0,4400.0,6800.0,5700.0,7000.0,6900.0,80500.0
Siwan,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,25600.0,141000.0,11400.0,51200.0,122200.0,59400.0,137600.0,66000.0,84400.0,39000.0,144800.0,30800.0,913400.0
Siwan,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,150000.0,0.0,100000.0,150000.0,0.0,150000.0,0.0,100000.0,0.0,130000.0,0.0,100000.0,880000.0
Siwan,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,134200.0,11400.0,51200.0,122200.0,59400.0,137600.0,66000.0,84400.0,39000.0,144800.0,72200.0,65400.0,987800.0
Siwan,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,41400.0,129600.0,60200.0,79000.0,62800.0,71800.0,71600.0,81600.0,45400.0,24200.0,72600.0,65400.0,805600.0
Siwan,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Siwan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2700.0,2200.0,0.0,1900.0,4200.0,1600.0,6200.0,2900.0,5700.0,4200.0,9400.0,6500.0,47500.0
Siwan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2200.0,0.0,4000.0,4600.0,0.0,7000.0,0.0,7000.0,0.0,8500.0,0.0,8500.0,41800.0
Siwan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,2200.0,0.0,1900.0,4200.0,1600.0,6200.0,2900.0,5700.0,3500.0,9400.0,1500.0,9700.0,48800.0
Siwan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2700.0,2200.0,4600.0,2300.0,2600.0,2400.0,3300.0,4200.0,2200.0,3300.0,7900.0,5300.0,43000.0
Siwan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,-2500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-2500.0
Siwan,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Siwan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Siwan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Siwan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Siwan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Siwan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Siwan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Siwan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Siwan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Siwan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Siwan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Siwan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Siwan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Siwan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Siwan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Siwan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Siwan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Siwan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Siwan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Siwan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Siwan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Siwan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Siwan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Siwan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Siwan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Siwan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Siwan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Siwan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Siwan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Siwan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Siwan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Siwan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Siwan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Siwan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Siwan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Siwan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Siwan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Siwan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Siwan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Siwan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Siwan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Siwan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Siwan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Siwan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Siwan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Siwan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Siwan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Siwan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Siwan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Siwan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Siwan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Siwan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Siwan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Siwan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Siwan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Siwan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Siwan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Siwan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Siwan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Siwan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Siwan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Siwan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Siwan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Supaul,1.1,Total number of pregnant women Registered for ANC,TOTAL,7087.0,7233.0,6797.0,5459.0,4647.0,4780.0,3620.0,4025.0,3958.0,4301.0,4814.0,6393.0,63114.0
Supaul,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3499.0,3299.0,3107.0,2714.0,2165.0,2139.0,1791.0,1979.0,1945.0,2026.0,2287.0,3173.0,30124.0
Supaul,1.2,Number of Pregnant women registered under JSY,TOTAL,7087.0,7233.0,6797.0,5459.0,4647.0,4780.0,3620.0,4025.0,3958.0,4301.0,4814.0,6393.0,63114.0
Supaul,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3269.0,3240.0,3361.0,3563.0,3281.0,3301.0,2888.0,2943.0,2691.0,2449.0,2605.0,2820.0,36411.0
Supaul,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4441.0,4374.0,4194.0,3561.0,2775.0,2766.0,2133.0,2389.0,2304.0,2403.0,2719.0,3621.0,37680.0
Supaul,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5994.0,6702.0,6326.0,5701.0,5367.0,5065.0,3985.0,3785.0,3690.0,3868.0,4008.0,5521.0,60012.0
Supaul,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3401.0,3607.0,3981.0,3486.0,3440.0,3596.0,2810.0,3137.0,2528.0,2752.0,2899.0,3143.0,38780.0
Supaul,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,64.0,94.0,197.0,114.0,148.0,164.0,88.0,132.0,94.0,174.0,53.0,183.0,1505.0
Supaul,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,3.0,7.0,8.0,3.0,9.0,2.0,11.0,2.0,5.0,2.0,1.0,53.0
Supaul,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1447.0,1815.0,1804.0,1742.0,1781.0,1147.0,1080.0,1092.0,1219.0,1295.0,1320.0,1681.0,17423.0
Supaul,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,6.0,18.0,6.0,7.0,6.0,11.0,5.0,6.0,5.0,5.0,6.0,6.0,87.0
Supaul,1.8,Number of pregnancy test kits used at SC level,TOTAL,580.0,616.0,554.0,560.0,472.0,504.0,311.0,481.0,311.0,382.0,119.0,67.0,4957.0
Supaul,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,38.0,81.0,78.0,101.0,106.0,159.0,142.0,135.0,79.0,68.0,49.0,68.0,1104.0
Supaul,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,709.0,640.0,618.0,571.0,581.0,781.0,811.0,1069.0,878.0,729.0,590.0,604.0,8581.0
Supaul,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,747.0,721.0,696.0,672.0,687.0,940.0,953.0,1204.0,957.0,797.0,639.0,672.0,9685.0
Supaul,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,282.0,283.0,303.0,256.0,250.0,377.0,426.0,424.0,441.0,305.0,246.0,273.0,3866.0
Supaul,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,4.0,2.0,0.0,2.0,0.0,0.0,0.0,4.0,0.0,0.0,15.0,27.0
Supaul,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2715.0,2899.0,2560.0,3176.0,4497.0,5233.0,5535.0,5094.0,4221.0,3274.0,2596.0,2419.0,44219.0
Supaul,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2451.0,2537.0,2281.0,2790.0,4067.0,4543.0,3908.0,4465.0,4117.0,3225.0,2468.0,2281.0,39133.0
Supaul,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2131.0,2205.0,2083.0,2716.0,2852.0,1521.0,1482.0,1021.0,594.0,2123.0,980.0,1534.0,21242.0
Supaul,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1412.0,1259.0,1505.0,1510.0,1683.0,665.0,729.0,441.0,1377.0,590.0,522.0,1301.0,12994.0
Supaul,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Supaul,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Supaul,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Supaul,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Supaul,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,2.0,3.0,1.0,3.0,4.0,6.0,3.0,8.0,5.0,6.0,1.0,1.0,43.0
Supaul,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,18.0,17.0,13.0,4.0,23.0,26.0,13.0,32.0,10.0,11.0,28.0,15.0,210.0
Supaul,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Supaul,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,20.0,20.0,14.0,7.0,27.0,32.0,16.0,40.0,15.0,17.0,29.0,16.0,253.0
Supaul,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Supaul,4.1.1.a,Number of male live births,TOTAL,1743.0,1858.0,1637.0,1911.0,2575.0,3160.0,3180.0,3127.0,2528.0,2022.0,1622.0,1549.0,26912.0
Supaul,4.1.1.b,Number of female live births,TOTAL,1691.0,1726.0,1584.0,1873.0,2563.0,2945.0,3207.0,3115.0,2574.0,2000.0,1572.0,1508.0,26358.0
Supaul,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3434.0,3584.0,3221.0,3784.0,5138.0,6105.0,6387.0,6242.0,5102.0,4022.0,3194.0,3057.0,53270.0
Supaul,4.1.2,Number of still births,TOTAL,53.0,65.0,46.0,66.0,65.0,93.0,111.0,85.0,74.0,67.0,54.0,46.0,825.0
Supaul,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,8.0,4.0,4.0,6.0,3.0,7.0,6.0,9.0,5.0,5.0,3.0,7.0,67.0
Supaul,4.2.1,Number of Newborns weighed at birth,TOTAL,3168.0,3455.0,3133.0,3675.0,5056.0,5889.0,6183.0,6060.0,4945.0,3896.0,3075.0,2857.0,51392.0
Supaul,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,184.0,220.0,186.0,261.0,367.0,305.0,320.0,253.0,223.0,180.0,119.0,243.0,2861.0
Supaul,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3293.0,3496.0,3144.0,3688.0,5023.0,5838.0,6258.0,6022.0,4955.0,3908.0,3091.0,2948.0,51664.0
Supaul,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,21.0,25.0,10.0,12.0,23.0,24.0,24.0,12.0,12.0,13.0,6.0,12.0,194.0
Supaul,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,15.0,25.0,5.0,5.0,6.0,8.0,0.0,80.0,25.0,10.0,10.0,5.0,194.0
Supaul,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,20.0,23.0,26.0,13.0,32.0,10.0,11.0,28.0,15.0,178.0
Supaul,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Supaul,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,36.0,50.0,15.0,37.0,52.0,58.0,37.0,124.0,47.0,34.0,44.0,32.0,566.0
Supaul,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Supaul,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,24.0,43.0,16.0,26.0,46.0,56.0,34.0,124.0,46.0,35.0,45.0,14.0,509.0
Supaul,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,1.0,0.0,1.0,2.0,1.0,1.0,81.0,2.0,4.0,1.0,1.0,96.0
Supaul,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,24.0,42.0,12.0,14.0,21.0,24.0,15.0,88.0,34.0,12.0,16.0,11.0,313.0
Supaul,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,25.0,24.0,19.0,12.0,11.0,37.0,5.0,14.0,8.0,7.0,11.0,8.0,181.0
Supaul,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1607.0,1490.0,1569.0,1806.0,2652.0,2483.0,2259.0,2205.0,2320.0,1824.0,1267.0,1254.0,22736.0
Supaul,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1024.0,1078.0,1160.0,1064.0,1453.0,1639.0,1150.0,1149.0,1329.0,776.0,673.0,704.0,13199.0
Supaul,6.3,PNC maternal complications attended,TOTAL,9.0,29.0,6.0,7.0,8.0,18.0,38.0,94.0,34.0,25.0,31.0,14.0,313.0
Supaul,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Supaul,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Supaul,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,42.0,47.0,49.0,55.0,56.0,60.0,47.0,50.0,36.0,37.0,59.0,84.0,622.0
Supaul,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,81.0,111.0,81.0,86.0,89.0,99.0,77.0,81.0,67.0,64.0,201.0,230.0,1267.0
Supaul,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,123.0,158.0,130.0,141.0,145.0,159.0,124.0,131.0,103.0,101.0,260.0,314.0,1889.0
Supaul,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,1.0,0.0,5.0,5.0,58.0,28.0,60.0,101.0,22.0,35.0,17.0,332.0
Supaul,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,1.0,1.0,0.0,2.0,4.0,3.0,17.0
Supaul,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,3.0,0.0,2.0,2.0,6.0,0.0,11.0,25.0
Supaul,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Supaul,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,0.0,6.0,5.0,67.0,29.0,63.0,103.0,30.0,39.0,31.0,374.0
Supaul,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Supaul,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Supaul,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Supaul,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,28.0,36.0,30.0,497.0,258.0,350.0,235.0,936.0,2582.0,2244.0,732.0,407.0,8335.0
Supaul,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,59.0,30.0,14.0,151.0,66.0,143.0,104.0,266.0,848.0,734.0,559.0,271.0,3245.0
Supaul,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,52.0,49.0,27.0,38.0,45.0,102.0,80.0,199.0,312.0,308.0,456.0,423.0,2091.0
Supaul,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Supaul,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,139.0,115.0,71.0,686.0,369.0,595.0,419.0,1401.0,3742.0,3286.0,1747.0,1101.0,13671.0
Supaul,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,5.0,16.0,0.0,0.0,,3.0,6.0,,,13.0,7.0,28.0,78.0
Supaul,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,6.0,7.0,0.0,3.0,25.0
Supaul,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,12.0,3.0,0.0,3.0,53.0,29.0,12.0,7.0,119.0
Supaul,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,7.0
Supaul,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Supaul,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,12.0,3.0,9.0,3.0,59.0,36.0,19.0,10.0,151.0
Supaul,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Supaul,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,333.0,290.0,279.0,429.0,321.0,312.0,269.0,265.0,275.0,258.0,228.0,234.0,3493.0
Supaul,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,100.0,111.0,88.0,163.0,82.0,74.0,75.0,88.0,150.0,69.0,53.0,63.0,1116.0
Supaul,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,60.0,31.0,,2.0,1.0,1.0,2.0,4.0,2.0,15.0,6.0,2.0,126.0
Supaul,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,15.0,53.0,56.0,97.0,75.0,63.0,67.0,48.0,45.0,33.0,161.0,42.0,755.0
Supaul,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Supaul,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,508.0,485.0,423.0,691.0,479.0,450.0,413.0,405.0,472.0,375.0,448.0,341.0,5490.0
Supaul,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,148.0,168.0,184.0,295.0,189.0,231.0,97.0,111.0,49.0,121.0,64.0,111.0,1768.0
Supaul,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Supaul,9.06,Number of IUCD removals,TOTAL,179.0,168.0,144.0,200.0,199.0,185.0,184.0,187.0,153.0,167.0,108.0,119.0,1993.0
Supaul,9.07,Number of Oral Pills cycles distributed,TOTAL,1021.0,1484.0,800.0,1159.0,1136.0,1041.0,1045.0,590.0,995.0,667.0,507.0,565.0,11010.0
Supaul,9.08,Number of Condom pieces distributed,TOTAL,5411.0,5857.0,5672.0,11303.0,7552.0,6461.0,6610.0,5611.0,6721.0,7168.0,4180.0,4000.0,76546.0
Supaul,9.09,Number of Centchroman (weekly) pills given,TOTAL,3.0,0.0,6.0,11.0,127.0,0.0,0.0,10.0,13.0,0.0,0.0,0.0,170.0
Supaul,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,121.0,134.0,110.0,156.0,164.0,126.0,75.0,63.0,96.0,96.0,64.0,91.0,1296.0
Supaul,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,4.0
Supaul,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,6.0
Supaul,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,1.0,,,1.0,1.0,,,,1.0,-1.0
Supaul,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4202.0,4142.0,4103.0,4491.0,5542.0,7139.0,7452.0,7356.0,6878.0,5369.0,3897.0,4127.0,64698.0
Supaul,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4516.0,3776.0,3939.0,3576.0,3410.0,4262.0,4931.0,6922.0,6857.0,1680.0,534.0,366.0,44769.0
Supaul,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,5723.0,4767.0,3866.0,3838.0,3521.0,3794.0,3800.0,4610.0,5769.0,6101.0,3201.0,1571.0,50561.0
Supaul,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,5883.0,5401.0,4624.0,4035.0,3531.0,3896.0,3496.0,4036.0,4192.0,4576.0,4257.0,4166.0,52093.0
Supaul,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5335.0,5478.0,5098.0,15911.0
Supaul,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,2546.0,4986.0,7537.0
Supaul,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,41.0,1758.0,1799.0
Supaul,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3157.0,3372.0,3086.0,3721.0,4875.0,5888.0,5848.0,5703.0,4729.0,3605.0,2835.0,2667.0,49486.0
Supaul,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4467.0,3612.0,4029.0,3625.0,3415.0,4019.0,4605.0,5715.0,5309.0,5702.0,4699.0,4931.0,54128.0
Supaul,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5631.0,4533.0,3959.0,3872.0,3515.0,3496.0,3540.0,3874.0,4466.0,4939.0,4555.0,5628.0,52008.0
Supaul,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5776.0,5116.0,4625.0,4030.0,3552.0,3590.0,3271.0,3219.0,3251.0,3677.0,3500.0,4894.0,48501.0
Supaul,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2594.0,2828.0,2494.0,2986.0,4141.0,4923.0,4978.0,4805.0,4194.0,3070.0,2425.0,2179.0,41617.0
Supaul,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4752.0,3904.0,4100.0,3679.0,3413.0,4362.0,4949.0,6851.0,7150.0,1691.0,505.0,470.0,45826.0
Supaul,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,6133.0,5065.0,4024.0,3965.0,3603.0,3861.0,3827.0,4634.0,5751.0,6063.0,3027.0,1471.0,51424.0
Supaul,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,6112.0,5672.0,4869.0,4314.0,3664.0,3990.0,3599.0,4011.0,4153.0,4571.0,3962.0,3844.0,52761.0
Supaul,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3464.0,3532.0,4449.0,5289.0,4420.0,5763.0,4682.0,4482.0,4554.0,3756.0,3212.0,3723.0,51326.0
Supaul,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3512.0,2917.0,2759.0,2800.0,2148.0,2553.0,2714.0,2673.0,3282.0,3307.0,3513.0,4614.0,36792.0
Supaul,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,0.0,15.0
Supaul,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1789.0,1864.0,2228.0,2678.0,2309.0,2870.0,2350.0,2199.0,2162.0,1776.0,1597.0,1777.0,25599.0
Supaul,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1521.0,1491.0,2063.0,2386.0,2032.0,2659.0,2224.0,2030.0,2023.0,1677.0,1396.0,1543.0,23045.0
Supaul,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3310.0,3355.0,4291.0,5064.0,4341.0,5529.0,4574.0,4229.0,4185.0,3453.0,2993.0,3320.0,48644.0
Supaul,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4106.0,3587.0,3239.0,3068.0,2445.0,2865.0,2850.0,2787.0,3425.0,3501.0,3712.0,4969.0,40554.0
Supaul,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4047.0,3444.0,3250.0,3067.0,2444.0,2678.0,2734.0,2456.0,2969.0,2936.0,3272.0,4349.0,37646.0
Supaul,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,230.0,126.0,349.0,157.0,159.0,83.0,112.0,24.0,79.0,80.0,50.0,127.0,1576.0
Supaul,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,271.0,282.0,224.0,249.0,176.0,194.0,313.0,257.0,335.0,286.0,321.0,451.0,3359.0
Supaul,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,267.0,252.0,215.0,252.0,163.0,201.0,304.0,235.0,263.0,259.0,271.0,377.0,3059.0
Supaul,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,538.0,534.0,439.0,501.0,339.0,395.0,617.0,492.0,598.0,545.0,592.0,828.0,6418.0
Supaul,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,12.0,7.0,9.0,36.0,23.0,47.0,39.0,21.0,37.0,16.0,12.0,16.0,275.0
Supaul,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,481.0,445.0,510.0,487.0,451.0,522.0,552.0,446.0,413.0,430.0,466.0,408.0,5611.0
Supaul,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1124.0,986.0,1035.0,1180.0,1018.0,1165.0,972.0,1039.0,982.0,1020.0,1023.0,1040.0,12584.0
Supaul,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,29.0,11.0,12.0,14.0,9.0,39.0,47.0,15.0,8.0,8.0,3.0,7.0,202.0
Supaul,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,3.0,3.0,3.0,2.0,2.0,3.0,3.0,2.0,1.0,2.0,1.0,28.0
Supaul,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1878.0,1871.0,1878.0,1878.0,1878.0,1876.0,1861.0,1863.0,1870.0,1829.0,1851.0,1843.0,22376.0
Supaul,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1835.0,1803.0,1790.0,1819.0,1773.0,1807.0,1785.0,1812.0,1817.0,1773.0,1745.0,1822.0,21581.0
Supaul,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1658.0,1652.0,1626.0,1651.0,1620.0,1663.0,1636.0,1687.0,1694.0,1592.0,1588.0,1716.0,19783.0
Supaul,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3024.0,3066.0,3769.0,4448.0,3593.0,4872.0,4139.0,4001.0,3986.0,3181.0,2732.0,3482.0,44293.0
Supaul,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,206.0,150.0,223.0,412.0,222.0,301.0,204.0,239.0,296.0,254.0,440.0,385.0,3332.0
Supaul,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,8.0,40.0,34.0,49.0,32.0,82.0,29.0,40.0,23.0,21.0,85.0,48.0,491.0
Supaul,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,1.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,17.0
Supaul,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,3291.0,3204.0,2929.0,2466.0,1989.0,1791.0,1594.0,1603.0,1174.0,1162.0,1091.0,1450.0,23744.0
Supaul,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Supaul,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,85.0,230.0,132.0,34.0,0.0,0.0,0.0,481.0
Supaul,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,85.0,117.0,132.0,34.0,0.0,0.0,0.0,368.0
Supaul,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Supaul,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,2.0,1.0,1.0,,2.0,,,,,,-1.0
Supaul,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1615.0,1627.0,1601.0,1638.0,1602.0,1631.0,1657.0,1643.0,1644.0,1654.0,1628.0,1492.0,-1.0
Supaul,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Supaul,14.05,Number of RKS meetings held during the month,TOTAL,2.0,4.0,5.0,3.0,2.0,2.0,4.0,4.0,1.0,6.0,3.0,6.0,42.0
Supaul,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,1.0,2.0,,,,2.0,,,,,,-1.0
Supaul,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,941.0,739.0,480.0,827.0,1157.0,1282.0,868.0,806.0,1122.0,1354.0,933.0,1019.0,11528.0
Supaul,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Supaul,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,2.0,0.0,0.0,,,,,1.0,,,,-1.0
Supaul,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,3054.0,3190.0,2883.0,2922.0,3661.0,4008.0,3478.0,3894.0,3221.0,3306.0,2676.0,2893.0,39186.0
Supaul,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3504.0,3766.0,3349.0,3615.0,4180.0,4180.0,3651.0,4032.0,3443.0,3033.0,3587.0,2995.0,43335.0
Supaul,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,3046.0,3073.0,2634.0,3260.0,3813.0,3736.0,3314.0,3113.0,3526.0,3359.0,2516.0,2941.0,38331.0
Supaul,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5474.0,5509.0,5286.0,6281.0,7661.0,7867.0,7105.0,8066.0,9039.0,7591.0,5189.0,5372.0,80440.0
Supaul,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,6100.0,6263.0,5517.0,6182.0,7474.0,7744.0,6792.0,7007.0,6747.0,6665.0,5192.0,5834.0,77517.0
Supaul,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,8978.0,9275.0,8635.0,9896.0,11841.0,12047.0,10756.0,12098.0,12482.0,10624.0,8776.0,8367.0,123775.0
Supaul,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,5.0,4.0,8.0,4.0,8.0,6.0,5.0,7.0,5.0,3.0,3.0,60.0
Supaul,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,1.0,1.0,1.0,0.0,0.0,2.0,0.0,2.0,0.0,1.0,8.0
Supaul,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2.0,5.0,5.0,9.0,5.0,8.0,6.0,7.0,7.0,7.0,3.0,4.0,68.0
Supaul,14.11,In-Patient Head Count at midnight,TOTAL,6654.0,7088.0,6722.0,7023.0,7864.0,8791.0,8656.0,8112.0,8481.0,7428.0,6508.0,6703.0,90030.0
Supaul,14.12.1,OPD attendance (All),TOTAL,147682.0,150481.0,145350.0,160796.0,159452.0,197663.0,150215.0,141807.0,123346.0,122273.0,116919.0,132108.0,1748092.0
Supaul,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,247.0,486.0,493.0,701.0,418.0,624.0,484.0,1564.0,3267.0,3451.0,1664.0,826.0,14225.0
Supaul,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,1.0,0.0,0.0,10.0,0.0,2.0,0.0,0.0,0.0,0.0,46.0,59.0
Supaul,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3620.0,3961.0,3590.0,4488.0,4438.0,3885.0,3378.0,3622.0,4149.0,3483.0,3613.0,4010.0,46237.0
Supaul,14.14.a,Number of patients given AYUSH treatment,TOTAL,17941.0,20003.0,16561.0,20446.0,21606.0,33374.0,23022.0,15834.0,11759.0,12690.0,13217.0,16936.0,223389.0
Supaul,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,3120.0,3335.0,2542.0,3875.0,2581.0,2786.0,3035.0,2120.0,3348.0,2839.0,3348.0,2658.0,35587.0
Supaul,14.14.c,Number of Adolescents counselled,TOTAL,20.0,20.0,0.0,7.0,0.0,0.0,28.0,8.0,28.0,28.0,50.0,42.0,231.0
Supaul,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2752.0,3162.0,3067.0,3051.0,3064.0,3024.0,2288.0,2941.0,2433.0,2865.0,3219.0,3656.0,35522.0
Supaul,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,20.0,27.0,28.0,19.0,24.0,19.0,16.0,19.0,25.0,14.0,15.0,23.0,249.0
Supaul,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,234.0,231.0,270.0,336.0,477.0,119.0,74.0,198.0,178.0,98.0,142.0,228.0,2585.0
Supaul,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,2.0,1.0,2.0,2.0,4.0,3.0,2.0,0.0,1.0,2.0,20.0
Supaul,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,222.0,268.0,222.0,237.0,182.0,151.0,92.0,151.0,185.0,152.0,156.0,246.0,2264.0
Supaul,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,3.0,1.0,2.0,1.0,0.0,4.0,1.0,0.0,1.0,2.0,16.0
Supaul,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,132.0,116.0,279.0,334.0,301.0,82.0,116.0,194.0,272.0,234.0,200.0,423.0,2683.0
Supaul,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,6.0
Supaul,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,588.0,615.0,771.0,907.0,960.0,352.0,282.0,543.0,635.0,484.0,498.0,897.0,7532.0
Supaul,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,2.0,6.0,2.0,4.0,3.0,9.0,7.0,3.0,0.0,2.0,4.0,42.0
Supaul,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,17.0,10.0,33.0
Supaul,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0,40.0,14.0,76.0
Supaul,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0,57.0,24.0,109.0
Supaul,15.4.1,Number of blood smears examined for Malaria,TOTAL,30.0,29.0,27.0,29.0,25.0,0.0,28.0,29.0,31.0,38.0,40.0,54.0,360.0
Supaul,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Supaul,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,354.0,0.0,550.0,1200.0,1950.0,2700.0,2800.0,4600.0,2900.0,2000.0,3635.0,4135.0,26824.0
Supaul,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,3250.0,2500.0,3000.0,3000.0,2000.0,3000.0,1000.0,1500.0,2000.0,3000.0,0.0,26250.0
Supaul,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2354.0,2700.0,1850.0,2250.0,2250.0,1900.0,1200.0,2700.0,2400.0,1250.0,2500.0,500.0,23854.0
Supaul,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,550.0,1200.0,1950.0,2700.0,2800.0,4600.0,2900.0,2000.0,2750.0,4135.0,3635.0,29220.0
Supaul,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,,0.0,0.0,,0.0,,0.0,,0.0,1750.0,1500.0,3250.0
Supaul,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,0.0,0.0,,0.0,,0.0,,5000.0,0.0,0.0,5000.0
Supaul,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,0.0,0.0,,0.0,,0.0,,3200.0,250.0,450.0,3900.0
Supaul,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0,1500.0,1050.0,4350.0
Supaul,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,0.0,150.0,300.0,650.0,50.0,250.0,65.0,0.0,25.0,45.0,550.0,2085.0
Supaul,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000.0,2000.0,2000.0,2000.0,300.0,1500.0,1200.0,0.0,1150.0,600.0,1600.0,1000.0,14350.0
Supaul,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1000.0,1850.0,1700.0,1650.0,900.0,1300.0,1385.0,65.0,1125.0,625.0,1095.0,1375.0,14070.0
Supaul,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,150.0,450.0,650.0,50.0,250.0,65.0,0.0,25.0,0.0,550.0,175.0,2365.0
Supaul,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,200.0,100.0,250.0,750.0,1650.0,2150.0,2200.0,2725.0,1800.0,1000.0,1265.0,1590.0,15680.0
Supaul,16.1.3,Stock position of TT vaccines,2. Stocks Received,1500.0,1900.0,1500.0,2500.0,1500.0,1600.0,1600.0,800.0,1000.0,750.0,1500.0,1000.0,17150.0
Supaul,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1600.0,1750.0,1000.0,1600.0,1000.0,1550.0,1700.0,1725.0,1800.0,750.0,1175.0,700.0,16350.0
Supaul,16.1.3,Stock position of TT vaccines,5. Total Stock,100.0,250.0,750.0,1650.0,2150.0,2200.0,2100.0,1800.0,1000.0,1000.0,1590.0,1890.0,16480.0
Supaul,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,50.0,0.0,375.0,500.0,900.0,1800.0,875.0,1575.0,1200.0,950.0,1550.0,2500.0,12275.0
Supaul,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1100.0,1700.0,1500.0,1500.0,1000.0,0.0,1600.0,1000.0,1100.0,1000.0,2000.0,1000.0,14500.0
Supaul,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1150.0,1325.0,1375.0,1100.0,100.0,925.0,900.0,1375.0,1350.0,750.0,1050.0,750.0,12150.0
Supaul,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,375.0,500.0,900.0,1800.0,875.0,1575.0,1200.0,950.0,1200.0,2500.0,2750.0,14625.0
Supaul,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,90.0,0.0,150.0,450.0,200.0,600.0,581.0,481.0,800.0,350.0,1972.0,1700.0,7374.0
Supaul,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1500.0,2000.0,2000.0,2000.0,2000.0,2000.0,1600.0,1700.0,1800.0,1500.0,2000.0,400.0,20500.0
Supaul,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1590.0,1850.0,1700.0,2250.0,1600.0,1969.0,1700.0,1381.0,2250.0,1600.0,1700.0,1150.0,20740.0
Supaul,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,150.0,450.0,200.0,600.0,631.0,481.0,800.0,350.0,250.0,2272.0,950.0,7134.0
Supaul,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,600.0,0.0,740.0,1100.0,1500.0,1800.0,2100.0,2025.0,1075.0,100.0,76.0,200.0,11316.0
Supaul,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1800.0,0.0,2400.0,2400.0,1800.0,2000.0,1400.0,1250.0,1200.0,1000.0,1100.0,200.0,16550.0
Supaul,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2310.0,0.0,2040.0,2000.0,1500.0,1700.0,1475.0,2200.0,2175.0,1100.0,976.0,340.0,17816.0
Supaul,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,90.0,0.0,1100.0,1500.0,1800.0,2100.0,2025.0,1075.0,100.0,0.0,200.0,60.0,10050.0
Supaul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,2400.0,600.0,800.0,,600.0,1200.0,,300.0,,850.0,,6750.0
Supaul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,,0.0,,0.0,,0.0
Supaul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,1200.0,0.0,300.0,,600.0,600.0,,0.0,,0.0,,2700.0
Supaul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,1200.0,600.0,500.0,0.0,0.0,600.0,0.0,300.0,0.0,850.0,0.0,4050.0
Supaul,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,30000.0,12000.0,12000.0,,0.0,0.0,,0.0,0.0,0.0,,54000.0
Supaul,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,,0.0
Supaul,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,,0.0
Supaul,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,30000.0,12000.0,12000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,54000.0
Supaul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,30000.0,1000.0,500.0,,,1000.0,,600.0,,3700.0,,36800.0
Supaul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,,0.0,,0.0,,0.0,,0.0
Supaul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,12000.0,0.0,0.0,,,0.0,,0.0,,0.0,,12000.0
Supaul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,18000.0,1000.0,500.0,0.0,0.0,1000.0,0.0,600.0,0.0,3700.0,0.0,24800.0
Supaul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,500.0,300.0,200.0,,,300.0,,200.0,,2600.0,,4100.0
Supaul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,,0.0,,0.0,,0.0,,0.0
Supaul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,,,0.0,,0.0,,0.0,,0.0
Supaul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,500.0,300.0,200.0,0.0,0.0,300.0,0.0,200.0,0.0,2600.0,0.0,4100.0
Supaul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,0.0,33.0,33.0,,,33.0,,33.0,33.0,33.0,32.0,230.0
Supaul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0,0.0,0.0
Supaul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,0.0,,,0.0,,33.0,0.0,0.0,32.0,65.0
Supaul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,33.0,33.0,0.0,0.0,33.0,0.0,0.0,33.0,33.0,0.0,165.0
Supaul,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,50000.0,,,,,,,,,50000.0
Supaul,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,0.0,,,,,,,,,0.0
Supaul,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,0.0,,,,,,,,,0.0
Supaul,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,50000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50000.0
Supaul,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,100000.0,,,,,,,,,100000.0
Supaul,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,0.0,,,,,,,,,0.0
Supaul,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,0.0,,,,,,,,,0.0
Supaul,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100000.0
Supaul,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,0.0,,,,,,,,,0.0
Supaul,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,0.0,,,,,,,,,0.0
Supaul,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,0.0,,,,,,,,,0.0
Supaul,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,0.0,,,,,,,,,0.0
Supaul,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,0.0,,,,,,,,,0.0
Supaul,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,0.0,,,,,,,,,0.0
Supaul,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,0.0,,,,,,,,,0.0
Supaul,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,0.0,,,,,,,,,0.0
Supaul,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,0.0,,,,,,,,,0.0
Supaul,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,0.0,,,,,,,,,0.0
Supaul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,0.0,,,,,,,,,0.0
Supaul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,0.0,,,,,,,,,0.0
Supaul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,1000000.0,,,,,,,,,1000000.0
Supaul,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,0.0,,,,,,,,,0.0
Supaul,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,100000.0,,,,,,,,,100000.0
Supaul,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,900000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,900000.0
Supaul,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,50000.0,,,,,,,,,50000.0
Supaul,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,0.0,,,,,,,,,0.0
Supaul,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,0.0,,,,,,,,,0.0
Supaul,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,50000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50000.0
Supaul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Supaul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Supaul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Supaul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Supaul,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,6345.0,,,,,,,,,6345.0
Supaul,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,6000.0,,,,,,,,,6000.0
Supaul,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,5900.0,,,,,,,,,5900.0
Supaul,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,6445.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6445.0
Supaul,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,200000.0,,,,,,,,,200000.0
Supaul,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,0.0,,,,,,,,,0.0
Supaul,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,0.0,,,,,,,,,0.0
Supaul,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,200000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200000.0
Supaul,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3300.0,0.0,10700.0,5600.0,100.0,16900.0,9700.0,2900.0,19300.0,9500.0,3400.0,0.0,81400.0
Supaul,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,15000.0,0.0,0.0,20000.0,0.0,0.0,20000.0,0.0,0.0,0.0,14000.0,69000.0
Supaul,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3300.0,4300.0,5100.0,5500.0,3200.0,7200.0,6800.0,3600.0,9800.0,6000.0,3400.0,7900.0,66100.0
Supaul,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,10700.0,5600.0,100.0,16900.0,9700.0,2900.0,19300.0,9500.0,3500.0,0.0,6100.0,84300.0
Supaul,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,112000.0,32000.0,64000.0,20000.0,4000.0,152600.0,85400.0,38800.0,188400.0,117000.0,68800.0,8800.0,891800.0
Supaul,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,100000.0,0.0,30000.0,200000.0,0.0,0.0,200000.0,0.0,0.0,0.0,150000.0,680000.0
Supaul,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,80000.0,68000.0,44000.0,46000.0,51400.0,67200.0,46600.0,50400.0,71400.0,52400.0,60000.0,52000.0,689400.0
Supaul,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,32000.0,64000.0,20000.0,4000.0,152600.0,85400.0,38800.0,188400.0,117000.0,64600.0,8800.0,106800.0,882400.0
Supaul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,2600.0,0.0,100.0,2300.0,70.0,0.0,13000.0,6400.0,4900.0,1100.0,30470.0
Supaul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,5000.0,0.0,600.0,4000.0,0.0,800.0,13000.0,0.0,0.0,0.0,0.0,23400.0
Supaul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Supaul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,2400.0,2600.0,100.0,1800.0,2230.0,870.0,0.0,6600.0,2700.0,3800.0,900.0,24000.0
Supaul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,2600.0,0.0,500.0,2300.0,70.0,0.0,13000.0,6400.0,3700.0,1100.0,200.0,29870.0
Supaul,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Supaul,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Supaul,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Supaul,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Supaul,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Supaul,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Supaul,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Supaul,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Supaul,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Supaul,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Supaul,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Supaul,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Supaul,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Supaul,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Supaul,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Supaul,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Supaul,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Supaul,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Supaul,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Supaul,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Supaul,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Supaul,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Supaul,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Supaul,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Supaul,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Supaul,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Supaul,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Supaul,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Supaul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Supaul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Supaul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Supaul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Supaul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Supaul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Supaul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Supaul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Supaul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Supaul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Supaul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Supaul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Supaul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Supaul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Supaul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Supaul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Supaul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Supaul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Supaul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Supaul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Supaul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Supaul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Supaul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Supaul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Supaul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Supaul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Supaul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Supaul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Supaul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Supaul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Supaul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Supaul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Supaul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Supaul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Supaul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Vaishali,1.1,Total number of pregnant women Registered for ANC,TOTAL,7756.0,7036.0,5950.0,9573.0,8195.0,8643.0,6981.0,6918.0,6124.0,6905.0,7951.0,8607.0,90639.0
Vaishali,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2926.0,2932.0,2541.0,3683.0,3953.0,4761.0,3952.0,3875.0,3196.0,3684.0,4676.0,4662.0,44841.0
Vaishali,1.2,Number of Pregnant women registered under JSY,TOTAL,7756.0,7036.0,5950.0,9573.0,8195.0,8643.0,6981.0,6918.0,6124.0,6903.0,7973.0,8607.0,90659.0
Vaishali,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4244.0,4521.0,3938.0,5088.0,4917.0,5665.0,5160.0,5107.0,4711.0,4701.0,5014.0,5106.0,58172.0
Vaishali,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5454.0,5136.0,4038.0,6547.0,5473.0,5700.0,4647.0,4623.0,4054.0,4827.0,5516.0,5699.0,61714.0
Vaishali,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,7341.0,7240.0,5582.0,8291.0,7863.0,8435.0,7401.0,6390.0,6026.0,5969.0,6503.0,8177.0,85218.0
Vaishali,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4103.0,4491.0,3874.0,5041.0,4851.0,5650.0,5007.0,4937.0,4476.0,5173.0,4851.0,4863.0,57317.0
Vaishali,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,121.0,20.0,164.0,159.0,299.0,991.0,875.0,199.0,127.0,190.0,126.0,121.0,3392.0
Vaishali,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,5.0,4.0,0.0,1.0,13.0
Vaishali,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1707.0,544.0,1186.0,944.0,1384.0,1122.0,1042.0,1223.0,1112.0,1145.0,1175.0,1210.0,13794.0
Vaishali,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,2.0,6.0,1.0,3.0,3.0,1.0,5.0,4.0,1.0,1.0,2.0,33.0
Vaishali,1.8,Number of pregnancy test kits used at SC level,TOTAL,298.0,187.0,76.0,341.0,1140.0,1114.0,919.0,804.0,740.0,727.0,897.0,1006.0,8249.0
Vaishali,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,132.0,148.0,33.0,93.0,143.0,126.0,119.0,91.0,114.0,99.0,70.0,100.0,1268.0
Vaishali,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,580.0,517.0,320.0,468.0,586.0,551.0,507.0,503.0,467.0,463.0,461.0,482.0,5905.0
Vaishali,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,712.0,665.0,353.0,561.0,729.0,677.0,626.0,594.0,581.0,562.0,531.0,582.0,7173.0
Vaishali,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,331.0,301.0,285.0,452.0,612.0,575.0,516.0,510.0,511.0,470.0,481.0,430.0,5474.0
Vaishali,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,4592.0,4206.0,3715.0,5430.0,6436.0,5548.0,5583.0,4990.0,5383.0,5059.0,4524.0,3744.0,59210.0
Vaishali,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,4254.0,4153.0,3472.0,5368.0,6424.0,5513.0,5451.0,4703.0,5154.0,4828.0,4414.0,3717.0,57451.0
Vaishali,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2180.0,1276.0,1904.0,2163.0,1915.0,1479.0,2349.0,3599.0,7083.0,13244.0,9509.0,6947.0,53648.0
Vaishali,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1814.0,805.0,950.0,1977.0,1538.0,1897.0,3176.0,2454.0,5526.0,9583.0,9564.0,9378.0,48662.0
Vaishali,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Vaishali,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Vaishali,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Vaishali,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Vaishali,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,69.0,46.0,52.0,45.0,6.0,27.0,31.0,41.0,46.0,31.0,51.0,36.0,481.0
Vaishali,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vaishali,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,69.0,46.0,52.0,45.0,6.0,27.0,31.0,41.0,46.0,31.0,51.0,36.0,481.0
Vaishali,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Vaishali,4.1.1.a,Number of male live births,TOTAL,2777.0,2534.0,2151.0,3185.0,3677.0,3226.0,3180.0,2872.0,3064.0,2919.0,2633.0,2222.0,34440.0
Vaishali,4.1.1.b,Number of female live births,TOTAL,2487.0,2307.0,1958.0,2792.0,3441.0,2956.0,2998.0,2669.0,2852.0,2671.0,2389.0,1997.0,31517.0
Vaishali,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5264.0,4841.0,4109.0,5977.0,7118.0,6182.0,6178.0,5541.0,5916.0,5590.0,5022.0,4219.0,65957.0
Vaishali,4.1.2,Number of still births,TOTAL,39.0,44.0,44.0,61.0,55.0,61.0,58.0,53.0,61.0,53.0,45.0,37.0,611.0
Vaishali,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,5.0,9.0,5.0,18.0,12.0,24.0,7.0,21.0,23.0,21.0,18.0,38.0,201.0
Vaishali,4.2.1,Number of Newborns weighed at birth,TOTAL,4996.0,4826.0,3944.0,5892.0,7063.0,5998.0,6164.0,5502.0,5730.0,5537.0,4999.0,4203.0,64854.0
Vaishali,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,201.0,221.0,155.0,168.0,176.0,143.0,191.0,185.0,115.0,109.0,124.0,120.0,1908.0
Vaishali,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4923.0,4777.0,4006.0,5774.0,7054.0,5974.0,5728.0,4989.0,5691.0,5343.0,4902.0,4092.0,63253.0
Vaishali,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,15.0,2.0,13.0,0.0,2.0,18.0,0.0,0.0,0.0,1.0,1.0,52.0
Vaishali,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,19.0,18.0,0.0,28.0,38.0,19.0,19.0,20.0,22.0,0.0,2.0,1.0,186.0
Vaishali,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,76.0,51.0,62.0,47.0,16.0,35.0,42.0,55.0,61.0,52.0,56.0,42.0,595.0
Vaishali,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vaishali,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,95.0,84.0,64.0,88.0,54.0,56.0,79.0,75.0,83.0,52.0,59.0,44.0,833.0
Vaishali,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Vaishali,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,95.0,72.0,62.0,77.0,54.0,56.0,137.0,85.0,83.0,52.0,59.0,44.0,876.0
Vaishali,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,1.0,1.0,16.0,0.0,11.0,10.0,5.0,3.0,0.0,1.0,48.0
Vaishali,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,95.0,72.0,62.0,76.0,70.0,56.0,91.0,75.0,83.0,52.0,59.0,44.0,835.0
Vaishali,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Vaishali,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2782.0,2665.0,2322.0,4007.0,4451.0,4375.0,3932.0,3786.0,3926.0,3850.0,3875.0,3038.0,43009.0
Vaishali,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2528.0,1754.0,1330.0,2116.0,3013.0,3304.0,2984.0,2511.0,2128.0,2695.0,2602.0,2372.0,29337.0
Vaishali,6.3,PNC maternal complications attended,TOTAL,1.0,12.0,4.0,17.0,0.0,10.0,0.0,2.0,1.0,2.0,0.0,1.0,50.0
Vaishali,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3.0,6.0,3.0,17.0,7.0,21.0,4.0,21.0,19.0,19.0,16.0,32.0,168.0
Vaishali,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,1.0,0.0,2.0,0.0,0.0,0.0,3.0,0.0,2.0,0.0,8.0
Vaishali,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3.0,6.0,4.0,17.0,9.0,21.0,4.0,21.0,22.0,19.0,18.0,32.0,176.0
Vaishali,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,144.0,128.0,45.0,124.0,200.0,296.0,249.0,157.0,146.0,236.0,124.0,260.0,2109.0
Vaishali,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,100.0,87.0,41.0,128.0,236.0,325.0,352.0,624.0,879.0,879.0,615.0,1037.0,5303.0
Vaishali,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,244.0,215.0,86.0,252.0,436.0,621.0,601.0,781.0,1025.0,1115.0,739.0,1297.0,7412.0
Vaishali,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27.0,0.0,64.0,33.0,32.0,156.0
Vaishali,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,1.0,1.0,12.0,0.0,6.0,1.0,16.0,28.0,8.0,14.0,1.0,89.0
Vaishali,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Vaishali,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,7.0,0.0,1.0,4.0,1.0,2.0,0.0,5.0,4.0,1.0,1.0,0.0,26.0
Vaishali,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vaishali,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,8.0,1.0,2.0,16.0,1.0,8.0,1.0,21.0,32.0,9.0,17.0,1.0,117.0
Vaishali,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,4.0,4.0
Vaishali,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vaishali,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,305.0,92.0,100.0,1050.0,254.0,734.0,401.0,2221.0,2471.0,1582.0,1753.0,1230.0,12193.0
Vaishali,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,25.0,0.0,4.0,80.0,30.0,89.0,73.0,288.0,255.0,214.0,347.0,242.0,1647.0
Vaishali,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,55.0,48.0,41.0,101.0,49.0,103.0,78.0,383.0,376.0,226.0,338.0,210.0,2008.0
Vaishali,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vaishali,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,385.0,140.0,145.0,1231.0,333.0,926.0,552.0,2892.0,3102.0,2022.0,2438.0,1682.0,15848.0
Vaishali,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,192.0,0.0,10.0,,195.0,130.0,121.0,121.0,1207.0,1976.0
Vaishali,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,21.0,0.0,0.0,8.0,0.0,18.0,4.0,0.0,0.0,0.0,0.0,2.0,53.0
Vaishali,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,18.0,8.0,9.0,0.0,2.0,3.0,6.0,5.0,7.0,8.0,12.0,78.0
Vaishali,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vaishali,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,21.0,18.0,8.0,17.0,0.0,20.0,7.0,6.0,5.0,7.0,8.0,14.0,131.0
Vaishali,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,367.0,378.0,300.0,1203.0,660.0,791.0,603.0,495.0,549.0,527.0,558.0,619.0,7050.0
Vaishali,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,181.0,173.0,132.0,627.0,233.0,255.0,221.0,175.0,186.0,166.0,313.0,202.0,2864.0
Vaishali,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,19.0,18.0,5.0,57.0,23.0,43.0,19.0,19.0,55.0,26.0,46.0,20.0,350.0
Vaishali,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,98.0,12.0,66.0,119.0,95.0,87.0,97.0,116.0,117.0,138.0,133.0,358.0,1436.0
Vaishali,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vaishali,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,665.0,581.0,503.0,2006.0,1011.0,1176.0,940.0,805.0,907.0,857.0,1050.0,1199.0,11700.0
Vaishali,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,105.0,40.0,87.0,230.0,154.0,111.0,111.0,148.0,197.0,302.0,386.0,418.0,2289.0
Vaishali,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0,,,0.0
Vaishali,9.06,Number of IUCD removals,TOTAL,229.0,147.0,165.0,428.0,290.0,274.0,222.0,210.0,244.0,170.0,159.0,187.0,2725.0
Vaishali,9.07,Number of Oral Pills cycles distributed,TOTAL,2435.0,2260.0,1827.0,4135.0,5359.0,3478.0,3185.0,2709.0,3623.0,3016.0,2943.0,3209.0,38179.0
Vaishali,9.08,Number of Condom pieces distributed,TOTAL,16314.0,13977.0,14575.0,38116.0,36049.0,30338.0,25868.0,22756.0,25973.0,22505.0,22962.0,23478.0,292911.0
Vaishali,9.09,Number of Centchroman (weekly) pills given,TOTAL,135.0,65.0,51.0,312.0,177.0,279.0,1.0,0.0,94.0,111.0,62.0,248.0,1535.0
Vaishali,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,122.0,115.0,133.0,1043.0,508.0,279.0,245.0,145.0,213.0,213.0,227.0,326.0,3569.0
Vaishali,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Vaishali,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Vaishali,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Vaishali,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,6539.0,6332.0,4826.0,7453.0,8626.0,8786.0,8028.0,7746.0,8069.0,7811.0,7232.0,6226.0,87674.0
Vaishali,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,7547.0,6499.0,5021.0,7173.0,6123.0,7826.0,7837.0,8532.0,7503.0,1281.0,208.0,105.0,65655.0
Vaishali,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,7922.0,7257.0,5195.0,7370.0,6709.0,6903.0,6940.0,7829.0,8052.0,7720.0,3513.0,1683.0,77093.0
Vaishali,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,7603.0,7670.0,5307.0,7582.0,6720.0,7153.0,6469.0,6837.0,7183.0,7792.0,6349.0,5071.0,81736.0
Vaishali,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6320.0,6915.0,7605.0,20840.0
Vaishali,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3403.0,6391.0,9794.0
Vaishali,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2648.0,2650.0
Vaishali,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,5490.0,5651.0,3975.0,6370.0,7571.0,6657.0,6316.0,4221.0,5910.0,5999.0,5497.0,4598.0,68255.0
Vaishali,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7259.0,6434.0,5109.0,7092.0,6113.0,6739.0,6688.0,4710.0,7107.0,6496.0,7110.0,7245.0,78102.0
Vaishali,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7836.0,7184.0,5203.0,7326.0,6682.0,6071.0,5883.0,4181.0,6973.0,7772.0,6591.0,7792.0,79494.0
Vaishali,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,7477.0,7567.0,5326.0,7469.0,6691.0,6268.0,5478.0,3705.0,6014.0,7237.0,6404.0,7386.0,77022.0
Vaishali,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3670.0,3802.0,3198.0,5032.0,5887.0,5266.0,5193.0,4686.0,5083.0,4917.0,4386.0,3469.0,54589.0
Vaishali,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,7386.0,6485.0,4992.0,7086.0,6482.0,7656.0,7729.0,8501.0,7449.0,1222.0,482.0,111.0,65581.0
Vaishali,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7817.0,7247.0,5246.0,7375.0,6692.0,6755.0,6797.0,7788.0,7969.0,7576.0,3776.0,1718.0,76756.0
Vaishali,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,7554.0,7634.0,5336.0,7562.0,6661.0,7121.0,6366.0,6813.0,7170.0,7669.0,6394.0,5132.0,81412.0
Vaishali,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5557.0,6231.0,5134.0,8271.0,6703.0,7704.0,6511.0,7179.0,5824.0,5786.0,5567.0,5909.0,76376.0
Vaishali,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5178.0,5072.0,4227.0,6344.0,4655.0,5168.0,4396.0,4500.0,4196.0,4774.0,5295.0,5870.0,59675.0
Vaishali,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2079.0,2407.0,3753.0,5416.0,4138.0,5423.0,4047.0,4695.0,3859.0,4301.0,4763.0,5340.0,50221.0
Vaishali,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2983.0,3264.0,2646.0,4391.0,3578.0,4079.0,3362.0,3656.0,2975.0,3063.0,2948.0,3125.0,40070.0
Vaishali,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2543.0,2932.0,2464.0,3783.0,3093.0,3534.0,3111.0,3197.0,2538.0,2534.0,2445.0,2672.0,34846.0
Vaishali,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5526.0,6196.0,5110.0,8174.0,6671.0,7613.0,6473.0,6853.0,5513.0,5597.0,5393.0,5797.0,74916.0
Vaishali,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6302.0,6034.0,4659.0,7083.0,5197.0,5564.0,4882.0,4766.0,4868.0,5561.0,5966.0,6697.0,67579.0
Vaishali,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6311.0,6004.0,4656.0,7040.0,5190.0,5030.0,4420.0,2954.0,4568.0,5496.0,6013.0,6744.0,64426.0
Vaishali,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,31.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,61.0,92.0
Vaishali,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2506.0,2634.0,2035.0,2929.0,2348.0,2489.0,1989.0,1829.0,1790.0,1974.0,2023.0,2212.0,26758.0
Vaishali,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2193.0,2354.0,1700.0,2581.0,2032.0,2201.0,1666.0,1461.0,1454.0,1707.0,1801.0,2010.0,23160.0
Vaishali,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,4699.0,4988.0,3735.0,5510.0,4380.0,4690.0,3655.0,3290.0,3244.0,3681.0,3824.0,4222.0,49918.0
Vaishali,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1486.0,1759.0,1391.0,1993.0,1515.0,2032.0,2060.0,1791.0,1719.0,1910.0,1842.0,2046.0,21544.0
Vaishali,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1959.0,1940.0,1670.0,2322.0,1641.0,1849.0,2357.0,1927.0,2132.0,2303.0,1964.0,1841.0,23905.0
Vaishali,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,3349.0,3095.0,2385.0,3910.0,3093.0,3091.0,4370.0,3234.0,3168.0,5095.0,3456.0,3057.0,41303.0
Vaishali,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,10.0,2.0,0.0,2.0,6.0,0.0,0.0,1.0,2.0,34.0,13.0,70.0
Vaishali,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Vaishali,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,18.0,49.0,2.0,4.0,0.0,1.0,0.0,0.0,0.0,0.0,74.0
Vaishali,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3675.0,3695.0,3390.0,4065.0,3617.0,3498.0,3614.0,3578.0,3650.0,3595.0,3460.0,3625.0,43462.0
Vaishali,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3634.0,3677.0,2850.0,4047.0,3585.0,3486.0,3539.0,3561.0,3602.0,3575.0,3347.0,3607.0,42510.0
Vaishali,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3332.0,3425.0,2537.0,3809.0,3302.0,3270.0,3281.0,3303.0,3302.0,3334.0,3046.0,3362.0,39303.0
Vaishali,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,507.0,559.0,1671.0,3448.0,3176.0,3370.0,3091.0,3027.0,3142.0,3597.0,5054.0,5786.0,36428.0
Vaishali,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4341.0,4725.0,3923.0,6940.0,5594.0,6779.0,5784.0,6250.0,5029.0,4958.0,5062.0,5189.0,64574.0
Vaishali,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,953.0,666.0,731.0,1503.0,807.0,1185.0,1243.0,1295.0,1529.0,1408.0,1527.0,1785.0,14632.0
Vaishali,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,360.0,247.0,246.0,685.0,288.0,335.0,559.0,434.0,572.0,506.0,329.0,543.0,5104.0
Vaishali,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,0.0,16.0
Vaishali,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,899.0,552.0,714.0,988.0,774.0,968.0,677.0,1513.0,894.0,785.0,513.0,779.0,10056.0
Vaishali,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,31.0,31.0,25.0,12.0,15.0,8.0,0.0,0.0,24.0,0.0,0.0,0.0,146.0
Vaishali,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,556.0,689.0,384.0,821.0,122.0,121.0,130.0,0.0,58.0,2.0,69.0,33.0,2985.0
Vaishali,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,15.0,11.0,7.0,34.0
Vaishali,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,15.0,11.0,7.0,34.0
Vaishali,13.3,Number of School children detected with Refractive errors,TOTAL,96.0,68.0,82.0,103.0,85.0,60.0,0.0,49.0,51.0,89.0,52.0,61.0,796.0
Vaishali,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,39.0,0.0,0.0,0.0,0.0,0.0,39.0
Vaishali,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Vaishali,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Vaishali,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2541.0,2538.0,2182.0,2458.0,2446.0,2528.0,2477.0,2515.0,2466.0,2522.0,2480.0,2583.0,-1.0
Vaishali,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Vaishali,14.05,Number of RKS meetings held during the month,TOTAL,8.0,6.0,4.0,9.0,8.0,10.0,9.0,6.0,11.0,10.0,9.0,8.0,98.0
Vaishali,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,1.0,,,,,,,,,,,-1.0
Vaishali,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1424.0,2203.0,2091.0,2851.0,2956.0,2658.0,3309.0,3658.0,2854.0,3311.0,3458.0,3068.0,33841.0
Vaishali,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Vaishali,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,1.0,,-1.0
Vaishali,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1610.0,1864.0,1901.0,1934.0,2740.0,2524.0,2295.0,2408.0,2341.0,2073.0,1970.0,1833.0,25493.0
Vaishali,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2558.0,3081.0,3099.0,3327.0,3184.0,3599.0,3550.0,2934.0,3024.0,2313.0,2506.0,2608.0,35783.0
Vaishali,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1703.0,2179.0,2201.0,1938.0,2801.0,2570.0,2285.0,2354.0,2244.0,2252.0,2046.0,2088.0,26661.0
Vaishali,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,6970.0,6760.0,5869.0,9217.0,8979.0,8879.0,8296.0,9288.0,10518.0,8659.0,8368.0,7441.0,99244.0
Vaishali,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,3313.0,4043.0,4102.0,3872.0,5541.0,5094.0,4580.0,4762.0,4585.0,4325.0,4016.0,3921.0,52154.0
Vaishali,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9528.0,9841.0,8968.0,12544.0,12163.0,12478.0,11846.0,12222.0,13542.0,10972.0,10874.0,10049.0,135027.0
Vaishali,14.10.2.a,Number of death cases of Inpatient males,TOTAL,4.0,3.0,9.0,6.0,8.0,8.0,7.0,8.0,5.0,6.0,4.0,10.0,78.0
Vaishali,14.10.2.b,Number of death cases of Inpatient females,TOTAL,8.0,6.0,2.0,2.0,4.0,3.0,4.0,5.0,3.0,5.0,1.0,3.0,46.0
Vaishali,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,9.0,11.0,8.0,12.0,11.0,11.0,13.0,8.0,11.0,5.0,13.0,124.0
Vaishali,14.11,In-Patient Head Count at midnight,TOTAL,6968.0,9277.0,7933.0,10187.0,12028.0,12071.0,11115.0,10942.0,12334.0,9994.0,10146.0,8656.0,121651.0
Vaishali,14.12.1,OPD attendance (All),TOTAL,182171.0,190063.0,180673.0,235284.0,223773.0,255368.0,203561.0,203714.0,201071.0,185316.0,210226.0,202590.0,2473810.0
Vaishali,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,488.0,176.0,177.0,1252.0,390.0,1040.0,622.0,2847.0,3239.0,2027.0,2522.0,1714.0,16494.0
Vaishali,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,35.0,24.0,0.0,0.0,0.0,0.0,110.0,0.0,68.0,28.0,0.0,706.0,971.0
Vaishali,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3373.0,3618.0,5122.0,4460.0,5866.0,8211.0,7355.0,6110.0,5183.0,5601.0,4899.0,4938.0,64736.0
Vaishali,14.14.a,Number of patients given AYUSH treatment,TOTAL,19017.0,22344.0,22583.0,25090.0,29499.0,39411.0,26828.0,23046.0,16972.0,23750.0,24503.0,18938.0,291981.0
Vaishali,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4267.0,5809.0,6585.0,6450.0,6536.0,7554.0,6106.0,6879.0,6109.0,4741.0,6334.0,5076.0,72446.0
Vaishali,14.14.c,Number of Adolescents counselled,TOTAL,116.0,92.0,74.0,186.0,198.0,129.0,198.0,160.0,148.0,217.0,336.0,302.0,2156.0
Vaishali,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5102.0,4752.0,5086.0,7051.0,6785.0,7839.0,5793.0,7080.0,6923.0,6320.0,7545.0,7919.0,78195.0
Vaishali,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,77.0,69.0,47.0,81.0,58.0,65.0,60.0,47.0,41.0,52.0,42.0,43.0,682.0
Vaishali,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,213.0,250.0,258.0,318.0,396.0,318.0,448.0,395.0,382.0,291.0,283.0,247.0,3799.0
Vaishali,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,24.0,23.0,31.0,36.0,6.0,32.0,21.0,32.0,24.0,20.0,26.0,9.0,284.0
Vaishali,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,450.0,344.0,354.0,1013.0,577.0,1001.0,900.0,2154.0,2187.0,1510.0,2000.0,1254.0,13744.0
Vaishali,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,15.0,13.0,30.0,25.0,1.0,19.0,9.0,89.0,100.0,16.0,21.0,9.0,347.0
Vaishali,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2161.0,2159.0,2707.0,3183.0,3143.0,2879.0,2000.0,2164.0,1868.0,1944.0,1823.0,1413.0,27444.0
Vaishali,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,6.0,6.0,4.0,9.0,3.0,0.0,261.0,292.0,4.0,2.0,1.0,591.0
Vaishali,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2824.0,2753.0,3319.0,4514.0,4116.0,4198.0,3348.0,4713.0,4437.0,3745.0,4106.0,2914.0,44987.0
Vaishali,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,42.0,42.0,67.0,65.0,16.0,54.0,30.0,382.0,416.0,40.0,49.0,19.0,1222.0
Vaishali,15.2,Number of Widal tests conducted,Number tested,20.0,0.0,0.0,4.0,190.0,80.0,61.0,75.0,4.0,11.0,468.0,53.0,966.0
Vaishali,15.3.a,Number of VDRL tests conducted on males,Number tested,1.0,3.0,1.0,0.0,6.0,2.0,1.0,20.0,0.0,0.0,0.0,0.0,34.0
Vaishali,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,27.0,0.0,1.0,0.0,0.0,8.0,1.0,1.0,2.0,0.0,0.0,5.0,45.0
Vaishali,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,14.0,24.0,82.0,0.0,39.0,43.0,20.0,30.0,27.0,50.0,45.0,112.0,486.0
Vaishali,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,42.0,27.0,84.0,0.0,45.0,53.0,22.0,51.0,29.0,50.0,45.0,117.0,565.0
Vaishali,15.4.1,Number of blood smears examined for Malaria,TOTAL,273.0,211.0,204.0,383.0,360.0,364.0,178.0,170.0,163.0,115.0,170.0,222.0,2813.0
Vaishali,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,8.0,1.0,7.0,119.0,55.0,27.0,7.0,8.0,1.0,2.0,2.0,2.0,239.0
Vaishali,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,0.0,0.0,60.0,27.0,7.0,1.0,0.0,0.0,0.0,0.0,0.0,97.0
Vaishali,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2830.0,3580.0,5523.0,4873.0,3073.0,1923.0,0.0,1300.0,2200.0,1850.0,2450.0,3150.0,32752.0
Vaishali,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3000.0,6093.0,2000.0,2000.0,2000.0,2000.0,2500.0,6000.0,3000.0,2000.0,3000.0,2167.0,35760.0
Vaishali,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2250.0,4150.0,2650.0,3800.0,3150.0,3923.0,1200.0,5100.0,3350.0,1400.0,2300.0,2250.0,35523.0
Vaishali,16.1.1,Stock position of DPT vaccines,5. Total Stock,3580.0,5523.0,4873.0,3073.0,1923.0,0.0,1300.0,2200.0,1850.0,2450.0,3150.0,3067.0,32989.0
Vaishali,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5750.0,4000.0,9750.0
Vaishali,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7600.0,0.0,0.0,7600.0
Vaishali,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1850.0,1750.0,2025.0,5625.0
Vaishali,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5750.0,4000.0,1975.0,11725.0
Vaishali,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1712.0,2190.0,1660.0,710.0,75.0,100.0,0.0,10.0,535.0,35.0,1050.0,500.0,8577.0
Vaishali,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,3000.0,1650.0,3000.0,2900.0,1700.0,1500.0,1800.0,1850.0,2500.0,2000.0,2000.0,25900.0
Vaishali,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1522.0,3530.0,2600.0,3635.0,2875.0,1800.0,1490.0,1275.0,2350.0,1485.0,2550.0,2408.0,27520.0
Vaishali,16.1.2,Stock position of OPV vaccines,5. Total Stock,2190.0,1660.0,710.0,75.0,100.0,0.0,10.0,535.0,35.0,1050.0,500.0,92.0,6957.0
Vaishali,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,550.0,1450.0,2050.0,2375.0,475.0,875.0,3445.0,345.0,2295.0,3545.0,2545.0,2965.0,22915.0
Vaishali,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,4000.0,3000.0,2000.0,2600.0,4000.0,3000.0,5000.0,4000.0,1000.0,3000.0,2000.0,35600.0
Vaishali,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1100.0,3400.0,2675.0,3900.0,2200.0,1430.0,6100.0,3050.0,2750.0,2000.0,2580.0,3050.0,34235.0
Vaishali,16.1.3,Stock position of TT vaccines,5. Total Stock,1450.0,2050.0,2375.0,475.0,875.0,3445.0,345.0,2295.0,3545.0,2545.0,2965.0,1915.0,24280.0
Vaishali,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,705.0,210.0,1272.0,1350.0,1200.0,850.0,1300.0,1775.0,1500.0,2275.0,2070.0,14507.0
Vaishali,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,1000.0,2000.0,2000.0,1500.0,2000.0,2000.0,2000.0,1500.0,1500.0,1500.0,1500.0,19500.0
Vaishali,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,295.0,1495.0,938.0,1922.0,1650.0,2350.0,1550.0,1525.0,1775.0,725.0,1705.0,1625.0,17555.0
Vaishali,16.1.5,Stock position of BCG vaccines,5. Total Stock,705.0,210.0,1272.0,1350.0,1200.0,850.0,1300.0,1775.0,1500.0,2275.0,2070.0,1945.0,16452.0
Vaishali,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,989.0,1689.0,2089.0,1739.0,439.0,400.0,250.0,1200.0,500.0,200.0,50.0,700.0,10245.0
Vaishali,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,4000.0,3000.0,3000.0,3000.0,4100.0,3100.0,3000.0,2500.0,2500.0,4700.0,3250.0,38150.0
Vaishali,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1300.0,3600.0,3350.0,4300.0,3039.0,4250.0,2150.0,3700.0,2800.0,2650.0,4050.0,3650.0,38839.0
Vaishali,16.1.6,Stock position of Measles vaccines,5. Total Stock,1689.0,2089.0,1739.0,439.0,400.0,250.0,1200.0,500.0,200.0,50.0,700.0,300.0,9556.0
Vaishali,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,7895.0,4000.0,5400.0,1140.0,0.0,300.0,200.0,150.0,200.0,1080.0,1730.0,22095.0
Vaishali,16.1.7,Stock position of JE vaccines,2. Stocks Received,7895.0,0.0,7000.0,0.0,1000.0,3100.0,2000.0,3000.0,2900.0,3000.0,1500.0,2000.0,33395.0
Vaishali,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,3895.0,5600.0,4260.0,2140.0,2800.0,2100.0,3050.0,2850.0,2120.0,850.0,3700.0,33365.0
Vaishali,16.1.7,Stock position of JE vaccines,5. Total Stock,7895.0,4000.0,5400.0,1140.0,0.0,300.0,200.0,150.0,200.0,1080.0,1730.0,30.0,22125.0
Vaishali,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,360.0,1370.0,1049.0,2424.0,2174.0,2278.0,940.0,870.0,2670.0,980.0,2080.0,2930.0,20125.0
Vaishali,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,3000.0,4000.0,4000.0,3000.0,4500.0,4000.0,5000.0,1500.0,3000.0,3000.0,2000.0,40000.0
Vaishali,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1990.0,3321.0,2625.0,4250.0,2896.0,5838.0,4070.0,3200.0,3190.0,1900.0,2150.0,2150.0,37580.0
Vaishali,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1370.0,1049.0,2424.0,2174.0,2278.0,940.0,870.0,2670.0,980.0,2080.0,2930.0,2780.0,22545.0
Vaishali,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,8400.0,1800.0,1800.0,1800.0,1800.0,,0.0,0.0,600.0,16200.0
Vaishali,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,12000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,12600.0
Vaishali,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,3600.0,6600.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,10200.0
Vaishali,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,8400.0,1800.0,1800.0,1800.0,1800.0,1800.0,0.0,0.0,600.0,600.0,18600.0
Vaishali,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,1000.0,1000.0,200.0,108000.0,24000.0,24000.0,24000.0,24000.0,24000.0,24000.0,24000.0,12000.0,290200.0
Vaishali,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,150000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150000.0
Vaishali,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,800.0,42200.0,84000.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,0.0,139000.0
Vaishali,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,1000.0,200.0,108000.0,24000.0,24000.0,24000.0,24000.0,24000.0,24000.0,24000.0,12000.0,12000.0,301200.0
Vaishali,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1300.0,1300.0,500.0,13500.0,2500.0,2500.0,2500.0,2500.0,,0.0,0.0,1500.0,28100.0
Vaishali,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,18000.0,0.0,0.0,0.0,0.0,0.0,,0.0,1500.0,0.0,19500.0
Vaishali,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,800.0,5000.0,11000.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,16800.0
Vaishali,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1300.0,500.0,13500.0,2500.0,2500.0,2500.0,2500.0,2500.0,0.0,0.0,1500.0,1500.0,30800.0
Vaishali,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,120.0,120.0,60.0,3480.0,540.0,540.0,540.0,540.0,,0.0,0.0,240.0,6180.0
Vaishali,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,,0.0,240.0,0.0,5240.0
Vaishali,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,60.0,1580.0,2940.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,4580.0
Vaishali,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,120.0,60.0,3480.0,540.0,540.0,540.0,540.0,540.0,0.0,0.0,240.0,240.0,6840.0
Vaishali,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,,0.0,0.0,0.0,16000.0
Vaishali,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,,0.0,0.0,0.0,2000.0
Vaishali,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,2000.0
Vaishali,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,2000.0,2000.0,2000.0,2000.0,0.0,2000.0,2000.0,0.0,0.0,0.0,0.0,0.0,12000.0
Vaishali,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,200000.0,200000.0
Vaishali,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200000.0,200000.0
Vaishali,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,400000.0,400000.0,400000.0,250000.0,250000.0,250000.0,250000.0,250000.0,,0.0,0.0,0.0,2450000.0
Vaishali,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,200000.0,200000.0
Vaishali,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,190000.0,0.0,0.0,0.0,,0.0,0.0,0.0,190000.0
Vaishali,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,150000.0,0.0,0.0,0.0,0.0,250000.0,,0.0,0.0,0.0,400000.0
Vaishali,16.3.07,Stock Position of IFA Tablets,5. Total Stock,400000.0,400000.0,250000.0,250000.0,60000.0,250000.0,250000.0,0.0,0.0,0.0,0.0,200000.0,2060000.0
Vaishali,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,1800.0,1800.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,3600.0
Vaishali,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,1800.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,1800.0
Vaishali,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,1800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0
Vaishali,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,7500.0,7500.0
Vaishali,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Vaishali,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7500.0,7500.0
Vaishali,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,10000.0,10000.0,10000.0,10000.0,10000.0,40000.0,40000.0,40000.0,12000.0,12000.0,12000.0,30000.0,236000.0
Vaishali,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,30000.0,0.0,0.0,0.0,0.0,0.0,18000.0,0.0,48000.0
Vaishali,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28000.0,,0.0,0.0,1000.0,29000.0
Vaishali,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,10000.0,10000.0,10000.0,10000.0,40000.0,40000.0,40000.0,12000.0,12000.0,12000.0,30000.0,29000.0,255000.0
Vaishali,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,800.0,10800.0,600.0,5600.0,4200.0,7000.0,6400.0,5400.0,6500.0,5200.0,9500.0,8800.0,70800.0
Vaishali,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,10000.0,0.0,12000.0,10000.0,10000.0,10000.0,8000.0,10000.0,10000.0,10000.0,9000.0,10000.0,109000.0
Vaishali,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,10200.0,7000.0,11400.0,7200.0,10600.0,9000.0,8900.0,11300.0,5700.0,9700.0,10000.0,101000.0
Vaishali,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,10800.0,600.0,5600.0,4200.0,7000.0,6400.0,5400.0,6500.0,5200.0,9500.0,8800.0,8800.0,78800.0
Vaishali,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,31335.0,148895.0,64695.0,34695.0,78295.0,111695.0,103295.0,81695.0,97095.0,78695.0,107895.0,105495.0,1043780.0
Vaishali,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,117560.0,0.0,86000.0,155600.0,100000.0,100000.0,80000.0,100000.0,100000.0,100000.0,100000.0,60000.0,1099160.0
Vaishali,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,84200.0,116000.0,112000.0,66600.0,108400.0,101600.0,84600.0,118400.0,70800.0,102400.0,108600.0,1073600.0
Vaishali,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,148895.0,64695.0,34695.0,78295.0,111695.0,103295.0,81695.0,97095.0,78695.0,107895.0,105495.0,56895.0,1069340.0
Vaishali,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,17867.0,13067.0,8067.0,1667.0,23267.0,23567.0,14667.0,6367.0,2767.0,3867.0,8267.0,0.0,123437.0
Vaishali,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,3500.0,29700.0,10000.0,0.0,2000.0,5000.0,8000.0,9000.0,0.0,8000.0,75200.0
Vaishali,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vaishali,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4800.0,5000.0,9900.0,8100.0,9700.0,8900.0,10300.0,8600.0,6900.0,8267.0,8267.0,5033.0,93767.0
Vaishali,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,13067.0,8067.0,1667.0,23267.0,23567.0,14667.0,6367.0,2767.0,3867.0,4600.0,0.0,2967.0,104870.0
Vaishali,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Vaishali,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Vaishali,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Vaishali,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Vaishali,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Vaishali,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Vaishali,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Vaishali,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Vaishali,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Vaishali,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Vaishali,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Vaishali,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Vaishali,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Vaishali,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Vaishali,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Vaishali,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Vaishali,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Vaishali,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Vaishali,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Vaishali,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Vaishali,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Vaishali,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Vaishali,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Vaishali,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Vaishali,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Vaishali,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Vaishali,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Vaishali,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Vaishali,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Vaishali,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Vaishali,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Vaishali,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Vaishali,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Vaishali,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Vaishali,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Vaishali,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Vaishali,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Vaishali,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Vaishali,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Vaishali,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Vaishali,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Vaishali,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Vaishali,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Vaishali,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Vaishali,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Vaishali,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Vaishali,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Vaishali,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Vaishali,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Vaishali,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Vaishali,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Vaishali,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Vaishali,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Vaishali,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Vaishali,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Vaishali,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Vaishali,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
West Champaran,1.1,Total number of pregnant women Registered for ANC,TOTAL,8926.0,7768.0,7258.0,8198.0,7860.0,7372.0,6301.0,5922.0,4631.0,5325.0,5766.0,7535.0,82862.0
West Champaran,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4194.0,3496.0,3554.0,3927.0,3823.0,3611.0,3184.0,3013.0,2596.0,2901.0,2636.0,3377.0,40312.0
West Champaran,1.2,Number of Pregnant women registered under JSY,TOTAL,8592.0,7466.0,7074.0,8383.0,9340.0,7982.0,7126.0,6418.0,5597.0,6062.0,6728.0,8306.0,89074.0
West Champaran,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4381.0,3717.0,4166.0,4470.0,4377.0,4157.0,3928.0,3655.0,2869.0,3127.0,2664.0,3475.0,44986.0
West Champaran,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5733.0,5049.0,4856.0,5719.0,5300.0,5053.0,4103.0,3801.0,3075.0,3465.0,3957.0,4697.0,54808.0
West Champaran,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6420.0,6223.0,6104.0,6598.0,6803.0,6465.0,5819.0,5017.0,3823.0,4183.0,4535.0,6428.0,68418.0
West Champaran,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,5690.0,5215.0,5901.0,5469.0,4907.0,4260.0,4489.0,3904.0,2627.0,3514.0,2760.0,2912.0,51648.0
West Champaran,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,252.0,308.0,137.0,143.0,92.0,120.0,1432.0,24.0,54.0,49.0,107.0,90.0,2808.0
West Champaran,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,12.0,12.0,2.0,4.0,0.0,1.0,0.0,0.0,5.0,3.0,2.0,4.0,45.0
West Champaran,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,72.0,94.0,127.0,108.0,189.0,204.0,211.0,19.0,152.0,34.0,38.0,113.0,1361.0
West Champaran,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,27.0,0.0,22.0,22.0,0.0,12.0,3.0,0.0,86.0
West Champaran,1.8,Number of pregnancy test kits used at SC level,TOTAL,5.0,8.0,0.0,0.0,0.0,0.0,1.0,3.0,5.0,3.0,598.0,445.0,1068.0
West Champaran,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,145.0,80.0,108.0,68.0,46.0,21.0,68.0,33.0,47.0,25.0,43.0,20.0,704.0
West Champaran,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,934.0,773.0,712.0,805.0,1372.0,1693.0,1455.0,1545.0,1486.0,1236.0,1517.0,1541.0,15069.0
West Champaran,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1079.0,853.0,820.0,873.0,1418.0,1714.0,1523.0,1578.0,1533.0,1261.0,1560.0,1561.0,15773.0
West Champaran,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,512.0,326.0,312.0,391.0,497.0,498.0,448.0,411.0,367.0,371.0,328.0,350.0,4811.0
West Champaran,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,7.0
West Champaran,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,5339.0,4613.0,4177.0,5598.0,6772.0,6890.0,6572.0,6033.0,6466.0,5747.0,4961.0,4016.0,67184.0
West Champaran,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,4764.0,4166.0,3523.0,5380.0,5977.0,6047.0,5933.0,5525.0,5636.0,5110.0,4465.0,3934.0,60460.0
West Champaran,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1224.0,791.0,380.0,807.0,41.0,0.0,0.0,600.0,1760.0,11237.0,6419.0,6030.0,29289.0
West Champaran,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1265.0,787.0,555.0,1134.0,91.0,0.0,0.0,250.0,635.0,3138.0,2745.0,5153.0,15753.0
West Champaran,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
West Champaran,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
West Champaran,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
West Champaran,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
West Champaran,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
West Champaran,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,23.0,22.0,12.0,13.0,26.0,29.0,23.0,17.0,0.0,13.0,13.0,16.0,207.0
West Champaran,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Champaran,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,23.0,22.0,12.0,13.0,26.0,29.0,23.0,17.0,0.0,13.0,13.0,16.0,207.0
West Champaran,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
West Champaran,4.1.1.a,Number of male live births,TOTAL,3467.0,3028.0,2964.0,3646.0,4192.0,4366.0,4120.0,3803.0,4206.0,3569.0,3319.0,2885.0,43565.0
West Champaran,4.1.1.b,Number of female live births,TOTAL,3461.0,3055.0,2816.0,3498.0,3889.0,4138.0,3912.0,3710.0,3700.0,3400.0,3065.0,2636.0,41280.0
West Champaran,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,6928.0,6083.0,5780.0,7144.0,8081.0,8504.0,8032.0,7513.0,7906.0,6969.0,6384.0,5521.0,84845.0
West Champaran,4.1.2,Number of still births,TOTAL,71.0,128.0,71.0,87.0,101.0,98.0,110.0,78.0,95.0,86.0,80.0,59.0,1064.0
West Champaran,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,6.0,48.0,23.0,0.0,2.0,10.0,6.0,13.0,0.0,16.0,6.0,130.0
West Champaran,4.2.1,Number of Newborns weighed at birth,TOTAL,6012.0,5246.0,4704.0,5861.0,7291.0,7448.0,6932.0,5093.0,6537.0,6155.0,4857.0,4264.0,70400.0
West Champaran,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,81.0,129.0,133.0,201.0,145.0,137.0,128.0,510.0,477.0,99.0,62.0,141.0,2243.0
West Champaran,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,5936.0,5021.0,4744.0,6020.0,7310.0,7480.0,7187.0,6619.0,7065.0,6286.0,5616.0,4711.0,73995.0
West Champaran,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
West Champaran,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
West Champaran,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Champaran,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
West Champaran,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
West Champaran,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,29.0,0.0,29.0,27.0,19.0,22.0,22.0,8.0,12.0,3.0,5.0,176.0
West Champaran,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1051.0,788.0,1086.0,1525.0,1749.0,2094.0,1449.0,1082.0,1535.0,1057.0,1097.0,655.0,15168.0
West Champaran,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1638.0,1079.0,885.0,1519.0,1825.0,1751.0,1901.0,1401.0,1460.0,1104.0,1079.0,790.0,16432.0
West Champaran,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0,0.0,0.0,0.0,25.0
West Champaran,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,7.0
West Champaran,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,16.0,10.0,31.0
West Champaran,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,7.0,16.0,10.0,38.0
West Champaran,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,220.0,219.0,223.0,279.0,262.0,256.0,207.0,201.0,289.0,219.0,109.0,0.0,2484.0
West Champaran,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,746.0,785.0,792.0,950.0,821.0,835.0,822.0,907.0,835.0,737.0,789.0,0.0,9019.0
West Champaran,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,966.0,1004.0,1015.0,1229.0,1083.0,1091.0,1029.0,1108.0,1124.0,956.0,898.0,0.0,11503.0
West Champaran,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,23.0,18.0,0.0,0.0,23.0,31.0,18.0,0.0,1.0,0.0,0.0,114.0
West Champaran,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
West Champaran,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Champaran,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,23.0,18.0,0.0,0.0,23.0,31.0,18.0,0.0,1.0,0.0,0.0,114.0
West Champaran,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,20.0,11.0,31.0
West Champaran,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
West Champaran,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Champaran,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Champaran,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,522.0,226.0,140.0,907.0,728.0,691.0,159.0,1652.0,2381.0,1471.0,1444.0,1252.0,11573.0
West Champaran,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
West Champaran,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,40.0,10.0,4.0,48.0,94.0,27.0,12.0,122.0,587.0,436.0,749.0,389.0,2518.0
West Champaran,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Champaran,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,562.0,236.0,144.0,955.0,822.0,718.0,171.0,1774.0,2968.0,1907.0,2193.0,1641.0,14091.0
West Champaran,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,80.0,62.0,890.0,49.0,659.0,70.0,777.0,127.0,1678.0,1832.0,2312.0,5323.0,13859.0
West Champaran,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
West Champaran,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Champaran,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
West Champaran,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,235.0,166.0,144.0,426.0,279.0,205.0,161.0,141.0,103.0,129.0,110.0,145.0,2244.0
West Champaran,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,107.0,81.0,80.0,353.0,190.0,159.0,120.0,118.0,143.0,101.0,119.0,100.0,1671.0
West Champaran,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
West Champaran,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,63.0,44.0,3.0,16.0,57.0,7.0,2.0,22.0,7.0,,6.0,8.0,235.0
West Champaran,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
West Champaran,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,405.0,291.0,227.0,795.0,526.0,371.0,283.0,281.0,253.0,230.0,235.0,253.0,4150.0
West Champaran,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,20.0,32.0,68.0,88.0,86.0,41.0,14.0,34.0,14.0,55.0,30.0,50.0,532.0
West Champaran,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,2.0,7.0,1.0,1.0,,2.0,,1.0,4.0,8.0,5.0,1.0,32.0
West Champaran,9.06,Number of IUCD removals,TOTAL,138.0,124.0,138.0,146.0,187.0,107.0,76.0,72.0,160.0,63.0,124.0,60.0,1395.0
West Champaran,9.07,Number of Oral Pills cycles distributed,TOTAL,1164.0,1878.0,1717.0,2264.0,2840.0,2357.0,2629.0,2523.0,1931.0,2128.0,2039.0,2388.0,25858.0
West Champaran,9.08,Number of Condom pieces distributed,TOTAL,7344.0,5699.0,5714.0,6333.0,7244.0,7627.0,7624.0,8230.0,7016.0,6127.0,6005.0,5781.0,80744.0
West Champaran,9.09,Number of Centchroman (weekly) pills given,TOTAL,24.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0
West Champaran,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,9.0,56.0,0.0,21.0,64.0,33.0,40.0,25.0,38.0,11.0,9.0,5.0,311.0
West Champaran,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
West Champaran,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,8291.0,6974.0,6073.0,7699.0,9004.0,9632.0,8743.0,8814.0,9157.0,8478.0,7639.0,6660.0,97164.0
West Champaran,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,8184.0,7225.0,6333.0,6278.0,5837.0,7461.0,7799.0,9018.0,7039.0,2477.0,157.0,193.0,68001.0
West Champaran,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,8495.0,7461.0,6348.0,7023.0,6455.0,6482.0,6854.0,7439.0,6618.0,7184.0,3701.0,2054.0,76114.0
West Champaran,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,8140.0,7568.0,6567.0,6944.0,6728.0,6987.0,6256.0,6580.0,5651.0,7034.0,6128.0,5440.0,80023.0
West Champaran,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,4849.0,7446.0,7578.0,19878.0
West Champaran,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,11.0,2712.0,6774.0,9502.0
West Champaran,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0,2536.0,2565.0
West Champaran,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,7075.0,5906.0,5532.0,6511.0,7837.0,8398.0,7076.0,7074.0,7672.0,6719.0,5885.0,4273.0,79958.0
West Champaran,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,8116.0,6709.0,6389.0,5963.0,5481.0,7286.0,6929.0,8047.0,7300.0,5792.0,6187.0,7262.0,81461.0
West Champaran,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,8728.0,7036.0,6324.0,6518.0,5980.0,6237.0,6264.0,6651.0,6706.0,6885.0,5791.0,7561.0,80681.0
West Champaran,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,8082.0,7028.0,6598.0,6476.0,6206.0,6898.0,5653.0,5859.0,5783.0,6609.0,6122.0,6773.0,78087.0
West Champaran,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,4689.0,3368.0,3415.0,3972.0,4905.0,4665.0,4302.0,4192.0,3361.0,3357.0,3521.0,2855.0,46602.0
West Champaran,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,7725.0,7716.0,6582.0,6305.0,5996.0,7422.0,7656.0,9082.0,7250.0,2747.0,361.0,328.0,69170.0
West Champaran,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7755.0,7609.0,6531.0,7162.0,6506.0,6446.0,6982.0,7460.0,6548.0,7253.0,3708.0,2041.0,76001.0
West Champaran,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,7312.0,7350.0,6679.0,7170.0,6753.0,7017.0,6389.0,6639.0,5844.0,7019.0,6074.0,5264.0,79510.0
West Champaran,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,6130.0,6060.0,5760.0,6821.0,6981.0,7323.0,6399.0,7896.0,5748.0,5618.0,5746.0,5665.0,76147.0
West Champaran,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4179.0,3575.0,2727.0,3078.0,3098.0,3178.0,3132.0,3535.0,3236.0,3373.0,4874.0,5526.0,43511.0
West Champaran,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,4749.0,4522.0,3872.0,4866.0,4858.0,5061.0,5050.0,5522.0,4438.0,3415.0,5245.0,5432.0,57030.0
West Champaran,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3546.0,3038.0,2815.0,3387.0,3459.0,3636.0,3220.0,4070.0,2976.0,2772.0,2990.0,2881.0,38790.0
West Champaran,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3210.0,2784.0,2473.0,2917.0,3166.0,3205.0,2978.0,3469.0,2530.0,2511.0,2662.0,2516.0,34421.0
West Champaran,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6756.0,5822.0,5288.0,6304.0,6625.0,6841.0,6198.0,7539.0,5506.0,5283.0,5652.0,5397.0,73211.0
West Champaran,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6132.0,5366.0,4684.0,5126.0,4419.0,4730.0,4718.0,4771.0,4051.0,4372.0,5502.0,6251.0,60122.0
West Champaran,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5965.0,5209.0,4668.0,4875.0,4220.0,4649.0,4420.0,4434.0,4057.0,4322.0,5468.0,6082.0,58369.0
West Champaran,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2158.0,2051.0,1634.0,1931.0,1484.0,1554.0,1346.0,1500.0,1372.0,1312.0,1595.0,2059.0,19996.0
West Champaran,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1946.0,1930.0,1417.0,1758.0,1296.0,1425.0,1119.0,1285.0,1197.0,1294.0,1442.0,1736.0,17845.0
West Champaran,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,4104.0,3981.0,3051.0,3689.0,2780.0,2979.0,2465.0,2785.0,2569.0,2606.0,3037.0,3795.0,37841.0
West Champaran,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,189.0,241.0,182.0,345.0,259.0,281.0,361.0,339.0,313.0,384.0,769.0,771.0,4434.0
West Champaran,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1660.0,1632.0,1583.0,1661.0,1614.0,1585.0,1717.0,1835.0,1476.0,1889.0,2284.0,2134.0,21070.0
West Champaran,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2905.0,2764.0,2558.0,3184.0,2937.0,3060.0,3487.0,3535.0,2678.0,4121.0,4699.0,4131.0,40059.0
West Champaran,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,34.0,8.0,0.0,0.0,0.0,0.0,63.0,3.0,0.0,0.0,4.0,115.0
West Champaran,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,21.0,0.0,0.0,12.0,35.0,0.0,9.0,0.0,0.0,77.0
West Champaran,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3356.0,3272.0,3315.0,3533.0,3569.0,3492.0,3550.0,3238.0,2862.0,3096.0,3103.0,3669.0,40055.0
West Champaran,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3249.0,3229.0,3239.0,3472.0,3512.0,3457.0,3446.0,3179.0,2801.0,2977.0,2984.0,3476.0,39021.0
West Champaran,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2621.0,2636.0,2644.0,2840.0,2837.0,2857.0,2884.0,2655.0,2183.0,2486.0,2473.0,2912.0,32028.0
West Champaran,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,3183.0,2758.0,2366.0,2994.0,2548.0,2896.0,2910.0,3231.0,2855.0,2385.0,4701.0,5754.0,38581.0
West Champaran,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4393.0,4120.0,3952.0,4740.0,4961.0,5385.0,4582.0,5730.0,4417.0,3937.0,3738.0,3813.0,53768.0
West Champaran,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1030.0,923.0,849.0,1153.0,1218.0,1098.0,810.0,1100.0,1173.0,877.0,1047.0,1254.0,12532.0
West Champaran,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,29.0,47.0,18.0,53.0,44.0,51.0,48.0,73.0,327.0,53.0,48.0,33.0,824.0
West Champaran,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,7.0,8.0
West Champaran,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,284.0,402.0,259.0,221.0,279.0,449.0,444.0,881.0,1128.0,853.0,865.0,1168.0,7233.0
West Champaran,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,8.0
West Champaran,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,13.1,Number of Patients operated for cataract,TOTAL,0.0,55.0,0.0,0.0,320.0,0.0,46.0,150.0,41.0,21.0,3312.0,25.0,3970.0
West Champaran,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,55.0,0.0,0.0,320.0,0.0,46.0,150.0,41.0,21.0,3312.0,25.0,3970.0
West Champaran,13.3,Number of School children detected with Refractive errors,TOTAL,165.0,0.0,0.0,0.0,13.0,0.0,0.0,0.0,10.0,0.0,2686.0,0.0,2874.0
West Champaran,13.4,Number of children provided free glasses,TOTAL,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,15.0
West Champaran,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
West Champaran,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
West Champaran,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2713.0,2687.0,2801.0,2854.0,2971.0,2937.0,2589.0,2643.0,2100.0,2345.0,2263.0,2699.0,-1.0
West Champaran,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
West Champaran,14.05,Number of RKS meetings held during the month,TOTAL,7.0,4.0,4.0,10.0,9.0,109.0,13.0,151.0,12.0,9.0,7.0,19.0,354.0
West Champaran,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
West Champaran,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,862.0,454.0,371.0,341.0,464.0,314.0,213.0,237.0,1038.0,1499.0,945.0,1063.0,7801.0
West Champaran,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
West Champaran,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
West Champaran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,641.0,953.0,696.0,671.0,1210.0,848.0,526.0,800.0,889.0,1133.0,344.0,607.0,9318.0
West Champaran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1925.0,3044.0,2289.0,2657.0,2876.0,2576.0,1980.0,2155.0,2414.0,1994.0,2191.0,1969.0,28070.0
West Champaran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,487.0,759.0,657.0,643.0,1259.0,578.0,448.0,715.0,811.0,724.0,255.0,1256.0,8592.0
West Champaran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5995.0,5803.0,4816.0,5824.0,7065.0,6884.0,5664.0,7380.0,7604.0,6725.0,4877.0,4644.0,73281.0
West Champaran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1128.0,1712.0,1353.0,1314.0,2469.0,1426.0,974.0,1515.0,1700.0,1857.0,599.0,1863.0,17910.0
West Champaran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7920.0,8847.0,7105.0,8481.0,9941.0,9460.0,7644.0,9535.0,10018.0,8719.0,7068.0,6613.0,101351.0
West Champaran,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,43.0,30.0,31.0,35.0,40.0,40.0,40.0,42.0,39.0,31.0,32.0,403.0
West Champaran,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,20.0,34.0,29.0,31.0,28.0,32.0,19.0,27.0,18.0,32.0,22.0,292.0
West Champaran,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,63.0,64.0,60.0,66.0,68.0,72.0,59.0,69.0,57.0,63.0,54.0,695.0
West Champaran,14.11,In-Patient Head Count at midnight,TOTAL,7520.0,7947.0,6432.0,8451.0,9715.0,8170.0,7737.0,10227.0,10205.0,8168.0,6934.0,11084.0,102590.0
West Champaran,14.12.1,OPD attendance (All),TOTAL,141828.0,157905.0,147270.0,168798.0,176095.0,189298.0,143229.0,148362.0,135821.0,125086.0,122685.0,136771.0,1793148.0
West Champaran,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,297.0,2279.0,143.0,1028.0,508.0,2491.0,594.0,1141.0,1724.0,1345.0,1504.0,1031.0,14085.0
West Champaran,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,276.0,0.0,68.0,0.0,42.0,28.0,70.0,158.0,481.0,246.0,170.0,1539.0
West Champaran,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1406.0,1209.0,1801.0,1632.0,2123.0,1505.0,1674.0,2356.0,2806.0,1745.0,1206.0,1077.0,20540.0
West Champaran,14.14.a,Number of patients given AYUSH treatment,TOTAL,18078.0,25667.0,29108.0,27984.0,30392.0,25507.0,17908.0,18245.0,11611.0,13287.0,11342.0,13971.0,243100.0
West Champaran,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4903.0,4715.0,4541.0,5754.0,5231.0,5358.0,4707.0,5501.0,5217.0,5522.0,9060.0,4151.0,64660.0
West Champaran,14.14.c,Number of Adolescents counselled,TOTAL,0.0,115.0,32.0,43.0,0.0,0.0,0.0,0.0,0.0,18.0,449.0,39.0,696.0
West Champaran,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,65.0,157.0,13.0,79.0,201.0,408.0,0.0,260.0,349.0,60.0,0.0,65.0,1657.0
West Champaran,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,5.0,0.0,6.0,32.0,12.0,12.0,0.0,4.0,5.0,0.0,0.0,0.0,76.0
West Champaran,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,606.0,841.0,508.0,703.0,595.0,360.0,517.0,288.0,803.0,416.0,463.0,73.0,6173.0
West Champaran,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,7.0,4.0,5.0,3.0,2.0,2.0,0.0,3.0,4.0,5.0,2.0,42.0
West Champaran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,600.0,369.0,560.0,905.0,1015.0,435.0,938.0,889.0,1191.0,450.0,650.0,62.0,8064.0
West Champaran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,6.0,4.0,3.0,3.0,3.0,4.0,0.0,0.0,7.0,3.0,3.0,0.0,36.0
West Champaran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,941.0,748.0,695.0,637.0,702.0,880.0,1127.0,977.0,760.0,1020.0,1113.0,258.0,9858.0
West Champaran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
West Champaran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2147.0,1958.0,1763.0,2245.0,2312.0,1675.0,2582.0,2154.0,2754.0,1886.0,2226.0,393.0,24095.0
West Champaran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,13.0,11.0,7.0,8.0,6.0,6.0,2.0,0.0,10.0,7.0,8.0,3.0,81.0
West Champaran,15.2,Number of Widal tests conducted,Number tested,0.0,40.0,0.0,31.0,565.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,636.0
West Champaran,15.3.a,Number of VDRL tests conducted on males,Number tested,26.0,23.0,30.0,14.0,26.0,18.0,0.0,0.0,22.0,0.0,0.0,0.0,159.0
West Champaran,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,24.0,27.0,0.0,13.0,24.0,14.0,0.0,0.0,29.0,0.0,0.0,0.0,131.0
West Champaran,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,16.0,15.0,13.0,17.0,13.0,19.0,0.0,0.0,16.0,0.0,0.0,0.0,109.0
West Champaran,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,66.0,65.0,43.0,44.0,63.0,51.0,0.0,0.0,67.0,0.0,0.0,0.0,399.0
West Champaran,15.4.1,Number of blood smears examined for Malaria,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,429.0,275.0,3377.0,674.0,3501.0,4181.0,3305.0,2803.0,4600.0,2120.0,1150.0,3350.0,29765.0
West Champaran,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4000.0,9000.0,500.0,10000.0,3000.0,3500.0,3000.0,4000.0,1000.0,7000.0,3650.0,2000.0,50650.0
West Champaran,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
West Champaran,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4154.0,5898.0,3203.0,7173.0,2320.0,4376.0,3502.0,2203.0,3480.0,7970.0,1450.0,1700.0,47429.0
West Champaran,16.1.1,Stock position of DPT vaccines,5. Total Stock,275.0,3377.0,674.0,3501.0,4181.0,3305.0,2803.0,4600.0,2120.0,1150.0,3350.0,3650.0,32986.0
West Champaran,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,0.0,9000.0,2950.0,3750.0,15700.0
West Champaran,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,9000.0,0.0,1450.0,4400.0,14850.0
West Champaran,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,0.0,6050.0,650.0,2300.0,9000.0
West Champaran,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,2950.0,3750.0,5850.0,21550.0
West Champaran,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,470.0,0.0,1891.0,154.0,1612.0,1396.0,27.0,525.0,1025.0,300.0,200.0,425.0,8025.0
West Champaran,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2500.0,5500.0,500.0,5500.0,2000.0,1000.0,3000.0,2500.0,1800.0,3500.0,1500.0,5500.0,34800.0
West Champaran,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
West Champaran,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2970.0,3609.0,2237.0,4042.0,2216.0,2369.0,2502.0,2000.0,2525.0,3600.0,1275.0,3750.0,33095.0
West Champaran,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,1891.0,154.0,1612.0,1396.0,27.0,525.0,1025.0,300.0,200.0,425.0,2175.0,9730.0
West Champaran,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,120.0,566.0,2700.0,558.0,3941.0,5448.0,3277.0,2358.0,4225.0,2520.0,3970.0,4900.0,34583.0
West Champaran,16.1.3,Stock position of TT vaccines,2. Stocks Received,3500.0,7000.0,500.0,9000.0,5000.0,3000.0,4000.0,5000.0,3000.0,7500.0,2000.0,3000.0,52500.0
West Champaran,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
West Champaran,16.1.3,Stock position of TT vaccines,4. Stock Distributed,3054.0,4866.0,2612.0,5617.0,3493.0,5171.0,4919.0,3133.0,4705.0,6050.0,1070.0,2975.0,47665.0
West Champaran,16.1.3,Stock position of TT vaccines,5. Total Stock,566.0,2700.0,588.0,3941.0,5448.0,3277.0,2358.0,4225.0,2520.0,3970.0,4900.0,4925.0,39418.0
West Champaran,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,759.0,390.0,3315.0,1414.0,4030.0,2255.0,1130.0,1324.0,2380.0,2215.0,1150.0,1550.0,21912.0
West Champaran,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2500.0,5500.0,0.0,6000.0,800.0,1900.0,2000.0,3000.0,2000.0,3500.0,1500.0,4000.0,32700.0
West Champaran,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
West Champaran,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2869.0,2575.0,1901.0,3384.0,2575.0,3025.0,1806.0,1944.0,2165.0,4565.0,1100.0,2700.0,30609.0
West Champaran,16.1.5,Stock position of BCG vaccines,5. Total Stock,390.0,3315.0,1414.0,4030.0,2255.0,1130.0,1324.0,2380.0,2215.0,1150.0,1550.0,2850.0,24003.0
West Champaran,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1428.0,577.0,480.0,32.0,2249.0,361.0,86.0,234.0,1900.0,1440.0,1650.0,1000.0,11437.0
West Champaran,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,4400.0,300.0,8000.0,600.0,4300.0,4500.0,4000.0,3200.0,7000.0,1500.0,5500.0,46300.0
West Champaran,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
West Champaran,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3851.0,4497.0,748.0,5783.0,2488.0,4575.0,4352.0,2334.0,3660.0,6790.0,2150.0,3650.0,44878.0
West Champaran,16.1.6,Stock position of Measles vaccines,5. Total Stock,577.0,480.0,32.0,2249.0,361.0,86.0,234.0,1900.0,1440.0,1650.0,1000.0,2850.0,12859.0
West Champaran,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,595.0,141.0,2206.0,670.0,1050.0,13.0,991.0,689.0,1030.0,200.0,550.0,1150.0,9285.0
West Champaran,16.1.7,Stock position of JE vaccines,2. Stocks Received,2500.0,5000.0,2000.0,5500.0,0.0,6250.0,3000.0,3500.0,2500.0,5800.0,3000.0,6000.0,45050.0
West Champaran,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
West Champaran,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2954.0,2935.0,3536.0,5120.0,1037.0,5272.0,3302.0,3159.0,3330.0,5450.0,2400.0,4250.0,42745.0
West Champaran,16.1.7,Stock position of JE vaccines,5. Total Stock,141.0,2206.0,670.0,1050.0,13.0,991.0,689.0,1030.0,200.0,550.0,1150.0,2900.0,11590.0
West Champaran,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,106.0,176.0,2679.0,700.0,2410.0,2277.0,1943.0,3334.0,3200.0,2680.0,2130.0,3600.0,25235.0
West Champaran,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,4000.0,7000.0,500.0,6500.0,2500.0,3500.0,4000.0,3000.0,3000.0,4500.0,2600.0,3000.0,44100.0
West Champaran,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
West Champaran,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3930.0,4497.0,2479.0,4790.0,2633.0,3834.0,2609.0,3134.0,3520.0,5050.0,1130.0,1800.0,39406.0
West Champaran,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,176.0,2679.0,700.0,2410.0,2277.0,1943.0,3334.0,3200.0,2680.0,2130.0,3600.0,4800.0,29929.0
West Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
West Champaran,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
West Champaran,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
West Champaran,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
West Champaran,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
West Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,13200.0,13800.0,2000.0,13500.0,3100.0,13100.0,10900.0,0.0,13900.0,13600.0,10000.0,500.0,107600.0
West Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000.0,,20000.0,0.0,20000.0,10000.0,0.0,20000.0,12000.0,10000.0,,10000.0,114000.0
West Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,0.0,,,,,,0.0
West Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,11400.0,11800.0,8500.0,10400.0,10000.0,12200.0,10900.0,6100.0,12300.0,13600.0,9500.0,9600.0,126300.0
West Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,13800.0,2000.0,13500.0,3100.0,13100.0,10900.0,0.0,13900.0,13600.0,10000.0,500.0,900.0,95300.0
West Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,156231.0,118231.0,20231.0,98231.0,6000.0,77800.0,206600.0,110000.0,110000.0,141600.0,205800.0,76800.0,1327524.0
West Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000.0,,200000.0,0.0,200000.0,250000.0,0.0,100000.0,160000.0,200000.0,,80000.0,1290000.0
West Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,0.0,,,,,,0.0
West Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,138000.0,98000.0,122000.0,92231.0,128200.0,121200.0,96600.0,100000.0,128400.0,135800.0,129000.0,122200.0,1411631.0
West Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,118231.0,20231.0,98231.0,6000.0,77800.0,206600.0,110000.0,110000.0,141600.0,205800.0,76800.0,34600.0,1205893.0
West Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5287.0,3087.0,987.0,2987.0,887.0,770.0,1870.0,1270.0,7500.0,10700.0,14000.0,8500.0,57845.0
West Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2800.0,,5000.0,0.0,3500.0,6000.0,0.0,8000.0,9000.0,10000.0,,6000.0,50300.0
West Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,0.0,,,,,,0.0
West Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,5000.0,2100.0,3000.0,2100.0,3617.0,4900.0,600.0,1770.0,5800.0,6700.0,5500.0,9300.0,50387.0
West Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3087.0,987.0,2987.0,887.0,770.0,1870.0,1270.0,7500.0,10700.0,14000.0,8500.0,5200.0,57758.0
West Champaran,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
West Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
West Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
West Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
West Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
West Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
West Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
West Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
West Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
West Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
West Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
West Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
West Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
West Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
West Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
West Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
West Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
West Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
West Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
West Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
West Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
West Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
West Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
West Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
West Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
West Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
West Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
West Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
West Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
West Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
West Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
West Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
West Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
West Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
West Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
West Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
West Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
West Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
West Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
West Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
West Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
West Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
West Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
West Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
West Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
